tests
true
done tests

Interaction	O	O
of	O	O
sickle	cell_type	O
erythrocytes	cell_type	cell_type
with	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
the	O	O
presence	O	O
of	O	O
endothelial	O	O
cell	O	O
conditioned	O	O
medium	O	O
induces	O	O
oxidant	O	O
stress	O	O
leading	O	O
to	O	O
transendothelial	O	O
migration	O	O
of	O	O
monocytes	cell_type	cell_type
.	O	O
The	O	O
abnormal	O	O
adherence	O	O
of	O	O
sickle	cell_type	O
red	cell_type	O
blood	cell_type	O
cells	cell_type	O
(	O	O
SS	cell_type	protein
RBC	cell_type	protein
)	O	O
to	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
has	O	O
been	O	O
thought	O	O
to	O	O
contribute	O	O
to	O	O
vascular	O	protein
occlusion	O	O
,	O	O
a	O	O
major	O	O
cause	O	O
of	O	O
morbidity	O	O
in	O	O
sickle	O	O
cell	O	O
disease	O	O
(	O	O
SCD	O	O
).	O	O
We	O	O
determined	O	O
whether	O	O
the	O	O
interaction	O	O
of	O	O
SS	cell_type	O
RBC	cell_type	O
with	O	O
cultured	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
induced	O	O
cellular	O	O
oxidant	O	O
stress	O	O
that	O	O
would	O	O
culminate	O	O
in	O	O
expression	O	O
of	O	O
cell	protein	O
adhesion	protein	protein
molecules	protein	protein
(	O	O
CAMs	protein	protein
)	O	O
involved	O	O
in	O	O
the	O	O
adhesion	O	O
and	O	O
diapedesis	O	O
of	O	O
monocytes	cell_type	cell_type
and	O	O
the	O	O
adherence	O	O
of	O	O
SS	cell_type	O
reticulocytes	cell_type	O
.	O	O
We	O	O
showed	O	O
that	O	O
the	O	O
interaction	O	O
of	O	O
SS	cell_type	O
RBC	cell_type	O
at	O	O
2%	O	O
concentration	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
multimers	O	O
of	O	O
von	protein	O
Willebrand	protein	protein
factor	protein	protein
(	O	O
vWf	protein	protein
),	O	O
derived	O	O
from	O	O
endothelial	O	O
cell-derived	O	O
conditioned	O	O
medium	O	O
(	O	O
E-CM	O	O
)	O	O
with	O	O
cultured	cell_line	cell_line
human	cell_line	cell_line
umbilical	cell_line	cell_line
vein	cell_line	cell_line
endothelial	cell_line	cell_line
cells	cell_line	cell_line
(	O	O
HUVEC	cell_line	cell_line
),	O	O
resulted	O	O
in	O	O
a	O	O
fivefold	O	O
increased	O	O
formation	O	O
of	O	O
thiobarbituric	O	O
acid-reactive	O	O
substances	O	O
(	O	O
TBARS	O	protein
)	O	O
and	O	O
activation	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
NF-kB	protein	protein
,	O	O
both	O	O
indicators	O	O
of	O	O
cellular	O	O
oxidant	O	O
stress	O	O
.	O	O
Normal	cell_type	O
RBC	cell_type	O
show	O	O
none	O	O
of	O	O
these	O	O
phenomena.	O	O
The	O	O
oxidant	O	O
stress-induced	O	O
signaling	O	O
resulted	O	O
in	O	O
an	O	O
increased	O	O
surface	O	O
expression	O	O
of	O	O
a	O	O
subset	O	O
of	O	O
CAMs	protein	protein
,	O	O
ICAM-1	protein	protein
,	O	O
E-selectin	protein	protein
,	O	O
and	O	O
VCAM-1	protein	protein
in	O	O
HUVEC	cell_line	cell_type
.	O	O
The	O	O
addition	O	O
of	O	O
oxygen	protein	O
radical	protein	O
scavenger	protein	O
enzymes	protein	O
(	O	O
catalase	protein	protein
,	O	O
superoxide	protein	O
dismutase	protein	O
)	O	O
and	O	O
antioxidant	O	O
(	O	O
probucol	O	O
)	O	O
inhibited	O	O
these	O	O
events.	O	O
Additionally,	O	O
preincubation	O	O
of	O	O
HUVEC	cell_line	cell_line
with	O	O
a	O	O
synthetic	O	O
peptide	O	O
Arg-Gly-Asp	O	O
(	O	O
RGD	O	O
)	O	O
that	O	O
prevents	O	O
vWf	protein	protein
-mediated	O	O
adhesion	O	O
of	O	O
SS	cell_type	O
RBC	cell_type	O
reduced	O	O
the	O	O
surface	O	O
expression	O	O
of	O	O
VCAM-1	protein	protein
and	O	O
NF-kB	protein	protein
activation	O	O
.	O	O
Furthermore,	O	O
SS	cell_type	O
RBC	cell_type	protein
-induced	O	O
oxidant	O	O
stress	O	O
resulted	O	O
in	O	O
a	O	O
twofold	O	O
increase	O	O
in	O	O
the	O	O
transendothelial	O	O
migration	O	O
of	O	O
both	O	O
monocyte-like	cell_line	cell_type
HL-60	cell_line	cell_type
cells	cell_line	cell_type
and	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
monocytes	cell_type	cell_type
,	O	O
and	O	O
approximately	O	O
a	O	O
sixfold	O	O
increase	O	O
in	O	O
platelet-endothelial	protein	cell_type
cell	protein	cell_type
adhesion	protein	O
molecule-1	protein	protein
(	O	O
PECAM-1	protein	protein
)	O	O
phosphorylation	O	O
,	O	O
each	O	O
of	O	O
which	O	O
was	O	O
blocked	O	O
by	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
inhibitor	O	O
and	O	O
antioxidants	O	O
.	O	O
These	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
adherence/contact	O	O
of	O	O
SS	cell_type	O
RBC	cell_type	O
to	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
large	O	O
vessel	O	O
can	O	O
generate	O	O
enhanced	O	O
oxidant	O	O
stress	O	O
leading	O	O
to	O	O
increased	O	O
adhesion	O	O
and	O	O
diapedesis	O	O
of	O	O
monocytes	cell_type	cell_type
,	O	O
as	O	O
well	O	O
as	O	O
heightened	O	O
adherence	O	O
of	O	O
SS	cell_type	O
reticulocytes	cell_type	O
,	O	O
indicating	O	O
that	O	O
injury/activation	O	O
of	O	O
endothelium	O	O
can	O	O
contribute	O	O
to	O	O
vaso-occlusion	O	O
in	O	O
SCD	O	O
.	O	O

Signal	O	O
transduction	O	O
abnormalities	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
from	O	O
patients	O	O
with	O	O
advanced	O	O
renal	O	O
carcinoma	O	O
:	O	O
clinical	O	O
relevance	O	O
and	O	O
effects	O	O
of	O	O
cytokine	protein	protein
therapy	O	O
.	O	O
Studies	O	O
have	O	O
demonstrated	O	O
abnormalities	O	O
of	O	O
the	O	O
CD3/T-cell	protein	protein
antigen	protein	protein
receptor	protein	protein
(	O	O
TCR	protein	protein
)	O	O
and	O	O
pathways	O	O
of	O	O
signal	O	O
transduction	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
from	O	O
animals	O	O
and	O	O
patients	O	O
with	O	O
advanced	O	O
malignancy	O	O
.	O	O
Diminished	O	O
expression	O	O
of	O	O
TCRzeta	protein	protein
and	O	O
p56(lck)	protein	protein
that	O	O
are	O	O
associated	O	O
with	O	O
the	O	O
TCR	protein	protein
and	O	O
reduced	O	O
nuclear	O	O
localization	O	O
of	O	O
RelA	protein	protein
containing	protein	protein
nuclear	protein	protein
factor	protein	protein
kappaB	protein	protein
(	protein	O
NFkappaB	protein	protein
)	protein	protein
complexes	protein	protein
have	O	O
been	O	O
noted.	O	O
These	O	O
defects	O	O
have	O	O
been	O	O
described	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
from	O	O
patients	O	O
with	O	O
malignant	O	O
melanoma	O	O
,	O	O
renal	O	O
cell	O	O
carcinoma	O	O
(	O	O
RCC	O	O
),	O	O
ovarian	O	O
cancer	O	O
,	O	O
and	O	O
colorectal	O	O
cancer	O	O
.	O	O
Preliminary	O	O
observations	O	O
also	O	O
indicate	O	O
possible	O	O
correlation	O	O
with	O	O
clinical	O	O
variables	O	O
such	O	O
as	O	O
stage	O	O
in	O	O
selected	O	O
instances.	O	O
To	O	O
further	O	O
characterize	O	O
altered	O	O
expression	O	O
of	O	O
TCRzeta	protein	protein
,	O	O
p56(lck)	protein	protein
,	O	O
and	O	O
impaired	O	O
activation	O	O
of	O	O
NFkappaB	protein	protein
,	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
were	O	O
obtained	O	O
from	O	O
65	O	O
patients	O	O
with	O	O
RCC	O	O
,	O	O
the	O	O
majority	O	O
of	O	O
whom	O	O
were	O	O
receiving	O	O
combination	O	O
cytokine	protein	O
therapy	O	O
[	O	O
interleukin	protein	protein
(IL)-2	protein	protein
,	O	O
IFN	protein	protein
alpha	protein	protein
-containing	O	O
regimens	O	O
]	O	O
and	O	O
37	O	O
control	O	O
individuals.	O	O
In	O	O
29	O	O
of	O	O
these	O	O
patients	O	O
,	O	O
levels	O	O
of	O	O
TCRzeta	protein	protein
and	O	O
p56(lck)	protein	protein
were	O	O
determined	O	O
by	O	O
Western	O	O
blots	O	O
of	O	O
T-cell	O	O
lysates	O	O
and	O	O
semiquantitated	O	O
using	O	O
densitometry	O	O
.	O	O
Relative	O	O
levels	O	O
were	O	O
then	O	O
correlated	O	O
with	O	O
a	O	O
series	O	O
of	O	O
clinical	O	O
variables	O	O
including	O	O
response	O	O
to	O	O
therapy	O	O
,	O	O
performance	O	O
status	O	O
,	O	O
survival,	O	O
disease	O	O
sites	O	O
,	O	O
age,	O	O
and	O	O
others.	O	O
In	O	O
another	O	O
group	O	O
of	O	O
28	O	O
patients	O	O
(three	O	O
individuals	O	O
from	O	O
the	O	O
first	O	O
group),	O	O
the	O	O
frequency	O	O
of	O	O
abnormal	O	O
NFkappaB	protein	protein
activation	O	O
was	O	O
studied	O	O
using	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assays	O	O
after	O	O
activation	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
phorbol	O	O
myristate	O	O
acetate/ionomycin	O	O
or	O	O
anti-CD3	protein	protein
monoclonal	protein	protein
antibody	protein	protein
.	O	O
Changes	O	O
in	O	O
these	O	O
signaling	O	protein
molecules	O	protein
during	O	O
cytokine	protein	O
treatment	O	O
were	O	O
also	O	O
investigated.	O	O
TCRzeta	protein	protein
and	O	O
p56(lck)	protein	protein
were	O	O
detected	O	O
in	O	O
the	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
27	O	O
of	O	O
29	O	O
patients	O	O
,	O	O
and	O	O
overall,	O	O
reduced	O	O
levels	O	O
were	O	O
noted	O	O
visually	O	O
in	O	O
12	O	O
of	O	O
29	O	O
(41%)	O	O
and	O	O
13	O	O
of	O	O
29	O	O
(45%)	O	O
individuals,	O	O
respectively.	O	O
When	O	O
levels	O	O
were	O	O
semiquantitated	O	O
using	O	O
densitometry	O	O
,	O	O
significant	O	O
decreases	O	O
of	O	O
TCRzeta	protein	protein
(P	O	O
=	O	O
0.029)	O	O
and	O	O
p56(lck)	protein	protein
(P	O	O
=	O	O
0.029)	O	O
but	O	O
not	O	O
CD3epsilon	protein	protein
(P	O	O
=	O	O
0.131),	O	O
compared	O	O
with	O	O
control	O	O
levels,	O	O
were	O	O
found.	O	O
In	O	O
patients	O	O
treated	O	O
with	O	O
IL-2/	O	protein
IFN	protein	protein
alpha	protein	protein
-based	O	O
therapy	O	O
,	O	O
relative	O	O
levels	O	O
of	O	O
TCRzeta	protein	protein
increased	O	O
significantly	O	O
(P	O	O
=	O	O
0.002)	O	O
on	O	O
day	O	O
15	O	O
of	O	O
cycle	O	O
one	O	O
compared	O	O
with	O	O
the	O	O
baseline.	O	O
Correlations	O	O
of	O	O
TCRzeta	protein	protein
or	O	O
p56(lck)	protein	O
levels	O	O
with	O	O
response	O	O
or	O	O
disease	O	O
variables,	O	O
except	O	O
for	O	O
lower	O	O
TCRzeta	protein	O
levels	O	O
(P	O	O
&lt;	O	O
0.001)	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
bone	O	O
metastases	O	O
,	O	O
were	O	O
not	O	O
found.	O	O
Abnormal	O	O
NFkappaB	protein	protein
activation	O	O
after	O	O
stimulation	O	O
with	O	O
phorbol	O	O
myristate	O	O
acetate/ionomycin	O	O
and/or	O	O
anti-CD3	protein	protein
monoclonal	protein	protein
antibody	protein	protein
was	O	O
found	O	O
in	O	O
59%	O	O
of	O	O
patients	O	O
(17	O	O
of	O	O
28)	O	O
and	O	O
was	O	O
not	O	O
accounted	O	O
for	O	O
by	O	O
the	O	O
advanced	O	O
age	O	O
of	O	O
the	O	O
study	O	O
cohort.	O	O
Activation	O	O
of	O	O
NFkappaB	protein	protein
in	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
was	O	O
inducible	O	O
during	O	O
cytokine	protein	O
therapy	O	O
in	O	O
four	O	O
of	O	O
six	O	O
individuals	O	O
who	O	O
displayed	O	O
impaired	O	O
NFkappaB	protein	protein
activity	O	O
prior	O	O
to	O	O
therapy.	O	O
Moreover,	O	O
impaired	O	O
activation	O	O
of	O	O
NFkappaB	protein	protein
does	O	O
not	O	O
appear	O	O
linked	O	O
to	O	O
a	O	O
reduction	O	O
of	O	O
TCRzeta	protein	protein
expression	O	O
,	O	O
because	O	O
in	O	O
five	O	O
patients	O	O
,	O	O
normal	O	O
TCRzeta	protein	O
levels	O	O
were	O	O
present	O	O
although	O	O
kappaB	protein	O
binding	O	O
was	O	O
not	O	O
inducible.	O	O
In	O	O
the	O	O
majority	O	O
of	O	O
patients	O	O
with	O	O
advanced	O	O
RCC	O	O
,	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
express	O	O
TCRzeta	protein	protein
and	O	O
p56(lck)	protein	protein
,	O	O
and	O	O
in	O	O
a	O	O
subset,	O	O
reduced	O	O
levels	O	O
of	O	O
these	O	O
TCRzeta	protein	protein
associated	protein	protein
molecules	protein	protein
are	O	O
seen	O	O
that	O	O
may	O	O
increase	O	O
during	O	O
cytokine	protein	protein
-based	O	O
therapy	O	O
.	O	O
Abnormal	O	O
activation	O	O
of	O	O
NFkappaB	protein	protein
is	O	O
also	O	O
present	O	O
in	O	O
&gt;50%	O	O
of	O	O
patients	O	O
and	O	O
may	O	O
also	O	O
revert	O	O
to	O	O
normal	O	O
during	O	O
IL-2/	O	protein
IFN	protein	protein
alpha	protein	protein
-based	O	O
treatment	O	O
.	O	O
This	O	O
alteration	O	O
in	O	O
NFkappaB	protein	protein
activation	O	O
occurred	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
normal	O	O
expression	O	O
of	O	O
TCRzeta	DNA	protein
-associated	DNA	O
signaling	DNA	O
elements	DNA	O
.	O	O
The	O	O
clinical	O	O
significance	O	O
of	O	O
these	O	O
findings	O	O
remains	O	O
unclear.	O	O

Identification	O	O
of	O	O
transcription	protein	protein
factors	protein	protein
expressed	O	O
during	O	O
ATRA-induced	O	O
neutrophil	O	O
differentiation	O	O
of	O	O
HL60	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
A	O	O
recent	O	O
clinical	O	O
therapeutic	O	O
initiative	O	O
has	O	O
been	O	O
the	O	O
use	O	O
of	O	O
chemical	O	O
agents	O	O
which	O	O
induce	O	O
the	O	O
leukaemic	cell_type	O
cells	cell_type	O
to	O	O
overcome	O	O
their	O	O
block	O	O
in	O	O
differentiation.	O	O
In	O	O
order	O	O
to	O	O
understand	O	O
this	O	O
block	O	O
the	O	O
cascade	O	O
of	O	O
molecular	O	O
events	O	O
needs	O	O
to	O	O
be	O	O
characterized.	O	O
Haemopoietic	O	O
differentiation	O	O
is	O	O
ultimately	O	O
controlled	O	O
at	O	O
the	O	O
level	O	O
of	O	O
gene	O	O
transcription	O	O
which	O	O
is	O	O
mediated	O	O
by	O	O
an	O	O
array	O	O
of	O	O
transcription	protein	protein
factors	protein	protein
.	O	O
Many	O	O
transcription	protein	protein
factors	protein	protein
contain	O	O
similar	O	O
structural	protein	O
protein	protein	O
sequences	protein	O
,	O	O
and	O	O
we	O	O
have	O	O
used	O	O
an	O	O
RT-PCR	O	O
-based	O	O
approach	O	O
to	O	O
isolate	O	O
sequences,	O	O
from	O	O
transcription	protein	O
factor	protein	O
gene	O	O
families	O	O
which	O	O
share	O	O
similar	O	O
domains.	O	O
Degenerate	O	O
primers	O	O
corresponding	O	O
to	O	O
the	O	O
TFIIIA	DNA	protein
zinc-finger	DNA	protein
consensus	DNA	protein
amino	DNA	protein
acid	DNA	protein
sequences	DNA	protein
and	O	O
to	O	O
the	O	O
POU-homeodomain	protein	protein
and	O	O
POU-specific	protein	protein
domain	protein	protein
were	O	O
used	O	O
to	O	O
amplify	O	O
genes	O	O
on	O	O
the	O	O
basis	O	O
that	O	O
they	O	O
contained	O	O
similarities	O	O
in	O	O
structural	O	O
motifs	O	O
shared	O	O
within	O	O
these	O	O
families	O	O
of	O	O
transcription	protein	protein
factors	protein	protein
.	O	O
A	O	O
serum-independent	cell_line	cell_line
HL60	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
was	O	O
induced	O	O
towards	O	O
the	O	O
neutrophil	O	cell_type
lineage	O	cell_type
by	O	O
treatment	O	O
with	O	O
all-trans	O	O
retinoic	O	O
acid	O	O
(	O	O
ATRA	O	O
)	O	O
for	O	O
24	O	O
h.	O	O
CD38+	cell_type	cell_type
cells	cell_type	cell_type
committed	O	O
towards	O	O
this	O	O
lineage	O	O
were	O	O
enriched	O	O
and	O	O
a	O	O
population	O	O
of	O	O
these	O	O
cells	O	O
treated	O	O
with	O	O
dihydroxyvitamin	O	O
D3	O	O
to	O	O
induce	O	O
neutrophil	O	cell_type
maturation.	O	O
RNA	O	O
extracted	O	O
from	O	O
uninduced,	O	O
ATRA	cell_line	O
-induced	cell_line	O
CD38+	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
and	O	O
vitamin	cell_line	O
D3	cell_line	O
treated	cell_line	O
maturing	cell_line	O
cell	cell_line	O
cultures	cell_line	O
were	O	O
amplified	O	O
using	O	O
the	O	O
degenerate	O	O
primers	O	O
.	O	O
PCR	DNA	O
fragments	DNA	O
were	O	O
cloned,	O	O
sequenced,	O	O
clustered	O	O
into	O	O
homologous	O	O
groups,	O	O
and	O	O
the	O	O
group	O	O
sequences	O	O
searched	O	O
on	O	O
the	O	O
GenBank	O	O
database	O	O
.	O	O
The	O	O
Oct	O	protein
1	O	protein
transcription	protein	protein
factor	protein	protein
,	O	O
and	O	O
a	O	O
very	O	O
close	O	O
homologue,	O	O
KIAA0144	DNA	O
,	O	O
was	O	O
identified	O	O
using	O	O
the	O	O
POU	O	protein
family	O	protein
primers	O	protein
.	O	O
The	O	O
zinc-finger	O	O
primers	O	O
identified	O	O
three	O	O
zinc-finger	O	DNA
genes	O	DNA
.	O	O
The	O	O
pattern	O	O
of	O	O
gene	O	O
expression	O	O
was	O	O
suggested	O	O
from	O	O
the	O	O
number	O	O
of	O	O
clones	O	O
in	O	O
each	O	O
group	O	O
at	O	O
neutrophil	O	cell_type
commitment	O	O
and	O	O
maturation.	O	O
The	O	O
differential	O	O
expression	O	O
of	O	O
the	O	O
genes	O	O
in	O	O
the	O	O
zinc	O	protein
finger	O	protein
and	O	O
POU	O	protein
families	O	protein
will	O	O
lead	O	O
to	O	O
a	O	O
better	O	O
understanding	O	O
of	O	O
the	O	O
cascade	O	O
of	O	O
gene	O	O
expression	O	O
which	O	O
occurs	O	O
following	O	O
ATRA	O	O
-induced	O	O
differentiation	O	O
.	O	O

GATA-3	protein	protein
-dependent	O	O
enhancer	O	O
activity	O	O
in	O	O
IL-4	DNA	DNA
gene	DNA	DNA
regulation	O	O
.	O	O
Previously,	O	O
we	O	O
analyzed	O	O
the	O	O
proximal	DNA	DNA
IL-4	DNA	DNA
promoter	DNA	DNA
in	O	O
directing	O	O
Th2-specific	O	O
activity	O	O
.	O	O
An	O	O
800-base	DNA	DNA
pair	DNA	DNA
proximal	DNA	DNA
promoter	DNA	DNA
conferred	O	O
some	O	O
Th2-selective	O	O
expression	O	O
in	O	O
transgenic	O	O
mice	O	O
.	O	O
However,	O	O
this	O	O
region	O	O
directed	O	O
extremely	O	O
low	O	O
reporter	O	O
mRNA	O	O
levels	O	O
relative	O	O
to	O	O
endogenous	O	O
IL-4	RNA	RNA
mRNA	RNA	RNA
,	O	O
suggesting	O	O
that	O	O
full	O	O
gene	O	O
activity	O	O
requires	O	O
additional	O	O
enhancer	DNA	DNA
elements	DNA	DNA
.	O	O
Here,	O	O
we	O	O
analyzed	O	O
large	O	O
genomic	DNA	O
IL-4	DNA	protein
regions	DNA	O
for	O	O
enhancer	O	O
activity	O	O
and	O	O
interaction	O	O
with	O	O
transcription	protein	protein
factors	protein	protein
.	O	O
The	O	O
proximal	O	DNA
IL-4	DNA	DNA
promoter	DNA	DNA
is	O	O
only	O	O
moderately	O	O
augmented	O	O
by	O	O
GATA-3	protein	protein
,	O	O
but	O	O
certain	O	O
genomic	DNA	DNA
regions	DNA	DNA
significantly	O	O
enhanced	O	O
GATA-3	DNA	DNA
promoter	DNA	DNA
transactivation	O	O
.	O	O
Some	O	O
enhancing	O	O
regions	O	O
contained	O	O
consensus,	O	O
GATA	DNA	DNA
sites	DNA	DNA
that	O	O
bound	O	O
Th2-specific	protein	protein
complexes	protein	protein
.	O	O
However,	O	O
retroviral	O	O
transduction	O	O
of	O	O
GATA-3	protein	protein
into	O	O
developing	cell_type	O
T	cell_type	cell_type
cells	cell_type	cell_type
induced	O	O
IL-5	protein	protein
to	O	O
full	O	O
Th2	protein	O
levels	O	O
,	O	O
but	O	O
only	O	O
partially	O	O
restored	O	O
IL-4	protein	protein
production	O	O
.	O	O
Thus,	O	O
we	O	O
propose	O	O
that	O	O
GATA-3	protein	protein
is	O	O
permissive,	O	O
but	O	O
not	O	O
sufficient,	O	O
for	O	O
full	O	O
IL-4	protein	protein
enhancement	O	O
and	O	O
may	O	O
act	O	O
through	O	O
GATA	DNA	DNA
elements	DNA	DNA
surrounding	O	O
the	O	O
IL-13	DNA	protein
/	DNA	O
IL-4	DNA	DNA
gene	DNA	DNA
locus	DNA	DNA
.	O	O

Position	O	O
effect	O	O
of	O	O
translocations	O	O
involving	O	O
the	O	O
inactive	DNA	O
X	DNA	DNA
chromosome	DNA	DNA
:	O	O
physical	O	O
linkage	O	O
to	O	O
XIC/XIST	DNA	O
does	O	O
not	O	O
lead	O	O
to	O	O
long-range	O	O
de	O	O
novo	O	O
inactivation	O	O
in	O	O
human	cell_type	cell_type
differentiated	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Given	O	O
the	O	O
reported	O	O
long-range	O	O
cis-inactivating	O	O
effect	O	O
of	O	O
the	O	O
XIST	DNA	DNA
gene	DNA	DNA
in	O	O
early	O	O
embryonic	O	O
development	O	O
and	O	O
the	O	O
lack	O	O
of	O	O
requirement	O	O
of	O	O
X-chromosome-specific	DNA	DNA
elements	DNA	DNA
for	O	O
propagating	O	O
the	O	O
inactive	O	O
state,	O	O
there	O	O
exists	O	O
the	O	O
possibility	O	O
of	O	O
cis	O	O
inactivation	O	O
of	O	O
autosomal	O	O
material	O	O
after	O	O
de	O	O
novo	O	O
translocation	O	O
to	O	O
an	O	O
inactive	DNA	O
X	DNA	DNA
chromosome	DNA	DNA
(	O	DNA
Xi	DNA	DNA
)	O	O
in	O	O
differentiated	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
We	O	O
have	O	O
analyzed	O	O
de	O	O
novo	O	O
radiation-induced	O	O
translocations	O	O
between	O	O
the	O	O
Xi	DNA	O
and	O	O
autosomes	DNA	O
to	O	O
study	O	O
the	O	O
maintenance	O	O
and	O	O
spreading	O	O
of	O	O
X-chromosome	DNA	DNA
inactivation	O	O
(	O	O
X	O	DNA
inactivation	O	O
)	O	O
in	O	O
relation	O	O
to	O	O
the	O	O
position	O	O
of	O	O
the	O	O
X-inactivation	O	O
center	O	O
(XIC)/XIST	DNA	O
in	O	O
differentiated	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Autosome/	O	O
Xi	DNA	O
translocations	O	O
were	O	O
detected	O	O
by	O	O
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
).	O	O
The	O	O
activation	O	O
status	O	O
of	O	O
the	O	O
chromosomes	DNA	DNA
involved	O	O
in	O	O
the	O	O
translocation	O	O
was	O	O
determined	O	O
by	O	O
simultaneous	O	O
immunocytogenetic	O	O
studies	O	O
using	O	O
antibodies	protein	protein
against	O	O
either	O	O
BrdU	protein	O
incorporated	O	O
at	O	O
late	O	O
S	O	O
phase	O	O
or	O	O
acetylated	protein	O
histone	protein	protein
H4	protein	protein
.	O	O
The	O	O
position	O	O
of	O	O
XIC/XIST	DNA	protein
in	O	O
the	O	O
reciprocal	O	O
products	O	O
of	O	O
the	O	O
translocation	O	O
was	O	O
determined	O	O
by	O	O
XIST-specific	O	O
FISH	O	O
and	O	O
computer	O	O
enhancement	O	O
.	O	O
In	O	O
other	O	O
experiments,	O	O
the	O	O
Xq13	DNA	DNA
region	DNA	DNA
carrying	O	O
XIC/XIST	DNA	DNA
was	O	O
localized	O	O
by	O	O
computer	O	O
enhancement	O	O
of	O	O
the	O	O
DAPI	O	protein
banding	O	protein
pattern	O	O
.	O	O
Our	O	O
study	O	O
in	O	O
differentiated	cell_type	cell_type
cells	cell_type	cell_type
provides	O	O
a	O	O
visual	O	O
demonstration	O	O
that	O	O
physical	O	O
separation	O	O
from	O	O
XIC/XIST	DNA	O
does	O	O
not	O	O
result	O	O
in	O	O
reactivation	O	O
of	O	O
inactive	DNA	O
X-chromosome	DNA	DNA
material	O	O
and	O	O
that	O	O
X	O	O
inactivation	O	O
is	O	O
not	O	O
spread	O	O
to	O	O
the	O	O
translocated	DNA	O
autosomes	DNA	O
irrespective	O	O
of	O	O
the	O	O
position	O	O
of	O	O
XIC/XIST	DNA	protein
.	O	O
This	O	O
observation	O	O
suggests	O	O
that	O	O
physical	O	O
linkage	O	O
to	O	O
XIC/XIST	DNA	O
does	O	O
not	O	O
lead	O	O
to	O	O
de	O	O
novo	O	O
inactivation	O	O
of	O	O
autosomal	O	O
material	O	O
.	O	O

Interleukin	O	protein
-4	O	protein
and	O	O
-13	O	O
induce	O	O
upregulation	O	O
of	O	O
the	O	O
murine	O	DNA
macrophage	O	DNA
12/15-lipoxygenase	protein	DNA
activity	protein	O
:	O	O
evidence	O	O
for	O	O
the	O	O
involvement	O	O
of	O	O
transcription	protein	protein
factor	protein	protein
STAT6	protein	protein
.	O	O
When	O	O
human	O	cell_type
monocytes	cell_type	cell_type
or	O	O
alveolar	cell_type	cell_type
macrophages	cell_type	cell_type
are	O	O
cultured	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
interleukin	protein	protein
(IL)-4	protein	protein
or	O	O
IL-13	protein	protein
,	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
reticulocyte-type	protein	O
15-lipoxygenase	protein	protein
is	O	O
induced.	O	O
In	O	O
mice	O	O
a	O	O
15-lipoxygenase	protein	protein
is	O	O
not	O	O
expressed,	O	O
but	O	O
a	O	O
leukocyte-type	protein	O
12-lipoxygenase	protein	protein
is	O	O
present	O	O
in	O	O
peritoneal	cell_type	cell_type
macrophages	cell_type	cell_type
.	O	O
To	O	O
investigate	O	O
whether	O	O
both	O	O
lipoxygenase	protein	protein
isoforms	protein	protein
exhibit	O	O
a	O	O
similar	O	O
regulatory	O	O
response	O	O
toward	O	O
cytokine	protein	protein
stimulation	O	O
,	O	O
we	O	O
studied	O	O
the	O	O
regulation	O	O
of	O	O
the	O	O
leukocyte-type	protein	O
12-lipoxygenase	protein	O
of	O	O
murine	cell_type	cell_type
peritoneal	cell_type	cell_type
macrophages	cell_type	cell_type
by	O	O
interleukins	protein	protein
and	O	O
found	O	O
that	O	O
the	O	O
activity	O	O
of	O	O
this	O	O
enzyme	protein	O
is	O	O
upregulated	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
when	O	O
the	O	O
cells	O	O
were	O	O
cultured	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
IL-4	protein	protein
or	O	O
IL-13	protein	protein
but	O	O
not	O	O
by	O	O
IL-10	protein	protein
.	O	O
When	O	O
peripheral	O	cell_type
murine	O	cell_type
monocytes	cell_type	cell_type
that	O	O
do	O	O
not	O	O
express	O	O
the	O	O
lipoxygenase	protein	protein
were	O	O
treated	O	O
with	O	O
IL-4	protein	protein
expression	O	O
of	O	O
12/15-lipoxygenase	RNA	RNA
mRNA	RNA	RNA
was	O	O
induced,	O	O
suggesting	O	O
pretranslational	O	O
control	O	O
mechanisms	O	O
.	O	O
In	O	O
contrast,	O	O
no	O	O
upregulation	O	O
of	O	O
the	O	O
lipoxygenase	protein	protein
activity	O	O
was	O	O
observed	O	O
when	O	O
the	O	O
macrophages	cell_type	cell_type
were	O	O
prepared	O	O
from	O	O
homozygous	O	O
STAT6	protein	protein
-deficient	O	O
mice	O	O
.	O	O
Peritoneal	cell_type	O
macrophages	cell_type	cell_type
of	O	O
transgenic	O	O
mice	O	O
that	O	O
systemically	O	O
overexpress	O	O
IL-4	protein	protein
exhibited	O	O
a	O	O
threefold	O	O
to	O	O
fourfold	O	O
higher	O	O
12-lipoxygenase	protein	O
activity	O	O
than	O	O
cells	O	O
prepared	O	O
from	O	O
control	O	O
animals.	O	O
A	O	O
similar	O	O
upregulation	O	O
of	O	O
12-lipoxygenase	protein	protein
activity	O	O
was	O	O
detected	O	O
in	O	O
heart,	O	O
spleen,	O	O
and	O	O
lung	O	O
of	O	O
the	O	O
transgenic	O	O
animals.	O	O
Moreover,	O	O
a	O	O
strong	O	O
induction	O	O
of	O	O
the	O	O
enzyme	O	O
was	O	O
observed	O	O
in	O	O
red	cell_type	cell_type
cells	cell_type	cell_type
during	O	O
experimental	O	O
anemia	O	O
in	O	O
mice	O	O
.	O	O
The	O	O
data	O	O
presented	O	O
here	O	O
indicate	O	O
that	O	O
(1)	O	O
the	O	O
12-lipoxygenase	protein	protein
activity	O	O
of	O	O
murine	O	cell_type
macrophages	O	cell_type
is	O	O
upregulated	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
by	O	O
IL-4	protein	protein
and/or	O	O
IL-13	protein	protein
,	O	O
(2)	O	O
this	O	O
upregulation	O	O
requires	O	O
expression	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
STAT6	protein	protein
,	O	O
and	O	O
(3)	O	O
the	O	O
constitutive	O	O
expression	O	O
of	O	O
the	O	O
enzyme	O	O
appears	O	O
to	O	O
be	O	O
STAT6	protein	protein
independent	O	O
.	O	O
The	O	O
cytokine	protein	protein
-dependent	O	O
upregulation	O	O
of	O	O
the	O	O
murine	protein	DNA
macrophage	protein	DNA
12-lipoxygenase	protein	DNA
and	O	O
its	O	O
induction	O	O
during	O	O
experimental	O	O
anemia	O	O
suggests	O	O
its	O	O
close	O	O
relatedness	O	O
with	O	O
the	O	O
human	protein	O
reticulocyte-type	protein	O
15-lipoxygenase	protein	protein
despite	O	O
their	O	O
differences	O	O
in	O	O
the	O	O
positional	O	O
specificity	O	O
of	O	O
arachidonic	O	O
acid	O	O
oxygenation	O	O
.	O	O

Interferon-gamma-induced	protein	protein
factor	protein	protein
binding	O	O
to	O	O
the	O	O
interleukin-4	DNA	DNA
-responsive	DNA	DNA
element	DNA	DNA
of	O	O
CD23b	DNA	DNA
promoter	DNA	DNA
in	O	O
human	cell_type	cell_type
tonsillar	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
:	O	O
role	O	O
in	O	O
transient	O	O
up-regulation	O	O
of	O	O
the	O	O
interleukin-4	RNA	protein
-induced	RNA	O
CD23b	RNA	RNA
mRNA	RNA	RNA
.	O	O
Stimulation	O	O
of	O	O
human	cell_type	cell_type
tonsillar	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
interleukin-4	protein	protein
(	O	O
IL-4	protein	protein
)	O	O
and	O	O
interferon-gamma	protein	protein
(	O	O
IFN-gamma	protein	protein
)	O	O
rapidly	O	O
induced	O	O
the	O	O
activation	O	O
of	O	O
distinct	O	O
nuclear	protein	protein
factors	protein	protein
with	O	O
different	O	O
mobilities,	O	O
both	O	O
of	O	O
which	O	O
bind	O	O
the	O	O
IL-4	DNA	DNA
response	DNA	DNA
element	DNA	DNA
(	O	O
IL-4RE	DNA	DNA
)	O	O
of	O	O
CD23b	DNA	DNA
promoter	DNA	DNA
as	O	O
examined	O	O
by	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assays	O	O
(	O	O
EMSA	O	O
).	O	O
Co-treatment	O	O
of	O	O
IL-4	protein	protein
and	O	O
IFN-gamma	protein	protein
induced,	O	O
in	O	O
addition	O	O
to	O	O
the	O	O
two	O	O
distinct	O	O
complexes,	O	O
a	O	O
new	O	O
complex	O	O
with	O	O
an	O	O
intermediate	O	O
mobility	O	O
.	O	O
The	O	O
IL-4	protein	protein
-induced	protein	O
complex	protein	O
reacted	O	O
with	O	O
anti-	protein	O
STAT	protein	protein
(signal	protein	protein
transducers	protein	protein
and	protein	O
activators	protein	O
of	protein	O
transcription)	protein	O
6	protein	O
,	O	O
resulting	O	O
in	O	O
a	O	O
supershift	O	O
whereas	O	O
the	O	O
formation	O	O
of	O	O
the	O	O
IFN-gamma	protein	protein
-induced	protein	protein
complex	protein	protein
was	O	O
inhibited	O	O
by	O	O
anti-	protein	O
STAT	protein	protein
1	protein	protein
.	O	O
The	O	O
intermediate	O	protein
complex	O	protein
appeared	O	O
to	O	O
react	O	O
with	O	O
both	O	O
anti-	protein	O
STAT	protein	protein
6	protein	protein
and	O	O
anti-	protein	O
STAT	protein	protein
1	protein	protein
.	O	O
Although	O	O
IFN-gamma	protein	protein
alone	O	O
did	O	O
not	O	O
induce	O	O
CD23	RNA	RNA
mRNA	RNA	RNA
transcription	O	O
,	O	O
Northern	O	O
blot	O	O
analysis	O	O
revealed	O	O
a	O	O
transient	O	O
up-regulation	O	O
of	O	O
the	O	O
IL-4	RNA	protein
-induced	RNA	O
CD23	RNA	RNA
mRNA	RNA	RNA
by	O	O
IFN-gamma	protein	protein
within	O	O
2	O	O
h	O	O
of	O	O
IFN-gamma	protein	protein
treatment	O	O
in	O	O
these	O	O
tonsillar	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
The	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
IL-4RE	DNA	DNA
of	O	O
the	O	O
IL-4	DNA	DNA
-inducible	DNA	DNA
gene	DNA	DNA
can	O	O
accommodate	O	O
both	O	O
IL-4-	O	O
and	O	O
IFN-gamma-	O	protein
activated	O	protein
factors	O	protein
,	O	O
such	O	O
as	O	O
STAT	protein	protein
6	protein	protein
and	O	O
STAT	protein	protein
1	protein	protein
,	O	O
either	O	O
in	O	O
homodimeric	O	O
or	O	O
heterodimeric	O	O
forms	O	O
and	O	O
the	O	O
binding	O	O
of	O	O
these	O	O
different	O	O
proteins	O	O
to	O	O
the	O	O
respective	O	O
promoter	O	O
may	O	O
play	O	O
a	O	O
potential	O	O
regulatory	O	O
role	O	O
in	O	O
the	O	O
IL-4	protein	DNA
-inducible	O	DNA
gene	O	DNA
expression	O	O
.	O	O

A	O	O
p56lck	protein	protein
-independent	O	O
pathway	O	O
of	O	O
CD2	protein	protein
signaling	O	O
involves	O	O
Jun	protein	protein
kinase	protein	protein
.	O	O
The	O	O
p56	protein	protein
Src	protein	protein
family	protein	protein
non-receptor	protein	protein
tyrosine	protein	protein
kinase	protein	protein
has	O	O
been	O	O
shown	O	O
to	O	O
be	O	O
critical	O	O
for	O	O
T	O	O
lymphocyte	O	O
differentiation	O	O
and	O	O
activation	O	O
.	O	O
Hence	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
p56	protein	protein
,	O	O
T	protein	protein
cell	protein	protein
receptor	protein	protein
triggered	O	O
activation	O	O
does	O	O
not	O	O
occur.	O	O
We	O	O
now	O	O
provide	O	O
evidence	O	O
for	O	O
a	O	O
CD2	protein	protein
-based	O	O
signaling	O	O
pathway	O	O
which,	O	O
in	O	O
contrast	O	O
to	O	O
that	O	O
of	O	O
the	O	O
T	protein	protein
cell	protein	protein
receptor	protein	protein
,	O	O
is	O	O
independent	O	O
of	O	O
p56	protein	protein
.	O	O
CD2	protein	protein
-mediated	O	O
interleukin-2	protein	protein
production	O	O
occurs	O	O
via	O	O
activation	O	O
of	O	O
Jun	protein	protein
kinase	protein	protein
in	O	O
cell	O	cell_line
lines	O	cell_line
lacking	O	O
p56	protein	protein
.	O	O
Jun	protein	protein
kinase	protein	protein
then	O	O
facilitates	O	O
the	O	O
binding	O	O
of	O	O
c-Jun/c-Fos	protein	protein
heterodimers	protein	protein
to	O	O
the	O	O
AP-1	DNA	DNA
consensus	DNA	DNA
site	DNA	DNA
and	O	O
the	O	O
subsequent	O	O
transcriptional	O	O
activity	O	O
of	O	O
the	O	O
interleukin-2	DNA	DNA
promoter	DNA	DNA
.	O	O
These	O	O
data	O	O
elucidate	O	O
differences	O	O
between	O	O
TCR	protein	protein
and	O	O
CD2	protein	protein
signaling	O	O
pathways	O	O
in	O	O
the	O	O
same	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Activation	O	O
of	O	O
E2F	protein	protein
-mediated	O	O
transcription	O	O
by	O	O
human	protein	O
T-cell	protein	O
leukemia	protein	O
virus	protein	O
type	protein	O
I	protein	protein
Tax	protein	protein
protein	protein	protein
in	O	O
a	O	O
p16(INK4A)-negative	cell_line	cell_line
T-cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
The	O	O
human	O	O
T-cell	O	O
leukemia	O	O
virus	O	O
type	O	O
I	O	O
(	O	O
HTLV-I	O	O
)	O	O
is	O	O
a	O	O
causative	O	O
agent	O	O
of	O	O
adult	O	O
T-cell	O	O
leukemia	O	O
.	O	O
Although	O	O
the	O	O
exact	O	O
mechanism	O	O
by	O	O
which	O	O
HTLV-I	O	O
contributes	O	O
to	O	O
leukemogenesis	O	O
is	O	O
still	O	O
unclear,	O	O
the	O	O
Tax	protein	protein
protein	protein	protein
is	O	O
thought	O	O
to	O	O
play	O	O
a	O	O
major	O	O
role	O	O
in	O	O
this	O	O
process.	O	O
This	O	O
40-kDa	O	O
polypeptide	O	O
is	O	O
able	O	O
to	O	O
interact	O	O
with	O	O
the	O	O
tumor	protein	O
suppressor	protein	O
p16(INK4A)	protein	protein
.	O	O
Consequently,	O	O
Tax	protein	protein
can	O	O
activate	O	O
the	O	O
signaling	O	O
pathway	O	O
that	O	O
lead	O	O
to	O	O
the	O	O
release	O	O
of	O	O
E2F	protein	protein
that	O	O
in	O	O
turn	O	O
induces	O	O
expression	O	O
of	O	O
factors	O	O
required	O	O
for	O	O
cell	O	O
cycle	O	O
progression	O	O
.	O	O
In	O	O
this	O	O
paper,	O	O
we	O	O
demonstrate	O	O
that	O	O
Tax	protein	protein
can	O	O
also	O	O
activate	O	O
E2F	protein	protein
-mediated	O	O
transcription	O	O
independently	O	O
of	O	O
p16(INK4A)	protein	protein
.	O	O
Indeed,	O	O
when	O	O
Tax	protein	protein
is	O	O
coexpressed	O	O
with	O	O
the	O	O
E2F-1	protein	protein
transcription	protein	protein
factor	protein	protein
in	O	O
CEM	cell_line	cell_line
T-cells	cell_line	cell_line
,	O	O
which	O	O
lack	O	O
expression	O	O
of	O	O
p16(INK4A)	protein	protein
,	O	O
it	O	O
strongly	O	O
potentiates	O	O
the	O	O
E2F	protein	protein
-dependent	O	O
activation	O	O
of	O	O
a	O	O
reporter	O	O
construct	O	O
driven	O	O
by	O	O
a	O	O
promoter	O	DNA
containing	O	O
E2F	DNA	DNA
binding	DNA	DNA
sites	DNA	DNA
.	O	O
This	O	O
stimulation	O	O
is	O	O
abrogated	O	O
by	O	O
mutations	O	O
affecting	O	O
the	O	O
E2F	DNA	DNA
-binding	DNA	DNA
sites	DNA	DNA
.	O	O
In	O	O
addition,	O	O
Tax	protein	protein
also	O	O
stimulates	O	O
the	O	O
transcription	O	O
of	O	O
the	O	O
E2F-1	DNA	DNA
gene	DNA	DNA
itself.	O	O
Using	O	O
Tax	protein	protein
mutants	O	protein
that	O	O
fail	O	O
to	O	O
activate	O	O
either	O	O
ATF	protein	O
-or	O	O
NF-kappaB-dependent	DNA	O
promoters	DNA	O
and	O	O
different	O	O
5'	DNA	DNA
truncation	DNA	DNA
mutants	DNA	DNA
of	O	O
the	O	O
E2F-1	DNA	DNA
promoter	DNA	DNA
,	O	O
we	O	O
show	O	O
that	O	O
the	O	O
Tax	protein	protein
-dependent	O	O
transcriptional	O	O
control	O	O
of	O	O
the	O	O
E2F1	DNA	DNA
gene	DNA	DNA
involves,	O	O
at	O	O
least	O	O
in	O	O
part,	O	O
the	O	O
ATF	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
located	O	O
in	O	O
the	O	O
E2F-1	DNA	DNA
promoter	DNA	DNA
.	O	O

Inducible	O	O
nitric	O	O
oxide	O	O
:	O	O
an	O	O
autoregulatory	O	O
feedback	O	O
inhibitor	O	O
of	O	O
vascular	O	O
inflammation	O	O
.	O	O
Inducible	O	O
nitric	O	O
oxide	O	O
(	O	O
iNO	O	O
)	O	O
is	O	O
produced	O	O
at	O	O
sites	O	O
of	O	O
vascular	O	O
inflammation	O	O
by	O	O
resident	O	O
and	O	O
nonresident	O	O
vascular	cell_type	O
wall	cell_type	O
cells	cell_type	O
,	O	O
but	O	O
its	O	O
role	O	O
in	O	O
the	O	O
inflammatory	O	O
process	O	O
is	O	O
not	O	O
known.	O	O
In	O	O
this	O	O
study,	O	O
we	O	O
show	O	O
that	O	O
a	O	O
novel	O	O
function	O	O
of	O	O
iNO	O	O
is	O	O
to	O	O
terminate	O	O
inflammatory	O	O
processes	O	O
.	O	O
We	O	O
find	O	O
that	O	O
iNO	O	O
produced	O	O
by	O	O
murine	cell_line	cell_type
macrophage-like	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
RAW264.7	cell_line	protein
,	O	O
can	O	O
inhibit	O	O
cytokine	protein	protein
-induced	O	O
endothelial	O	O
cell	O	O
activation	O	O
in	O	O
a	O	O
separated	O	O
and	O	O
mixed	O	O
endothelial-RAW264.7	cell_line	protein
coculture	cell_line	O
system	cell_line	O
.	O	O
Both	O	O
iNO	O	O
production	O	O
and	O	O
endothelial	O	O
VCAM-1	protein	protein
expression	O	O
were	O	O
induced	O	O
simultaneously	O	O
with	O	O
bacterial	O	O
LPS	O	O
and	O	O
murine-specific	protein	O
IFN-gamma	protein	protein
.	O	O
Inhibition	O	O
of	O	O
iNO	protein	protein
synthase	protein	protein
(	O	O
iNOS	protein	protein
)	O	O
activity	O	O
with	O	O
N	O	protein
omega-monomethyl-L-arginine	O	protein
in	O	O
endothelial-RAW264.7	cell_line	protein
cocultures	cell_line	O
,	O	O
stimulated	O	O
with	O	O
murine-specific	protein	O
IFN-gamma	protein	protein
and	O	O
LPS	O	O
,	O	O
decreased	O	O
iNO	O	O
production	O	O
by	O	O
86%,	O	O
augmented	O	O
VCAM-1	protein	protein
and	O	O
iNOS	protein	protein
expression	O	O
in	O	O
endothelial	O	O
and	O	O
RAW264.7	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
respectively,	O	O
and	O	O
increased	O	O
monocyte	O	O
adhesion	O	O
to	O	O
the	O	O
endothelial	O	protein
cell	O	protein
surface	O	protein
.	O	O
Transient	O	O
transfection	O	O
studies	O	O
using	O	O
various	O	O
VCAM-1	DNA	DNA
promoter	DNA	DNA
constructs	O	DNA
demonstrated	O	O
that	O	O
inhibitory	O	O
effects	O	O
of	O	O
iNO	O	O
on	O	O
VCAM-1	protein	protein
gene	O	O
transcription	O	O
were	O	O
mediated,	O	O
in	O	O
part,	O	O
by	O	O
inhibitory	O	O
effects	O	O
of	O	O
iNO	O	O
on	O	O
kappa	DNA	O
B	DNA	O
cis-acting	DNA	DNA
elements	DNA	DNA
.	O	O
Immunofluorescence	O	O
studies	O	O
using	O	O
an	O	O
Ab	O	O
to	O	O
the	O	O
RelA	protein	protein
(	protein	O
p65	protein	protein
)	protein	O
subunit	protein	O
of	O	O
nuclear	O	protein
factor-kappa	protein	protein
B	protein	protein
revealed	O	O
that	O	O
iNO	O	O
inhibited	O	O
the	O	O
activation	O	O
of	O	O
nuclear	protein	protein
factor-kappa	protein	protein
B	protein	protein
.	O	O
These	O	O
studies	O	O
indicate	O	O
that	O	O
iNO	O	O
attenuates	O	O
iNOS	protein	protein
expression	O	O
in	O	O
macrophages	cell_type	cell_type
and	O	O
inhibits	O	O
monocyte	O	O
adhesion	O	O
to	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
and	O	O
suggest	O	O
that	O	O
endogenously	O	O
derived	O	O
iNO	O	O
may	O	O
be	O	O
an	O	O
important	O	O
autoregulatory	O	O
inhibitor	O	O
of	O	O
vascular	O	O
inflammation	O	O

Detection	O	O
of	O	O
oestrogen	protein	protein
receptor	protein	protein
variants	protein	protein
in	O	O
endometrium	O	O
,	O	O
myometrium	O	O
,	O	O
leiomyoma	O	O
and	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
:	O	O
comparison	O	O
to	O	O
variants	O	O
present	O	O
in	O	O
breast	O	O
cancer	O	O
.	O	O
Oestradiol	O	O
has	O	O
mitogenic	O	O
and	O	O
regulatory	O	O
effects	O	O
on	O	O
various	O	O
organs	O	O
and	O	O
cells,	O	O
mediated	O	O
mainly	O	O
by	O	O
its	O	O
nuclear	protein	protein
receptor	protein	protein
(	O	O
ER	protein	protein
).	O	O
The	O	O
presence	O	O
of	O	O
aberrant	O	O
ER	protein	protein
forms	O	O
in	O	O
Oestrogen-dependent	O	O
tumours	O	O
has	O	O
been	O	O
discussed	O	O
in	O	O
correlation	O	O
with	O	O
tumour	O	O
progression	O	O
.	O	O
ER	protein	protein
variants,	O	O
generated	O	O
by	O	O
alternative	O	O
splicing,	O	O
have	O	O
been	O	O
detected	O	O
in	O	O
human	O	O
breast	O	O
cancer	O	O
,	O	O
but	O	O
also	O	O
in	O	O
normal	O	O
mammary	O	O
glands	O	O
,	O	O
therefore	O	O
their	O	O
role	O	O
in	O	O
tumorigenesis	O	O
has	O	O
been	O	O
questioned.	O	O
We	O	O
have	O	O
investigated,	O	O
by	O	O
the	O	O
use	O	O
of	O	O
the	O	O
reverse	O	O
transcription	O	O
polymerase	O	O
chain	O	O
reaction	O	O
amplification	O	O
technique	O	O
,	O	O
the	O	O
possible	O	O
existence	O	O
of	O	O
ER	protein	protein
variants	O	protein
in	O	O
other	O	O
normal	O	O
oestrogen	O	O
target	O	O
organs	O	O
and	O	O
cells,	O	O
such	O	O
as	O	O
uterus	O	O
(	O	O
myometrium	O	O
and	O	O
endometrium	O	O
),	O	O
in	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
in	O	O
a	O	O
benign	O	O
uterus	O	O
tumour	O	O
(	O	O
leiomyoma	O	O
).	O	O
We	O	O
have	O	O
detected	O	O
variant	O	O
ER	protein	protein
in	O	O
these	O	O
samples	O	O
and	O	O
have	O	O
compared	O	O
the	O	O
variant	O	O
profile	O	O
to	O	O
that	O	O
observed	O	O
in	O	O
breast	O	O
cancer	O	O
.	O	O
All	O	O
tissues	O	O
and	O	O
cells	O	O
studied	O	O
expressed	O	O
both	O	O
wild-type	protein	O
ER	protein	protein
and	O	O
variant	protein	O
species	protein	O
.	O	O
Variant	O	O
forms	O	O
encompassed	O	O
ER	protein	protein
with	O	O
deletions	O	O
of	O	O
exons	O	DNA
2	O	DNA
,	O	O
5	O	O
and	O	O
7	O	O
.	O	O
Variants	O	O
with	O	O
exon	DNA	RNA
5	DNA	RNA
deleted	O	RNA
were	O	O
detected	O	O
only	O	O
in	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
in	O	O
breast	O	O
cancer	O	O
.	O	O
Variants	O	O
with	O	O
exons	O	DNA
2	O	DNA
and	O	O
7	O	O
deleted	O	O
were	O	O
present	O	O
in	O	O
all	O	O
specimens	O	O
tested.	O	O
These	O	O
results	O	O
corroborate	O	O
previous	O	O
findings	O	O
that	O	O
the	O	O
presence	O	O
of	O	O
ER	protein	protein
variants	O	protein
is	O	O
not	O	O
a	O	O
characteristic	O	O
of	O	O
breast	O	O
cancer	O	O
.	O	O
The	O	O
physiological	O	O
significance	O	O
and	O	O
possible	O	O
clinical	O	O
relevance	O	O
of	O	O
the	O	O
variant	O	O
ER	protein	protein
forms	O	O
remain	O	O
to	O	O
be	O	O
elucidated.	O	O

p21ras	protein	DNA
initiates	O	O
Rac-1	protein	protein
but	O	O
not	O	O
phosphatidyl	protein	protein
inositol	protein	protein
3	protein	protein
kinase	protein	protein
/PKB	protein	protein
,	O	O
mediated	O	O
signaling	O	O
pathways	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
p21ras	protein	DNA
is	O	O
activated	O	O
by	O	O
the	O	O
T	protein	protein
cell	protein	protein
antigen	protein	protein
receptor	protein	protein
(	O	O
TCR	protein	protein
)	O	O
and	O	O
then	O	O
co-ordinates	O	O
important	O	O
signaling	O	O
pathways	O	O
for	O	O
T	protein	O
lymphocyte	protein	O
activation	O	O
.	O	O
Effector	O	O
pathways	O	O
for	O	O
this	O	O
guanine	protein	O
nucleotide	protein	O
binding	protein	O
protein	protein	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
are	O	O
mediated	O	O
by	O	O
the	O	O
serine/threonine	protein	protein
kinase	protein	protein
Raf-1	protein	protein
and	O	O
the	O	O
Ras-related	protein	protein
GTPase	protein	protein
Rac-1	protein	protein
.	O	O
In	O	O
fibroblasts	cell_type	cell_type
,	O	O
an	O	O
important	O	O
effector	O	O
for	O	O
the	O	O
Ras	DNA	protein
oncogene	DNA	protein
is	O	O
Phosphatidylinositol	protein	protein
3-kinase	protein	protein
(	O	O
PtdIns	protein	protein
3-kinase	protein	protein
).	O	O
Activation	O	O
of	O	O
this	O	O
lipid	protein	O
kinase	protein	O
is	O	O
able	O	O
to	O	O
induce	O	O
critical	O	O
Rac-1	protein	protein
signaling	O	O
pathways	O	O
and	O	O
can	O	O
couple	O	O
p21ras	protein	DNA
to	O	O
cell	O	O
survival	O	O
mechanisms	O	O
via	O	O
the	O	O
serine	protein	protein
/threonine	protein	protein
kinase	protein	protein
Akt/PKB	protein	protein
.	O	O
The	O	O
role	O	O
of	O	O
PtdIns	protein	protein
3-kinase	protein	protein
in	O	O
Ras	protein	protein
signaling	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
has	O	O
not	O	O
been	O	O
explored.	O	O
In	O	O
the	O	O
present	O	O
study,	O	O
we	O	O
examined	O	O
the	O	O
ability	O	O
of	O	O
PtdIns	protein	protein
3-kinase	protein	protein
to	O	O
initiate	O	O
the	O	O
Rac-1	protein	protein
signaling	O	O
pathways	O	O
important	O	O
for	O	O
T	O	O
cell	O	O
activation	O	O
.	O	O
We	O	O
also	O	O
examined	O	O
the	O	O
possibility	O	O
that	O	O
Akt/PKB	protein	O
is	O	O
regulated	O	O
by	O	O
Ras	O	protein
signaling	O	O
pathways	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
The	O	O
results	O	O
show	O	O
that	O	O
Ras	protein	protein
can	O	O
initiate	O	O
a	O	O
Rac-1	protein	protein
mediated	O	O
pathway	O	O
that	O	O
regulates	O	O
the	O	O
transcriptional	O	O
function	O	O
of	O	O
AP-1	protein	protein
complexes	protein	protein
.	O	O
PtdIns	protein	protein
3-kinase	protein	protein
signals	O	O
cannot	O	O
mimic	O	O
p21ras	protein	DNA
and	O	O
induce	O	O
the	O	O
Rac	protein	protein
mediated	O	O
responses	O	O
of	O	O
AP-1	protein	protein
transcriptional	O	O
activation	O	O
.	O	O
Moreover,	O	O
neither	O	O
TCR	protein	protein
or	O	O
Ras	protein	protein
activation	O	O
of	O	O
AP-1	protein	protein
is	O	O
dependent	O	O
on	O	O
PtdIns	protein	protein
3-kinase	protein	protein
.	O	O
PKB	protein	protein
is	O	O
activated	O	O
in	O	O
response	O	O
to	O	O
triggering	O	O
of	O	O
the	O	O
T	protein	protein
cell	protein	protein
antigen	protein	protein
receptor	protein	protein
;	O	O
PtdIns	protein	protein
3-kinase	protein	protein
activity	O	O
is	O	O
both	O	O
required	O	O
and	O	O
sufficient	O	O
for	O	O
this	O	O
TCR	protein	protein
response	O	O
.	O	O
In	O	O
contrast,	O	O
p21ras	protein	DNA
signals	O	O
are	O	O
unable	O	O
to	O	O
induce	O	O
Akt/PKB	protein	O
activity	O	O
in	O	O
T	cell_type	O
cell	cell_type	O
nor	O	O
is	O	O
Ras	protein	protein
function	O	O
required	O	O
for	O	O
Akt/PKB	protein	O
activation	O	O
in	O	O
response	O	O
to	O	O
the	O	O
TCR	protein	protein
.	O	O
The	O	O
present	O	O
data	O	O
thus	O	O
highlight	O	O
that	O	O
PtdIns	protein	protein
3-kinase	protein	protein
and	O	O
Akt/PKB	protein	O
are	O	O
not	O	O
universal	O	O
Ras	protein	protein
effector	protein	protein
molecules	protein	protein
.	O	O
Ras	protein	protein
can	O	O
initiate	O	O
Rac-1	protein	protein
regulated	O	O
signaling	O	O
pathways	O	O
in	O	O
the	O	O
context	O	O
of	O	O
T	protein	protein
cell	protein	protein
antigen	protein	protein
receptor	protein	protein
function	O	O
independently	O	O
of	O	O
PtdIns	protein	protein
3-kinase	protein	protein
activity	O	O
.	O	O

Interleukin	protein	protein
1beta	protein	protein
mediates	O	O
the	O	O
modulatory	O	O
effects	O	O
of	O	O
monocytes	cell_type	cell_type
on	O	O
LNCaP	cell_type	cell_line
human	cell_type	cell_line
prostate	cell_type	cell_line
cancer	cell_type	cell_line
cells	cell_type	cell_line
.	O	O
Proliferative	O	O
and	O	O
secretory	O	O
responses	O	O
in	O	O
androgen-sensitive	cell_type	O
prostate	cell_type	O
cancer	cell_type	O
LNCaP	cell_type	cell_type
cells	cell_type	cell_type
are	O	O
regulated	O	O
by	O	O
steroid	O	O
and	O	O
peptide	O	O
hormones	O	O
and	O	O
by	O	O
differentiation-promoting	O	O
substances	O	O
.	O	O
In	O	O
the	O	O
present	O	O
study,	O	O
we	O	O
evaluated	O	O
whether	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
monocytes	cell_type	cell_type
that	O	O
exhibit	O	O
anti-tumour	O	O
activity	O	O
in	O	O
haematopoietic	O	O
and	O	O
solid	O	O
tumours	O	O
influence	O	O
growth	O	O
and	O	O
secretion	O	O
in	O	O
the	O	O
LNCaP	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
For	O	O
this	O	O
purpose,	O	O
LNCaP	cell_line	cell_line
cells	cell_line	cell_line
were	O	O
incubated	O	O
with	O	O
monocyte-conditioned	O	O
medium	O	O
(	O	O
MCM	O	O
),	O	O
and	O	O
proliferation	O	O
as	O	O
well	O	O
as	O	O
expression	O	O
of	O	O
androgen	protein	protein
receptor	protein	protein
(	O	O
AR	protein	protein
)	O	O
and	O	O
secretion	O	O
of	O	O
prostate-specific	protein	protein
antigen	protein	protein
(	O	O
PSA	protein	O
)	O	O
were	O	O
assessed.	O	O
Conditioned	O	O
medium	O	O
from	O	O
monocytes	cell_type	cell_type
reduced	O	O
proliferation	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner.	O	O
Incubation	O	O
with	O	O
40%	O	O
MCM	O	O
caused	O	O
a	O	O
50%	O	O
reduction	O	O
in	O	O
cell	O	O
proliferation	O	O
.	O	O
AR	protein	protein
protein	protein	protein
decreased	O	O
by	O	O
70%	O	O
and	O	O
PSA	protein	O
levels	O	O
in	O	O
supernatants	O	O
from	O	O
LNCaP	cell_line	cell_line
cells	cell_line	cell_line
were	O	O
reduced	O	O
by	O	O
approximately	O	O
80%	O	O
following	O	O
treatment	O	O
with	O	O
MCM	O	O
.	O	O
We	O	O
focused	O	O
on	O	O
the	O	O
contribution	O	O
of	O	O
two	O	O
major	O	O
products	O	O
of	O	O
activated	O	cell_type
monocytes	cell_type	cell_type
,	O	O
prostaglandin	O	O
E2	O	O
and	O	O
interleukin	protein	protein
1beta	protein	protein
(	O	O
IL-1beta	protein	protein
),	O	O
to	O	O
the	O	O
MCM	O	O
modulatory	O	O
action.	O	O
LNCaP	cell_line	cell_line
cells	cell_line	cell_line
treated	O	O
with	O	O
prostaglandin	O	O
E2	O	O
showed	O	O
neither	O	O
a	O	O
reduction	O	O
in	O	O
proliferation	O	O
nor	O	O
a	O	O
down-regulation	O	O
of	O	O
AR	protein	protein
and	O	O
PSA	protein	O
levels	O	O
.	O	O
The	O	O
effects	O	O
of	O	O
MCM	O	O
on	O	O
cellular	O	O
proliferation	O	O
,	O	O
AR	protein	protein
protein	protein	protein
and	O	O
PSA	protein	O
secretion	O	O
were	O	O
abolished	O	O
by	O	O
pretreatment	O	O
of	O	O
MCM	O	O
with	O	O
a	O	O
neutralizing	O	O
anti-	protein	protein
IL-1beta	protein	protein
antibody	protein	protein
.	O	O
In	O	O
addition,	O	O
recombinant	O	O
IL-1beta	protein	protein
was	O	O
able	O	O
to	O	O
replace	O	O
MCM	O	O
for	O	O
the	O	O
inhibition	O	O
of	O	O
proliferation	O	O
and	O	O
down-regulation	O	O
of	O	O
AR	protein	protein
and	O	O
PSA	protein	O
proteins.	O	O
LNCaP	cell_line	cell_line
cells	cell_line	cell_line
were	O	O
shown	O	O
to	O	O
express	O	O
the	O	O
IL-1beta	protein	protein
receptor	O	protein
type	O	protein
1,	O	O
which	O	O
transduces	O	O
IL-1beta	protein	protein
signal	O	O
.	O	O
Our	O	O
findings	O	O
reveal	O	O
that	O	O
monocyte-derived	protein	O
IL-1beta	protein	protein
inhibits	O	O
the	O	O
proliferation	O	O
of	O	O
androgen-responsive	cell_type	O
prostate	cell_type	O
tumour	cell_type	O
cells	cell_type	O
and	O	O
reduces	O	O
AR	protein	O
and	O	O
PSA	protein	O
levels	O	O
.	O	O

Differential	O	O
responsiveness	O	O
of	O	O
the	O	O
IL-5	O	protein
and	O	O
IL-4	O	DNA
genes	O	DNA
to	O	O
transcription	protein	protein
factor	protein	protein
GATA-3	protein	protein
.	O	O
The	O	O
cytokines	protein	protein
IL-4	protein	protein
and	O	O
IL-5	protein	protein
are	O	O
often	O	O
coordinately	O	O
produced	O	O
by	O	O
Th2	cell_line	cell_type
cells	cell_line	cell_type
as	O	O
in	O	O
asthma	O	O
.	O	O
However,	O	O
it	O	O
is	O	O
unclear	O	O
whether	O	O
similar	O	O
molecular	O	O
mechanisms	O	O
underlie	O	O
transcription	O	O
of	O	O
the	O	O
two	O	O
genes	DNA	O
.	O	O
We	O	O
have	O	O
previously	O	O
shown	O	O
that	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
GATA-3	protein	protein
is	O	O
expressed	O	O
in	O	O
Th2	O	cell_line
but	O	O
not	O	O
Th1	O	cell_type
cells	O	cell_type
and	O	O
is	O	O
crucial	O	O
for	O	O
activation	O	O
of	O	O
the	O	O
IL-5	DNA	DNA
promoter	DNA	DNA
by	O	O
different	O	O
stimuli.	O	O
In	O	O
a	O	O
different	O	O
study,	O	O
GATA-3	protein	protein
was	O	O
shown	O	O
to	O	O
be	O	O
sufficient	O	O
for	O	O
the	O	O
expression	O	O
of	O	O
IL-4	protein	protein
and	O	O
other	O	O
Th2	DNA	DNA
cytokine	DNA	DNA
genes	DNA	DNA
.	O	O
Here,	O	O
we	O	O
show	O	O
that	O	O
ectopic	O	O
expression	O	O
of	O	O
GATA-3	protein	protein
is	O	O
sufficient	O	O
to	O	O
drive	O	O
IL-5	protein	protein
but	O	O
not	O	O
IL-4	protein	protein
gene	O	O
expression	O	O
.	O	O
Also,	O	O
in	O	O
Th2	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
antisense	O	O
GATA-3	protein	protein
RNA	O	protein
inhibits	O	O
IL-5	protein	protein
but	O	O
not	O	O
IL-4	protein	protein
promoter	O	O
activation	O	O
.	O	O
The	O	O
induction	O	O
of	O	O
IL-5	DNA	protein
gene	DNA	O
expression	O	O
by	O	O
GATA-3	protein	protein
involves	O	O
high	O	O
affinity	O	O
binding	O	O
of	O	O
GATA-3	protein	protein
to	O	O
an	O	O
inverted	O	O
GATA	DNA	O
repeat	DNA	O
in	O	O
the	O	O
IL-5	DNA	DNA
promoter	DNA	DNA
.	O	O

The	O	O
interleukin	DNA	protein
2	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
chain	DNA	protein
/CD25	DNA	O
promoter	DNA	O
is	O	O
a	O	O
target	O	O
for	O	O
nuclear	protein	protein
factor	protein	protein
of	protein	protein
activated	protein	protein
T	protein	protein
cells	protein	protein
.	O	O
The	O	O
expression	O	O
of	O	O
the	O	O
murine	protein	DNA
interleukin	protein	DNA
(IL)-2	protein	DNA
receptor	protein	DNA
alpha	protein	DNA
chain	protein	DNA
/CD25	protein	DNA
is	O	O
strongly	O	O
induced	O	O
at	O	O
the	O	O
transcriptional	O	O
level	O	O
after	O	O
T	O	O
cell	O	O
activation	O	O
.	O	O
We	O	O
show	O	O
here	O	O
that	O	O
nuclear	protein	protein
factor	protein	protein
of	protein	protein
activated	protein	protein
T	protein	protein
cell	protein	protein
(NF-AT)	protein	protein
factors	protein	protein
are	O	O
involved	O	O
in	O	O
the	O	O
control	O	O
of	O	O
CD25	DNA	DNA
promoter	DNA	DNA
induction	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
NF-ATp	protein	protein
and	O	O
NF-ATc	protein	protein
bind	O	O
to	O	O
two	O	O
sites	O	O
around	O	O
positions	O	O
-585	O	O
and	O	O
-650	O	O
located	O	O
upstream	O	O
of	O	O
the	O	O
proximal	DNA	DNA
CD25	DNA	DNA
promoter	DNA	DNA
.	O	O
Immediately	O	O
3'	O	O
from	O	O
these	O	O
NF-AT	DNA	protein
motifs	DNA	protein
,	O	O
nonconsensus	DNA	DNA
sites	DNA	DNA
are	O	O
located	O	O
for	O	O
the	O	O
binding	O	O
of	O	O
AP-1	protein	protein
-like	protein	protein
factors	protein	protein
.	O	O
Mutations	O	O
of	O	O
sites	O	O
that	O	O
suppress	O	O
NF-AT	protein	protein
binding	O	O
impair	O	O
the	O	O
induction	O	O
and	O	O
strong	O	O
NF-ATp	protein	protein
-mediated	O	O
transactivation	O	O
of	O	O
the	O	O
CD25	DNA	DNA
promoter	DNA	DNA
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
from	O	O
NF-ATp	protein	protein
-deficient	O	O
mice	O	O
,	O	O
the	O	O
expression	O	O
of	O	O
CD25	protein	protein
is	O	O
severely	O	O
impaired,	O	O
leading	O	O
to	O	O
a	O	O
delayed	O	O
IL-2	protein	protein
receptor	protein	protein
expression	O	O
after	O	O
T	O	O
cell	O	O
receptor	O	O
(	O	O
TCR	protein	protein
)/	O	protein
CD3	protein	protein
stimulation	O	O
.	O	O
Our	O	O
data	O	O
indicate	O	O
an	O	O
important	O	O
role	O	O
for	O	O
NF-AT	protein	protein
in	O	O
the	O	O
faithful	O	O
expression	O	O
of	O	O
high	protein	O
affinity	protein	O
IL-2	protein	protein
receptors	protein	protein
and	O	O
a	O	O
close	O	O
link	O	O
between	O	O
the	O	O
TCR	protein	protein
-mediated	O	O
induction	O	O
of	O	O
IL-2	protein	protein
and	O	O
IL-2	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
chain	DNA	protein
promoters	DNA	protein
,	O	O
both	O	O
of	O	O
which	O	O
are	O	O
regulated	O	O
by	O	O
NF-AT	protein	protein
factors	protein	protein
.	O	O

A	O	O
novel	O	O
mutation	O	O
in	O	O
the	O	O
coding	O	O
sequence	O	O
of	O	O
the	O	O
FY*B	DNA	O
allele	DNA	O
of	O	O
the	O	O
Duffy	DNA	protein
chemokine	DNA	protein
receptor	DNA	protein
gene	DNA	O
is	O	O
associated	O	O
with	O	O
an	O	O
altered	O	O
erythrocyte	O	O
phenotype	O	O
.	O	O
The	O	O
Duffy	O	O
blood	O	O
group	O	O
system	O	O
is	O	O
of	O	O
clinical	O	O
and	O	O
biological	O	O
significance	O	O
.	O	O
Antibodies	protein	O
to	O	O
Duffy	protein	O
antigens	protein	O
are	O	O
responsible	O	O
for	O	O
some	O	O
cases	O	O
of	O	O
transfusion	O	O
incompatibility	O	O
and	O	O
newborn	O	O
hemolytic	O	O
disease	O	O
.	O	O
The	O	O
Duffy	protein	O
protein	protein	O
is	O	O
a	O	O
receptor	O	O
for	O	O
the	O	O
Plasmodium	protein	O
vivax	protein	O
erythrocyte-binding	protein	O
protein	protein	O
and	O	O
is	O	O
also	O	O
a	O	O
receptor	O	O
for	O	O
various	O	O
chemokines	protein	protein
(thus	O	O
renamed	O	O
Duffy	protein	O
Antigen	protein	O
Receptor	protein	O
for	protein	O
Chemokines	protein	O
[	O	O
DARC	protein	O
]).	O	O
The	O	O
two	O	O
Duffy	protein	O
polymorphic	protein	O
antigens	protein	O
,	O	O
Fya	protein	O
and	O	O
Fyb	protein	O
(coded	O	O
by	O	O
the	O	O
FY*A	O	O
and	O	O
FY*B	O	O
alleles	O	O
),	O	O
are	O	O
present	O	O
on	O	O
erythrocyte	protein	cell_type
membranes	protein	cell_type
.	O	O
The	O	O
Fy(a-b-)	O	O
phenotype	O	O
is	O	O
the	O	O
predominant	O	O
one	O	O
in	O	O
populations	O	O
of	O	O
black	O	O
people	O	O
and	O	O
also	O	O
occurs	O	O
in	O	O
other	O	O
populations,	O	O
including	O	O
some	O	O
non-Ashkenazi	O	O
Jewish	O	O
groups	O	O
.	O	O
The	O	O
Fy(a-b-)	O	O
phenotype	O	O
has	O	O
been	O	O
associated	O	O
with	O	O
a	O	O
mutation	O	O
in	O	O
the	O	O
FY*B	DNA	DNA
promoter	DNA	DNA
at	O	O
the	O	O
GATA	DNA	DNA
box	DNA	DNA
that	O	O
abolishes	O	O
the	O	O
expression	O	O
of	O	O
erythrocyte	protein	protein
Duffy	protein	protein
protein	protein	protein
.	O	O
We	O	O
describe	O	O
here	O	O
a	O	O
novel	O	O
mutation	O	O
,	O	O
present	O	O
in	O	O
the	O	O
FY*B	DNA	DNA
coding	DNA	DNA
sequence	DNA	DNA
(	O	O
271C	O	DNA
--&gt;	O	O
T	O	O
),	O	O
that	O	O
is	O	O
associated	O	O
with	O	O
some	O	O
Fy(b-)	O	O
phenotypes	O	O
among	O	O
non-Ashkenazi	O	O
Jews	O	O
and	O	O
among	O	O
Brazilian	O	O
blacks	O	O
.	O	O
The	O	O
mutation	O	O
is	O	O
present	O	O
in	O	O
Fy(b-)	O	O
individuals	O	O
,	O	O
who	O	O
have	O	O
wild-type	DNA	O
FY*B	DNA	O
GATA	DNA	O
and	O	O
carry	O	O
the	O	O
previously	O	O
described	O	O
304G	O	protein
--&gt;	O	O
A	O	O
substitution	O	O
.	O	O
The	O	O
271C	O	cell_line
--&gt;	O	O
T	O	O
and	O	O
304G	O	protein
--&gt;	O	O
A	O	O
can	O	O
be	O	O
identified	O	O
by	O	O
restriction	DNA	O
enzyme-generated	DNA	O
restriction	DNA	O
fragment	DNA	O
length	DNA	O
polymorphisms	DNA	O
.	O	O
The	O	O
271C	O	cell_line
--&gt;	O	O
T	O	O
substitution	O	O
represents	O	O
a	O	O
considerable	O	O
change	O	O
in	O	O
chemical	O	O
nature	O	O
(	O	O
Arg91	O	protein
--&gt;	O	O
Cys	O	O
),	O	O
one	O	O
which	O	O
may	O	O
affect	O	O
the	O	O
antigenic	O	O
determinants	O	O
of	O	O
DARC	protein	O
,	O	O
and	O	O
thus	O	O
be	O	O
of	O	O
clinical	O	O
significance.	O	O
The	O	O
mutation	O	O
may	O	O
have	O	O
implications	O	O
for	O	O
some	O	O
physiological	O	O
roles	O	O
of	O	O
DARC	protein	O
and	O	O
be	O	O
of	O	O
interest	O	O
in	O	O
malaria	O	O
research	O	O
and	O	O
in	O	O
studies	O	O
of	O	O
population	O	O
genetics	O	O
.	O	O

Establishment	O	O
and	O	O
characterization	O	O
of	O	O
EBV-positive	O	O
and	O	O
EBV-negative	O	O
primary	O	O
effusion	O	O
lymphoma	O	O
cell	O	O
lines	O	O
harbouring	O	O
human	O	O
herpesvirus	O	O
type-8	O	O
.	O	O
In	O	O
this	O	O
study	O	O
we	O	O
report	O	O
on	O	O
the	O	O
establishment	O	O
and	O	O
characterization	O	O
of	O	O
two	O	O
novel	O	O
lymphoma	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
(	O	O
CRO-AP/3	cell_line	protein
and	O	O
CRO-AP/5	cell_line	protein
)	O	O
which	O	O
carry	O	O
infection	O	O
by	O	O
human	O	O
herpesvirus	O	O
type-8	O	O
(	O	O
HHV-8	O	O
)	O	O
and	O	O
have	O	O
derived	O	O
from	O	O
AIDS-related	O	O
primary	O	O
effusion	O	O
lymphoma	O	O
(	O	O
PEL	cell_line	O
).	O	O
These	O	O
two	O	O
cell	cell_line	O
lines	cell_line	O
are	O	O
representative	O	O
of	O	O
different	O	O
virologic	O	O
subtypes	O	O
of	O	O
PEL	cell_line	O
,	O	O
i.e.	O	O
HHV-8	cell_line	O
+/EBV-	cell_line	O
PEL	cell_line	O
in	O	O
the	O	O
case	O	O
of	O	O
CRO-AP/3	cell_line	protein
and	cell_line	O
HHV-8	cell_line	O
+/EBV+	cell_line	O
PEL	cell_line	O
in	O	O
the	O	O
case	O	O
of	O	O
CRO-AP/5	cell_line	protein
.	O	O
Consistent	O	O
with	O	O
the	O	O
diagnosis	O	O
of	O	O
PEL	cell_line	O
,	O	O
both	O	O
CRO-AP/3	cell_line	protein
and	O	O
CRO-AP/5	cell_line	protein
expressed	O	O
indeterminate	O	O
(i.e.	O	O
non-B,	O	O
non-T)	O	O
phenotypes	O	O
although	O	O
immunogenotypic	O	O
studies	O	O
documented	O	O
their	O	O
B-cell	cell_type	O
origin	cell_type	O
.	O	O
Both	O	O
cell	cell_line	O
lines	cell_line	O
are	O	O
devoid	O	O
of	O	O
genetic	O	O
lesions	O	O
of	O	O
c-MYC	protein	protein
,	O	O
BCL-2	protein	protein
and	O	O
p53	protein	protein
as	O	O
well	O	O
as	O	O
gross	O	O
rearrangements	O	O
of	O	O
BCL-6	protein	protein
.	O	O
Detailed	O	O
histogenetic	O	O
characterization	O	O
of	O	O
these	O	O
novel	O	O
PEL	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
suggests	O	O
that	O	O
PEL	cell_line	O
may	O	O
derive	O	O
from	O	O
a	O	O
post-germinal	cell_line	O
centre	cell_line	O
B	cell_line	O
cell	cell_line	O
which	O	O
has	O	O
undergone	O	O
pre-terminal	O	O
differentiation	O	O
.	O	O
The	O	O
CRO-AP/3	cell_line	protein
and	O	O
CRO-AP/5	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
may	O	O
provide	O	O
a	O	O
valuable	O	O
model	O	O
for	O	O
clarifying	O	O
the	O	O
pathogenesis	O	O
of	O	O
PEL	cell_line	O
.	O	O
In	O	O
particular,	O	O
these	O	O
cell	cell_line	O
lines	cell_line	O
may	O	O
help	O	O
understand	O	O
the	O	O
relative	O	O
contribution	O	O
of	O	O
HHV-8	O	O
and	O	O
EBV	O	O
to	O	O
PEL	O	O
growth	O	O
and	O	O
development	O	O
and	O	O
may	O	O
facilitate	O	O
the	O	O
identification	O	O
of	O	O
recurrent	O	O
cytogenetic	O	O
abnormalities	O	O
highlighting	O	O
putative	O	O
novel	O	O
cancer	O	O
related	O	O
loci	O	O
relevant	O	O
to	O	O
PEL	cell_line	O
.	O	O

Two-site	O	O
interaction	O	O
of	O	O
nuclear	protein	protein
factor	protein	protein
of	protein	protein
activated	protein	protein
T	protein	protein
cells	protein	protein
with	O	O
activated	O	O
calcineurin	protein	protein
.	O	O
Transcription	protein	protein
factors	protein	protein
belonging	O	O
to	O	O
the	O	O
nuclear	protein	protein
factor	protein	protein
of	protein	protein
activated	protein	protein
T	protein	protein
cells	protein	protein
(NFAT)	protein	protein
family	protein	protein
regulate	O	O
the	O	O
expression	O	O
of	O	O
cytokine	DNA	DNA
genes	DNA	DNA
and	O	O
other	O	O
inducible	O	DNA
genes	O	DNA
during	O	O
the	O	O
immune	O	O
response	O	O
.	O	O
The	O	O
functions	O	O
of	O	O
NFAT	protein	protein
proteins	protein	protein
are	O	O
directly	O	O
controlled	O	O
by	O	O
the	O	O
calcium-	O	O
and	O	O
calmodulin-	O	O
dependent	O	O
phosphatase	O	O
calcineurin	protein	protein
.	O	O
Here	O	O
we	O	O
show	O	O
that	O	O
the	O	O
binding	O	O
of	O	O
calcineurin	protein	protein
to	O	O
NFAT	protein	protein
is	O	O
substantially	O	O
increased	O	O
when	O	O
calcineurin	protein	protein
is	O	O
activated	O	O
with	O	O
calmodulin	protein	protein
and	O	O
calcium	O	O
.	O	O
FK506.FKBP12	O	protein
drug-immunophilin	O	protein
complexes	O	protein
inhibited	O	O
the	O	O
interaction	O	O
of	O	O
NFAT	protein	protein
with	O	O
activated	O	O
calcineurin	protein	protein
much	O	O
more	O	O
effectively	O	O
than	O	O
they	O	O
inhibited	O	O
the	O	O
interaction	O	O
with	O	O
inactive	O	O
calcineurin	protein	protein
,	O	O
suggesting	O	O
that	O	O
part	O	O
of	O	O
the	O	O
interaction	O	O
with	O	O
activated	O	O
calcineurin	protein	protein
involved	O	O
the	O	O
enzyme	DNA	DNA
active	DNA	DNA
site	DNA	DNA
.	O	O
We	O	O
have	O	O
previously	O	O
shown	O	O
that	O	O
NFAT	protein	protein
is	O	O
targeted	O	O
to	O	O
inactive	O	O
calcineurin	protein	protein
at	O	O
a	O	O
region	O	O
distinct	O	O
from	O	O
the	O	O
calcineurin	DNA	DNA
active	DNA	DNA
site	DNA	DNA
(Aramburu,	O	O
J.,	O	O
Garcia-Cozar,	O	O
F.	O	O
J.,	O	O
Raghavan,	O	O
A.,	O	O
Okamura,	O	O
H.,	O	O
Rao,	O	O
A.,	O	O
and	O	O
Hogan,	O	O
P.	O	O
G.	O	O
(1998)	O	O
Mol.	O	O
Cell	O	O
1,	O	O
627-637);	O	O
this	O	O
region	O	O
is	O	O
also	O	O
involved	O	O
in	O	O
NFAT	protein	O
binding	O	O
to	O	O
activated	O	O
calcineurin	protein	protein
,	O	O
since	O	O
binding	O	O
is	O	O
inhibited	O	O
by	O	O
an	O	O
NFAT	O	protein
peptide	O	O
spanning	O	O
the	O	O
calcineurin	protein	protein
docking	O	protein
site	O	protein
on	O	O
NFAT	protein	protein
.	O	O
The	O	O
interacting	O	O
surfaces	O	O
are	O	O
located	O	O
on	O	O
the	O	O
catalytic	protein	protein
domain	protein	protein
of	O	O
the	O	O
calcineurin	protein	protein
A	protein	protein
chain	protein	protein
and	O	O
on	O	O
an	O	O
86-amino	protein	O
acid	protein	O
fragment	protein	O
of	O	O
the	O	O
NFAT	protein	protein
regulatory	protein	protein
domain	protein	protein
.	O	O
NFAT	protein	protein
binding	O	O
to	O	O
the	O	O
calcineurin	protein	protein
catalytic	protein	protein
domain	protein	protein
was	O	O
inhibited	O	O
by	O	O
the	O	O
calcineurin	protein	protein
autoinhibitory	protein	protein
domain	protein	protein
and	O	O
the	O	O
RII	O	O
substrate	O	O
peptide	O	O
,	O	O
which	O	O
bind	O	O
in	O	O
the	O	O
calcineurin	protein	DNA
active	protein	DNA
site	protein	DNA
,	O	O
as	O	O
well	O	O
as	O	O
by	O	O
the	O	O
NFAT	protein	DNA
docking	O	DNA
site	O	DNA
peptide	O	O
,	O	O
which	O	O
binds	O	O
to	O	O
a	O	O
region	O	O
of	O	O
calcineurin	protein	protein
distinct	O	O
from	O	O
the	O	O
active	protein	DNA
site	protein	DNA
.	O	O
We	O	O
propose	O	O
that,	O	O
in	O	O
resting	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
NFAT	protein	protein
is	O	O
targeted	O	O
to	O	O
a	O	O
region	O	O
of	O	O
the	O	O
calcineurin	protein	protein
catalytic	protein	protein
domain	protein	protein
that	O	O
does	O	O
not	O	O
overlap	O	O
the	O	O
calcineurin	protein	protein
active	protein	protein
site	protein	protein
.	O	O
Upon	O	O
cell	O	O
activation,	O	O
displacement	O	O
of	O	O
the	O	O
autoinhibitory	protein	protein
domain	protein	protein
by	O	O
calmodulin	protein	protein
binding	O	protein
allows	O	O
NFAT	protein	O
to	O	O
bind	O	O
additionally	O	O
to	O	O
the	O	O
calcineurin	protein	protein
active	protein	protein
site	protein	protein
,	O	O
thus	O	O
positioning	O	O
NFAT	protein	protein
for	O	O
immediate	O	O
dephosphorylation	O	O
at	O	O
functional	O	O
phosphoserine	O	O
residues	O	O
.	O	O

Nuclear	protein	protein
factor-kappaB	protein	protein
induction	O	O
in	O	O
CD45RO+	O	O
and	O	O
CD45RA+	O	O
T	O	O
cell	O	O
subsets	O	O
during	O	O
aging.	O	O
An	O	O
increase	O	O
in	O	O
the	O	O
ratio	O	O
of	O	O
memory	O	O
to	O	O
naive	O	cell_type
T	O	cell_type
cells	O	cell_type
has	O	O
been	O	O
postulated	O	O
to	O	O
underlie	O	O
immune	O	O
hyporesponsiveness	O	O
accompanying	O	O
aging.	O	O
Our	O	O
analyses	O	O
of	O	O
the	O	O
induction	O	O
of	O	O
nuclear	protein	protein
factor-kappaB	protein	protein
(	O	O
NFkappaB	protein	protein
)	O	O
in	O	O
activated	O	O
memory	O	O
(CD45RO+)	O	O
and	O	O
naive	O	O
(CD45RA+)	O	O
T	O	O
cell	O	O
subsets	O	O
from	O	O
young	O	O
and	O	O
elderly	O	O
donors	O	O
has	O	O
demonstrated	O	O
that,	O	O
regardless	O	O
of	O	O
donor	O	O
age,	O	O
memory	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
are	O	O
not	O	O
significantly	O	O
altered	O	O
in	O	O
their	O	O
responsiveness	O	O
to	O	O
TNF-alpha	protein	protein
-mediated	O	O
induction	O	O
of	O	O
NFkappaB	protein	protein
.	O	O
Although	O	O
treatment	O	O
with	O	O
TNF-alpha	protein	protein
induced	O	O
nuclear	O	O
localization	O	O
of	O	O
NFkappaB	protein	protein
in	O	O
both	O	O
memory	O	O
and	O	O
naive	O	O
T	O	O
cell	O	O
subsets	O	O
,	O	O
irrespective	O	O
of	O	O
the	O	O
age	O	O
of	O	O
the	O	O
donor,	O	O
the	O	O
levels	O	O
of	O	O
induced	O	O
NFkappaB	protein	protein
were	O	O
significantly	O	O
lower	O	O
in	O	O
both	O	O
subsets	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
obtained	O	O
from	O	O
the	O	O
elderly,	O	O
when	O	O
compared	O	O
to	O	O
those	O	O
in	O	O
young.	O	O
Examination	O	O
of	O	O
IkappaB	protein	protein
alpha	protein	protein
regulation	O	O
revealed	O	O
that	O	O
TNF-alpha	protein	protein
-mediated	O	O
degradation	O	O
of	O	O
IkappaB	protein	protein
alpha	protein	protein
in	O	O
both	O	O
memory	O	O
and	O	O
naive	O	cell_type
T	O	cell_type
cells	O	cell_type
from	O	O
the	O	O
elderly	O	O
was	O	O
severely	O	O
impaired,	O	O
thus	O	O
contributing	O	O
to	O	O
the	O	O
lowered	O	O
induction	O	O
of	O	O
the	O	O
observed	O	O
NFkappaB	protein	protein
.	O	O
In	O	O
addition,	O	O
this	O	O
age-related	O	O
decrease	O	O
in	O	O
induction	O	O
of	O	O
nuclear	protein	O
NFkappaB	protein	protein
correlated	O	O
with	O	O
decrease	O	O
in	O	O
intracellular	O	O
IL-2	protein	protein
receptor	O	protein
expression	O	O
and	O	O
anti-CD3	protein	protein
-induced	O	O
proliferation	O	O
of	O	O
both	O	O
memory	O	O
and	O	O
naive	O	cell_type
T	O	cell_type
cells	O	cell_type
subsets	O	O
.	O	O
Taken	O	O
together,	O	O
our	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
age-related	O	O
hyporesponsiveness	O	O
cannot	O	O
be	O	O
attributed	O	O
to	O	O
a	O	O
skewing	O	O
of	O	O
the	O	O
T	O	O
cell	O	O
population	O	O
towards	O	O
a	O	O
memory	O	O
phenotype	O	O
in	O	O
the	O	O
elderly.	O	O

Cyclosporin	O	O
A	O	O
-resistant	O	O
transactivation	O	O
of	O	O
the	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
requires	O	O
activity	O	O
of	O	O
okadaic	protein	O
acid-sensitive	protein	O
serine	protein	O
/threonine	protein	O
phosphatases	protein	O
.	O	O
Expression	O	O
of	O	O
the	O	O
IL-2	DNA	DNA
gene	DNA	DNA
requires	O	O
activation	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
through	O	O
stimulation	O	O
of	O	O
the	O	O
TCR	protein	protein
and	O	O
costimulation	O	O
through	O	O
accessory	protein	protein
receptors	protein	protein
.	O	O
We	O	O
have	O	O
found	O	O
recently	O	O
that	O	O
okadaic	protein	O
acid-sensitive	protein	O
Ser	protein	O
/Thr	protein	O
phosphatases	protein	O
are	O	O
involved	O	O
in	O	O
a	O	O
cyclosporin	O	O
A	O	O
-insensitive	O	O
pathway	O	O
that	O	O
selectively	O	O
transmits	O	O
costimulatory	O	O
signals.	O	O
In	O	O
this	O	O
study,	O	O
we	O	O
analyzed	O	O
whether	O	O
activities	O	O
of	O	O
these	O	O
phosphatases	O	O
are	O	O
necessary	O	O
for	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
IL-2	DNA	DNA
gene	DNA	DNA
.	O	O
In	O	O
both	O	O
activated	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
and	O	O
activated	cell_line	O
tumorigenic	cell_line	O
T	cell_line	O
cell	cell_line	O
lines	cell_line	O
,	O	O
IL-2	protein	DNA
gene	O	DNA
expression	O	O
was	O	O
blocked	O	O
at	O	O
the	O	O
transcriptional	O	O
level	O	O
by	O	O
okadaic	O	O
acid	O	O
.	O	O
The	O	O
transcription	protein	protein
factors	protein	protein
active	O	O
at	O	O
the	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
were	O	O
differentially	O	O
influenced:	O	O
upon	O	O
down-modulation	O	O
of	O	O
okadaic	protein	O
acid	protein	O
-sensitive	protein	O
phosphatases	protein	O
,	O	O
transactivation	O	O
by	O	O
octamer,	O	O
NF-kappa	protein	protein
B	protein	protein
,	O	O
and	O	O
NF	protein	protein
of	protein	O
activated	protein	cell_type
T	protein	cell_type
cells	protein	cell_type
proteins	protein	O
was	O	O
abrogated,	O	O
while	O	O
transactivation	O	O
by	O	O
AP-1	protein	protein
proteins	protein	protein
was	protein	O
even	protein	O
enhanced.	protein	O

YM268	O	O
increases	O	O
the	O	O
glucose	O	O
uptake	O	O
,	O	O
cell	O	O
differentiation,	O	O
and	O	O
mRNA	O	O
expression	O	O
of	O	O
glucose	protein	O
transporter	protein	O
in	O	O
3T3-L1	cell_type	cell_line
adipocytes	cell_type	cell_line
.	O	O
The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
effects	O	O
of	O	O
bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane	O	O
(	O	O
YM-268	O	protein
),	O	O
a	O	O
thiazolidinedione	O	O
derivative	O	O
,	O	O
on	O	O
glucose	O	O
uptake	O	O
,	O	O
adipocyte	cell_type	O
differentiation	O	O
through	O	O
peroxisome	protein	protein
proliferator-activated	protein	protein
receptor	protein	protein
gamma	protein	protein
(	O	O
PPARgamma	protein	protein
),	O	O
and	O	O
phosphatidylinositol	protein	protein
3-kinase	protein	protein
(	O	O
PI	protein	protein
3-kinase	protein	protein
)	O	O
activity	O	O
in	O	O
cultured	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
YM268	O	O
and	O	O
pioglitazone	O	O
dose-dependently	O	O
increased	O	O
the	O	O
2-deoxyglucose	O	O
uptake	O	O
in	O	O
3T3-L1	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
YM268	O	O
facilitated	O	O
the	O	O
insulin-stimulated	O	O
triglyceride	O	O
accumulation	O	O
in	O	O
3T3-L1	cell_type	cell_line
adipocytes	cell_type	cell_line
and	O	O
increased	O	O
the	O	O
mRNA	O	O
expression	O	O
of	O	O
fatty	protein	O
acid-binding	protein	O
protein	protein	O
.	O	O
YM268	O	protein
,	O	O
with	O	O
and	O	O
without	O	O
insulin	O	O
,	O	O
increased	O	O
the	O	O
mRNA	O	O
expression	O	O
of	O	O
glucose	protein	O
transporter	protein	O
isoforms	O	O
such	O	O
as	O	O
GLUT1	protein	protein
and	O	O
GLUT4	protein	protein
,	O	O
indicating	O	O
enhancement	O	O
of	O	O
adipocyte	cell_type	O
differentiation	O	O
.	O	O
Additionally,	O	O
YM268	O	O
and	O	O
pioglitazone	O	O
showed	O	O
activity	O	O
of	O	O
the	O	O
PPARgamma	protein	protein
ligand	protein	protein
,	O	O
a	O	O
member	O	O
of	O	O
the	O	O
nuclear	protein	protein
receptor	protein	protein
superfamily	protein	protein
responsible	O	O
for	O	O
adipogenesis	O	O
.	O	O
To	O	O
examine	O	O
the	O	O
possible	O	O
involvement	O	O
of	O	O
the	O	O
increased	O	O
activity	O	O
of	O	O
PI	protein	protein
3-kinase	protein	protein
in	O	O
YM268	O	cell_line
-stimulated	O	cell_line
glucose	O	cell_line
uptake	O	O
,	O	O
the	O	O
enzyme	O	O
activity	O	O
was	O	O
estimated	O	O
by	O	O
measuring	O	O
the	O	O
phosphatidylinositol-3,4,5-trisphosphate	O	protein
(	O	O
PI-3,4,5-P3	O	protein
)	O	O
concentration	O	O
in	O	O
human	cell_type	cell_type
monocytic	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Insulin	O	O
dose-dependently	O	O
increased	O	O
the	O	O
PI-3,4,5-P3	O	protein
production	O	O
but	O	O
YM268	O	O
had	O	O
no	O	O
significant	O	O
effect	O	O
on	O	O
the	O	O
insulin	O	O
-dependent	O	O
and	O	O
-independent	O	O
PI	O	protein
3-kinase	O	protein
activation	O	O
.	O	O
These	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
mechanism	O	O
by	O	O
which	O	O
YM268	O	protein
increased	O	O
glucose	O	O
uptake	O	O
,	O	O
may	O	O
be	O	O
accounted	O	O
for	O	O
in	O	O
part	O	O
by	O	O
the	O	O
enhancement	O	O
of	O	O
GLUT1	protein	protein
and	O	O
GLUT4	protein	O
expression	O	O
through	O	O
PPARgamma	protein	protein
activation	O	O
.	O	O

The	O	O
nuclear	protein	O
receptor	protein	O
PPARgamma	protein	protein
-	O	O
bigger	O	O
than	O	O
fat	O	O
.	O	O
Work	O	O
reported	O	O
over	O	O
the	O	O
past	O	O
year	O	O
has	O	O
provided	O	O
insights	O	O
into	O	O
the	O	O
mechanisms	O	O
whereby	O	O
ligand	O	O
activation	O	O
of	O	O
the	O	O
nuclear	protein	protein
receptor	protein	protein
peroxisome	protein	protein
proliferator-activated	protein	protein
receptor	protein	protein
gamma	protein	protein
(	O	O
PPARgamma	protein	protein
)	O	O
regulates	O	O
systemic	O	O
glucose	O	O
and	O	O
lipid	O	O
homeostasis	O	O
.	O	O
PPARgamma	protein	protein
has	O	O
also	O	O
been	O	O
implicated	O	O
recently	O	O
in	O	O
the	O	O
biology	O	O
of	O	O
monocytes	O	cell_type
and	O	O
in	O	O
cell-cycle	O	O
regulation	O	O
and	O	O
cancer	O	O
.	O	O
Polyunsaturated	O	O
fatty	O	O
acids	O	O
and	O	O
eicosanoids	O	O
bind	O	O
and	O	O
activate	O	O
PPARgamma	protein	protein
,	O	O
suggesting	O	O
that	O	O
these	O	O
lipids	O	O
may	O	O
serve	O	O
as	O	O
hormonal	O	O
regulators	O	O
of	O	O
a	O	O
variety	O	O
of	O	O
biological	O	O
processes	O	O
.	O	O

The	O	O
role	O	O
of	O	O
caspases	O	protein
in	O	O
T	O	O
cell	O	O
development	O	O
and	O	O
the	O	O
control	O	O
of	O	O
immune	O	O
responses	O	O
.	O	O
Apoptosis	O	O
is	O	O
responsible	O	O
for	O	O
the	O	O
removal	O	O
of	O	O
potentially	O	O
autoreactive	O	O
or	O	O
useless	O	O
T	O	cell_type
cells	O	cell_type
during	O	O
thymic	O	O
selection	O	O
and	O	O
activated	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
the	O	O
periphery.	O	O
Specific	O	O
families	O	O
of	O	O
receptors	protein	protein
,	O	O
kinases	protein	protein
,	O	O
transcription	protein	protein
factors	protein	protein
,	O	O
and	O	O
cysteine	protein	O
proteases	protein	O
,	O	O
termed	protein	O
caspases	protein	protein
,	O	O
are	O	O
involved	O	O
in	O	O
the	O	O
apoptotic	O	O
cascade	O	O
leading	O	O
to	O	O
proteolysis	O	O
of	O	O
specific	O	O
substrates	O	O
and	O	O
to	O	O
morphological	O	O
changes	O	O
associated	O	O
with	O	O
programmed	O	O
cell	O	O
death	O	O
.	O	O
Although	O	O
common	O	O
members	O	O
of	O	O
the	O	O
apoptotic	O	O
cascade	O	O
are	O	O
shared	O	O
between	O	O
different	O	O
cell	O	O
types,	O	O
it	O	O
appears	O	O
that	O	O
cell-specific	protein	protein
factors	protein	protein
can	O	O
influence	O	O
the	O	O
response	O	O
to	O	O
a	O	O
given	O	O
apoptotic	O	O
stimuli	O	O
.	O	O
Characterization	O	O
and	O	O
understanding	O	O
of	O	O
the	O	O
basic	O	protein
mechanisms	O	O
involved	O	O
in	O	O
the	O	O
different	O	O
pathways	O	O
protecting	O	O
or	O	O
leading	O	O
to	O	O
cell	O	O
death	O	O
may	O	O
provide	O	O
novel	O	O
ways	O	O
to	O	O
control	O	O
inappropriate	O	O
apoptosis	O	O
involved	O	O
in	O	O
several	O	O
diseases.	O	O

Cross-priming	O	O
of	O	O
CTL	O	O
responses	O	O
in	O	O
vivo	O	O
does	O	O
not	O	O
require	O	O
antigenic	O	O
peptides	O	O
in	O	O
the	O	O
endoplasmic	O	O
reticulum	O	O
of	O	O
immunizing	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
It	O	O
has	O	O
been	O	O
proposed	O	O
that	O	O
the	O	O
cross-priming	O	O
of	O	O
CTL	O	O
responses	O	O
in	O	O
vivo	O	O
involves	O	O
the	O	O
transfer	O	O
to	O	O
host	O	O
APCs	cell_type	cell_type
of	O	O
heat	protein	protein
shock	protein	protein
protein	protein	protein
glycoprotein	protein	protein
96	protein	protein
-chaperoned	O	O
antigenic	O	O
peptides	O	O
released	O	O
from	O	O
the	O	O
endoplasmic	O	O
reticulum	O	O
(	O	O
ER	O	protein
)	O	O
of	O	O
dying	O	O
or	O	O
infected	O	O
cells	O	O
.	O	O
We	O	O
have	O	O
tested	O	O
this	O	O
possibility	O	O
directly	O	O
using	O	O
TAP-deficient	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
lacking	O	O
antigenic	O	O
ER	O	protein
peptides	O	O
derived	O	O
from	O	O
two	O	O
model	O	O
Ags	protein	O
,	O	O
the	O	O
human	O	protein
adenovirus	O	protein
type	O	protein
5	O	protein
early	O	protein
regions	O	protein
E1A	O	protein
and	O	O
E1B	O	protein
.	O	O
Although	O	O
both	O	O
proteins	O	O
were	O	O
well	O	O
expressed,	O	O
the	O	O
cells	O	O
were	O	O
not	O	O
recognized	O	O
by	O	O
E1A-	O	protein
or	O	O
E1B-	O	O
specific	O	O
CTLs	O	cell_type
unless	O	O
the	O	O
relevant	O	O
epitope	O	O
was	O	O
either	O	O
provided	O	O
exogenously	O	O
as	O	O
a	O	O
synthetic	O	O
peptide	O	O
or	O	O
targeted	O	O
to	O	O
the	O	O
ER	O	protein
in	O	O
a	O	O
TAP-independent	O	O
fashion	O	O
.	O	O
Despite	O	O
the	O	O
absence	O	O
of	O	O
these	O	O
ER	O	protein
peptides,	O	O
the	O	O
TAP1-/-	cell_type	cell_line
cells	cell_type	cell_line
were	O	O
able	O	O
to	O	O
efficiently	O	O
cross-prime	O	O
E1A-	O	O
and	O	O
E1B-	O	O
specific	O	O
CTLs	O	cell_type
following	O	O
immunization	O	O
of	O	O
syngeneic	O	O
mice	O	O
.	O	O
These	O	O
results	O	O
indicate	O	O
that,	O	O
although	O	O
purified	O	O
peptide/glycoprotein	protein	O
96	protein	O
complexes	protein	O
are	O	O
potent	O	O
immunogens,	O	O
the	O	O
mechanism	O	O
of	O	O
CTL	O	O
cross-priming	O	O
in	O	O
vivo	O	O
does	O	O
not	O	O
depend	O	O
upon	O	O
antigenic	O	O
peptides	O	O
in	O	O
the	O	O
ER	O	protein
of	O	O
immunizing	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

A	O	O
critical	O	O
role	O	O
of	O	O
the	O	O
p75	protein	protein
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
receptor	protein	protein
(	O	O
p75TNF-R	protein	protein
)	O	O
in	O	O
organ	O	O
inflammation	O	O
independent	O	O
of	O	O
TNF	protein	protein
,	O	O
lymphotoxin	protein	protein
alpha	protein	protein
,	O	O
or	O	O
the	O	O
p55TNF-R.	protein	protein
Despite	O	protein
overwhelming	O	O
evidence	O	O
that	O	O
enhanced	O	O
production	O	O
of	O	O
the	O	O
p75	protein	protein
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
receptor	protein	protein
(	O	O
p75TNF-R	protein	protein
)	O	O
accompanies	O	O
development	O	O
of	O	O
specific	O	O
human	O	O
inflammatory	O	O
pathologies	O	O
such	O	O
as	O	O
multi-organ	O	O
failure	O	O
during	O	O
sepsis	O	O
,	O	O
inflammatory	O	O
liver	O	O
disease	O	O
,	O	O
pancreatitis	O	O
,	O	O
respiratory	O	O
distress	O	O
syndrome	O	O
,	O	O
or	O	O
AIDS	O	O
,	O	O
the	O	O
function	O	O
of	O	O
this	O	O
receptor	O	O
remains	O	O
poorly	O	O
defined	O	O
in	O	O
vivo.	O	O
We	O	O
show	O	O
here	O	O
that	O	O
at	O	O
levels	O	O
relevant	O	O
to	O	O
human	O	O
disease	O	O
,	O	O
production	O	O
of	O	O
the	O	O
human	protein	O
p75TNF-R	protein	protein
in	O	O
transgenic	O	O
mice	O	O
results	O	O
in	O	O
a	O	O
severe	O	O
inflammatory	O	O
syndrome	O	O
involving	O	O
mainly	O	O
the	O	O
pancreas	O	O
,	O	O
liver	O	O
,	O	O
kidney	O	O
,	O	O
and	O	O
lung	O	O
,	O	O
and	O	O
characterized	O	O
by	O	O
constitutively	O	O
increased	O	O
NF-kappaB	protein	protein
activity	O	O
in	O	O
the	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cell	cell_type	cell_type
compartment	O	O
.	O	O
This	O	O
process	O	O
is	O	O
shown	O	O
to	O	O
evolve	O	O
independently	O	O
of	O	O
the	O	O
presence	O	O
of	O	O
TNF	protein	protein
,	O	O
lymphotoxin	protein	protein
alpha	protein	protein
,	O	O
or	O	O
the	O	O
p55TNF-R	protein	protein
,	O	O
although	O	O
coexpression	O	O
of	O	O
a	O	O
human	DNA	O
TNF	DNA	protein
transgene	DNA	O
accelerated	O	O
pathology	O	O
.	O	O
These	O	O
results	O	O
establish	O	O
an	O	O
independent	O	O
role	O	O
for	O	O
enhanced	O	O
p75TNF-R	protein	protein
production	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
inflammatory	O	O
disease	O	O
and	O	O
implicate	O	O
the	O	O
direct	O	O
involvement	O	O
of	O	O
this	O	O
receptor	O	O
in	O	O
a	O	O
wide	O	O
range	O	O
of	O	O
human	O	O
inflammatory	O	O
pathologies	O	O
.	O	O

Expression	O	O
status	O	O
of	O	O
BCL-6	protein	protein
and	O	O
syndecan-1	protein	O
identifies	O	O
distinct	O	O
histogenetic	O	O
subtypes	O	O
of	O	O
Hodgkin's	O	O
disease	O	O
.	O	O
The	O	O
tumor	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
most	O	O
cases	O	O
of	O	O
Hodgkin's	O	O
disease	O	O
(	O	O
HD	O	O
)	O	O
have	O	O
been	O	O
recently	O	O
recognized	O	O
to	O	O
originate	O	O
from	O	O
the	O	O
B-cell	cell_type	cell_type
lineage	cell_type	cell_type
,	O	O
but	O	O
their	O	O
precise	O	O
differentiation	O	O
stage	O	O
is	O	O
not	O	O
fully	O	O
clarified.	O	O
Recently,	O	O
we	O	O
have	O	O
reported	O	O
that	O	O
the	O	O
histogenesis	O	O
of	O	O
B-cell	cell_type	O
lymphomas	cell_type	O
may	O	O
be	O	O
assessed	O	O
by	O	O
monitoring	O	O
the	O	O
expression	O	O
pattern	O	O
of	O	O
BCL-6	protein	protein
,	O	O
a	O	O
transcription	protein	protein
factor	protein	protein
expressed	O	O
in	O	O
germinal	cell_type	cell_type
center	cell_type	cell_type
(GC)	cell_type	cell_type
B	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
and	O	O
CD138/	protein	protein
syndecan-1	protein	protein
(	O	O
syn-1	protein	protein
),	O	O
a	O	O
proteoglycan	O	O
associated	O	O
with	O	O
post-GC,	O	O
terminal	O	O
B-cell	O	O
differentiation	O	O
.	O	O
In	O	O
this	O	O
study,	O	O
we	O	O
have	O	O
applied	O	O
these	O	O
two	O	O
markers	O	O
to	O	O
the	O	O
study	O	O
of	O	O
HD	O	O
histogenesis.	O	O
We	O	O
have	O	O
found	O	O
that	O	O
in	O	O
nodular	O	O
lymphocyte	O	O
predominance	O	O
HD	O	O
(	O	O
NLPHD	O	O
)	O	O
tumor	cell_type	cell_type
cells	cell_type	cell_type
consistently	O	O
display	O	O
the	O	O
BCL-6	protein	protein
(+)/	O	O
syn-1	protein	O
(-)	O	O
phenotype	O	O
,	O	O
indicating	O	O
their	O	O
derivation	O	O
from	O	O
GC	cell_type	cell_type
B	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Conversely,	O	O
classic	O	O
HD	O	O
(	O	O
CHD	O	O
)	O	O
is	O	O
heterogeneous	O	O
because	O	O
the	O	O
tumor	cell_type	O
cells	cell_type	O
of	O	O
a	O	O
fraction	O	O
of	O	O
CHD	O	O
display	O	O
the	O	O
BCL-6	protein	protein
(-)/	O	O
syn-1	protein	O
(+)	O	O
phenotype	O	O
of	O	O
post-GC	O	O
B-cells,	O	O
whereas	O	O
another	O	O
fraction	O	O
of	O	O
CHD	O	O
is	O	O
constituted	O	O
by	O	O
a	O	O
mixture	O	O
of	O	O
tumor	cell_type	cell_type
cells	cell_type	cell_type
reflecting	O	O
the	O	O
GC	O	O
(	O	O
BCL-6	protein	protein
(+)/	O	O
syn-1	protein	O
(-))	O	O
or	O	O
post-GC	O	O
(	O	O
BCL-6	protein	protein
(-)/	O	O
syn-1	protein	O
(+))	O	O
phenotypes	O	O
.	O	O
BCL-6	cell_line	protein
(-)/	cell_line	protein
syn-1	cell_line	protein
(+)	cell_line	O
tumor	cell_line	O
cells	cell_line	O
of	O	O
CHD	O	O
are	O	O
mostly	O	O
found	O	O
surrounded	O	O
by	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
expressing	O	O
CD40L	protein	protein
,	O	O
consistent	O	O
with	O	O
the	O	O
observation	O	O
that	O	O
CD40	protein	protein
signaling	O	O
downregulates	O	O
BCL-6	protein	protein
expression	O	O
.	O	O
These	O	O
data	O	O
indicate	O	O
that	O	O
tumor	cell_type	O
cells	cell_type	O
of	O	O
NLPHD	O	O
uniformly	O	O
display	O	O
a	O	O
GC	O	O
B-cell	O	O
phenotype	O	O
,	O	O
whereas	O	O
the	O	O
phenotype	O	O
of	O	O
tumor	cell_type	O
cells	cell_type	O
of	O	O
CHD	O	O
appears	O	O
to	O	O
be	O	O
modulated	O	O
by	O	O
the	O	O
surrounding	O	O
cellular	O	O
background,	O	O
particularly	O	O
CD40L	cell_type	protein
+	cell_type	O
reactive	cell_type	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Molecular	O	O
and	O	O
cellular	O	O
analysis	O	O
of	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
-induced	O	O
apoptosis	O	O
in	O	O
lymphoblastoid	O	O
T-cell-line-expressing	O	O
wild-type	O	O
and	O	O
mutated	O	protein
CD4	O	protein
receptors	protein	protein
.	O	O
We	O	O
have	O	O
previously	O	O
shown	O	O
that	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
CD4	protein	protein
cytoplasmic	protein	protein
tail	protein	protein
is	O	O
critical	O	O
for	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
(HIV)-induced	O	O
apoptosis	O	O
(J.Corbeil,	O	O
M.Tremblay,	O	O
and	O	O
D.D.Richman,	O	O
J.Exp.Med.183:39-48,	O	O
1996).	O	O
We	O	O
have	O	O
pursued	O	O
our	O	O
investigation	O	O
of	O	O
the	O	O
role	O	O
of	O	O
the	O	O
CD4	protein	protein
transduction	O	O
pathway	O	O
in	O	O
HIV-induced	O	O
apoptosis	O	O
.	O	O
To	O	O
do	O	O
this,	O	O
wild-type	O	O
and	O	O
mutant	O	O
forms	O	O
of	O	O
the	O	O
CD4	protein	protein
cytoplasmic	protein	protein
tail	protein	protein
were	O	O
stably	O	O
expressed	O	O
in	O	O
the	O	O
lymphoblastoid	cell_line	cell_line
T-cell	cell_line	cell_line
line	cell_line	cell_line
A2.01	cell_line	cell_line
.	O	O
Apoptosis	O	O
was	O	O
prevented	O	O
when	O	O
CD4	protein	protein
truncated	O	protein
at	O	O
residue	O	O
402	O	O
was	O	O
expressed;	O	O
however,	O	O
cells	O	O
expressing	O	O
mutated	O	protein
receptors	O	protein
that	O	O
do	O	O
not	O	O
associate	O	O
with	O	O
p56(lck)	protein	protein
(mutated	O	O
at	O	O
the	O	O
dicysteine	protein	O
motif	protein	O
and	O	O
truncated	O	O
at	O	O
residue	O	O
418	O	O
)	O	O
but	O	O
which	O	O
conserved	O	O
proximal	O	protein
domains	O	protein
of	O	O
the	O	O
cytoplasmic	protein	protein
tail	protein	protein
underwent	O	O
apoptosis	O	O
like	O	O
wild-	protein	O
type	protein	O
CD4	protein	protein
.	O	O
The	O	O
differences	O	O
between	O	O
wild-type	O	O
and	O	O
mutated	O	protein
receptors	O	protein
in	O	O
the	O	O
induction	O	O
of	O	O
apoptosis	O	O
were	O	O
not	O	O
related	O	O
to	O	O
levels	O	O
of	O	O
p56(lck)	protein	protein
or	O	O
NF-	protein	protein
kappaB	protein	protein
activation	O	O
.	O	O
Initial	O	O
signaling	O	O
through	O	O
the	O	O
CD4	protein	protein
receptor	protein	protein
played	O	O
a	O	O
major	O	O
role	O	O
in	O	O
the	O	O
sensitization	O	O
of	O	O
HIV-infected	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
to	O	O
undergo	O	O
apoptosis	O	O
.	O	O
Incubation	O	O
of	O	O
HIV-infected	cell_type	O
cells	cell_type	O
with	O	O
monoclonal	protein	protein
antibody	protein	protein
(MAb)	protein	protein
13B8-2	protein	protein
,	O	O
which	O	O
binds	O	O
to	O	O
CD4	protein	protein
in	O	O
a	O	O
region	O	O
critical	O	O
for	O	O
dimerization	O	O
of	O	O
the	O	O
receptor,	O	O
prevented	O	O
apoptosis	O	O
without	O	O
inhibiting	O	O
HIV	O	O
replication	O	O
.	O	O
Moreover,	O	O
the	O	O
apoptotic	O	O
process	O	O
was	O	O
not	O	O
related	O	O
to	O	O
Fas	protein	protein
-Fas	protein	protein
ligand	protein	protein
interaction	O	O
;	O	O
however,	O	O
an	O	O
antagonistic	O	O
anti-Fas	O	protein
MAb	O	protein
(ZB-4)	O	protein
enhanced	O	O
apoptosis	O	O
in	O	O
HIV-infected	cell_type	cell_type
cells	cell_type	cell_type
without	O	O
inducing	O	O
apoptosis	O	O
in	O	O
uninfected	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
These	O	O
observations	O	O
demonstrate	O	O
that	O	O
CD4	protein	protein
signaling	O	O
mediates	O	O
HIV-induced	O	O
apoptosis	O	O
by	O	O
a	O	O
mechanism	O	O
independent	O	O
of	O	O
Fas	protein	protein
-Fas	protein	protein
ligand	protein	protein
interaction	O	O
,	O	O
does	O	O
not	O	O
require	O	O
p56(lck)	protein	protein
signaling	O	O
,	O	O
and	O	O
may	O	O
involve	O	O
a	O	O
critical	O	O
region	O	O
for	O	O
CD4	protein	protein
dimerization	O	protein
.	O	O

p130	protein	protein
,	O	O
p107	protein	protein
,	O	O
and	O	O
pRb	protein	protein
are	O	O
differentially	O	O
regulated	O	O
in	O	O
proliferating	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
during	O	O
cell	O	O
cycle	O	O
arrest	O	O
by	O	O
alpha-interferon	protein	protein
.	O	O
We	O	O
have	O	O
determined	O	O
how	O	O
the	O	O
phosphorylation	O	O
of	O	O
the	O	O
retinoblastoma	protein	protein
family	protein	protein
(	O	O
pRb	protein	protein
,	O	O
p107	protein	protein
,	O	O
and	O	O
p130	protein	protein
)	O	O
is	O	O
governed	O	O
in	O	O
individual	O	O
cell	O	O
cycle	O	O
phases	O	O
of	O	O
Daudi	cell_line	cell_line
B-cells	cell_line	cell_line
during	O	O
cell	O	O
cycle	O	O
exit	O	O
triggered	O	O
by	O	O
alpha-interferon	protein	protein
(	O	O
alpha-IFN	protein	protein
).	O	O
alpha-IFN	protein	protein
causes	O	O
dephosphorylation	O	O
of	O	O
pRb	protein	protein
and	O	O
loss	O	O
of	O	O
p130	protein	protein
phosphorylated	protein	protein
Form	protein	protein
3	protein	protein
.	O	O
However,	O	O
the	O	O
change	O	O
in	O	O
p130	protein	O
phosphorylation	O	O
in	O	O
response	O	O
to	O	O
alpha-IFN	protein	protein
occurs	O	O
before	O	O
dephosphorylation	O	O
of	O	O
pRb	protein	protein
is	O	O
complete	O	O
because	O	O
loss	O	O
of	O	O
p130	protein	protein
Form	protein	protein
3	protein	protein
occurs	O	O
throughout	O	O
the	O	O
cell	O	O
cycle	O	O
prior	O	O
to	O	O
complete	O	O
arrest	O	O
in	O	O
G1,	O	O
whereas	O	O
pRb	protein	protein
is	O	O
dephosphorylated	O	O
only	O	O
in	O	O
G1	O	O
.	O	O
In	O	O
contrast,	O	O
p107	protein	protein
is	O	O
dephosphorylated	O	O
and	O	O
is	O	O
then	O	O
depleted	O	O
from	O	O
cells	O	O
as	O	O
they	O	O
exit	O	O
the	O	O
cell	O	O
cycle.	O	O
p130	protein	protein
,	O	O
predominantly	O	O
in	O	O
Form	O	O
1,	O	O
and	O	O
hypophosphorylated	protein	O
pRb	protein	protein
bind	O	O
an	O	O
E2F	DNA	protein
DNA	DNA	O
binding	DNA	O
site	DNA	O
;	O	O
p130	protein	protein
complexes	O	protein
E2F-4	protein	protein
,	O	O
whereas	O	O
pRb	protein	protein
binds	O	O
both	O	O
E2F-4	O	protein
and	O	O
E2F-1	protein	protein
.	O	O
The	O	O
phosphorylated	O	O
forms	O	O
of	O	O
E2F-4	protein	protein
that	O	O
bind	O	O
to	O	O
the	O	O
E2F	DNA	DNA
DNA	DNA	DNA
site	DNA	DNA
are	O	O
different	O	O
from	O	O
hyperphosphorylated	O	O
E2F-4	protein	protein
,	O	O
which	O	O
predominates	O	O
in	O	O
primary	cell_type	cell_type
hemopoietic	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
G0	O	O
.	O	O
We	O	O
conclude	O	O
that	O	O
although	O	O
cell	O	O
cycle	O	O
arrest	O	O
induced	O	O
by	O	O
alpha-IFN	protein	protein
may	O	O
be	O	O
mediated	O	O
in	O	O
part	O	O
by	O	O
formation	O	O
of	O	O
a	O	O
complex	O	O
containing	O	O
p130	protein	protein
and	O	O
E2F-4	protein	protein
,	O	O
alpha-IFN	protein	protein
does	O	O
not	O	O
induce	O	O
hyperphosphorylation	O	O
of	O	O
E2F-4	protein	protein
,	O	O
which	O	O
characterizes	O	O
primary	cell_type	cell_type
hemopoietic	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
G0	O	O
.	O	O

The	O	O
transcription	protein	protein
factors	protein	protein
c-myb	protein	protein
and	O	O
C/EBP	protein	protein
alpha	protein	protein
regulate	O	O
the	O	O
monocytic/myeloic	DNA	DNA
gene	DNA	DNA
MRP14	DNA	DNA
.	O	O
The	O	O
entry	O	O
of	O	O
microorganisms	O	O
into	O	O
the	O	O
body	O	O
induces	O	O
inflammatory	O	O
processes	O	O
.	O	O
During	O	O
this	O	O
process	O	O
a	O	O
sequence	O	O
of	O	O
cellular,	O	O
humoral,	O	O
non-specific	O	O
and	O	O
specific	O	O
actions	O	O
are	O	O
evoked	O	O
to	O	O
combat	O	O
the	O	O
infection.	O	O
Macrophages	cell_type	O
and	O	O
granulocytes	cell_type	cell_type
,	O	O
which	O	O
are	O	O
developed	O	O
from	O	O
a	O	O
common	O	O
progenitor	O	O
cell,	O	O
are	O	O
the	O	O
cellular	O	O
components	O	O
of	O	O
the	O	O
specific	O	O
and	O	O
non-specific	O	O
immunoreaction	O	O
.	O	O
MRP14	DNA	O
(	O	O
Macrophage	protein	protein
migration	protein	O
inhibitory	protein	O
related	protein	O
protein	protein	O
)	O	O
and	O	O
MRP8	protein	protein
,	O	O
two	O	O
S-100	protein	protein
proteins	protein	protein
contained	O	O
in	O	O
high	O	O
concentrations	O	O
in	O	O
these	O	O
cells	O	O
are	O	O
obviously	O	O
essential	O	O
for	O	O
adhesion	O	O
and	O	O
migration	O	O
of	O	O
monocytes	cell_type	cell_type
and	O	O
granulocytes	cell_type	cell_type
.	O	O
To	O	O
investigate	O	O
the	O	O
transcriptional	O	O
regulation	O	O
of	O	O
these	O	O
genes	O	O
we	O	O
cotransfected	O	O
constructs	O	O
expressing	O	O
CAT	protein	protein
under	O	O
control	O	O
of	O	O
the	O	O
MRP14	DNA	DNA
promoter	DNA	DNA
and	O	O
expression	O	O
constructs	O	O
of	O	O
C/EBP	protein	protein
alpha	protein	protein
and	O	O
v-myb	protein	protein
,	O	O
two	O	O
transcription	protein	protein
factors	protein	protein
involved	O	O
in	O	O
myeloid/monocytic	O	O
differentiation	O	O
.	O	O
Transfection	O	O
with	O	O
C/EBP	protein	protein
alpha	protein	protein
revealed	O	O
a	O	O
massive	O	O
enhancement	O	O
of	O	O
the	O	O
MRP14	DNA	DNA
promoter	DNA	DNA
in	O	O
both,	O	O
HL	cell_type	cell_line
60	cell_type	cell_line
cells	cell_type	cell_line
(granulocytic	O	O
differentiated)	O	O
and	O	O
L132	cell_type	protein
fibroblasts	cell_type	protein
.	O	O
In	O	O
contrast,	O	O
v-myb	protein	DNA
reduces	O	DNA
MRP14	DNA	DNA
promoter	DNA	DNA
activity	O	O
.	O	O
Northern	O	O
blot	O	O
analysis	O	O
of	O	O
L132	cell_type	cell_line
cells	cell_type	cell_line
transfected	O	O
with	O	O
the	O	O
C/EBP	protein	protein
alpha	protein	protein
expression	O	O
vector	O	O
demonstrate	O	O
that	O	O
C/EBP	protein	protein
alpha	protein	protein
is	O	O
sufficient	O	O
to	O	O
enhance	O	O
MRP14	protein	O
expression	O	O
in	O	O
the	O	O
context	O	O
of	O	O
the	O	O
whole	O	O
genome.	O	O

A	O	O
CD28	protein	protein
-associated	O	O
signaling	O	O
pathway	O	O
leading	O	O
to	O	O
cytokine	DNA	DNA
gene	DNA	DNA
transcription	O	O
and	O	O
T	O	O
cell	O	O
proliferation	O	O
without	O	O
TCR	protein	protein
engagement	O	O
.	O	O
Stimulation	O	O
of	O	O
resting	cell_type	cell_type
human	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
the	O	O
CD28	protein	protein
-specific	protein	O
mAb	protein	protein
BW	protein	protein
828	protein	protein
induces	O	O
proliferation	O	O
and	O	O
cytokine	protein	protein
synthesis	O	O
without	O	O
further	O	O
requirement	O	O
for	O	O
TCR	protein	protein
coengagement	O	O
.	O	O
This	O	O
observation	O	O
prompted	O	O
us	O	O
to	O	O
postulate	O	O
that	O	O
signal	O	protein
2	O	protein
(	O	protein
costimulatory	O	protein
signal	O	protein
)	O	O
alone	O	O
without	O	O
signal	O	O
1	O	O
(	O	O
TCR	protein	protein
signal	O	O
)	O	O
can	O	O
activate	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
To	O	O
test	O	O
whether	O	O
this	O	O
putative	O	O
function	O	O
of	O	O
CD28	protein	protein
is	O	O
mediated	O	O
via	O	O
a	O	O
particular	O	O
signaling	O	O
pathway,	O	O
we	O	O
compared	O	O
early	O	O
signaling	O	O
events	O	O
initiated	O	O
in	O	O
resting	O	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
the	O	O
stimulatory	protein	O
mAb	protein	protein
BW	protein	protein
828	protein	protein
with	O	O
signals	O	O
triggered	O	O
by	O	O
the	O	O
nonstimulating	protein	O
CD28	protein	protein
mAb	protein	protein
9.3	protein	protein
.	O	O
Stimulation	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
BW	protein	O
828	protein	O
induced	O	O
an	O	O
increase	O	O
in	O	O
intracellular	O	O
Ca2+	O	O
,	O	O
but	O	O
did	O	O
not	O	O
lead	O	O
to	O	O
detectable	O	O
activation	O	O
of	O	O
the	O	O
protein	protein	protein
kinases	protein	protein
p56(lck)	protein	protein
and	O	O
c-Raf-1	protein	protein
.	O	O
This	O	O
pathway	O	O
resulted	O	O
in	O	O
the	O	O
induction	O	O
of	O	O
the	O	O
transcription	protein	protein
factors	protein	protein
NF-kappa	protein	protein
B	protein	protein
,	O	O
NF-AT	protein	protein
,	O	O
and	O	O
proteins	O	O
binding	O	O
to	O	O
the	O	O
CD28	protein	DNA
response	O	DNA
element	O	DNA
of	O	O
the	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
.	O	O
On	O	O
the	O	O
other	O	O
hand,	O	O
stimulation	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
mAb	protein	protein
9.3	protein	protein
increased	O	O
the	O	O
level	O	O
of	O	O
intracellular	O	O
Ca2+	O	O
and	O	O
triggered	O	O
the	O	O
activation	O	O
of	O	O
p56(lck)	protein	protein
and	O	O
c-Raf-1	protein	protein
,	O	O
but	O	O
was	O	O
unable	O	O
to	O	O
induce	O	O
the	O	O
binding	O	O
of	O	O
transcription	protein	protein
factors	protein	protein
to	O	O
the	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
.	O	O
In	O	O
contrast	O	O
to	O	O
the	O	O
differential	O	O
signaling	O	O
of	O	O
BW	protein	O
828	protein	O
and	O	O
9.3	protein	O
in	O	O
resting	O	O
T	O	O
cells,	O	O
the	O	O
two	O	O
mAbs	O	protein
exhibited	O	O
a	O	O
similar	O	O
pattern	O	O
of	O	O
early	O	O
signaling	O	O
events	O	O
in	O	O
activated	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
Jurkat	cell_type	cell_line
cells	cell_type	cell_line
(	O	O
p56(lck)	protein	protein
activation	O	O
,	O	O
association	O	O
of	O	O
phosphatidylinositol	protein	protein
3-kinase	protein	protein
with	O	O
CD28	protein	protein
),	O	O
indicating	O	O
that	O	O
the	O	O
signaling	O	O
capacity	O	O
of	O	O
CD28	protein	protein
changes	O	O
with	O	O
activation.	O	O
These	O	O
data	O	O
support	O	O
the	O	O
view	O	O
that	O	O
stimulation	O	O
through	O	O
CD28	protein	protein
can	O	O
induce	O	O
some	O	O
effector	O	O
functions	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
suggest	O	O
that	O	O
this	O	O
capacity	O	O
is	O	O
associated	O	O
with	O	O
a	O	O
particular	O	O
pattern	O	O
of	O	O
early	O	O
signaling	O	O
events	O	O

Decreased	O	O
IL-12	protein	protein
production	O	O
and	O	O
Th1	O	O
cell	O	O
development	O	O
by	O	O
acetyl	O	O
salicylic	O	O
acid	O	O
-mediated	O	O
inhibition	O	O
of	O	O
NF-kappaB	protein	protein
.	O	O
IL-12	protein	protein
is	O	O
a	O	O
75-kDa	protein	protein
heterodimeric	protein	protein
cytokine	protein	protein
composed	O	O
of	O	O
two	O	O
covalently	O	O
linked	O	O
p35	O	O
and	O	O
p40	O	protein
chains	O	protein
.	O	O
This	O	O
pro-inflammatory	protein	protein
cytokine	protein	protein
plays	O	O
a	O	O
prominent	O	O
role	O	O
in	O	O
the	O	O
development	O	O
of	O	O
Th1	O	O
cell-mediated	O	O
immune	O	O
responses	O	O
.	O	O
Th1	O	O
cell-mediated	O	O
immune	O	O
responses	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
chronic	O	O
inflammatory	O	O
autoimmune	O	O
diseases	O	O
.	O	O
Thus,	O	O
IL-12	protein	protein
appears	O	O
to	O	O
be	O	O
a	O	O
critical	O	O
factor	O	O
in	O	O
the	O	O
generation	O	O
and	O	O
maintenance	O	O
of	O	O
chronic	O	O
inflammatory	O	O
conditions	O	O
.	O	O
In	O	O
this	O	O
study,	O	O
we	O	O
investigated	O	O
the	O	O
effects	O	O
of	O	O
a	O	O
commonly	O	O
prescribed	O	O
anti-inflammatory	O	O
drug	O	O
,	O	O
acetyl	O	O
salicylic	O	O
acid	O	O
(	O	O
ASA	O	O
),	O	O
on	O	O
IL-12	protein	protein
production	O	O
and	O	O
Th1	O	O
cell	O	O
development	O	O
.	O	O
ASA	O	O
was	O	O
found	O	O
to	O	O
inhibit	O	O
secretion	O	O
of	O	O
the	O	O
IL-12	protein	protein
heterodimer	protein	protein
as	O	O
well	O	O
as	O	O
p40	protein	protein
monomer	protein	protein
by	O	O
human	cell_type	cell_type
monocytic	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
This	O	O
was	O	O
associated	O	O
with	O	O
the	O	O
down-regulation	O	O
of	O	O
IL-12p40	RNA	RNA
mRNA	RNA	RNA
expression	O	O
.	O	O
Analysis	O	O
of	O	O
the	O	O
regulation	O	O
of	O	O
the	O	O
p40	DNA	DNA
gene	DNA	DNA
promoter	DNA	DNA
revealed	O	O
that	O	O
ASA	O	O
inhibited	O	O
NF-kappaB	protein	protein
activation	O	O
and	O	O
binding	O	O
to	O	O
the	O	O
p40-kappaB	DNA	DNA
site	DNA	DNA
in	O	O
the	O	O
p40	DNA	DNA
promoter	DNA	DNA
,	O	O
leading	O	O
to	O	O
transcriptional	O	O
repression	O	O
of	O	O
the	O	O
p40	DNA	DNA
gene	DNA	DNA
.	O	O
Addition	O	O
of	O	O
ASA	O	O
to	O	O
an	O	O
in	O	O
vitro	O	O
T	O	O
helper	O	O
cell	O	O
differentiation	O	O
system	O	O
,	O	O
at	O	O
concentrations	O	O
compatible	O	O
with	O	O
plasma	O	O
levels	O	O
reached	O	O
during	O	O
anti-inflammatory	O	O
therapy	O	O
,	O	O
resulted	O	O
in	O	O
reduced	O	O
development	O	O
of	O	O
Th1	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
These	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
inhibition	O	O
of	O	O
NF-kappaB	protein	protein
activation	O	O
by	O	O
ASA	O	O
leads	O	O
to	O	O
down-regulation	O	O
of	O	O
IL-12	protein	protein
production	O	O
and	O	O
inhibition	O	O
of	O	O
Th1	O	O
cell	O	O
development	O	O
.	O	O

Attenuation	O	O
of	O	O
HLA-DR	protein	protein
expression	O	O
by	O	O
mononuclear	cell_type	cell_type
phagocytes	cell_type	cell_type
infected	O	O
with	O	O
Mycobacterium	O	O
tuberculosis	O	O
is	O	O
related	O	O
to	O	O
intracellular	O	O
sequestration	O	O
of	O	O
immature	protein	protein
class	protein	protein
II	protein	protein
heterodimers	protein	protein
.	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
expression	O	O
was	O	O
examined	O	O
in	O	O
macrophages	cell_type	cell_type
infected	O	O
with	O	O
Mycobacterium	O	O
tuberculosis	O	O
.	O	O
IFN-gamma	protein	protein
increased	O	O
the	O	O
surface	O	O
expression	O	O
of	O	O
class	protein	protein
II	protein	protein
molecules	protein	protein
in	O	O
THP-1	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
this	O	O
was	O	O
markedly	O	O
reduced	O	O
in	O	O
cells	O	O
infected	O	O
with	O	O
M.	O	O
tuberculosis	O	O
.	O	O
Despite	O	O
this	O	O
effect,	O	O
steady	O	O
state	O	O
levels	O	O
of	O	O
HLA-DRalpha	protein	protein
,	O	O
HLA-DRbeta	protein	protein
,	O	O
and	O	O
invariant	protein	O
(Ii)	protein	O
chains	protein	O
were	O	O
equivalent	O	O
in	O	O
control	O	O
and	O	O
infected	O	O
cells	O	O
.	O	O
Metabolic	O	O
labeling	O	O
combined	O	O
with	O	O
pulse-chase	O	O
experiments	O	O
and	O	O
biochemical	O	O
analysis	O	O
showed	O	O
that	O	O
the	O	O
majority	O	O
of	O	O
class	protein	protein
II	protein	protein
molecules	protein	protein
in	O	O
infected	O	cell_type
cells	O	cell_type
became	O	O
resistant	O	O
to	O	O
endoglycosidase	protein	protein
H	protein	protein
,	O	O
consistent	O	O
with	O	O
normal	O	O
Golgi	O	O
processing	O	O
.	O	O
However,	O	O
results	O	O
of	O	O
intracellular	O	O
staining	O	O
and	O	O
dual	O	O
color	O	O
confocal	O	O
microscopy	O	O
revealed	O	O
a	O	O
significant	O	O
defect	O	O
in	O	O
transport	O	O
of	O	O
newly	O	O
synthesized	O	O
class	protein	protein
II	protein	protein
molecules	protein	protein
through	O	O
the	O	O
endocytic	O	O
compartment	O	O
.	O	O
Thus,	O	O
compared	O	O
with	O	O
findings	O	O
in	O	O
control	O	O
cells,	O	O
class	protein	protein
II	protein	protein
molecules	protein	protein
in	O	O
infected	cell_type	cell_type
cells	cell_type	cell_type
colocalized	O	O
to	O	O
a	O	O
minimal	O	O
extent	O	O
with	O	O
a	O	O
lysosomal-associated	protein	protein
membrane	protein	protein
protein-1	protein	protein
+	O	O
endosomal	O	O
compartment	O	O
.	O	O
In	O	O
addition,	O	O
in	O	O
contrast	O	O
to	O	O
control	cell_type	O
cells	cell_type	O
,	O	O
class	protein	protein
II	protein	protein
molecules	protein	protein
in	O	O
infected	cell_type	cell_type
cells	cell_type	cell_type
failed	O	O
to	O	O
colocalize	O	O
with	O	O
endocytosed	protein	O
BSA	protein	O
under	O	O
conditions	O	O
where	O	O
this	O	O
marker	O	O
is	O	O
known	O	O
to	O	O
label	O	O
late	O	O
endosomes	O	O
,	O	O
lysosomes	O	O
,	O	O
and	O	O
the	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
compartment	O	protein
.	O	O
Consistent	O	O
with	O	O
defective	O	O
transport	O	O
along	O	O
the	O	O
endocytic	O	O
pathway	O	O
,	O	O
the	O	O
maturation	O	O
of	O	O
SDS-stable	protein	O
class	protein	protein
II	protein	protein
alphabeta	protein	protein
dimers	protein	protein
--dependent	O	O
upon	O	O
removal	O	O
of	O	O
Ii	protein	O
chain	protein	O
and	O	O
peptide	O	O
loading	O	O
of	O	O
class	protein	protein
II	protein	protein
dimers	protein	protein
in	O	O
the	O	O
MHC	protein	DNA
class	protein	DNA
II	protein	DNA
compartment	O	O
--was	O	O
markedly	O	O
impaired	O	O
in	O	O
M.	O	O
tuberculosis	O	O
-infected	cell_type	O
cells	cell_type	O
.	O	O
These	O	O
findings	O	O
indicate	O	O
that	O	O
defective	O	O
transport	O	O
and	O	O
processing	O	O
of	O	O
class	protein	protein
II	protein	protein
molecules	protein	protein
through	O	O
the	O	O
endosomal/lysosomal	O	O
system	O	O
is	O	O
responsible	O	O
for	O	O
diminished	O	O
cell	O	O
surface	O	O
expression	O	O
of	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
molecules	protein	protein
in	O	O
cells	O	O
infected	O	O
with	O	O
M.	O	O
tuberculosis	O	O
.	O	O

Identification	O	O
of	O	O
upstream	DNA	DNA
regulatory	DNA	DNA
elements	DNA	DNA
that	O	O
repress	O	O
expression	O	O
of	O	O
adult	DNA	O
beta-like	DNA	DNA
globin	DNA	DNA
genes	DNA	DNA
in	O	O
a	O	O
primitive	O	O
erythroid	O	O
environment	O	O
.	O	O
Our	O	O
investigations	O	O
have	O	O
focused	O	O
on	O	O
localizing	O	O
cis-elements	DNA	DNA
responsible	O	O
for	O	O
the	O	O
down	O	O
regulation	O	O
of	O	O
the	O	O
adult	DNA	O
beta-like	DNA	DNA
globin	DNA	DNA
genes	DNA	DNA
(	O	O
delta	DNA	O
and	O	O
beta	DNA	O
)	O	O
in	O	O
immature	O	cell_type
,	O	O
or	O	O
primitive	O	O
erythroid	O	O
tissues	O	O
.	O	O
We	O	O
studied	O	O
their	O	O
activity	O	O
after	O	O
transfection	O	O
into	O	O
K562	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
an	O	O
erythroleukemia	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
with	O	O
an	O	O
embryonic-fetal	O	O
phenotype	O	O
.	O	O
Analyzed	O	O
DNA	DNA	O
sequences	DNA	O
included	O	O
delta	O	O
and	O	O
beta	O	O
5'	O	DNA
flanking	O	DNA
regions	O	DNA
extending	O	O
from	O	O
approximately	O	O
-500	DNA	O
to	DNA	O
+50bp	DNA	DNA
(	O	DNA
promoter	DNA	DNA
regions	DNA	DNA
),	O	O
truncated	O	O
delta	O	O
and	O	O
beta	DNA	O
5'	DNA	DNA
flanking	DNA	DNA
regions	DNA	DNA
extending	O	O
from	O	O
approximately	O	O
-250	DNA	O
to	DNA	O
+50	DNA	O
bp	DNA	O
,	O	O
and	O	O
chimeric	DNA	O
promoter	DNA	O
constructions	DNA	O
,	O	O
which	O	O
consisted	O	O
of	O	O
a	O	O
distal	O	O
delta	O	O
or	O	O
beta	O	O
fragment	O	O
fused	O	O
to	O	O
a	O	O
proximal	O	DNA
beta	O	DNA
or	O	O
delta	O	O
sequence	O	O
.	O	O
In	O	O
CAT	DNA	protein
reporter	DNA	O
constructions	DNA	O
no	O	O
appreciable	O	O
level	O	O
of	O	O
CAT	protein	protein
activity	O	O
was	O	O
supported	O	O
by	O	O
the	O	O
beta	DNA	DNA
globin	DNA	DNA
promoter	DNA	DNA
,	O	O
and	O	O
only	O	O
low	O	O
level	O	O
activity	O	O
by	O	O
the	O	O
delta	DNA	DNA
promoter	DNA	DNA
.	O	O
Truncation	O	O
of	O	O
the	O	O
beta	DNA	DNA
globin	DNA	DNA
promoter	DNA	DNA
led	O	O
to	O	O
a	O	O
2-3	O	O
fold	O	O
increase	O	O
in	O	O
promoter	O	O
activity	O	O
.	O	O
In	O	O
contrast,	O	O
deletion	O	O
of	O	O
the	O	O
upstream	DNA	O
portion	DNA	O
of	O	O
the	O	O
delta	DNA	DNA
promoter	DNA	DNA
led	O	O
to	O	O
a	O	O
10	O	O
fold	O	O
decrease	O	O
in	O	O
expression.	O	O
Coupling	O	O
of	O	O
the	O	O
upstream	DNA	DNA
beta	DNA	DNA
globin	DNA	DNA
sequence	DNA	DNA
from	O	O
approximately	O	O
-500	O	O
to	O	O
-250	O	DNA
bp	O	DNA
to	O	O
the	O	O
truncated	O	DNA
delta	DNA	DNA
promoter	DNA	DNA
fragment	O	DNA
led	O	O
to	O	O
complete	O	O
extinction	O	O
of	O	O
transcription	O	O
activity,	O	O
consistent	O	O
with	O	O
a	O	O
negative	O	O
regulatory	O	O
effect	O	O
of	O	O
the	O	O
beta	DNA	DNA
globin	DNA	DNA
gene	DNA	DNA
upstream	DNA	DNA
element	DNA	DNA
(s).	O	O
Fusion	O	O
of	O	O
the	O	O
upstream	DNA	O
portion	DNA	O
of	O	O
the	O	O
delta	DNA	DNA
promoter	DNA	DNA
to	O	O
the	O	O
truncated	O	protein
beta	DNA	protein
globin	DNA	protein
promoter	DNA	O
yielded	O	O
a	O	O
modest	O	O
increase	O	O
in	O	O
promoter	O	O
strength	O	O
relative	O	O
to	O	O
the	O	O
truncated	DNA	DNA
beta	DNA	DNA
gene	DNA	DNA
promoter	DNA	DNA
,	O	O
indicating	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
positive	DNA	DNA
transcriptional	DNA	DNA
element	DNA	DNA
(s)	O	O
in	O	O
the	O	O
upstream	DNA	O
delta	DNA	O
globin	DNA	DNA
regulatory	DNA	DNA
region	DNA	DNA
.	O	O
Site-directed	O	O
mutagenesis	O	O
of	O	O
binding	O	O
sites	O	O
for	O	O
the	O	O
repressor	O	protein
proteins	O	protein
BP1	O	protein
and	O	O
BP2	O	protein
in	O	O
the	O	O
upstream	DNA	O
portion	DNA	O
of	O	O
the	O	O
beta	DNA	DNA
globin	DNA	DNA
gene	DNA	DNA
flanking	DNA	DNA
region	DNA	DNA
led	O	O
to	O	O
a	O	O
4-6	O	O
fold	O	O
increase	O	O
in	O	O
promoter	O	O
activity	O	O
.	O	O
DNase	protein	protein
I	protein	protein
footprinting	O	O
of	O	O
the	O	O
upstream	DNA	DNA
delta-globin	DNA	DNA
region	DNA	DNA
revealed	O	O
protected	DNA	O
sequences	DNA	O
corresponding	O	O
to	O	O
consensus	DNA	DNA
binding	DNA	DNA
sites	DNA	DNA
for	O	O
GATA-1	protein	protein
and	O	O
BP2	protein	protein
.	O	O
These	O	O
results	O	O
confirm	O	O
that	O	O
sequences	O	O
in	O	O
the	O	O
upstream	DNA	DNA
promoter	DNA	DNA
region	DNA	DNA
of	O	O
the	O	O
adult	DNA	DNA
beta	DNA	DNA
globin	DNA	DNA
gene	DNA	DNA
contribute	O	O
to	O	O
its	O	O
factor-mediated	O	O
suppression	O	O
early	O	O
in	O	O
development	O	O
and	O	O
then	O	O
may	O	O
modulate	O	O
its	O	O
expression	O	O
at	O	O
a	O	O
later	O	O
stage.	O	O

Analysis	O	O
of	O	O
cytokine	protein	protein
signaling	O	O
in	O	O
patients	O	O
with	O	O
extrinsic	O	O
asthma	O	O
and	O	O
hyperimmunoglobulin	O	O
E	O	O
.	O	O
BACKGROUND:	O	O
Recent	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
regulation	O	O
of	O	O
class	O	O
switching	O	O
to	O	O
IgE	protein	protein
by	O	O
cytokines	protein	protein
is	O	O
mediated	O	O
by	O	O
STAT	protein	protein
transcription	protein	protein
factors	protein	protein
.	O	O
The	O	O
induction	O	O
of	O	O
IgE	protein	protein
by	O	O
IL-4	protein	protein
and	O	O
IL-13	protein	protein
occurs	O	O
through	O	O
the	O	O
activation	O	O
of	O	O
the	O	O
intracellular	protein	protein
signal-transducing	protein	protein
protein	protein	protein
Stat6	protein	protein
,	O	O
whereas	O	O
the	O	O
inhibition	O	O
of	O	O
IgE	protein	protein
class	O	protein
switching	O	O
by	O	O
interferon-y	protein	O
(	O	O
IFN-gamma	protein	protein
)	O	O
occurs	O	O
through	O	O
the	O	O
activation	O	O
of	O	O
Statl	protein	protein
.	O	O
OBJECTIVE:	O	O
We	O	O
hypothesized	O	O
that	O	O
in	O	O
extrinsic	O	O
asthma	O	O
or	O	O
in	O	O
cases	O	O
of	O	O
markedly	O	O
elevated	O	O
IgE	protein	protein
(ie,	O	O
hyperimmunoglobulin	O	O
E	O	O
[	O	O
HIE	O	O
])	O	O
increased	O	O
levels	O	O
of	O	O
IgE	protein	protein
may	O	O
be	O	O
associated	O	O
with	O	O
alterations	O	O
in	O	O
the	O	O
cytokine	protein	protein
levels	O	O
or	O	O
the	O	O
activation	O	O
of	O	O
Stat6	protein	protein
.	O	O
METHODS:	O	O
PBMCs	cell_type	cell_type
and	O	O
sera	O	O
from	O	O
8	O	O
patients	O	O
with	O	O
extrinsic	O	O
asthma	O	O
(mean	O	O
IgE	protein	protein
,	O	O
285+/-100	O	O
IU/mL),	O	O
3	O	O
patients	O	O
with	O	O
HIE	O	O
(mean	O	O
IgE	protein	protein
,	O	O
7050+/-1122	O	O
IU/mL),	O	O
and	O	O
14	O	O
nonatopic	O	O
control	O	O
subjects	O	O
(mean	O	O
IgE	protein	protein
,	O	O
112+/-28	O	O
IU/mL)	O	O
were	O	O
analyzed.	O	O
RESULTS:	O	O
The	O	O
mean	O	O
IL-4	protein	protein
level	O	O
detected	O	O
by	O	O
ELISA	O	O
was	O	O
much	O	O
greater	O	O
in	O	O
patients	O	O
with	O	O
HIE	O	O
than	O	O
control	O	O
subjects	O	O
(88.6+/-11.5	O	O
pg/mL	O	O
vs	O	O
11.5+/-7.1	O	O
pg/mL,	O	O
P	O	O
=	O	O
.005),	O	O
and	O	O
increased	O	O
IL-4	protein	protein
levels	O	O
among	O	O
patients	O	O
with	O	O
both	O	O
asthma	O	O
and	O	O
HIE	O	O
correlated	O	O
with	O	O
the	O	O
increased	O	O
IgE	protein	protein
levels	O	O
.	O	O
In	O	O
contrast,	O	O
IL-13	protein	protein
levels	O	O
were	O	O
not	O	O
elevated.	O	O
Levels	O	O
of	O	O
Stat6	protein	protein
protein	O	protein
present	O	O
in	O	O
PBMCs	cell_type	cell_type
did	O	O
not	O	O
differ	O	O
in	O	O
the	O	O
patients	O	O
and	O	O
control	O	O
subjects.	O	O
Examination	O	O
of	O	O
Stat6	protein	protein
DNA-binding	O	O
activity	O	O
demonstrated	O	O
no	O	O
activation	O	O
of	O	O
IL-4	protein	protein
signaling	O	O
in	O	O
patients	O	O
with	O	O
either	O	O
HIE	O	O
or	O	O
acute	O	O
asthma.	O	O
Interestingly,	O	O
evidence	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
that	O	O
have	O	O
already	O	O
switched	O	O
to	O	O
IgE	protein	protein
was	O	O
seen	O	O
in	O	O
PBMCs	cell_type	cell_type
of	O	O
several	O	O
patients	O	O
with	O	O
asthma	O	O
or	O	O
HIE	O	O
.	O	O
CONCLUSION:	O	O
These	O	O
results	O	O
indicate	O	O
that	O	O
(1)	O	O
IgE	protein	protein
production	O	O
in	O	O
asthma	O	O
and	O	O
HIE	O	O
usually	O	O
is	O	O
associated	O	O
with	O	O
elevated	O	O
levels	O	O
of	O	O
IL-4	protein	protein
,	O	O
but	O	O
not	O	O
IL-13	protein	protein
,	O	O
in	O	O
the	O	O
peripheral	O	O
blood;	O	O
(2)	O	O
the	O	O
increased	O	O
sera	O	O
IL-4	protein	O
levels	O	O
in	O	O
asthma	O	O
and	O	O
HIE	O	O
are	O	O
not	O	O
sufficient	O	O
to	O	O
induce	O	O
Stat6	protein	protein
activation	O	O
in	O	O
PBMCs	cell_type	cell_type
;	O	O
and	O	O
(3)	O	O
evidence	O	O
of	O	O
switch	O	O
recombination	O	O
to	O	O
epsilon	O	O
may	O	O
be	O	O
detected	O	O
in	O	O
isolated	O	O
cases	O	O
of	O	O
elevated	O	O
IgE	protein	protein
.	O	O
This	O	O
implies	O	O
that	O	O
high	O	O
levels	O	O
of	O	O
IgE	protein	protein
in	O	O
these	O	O
patients	O	O
either	O	O
results	O	O
from	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
that	O	O
have	O	O
already	O	O
undergone	O	O
class	O	O
switching	O	O
,	O	O
from	O	O
Ig	O	O
class	O	O
switching	O	O
that	O	O
is	O	O
localized	O	O
to	O	O
target	O	O
tissues	O	O
,	O	O
or	O	O
both.	O	O

Carboxyl-terminal	protein	protein
15-amino	protein	protein
acid	protein	protein
sequence	protein	protein
of	O	O
NFATx1	protein	protein
is	O	O
possibly	O	O
created	O	O
by	O	O
tissue-specific	O	O
splicing	O	O
and	O	O
is	O	O
essential	O	O
for	O	O
transactivation	O	O
activity	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
NFAT	protein	protein
regulates	O	O
transcription	O	O
of	O	O
a	O	O
number	O	O
of	O	O
cytokine	O	protein
and	O	O
other	O	O
immunoregulatory	DNA	DNA
genes	DNA	DNA
.	O	O
We	O	O
have	O	O
isolated	O	O
NFATx	protein	protein
,	O	O
which	O	O
is	O	O
one	O	O
of	O	O
four	O	O
members	O	O
of	O	O
the	O	O
NFAT	protein	protein
family	protein	protein
of	O	O
transcription	protein	protein
factors	protein	protein
and	O	O
is	O	O
preferentially	O	O
expressed	O	O
in	O	O
the	O	O
thymus	O	O
and	O	O
peripheral	cell_type	O
blood	cell_type	O
leukocytes	cell_type	cell_type
,	O	O
and	O	O
an	O	O
isoform	O	O
of	O	O
NFATx	protein	protein
,	O	O
NFATx1	protein	protein
.	O	O
Here	O	O
we	O	O
provide	O	O
evidence	O	O
showing	O	O
that	O	O
15	O	O
amino	O	O
acids	O	O
in	O	O
the	O	O
carboxyl-terminal	protein	protein
end	protein	protein
of	O	O
NFATx1	protein	protein
are	O	O
required	O	O
for	O	O
its	O	O
maximum	O	O
transactivation	O	O
activity	O	O
in	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
A	O	O
fusion	O	O
between	O	O
these	O	O
15	O	O
amino	O	O
acids	O	O
and	O	O
the	O	O
GAL4	protein	protein
DNA	protein	protein
binding	protein	protein
domain	protein	protein
was	O	O
capable	O	O
of	O	O
transactivating	O	O
reporters	O	O
driven	O	O
by	O	O
the	O	O
GAL4	DNA	protein
DNA	DNA	O
binding	DNA	O
site	DNA	O
.	O	O
Interestingly,	O	O
this	O	O
15-amino	protein	O
acid	protein	O
transactivation	protein	O
sequence	protein	O
is	O	O
well	O	O
conserved	O	O
in	O	O
NFAT	protein	protein
family	protein	protein
proteins	protein	protein
,	O	O
although	O	O
the	O	O
sequences	O	O
contiguous	O	O
to	O	O
the	O	O
carboxyl-terminal	protein	protein
regions	protein	protein
of	O	O
the	O	O
NFAT	protein	protein
family	protein	protein
are	O	O
much	O	O
less	O	O
conserved.	O	O
We	O	O
also	O	O
report	O	O
three	O	O
additional	O	O
isoforms	O	O
of	O	O
NFATx	protein	protein
,	O	O
designated	O	O
NFATx2	protein	protein
,	O	O
NFATx3	protein	protein
,	O	O
and	O	O
NFATx4	protein	protein
.	O	O
This	O	O
transactivation	O	O
sequence	O	O
is	O	O
altered	O	O
by	O	O
tissue-specific	O	O
alternative	O	O
splicing	O	O
in	O	O
newly	O	O
isolated	O	O
NFATx	protein	protein
isoforms	protein	protein
,	O	O
resulting	O	O
in	O	O
lower	O	O
transactivation	O	O
activity	O	O
in	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
NFATx1	protein	protein
is	O	O
expressed	O	O
predominantly	O	O
in	O	O
the	O	O
thymus	O	O
and	O	O
peripheral	cell_type	O
blood	cell_type	O
leukocyte	cell_type	O
,	O	O
while	O	O
the	O	O
skeletal	O	O
muscle	O	O
expressed	O	O
primarily	O	O
NFATx2	protein	protein
.	O	O
In	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
transcription	O	O
from	O	O
the	O	O
NFAT	DNA	DNA
site	DNA	DNA
of	O	O
the	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
is	O	O
activated	O	O
strongly	O	O
by	O	O
NFATx1	protein	protein
but	O	O
only	O	O
weakly	O	O
by	O	O
NFATx2	protein	protein
.	O	O
These	O	O
data	O	O
demonstrate	O	O
that	O	O
the	O	O
15-amino	protein	DNA
acid	protein	DNA
sequence	protein	DNA
of	O	O
NFATx1	protein	protein
is	O	O
a	O	O
major	protein	DNA
transactivation	protein	DNA
sequence	protein	DNA
required	O	O
for	O	O
induction	O	O
of	O	O
genes	O	O
by	O	O
NFATx1	protein	protein
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
possibly	O	O
regulates	O	O
NFAT	protein	protein
activity	O	O
through	O	O
tissue-specific	O	O
alternative	O	O
splicing	O	O
.	O	O

Altered	protein	O
DNA-binding	protein	O
specificity	protein	O
mutants	protein	O
of	O	O
EKLF	protein	protein
and	O	O
Sp1	O	protein
show	O	O
that	O	O
EKLF	protein	protein
is	O	O
an	O	O
activator	O	O
of	O	O
the	O	O
beta-globin	DNA	DNA
locus	DNA	DNA
control	DNA	DNA
region	DNA	DNA
in	O	O
vivo.	O	O
The	O	O
locus	DNA	DNA
control	DNA	DNA
region	DNA	DNA
of	O	O
the	O	O
beta-globin	DNA	DNA
cluster	DNA	DNA
contains	O	O
five	O	O
DNase	DNA	DNA
I	DNA	DNA
hypersensitive	DNA	DNA
sites	DNA	DNA
(	O	O
5'HS1-5	DNA	DNA
)	O	O
required	O	O
for	O	O
locus	O	O
activation	O	O
.	O	O
5'HS3	DNA	DNA
contains	O	O
six	O	O
G-rich	DNA	DNA
motifs	DNA	DNA
that	O	O
are	O	O
essential	O	O
for	O	O
its	O	O
activity.	O	O
Members	O	O
of	O	O
a	O	O
protein	O	O
family,	O	O
characterized	O	O
by	O	O
three	O	O
zinc	protein	protein
fingers	protein	protein
highly	O	O
homologous	O	O
to	O	O
those	O	O
found	O	O
in	O	O
transcription	protein	O
factor	protein	O
Sp1	protein	protein
,	O	O
interact	O	O
with	O	O
these	O	O
motifs.	O	O
Because	O	O
point	O	O
mutagenesis	O	O
cannot	O	O
distinguish	O	O
between	O	O
family	O	O
members,	O	O
it	O	O
is	O	O
not	O	O
known	O	O
which	O	O
protein	O	O
activates	O	O
5'HS3	DNA	DNA
.	O	O
We	O	O
show	O	O
that	O	O
the	O	O
function	O	O
of	O	O
such	O	O
closely	O	O
related	O	O
proteins	O	O
can	O	O
be	O	O
distinguished	O	O
in	O	O
vivo	O	O
by	O	O
matching	O	O
point	O	O
mutations	O	O
in	O	O
5'HS3	DNA	DNA
with	O	O
amino	O	O
acid	O	O
changes	O	O
in	O	O
the	O	O
zinc	protein	O
fingers	protein	O
of	O	O
Sp1	protein	protein
and	O	O
EKLF	protein	protein
.	O	O
Testing	O	O
their	O	O
activity	O	O
in	O	O
transgenic	O	O
mice	O	O
shows	O	O
that	O	O
EKLF	protein	protein
is	O	O
a	O	O
direct	O	O
activator	O	O
of	O	O
5'HS3	DNA	DNA
.	O	O

The	O	O
Epstein-Barr	protein	O
virus	protein	O
Rta	protein	protein
protein	protein	protein
activates	O	O
lytic	DNA	DNA
cycle	DNA	DNA
genes	DNA	DNA
and	O	O
can	O	O
disrupt	O	O
latency	O	O
in	O	O
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
The	O	O
transition	O	O
of	O	O
Epstein-Barr	O	O
virus	O	O
(	O	O
EBV	O	O
)	O	O
from	O	O
latency	O	O
into	O	O
the	O	O
lytic	O	O
cycle	O	O
is	O	O
associated	O	O
with	O	O
the	O	O
expression	O	O
of	O	O
two	O	O
immediate-early	DNA	DNA
viral	DNA	DNA
genes	DNA	DNA
,	O	O
BZLF1	DNA	DNA
and	O	O
BRLF1	DNA	protein
.	O	O
Overexpression	O	O
of	O	O
ZEBRA,	O	O
the	O	O
product	O	O
of	O	O
BZLF1	DNA	protein
,	O	O
is	O	O
sufficient	O	O
to	O	O
disrupt	O	O
latency	O	O
in	O	O
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
and	O	O
epithelial	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
stimulating	O	O
expression	O	O
of	O	O
lytic	DNA	DNA
cycle	DNA	DNA
genes	DNA	DNA
,	O	O
including	O	O
BRLF1	DNA	protein
.	O	O
The	O	O
BRLF1	protein	protein
product	protein	protein
Rta	protein	protein
functions	O	O
as	O	O
a	O	O
transcriptional	O	protein
activator	O	protein
in	O	O
both	O	O
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
and	O	O
epithelial	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
However,	O	O
Rta	protein	O
has	O	O
recently	O	O
been	O	O
reported	O	O
to	O	O
disrupt	O	O
latency	O	O
in	O	O
an	O	O
epithelial	O	O
specific	O	O
manner	O	O
(S.	O	O
Zalani,	O	O
E.	O	O
Holley-Guthrie,	O	O
and	O	O
S.	O	O
Kenney,	O	O
Proc.	O	O
Natl.	O	O
Acad.	O	O
Sci.	O	O
USA	O	O
93:9194-9199,	O	O
1996).	O	O
Here	O	O
we	O	O
demonstrate	O	O
that	O	O
expression	O	O
of	O	O
Rta	protein	protein
is	O	O
also	O	O
sufficient	O	O
for	O	O
disruption	O	O
of	O	O
latency	O	O
in	O	O
a	O	O
permissive	cell_line	cell_line
B-cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
In	O	O
HH514-16	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
transfection	O	O
of	O	O
Rta	protein	O
leads	O	O
to	O	O
synthesis	O	O
of	O	O
ZEBRA	protein	protein
,	O	O
viral	O	O
DNA	O	O
replication	O	O
,	O	O
and	O	O
late	O	O
gene	O	O
expression	O	O
.	O	O
However,	O	O
Rta	protein	O
by	O	O
itself	O	O
is	O	O
less	O	O
potent	O	O
than	O	O
ZEBRA	protein	protein
in	O	O
the	O	O
ability	O	O
to	O	O
activate	O	O
most	O	O
early	O	O
and	O	O
late	O	O
lytic	DNA	O
cycle	DNA	O
genes	DNA	O
.	O	O
In	O	O
light	O	O
of	O	O
previous	O	O
work	O	O
implicating	O	O
ZEBRA	protein	protein
in	O	O
the	O	O
activation	O	O
of	O	O
Rta	protein	O
,	O	O
we	O	O
suggest	O	O
a	O	O
cooperative	O	O
model	O	O
for	O	O
EBV	O	O
entry	O	O
into	O	O
the	O	O
lytic	O	O
cycle	O	O
.	O	O
Expression	O	O
of	O	O
either	O	O
BZLF1	DNA	protein
or	O	O
BRLF1	DNA	O
triggers	O	O
expression	O	O
of	O	O
the	O	O
other	O	O
immediate-early	protein	protein
factor	protein	protein
,	O	O
and	O	O
together	O	O
these	O	O
activators	O	O
act	O	O
individually	O	O
or	O	O
in	O	O
synergy	O	O
on	O	O
downstream	DNA	O
targets	DNA	O
to	O	O
activate	O	O
the	O	O
viral	O	O
lytic	O	O
cycle	O	O
.	O	O

Transcription	O	O
of	O	O
a	O	O
minimal	DNA	DNA
promoter	DNA	DNA
from	O	O
the	O	O
NF-IL6	DNA	DNA
gene	DNA	DNA
is	O	O
regulated	O	O
by	O	O
CREB/ATF	protein	O
and	O	O
SP1	protein	protein
proteins	protein	protein
in	O	O
U937	cell_line	cell_line
promonocytic	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
NF-IL6	protein	protein
is	O	O
an	O	O
important	O	O
transcriptional	O	O
regulator	O	O
of	O	O
genes	O	O
induced	O	O
in	O	O
activated	cell_type	O
monocytes/	cell_type	cell_type
macrophages	cell_type	cell_type
,	O	O
and	O	O
NF-IL6	protein	protein
is	O	O
the	O	O
only	O	O
CCAAT/enhancer-binding	protein	protein
protein	protein	protein
(C/EBP)	protein	protein
family	protein	protein
member	O	protein
whose	O	O
steady-state	O	O
mRNA	O	O
levels	O	O
increase	O	O
upon	O	O
activation	O	O
of	O	O
monocytes	cell_type	cell_type
(1).	O	O
We	O	O
show	O	O
that	O	O
increased	O	O
transcription	O	O
of	O	O
the	O	O
NF-IL6	DNA	DNA
gene	DNA	DNA
is	O	O
responsible,	O	O
at	O	O
least	O	O
in	O	O
part,	O	O
for	O	O
induction	O	O
of	O	O
NF-IL6	RNA	RNA
mRNA	RNA	RNA
following	O	O
activation	O	O
of	O	O
U937	cell_line	cell_line
promonocytic	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
We	O	O
have	O	O
identified	O	O
a	O	O
104-bp	DNA	DNA
minimal	DNA	DNA
promoter	DNA	DNA
region	DNA	DNA
of	O	O
the	O	O
NF-IL6	DNA	DNA
gene	DNA	DNA
that	O	O
is	O	O
sufficient	O	O
for	O	O
basal	O	O
and	O	O
activation-dependent	O	O
induction	O	O
of	O	O
transcription	O	O
in	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
This	O	O
region	O	O
contains	O	O
binding	O	DNA
sites	O	DNA
for	O	O
the	O	O
cAMP	protein	O
response	protein	O
element-binding	protein	O
protein/activation	protein	O
transcription	protein	protein
factor	protein	protein
(	O	O
CREB/ATF	protein	protein
)	O	O
and	O	O
Sp1	protein	protein
families	O	O
of	O	O
transcription	protein	protein
factors	protein	protein
.	O	O
Each	O	O
site	O	O
is	O	O
functionally	O	O
important	O	O
and	O	O
contributes	O	O
independently	O	O
to	O	O
transcription	O	O
of	O	O
the	O	O
NF-IL6	DNA	DNA
gene	DNA	DNA
in	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
.	O	O

CIITA	protein	DNA
B-cell-specific	DNA	DNA
promoter	DNA	DNA
suppression	O	O
in	O	O
MHC	cell_line	cell_line
class	cell_line	cell_line
II	cell_line	cell_line
-silenced	cell_line	cell_line
cell	cell_line	cell_line
hybrids	cell_line	cell_line
.	O	O
In	O	O
this	O	O
study,	O	O
various	O	O
sets	O	O
of	O	O
somatic	cell_line	O
cell	cell_line	O
hybrids	cell_line	O
,	O	O
generated	O	O
by	O	O
the	O	O
fusion	O	O
of	O	O
epithelial	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
with	O	O
B-lymphoblastoid	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
,	O	O
were	O	O
analyzed	O	O
for	O	O
the	O	O
expression	O	O
of	O	O
major	protein	protein
histocompatibility	protein	protein
complex	protein	protein
(MHC)	protein	protein
class	protein	protein
II	protein	protein
antigens	protein	protein
.	O	O
We	O	O
first	O	O
demonstrate,	O	O
in	O	O
human	cell_line	O
and	cell_line	O
mouse	cell_line	O
intraspecies	cell_line	O
hybrids	cell_line	O
,	O	O
the	O	O
coordinate	O	O
suppression	O	O
of	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
,	O	O
Ii	protein	DNA
(	O	O
invariant	protein	O
chain	protein	O
)	O	O
and	O	O
HLA-DM	DNA	DNA
gene	DNA	DNA
transcription	O	O
,	O	O
and	O	O
the	O	O
release	O	O
of	O	O
the	O	O
silencing	O	O
by	O	O
the	O	O
addition	O	O
of	O	O
interferon	protein	protein
gamma	protein	protein
.	O	O
Using	O	O
interspecies	O	O
hybrids,	O	O
the	O	O
segregation	O	O
of	O	O
human	DNA	O
chromosomes	DNA	O
allowed	O	O
us	O	O
to	O	O
establish	O	O
that	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
extinction	O	O
is	O	O
linked	O	O
to	O	O
the	O	O
presence	O	O
in	O	O
the	O	O
hybrids	O	O
of	O	O
the	O	O
chromosomes	DNA	DNA
from	O	O
the	O	O
epithelial	cell_type	O
fusion	cell_type	O
partner	cell_type	O
.	O	O
Moreover,	O	O
our	O	O
data	O	O
provide	O	O
evidence	O	O
that	O	O
the	O	O
expression	O	O
pattern	O	O
of	O	O
MHC	RNA	protein
class	RNA	protein
II	RNA	protein
mRNA	RNA	O
is	O	O
correlated	O	O
with	O	O
that	O	O
of	O	O
the	O	O
class	protein	protein
II	protein	protein
transactivator	protein	protein
(	O	O
CIITA	protein	protein
),	O	O
suggesting	O	O
that	O	O
CIITA	protein	protein
is	O	O
the	O	O
actual	O	O
target	O	O
of	O	O
the	O	O
silencing.	O	O
To	O	O
gain	O	O
further	O	O
insight	O	O
into	O	O
the	O	O
suppression	O	O
phenomenon	O	O
we	O	O
performed	O	O
luciferase	O	protein
assays	O	O
which	O	O
show	O	O
that	O	O
silencing	O	O
affects	O	O
the	O	O
activity	O	O
of	O	O
the	O	O
B-cell-specific	DNA	DNA
promoter	DNA	DNA
of	O	O
CIITA	protein	protein
.	O	O
These	O	O
results	O	O
therefore	O	O
demonstrate	O	O
that	O	O
the	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
gene	O	O
silencing	O	O
in	O	O
somatic	cell_line	O
cell	cell_line	O
hybrids	cell_line	O
is	O	O
due	O	O
to	O	O
an	O	O
active	O	O
suppression	O	O
of	O	O
one	O	O
of	O	O
the	O	O
promoters	DNA	DNA
of	O	O
the	O	O
CIITA	DNA	DNA
gene	DNA	DNA
,	O	O
mediated	O	O
by	O	O
the	O	O
epithelial	cell_type	O
cell	cell_type	O
fusion	cell_type	O
partner	cell_type	O
.	O	O

Class	O	O
II	O	O
transactivator-independent	O	O
endothelial	O	O
cell	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
gene	O	O
activation	O	O
induced	O	O
by	O	O
lymphocyte	O	O
adhesion	O	O
.	O	O
NK	O	cell_type
cells	O	cell_type
induce	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
molecules	O	protein
on	O	O
the	O	O
surface	O	O
of	O	O
allogeneic	O	O
endothelial	O	cell_type
cells	O	cell_type
in	O	O
an	O	O
adhesion-dependent,	O	O
IFN-gamma	protein	protein
-independent	O	O
manner	O	O
.	O	O
Here,	O	O
we	O	O
demonstrate	O	O
that	O	O
NK	cell_line	cell_type
cells	cell_line	cell_type
induce	O	O
HLA-DR	protein	protein
on	O	O
the	O	O
surface	O	O
of	O	O
a	O	O
mutant	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
that	O	O
is	O	O
defective	O	O
in	O	O
IFN-gamma	protein	protein
-induced	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
expression	O	O
.	O	O
RNA	O	O
analysis	O	O
in	O	O
these	O	O
cells	O	O
and	O	O
in	O	O
a	O	O
cell	O	O
line	O	O
that	O	O
is	O	O
defective	O	O
in	O	O
class	protein	protein
II	protein	protein
transactivator	protein	protein
(	O	O
CIITA	protein	protein
)	O	O
demonstrates	O	O
that	O	O
NK	O	O
cell-induced	O	O
HLA-DR	RNA	protein
alpha	RNA	protein
mRNA	RNA	O
expression	O	O
is	O	O
also	O	O
CIITA	protein	protein
-independent	O	O
.	O	O
The	O	O
Janus	cell_line	cell_line
kinase-1-deficient	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
U4A	cell_line	cell_line
expresses	O	cell_line
HLA-DR	RNA	cell_line
alpha	RNA	RNA
mRNA	RNA	RNA
in	O	O
response	O	O
to	O	O
NK	O	O
cell	O	O
activation	O	O
,	O	O
and	O	O
HLA-DR	DNA	DNA
alpha	DNA	DNA
promoter	DNA	DNA
constructs	DNA	DNA
transfected	O	O
into	O	O
these	O	O
cells	O	O
are	O	O
induced	O	O
by	O	O
NK	cell_line	cell_type
cells	cell_line	cell_type
but	O	O
not	O	O
IFN-gamma	protein	protein
.	O	O
These	O	O
data	O	O
indicate	O	O
that	O	O
the	O	O
IFN-gamma	protein	protein
-independent	O	O
component	O	O
of	O	O
the	O	O
target	O	O
cell	O	O
HLA-DR	protein	protein
expression	O	O
induced	O	O
by	O	O
lymphocyte	O	O
adhesion	O	O
uses	O	O
a	O	O
signaling	O	O
pathway	O	O
that	O	O
is	O	O
distinct	O	O
from	O	O
the	O	O
IFN-gamma	protein	protein
-dependent	O	O
mechanism	O	O
and	O	O
also	O	O
suggest	O	O
that	O	O
CIITA	protein	protein
is	O	O
not	O	O
required.	O	O

Effects	O	O
of	O	O
overexpression	O	O
of	O	O
IL-1	protein	protein
receptor-associated	protein	protein
kinase	protein	protein
on	O	O
NFkappaB	protein	protein
activation	O	O
,	O	O
IL-2	protein	protein
production	O	O
and	O	O
stress-activated	O	protein
protein	O	protein
kinases	O	protein
in	O	O
the	O	O
murine	cell_line	cell_line
T	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
EL4	cell_line	cell_line
.	O	O
The	O	O
association	O	O
and	O	O
activation	O	O
of	O	O
the	O	O
IL-1	protein	protein
receptor-associated	protein	protein
protein	protein	protein
kinase	protein	protein
(	O	O
IRAK	protein	protein
)	O	O
to	O	O
the	O	O
IL-1	protein	protein
receptor	protein	protein
complex	protein	protein
is	O	O
one	O	O
of	O	O
the	O	O
earliest	O	O
events	O	O
detectable	O	O
in	O	O
IL-1	protein	O
signal	O	O
transduction	O	O
.	O	O
We	O	O
generated	O	O
permanent	O	O
clones	O	O
of	O	O
the	O	O
murine	cell_line	cell_line
T	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
EL4	cell_line	cell_line
6.1	cell_line	cell_line
overexpressing	O	cell_line
human	protein	cell_line
(h)	protein	cell_line
IRAK	protein	cell_line
to	O	O
evaluate	O	O
the	O	O
role	O	O
of	O	O
this	O	O
kinase	O	O
in	O	O
IL-1	protein	protein
signaling	O	O
.	O	O
Overexpression	O	O
of	O	O
hIRAK	protein	protein
enhanced	O	O
IL-1	protein	protein
-stimulated	O	O
activation	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
NFkappaB	protein	protein
,	O	O
whereas	O	O
a	O	O
truncated	O	protein
form	O	protein
(	O	O
N-IRAK	protein	protein
)	O	O
specifically	O	O
inhibited	O	O
IL-1	protein	protein
-dependent	O	O
NFkappaB	protein	protein
activity	O	O
.	O	O
In	O	O
clones	O	O
stably	O	O
overexpressing	O	O
hIRAK	protein	O
a	O	O
weak	O	O
constitutive	O	O
activation	O	O
of	O	O
NFkappaB	protein	protein
correlated	O	O
with	O	O
a	O	O
low	O	O
basal	O	O
IL-2	protein	protein
production	O	O
which	O	O
was	O	O
enhanced	O	O
in	O	O
an	O	O
IL-1	protein	protein
-dependent	O	O
manner	O	O
.	O	O
Compared	O	O
to	O	O
the	O	O
parental	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
the	O	O
dose-response	O	O
curve	O	O
of	O	O
IL-1	protein	protein
-induced	O	O
IL-2	protein	protein
production	O	O
was	O	O
shifted	O	O
in	O	O
both	O	O
potency	O	O
and	O	O
efficacy.	O	O
These	O	O
results	O	O
demonstrate	O	O
that	O	O
IRAK	protein	protein
directly	O	O
triggers	O	O
NFkappaB	protein	protein
-mediated	O	O
gene	O	O
expression	O	O
in	O	O
EL4	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Qualitatively	O	O
different	O	O
effects	O	O
were	O	O
observed	O	O
for	O	O
the	O	O
IL-1	protein	protein
-induced	O	O
activation	O	O
of	O	O
stress-activated	protein	protein
protein	protein	protein
(SAP)	protein	protein
kinases	protein	protein
:	O	O
permanent	O	O
overexpression	O	O
of	O	O
IRAK	protein	protein
did	O	O
not	O	O
affect	O	O
the	O	O
dose	O	O
dependence	O	O
but	O	O
prolonged	O	O
the	O	O
kinetics	O	O
of	O	O
IL-1	protein	protein
-induced	O	O
activation	O	O
of	O	O
SAP	protein	protein
kinases	protein	protein
,	O	O
suggesting	O	O
that	O	O
this	O	O
signaling	O	O
branch	O	O
may	O	O
be	O	O
regulated	O	O
by	O	O
distinct	O	O
mechanisms.	O	O

The	O	O
role	O	O
of	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
signaling	O	O
in	O	O
activated	O	O
DRA	DNA	O
transcription	O	O
.	O	O
Expression	O	O
of	O	O
human	DNA	protein
MHC	DNA	protein
HLA-DRA	DNA	protein
class	DNA	protein
II	DNA	protein
gene	DNA	O
can	O	O
be	O	O
up-regulated	O	O
in	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
Ig	O	protein
cross-linking	O	O
as	O	O
well	O	O
as	O	O
by	O	O
phorbol	O	O
esters	O	O
such	O	O
as	O	O
12-O-tetradecanoyl	O	O
phorbol	O	O
13-acetate	O	O
(	O	O
TPA	O	O
).	O	O
Induced	O	O
DRA	DNA	O
expression	O	O
involves	O	O
activation	O	O
of	O	O
restricted	protein	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
(	protein	O
PKC	protein	protein
)	protein	O
isoforms	protein	O
,	O	O
resulting	O	O
in	O	O
activated	O	protein
activator	O	protein
protein-1	protein	protein
-dependent	O	O
transcription	O	O
.	O	O
In	O	O
this	O	O
report	O	O
expression	O	O
profiles	O	O
and	O	O
activation	O	O
of	O	O
PKC	protein	protein
were	O	O
analyzed	O	O
in	O	O
human	cell_line	cell_type
Raji	cell_line	cell_type
B	cell_line	cell_type
lymphoblastoid	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
Transient	O	O
transfection	O	O
analysis	O	O
with	O	O
target	DNA	O
plasmids	DNA	DNA
containing	O	O
either	O	O
DRA	DNA	DNA
promoter	DNA	DNA
(wild-type	O	O
or	O	O
mutated)	O	O
or	O	O
TPA	DNA	O
response	DNA	O
elements	DNA	O
demonstrated	O	O
that	O	O
pretreatment	O	O
with	O	O
the	O	O
selective	O	O
PKC	protein	protein
inhibitor	O	O
GF	O	O
109203X	O	O
repressed	O	O
TPA	O	O
-mediated	O	O
activation	O	O
.	O	O
Western	O	O
analysis	O	O
performed	O	O
on	O	O
cellular	O	O
fractions	O	O
of	O	O
resting	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
of	O	O
TPA	cell_type	O
-activated	cell_type	O
cells	cell_type	O
revealed	O	O
abundant	O	O
expression	O	O
of	O	O
classical	protein	protein
PKC-alpha	protein	protein
(	O	O
cPKC-alpha	protein	protein
),	O	O
cPKC-betaII	protein	protein
,	O	O
and	O	O
atypical	protein	O
PKC-zeta	protein	protein
isoforms	protein	protein
and	O	O
identified	O	O
a	O	O
sustained	O	O
translocation	O	O
of	O	O
cPKC-alpha	protein	protein
and	O	O
cPKC-betaII	protein	O
from	O	O
the	O	O
cytosolic	O	O
compartment	O	O
to	O	O
membranes	O	O
.	O	O
As	O	O
expected,	O	O
the	O	O
distribution	O	O
of	O	O
atypical	protein	O
PKC-zeta	protein	protein
was	O	O
unaffected	O	O
by	O	O
TPA	O	O
treatment	O	O
and	O	O
displayed	O	O
an	O	O
even	O	O
distribution	O	O
between	O	O
cytosol	O	O
and	O	O
membranes	O	O
.	O	O
This	O	O
finding	O	O
was	O	O
confirmed	O	O
by	O	O
immunofluorescence	O	O
microscopy	O	O
.	O	O
The	O	O
TPA	O	O
-mediated	O	O
translocation	O	O
of	O	O
cPKC-alpha	protein	protein
and	O	O
cPKC-betaII	protein	O
was	O	O
not	O	O
influenced	O	O
by	O	O
pretreatment	O	O
with	O	O
GF	O	protein
109203X	O	protein
.	O	O
Finally,	O	O
functional	O	O
activation	O	O
and	O	O
translocation	O	O
of	O	O
PKC	protein	protein
were	O	O
investigated	O	O
with	O	O
a	O	O
selective	O	O
in	O	O
vitro	O	O
kinase	O	O
assay	O	O
.	O	O
Together,	O	O
these	O	O
results	O	O
show	O	O
that	O	O
activated	O	O
HLA-DRA	protein	DNA
expression	O	O
in	O	O
response	O	O
to	O	O
TPA	O	O
treatment	O	O
is	O	O
strictly	O	O
dependent	O	O
on	O	O
PKC	protein	protein
activation	O	O
acting	O	O
on	O	O
the	O	O
X2	DNA	DNA
box	DNA	DNA
of	O	O
the	O	O
DRA	DNA	DNA
promoter	DNA	DNA
and	O	O
that	O	O
selective	O	O
inhibition	O	O
of	O	O
PKC	protein	protein
enzymatic	O	O
activity	O	O
does	O	O
not	O	O
influence	O	O
subcellular	O	O
localization	O	O
of	O	O
expressed	O	O
PKC	protein	protein
isoenzymes	protein	protein
.	O	O
Thus,	O	O
the	O	O
translocation	O	O
event	O	O
per	O	O
se	O	O
occurs	O	O
independently	O	O
of	O	O
PKC	protein	protein
activation	O	O
in	O	O
these	O	O
cells.	O	O

Inhibition	O	O
of	O	O
RNA	protein	RNA
polymerase	protein	RNA
II	protein	RNA
transcription	O	O
in	O	O
human	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
synthetic	O	O
DNA-binding	O	O
ligands	O	O
[see	O	O
comments]	O	O
Sequence-specific	O	O
DNA-binding	O	O
small	O	O
molecules	O	O
that	O	O
can	O	O
permeate	O	O
human	cell_type	cell_type
cells	cell_type	cell_type
potentially	O	O
could	O	O
regulate	O	O
transcription	O	O
of	O	O
specific	O	O
genes.	O	O
Multiple	O	O
cellular	protein	O
DNA-binding	protein	O
transcription	protein	protein
factors	protein	protein
are	O	O
required	O	O
by	O	O
HIV	O	O
type	O	O
1	O	O
for	O	O
RNA	O	O
synthesis	O	O
.	O	O
Two	O	O
pyrrole-imidazole	O	O
polyamides	O	O
were	O	O
designed	O	O
to	O	O
bind	O	O
DNA	O	DNA
sequences	O	DNA
immediately	O	O
adjacent	O	O
to	O	O
binding	O	O
sites	O	O
for	O	O
the	O	O
transcription	protein	protein
factors	protein	protein
Ets-1	protein	protein
,	O	O
lymphoid-enhancer	protein	protein
binding	protein	protein
factor	protein	protein
1	protein	protein
,	O	O
and	O	O
TATA-box	protein	protein
binding	protein	protein
protein	protein	protein
.	O	O
These	O	O
synthetic	O	O
ligands	O	O
specifically	O	O
inhibit	O	O
DNA-binding	O	O
of	O	O
each	O	O
transcription	protein	O
factor	protein	O
and	O	O
HIV	O	O
type	O	O
1	O	O
transcription	O	O
in	O	O
cell-free	O	O
assays	O	O
.	O	O
When	O	O
used	O	O
in	O	O
combination,	O	O
the	O	O
polyamides	O	O
inhibit	O	O
virus	O	O
replication	O	O
by	O	O
&gt;99%	O	O
in	O	O
isolated	cell_type	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
lymphocytes	cell_type	cell_type
,	O	O
with	O	O
no	O	O
detectable	O	O
cell	O	O
toxicity.	O	O
The	O	O
ability	O	O
of	O	O
small	O	protein
molecules	O	protein
to	O	O
target	O	O
predetermined	O	O
DNA	DNA	O
sequences	DNA	O
located	O	O
within	O	O
RNA	DNA	DNA
polymerase	DNA	DNA
II	DNA	DNA
promoters	DNA	DNA
suggests	O	O
a	O	O
general	O	O
approach	O	O
for	O	O
regulation	O	O
of	O	O
gene	O	O
expression,	O	O
as	O	O
well	O	O
as	O	O
a	O	O
mechanism	O	O
for	O	O
the	O	O
inhibition	O	O
of	O	O
viral	O	O
replication	O	O
.	O	O

musculin	DNA	O
:	O	O
a	O	O
murine	DNA	protein
basic	DNA	protein
helix-loop-helix	DNA	protein
transcription	DNA	protein
factor	DNA	protein
gene	DNA	O
expressed	O	O
in	O	O
embryonic	O	O
skeletal	O	O
muscle	O	O
.	O	O
We	O	O
describe	O	O
the	O	O
embryonic	O	O
expression	O	O
of	O	O
musculin	protein	protein
,	O	O
a	O	O
new	O	O
murine	O	O
member	O	O
of	O	O
the	O	O
bHLH	protein	protein
family	protein	protein
of	O	O
transcription	protein	protein
factors	protein	protein
.	O	O
Musculin	O	protein
protein	O	protein
is	O	O
closely	O	O
related	O	O
to	O	O
human	protein	protein
ABF-1	protein	protein
,	O	O
which	O	O
is	O	O
expressed	O	O
in	O	O
activated	O	cell_type
B	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
and	O	O
to	O	O
epicardin/capsulin/Pod-1	protein	protein
,	O	O
which	O	O
is	O	O
expressed	O	O
in	O	O
branchial	cell_type	O
myoblasts	cell_type	O
,	O	O
visceral	O	O
and	O	O
urogenital	O	O
mesoderm	O	O
and	O	O
epicardium	O	O
.	O	O
In	O	O
situ	O	O
hybridisation	O	O
revealed	O	O
musculin	protein	O
expression	O	O
in	O	O
embryos	O	O
was	O	O
largely	O	O
restricted	O	O
to	O	O
the	O	O
embryonic	cell_type	O
skeletal	cell_type	O
muscle	cell_type	O
lineage	cell_type	O
.	O	O
While	O	O
all	O	O
skeletal	O	O
muscles	O	O
expressed	O	O
the	O	O
gene,	O	O
only	O	O
a	O	O
subset	O	O
of	O	O
myocytes	O	cell_type
within	O	O
each	O	O
muscle	O	O
were	O	O
positive,	O	O
indicating	O	O
molecular	O	O
heterogeneity	O	O
within	O	O
fetal	O	O
muscle	O	O
.	O	O
Copyright	O	O
1998	O	O
Elsevier	O	O
Science	O	O
Ireland	O	O
Ltd.	O	O
All	O	O
Rights	O	O
Reserved.	O	O

Induction	O	O
of	O	O
T	O	O
cell	O	O
anergy	O	O
by	O	O
high	O	O
concentrations	O	O
of	O	O
immunodominant	O	O
native	O	O
peptide	O	O
is	O	O
accompanied	O	O
by	O	O
IL-10	protein	protein
production	O	O
and	O	O
a	O	O
block	O	O
in	O	O
JNK	protein	protein
activity	O	O
.	O	O
The	O	O
ability	O	O
to	O	O
induce	O	O
anergy	O	O
in	O	O
antigen-specific	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
has	O	O
potential	O	O
therapeutic	O	O
value	O	O
for	O	O
altering	O	O
pathologic	O	O
immune	O	O
responses	O	O
.	O	O
This	O	O
study	O	O
was	O	O
undertaken	O	O
to	O	O
further	O	O
analyze	O	O
changes	O	O
in	O	O
cytokine	protein	protein
production	O	O
and	O	O
intracellular	O	O
signaling	O	O
during	O	O
anergy	O	O
induction	O	O
using	O	O
high	O	O
concentrations	O	O
of	O	O
native	O	O
peptide	O	O
ligand	O	O
of	O	O
tetanus	O	O
toxoid	O	O
(	O	O
TT	O	O
)-	O	O
and	O	O
myelin	O	protein
basic	O	protein
protein	O	protein
(MBP)-	O	protein
specific	O	protein
human	O	protein
T	O	protein
cell	O	protein
lines	O	protein
.	O	O
The	O	O
TT	cell_line	cell_line
-selected	cell_line	cell_line
T	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
could	O	O
be	O	O
rendered	O	O
unresponsive	O	O
to	O	O
its	O	O
dominant	O	O
epitope	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
(IC50	O	O
=	O	O
0.03	O	O
microg/ml).	O	O
The	O	O
TT	cell_line	cell_line
-selected	cell_line	cell_line
line	cell_line	cell_line
,	O	O
as	O	O
well	O	O
as	O	O
three	O	O
T	O	O
cell	O	O
clones	O	O
established	O	O
from	O	O
this	O	O
line,	O	O
continued	O	O
to	O	O
produce	O	O
IFN-gamma	protein	protein
and	O	O
significantly	O	O
increased	O	O
IL-4	protein	protein
and	O	O
IL-10	protein	protein
production	O	O
when	O	O
anergy	O	O
was	O	O
induced	O	O
with	O	O
high	O	O
concentrations	O	O
of	O	O
the	O	O
immunodominant	O	protein
epitope	O	protein
.	O	O
JNK	protein	protein
enzymatic	O	O
activity	O	O
was	O	O
blocked	O	O
in	O	O
anergized	cell_line	cell_type
T	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
The	O	O
MBP	protein	protein
-selected	O	O
line	O	O
could	O	O
likewise	O	O
be	O	O
rendered	O	O
unresponsive	O	O
by	O	O
incubation	O	O
with	O	O
supraoptimal	O	O
concentrations	O	O
of	O	O
immunodominant	O	O
peptide	O	O
and	O	O
anergy	O	O
induction	O	O
was	O	O
accompanied	O	O
by	O	O
IL-10	protein	protein
release	O	O
.	O	O
Both	O	O
T	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
could	O	O
be	O	O
anergized	O	O
by	O	O
the	O	O
autopresentation	O	O
of	O	O
native	O	O
peptide	O	O
since	O	O
anergy	O	O
was	O	O
induced	O	O
in	O	O
cultures	O	O
lacking	O	O
fresh	O	O
antigen-presenting	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
This	O	O
study	O	O
shows	O	O
that	O	O
the	O	O
mitogen-activated	protein	protein
protein	protein	protein
kinase	protein	protein
cascade	O	O
is	O	O
blocked	O	O
when	O	O
anergy	O	O
is	O	O
induced	O	O
to	O	O
high	O	O
concentrations	O	O
of	O	O
soluble	O	O
peptide	O	O
.	O	O
Copyright	O	O
1998	O	O
Academic	O	O
Press.	O	O

Upregulation	O	O
of	O	O
interleukin	protein	protein
6	protein	protein
and	O	O
granulocyte	protein	protein
colony-stimulating	protein	protein
factor	protein	protein
receptors	protein	protein
by	O	O
transcription	protein	protein
factor	protein	protein
CCAAT	protein	protein
enhancer	protein	protein
binding	protein	protein
protein	protein	protein
alpha	protein	protein
(	O	O
C/EBP	protein	protein
alpha	protein	protein
)	O	O
is	O	O
critical	O	O
for	O	O
granulopoiesis	O	O
.	O	O
Cytokines	O	protein
stimulate	O	O
granulopoiesis	O	O
through	O	O
signaling	O	protein
via	O	protein
receptors	O	protein
whose	O	O
expression	O	O
is	O	O
controlled	O	O
by	O	O
lineage-specific	O	O
transcription	protein	protein
factors	protein	protein
.	O	O
Previously,	O	O
we	O	O
demonstrated	O	O
that	O	O
granulocyte	RNA	protein
colony-stimulating	RNA	protein
factor	RNA	protein
(	RNA	O
G-CSF	RNA	protein
)	RNA	O
receptor	RNA	RNA
mRNA	RNA	RNA
was	O	O
undetectable	O	O
and	O	O
granulocyte	O	O
maturation	O	O
blocked	O	O
in	O	O
CCAAT	protein	DNA
enhancer	protein	DNA
binding	protein	O
protein	protein	protein
alpha	protein	protein
(	O	O
C/EBPalpha	protein	protein
)-deficient	O	O
mice	O	O
.	O	O
This	O	O
phenotype	O	O
is	O	O
distinct	O	O
from	O	O
that	O	O
of	O	O
G-CSF	O	protein
receptor-/-	O	O
mice	O	O
,	O	O
suggesting	O	O
that	O	O
other	O	O
genes	O	O
are	O	O
likely	O	O
to	O	O
be	O	O
adversely	O	O
affected	O	O
by	O	O
loss	O	O
of	O	O
C/EBPalpha	protein	protein
.	O	O
Here	O	O
we	O	O
demonstrate	O	O
loss	O	O
of	O	O
interleukin	protein	protein
6	protein	protein
(IL-6)	protein	protein
receptor	protein	protein
and	O	O
IL-6-responsive	protein	protein
colony-forming	protein	protein
units	protein	protein
(	O	O
CFU-IL6	protein	protein
)	O	O
in	O	O
C/EBPalpha	protein	protein
-/-	O	O
mice	O	O
.	O	O
The	O	O
observed	O	O
failure	O	O
of	O	O
granulopoiesis	O	O
could	O	O
be	O	O
rescued	O	O
by	O	O
the	O	O
addition	O	O
of	O	O
soluble	O	O
IL-6	protein	protein
receptor	protein	protein
and	O	O
IL-6	protein	protein
or	O	O
by	O	O
retroviral	O	O
transduction	O	O
of	O	O
G-CSF	protein	protein
receptors	protein	protein
,	O	O
demonstrating	O	O
that	O	O
loss	O	O
of	O	O
both	O	O
of	O	O
these	O	O
receptors	O	O
contributes	O	O
to	O	O
the	O	O
absolute	O	O
block	O	O
in	O	O
granulocyte	O	O
maturation	O	O
observed	O	O
in	O	O
C/EBPalpha	cell_type	protein
-deficient	cell_type	O
hematopoietic	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
The	O	O
results	O	O
of	O	O
these	O	O
and	O	O
other	O	O
studies	O	O
suggest	O	O
that	O	O
additional	O	O
C/EBPalpha	DNA	DNA
target	DNA	DNA
genes	DNA	DNA
,	O	O
possibly	O	O
other	O	O
cytokine	O	protein
receptors,	O	O
are	O	O
also	O	O
important	O	O
for	O	O
the	O	O
block	O	O
in	O	O
granulocyte	O	O
differentiation	O	O
observed	O	O
in	O	O
vivo	O	O
in	O	O
C/EBPalpha	protein	protein
-deficient	O	O
mice	O	O
.	O	O

Phosphatidylinositides	O	O
bind	O	O
to	O	O
plasma	protein	O
membrane	protein	O
CD14	protein	protein
and	O	O
can	O	O
prevent	O	O
monocyte	O	O
activation	O	O
by	O	O
bacterial	O	O
lipopolysaccharide	O	O
.	O	O
Although	O	O
bacterial	O	O
lipopolysaccharides	O	O
(	O	O
LPS	O	O
)	O	O
and	O	O
several	O	O
other	O	O
microbial	O	O
agonists	O	O
can	O	O
bind	O	O
to	O	O
mCD14	protein	protein
(	O	O
membrane	protein	O
CD14	protein	protein
),	O	O
a	O	O
cell-surface	O	O
receptor	O	O
found	O	O
principally	O	O
on	O	O
monocytes	cell_type	cell_type
and	O	O
neutrophils	cell_type	cell_type
,	O	O
host-derived	O	O
mCD14	protein	protein
ligands	O	O
are	O	O
poorly	O	O
defined.	O	O
We	O	O
report	O	O
here	O	O
that	O	O
phosphatidylinositol	O	protein
(	O	O
PtdIns	O	protein
),	O	O
phosphatidylinositol	O	protein
-4-phosphate	O	protein
,	O	O
and	O	O
other	O	O
phosphatidylinositides	O	O
can	O	O
bind	O	O
to	O	O
mCD14	protein	protein
.	O	O
Phosphatidylserine	O	O
(PS),	O	O
another	O	O
anionic	O	O
glycerophospholipid,	O	O
binds	O	O
to	O	O
mCD14	protein	protein
with	O	O
lower	O	O
apparent	O	O
affinity	O	O
than	O	O
does	O	O
PtdIns	O	O
.	O	O
LPS	protein	O
-binding	protein	O
protein	protein	O
,	O	O
a	O	O
lipid	O	O
transfer	O	O
protein	O	O
found	O	O
in	O	O
serum,	O	O
facilitates	O	O
both	O	O
PS	O	O
-and	O	O
PtdIns	O	O
-	O	O
mCD14	protein	protein
binding	O	O
.	O	O
PtdIns	O	O
binding	O	O
to	O	O
mCD14	protein	protein
can	O	O
be	O	O
blocked	O	O
by	O	O
anti-CD14	protein	protein
monoclonal	protein	protein
antibodies	protein	protein
that	O	O
inhibit	O	O
LPS	O	O
-mCD14	protein	O
binding	O	O
,	O	O
and	O	O
PtdIns	O	protein
can	O	O
inhibit	O	O
both	O	O
LPS	O	O
-mCD14	protein	O
binding	O	O
and	O	O
LPS	O	O
-induced	O	O
responses	O	O
in	O	O
monocytes	cell_type	cell_type
.	O	O
Serum-equilibrated	cell_type	O
PtdIns	cell_type	O
also	cell_type	O
binds	cell_type	O
to	cell_type	O
mCD14	cell_type	cell_line
-expressing	cell_type	cell_line
cells	cell_type	cell_line
,	O	O
raising	O	O
the	O	O
possibility	O	O
that	O	O
endogenous	O	protein
PtdIns	O	protein
may	O	O
modulate	O	O
cellular	O	O
responses	O	O
to	O	O
LPS	O	O
and	O	O
other	O	O
mCD14	protein	protein
ligands	O	O
in	O	O
vivo.	O	O

Protein	protein	protein
kinase	protein	protein
C	protein	protein
regulates	O	O
Fas	protein	protein
(	O	O
CD95/APO-1	protein	protein
)	O	O
expression	O	O
.	O	O
Fas	protein	protein
(	O	O
CD95/APO-1	protein	protein
)	O	O
is	O	O
a	O	O
transmembrane	protein	O
protein	protein	O
of	O	O
the	O	O
TNF/neuron	protein	protein
growth	protein	protein
factor	protein	protein
receptor	protein	protein
family	protein	protein
.	O	O
Ligation	O	O
of	O	O
Fas	protein	protein
by	O	O
specific	protein	O
Abs	protein	protein
or	O	O
Fas	protein	protein
ligand	protein	protein
(	O	O
FasL/CD95	protein	protein
ligand	protein	protein
)	O	O
induces	O	O
rapid	O	O
apoptotic	O	O
cell	O	O
death	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
cell	O	O
types.	O	O
Despite	O	O
progress	O	O
in	O	O
understanding	O	O
the	O	O
death	O	O
signals	O	O
transduced	O	O
from	O	O
Fas	protein	protein
,	O	O
very	O	O
little	O	O
is	O	O
known	O	O
with	O	O
regard	O	O
to	O	O
the	O	O
mechanisms	O	O
by	O	O
which	O	O
Fas	protein	protein
expression	O	O
is	O	O
regulated.	O	O
Using	O	O
our	O	O
previously	O	O
established	O	O
murine	cell_line	O
T	cell_line	O
cell	cell_line	O
hybridoma	cell_line	O
model	cell_line	O
A1.1	cell_line	O
,	O	O
we	O	O
show	O	O
that	O	O
specific	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
(	O	O
PKC	protein	protein
)	O	O
inhibitors	O	O
could	O	O
block	O	O
activation-induced	O	O
Fas	protein	O
expression	O	O
and	O	O
apoptosis.	O	O
The	O	O
activation	O	O
of	O	O
PKC	protein	protein
with	O	O
PMA	O	O
or	O	O
1-oleoyl-2-acetyl-sn-glycerol	O	O
could	O	O
mimic	O	O
the	O	O
TCR	protein	protein
signal	O	O
by	O	O
inducing	O	O
the	O	O
expression	O	O
of	O	O
Fas	protein	protein
but	O	O
not	O	O
FasL.	O	protein
PKC	protein	protein
-dependent	O	O
Fas	protein	O
expression	O	O
was	O	O
also	O	O
observed	O	O
in	O	O
several	O	O
murine	O	O
and	O	O
human	O	O
tumor	O	O
cell	O	O
lines	O	O
.	O	O
Since	O	O
the	O	O
inhibition	O	O
of	O	O
Ca2+	O	O
redistribution	O	O
by	O	O
an	O	O
inhibitor	O	O
of	O	O
intracellular	O	O
Ca2+	O	O
mobilization	O	O
,	O	O
8-(diethylamino)-octyl-3,4,5-trimethoxybenzoate	O	O
hydrochloride	O	O
,	O	O
inhibited	O	O
TCR-induced	protein	O
FasL	protein	protein
but	O	O
not	O	O
Fas	protein	protein
,	O	O
the	O	O
expression	O	O
of	O	O
Fas	protein	protein
appears	O	O
to	O	O
be	O	O
independent	O	O
of	O	O
Ca2+	O	O
mobilization	O	O
.	O	O
Significantly,	O	O
expression	O	O
of	O	O
the	O	O
newly	O	O
identified	O	O
Fas	DNA	DNA
-regulatory	DNA	DNA
gene	DNA	DNA
,	O	O
TDAG51	DNA	protein
,	O	O
was	O	O
found	O	O
to	O	O
be	O	O
dependent	O	O
upon	O	O
the	O	O
activity	O	O
of	O	O
PKC	protein	protein
.	O	O
PKC	protein	protein
activation	O	O
only	O	O
induced	O	O
Fas	protein	protein
expression	O	O
in	O	O
cells	O	O
expressing	O	O
wild-type	O	protein
TDAG51	DNA	protein
.	O	O
Thus,	O	O
Fas	protein	protein
expression	O	O
is	O	O
likely	O	O
mediated	O	O
by	O	O
PKC	protein	protein
through	O	O
TDAG51	DNA	protein
.	O	O

Retinoic	O	O
acid	O	O
inhibits	O	O
CD40	protein	protein
+	O	O
interleukin-4	protein	protein
-mediated	O	O
IgE	protein	protein
production	O	O
in	O	O
vitro.	O	O
To	O	O
elucidate	O	O
the	O	O
role	O	O
of	O	O
retinoic	O	O
acid	O	O
(RA)	O	O
in	O	O
anti-	protein	O
CD40	protein	protein
+	O	O
interleukin-4	protein	protein
(	O	O
IL-4	protein	protein
)-mediated	O	O
B-cell	O	O
activation	O	O
,	O	O
the	O	O
effect	O	O
of	O	O
10(-12)	O	O
to	O	O
10(-6)	O	O
mol/L	O	O
RA	O	O
was	O	O
studied	O	O
in	O	O
anti-CD40	protein	protein
(1	O	O
microgram/mL)	O	O
+	O	O
IL-4	protein	protein
(5	O	O
ng/mL)-mediated	O	O
proliferation	O	O
and	O	O
Ig	O	O
synthesis	O	O
by	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
(	O	O
PBMC	cell_type	cell_type
)	O	O
and	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
healthy	O	O
donors	O	O
.	O	O
Anti-CD40	protein	protein
+	O	O
IL-4	protein	protein
-mediated	O	O
proliferation	O	O
of	O	O
PBMC	cell_type	cell_type
and	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
was	O	O
inhibited	O	O
by	O	O
RA	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
,	O	O
with	O	O
maximal	O	O
inhibition	O	O
of	O	O
62%	O	O
+/-	O	O
5%	O	O
in	O	O
PBMC	cell_type	cell_type
and	O	O
55%	O	O
+/-	O	O
4.4%	O	O
in	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
all-trans	O	O
RA	O	O
,	O	O
and	O	O
58%	O	O
+/-	O	O
6.7%	O	O
and	O	O
51%	O	O
+/-	O	O
4.7%,	O	O
respectively	O	O
by	O	O
13-cis	O	O
RA	O	O
.	O	O
IgE	protein	protein
synthesis	O	O
was	O	O
even	O	O
more	O	O
markedly	O	O
inhibited	O	O
by	O	O
RA	O	O
starting	O	O
at	O	O
concentrations	O	O
of	O	O
&gt;10(-14)	O	O
mol/L	O	O
for	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
&gt;10(-10)	O	O
mol/L	O	O
for	O	O
PBMC	cell_type	cell_type
.	O	O
Maximal	O	O
inhibition	O	O
of	O	O
IgE	protein	protein
production	O	O
for	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
was	O	O
at	O	O
10(-8)	O	O
mol/L	O	O
for	O	O
all-trans	O	O
RA	O	O
(94%	O	O
+/-	O	O
1.8%)	O	O
and	O	O
96%	O	O
+/-	O	O
3.2%	O	O
for	O	O
13-cis	O	O
RA	O	O
.	O	O
Low	O	O
concentrations	O	O
of	O	O
RA	O	O
inhibiting	O	O
IgE	protein	protein
synthesis	O	O
(10(-10)	O	O
mol/L)	O	O
affected	O	O
neither	O	O
B-cell	O	O
proliferation	O	O
nor	O	O
the	O	O
production	O	O
of	O	O
IgA	protein	protein
,	O	O
IgG	protein	protein
,	O	O
and	O	O
IgM	protein	protein
.	O	O
Elucidation	O	O
of	O	O
the	O	O
mechanism	O	O
involved	O	O
in	O	O
this	O	O
inhibition	O	O
of	O	O
IgE	protein	protein
production	O	O
shows	O	O
that	O	O
epsilon	O	protein
germline	DNA	protein
transcription	O	O
is	O	O
decreased	O	O
by	O	O
RA	O	O
,	O	O
whereas	O	O
production	O	O
of	O	O
interferon-gamma	protein	protein
(	O	O
IFN-gamma	protein	protein
)	O	O
was	O	O
not	O	O
enhanced	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
RA	O	O
.	O	O
To	O	O
differentiate	O	O
whether	O	O
the	O	O
RA	O	O
effect	O	O
was	O	O
mediated	O	O
by	O	O
RA	O	protein
receptors	O	protein
alpha	O	protein
,	O	O
beta	O	O
,	O	O
and	O	O
gamma	O	protein
,	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
retinoic	protein	protein
acid	protein	protein
receptors	protein	protein
(	O	O
RAR	protein	protein
)	O	O
was	O	O
examined	O	O
by	O	O
reverse	protein	protein
transcriptase	protein	protein
-polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
RT-PCR	O	O
).	O	O
The	O	O
data	O	O
show	O	O
that	O	O
unstimulated	cell_type	cell_line
human	cell_type	cell_line
peripheral	cell_type	cell_line
B	cell_type	cell_line
cells	cell_type	cell_line
express	O	O
mRNA	O	O
of	O	O
the	O	O
RA	O	DNA
receptor	O	DNA
alpha	O	DNA
,	O	O
beta	O	O
,	O	O
and	O	O
gamma	O	protein
.	O	O
Using	O	O
retinoids	O	O
with	O	O
different	O	O
receptor	O	O
binding	O	O
specificity	O	O
(	O	O
CD336	O	protein
,	O	O
CD437	O	protein
,	O	O
CD2019	O	protein
,	O	O
CD367	O	protein
),	O	O
dose-dependent	O	O
inhibition	O	O
of	O	O
IgE	protein	protein
synthesis	O	O
was	O	O
shown	O	O
by	O	O
all	O	O
four	O	O
derivates,	O	O
but	O	O
was	O	O
most	O	O
marked	O	O
by	O	O
an	O	O
RA	O	O
binding	O	O
the	O	O
alpha	protein	protein
receptor	protein	protein
with	O	O
high	O	O
specificity.	O	O
Taken	O	O
together,	O	O
this	O	O
study	O	O
shows	O	O
that	O	O
RA	O	O
inhibits	O	O
IgE	protein	protein
production	O	O
of	O	O
anti-CD40	cell_line	protein
+	cell_line	O
IL-4	cell_line	protein
-stimulated	cell_line	O
B	cell_line	cell_type
cells	cell_line	cell_type
in	O	O
vitro.	O	O
Copyright	O	O
1998	O	O
by	O	O
The	O	O
American	O	O
Society	O	O
of	O	O
Hematology.	O	O

Human	O	O
T-cell	O	O
leukemia	O	O
virus	O	O
type	O	O
1	O	O
Tax	protein	protein
induction	O	O
of	O	O
NF-kappaB	protein	protein
involves	O	O
activation	O	O
of	O	O
the	O	O
IkappaB	protein	protein
kinase	protein	protein
alpha	protein	protein
(	O	O
IKKalpha	protein	protein
)	O	O
and	O	O
IKKbeta	protein	protein
cellular	protein	protein
kinases	protein	protein
.	O	O
Tax	protein	protein
corresponds	O	O
to	O	O
a	O	O
40-kDa	protein	protein
transforming	protein	protein
protein	protein	protein
from	O	O
the	O	O
pathogenic	O	O
retrovirus	O	O
human	O	O
T-cell	O	O
leukemia	O	O
virus	O	O
type	O	O
1	O	O
(	O	O
HTLV-1	O	O
)	O	O
that	O	O
activates	O	O
nuclear	O	O
expression	O	O
of	O	O
the	O	O
NF-kappaB	protein	protein
/Rel	protein	protein
family	protein	protein
of	O	O
transcription	protein	protein
factors	protein	protein
by	O	O
an	O	O
unknown	O	O
mechanism	O	O
.	O	O
Tax	protein	protein
expression	O	O
promotes	O	O
N-terminal	O	O
phosphorylation	O	O
and	O	O
degradation	O	O
of	O	O
IkappaB	protein	protein
alpha	protein	protein
,	O	O
a	O	O
principal	O	O
cytoplasmic	O	O
inhibitor	O	O
of	O	O
NF-kappaB	protein	protein
.	O	O
Our	O	O
studies	O	O
now	O	O
demonstrate	O	O
that	O	O
HTLV-1	O	O
Tax	protein	protein
activates	O	O
the	O	O
recently	O	O
identified	O	O
cellular	protein	O
kinases	protein	protein
IkappaB	protein	protein
kinase	protein	protein
alpha	protein	protein
(	O	O
IKKalpha	protein	protein
)	O	O
and	O	O
IKKbeta	protein	protein
,	O	O
which	O	O
normally	O	O
phosphorylate	O	O
IkappaB	protein	protein
alpha	protein	protein
on	O	O
both	O	O
of	O	O
its	O	O
N-terminal	O	protein
regulatory	O	protein
serines	O	protein
in	O	O
response	O	O
to	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
alpha	protein	protein
(	O	O
TNF-alpha	protein	protein
)	O	O
and	O	O
interleukin-1	protein	protein
(	O	O
IL-1	protein	protein
)	O	O
stimulation	O	O
.	O	O
In	O	O
contrast,	O	O
a	O	O
mutant	O	O
of	O	O
Tax	protein	protein
termed	O	O
M22	protein	protein
,	O	O
which	O	O
does	O	O
not	O	O
induce	O	O
NF-kappaB	protein	protein
,	O	O
fails	O	O
to	O	O
activate	O	O
either	O	O
IKKalpha	protein	protein
or	O	O
IKKbeta	protein	protein
.	O	O
Furthermore,	O	O
endogenous	O	O
IKK	O	O
enzymatic	O	O
activity	O	O
was	O	O
significantly	O	O
elevated	O	O
in	O	O
HTLV-1-infected	O	O
and	O	O
Tax-expressing	O	cell_line
T-cell	O	cell_line
lines	O	cell_line
.	O	O
Transfection	O	O
of	O	O
kinase-deficient	O	O
mutants	O	O
of	O	O
IKKalpha	protein	protein
and	O	O
IKKbeta	protein	protein
into	O	O
either	O	O
human	O	O
Jurkat	O	O
T	O	O
or	O	O
293	O	O
cells	O	O
also	O	O
inhibits	O	O
NF-kappaB	protein	protein
-dependent	O	O
reporter	DNA	O
gene	DNA	O
expression	O	O
induced	O	O
by	O	O
Tax	protein	protein
.	O	O
Similarly,	O	O
a	O	O
kinase-deficient	protein	O
mutant	protein	O
of	O	O
NIK	protein	protein
(	O	O
NF-kappaB	protein	protein
-inducing	protein	protein
kinase	protein	protein
),	O	O
which	O	O
represents	O	O
an	O	O
upstream	O	protein
kinase	O	protein
in	O	O
the	O	O
TNF-alpha	O	protein
and	O	O
IL-1	O	O
signaling	O	O
pathways	O	O
leading	O	O
to	O	O
IKKalpha	protein	protein
and	O	O
IKKbeta	protein	protein
activation,	O	O
blocks	O	O
Tax	protein	protein
induction	O	O
of	O	O
NF-kappaB	protein	protein
.	O	O
However,	O	O
plasma	DNA	O
membrane-proximal	DNA	protein
elements	DNA	protein
in	O	O
these	O	O
proinflammatory	protein	protein
cytokine	protein	protein
pathways	O	O
are	O	O
apparently	O	O
not	O	O
involved	O	O
since	O	O
dominant	O	O
negative	O	O
mutants	O	O
of	O	O
the	O	O
TRAF2	O	protein
and	O	O
TRAF6	O	protein
adaptors	O	protein
,	O	O
which	O	O
effectively	O	O
block	O	O
signaling	O	O
through	O	O
the	O	O
cytoplasmic	protein	O
tails	protein	O
of	O	O
the	O	O
TNF-alpha	protein	protein
and	O	O
IL-1	protein	protein
receptors,	O	O
respectively,	O	O
do	O	O
not	O	O
inhibit	O	O
Tax	protein	protein
induction	O	O
of	O	O
NF-kappaB	protein	protein
.	O	O
Together,	O	O
these	O	O
studies	O	O
demonstrate	O	O
that	O	O
HTLV-1	O	O
Tax	protein	protein
exploits	O	O
a	O	O
distal	O	O
part	O	O
of	O	O
the	O	O
proinflammatory	protein	protein
cytokine	protein	protein
signaling	O	O
cascade	O	O
leading	O	O
to	O	O
induction	O	O
of	O	O
NF-kappaB	protein	protein
.	O	O
The	O	O
pathological	O	O
alteration	O	O
of	O	O
this	O	O
cytokine	O	protein
pathway	O	O
leading	O	O
to	O	O
NF-kappaB	protein	protein
activation	O	O
by	O	O
Tax	protein	protein
may	O	O
play	O	O
a	O	O
central	O	O
role	O	O
in	O	O
HTLV-1	O	O
-mediated	O	O
transformation	O	O
of	O	O
human	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
clinically	O	O
manifested	O	O
as	O	O
the	O	O
adult	O	O
T-cell	O	O
leukemia	O	O

Role	O	O
of	O	O
IKK1	protein	protein
and	O	O
IKK2	protein	protein
in	O	O
lipopolysaccharide	O	O
signaling	O	O
in	O	O
human	cell_type	cell_type
monocytic	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Mononuclear	cell_type	O
phagocytes	cell_type	cell_type
play	O	O
a	O	O
major	O	O
role	O	O
in	O	O
immune	O	O
and	O	O
inflammatory	O	O
responses	O	O
.	O	O
Bacterial	O	O
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
induces	O	O
monocytes	cell_type	cell_type
to	O	O
express	O	O
a	O	O
variety	O	O
of	O	O
genes	O	O
by	O	O
activating	O	O
the	O	O
NF-kappaB/Rel	protein	protein
transcription	protein	protein
factor	protein	protein
family	protein	protein
.	O	O
Recently,	O	O
we	O	O
have	O	O
reported	O	O
that	O	O
the	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
and	O	O
interleukin	protein	protein
1	protein	protein
signaling	O	O
pathways	O	O
activate	O	O
two	O	O
kinases,	O	O
IKK1	protein	protein
and	O	O
IKK2	protein	protein
.	O	O
Phosphorylation	O	O
of	O	O
the	O	O
IkappaB	protein	protein
cytoplasmic	protein	protein
inhibitors	protein	protein
,	O	O
IkappaBalpha	protein	protein
,	O	O
IkappaBbeta	protein	protein
,	O	O
and	O	O
IkappaBepsilon	protein	protein
,	O	O
by	O	O
these	O	O
kinases	O	protein
triggers	O	O
proteolytic	O	O
degradation	O	O
and	O	O
the	O	O
release	O	O
of	O	O
NF-kappaB/Rel	protein	protein
proteins	protein	protein
into	O	O
the	O	O
nucleus.	O	O
At	O	O
present,	O	O
the	O	O
role	O	O
of	O	O
the	O	O
IKKs	O	protein
in	O	O
LPS	O	O
signaling	O	O
has	O	O
not	O	O
been	O	O
investigated.	O	O
Here,	O	O
we	O	O
report	O	O
that	O	O
LPS	O	O
induces	O	O
IKK	protein	protein
activity	O	O
in	O	O
human	cell_type	cell_type
monocytes	cell_type	cell_type
and	O	O
THP-1	cell_line	cell_line
monocytic	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
The	O	O
kinetics	O	O
of	O	O
activation	O	O
of	O	O
kinase	O	O
activity	O	O
in	O	O
monocytic	cell_type	cell_type
cells	cell_type	cell_type
are	O	O
relatively	O	O
slow	O	O
with	O	O
maximal	O	O
activity	O	O
observed	O	O
at	O	O
60	O	O
min,	O	O
which	O	O
coincides	O	O
with	O	O
the	O	O
degradation	O	O
of	O	O
IkappaBs	protein	protein
and	O	O
the	O	O
nuclear	O	O
translocation	O	O
of	O	O
NF-kappaB	protein	protein
.	O	O
In	O	O
transfection	O	O
experiments,	O	O
overexpression	O	O
of	O	O
wild	O	protein
type	O	protein
IKK1	protein	protein
,	O	O
a	O	O
dominant	protein	protein
negative	protein	protein
mutant	protein	protein
IKK1	protein	protein
(	O	O
K44M	protein	protein
),	O	O
or	O	O
wild	protein	O
type	protein	O
IKK2	protein	O
did	O	O
not	O	O
affect	O	O
LPS	O	O
-induced	O	O
kappaB	protein	protein
-dependent	O	O
transcription	O	O
in	O	O
monocytic	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
contrast,	O	O
a	O	O
dominant	O	O
negative	O	O
mutant	O	O
of	O	O
IKK2	protein	protein
inhibited	O	O
LPS	O	O
induction	O	O
of	O	O
kappaB	protein	protein
-dependent	O	O
transcription	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
.	O	O
These	O	O
results	O	O
indicate	O	O
that	O	O
LPS	O	O
induction	O	O
of	O	O
kappaB-dependent	O	DNA
gene	O	DNA
expression	O	O
in	O	O
human	cell_type	cell_type
monocytic	cell_type	cell_type
cells	cell_type	cell_type
requires	O	O
activation	O	O
of	O	O
IKK2	protein	protein
.	O	O

IL-7	protein	protein
reconstitutes	O	O
multiple	O	O
aspects	O	O
of	O	O
v-Abl	protein	protein
-mediated	O	O
signaling	O	O
.	O	O
The	O	O
mechanism	O	O
by	O	O
which	O	O
early	cell_type	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
are	O	O
selectively	O	O
transformed	O	O
by	O	O
v-Abl	protein	protein
is	O	O
currently	O	O
unknown.	O	O
Previous	O	O
studies	O	O
have	O	O
shown	O	O
constitutive	O	O
activation	O	O
of	O	O
IL-4	protein	protein
and	O	O
IL-7	protein	protein
signaling	O	O
pathways	O	O
,	O	O
as	O	O
measured	O	O
by	O	O
activation	O	O
of	O	O
Janus	protein	protein
protein	protein	protein
kinase	protein	protein
(JAK)1	protein	protein
,	O	O
JAK3	protein	protein
,	O	O
STAT5	protein	protein
,	O	O
and	O	O
STAT6	protein	protein
,	O	O
in	O	O
pre-B	cell_type	cell_type
cells	cell_type	cell_type
transformed	O	O
by	O	O
v-Abl	protein	protein
.	O	O
To	O	O
determine	O	O
whether	O	O
activation	O	O
of	O	O
these	O	O
cytokine	O	protein
signaling	O	O
pathways	O	O
by	O	O
v-Abl	protein	protein
is	O	O
important	O	O
in	O	O
the	O	O
cellular	O	O
events	O	O
induced	O	O
by	O	O
the	O	O
Abelson	O	O
murine	O	O
leukemia	O	O
virus	O	O
,	O	O
the	O	O
effects	O	O
of	O	O
IL-4	protein	protein
and	O	O
IL-7	protein	protein
on	O	O
pre-B	cell_type	cell_type
cells	cell_type	cell_type
transformed	O	O
with	O	O
a	O	O
temperature-sensitive	protein	O
v-Abl	protein	protein
mutant	protein	protein
were	O	O
examined.	O	O
Whereas	O	O
IL-4	protein	protein
had	O	O
little	O	O
or	O	O
no	O	O
effect,	O	O
IL-7	protein	protein
delayed	O	O
both	O	O
the	O	O
apoptosis	O	O
and	O	O
cell	O	O
cycle	O	O
arrest	O	O
that	O	O
occur	O	O
upon	O	O
v-Abl	protein	protein
kinase	O	protein
inactivation	O	O
.	O	O
IL-7	protein	protein
also	O	O
delayed	O	O
the	O	O
decreases	O	O
in	O	O
the	O	O
levels	O	O
of	O	O
c-Myc	protein	protein
,	O	O
Bcl-2	protein	protein
,	O	O
and	O	O
Bcl-xL	protein	protein
that	O	O
occur	O	O
upon	O	O
loss	O	O
of	O	O
v-Abl	protein	protein
kinase	O	protein
activity	O	O
.	O	O
IL-7	protein	protein
did	O	O
not	O	O
maintain	O	O
v-Abl	protein	protein
-mediated	O	O
differentiation	O	O
arrest	O	O
of	O	O
the	O	O
pre-B	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
as	O	O
activation	O	O
of	O	O
NF-kappaB	protein	protein
and	O	O
RAG	DNA	DNA
gene	DNA	DNA
transcription	O	O
was	O	O
unaffected	O	O
by	O	O
IL-7	protein	protein
.	O	O
These	O	O
results	O	O
identify	O	O
a	O	O
potential	O	O
role	O	O
for	O	O
IL-7	protein	protein
signaling	O	O
pathways	O	O
in	O	O
transformation	O	O
by	O	O
v-Abl	protein	protein
while	O	O
demonstrating	O	O
that	O	O
a	O	O
combination	O	O
of	O	O
IL-4	protein	protein
and	O	O
IL-7	protein	protein
signaling	O	O
cannot	O	O
substitute	O	O
for	O	O
an	O	O
active	O	O
v-Abl	protein	protein
kinase	O	protein
in	O	O
transformed	cell_type	cell_line
pre-B	cell_type	cell_line
cells	cell_type	cell_line
.	O	O

Differential	O	O
regulation	O	O
of	O	O
coproporphyrinogen	DNA	DNA
oxidase	DNA	DNA
gene	DNA	DNA
between	O	O
erythroid	O	O
and	O	O
nonerythroid	O	O
cells	O	O
.	O	O
Coproporphyrinogen	protein	protein
oxidase	protein	protein
(	O	O
CPO	protein	protein
)	O	O
catalyzes	O	O
the	O	O
sixth	O	O
step	O	O
of	O	O
the	O	O
heme	protein	O
biosynthetic	O	O
pathway	O	O
.	O	O
To	O	O
assess	O	O
the	O	O
tissue-specific	O	O
regulation	O	O
of	O	O
the	O	O
CPO	DNA	DNA
gene	DNA	DNA
promoter	DNA	DNA
,	O	O
mouse	DNA	DNA
genomic	DNA	DNA
DNA	DNA	DNA
clones	DNA	DNA
for	O	O
CPO	protein	O
were	O	O
isolated.	O	O
Structural	O	O
analysis	O	O
demonstrated	O	O
that	O	O
the	O	O
mouse	DNA	DNA
CPO	DNA	DNA
gene	DNA	DNA
spans	O	O
approximately	O	O
11	O	O
kb	O	O
and	O	O
consists	O	O
of	O	O
seven	DNA	O
exons	DNA	DNA
,	O	O
just	O	O
like	O	O
its	O	O
human	O	O
counterpart.	O	O
Functional	O	O
analysis	O	O
of	O	O
the	O	O
promoter	O	O
by	O	O
transient	O	O
transfection	O	O
assays	O	O
indicated	O	O
that	O	O
synergistic	O	O
action	O	O
between	O	O
an	O	O
SP-1	DNA	DNA
-like	DNA	DNA
element	DNA	DNA
at	O	O
-21/-12,	O	O
a	O	O
GATA	DNA	DNA
site	DNA	DNA
at	O	O
-59/-54,	O	O
and	O	O
a	O	O
novel	DNA	DNA
regulatory	DNA	DNA
element	DNA	DNA
,	O	O
CPRE	DNA	DNA
(-	O	DNA
GGACTACAG	DNA	DNA
-)	O	DNA
at	O	O
-49/-41,	O	O
is	O	O
essential	O	O
for	O	O
the	O	O
promoter	O	O
activity	O	O
in	O	O
murine	cell_type	cell_line
erythroleukemia	cell_type	cell_line
(MEL)	cell_type	cell_line
cells	cell_type	cell_line
.	O	O
In	O	O
nonerythroid	cell_line	cell_type
NIH3T3	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
however,	O	O
the	O	O
GATA	DNA	DNA
site	DNA	DNA
is	O	O
not	O	O
required.	O	O
Gel	O	O
mobility	O	O
shift	O	O
assays	O	O
demonstrated	O	O
that	O	O
specific	O	O
DNA-protein	protein	protein
complexes	protein	protein
can	O	O
be	O	O
formed	O	O
with	O	O
each	O	O
element,	O	O
and	O	O
that	O	O
there	O	O
are	O	O
cell-specific	O	O
differences	O	O
in	O	O
factors,	O	O
which	O	O
bind	O	O
to	O	O
the	O	O
SP-1	DNA	DNA
-like	DNA	DNA
element	DNA	DNA
between	O	O
MEL	O	O
and	O	O
NIH3T3	O	cell_line
cells	O	cell_line
.	O	O
These	O	O
results	O	O
provide	O	O
evidence	O	O
for	O	O
differential	O	O
regulation	O	O
of	O	O
the	O	O
promoter	O	O
function	O	O
of	O	O
CPO	protein	DNA
gene	O	DNA
between	O	O
erythroid	O	O
and	O	O
nonerythroid	O	O
cells	O	O
.	O	O
Copyright	O	O
1998	O	O
by	O	O
The	O	O
American	O	O
Society	O	O
of	O	O
Hematology	O	O

Tumor	protein	protein
suppressor	protein	protein
proteins	protein	protein
as	O	O
regulators	O	O
of	O	O
cell	O	O
differentiation	O	O
.	O	O
The	O	O
products	O	O
of	O	O
the	O	O
tumor	DNA	DNA
suppressor	DNA	DNA
genes	DNA	DNA
are	O	O
considered	O	O
to	O	O
function	O	O
as	O	O
specific	O	O
inhibitors	O	O
of	O	O
tumor	O	O
cell	O	O
growth.	O	O
In	O	O
this	O	O
communication,	O	O
we	O	O
present	O	O
evidence	O	O
to	O	O
show	O	O
that	O	O
these	O	O
proteins	O	O
inhibit	O	O
tumor	O	O
cell	O	O
proliferation	O	O
by	O	O
participating	O	O
in	O	O
the	O	O
activation	O	O
of	O	O
tumor	O	O
cell	O	O
differentiation	O	O
.	O	O
The	O	O
ML-1	cell_line	cell_line
human	cell_line	cell_line
myeloblastic	cell_line	cell_line
leukemia	cell_line	cell_line
cells	cell_line	cell_line
used	O	O
in	O	O
this	O	O
study	O	O
proliferate	O	O
when	O	O
treated	O	O
with	O	O
insulin-like	protein	O
growth	protein	O
factor	protein	O
I	protein	O
and	O	O
transferrin	protein	O
but	O	O
differentiate	O	O
to	O	O
monocytes	cell_type	cell_type
when	O	O
exposed	O	O
to	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
alpha	protein	protein
or	O	O
transforming	protein	protein
growth	protein	protein
factor	protein	protein
beta1	protein	protein
,	O	O
or	O	O
to	O	O
macrophage-like	cell_type	cell_type
cells	cell_type	cell_type
when	O	O
treated	O	O
with	O	O
both	O	O
these	O	O
cytokines	protein	protein
.	O	O
Initiation	O	O
of	O	O
proliferation	O	O
but	O	O
not	O	O
of	O	O
differentiation	O	O
was	O	O
followed	O	O
by	O	O
a	O	O
20-	O	O
to	O	O
25-fold	O	O
increase	O	O
in	O	O
the	O	O
nuclear	O	O
level	O	O
of	O	O
the	O	O
DNA	protein	DNA
polymerase-associated	protein	DNA
processivity	protein	DNA
factor	protein	DNA
PCNA	protein	DNA
and	O	O
of	O	O
the	O	O
proliferation-specific	protein	protein
transcription	protein	protein
factor	protein	protein
E2F1	protein	protein
.	O	O
In	O	O
contrast,	O	O
induction	O	O
of	O	O
differentiation	O	O
but	O	O
not	O	O
of	O	O
proliferation	O	O
was	O	O
followed	O	O
by	O	O
a	O	O
25-	O	O
to	O	O
30-fold	O	O
increase	O	O
in	O	O
the	O	O
nuclear	O	O
level	O	O
of	O	O
the	O	O
tumor	protein	protein
suppressor	protein	protein
proteins	protein	protein
p53	protein	protein
(wild	O	protein
type),	O	O
pRb	protein	protein
,	O	O
and	O	O
p130/Rb2	protein	protein
and	O	O
of	O	O
the	O	O
p53-dependent	protein	protein
cyclin	protein	protein
kinase	protein	protein
inhibitor	protein	O
p21/Cip1	protein	protein
.	O	O
p53	protein	O
and	O	O
p21/Cip1	protein	protein
,	O	O
respectively,	O	O
inhibit	O	O
the	O	O
expression	O	O
and	O	O
activation	O	O
of	O	O
PCNA	protein	O
,	O	O
whereas	O	O
p130	protein	protein
and	O	O
pRb	protein	protein
,	O	O
respectively,	O	O
inhibit	O	O
the	O	O
expression	O	O
and	O	O
activation	O	O
of	O	O
E2F1	protein	protein
.	O	O
As	O	O
a	O	O
result,	O	O
G1-S-associated	DNA	O
DNA	DNA	O
and	O	O
mRNA	O	O
synthesis	O	O
is	O	O
inhibited,	O	O
growth	O	O
uncoupled	O	O
from	O	O
differentiation,	O	O
and	O	O
maturation	O	O
enabled	O	O
to	O	O
proceed.	O	O
Where	O	O
this	O	O
function	O	O
of	O	O
the	O	O
tumor	protein	protein
suppressor	protein	protein
proteins	protein	protein
is	O	O
impaired,	O	O
the	O	O
capacity	O	O
for	O	O
differentiation	O	O
is	O	O
lost,	O	O
which	O	O
leads	O	O
to	O	O
the	O	O
sustained	O	O
proliferation	O	O
that	O	O
is	O	O
characteristic	O	O
of	O	O
the	O	O
cancer	cell_type	O
cell	cell_type	O
.	O	O

Transcription	protein	protein
factor	protein	protein
activation	O	O
in	O	O
lymphokine	O	protein
activated	O	protein
killer	cell_type	protein
cells	cell_type	protein
and	O	O
lymphocytes	cell_type	O
from	O	O
patients	O	O
receiving	O	O
IL-2	protein	protein
immunotherapy	O	O
.	O	O
Administration	O	O
of	O	O
the	O	O
cytokine	protein	protein
interleukin-2	protein	protein
(	O	O
IL-2	protein	protein
)	O	O
can	O	O
result	O	O
in	O	O
therapeutic	O	O
benefits	O	O
for	O	O
individuals	O	O
with	O	O
renal	O	O
cell	O	O
carcinoma	O	O
and	O	O
melanoma	O	O
.	O	O
Here	O	O
we	O	O
report	O	O
an	O	O
analysis	O	O
of	O	O
the	O	O
transcription	O	protein
factor	O	protein
families	O	protein
AP-1,	O	protein
Sp1,	O	protein
NF-kappaB	protein	protein
,	O	O
and	O	O
signal	protein	protein
transducers	protein	protein
and	protein	protein
activators	protein	protein
of	protein	protein
transcription	protein	protein
(	O	O
STAT	protein	protein
)	O	O
in	O	O
cancer	cell_type	O
patients'	cell_type	O
lymphocytes	cell_type	O
before	O	O
and	O	O
after	O	O
IL-2	protein	protein
immunotherapy	O	O
,	O	O
as	O	O
assessed	O	O
by	O	O
a	O	O
gel-shift	O	O
assay	O	O
.	O	O
An	O	O
in	O	O
vitro	O	O
surrogate	O	O
of	O	O
IL-2	protein	protein
immunotherapy	O	O
is	O	O
the	O	O
incubation	O	O
of	O	O
fresh	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
(	O	O
PBMC	cell_type	cell_type
)	O	O
from	O	O
healthy	O	O
individuals	O	O
in	O	O
IL-2	protein	protein
for	O	O
several	O	O
days,	O	O
resulting	O	O
in	O	O
the	O	O
production	O	O
of	O	O
lymphokine	protein	protein
-activated	O	protein
killer	O	protein
(LAK)	O	protein
activity	O	O
in	O	O
these	O	O
cultures.	O	O
One	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
describe	O	O
the	O	O
profile	O	O
of	O	O
transcription	O	protein
factor	O	protein
activation	O	O
in	O	O
these	O	O
different	O	O
populations,	O	O
and	O	O
assess	O	O
whether	O	O
the	O	O
patterns	O	O
observed	O	O
correlated	O	O
with	O	O
functional	O	O
differences	O	O
in	O	O
these	O	O
cells.	O	O
Prior	O	O
to	O	O
in	O	O
vivo	O	O
IL-2	protein	protein
administration,	O	O
the	O	O
typical	O	O
binding	O	O
pattern	O	O
of	O	O
transcription	protein	protein
factors	protein	protein
in	O	O
PBMC	cell_type	cell_type
from	O	O
patients	O	O
resembled	O	O
that	O	O
seen	O	O
in	O	O
fresh	O	O
PBMC	cell_type	cell_type
from	O	O
healthy	O	O
individuals	O	O
.	O	O
Over	O	O
a	O	O
3-week	O	O
course	O	O
of	O	O
IL-2	protein	protein
therapy,	O	O
in	O	O
most	O	O
patients	O	O
the	O	O
binding	O	O
patterns	O	O
of	O	O
AP-1	protein	protein
,	O	O
Sp1	protein	protein
,	O	O
and	O	O
NF-kappaB	protein	protein
proteins	O	protein
changed	O	O
to	O	O
resemble	O	O
those	O	O
seen	O	O
in	O	O
PBMC	cell_type	cell_type
activated	O	O
by	O	O
IL-2	protein	protein
in	O	O
vitro.	O	O
However,	O	O
the	O	O
cells	O	O
obtained	O	O
from	O	O
IL-2	protein	protein
-treated	O	O
patients	O	O
did	O	O
not	O	O
have	O	O
low-level	O	O
constitutive	O	O
expression	O	O
of	O	O
STAT	protein	protein
binding	protein	protein
factors	protein	protein
as	O	O
did	O	O
LAK	protein	cell_line
cells	protein	cell_line
.	O	O
When	O	O
these	O	O
patient	O	O
cells	O	O
were	O	O
further	O	O
stimulated	O	O
by	O	O
IL-2	protein	protein
in	O	O
vitro	O	O
,	O	O
additional	O	O
differences	O	O
in	O	O
STAT	protein	protein
induction	O	O
patterns	O	O
were	O	O
noted.	O	O
These	O	O
data	O	O
provide	O	O
further	O	O
information	O	O
on	O	O
the	O	O
molecular	O	O
events	O	O
occurring	O	O
in	O	O
immune	cell_type	cell_type
cells	cell_type	cell_type
generated	O	O
through	O	O
in	O	O
vivo	O	O
and	O	O
in	O	O
vitro	O	O
administration	O	O
of	O	O
IL-2	protein	protein
,	O	O
and	O	O
further	O	O
document	O	O
that	O	O
there	O	O
is	O	O
not	O	O
a	O	O
precise	O	O
congruence	O	O
between	O	O
PBMC	cell_type	cell_type
activated	O	O
in	O	O
vivo	O	O
and	O	O
in	O	O
vitro	O	O
by	O	O
IL-2	protein	protein
.	O	O

Activated	cell_type	O
platelets	cell_type	cell_type
induce	O	O
monocyte	protein	protein
chemotactic	protein	protein
protein-1	protein	protein
secretion	O	O
and	O	O
surface	O	O
expression	O	O
of	O	O
intercellular	cell_type	protein
adhesion	cell_type	protein
molecule-1	cell_type	protein
on	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
[see	O	O
comments]	O	O
BACKGROUND:	O	O
Platelet/endothelium	O	O
interaction	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
pathophysiology	O	O
of	O	O
inflammation	O	O
and	O	O
atherosclerosis	O	O
.	O	O
The	O	O
role	O	O
of	O	O
platelets	O	cell_type
for	O	O
monocyte	protein	protein
chemotactic	protein	protein
protein-1	protein	protein
(	O	O
MCP-1	protein	protein
)	O	O
secretion	O	O
and	O	O
surface	O	O
expression	O	O
of	O	O
intercellular	cell_type	protein
adhesion	cell_type	protein
molecule-1	cell_type	protein
(	O	O
ICAM-1	protein	protein
)	O	O
on	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
has	O	O
been	O	O
assessed.	O	O
METHODS	O	O
AND	O	O
RESULTS:	O	O
Monolayers	O	O
of	O	O
human	cell_type	O
umbilical	cell_type	O
vein	cell_type	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
incubated	O	O
with	O	O
nonstimulated	O	O
or	O	O
ADP-activated	cell_type	O
platelets	cell_type	O
for	O	O
6	O	O
hours,	O	O
and	O	O
secretion	O	O
of	O	O
MCP-1	protein	protein
and	O	O
surface	O	O
expression	O	O
of	O	O
ICAM-1	protein	protein
were	O	O
determined	O	O
by	O	O
ELISA	O	O
and	O	O
flow	O	O
cytometry	O	O
,	O	O
respectively.	O	O
In	O	O
the	O	O
presence	O	O
of	O	O
ADP-activated	cell_type	protein
platelets	cell_type	protein
,	O	O
both	O	O
MCP-1	protein	protein
secretion	O	O
and	O	O
ICAM-1	protein	protein
surface	O	O
expression	O	O
were	O	O
significantly	O	O
increased	O	O
compared	O	O
with	O	O
nonstimulated	cell_type	O
platelets	cell_type	cell_type
(P&lt;0.02).	O	O
Activation	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
nuclear	protein	protein
factor-kappaB	protein	protein
(	O	O
NF-kappaB	protein	protein
)	O	O
determined	O	O
by	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assay	O	O
and	O	O
kappaB	protein	protein
-dependent	O	O
transcriptional	O	O
activity	O	O
was	O	O
enhanced	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
activated	cell_type	cell_type
platelets	cell_type	cell_type
.	O	O
In	O	O
addition,	O	O
ADP-	cell_type	protein
activated	cell_type	protein
platelets	cell_type	protein
induced	O	O
MCP-1	O	protein
and	O	O
ICAM-1	O	protein
promoter-dependent	O	O
transcription	O	O
.	O	O
Liposomal	O	O
transfection	O	O
of	O	O
a	O	O
double-stranded	O	DNA
kappaB	O	DNA
phosphorothioate	O	O
oligonucleotide	O	O
,	O	O
but	O	O
not	O	O
of	O	O
the	O	O
mutated	O	O
form,	O	O
inhibited	O	O
MCP-1	protein	protein
secretion	O	O
and	O	O
surface	O	O
expression	O	O
of	O	O
ICAM-1	protein	protein
on	O	O
activated	O	O
endothelium	O	O
(P&lt;0.05).	O	O
CONCLUSIONS:	O	O
The	O	O
present	O	O
study	O	O
indicates	O	O
that	O	O
activated	cell_type	O
platelets	cell_type	cell_type
modulate	O	cell_type
chemotactic	O	cell_type
(	O	O
MCP-1	protein	protein
)	O	O
and	O	O
adhesive	O	O
(	O	O
ICAM-1	protein	protein
)	O	O
properties	O	O
of	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
via	O	O
an	O	O
NF-kappaB	protein	protein
-dependent	O	O
mechanism	O	O
.	O	O
Platelet-induced	O	O
activation	O	O
of	O	O
the	O	O
NF-kappaB	protein	protein
system	O	O
might	O	O
contribute	O	O
to	O	O
early	O	O
inflammatory	O	O
events	O	O
in	O	O
atherogenesis	O	O
.	O	O

Retinoid	protein	protein
X	protein	protein
receptor	protein	protein
and	O	O
c-cerbA/thyroid	protein	protein
hormone	protein	protein
receptor	protein	protein
regulate	O	O
erythroid	O	O
cell	O	O
growth	O	O
and	O	O
differentiation	O	O
.	O	O
Nuclear	protein	protein
receptors	protein	protein
are	O	O
important	O	O
regulators	O	O
of	O	O
erythroid	O	O
cell	O	O
development	O	O
.	O	O
Here	O	O
we	O	O
investigated	O	O
the	O	O
impact	O	O
of	O	O
retinoid	protein	protein
X	protein	protein
receptor	protein	protein
(	O	O
RXR	protein	protein
),	O	O
retinoic	protein	protein
acid	protein	protein
receptor	protein	protein
(	O	O
RAR	protein	protein
),	O	O
and	O	O
of	O	O
the	O	O
c-erbA/thyroid	protein	protein
hormone	protein	protein
(T3)	protein	protein
receptor	protein	protein
(	O	O
c-erbA/TR	protein	protein
)	O	O
on	O	O
growth	O	O
and	O	O
differentiation	O	O
of	O	O
erythroid	cell_type	cell_type
cells	cell_type	cell_type
using	O	O
an	O	O
in	O	O
vitro	O	O
culture	O	O
system	O	O
of	O	O
stem	cell_type	protein
cell	cell_type	protein
factor-dependent	cell_type	protein
erythroid	cell_type	protein
progenitors	cell_type	protein
.	O	O
RXR	protein	protein
,	O	O
RAR	protein	protein
,	O	O
and	O	O
c-erbA/TR	protein	protein
-specific	O	O
ligands	O	O
were	O	O
found	O	O
to	O	O
induce	O	O
erythroid-specific	DNA	DNA
gene	DNA	DNA
expression	O	O
and	O	O
to	O	O
accelerate	O	O
erythroid	O	O
differentiation	O	O
in	O	O
culture,	O	O
with	O	O
T3	O	protein
being	O	O
most	O	O
effective.	O	O
Furthermore,	O	O
while	O	O
ligand-activated	O	O
c-erbA/TR	protein	O
accelerated	O	O
differentiation	O	O
,	O	O
unliganded	O	O
c-erbA/TR	protein	DNA
effectively	O	O
blocked	O	O
differentiation	O	O
and	O	O
supported	O	O
sustained	O	O
progenitor	O	O
growth	O	O
in	O	O
culture.	O	O
Thus,	O	O
c-erbA/TR	protein	DNA
appears	O	O
to	O	O
act	O	O
as	O	O
a	O	O
binary	O	O
switch	O	O
affecting	O	O
erythroid	cell_type	O
cell	cell_type	O
fate	cell_type	O
:	O	O
unliganded	O	O
c-erbA/TR	protein	DNA
supports	O	O
growth	O	O
while	O	O
ligand-activated	O	O
c-erbA/TR	protein	DNA
induces	O	O
differentiation.	O	O
Additionally,	O	O
to	O	O
determine	O	O
the	O	O
impact	O	O
of	O	O
RXR	protein	protein
for	O	O
erythroid	O	O
cell	O	O
development	O	O
,	O	O
dominant	O	O
interfering	O	O
mutant	protein	O
RXRs	protein	protein
,	O	O
lacking	O	O
the	O	O
transcriptional	O	protein
activator	O	protein
functions	O	protein
AF-1	protein	protein
and	O	O
AF-2	protein	protein
,	O	O
or	O	O
AF-2	protein	protein
only,	O	O
or	O	O
the	O	O
entire	DNA	O
DNA-binding	DNA	protein
domain	DNA	protein
,	O	O
were	O	O
introduced	O	O
into	O	O
erythroid	cell_type	cell_type
progenitor	cell_type	cell_type
cells	cell_type	cell_type
via	O	O
recombinant	O	O
retrovirus	O	O
vectors	O	O
and	O	O
analyzed	O	O
for	O	O
RXR	protein	protein
-specific	O	O
effects.	O	O
It	O	O
was	O	O
found	O	O
that	O	O
expression	O	O
of	O	O
wild-type	protein	O
RXR	protein	protein
and	O	O
of	O	O
the	O	O
RXR	protein	protein
mutants	protein	protein
devoid	O	O
of	O	O
AF-1	protein	protein
and/or	O	O
AF-2	protein	O
supported	O	O
a	O	O
transient	O	O
outgrowth	O	O
of	O	O
erythroid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
marked	O	O
contrast,	O	O
expression	O	O
of	O	O
the	O	O
dominant	protein	O
interfering	protein	O
deltaDNA-binding	protein	protein
domain	protein	protein
RXR	protein	protein
,	O	O
containing	O	O
a	O	O
deletion	O	O
of	O	O
the	O	O
entire	DNA	O
DNA-binding	DNA	protein
domain	DNA	protein
,	O	O
was	O	O
incompatible	O	O
with	O	O
erythroid	O	O
cell	O	O
growth	O	O
in	O	O
vitro,	O	O
suggesting	O	O
a	O	O
pivotal	O	O
role	O	O
of	O	O
RXR	protein	protein
for	O	O
erythroid	O	O
cell	O	O
development	O	O
.	O	O

Peripheral	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
from	O	O
women	O	O
with	O	O
breast	O	O
cancer	O	O
exhibit	O	O
abnormal	O	O
protein	O	O
expression	O	O
of	O	O
several	protein	O
signaling	protein	protein
molecules	protein	protein
.	O	O
We	O	O
examined	O	O
signaling	O	O
molecules	O	O
of	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
obtained	O	O
from	O	O
women	O	O
with	O	O
breast	O	O
cancer	O	O
.	O	O
In	O	O
6	O	O
of	O	O
14	O	O
patients	O	O
,	O	O
T	cell_type	O
lymphocytes	cell_type	O
displayed	O	O
an	O	O
impaired	O	O
ability	O	O
to	O	O
translocate	O	O
NFeB	protein	protein
p65	protein	protein
(	O	O
Rel-A	protein	protein
)	O	O
following	O	O
activation	O	O
by	O	O
anti-CD3	O	protein
and	O	O
IL-2	protein	protein
.	O	O
This	O	O
observation	O	O
was	O	O
made	O	O
despite	O	O
normal	O	O
cytoplasmic	O	O
levels	O	O
of	O	O
the	O	O
Rel-A	protein	protein
protein	protein	protein
.	O	O
We	O	O
also	O	O
detected	O	O
abnormally	O	O
low	O	O
levels	O	O
of	O	O
the	O	O
signaling	protein	protein
molecules	protein	protein
T-cell	protein	protein
receptor	protein	protein
(TCR)-zeta	protein	protein
,	O	O
ZAP-70	protein	protein
and	O	O
p56lck	protein	protein
in	O	O
4	O	O
of	O	O
14	O	O
breast	O	O
cancer	O	O
patients	O	O
,	O	O
i.e.,	O	O
defects	O	O
in	O	O
T-cell	protein	O
signaling	protein	O
molecules	protein	O
.	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
from	O	O
6	O	O
of	O	O
the	O	O
14	O	O
patients	O	O
also	O	O
exhibited	O	O
an	O	O
increased	O	O
expression	O	O
of	O	O
the	O	O
dual	O	O
specificity	protein	O
phosphatase	protein	O
,	O	O
map	protein	protein
kinase	protein	protein
phosphatase-1	protein	protein
(	O	O
MKP-1	protein	protein
).	O	O
MKP-1	protein	protein
inactivates	O	O
MAP	protein	protein
kinase	protein	protein
and	O	O
therefore	O	O
may	O	O
interfere	O	O
with	O	O
the	O	O
activation	O	O
of	O	O
c-jun	DNA	O
and	O	O
c-fos	DNA	DNA
.	O	O
Abnormalities	O	O
of	O	O
I	O	O
or	O	O
more	O	O
signaling	protein	O
molecules	protein	O
were	O	O
found	O	O
in	O	O
9	O	O
of	O	O
14	O	O
patients	O	O
;	O	O
however,	O	O
only	O	O
3	O	O
patients	O	O
had	O	O
T	cell_type	O
cells	cell_type	O
that	O	O
exhibited	O	O
all	O	O
5	O	O
defects.	O	O
Our	O	O
data	O	O
have	O	O
implications	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
potentially	O	O
dysfunctional	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
patients	O	O
with	O	O
cancer	O	O
.	O	O
For	O	O
example,	O	O
the	O	O
analysis	O	O
of	O	O
only	O	O
1	O	O
signaling	protein	O
molecule	protein	O
may	O	O
allow	O	O
patients	O	O
with	O	O
significant	O	O
defects	O	O
in	O	O
T-cell	O	O
signaling	O	O
to	O	O
go	O	O
unnoticed.	O	O
Finally,	O	O
despite	O	O
impaired	O	O
Rel-A	protein	O
translocation	O	O
,	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
capable	O	O
of	O	O
transcribing	O	O
IL-2	protein	protein
.	O	O
Impairments	O	O
in	O	O
the	O	O
translocation	O	O
of	O	O
Rel-B	protein	protein
and	O	O
c-Rel	protein	protein
further	O	O
suggest	O	O
that	O	O
the	O	O
NFKB	protein	protein
family	protein	protein
members	protein	protein
Rel-A	protein	protein
,	O	O
Rel-B	protein	protein
and	O	O
c-Rel	protein	protein
are	O	O
not	O	O
required	O	O
for	O	O
the	O	O
transcription	O	O
of	O	O
IL-2	protein	protein
in	O	O
the	O	O
peripheral	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
of	O	O
patients	O	O
with	O	O
breast	O	O
cancer	O	O
.	O	O

Specific	O	O
glucocorticoid	O	O
binding	O	O
at	O	O
different	O	O
levels	O	O
of	O	O
human	O	O
motor	O	O
activity	O	O
.	O	O
We	O	O
studied	O	O
the	O	O
number	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
and	O	O
dissociation	O	O
constant	O	O
in	O	O
isolated	cell_type	cell_type
human	cell_type	cell_type
lymphocytes	cell_type	cell_type
as	O	O
well	O	O
as	O	O
blood	O	O
concentrations	O	O
of	O	O
hormones	O	O
produced	O	O
by	O	O
the	O	O
hypothalamic-hypophyseal-adrenocortical	O	O
system	O	O
in	O	O
three	O	O
experimental	O	O
series:	O	O
at	O	O
normal	O	O
(17	O	O
subjects	O	O
),	O	O
decreased	O	O
(10	O	O
subjects	O	O
,	O	O
a	O	O
360-d	O	O
head-down	O	O
bed	O	O
rest)	O	O
and	O	O
increased	O	O
(8	O	O
subjects	O	O
,	O	O
physical	O	O
exercise	O	O
on	O	O
bicycle	O	O
ergometer)	O	O
levels	O	O
of	O	O
motor	O	O
activity.	O	O
In	O	O
the	O	O
first	O	O
series	O	O
we	O	O
found	O	O
that	O	O
the	O	O
number	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
and	O	O
dissociation	O	O
constant	O	O
did	O	O
not	O	O
depend	O	O
on	O	O
the	O	O
season,	O	O
on	O	O
the	O	O
age	O	O
of	O	O
subjects	O	O
nor	O	O
on	O	O
cortisol	O	O
concentrations	O	O
in	O	O
blood.	O	O
In	O	O
the	O	O
second	O	O
series	O	O
we	O	O
observed	O	O
the	O	O
following:	O	O
at	O	O
the	O	O
end	O	O
of	O	O
the	O	O
first	O	O
month	O	O
of	O	O
bed	O	O
rest	O	O
the	O	O
number	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
and	O	O
receptor	O	O
affinity	O	O
significantly	O	O
increased;	O	O
at	O	O
the	O	O
beginning	O	O
of	O	O
the	O	O
third	O	O
month	O	O
of	O	O
bed	O	O
rest	O	O
specific	O	O
glucocorticoid	O	O
binding	O	O
significantly	O	O
decreased	O	O
and	O	O
circadian	O	O
rhythms	O	O
of	O	O
adrenocorticotropin	O	O
and	O	O
cortisol	O	O
in	O	O
blood	O	O
varied	O	O
markedly;	O	O
at	O	O
the	O	O
end	O	O
of	O	O
the	O	O
sixth	O	O
month	O	O
of	O	O
bed	O	O
rest	O	O
the	O	O
number	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
returned	O	O
to	O	O
prebed	O	O
rest	O	O
levels	O	O
and	O	O
dissociation	O	O
constant	O	O
decreased.	O	O
In	O	O
the	O	O
third	O	O
series	O	O
physical	O	O
exercises	O	O
that	O	O
induced	O	O
an	O	O
activation	O	O
of	O	O
the	O	O
hypothalamic-hypophyseal-adrenocortical	O	O
system	O	O
(maximal	O	O
physical	O	O
exercises	O	O
and	O	O
prolonged	O	O
submaximal	O	O
exercises	O	O
at	O	O
70%	O	O
of	O	O
maximal	O	O
oxygen	O	O
uptake)	O	O
led	O	O
to	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
the	O	O
number	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
without	O	O
changes	O	O
of	O	O
dissociation	O	O
constant.	O	O
These	O	O
results	O	O
indicate	O	O
that	O	O
both	O	O
a	O	O
decrease	O	O
and	O	O
an	O	O
increase	O	O
of	O	O
human	O	O
motor	O	O
activity	O	O
resulted	O	O
in	O	O
significant	O	O
changes	O	O
of	O	O
specific	O	O
glucocorticoid	O	O
binding	O	O
which	O	O
were	O	O
not	O	O
influenced	O	O
by	O	O
changes	O	O
of	O	O
circulating	O	O
hormone	O	O
concentrations	O	O
in	O	O
blood	O	O
but	O	O
by	O	O
some	O	O
other	O	O
factors	O	O
affected	O	O
by	O	O
physical	O	O
activity	O	O
.	O	O

The	O	O
small	protein	O
GTP	protein	protein
-binding	protein	protein
protein	protein	protein
Rho	protein	protein
potentiates	O	O
AP-1	protein	protein
transcription	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
The	O	O
Rho	protein	protein
family	O	protein
of	O	O
small	protein	O
GTP	protein	protein
-binding	protein	protein
proteins	protein	protein
is	O	O
involved	O	O
in	O	O
the	O	O
regulation	O	O
of	O	O
cytoskeletal	O	protein
structure	O	protein
,	O	O
gene	O	O
transcription	O	O
,	O	O
specific	O	O
cell	O	O
fate	O	O
development	O	O
,	O	O
and	O	O
transformation.	O	O
We	O	O
demonstrate	O	O
in	O	O
this	O	O
report	O	O
that	O	O
overexpression	O	O
of	O	O
an	O	O
activated	O	O
form	O	O
of	O	O
Rho	protein	protein
enhances	O	O
AP-1	protein	protein
activity	O	O
in	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
in	O	O
the	O	O
presence	O	O
of	O	O
phorbol	O	O
myristate	O	O
acetate	O	O
(	O	O
PMA	O	O
),	O	O
but	O	O
activated	O	O
Rho	protein	protein
(	O	O
V14Rho	protein	protein
)	O	O
has	O	O
little	O	O
or	O	O
no	O	O
effect	O	O
on	O	O
NFAT	protein	protein
,	O	O
Oct-1	protein	protein
,	O	O
and	O	O
NF-kappaB	DNA	DNA
enhancer	DNA	DNA
element	DNA	DNA
activities	O	O
under	O	O
similar	O	O
conditions.	O	O
Overexpression	O	O
of	O	O
a	O	O
V14Rho	DNA	DNA
construct	DNA	DNA
incapable	O	O
of	O	O
membrane	O	O
localization	O	O
(	O	O
CAAX	DNA	protein
deleted	DNA	protein
)	O	O
abolishes	O	O
PMA	O	O
-induced	O	O
AP-1	protein	protein
transcriptional	O	O
activation	O	O
.	O	O
The	O	O
effect	O	O
of	O	O
Rho	protein	protein
on	O	O
AP-1	protein	protein
is	O	O
independent	O	O
of	O	O
the	O	O
mitogen-activated	protein	protein
protein	protein	protein
kinase	protein	protein
pathway	O	O
,	O	O
as	O	O
a	O	O
dominant-negative	protein	O
MEK	protein	protein
and	O	O
a	O	O
MEK	protein	protein
inhibitor	O	protein
(	O	O
PD98059	O	O
)	O	O
did	O	O
not	O	O
affect	O	O
Rho	protein	protein
-induced	O	O
AP-1	protein	protein
activity	O	O
.	O	O
V14Rho	protein	protein
binds	O	O
strongly	O	O
to	O	O
protein	protein	protein
kinase	protein	protein
Calpha	protein	protein
(	O	O
PKCalpha	protein	protein
)	O	O
in	O	O
vivo;	O	O
however,	O	O
deletion	O	O
of	O	O
the	O	O
CAAX	DNA	DNA
site	DNA	DNA
on	O	O
V14Rho	protein	DNA
severely	O	O
diminished	O	O
this	O	O
association.	O	O
Evidence	O	O
for	O	O
a	O	O
role	O	O
for	O	O
PKCalpha	protein	protein
as	O	O
an	O	O
effector	O	O
of	O	O
Rho	protein	protein
was	O	O
obtained	O	O
by	O	O
the	O	O
observation	O	O
that	O	O
coexpression	O	O
of	O	O
the	O	O
N-terminal	protein	protein
domain	protein	protein
of	O	O
PKCalpha	protein	protein
blocked	O	O
the	O	O
effects	O	O
of	O	O
activated	O	O
Rho	protein	protein
plus	O	O
PMA	O	O
on	O	O
AP-1	protein	protein
transcriptional	O	O
activity	O	O
.	O	O
These	O	O
data	O	O
suggest	O	O
that	O	O
Rho	protein	protein
potentiates	O	O
AP-1	protein	protein
transcription	O	O
during	O	O
T-cell	O	O
activation	O	O

Changes	O	O
in	O	O
PKC	protein	protein
isoforms	protein	protein
in	O	O
human	cell_type	cell_type
alveolar	cell_type	cell_type
macrophages	cell_type	cell_type
compared	O	O
with	O	O
blood	cell_type	cell_type
monocytes	cell_type	cell_type
.	O	O
Alveolar	O	cell_type
macrophages	O	cell_type
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
host	O	O
defense	O	O
and	O	O
in	O	O
other	O	O
types	O	O
of	O	O
inflammatory	O	O
processes	O	O
in	O	O
the	O	O
lung	O	O
.	O	O
These	O	O
cells	O	O
exhibit	O	O
many	O	O
alterations	O	O
in	O	O
function	O	O
compared	O	O
with	O	O
their	O	O
precursor	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
blood	cell_type	cell_type
monocytes	cell_type	cell_type
.	O	O
To	O	O
evaluate	O	O
a	O	O
potential	O	O
mechanism	O	O
for	O	O
these	O	O
differences	O	O
in	O	O
function,	O	O
we	O	O
evaluated	O	O
expression	O	O
of	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
(	protein	O
PKC	protein	protein
)	protein	O
isoforms	protein	O
.	O	O
We	O	O
found	O	O
an	O	O
increase	O	O
in	O	O
Ca2+	protein	O
-dependent	protein	O
PKC	protein	protein
isoforms	protein	protein
in	O	O
monocytes	O	cell_type
compared	O	O
with	O	O
alveolar	O	cell_type
macrophages.	O	cell_type
We	O	O
also	O	O
found	O	O
differential	O	O
expression	O	O
of	O	O
the	O	O
Ca2+	protein	O
-independent	protein	O
isoforms	protein	O
in	O	O
alveolar	cell_type	cell_type
macrophages	cell_type	cell_type
compared	O	O
with	O	O
monocytes	cell_type	cell_type
.	O	O
One	O	O
consequence	O	O
of	O	O
the	O	O
activation	O	O
of	O	O
PKC	protein	protein
can	O	O
be	O	O
increased	O	O
expression	O	O
of	O	O
mitogen-activated	protein	protein
protein	protein	protein
(MAP)	protein	protein
kinase	protein	protein
pathways	O	O
.	O	O
Therefore,	O	O
we	O	O
also	O	O
evaluated	O	O
activation	O	O
of	O	O
the	O	O
MAP	protein	protein
kinase	protein	protein
extracellular	protein	protein
signal-regulated	protein	protein
kinase	protein	protein
(	protein	O
ERK	protein	protein
)	protein	O
2	protein	O
by	O	O
the	O	O
phorbol	O	O
ester	O	O
phorbol	O	O
12-myristate	O	O
13-acetate	O	O
(	O	O
PMA	O	O
).	O	O
PMA	O	O
activated	O	O
ERK2	protein	protein
kinase	protein	protein
in	O	O
both	O	O
alveolar	cell_type	cell_type
macrophages	cell_type	cell_type
and	O	O
monocytes	cell_type	cell_type
;	O	O
however,	O	O
monocytes	cell_type	cell_type
consistently	O	O
showed	O	O
a	O	O
significantly	O	O
greater	O	O
activation	O	O
of	O	O
ERK2	protein	protein
kinase	protein	protein
by	O	O
PMA	O	O
compared	O	O
with	O	O
alveolar	cell_type	cell_type
macrophages	cell_type	cell_type
.	O	O
Another	O	O
known	O	O
consequence	O	O
of	O	O
the	O	O
activation	O	O
of	O	O
PKC	protein	protein
and	O	O
subsequent	O	O
activation	O	O
of	O	O
ERK	protein	protein
kinase	protein	protein
is	O	O
activation	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
activator	protein	protein
protein-1	protein	protein
(	O	O
AP-1	protein	protein
).	O	O
We	O	O
evaluated	O	O
the	O	O
activation	O	O
of	O	O
AP-1	protein	protein
by	O	O
PMA	O	O
in	O	O
both	O	O
monocytes	cell_type	cell_type
and	O	O
macrophages.	O	O
We	O	O
found	O	O
very	O	O
little	O	O
detectable	O	O
activation	O	O
of	O	O
AP-1	protein	protein
,	O	O
as	O	O
assessed	O	O
in	O	O
a	O	O
gel	O	O
shift	O	O
assay	O	O
,	O	O
in	O	O
alveolar	cell_type	cell_type
macrophages	cell_type	cell_type
,	O	O
whereas	O	O
monocytes	cell_type	cell_type
showed	O	O
a	O	O
substantial	O	O
activation	O	O
of	O	O
AP-1	protein	protein
by	O	O
PMA	O	O
.	O	O
These	O	O
studies	O	O
show	O	O
that	O	O
the	O	O
differential	O	O
expression	O	O
of	O	O
PKC	protein	protein
isoforms	protein	protein
in	O	O
alveolar	cell_type	cell_type
macrophages	cell_type	cell_type
and	O	O
blood	cell_type	cell_type
monocytes	cell_type	cell_type
is	O	O
associated	O	O
with	O	O
important	O	O
functional	O	O
alterations	O	O
in	O	O
the	O	O
cells.	O	O

Expression	O	O
of	O	O
gamma-IFN	DNA	DNA
responsive	DNA	DNA
genes	DNA	DNA
in	O	O
scavenger	O	O
receptor	O	O
over-expressing	cell_type	O
monocytes	cell_type	cell_type
is	O	O
associated	O	O
with	O	O
xanthomatosis	O	O
.	O	O
We	O	O
have	O	O
recently	O	O
described	O	O
an	O	O
inherited	O	O
over-expression	O	O
of	O	O
the	O	O
macrophage	protein	protein
scavenger	protein	protein
receptor	protein	protein
(	O	O
SR	protein	protein
)	O	O
in	O	O
blood	cell_type	cell_type
monocytes	cell_type	cell_type
from	O	O
members	O	O
of	O	O
a	O	O
kindred,	O	O
only	O	O
two	O	O
of	O	O
whom	O	O
displayed	O	O
extensive	O	O
xanthomatosis	O	O
.	O	O
Using	O	O
mRNA	O	RNA
differential	O	O
display	O	O
we	O	O
demonstrated	O	O
abnormally	O	O
high	O	O
expression	O	O
of	O	O
the	O	O
signal	protein	protein
transducer	protein	protein
and	protein	protein
activator	protein	protein
of	protein	protein
transcription	protein	protein
(	O	O
STAT1alpha	protein	protein
)	O	O
in	O	O
monocytes	cell_type	cell_type
from	O	O
the	O	O
proband	cell_line	O
II-2	cell_line	protein
.	O	O
Expression	O	O
of	O	O
gamma-interferon	protein	protein
inducible	protein	protein
protein	protein	protein
10	protein	protein
(	O	O
IP-10	protein	protein
),	O	O
a	O	O
STAT1alpha	DNA	DNA
-responsive	DNA	DNA
gene	DNA	DNA
and	O	O
mediator	O	O
of	O	O
inflammatory	O	O
response,	O	O
was	O	O
also	O	O
abnormally	O	O
expressed	O	O
in	O	O
the	O	O
monocytes	cell_type	cell_type
from	O	O
II-2	cell_line	cell_line
.	O	O
Over-expression	O	O
of	O	O
both	O	O
genes	O	O
was	O	O
restricted	O	O
to	O	O
monocytes	cell_type	cell_type
from	O	O
II-2	cell_line	O
and	O	O
was	O	O
not	O	O
observed	O	O
in	O	O
monocytes	cell_type	cell_type
from	O	O
the	O	O
clinically	O	O
unaffected	O	O
family	O	O
members	O	O
,	O	O
unlike	O	O
that	O	O
of	O	O
SR	protein	O
.	O	O
Gel	O	O
retardation	O	O
assays	O	O
with	O	O
THP-1	cell_line	cell_line
cell	cell_line	cell_line
extracts	O	O
identified	O	O
gamma-IFN	protein	protein
inducible	O	protein
DNA	O	O
binding	O	O
activity	O	O
to	O	O
three	O	O
potential	O	O
STATI	DNA	protein
DNA	DNA	O
binding	DNA	O
elements	DNA	O
in	O	O
the	O	O
human	DNA	DNA
IP-10	DNA	DNA
promoter	DNA	DNA
region	DNA	DNA
from	O	O
nucleotides	DNA	DNA
-	DNA	DNA
245	DNA	DNA
to	DNA	O
-	DNA	O
188	DNA	O
.	O	O
Taken	O	O
together	O	O
these	O	O
results	O	O
suggest	O	O
that	O	O
gamma-interferon	O	protein
mediated	O	O
cell	O	O
activation	O	O
is	O	O
responsible	O	O
for	O	O
STAT1alpha	protein	protein
-induced	O	O
transcription	O	O
of	O	O
the	O	O
IP-10	protein	DNA
gene	O	DNA
in	O	O
THP-1	cell_line	cell_line
macrophages	cell_line	cell_line
as	O	O
well	O	O
as	O	O
in	O	O
monocytes	cell_type	cell_type
from	O	O
II-2	cell_line	cell_line
.	O	O
Analysis	O	O
of	O	O
monocytes	cell_type	cell_type
from	O	O
familial	O	O
hypercholesterolemic	O	O
(FH)	O	O
subjects	O	O
,	O	O
who	O	O
frequently	O	O
develop	O	O
xanthomatosis	O	O
,	O	O
revealed	O	O
a	O	O
significant	O	O
number	O	O
of	O	O
subjects	O	O
with	O	O
elevated	O	O
STAT1alpha	O	protein
and	O	O
IP-10	O	protein
expression	O	O
.	O	O
Our	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
inflammatory	O	O
effects	O	O
of	O	O
gamma-IFN	protein	protein
signaling	O	O
could	O	O
play	O	O
a	O	O
role	O	O
in	O	O
foam	O	O
cell	O	O
formation	O	O
and	O	O
xanthomatosis	O	O
.	O	O

Redox	O	O
signals	O	O
and	O	O
NF-kappaB	protein	protein
activation	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Accumulating	O	O
data	O	O
from	O	O
a	O	O
number	O	O
of	O	O
laboratories	O	O
have	O	O
recently	O	O
indicated	O	O
that	O	O
the	O	O
response	O	O
of	O	O
transcription	protein	protein
factor	protein	protein
NF-kappaB	protein	protein
to	O	O
alterations	O	O
in	O	O
the	O	O
redox	O	O
homeostasis	O	O
of	O	O
cells	O	O
may	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
modulating	O	O
immune	O	O
function	O	O
.	O	O
The	O	O
activation	O	O
of	O	O
NF-kappaB	protein	protein
has	O	O
been	O	O
recognized	O	O
to	O	O
regulate	O	O
a	O	O
number	O	O
of	O	O
genes	O	O
necessary	O	O
for	O	O
normal	O	O
T	O	O
cell	O	O
responses	O	O
including	O	O
IL-2	protein	protein
,	O	O
IL-6	protein	protein
,	O	O
IL-8	protein	protein
,	O	O
and	O	O
several	O	O
T	protein	O
cell	protein	protein
surface	protein	protein
receptors	protein	protein
.	O	O
Diminished	O	O
NF-kappaB	protein	protein
activity	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
occur	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
aging,	O	O
suggesting	O	O
that	O	O
impaired	O	O
activation	O	O
of	O	O
NF-kappaB	protein	protein
might	O	O
occur	O	O
during	O	O
cellular	O	O
senescence	O	O
.	O	O
In	O	O
addition,	O	O
aberrancies	O	O
in	O	O
NF-kappaB	protein	protein
activity	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
immunopathogenesis	O	O
of	O	O
diseases	O	O
involving	O	O
immune	O	O
or	O	O
inflammatory	O	O
processes	O	O
such	O	O
as	O	O
atherosclerosis	O	O
and	O	O
HIV-1	O	O
infection	O	O
.	O	O
The	O	O
role	O	O
of	O	O
H2O2	O	O
and	O	O
other	O	O
reactive	O	O
oxygen	O	O
species	O	O
(	O	O
ROS	O	O
)	O	O
as	O	O
an	O	O
integratory	O	O
secondary	O	O
messenger	O	O
for	O	O
divergent	O	O
T	O	O
cell	O	O
signals	O	O
has	O	O
been	O	O
complicated	O	O
by	O	O
the	O	O
fact	O	O
that	O	O
various	O	O
T	cell_line	O
cell	cell_line	O
lines	cell_line	O
and	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
differ	O	O
markedly	O	O
in	O	O
the	O	O
levels	O	O
of	O	O
NF-kappaB	protein	protein
activation	O	O
induced	O	O
by	O	O
oxidant	O	O
stress.	O	O
Additionally,	O	O
proposed	O	O
pathways	O	O
of	O	O
NF-kappaB	protein	protein
activation	O	O
have	O	O
been	O	O
based	O	O
on	O	O
indirect	O	O
evidence	O	O
provided	O	O
by	O	O
experiments	O	O
which	O	O
used	O	O
antioxidants	O	O
to	O	O
inhibit	O	O
active	O	O
NF-kappaB	protein	protein
formation	O	O
.	O	O
Further,	O	O
complete	O	O
activation	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
requires	O	O
at	O	O
least	O	O
two	O	O
signals,	O	O
one	O	O
that	O	O
stimulates	O	O
an	O	O
increase	O	O
in	O	O
intracellular	O	O
calcium	O	O
and	O	O
one	O	O
that	O	O
stimulates	O	O
enzymatic	O	O
processes	O	O
including	O	O
kinases.	O	O
Similarly,	O	O
substantial	O	O
evidence	O	O
indicates	O	O
that	O	O
full	O	O
activation	O	O
of	O	O
NF-kappaB	protein	protein
requires	O	O
dual	O	O
signals.	O	O
The	O	O
ability	O	O
of	O	O
H2O2	O	O
or	O	O
other	O	O
ROS	O	O
to	O	O
induce	O	O
T	O	O
cell	O	O
signals	O	O
and	O	O
functional	O	O
responses	O	O
by	O	O
these	O	O
two	O	O
mechanisms	O	O
is	O	O
reviewed	O	O
and	O	O
the	O	O
specific	O	O
response	O	O
of	O	O
NF-kappaB	protein	protein
to	O	O
redox	O	O
changes	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
is	O	O
examined.	O	O
Data	O	O
are	O	O
also	O	O
presented	O	O
to	O	O
suggest	O	O
that	O	O
the	O	O
redox	O	O
regulation	O	O
in	O	O
NF-kappaB	protein	protein
activation	O	O
may	O	O
be	O	O
relevant	O	O
to	O	O
immune-related	O	O
diseases	O	O
and	O	O
to	O	O
aging.	O	O

Uncoupling	O	O
of	O	O
nonreceptor	O	protein
tyrosine	protein	protein
kinases	protein	protein
from	O	O
PLC-gamma1	protein	protein
in	O	O
an	O	O
SLP-76-deficient	O	O
T	O	O
cell.	O	O
Activation	O	O
of	O	O
nonreceptor	protein	protein
protein	protein	protein
tyrosine	protein	protein
kinases	protein	protein
(	O	O
PTKs	protein	protein
)	O	O
is	O	O
essential	O	O
for	O	O
T	protein	O
cell	protein	O
receptor	protein	O
(	O	O
TCR	protein	protein
)	O	O
responsiveness	O	O
;	O	O
however,	O	O
the	O	O
function	O	O
of	O	O
individual	O	O
PTK	protein	protein
substrates	protein	O
is	O	O
often	O	O
uncertain.	O	O
A	O	O
mutant	cell_line	O
T	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
was	O	O
isolated	O	O
that	O	O
lacked	O	O
expression	O	O
of	O	O
SLP-76	protein	protein
(	O	O
SH2	protein	protein
domain-containing	protein	protein
leukocyte	protein	protein
protein	protein	protein
of	O	O
76	O	O
kilodaltons),	O	O
a	O	O
hematopoietically	protein	O
expressed	protein	O
adaptor	protein	O
protein	protein	O
and	O	O
PTK	protein	protein
substrate	protein	protein
.	O	O
SLP-76	protein	protein
was	O	O
not	O	O
required	O	O
for	O	O
TCR	protein	protein
-induced	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
most	O	O
proteins,	O	O
but	O	O
was	O	O
required	O	O
for	O	O
optimal	O	O
tyrosine	O	O
phosphorylation	O	O
and	O	O
activation	O	O
of	O	O
phospholipase	protein	protein
C-gamma1	protein	protein
(	O	O
PLC-gamma1	protein	protein
),	O	O
as	O	O
well	O	O
as	O	O
Ras	protein	protein
pathway	O	O
activation	O	O
.	O	O
TCR	protein	DNA
-inducible	O	DNA
gene	O	DNA
expression	O	O
was	O	O
dependent	O	O
on	O	O
SLP-76	protein	protein
.	O	O
Thus,	O	O
coupling	O	O
of	O	O
TCR-regulated	protein	O
PTKs	protein	O
to	O	O
downstream	O	O
signaling	O	O
pathways	O	O
requires	O	O
SLP-76	protein	protein
.	O	O

A	O	O
novel	O	O
function	O	O
of	O	O
Stat1	protein	protein
and	O	O
Stat3	protein	protein
proteins	O	protein
in	O	O
erythropoietin	protein	protein
-induced	O	O
erythroid	O	O
differentiation	O	O
of	O	O
a	O	O
human	cell_line	cell_line
leukemia	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
We	O	O
recently	O	O
determined	O	O
that	O	O
erythropoietin	protein	protein
(	O	O
EPO	protein	protein
)	O	O
activates	O	O
3	O	O
members	O	O
of	O	O
the	O	O
signal	O	protein
transducer	O	protein
and	O	protein
activator	O	protein
of	O	protein
transcription	O	protein
(STAT)	O	protein
family,	O	O
Stat1alpha	protein	protein
,	O	O
Stat3	protein	protein
,	O	O
and	O	O
Stat5	protein	protein
,	O	O
in	O	O
the	O	O
human	cell_line	O
EPO	cell_line	cell_line
-dependent	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
,	O	O
UT-7	cell_line	cell_line
and	O	O
UT-7/	cell_line	protein
EPO	cell_line	protein
(Kirito	O	O
et	O	O
al,	O	O
J	O	O
Biol	O	O
Chem	O	O
272:16507,	O	O
1997).	O	O
In	O	O
addition,	O	O
we	O	O
have	O	O
shown	O	O
that	O	O
Stat1alpha	protein	protein
,	O	O
but	O	O
not	O	O
Stat3	protein	protein
,	O	O
is	O	O
involved	O	O
in	O	O
EPO	protein	protein
-induced	O	O
cellular	O	O
proliferation	O	O
.	O	O
In	O	O
this	O	O
study,	O	O
we	O	O
examined	O	O
the	O	O
roles	O	O
of	O	O
Stat1alpha	protein	protein
and	O	O
Stat3	protein	protein
in	O	O
EPO	protein	protein
-induced	O	O
erythroid	O	O
differentiation	O	O
.	O	O
UT-7/GM	cell_line	O
was	O	O
used	O	O
as	O	O
a	O	O
model	O	O
system,	O	O
because	O	O
this	O	O
cell	O	O
line	O	O
can	O	O
differentiate	O	O
into	O	O
erythroid-lineage	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
EPO	protein	protein
treatment	O	O
(Komatsu	O	O
et	O	O
al,	O	O
Blood	O	O
89:4021,	O	O
1997).	O	O
We	O	O
found	O	O
that	O	O
EPO	protein	protein
did	O	O
not	O	O
activate	O	O
Stat1alpha	protein	protein
or	O	O
Stat3	protein	protein
in	O	O
UT-7/GM	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Transfection	O	O
experiments	O	O
showed	O	O
that	O	O
both	O	O
Stat1alpha	protein	protein
and	O	O
Stat3	protein	protein
inhibited	O	O
the	O	O
induction	O	O
by	O	O
EPO	protein	protein
of	O	O
gamma-globin	O	protein
and	O	O
erythroid-specific	O	O
5-aminolevulinate	O	O
synthetase	O	O
transcripts	O	O
,	O	O
resulting	O	O
in	O	O
a	O	O
reduction	O	O
of	O	O
the	O	O
percentage	O	O
of	O	O
hemoglobin-positive	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Dominant	O	O
negative	O	O
forms	O	O
of	O	O
Stat1alpha	protein	protein
or	O	O
Stat3	protein	protein
promoted	O	O
the	O	O
EPO	protein	protein
-induced	O	O
erythroid	O	O
differentiation	O	O
of	O	O
UT-7/GM	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
even	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
granulocyte-macrophage	protein	protein
colony-stimulating	protein	protein
factor	protein	protein
,	O	O
although	O	O
this	O	O
cytokine	O	protein
never	O	O
induced	O	O
erythroid	O	O
differentiation	O	O
of	O	O
the	O	O
parent	cell_line	O
UT-7/GM	cell_line	cell_line
cells	cell_line	cell_line
with	O	O
or	O	O
without	O	O
EPO	protein	protein
.	O	O
A	O	O
cell	O	O
cycle	O	O
analysis	O	O
showed	O	O
that	O	O
the	O	O
constitutive	O	O
activation	O	O
of	O	O
Stat1alpha	protein	protein
,	O	O
but	O	O
not	O	O
Stat3	protein	protein
,	O	O
shortened	O	O
the	O	O
period	O	O
of	O	O
G0/G1	O	O
prolongation	O	O
caused	O	O
by	O	O
EPO	protein	protein
stimulation	O	O
.	O	O
Taken	O	O
together,	O	O
our	O	O
data	O	O
suggest	O	O
that	O	O
Stat1alpha	protein	protein
and	O	O
Stat3	protein	protein
act	O	O
as	O	O
negative	O	O
regulators	O	O
in	O	O
EPO	protein	protein
-induced	O	O
erythroid	O	O
differentiation	O	O
.	O	O
Specifically,	O	O
Stat1alpha	protein	protein
may	O	O
activate	O	O
a	O	O
cell	DNA	O
cycle-associated	DNA	DNA
gene	DNA	DNA
(s),	O	O
leading	O	O
to	O	O
the	O	O
entry	O	O
of	O	O
cells	O	O
into	O	O
the	O	O
cell	O	O
cycle	O	O
.	O	O

Ro	O	O
09-2210	O	O
exhibits	O	O
potent	O	O
anti-proliferative	O	O
effects	O	O
on	O	O
activated	O	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
selectively	O	O
blocking	O	O
MKK	protein	O
activity	O	O
.	O	O
By	O	O
using	O	O
high	O	O
throughput	O	O
screening	O	O
of	O	O
microbial	O	O
broths	O	O
,	O	O
we	O	O
have	O	O
identified	O	O
a	O	O
compound,	O	O
designated	O	O
Ro	O	O
09-2210	O	O
,	O	O
which	O	O
is	O	O
able	O	O
to	O	O
block	O	O
anti-CD3	protein	protein
induced	O	O
peripheral	O	cell_type
blood	O	cell_type
T	O	cell_type
cell	O	cell_type
activation	O	O
with	O	O
an	O	O
IC50	O	O
=	O	O
40	O	O
nM.	O	O
Ro	O	O
09-2210	O	O
was	O	O
also	O	O
able	O	O
to	O	O
block	O	O
antigen-induced	O	O
IL-2	protein	protein
secretion	O	O
with	O	O
an	O	O
IC50	O	O
=	O	O
30	O	O
nM,	O	O
but	O	O
was	O	O
considerably	O	O
less	O	O
potent	O	O
at	O	O
blocking	O	O
Ca2+	O	O
flux	O	O
stimulated	O	O
by	O	O
anti-CD3	protein	protein
treatment	O	O
.	O	O
To	O	O
determine	O	O
the	O	O
mechanism	O	O
of	O	O
action	O	O
of	O	O
Ro	O	O
09-2210	O	O
,	O	O
we	O	O
set	O	O
up	O	O
a	O	O
transient	O	O
expression	O	O
system	O	O
in	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
using	O	O
a	O	O
variety	O	O
of	O	O
reporter	O	DNA
gene	O	DNA
constructs	O	DNA
and	O	O
showed	O	O
effective	O	O
inhibition	O	O
of	O	O
phorbol	O	O
ester	O	O
/	O	O
ionomycin	O	O
-induced	O	O
NF-AT	protein	protein
activation	O	O
and	O	O
anti-CD3	O	protein
induced	O	O
NF-AT	protein	protein
with	O	O
IC50	O	O
=	O	O
7.7	O	O
and	O	O
10	O	O
nM,	O	O
respectively.	O	O
Ro	O	O
09-2210	O	O
was	O	O
also	O	O
able	O	O
to	O	O
inhibit	O	O
phorbol	O	O
ester	O	O
/	O	O
ionomycin	O	O
-induced	O	O
activation	O	O
of	O	O
AP1	protein	protein
with	O	O
IC50	O	O
=	O	O
&lt;10	O	O
nM.	O	O
We	O	O
further	O	O
showed	O	O
that	O	O
Ro	O	O
09-2210	O	O
was	O	O
unable	O	O
to	O	O
inhibit	O	O
c-jun	DNA	O
induced	O	O
expression	O	O
of	O	O
AP1	DNA	protein
-dependent	DNA	O
reporter	DNA	O
constructs	DNA	O
(IC50	O	O
&gt;	O	O
500	O	O
nM),	O	O
but	O	O
was	O	O
able	O	O
to	O	O
potently	O	O
inhibit	O	O
ras-induced	O	O
AP1	protein	protein
activation	O	O
(IC50	O	O
=	O	O
20	O	O
nM).	O	O
This	O	O
suggested	O	O
that	O	O
Ro	O	O
09-2210	O	O
was	O	O
inhibiting	O	O
an	O	O
activator	O	O
of	O	O
AP-1	protein	protein
which	O	O
was	O	O
upstream	O	O
of	O	O
c-jun	DNA	O
and	O	O
downstream	O	O
of	O	O
ras	protein	O
signaling	O	O
.	O	O
To	O	O
investigate	O	O
further,	O	O
we	O	O
then	O	O
purified	O	O
a	O	O
number	O	O
of	O	O
different	O	O
kinases,	O	O
including	O	O
PKC	protein	protein
,	O	O
PhK	protein	O
,	O	O
ZAP-70	protein	protein
,	O	O
ERK	protein	protein
,	O	O
and	O	O
MEK	protein	protein
1	protein	protein
(a	O	O
MKK	protein	O
),	O	O
and	O	O
showed	O	O
that	O	O
Ro	O	O
09-2210	O	O
was	O	O
a	O	O
selective	O	O
inhibitor	O	O
of	O	O
MEK1	protein	protein
in	O	O
vitro	O	O
(IC50	O	O
=	O	O
59	O	O
nM).	O	O

Coactivation	O	O
by	O	O
OCA-B	protein	protein
:	O	O
definition	O	O
of	O	O
critical	O	O
regions	O	O
and	O	O
synergism	O	O
with	O	O
general	O	O
cofactors	O	O
.	O	O
Molecular	O	O
dissection	O	O
of	O	O
the	O	O
B-cell-specific	O	O
transcription	O	O
coactivator	O	protein
OCA-B	protein	protein
has	O	O
revealed	O	O
distinct	O	O
regions	O	O
important,	O	O
respectively,	O	O
for	O	O
recruitment	O	O
to	O	O
immunoglobulin	DNA	DNA
promoters	DNA	DNA
through	O	O
interaction	O	O
with	O	O
octamer-bound	protein	O
Oct-1	protein	protein
and	O	O
for	O	O
subsequent	O	O
coactivator	O	O
function.	O	O
Further	O	O
analysis	O	O
of	O	O
general	O	O
coactivator	O	O
requirements	O	O
showed	O	O
that	O	O
selective	O	O
removal	O	O
of	O	O
PC4	protein	O
from	O	O
the	O	O
essential	O	O
USA	O	O
fraction	O	O
severely	O	O
impairs	O	O
Oct-1	O	protein
and	O	O
OCA-B	O	protein
function	O	O
in	O	O
a	O	O
cell-free	O	O
system	O	O
reconstituted	O	O
with	O	O
partially	O	O
purified	O	O
factors.	O	O
Full	O	O
activity	O	O
can	O	O
be	O	O
restored	O	O
by	O	O
the	O	O
combined	O	O
action	O	O
of	O	O
recombinant	O	O
PC4	protein	O
and	O	O
the	O	O
PC4	protein	O
-depleted	O	O
USA	O	O
fraction	O	O
,	O	O
thus	O	O
suggesting	O	O
a	O	O
joint	O	O
requirement	O	O
for	O	O
PC4	protein	O
and	O	O
another,	O	O
USA-derived	O	O
component	O	O
(s)	O	O
for	O	O
optimal	O	O
function	O	O
of	O	O
Oct-1	protein	protein
/OCA-B	protein	protein
in	O	O
the	O	O
reconstituted	O	O
system	O	O
.	O	O
Indeed,	O	O
USA-derived	protein	O
PC2	protein	O
was	O	O
found	O	O
to	O	O
act	O	O
synergistically	O	O
with	O	O
PC4	protein	O
in	O	O
reproducing	O	O
the	O	O
function	O	O
of	O	O
intact	O	O
USA	O	O
in	O	O
the	O	O
assay	O	O
system	O	O
.	O	O
Consistent	O	O
with	O	O
the	O	O
requirement	O	O
for	O	O
PC4	protein	O
in	O	O
the	O	O
reconstituted	O	O
system	O	O
,	O	O
OCA-B	protein	protein
was	O	O
found	O	O
to	O	O
interact	O	O
directly	O	O
with	O	O
PC4	protein	protein
.	O	O
Surprisingly,	O	O
however,	O	O
removal	O	O
of	O	O
PC4	protein	O
from	O	O
the	O	O
unfractionated	O	O
nuclear	O	O
extract	O	O
has	O	O
no	O	O
detrimental	O	O
effect	O	O
on	O	O
OCA-B	protein	protein
/	O	O
Oct-1	protein	protein
-dependent	O	O
transcription	O	O
.	O	O
These	O	O
results	O	O
lead	O	O
to	O	O
a	O	O
general	O	O
model	O	O
for	O	O
the	O	O
synergistic	O	O
function	O	O
of	O	O
activation	O	protein
domains	O	protein
in	O	O
Oct-1	protein	protein
and	O	O
OCA-B	protein	protein
(mediated	O	O
by	O	O
the	O	O
combined	O	O
action	O	O
of	O	O
the	O	O
multiple	O	O
USA	O	O
components	O	O
)	O	O
and,	O	O
further,	O	O
suggest	O	O
a	O	O
functional	O	O
redundancy	O	O
in	O	O
general	protein	O
coactivators	protein	O
.	O	O

Activation	O	O
of	O	O
Stat-3	protein	protein
is	O	O
involved	O	O
in	O	O
the	O	O
induction	O	O
of	O	O
apoptosis	O	O
after	O	O
ligation	O	O
of	O	O
major	protein	protein
histocompatibility	protein	protein
complex	protein	protein
class	protein	protein
I	protein	protein
molecules	protein	protein
on	O	O
human	cell_line	cell_type
Jurkat	cell_line	cell_type
T	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
Activation	O	O
of	O	O
Janus	protein	protein
tyrosine	protein	protein
kinases	protein	protein
(	O	O
Jak	protein	protein
)	O	O
and	O	O
Signal	protein	protein
transducers	protein	protein
and	protein	protein
activators	protein	protein
of	protein	protein
transcription	protein	protein
(	O	protein
Stat	protein	protein
)	O	O
after	O	O
ligation	O	O
of	O	O
major	protein	protein
histocompatibility	protein	protein
complex	protein	protein
class	protein	protein
I	protein	protein
(	O	O
MHC-I	protein	protein
)	O	O
was	O	O
explored	O	O
in	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Cross-linking	O	O
of	O	O
MHC-I	protein	protein
mediated	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
Tyk2	protein	protein
,	O	O
but	O	O
not	O	O
Jak1	protein	protein
,	O	O
Jak2	protein	protein
,	O	O
and	O	O
Jak3	protein	protein
.	O	O
In	O	O
addition,	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
Stat-3	protein	protein
was	O	O
tyrosine	O	O
phosphorylated	O	O
in	O	O
the	O	O
cytoplasm	O	O
and	O	O
subsequently	O	O
translocated	O	O
to	O	O
the	O	O
cell	O	O
nucleus	O	O
.	O	O
Data	O	O
obtained	O	O
by	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assay	O	O
suggested	O	O
that	O	O
the	O	O
activated	protein	protein
Stat-3	protein	protein
protein	protein	protein
associates	O	O
with	O	O
the	O	O
human	DNA	DNA
serum-inducible	DNA	DNA
element	DNA	DNA
(	DNA	O
hSIE	DNA	DNA
)	DNA	O
DNA-probe	DNA	O
derived	O	O
from	O	O
the	O	O
interferon-gamma	DNA	DNA
activated	DNA	DNA
site	DNA	DNA
(	O	O
GAS	DNA	DNA
)	O	O
in	O	O
the	O	O
c-fos	DNA	DNA
promoter	DNA	DNA
,	O	O
a	O	O
common	O	DNA
DNA	O	DNA
sequence	O	DNA
for	O	O
Stat	protein	protein
protein	protein	protein
binding	O	protein
.	O	O
An	O	O
association	O	O
between	O	O
hSIE	DNA	O
and	O	O
Stat-3	protein	protein
after	O	O
MHC-I	protein	protein
ligation	O	O
was	O	O
directly	O	O
demonstrated	O	O
by	O	O
precipitating	O	O
Stat-3	protein	protein
from	O	O
nuclear	O	O
extracts	O	O
with	O	O
biotinylated	O	O
hSIE	DNA	O
probe	DNA	O
and	O	O
avidin	protein	O
-coupled	O	O
agarose	O	O
.	O	O
To	O	O
investigate	O	O
the	O	O
function	O	O
of	O	O
the	O	O
activated	O	O
Stat-3	protein	protein
,	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
were	O	O
transiently	O	O
transfected	O	O
with	O	O
a	O	O
Stat-3	protein	protein
isoform	protein	protein
lacking	O	O
the	O	O
transactivating	protein	protein
domain	protein	protein
.	O	O
This	O	O
dominant-negative	protein	O
acting	protein	O
Stat-3	protein	protein
isoform	protein	protein
significantly	O	O
inhibited	O	O
apoptosis	O	O
induced	O	O
by	O	O
ligation	O	O
of	O	O
MHC-I	protein	protein
.	O	O
In	O	O
conclusion,	O	O
our	O	O
data	O	O
suggest	O	O
the	O	O
involvement	O	O
of	O	O
the	O	O
Jak/Stat	protein	protein
signal	O	O
pathway	O	O
in	O	O
MHC-I	protein	protein
-induced	O	O
signal	O	O
transduction	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

IL-2	protein	protein
-induced	O	O
growth	O	O
of	O	O
CD8+	cell_type	cell_type
T	cell_type	cell_type
cell	cell_type	cell_type
prolymphocytic	cell_type	cell_type
leukemia	cell_type	cell_type
cells	cell_type	cell_type
mediated	O	O
by	O	O
NF-kappaB	protein	protein
induction	O	O
and	O	O
IL-2	protein	protein
receptor	protein	protein
alpha	protein	protein
expression	O	O
.	O	O
The	O	O
binding	O	O
of	O	O
interleukin-2	protein	protein
(	O	O
IL-2	protein	protein
)	O	O
to	O	O
its	O	O
receptor	O	O
on	O	O
normal	O	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
induces	O	O
nuclear	O	O
expression	O	O
of	O	O
nuclear	protein	protein
factor	protein	protein
kappaB	protein	protein
(	O	O
NF-kappaB	protein	protein
),	O	O
activation	O	O
of	O	O
the	O	O
IL-2	DNA	protein
receptor	DNA	protein
(IL-2R)	DNA	protein
alpha	DNA	protein
chain	DNA	protein
gene	DNA	O
,	O	O
and	O	O
cell	O	O
proliferation	O	O
.	O	O
In	O	O
the	O	O
present	O	O
study,	O	O
the	O	O
role	O	O
of	O	O
IL-2R	protein	protein
signaling	O	O
in	O	O
the	O	O
growth	O	O
of	O	O
CD8+	cell_line	cell_type
T	cell_line	cell_type
cell	cell_line	cell_type
prolymphocytic	cell_line	cell_type
leukemia	cell_line	cell_type
(T-PLL)	cell_line	cell_type
cells	cell_line	cell_type
has	O	O
been	O	O
investigated.	O	O
Flow	O	O
cytometry	O	O
revealed	O	O
that	O	O
primary	cell_type	cell_type
leukemia	cell_type	cell_type
cells	cell_type	cell_type
from	O	O
a	O	O
patient	O	O
with	O	O
CD8+	O	O
T-PLL	O	O
expressed	O	O
IL-2R	O	protein
alpha	O	protein
and	O	O
beta	O	O
chains	O	O
,	O	O
and	O	O
the	O	O
cells	O	O
showed	O	O
a	O	O
proliferative	O	O
response	O	O
and	O	O
an	O	O
increase	O	O
in	O	O
IL-2Ralpha	protein	protein
expression	O	O
on	O	O
culture	O	O
with	O	O
exogeneous	O	O
IL-2	protein	protein
.	O	O
Northern	O	O
blot	O	O
analysis	O	O
failed	O	O
to	O	O
detect	O	O
IL-2	RNA	RNA
mRNA	RNA	RNA
,	O	O
suggesting	O	O
that	O	O
IL-2	protein	protein
may	O	O
act	O	O
in	O	O
a	O	O
paracrine	O	O
manner	O	O
in	O	O
vivo.	O	O
Electrophoretic	O	O
mobility-shift	O	O
assays	O	O
revealed	O	O
that	O	O
recombinant	O	O
IL-2	protein	protein
increased	O	O
NF-kappaB	protein	protein
binding	O	O
activity	O	O
in	O	O
nuclear	O	O
extracts	O	O
of	O	O
the	O	O
leukemia	cell_type	O
cells	cell_type	O
,	O	O
and	O	O
Northern	O	O
blot	O	O
analysis	O	O
showed	O	O
that	O	O
IL-2	protein	protein
increased	O	O
the	O	O
abundance	O	O
of	O	O
mRNAs	O	RNA
encoding	O	O
the	O	O
NF-kappaB	protein	protein
components	O	protein
c-Rel	protein	protein
and	O	O
KBF1	protein	O
in	O	O
these	O	O
cells.	O	O
IL-2	protein	protein
binding	O	O
analysis	O	O
demonstrated	O	O
that	O	O
IL-2	protein	protein
markedly	O	O
increased	O	O
the	O	O
number	O	O
of	O	O
low	O	O
affinity	O	O
IL-2Rs	protein	protein
on	O	O
the	O	O
leukemia	cell_type	O
cells	cell_type	O
,	O	O
without	O	O
an	O	O
effect	O	O
on	O	O
the	O	O
number	O	O
of	O	O
high-affinity	protein	O
IL-2Rs	protein	protein
.	O	O
These	O	O
results	O	O
show	O	O
that	O	O
IL-2	protein	protein
is	O	O
capable	O	O
of	O	O
inducing	O	O
the	O	O
nuclear	O	O
expression	O	O
of	O	O
NF-kappaB	protein	protein
in	O	O
primary	cell_line	cell_type
CD8+	cell_line	cell_type
T-PLL	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
and	O	O
that	O	O
this	O	O
effect	O	O
is	O	O
mediated,	O	O
at	O	O
least	O	O
in	O	O
part,	O	O
at	O	O
a	O	O
pretranslational	O	O
level	O	O

Dimethyldithiocarbamate	O	O
inhibits	O	O
in	O	O
vitro	O	O
activation	O	O
of	O	O
primary	cell_type	cell_type
human	cell_type	cell_type
CD4+	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
Dithiocarbamates	O	O
(	O	O
DTC	O	O
),	O	O
a	O	O
diverse	O	O
group	O	O
of	O	O
industrial	O	O
and	O	O
therapeutic	O	O
chemicals	O	O
,	O	O
have	O	O
been	O	O
reported	O	O
to	O	O
inhibit,	O	O
enhance	O	O
or	O	O
have	O	O
no	O	O
effect	O	O
on	O	O
the	O	O
immune	O	O
system	O	O
.	O	O
These	O	O
apparent	O	O
inconsistencies	O	O
reflect	O	O
the	O	O
complexity	O	O
of	O	O
the	O	O
DTCs	O	O
biological	O	O
activities	O	O
and	O	O
are	O	O
probably	O	O
due	O	O
in	O	O
part	O	O
to	O	O
differences	O	O
in	O	O
dose,	O	O
route	O	O
of	O	O
exposure,	O	O
animal	O	O
species	O	O
used	O	O
and/or	O	O
specific	O	O
compound	O	O
tested.	O	O
The	O	O
studies	O	O
described	O	O
herein	O	O
were	O	O
undertaken	O	O
to	O	O
investigate	O	O
the	O	O
immunotoxicity	O	O
of	O	O
one	O	O
member	O	O
of	O	O
this	O	O
family,	O	O
dimethyldithiocarbamate	O	O
(	O	O
DMDTC	O	O
).	O	O
We	O	O
demonstrate	O	O
that	O	O
0.1-0.5	O	O
microM	O	O
DMDTC	O	O
inhibits	O	O
TNF-alpha	protein	protein
-induced	O	O
activation	O	O
of	O	O
NF-kappaB	protein	protein
in	O	O
primary	cell_type	cell_type
human	cell_type	cell_type
CD4+	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
This	O	O
inhibition	O	O
is	O	O
not	O	O
accompanied	O	O
by	O	O
a	O	O
loss	O	O
in	O	O
viability,	O	O
and	O	O
DMDTC	cell_type	O
-treated	cell_type	O
T	cell_type	cell_type
cells	cell_type	cell_type
retain	O	O
other	O	O
active	O	O
signaling	O	O
pathways	O	O
throughout	O	O
the	O	O
exposure	O	O
duration.	O	O
The	O	O
inhibition	O	O
of	O	O
NF-kappaB	protein	protein
is	O	O
apparently	O	O
permanent	O	O
as	O	O
DMDTC	cell_type	O
-treated	cell_type	O
T	cell_type	O
cells	cell_type	O
did	O	O
not	O	O
regain	O	O
normal	O	O
TNF-alpha	protein	protein
activation	O	O
,	O	O
even	O	O
after	O	O
72	O	O
h	O	O
in	O	O
culture.	O	O
DMDTC	O	O
does	O	O
not	O	O
appear	O	O
to	O	O
alter	O	O
NF-kappaB	protein	protein
directly	O	O
as	O	O
pre-incubation	O	O
of	O	O
nuclear	O	O
extracts	O	O
with	O	O
DMDTC	O	O
does	O	O
not	O	O
diminish	O	O
binding	O	O
activity	O	O
of	O	O
this	O	O
protein.	O	O
We	O	O
further	O	O
demonstrate	O	O
that	O	O
0.1-0.5	O	O
microM	O	O
DMDTC	O	O
inhibits	O	O
intracellular	O	O
IL-2	protein	protein
production	O	O
and	O	O
decreases	O	O
surface	O	O
expression	O	O
of	O	O
CD25	protein	protein
(the	O	O
alpha	protein	protein
subunit	protein	protein
of	O	O
the	O	O
IL-2	protein	protein
receptor	protein	protein
)	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
stimulated	O	O
with	O	O
phorbol	O	O
ester	O	O
.	O	O
These	O	O
data	O	O
demonstrate	O	O
that	O	O
DMDTC	O	O
is	O	O
a	O	O
potent	O	O
immunosuppressive	O	O
compound	O	O
in	O	O
vitro.	O	O

Human	DNA	O
15-lipoxygenase	DNA	DNA
gene	DNA	DNA
promoter	DNA	DNA
:	O	O
analysis	O	O
and	O	O
identification	O	O
of	O	O
DNA	DNA	DNA
binding	DNA	DNA
sites	DNA	DNA
for	O	O
IL-13-induced	protein	protein
regulatory	protein	protein
factors	protein	protein
in	O	O
monocytes	cell_type	cell_type
.	O	O
In	O	O
order	O	O
to	O	O
study	O	O
the	O	O
transcriptional	O	O
control	O	O
of	O	O
15-LO	protein	O
expression	O	O
,	O	O
we	O	O
have	O	O
cloned	O	O
and	O	O
sequenced	O	O
the	O	O
human	DNA	DNA
15-LO	DNA	DNA
promoter	DNA	DNA
region	DNA	DNA
.	O	O
The	O	O
15-LO	protein	DNA
promoter	O	DNA
is	O	O
associated	O	O
with	O	O
a	O	O
CpG	DNA	DNA
island	DNA	O
at	O	O
the	O	O
5'-end	DNA	O
of	O	O
the	O	O
gene,	O	O
and	O	O
sequence	O	O
analysis	O	O
reveals	O	O
putative	O	O
Sp1	O	O
and	O	O
Ap2	O	O
binding	O	O
site/s	O	O
and	O	O
absence	O	O
of	O	O
TATA	O	DNA
or	O	O
CAAT	O	DNA
motifs	O	DNA
.	O	O
Transcription	O	O
is	O	O
initiated	O	O
at	O	O
one	O	O
major	O	O
site.	O	O
Using	O	O
deletion	DNA	O
constructs	DNA	O
,	O	O
we	O	O
have	O	O
defined	O	O
an	O	O
active	DNA	DNA
promoter	DNA	DNA
region	DNA	DNA
of	O	O
1056	O	O
bp.	O	O
Gel-shift	O	O
assays	O	O
revealed	O	O
that	O	O
transcriptional	protein	protein
factor	protein	protein
(s)	O	O
induced	O	O
only	O	O
in	O	O
response	O	O
to	O	O
IL-13	protein	protein
treatment	O	O
of	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
monocytes	cell_type	cell_type
bind	O	O
to	O	O
the	O	O
15-LO	DNA	DNA
promoter	DNA	DNA
DNA	DNA	DNA
.	O	O
Two	O	O
regions,	O	O
DP1	DNA	protein
(	O	O
-140	DNA	DNA
to	DNA	DNA
-92	DNA	DNA
bp	DNA	DNA
)	O	O
and	O	O
DP2	DNA	protein
(	O	O
-353	DNA	O
to	DNA	O
-304	DNA	DNA
bp	DNA	DNA
)	O	O
of	O	O
the	O	O
promoter	O	O
were	O	O
essential	O	O
for	O	O
transcription	O	O
in	O	O
HeLa	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
monocytes	cell_type	cell_type
.	O	O
Hela	O	O
nuclear	O	O
extracts	O	O
contained	O	O
a	O	O
specific	protein	O
nuclear	protein	O
factor(s)	protein	O
binding	O	O
to	O	O
15-LO	DNA	DNA
promoter	DNA	DNA
DNA	DNA	DNA
which	O	O
are	O	O
distinct	O	O
from	O	O
those	O	O
derived	O	O
from	O	O
IL-13	cell_line	protein
-treated	cell_line	O
human	cell_line	O
peripheral	cell_line	O
monocyte	cell_line	O
nuclear	O	O
extracts	O	O
.	O	O
In	O	O
addition,	O	O
fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
results	O	O
refined	O	O
the	O	O
previous	O	O
localization	O	O
of	O	O
15-LO	protein	DNA
to	O	DNA
human	DNA	DNA
chromosome	DNA	DNA
17p13.3	DNA	DNA
.	O	O

Ex	O	O
vivo	O	O
activation	O	O
of	O	O
tumor-draining	cell_type	O
lymph	cell_type	O
node	cell_type	O
T	cell_type	cell_type
cells	cell_type	cell_type
reverses	O	O
defects	O	O
in	O	O
signal	protein	O
transduction	protein	O
molecules	protein	O
.	O	O
The	O	O
adoptive	O	O
transfer	O	O
of	O	O
tumor-draining	O	O
lymph	O	O
node	O	O
(	O	O
LN	O	O
)	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
activated	O	O
ex	O	O
vivo	O	O
with	O	O
anti-CD3	protein	protein
and	O	O
interleukin	protein	protein
2	protein	protein
(	O	O
IL-2	protein	protein
)	O	O
mediates	O	O
the	O	O
regression	O	O
of	O	O
the	O	O
poorly	O	O
immunogenic	O	O
murine	O	O
melanoma	O	O
D5	O	O
.	O	O
The	O	O
efficacy	O	O
of	O	O
the	O	O
activated	cell_type	cell_type
LN	cell_type	cell_type
cells	cell_type	cell_type
is	O	O
augmented	O	O
when	O	O
the	O	O
sensitizing	O	O
tumor	O	O
is	O	O
a	O	O
genetically	cell_line	O
modified	cell_line	O
variant	cell_line	O
(designated	O	O
D5G6	cell_line	O
)	O	O
that	O	O
secretes	O	O
granulocyte/macrophage-colony-stimulating	protein	O
factor	protein	O
.	O	O
In	O	O
contrast	O	O
to	O	O
anti-CD3/	cell_line	cell_line
IL-2	cell_line	cell_line
-	cell_line	cell_line
activated	cell_line	cell_line
LN	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
adoptive	O	O
transfer	O	O
of	O	O
freshly	O	O
isolated	O	O
tumor-draining	cell_type	O
LN	cell_type	O
T	cell_type	cell_type
cells	cell_type	cell_type
has	O	O
no	O	O
therapeutic	O	O
activity	O	O
.	O	O
To	O	O
determine	O	O
whether	O	O
the	O	O
acquisition	O	O
of	O	O
antitumor	O	O
function	O	O
during	O	O
ex	O	O
vivo	O	O
activation	O	O
is	O	O
associated	O	O
with	O	O
modifications	O	O
in	O	O
signal	O	O
transduction	O	O
capacity	O	O
,	O	O
the	O	O
protein	O	protein
tyrosine	protein	protein
kinases	protein	protein
p56lck	protein	protein
and	O	O
p59fyn	protein	protein
and	O	O
proteins	O	O
of	O	O
the	O	O
NF-kappaB	protein	protein
family	protein	protein
were	O	O
analyzed	O	O
in	O	O
tumor-draining	cell_type	cell_type
LN	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
The	O	O
levels	O	O
of	O	O
p56lck	protein	protein
and	O	O
p59fyn	protein	protein
were	O	O
lower	O	O
in	O	O
tumor-draining	O	O
than	O	O
in	O	O
normal	cell_type	cell_type
LN	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
production	O	O
of	O	O
tyrosine	protein	O
-phosphorylated	protein	O
substrates	protein	O
was	O	O
markedly	O	O
depressed	O	O
following	O	O
anti-CD3	protein	protein
stimulation	O	O
.	O	O
After	O	O
5-day	O	O
anti-CD3	protein	protein
/IL-2	protein	protein
activation,	O	O
levels	O	O
of	O	O
p56lck	protein	protein
and	O	O
p59fyn	protein	protein
and	O	O
protein	O	protein
tyrosine	O	protein
kinase	O	protein
activity	O	O
increased.	O	O
Interestingly,	O	O
the	O	O
levels	O	O
of	O	O
p56lck	protein	protein
,	O	O
p59fyn	protein	protein
,	O	O
and	O	O
tyrosine	O	protein
kinase	O	protein
activity	O	O
were	O	O
higher	O	O
in	O	O
activated	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
derived	O	O
from	O	O
LN	O	O
that	O	O
drained	O	O
D5G6	O	O
than	O	O
they	O	O
were	O	O
in	O	O
those	O	O
from	O	O
D5	O	O
tumors	O	O
.	O	O
In	O	O
contrast,	O	O
the	O	O
cytoplasmic	O	O
levels	O	O
of	O	O
c-Rel	protein	protein
and	O	O
Rel	protein	O
A	protein	O
were	O	O
normal	O	O
in	O	O
freshly	O	O
isolated	O	O
tumor-draining	O	O
LN	O	O
,	O	O
as	O	O
was	O	O
nuclear	O	O
kappaB	protein	protein
DNA-binding	O	O
activity	O	O
induced	O	O
by	O	O
anti-CD3	protein	protein
mAb	protein	protein
or	O	O
phorbol	O	O
myristate	O	O
acetate	O	O
.	O	O
Stimulation	O	O
of	O	O
activated	cell_type	cell_type
LN	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
D5	cell_type	cell_line
tumor	cell_type	cell_line
cells	cell_type	cell_line
induced	O	O
the	O	O
nuclear	O	O
translocation	O	O
of	O	O
NF-kappaB	protein	protein
.	O	O
These	O	O
findings	O	O
indicate	O	O
that	O	O
the	O	O
recovery	O	O
of	O	O
proteins	O	O
mediating	O	O
signal	O	O
transduction	O	O
through	O	O
the	O	O
T	protein	O
cell	protein	O
receptor/CD3	protein	protein
complex	protein	protein
in	O	O
LN	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
activated	O	O
ex	O	O
vivo	O	O
was	O	O
associated	O	O
with	O	O
the	O	O
acquisition	O	O
of	O	O
antitumor	O	O
function	O	O
.	O	O

Suppression	O	O
of	O	O
human	O	O
anti-porcine	O	O
T-cell	O	O
immune	O	O
responses	O	O
by	O	O
major	DNA	protein
histocompatibility	DNA	protein
complex	DNA	protein
class	DNA	protein
II	DNA	protein
transactivator	DNA	protein
constructs	DNA	O
lacking	O	O
the	O	O
amino	O	protein
terminal	O	protein
domain.	O	protein
BACKGROUND:	O	O
The	O	O
class	protein	protein
II	protein	protein
transactivator	protein	protein
(	O	O
CIITA	protein	protein
)	O	O
is	O	O
a	O	O
bi-	protein	O
or	protein	O
multifunctional	protein	protein
domain	protein	protein
protein	protein	protein
that	O	O
acts	O	O
as	O	O
a	O	O
transcriptional	protein	protein
activator	protein	protein
and	O	O
plays	O	O
a	O	O
critical	O	O
role	O	O
in	O	O
the	O	O
expression	O	O
of	O	O
MHC	DNA	protein
class	DNA	protein
II	DNA	protein
genes	DNA	O
.	O	O
We	O	O
have	O	O
previously	O	O
demonstrated	O	O
that	O	O
a	O	O
mutated	O	O
form	O	O
of	O	O
the	O	O
human	DNA	DNA
CIITA	DNA	DNA
gene	DNA	DNA
,	O	O
coding	O	O
for	O	O
a	O	O
protein	O	O
lacking	O	O
the	O	O
amino	protein	protein
terminal	protein	protein
151	protein	protein
amino	protein	protein
acids	protein	protein
,	O	O
acts	O	O
as	O	O
a	O	O
potent	O	O
dominant-negative	O	O
suppressor	O	O
of	O	O
HLA	protein	protein
class	protein	protein
II	protein	protein
expression	O	O
.	O	O
Porcine	protein	O
MHC	protein	protein
class	protein	protein
II	protein	protein
antigens	protein	protein
are	O	O
potent	O	O
stimulators	O	O
of	O	O
direct	O	O
T-cell	O	O
recognition	O	O
by	O	O
human	cell_type	cell_type
CD4+	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
are,	O	O
therefore,	O	O
likely	O	O
to	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
rejection	O	O
responses	O	O
to	O	O
transgenic	O	O
pig	O	O
donors	O	O
in	O	O
clinical	O	O
xenotransplantation	O	O
.	O	O
We	O	O
were,	O	O
therefore,	O	O
interested	O	O
in	O	O
examining	O	O
mutated	O	O
CIITA	DNA	protein
constructs	DNA	O
for	O	O
their	O	O
effect	O	O
on	O	O
porcine	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
expression	O	O
.	O	O
METHODS:	O	O
Stable	O	O
transfectants	O	O
of	O	O
the	O	O
porcine	cell_line	protein
vascular	cell_line	protein
endothelial	cell_line	protein
cell	cell_line	protein
line	cell_line	protein
PIEC	cell_line	protein
with	O	O
mutated	O	DNA
CIITA	DNA	DNA
constructs	DNA	DNA
were	O	O
tested	O	O
for	O	O
SLA-DR	protein	protein
and	O	O
SLA-DQ	protein	O
induction	O	O
by	O	O
recombinant	protein	protein
porcine	protein	protein
interferon-gamma	protein	protein
.	O	O
Transient	O	O
transfectants	O	O
of	O	O
the	O	O
porcine	cell_line	cell_line
B-cell	cell_line	cell_line
line	cell_line	cell_line
L23	cell_line	cell_line
with	O	O
the	O	O
mutated	O	DNA
CIITA	DNA	DNA
constructs	DNA	DNA
were	O	O
tested	O	O
for	O	O
the	O	O
suppression	O	O
of	O	O
constitutive	O	O
SLA-DR	O	protein
and	O	O
SLA-DQ	O	O
expression	O	O
.	O	O
T-cell	O	O
proliferation	O	O
studies	O	O
were	O	O
performed	O	O
using	O	O
highly	O	O
purified	O	O
human	cell_type	cell_type
CD4+	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
RESULTS:	O	O
In	O	O
preliminary	O	O
studies,	O	O
we	O	O
demonstrated	O	O
that	O	O
transfection	O	O
of	O	O
the	O	O
PIEC	cell_line	cell_line
line	cell_line	cell_line
with	O	O
full-length	O	cell_line
human	O	cell_line
CIITA	DNA	cell_line
constructs	DNA	cell_line
resulted	O	O
in	O	O
strong	O	O
expression	O	O
of	O	O
SLA-DR	protein	protein
and	O	O
SLA-DQ	protein	O
antigens,	O	O
thus	O	O
establishing	O	O
the	O	O
cross-species	O	O
effectiveness	O	O
of	O	O
human	protein	O
CIITA	protein	protein
in	O	O
the	O	O
pig	O	O
.	O	O
The	O	O
mutated	DNA	cell_line
human	DNA	cell_line
CIITA	DNA	cell_line
constructs	DNA	cell_line
were,	O	O
therefore,	O	O
tested	O	O
in	O	O
the	O	O
pig	O	O
.	O	O
PIEC	cell_line	cell_line
clones	cell_line	cell_line
stably	O	cell_line
transfected	O	cell_line
with	O	O
one	O	O
of	O	O
these	O	O
constructs	O	O
showed	O	O
up	O	O
to	O	O
99%	O	O
suppression	O	O
of	O	O
SLA-DR	protein	protein
and	O	O
SLA-DQ	protein	protein
antigen	O	protein
induction	O	O
and	O	O
marked	O	O
suppression	O	O
of	O	O
SLA-DRA	RNA	RNA
mRNA	RNA	RNA
induction	O	O
.	O	O
Moreover,	O	O
transient	O	O
transfection	O	O
of	O	O
the	O	O
porcine	cell_line	cell_line
B-cell	cell_line	cell_line
line	cell_line	cell_line
L23	cell_line	cell_line
showed	O	O
up	O	O
to	O	O
90%	O	O
suppression	O	O
of	O	O
constitutive	O	O
SLA-DR	O	O
and	O	O
SLA-DQ	O	protein
antigen	O	protein
expression	O	O
in	O	O
5-8	O	O
days.	O	O
In	O	O
functional	O	O
studies,	O	O
interferon-gamma	cell_line	protein
-stimulated	cell_line	O
PIEC	cell_line	cell_line
clones	cell_line	cell_line
transfected	O	O
with	O	O
this	O	O
mutated	protein	O
CIITA	protein	protein
construct	O	O
failed	O	O
to	O	O
stimulate	O	O
purified	O	O
human	cell_type	cell_type
CD4+	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
CONCLUSION:	O	O
Mutated	DNA	cell_line
human	DNA	cell_line
CIITA	DNA	cell_line
constructs	DNA	cell_line
are	O	O
potent	O	O
suppressors	O	O
of	O	O
porcine	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
expression	O	O
.	O	O

Macrophages	cell_type	O
in	O	O
human	O	O
atheroma	O	O
contain	O	O
PPARgamma	protein	protein
:	O	O
differentiation-dependent	protein	O
peroxisomal	protein	protein
proliferator-activated	protein	protein
receptor	protein	protein
gamma	protein	protein
(	O	O
PPARgamma	protein	protein
)	O	O
expression	O	O
and	O	O
reduction	O	O
of	O	O
MMP-9	protein	O
activity	O	O
through	O	O
PPARgamma	protein	protein
activation	O	O
in	O	O
mononuclear	O	cell_type
phagocytes	O	cell_type
in	O	O
vitro.	O	O
Mononuclear	cell_type	O
phagocytes	cell_type	cell_type
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
atherosclerosis	O	O
and	O	O
its	O	O
sequela	O	O
plaque	O	O
rupture	O	O
in	O	O
part	O	O
by	O	O
their	O	O
secretion	O	O
of	O	O
matrix	protein	protein
metalloproteinases	protein	protein
(	O	O
MMPs	protein	protein
),	O	O
including	O	O
MMP-9	protein	protein
.	O	O
Peroxisomal	protein	protein
proliferator-activated	protein	protein
receptor	protein	protein
gamma	protein	protein
(	O	O
PPARgamma	protein	protein
),	O	O
a	O	O
transcription	protein	protein
factor	protein	protein
in	O	O
the	O	O
nuclear	O	O
receptor	O	O
superfamily,	O	O
regulates	O	O
gene	O	O
expression	O	O
in	O	O
response	O	O
to	O	O
various	O	O
activators,	O	O
including	O	O
15-deoxy-delta12,14-prostaglandin	O	O
J2	O	O
and	O	O
the	O	O
antidiabetic	O	O
agent	O	O
troglitazone	O	O
.	O	O
The	O	O
role	O	O
of	O	O
PPARgamma	protein	protein
in	O	O
human	O	O
atherosclerosis	O	O
is	O	O
unexplored.	O	O
We	O	O
report	O	O
here	O	O
that	O	O
monocytes/macrophages	cell_type	cell_type
in	O	O
human	O	O
atherosclerotic	O	O
lesions	O	O
(n	O	O
=	O	O
12)	O	O
express	O	O
immunostainable	protein	O
PPARgamma	protein	protein
.	O	O
Normal	O	O
artery	O	O
specimens	O	O
(n	O	O
=	O	O
6)	O	O
reveal	O	O
minimal	protein	O
immunoreactive	protein	O
PPARgamma	protein	protein
.	O	O
Human	cell_type	cell_type
monocytes	cell_type	cell_type
and	O	O
monocyte-derived	cell_type	cell_type
macrophages	cell_type	cell_type
cultured	O	O
for	O	O
6	O	O
days	O	O
in	O	O
5%	O	O
human	O	O
serum	O	O
expressed	O	O
PPARgamma	RNA	RNA
mRNA	RNA	RNA
and	O	O
protein	O	O
by	O	O
reverse	O	protein
transcription-polymerase	O	protein
chain	O	protein
reaction	O	O
and	O	O
Western	O	O
blotting	O	O
,	O	O
respectively.	O	O
In	O	O
addition,	O	O
PPARgamma	RNA	RNA
mRNA	RNA	RNA
expression	O	O
in	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
increased	O	O
during	O	O
phorbol	O	O
12-myristate	O	O
13	O	O
acetate	O	O
-induced	O	O
differentiation	O	O
.	O	O
Stimulation	O	O
of	O	O
PPARgamma	protein	protein
with	O	O
troglitazone	O	O
or	O	O
15-deoxy-delta12,14-prostaglandin	O	O
J2	O	O
in	O	O
human	O	cell_type
monocyte-derived	cell_type	cell_type
macrophages	cell_type	cell_type
inhibited	O	O
MMP-9	protein	protein
gelatinolytic	O	O
activity	O	O
in	O	O
a	O	O
concentration-dependent	O	O
fashion	O	O
as	O	O
revealed	O	O
by	O	O
zymography	O	O
.	O	O
This	O	O
inhibition	O	O
correlates	O	O
with	O	O
decreased	O	O
MMP-9	protein	O
secretion	O	O
as	O	O
determined	O	O
by	O	O
Western	O	O
blotting	O	O
.	O	O
Thus,	O	O
PPARgamma	protein	protein
is	O	O
present	O	O
in	O	O
macrophages	cell_type	cell_type
in	O	O
human	O	O
atherosclerotic	O	O
lesions	O	O
and	O	O
may	O	O
regulate	O	O
expression	O	O
and	O	O
activity	O	O
of	O	O
MMP-9	protein	protein
,	O	O
an	O	O
enzyme	O	O
implicated	O	O
in	O	O
plaque	O	O
rupture	O	O
.	O	O
PPARgamma	protein	protein
is	O	O
likely	O	O
to	O	O
be	O	O
an	O	O
important	O	O
regulator	O	O
of	O	O
monocyte/macrophage	O	O
function	O	O
with	O	O
relevance	O	O
for	O	O
human	O	O
atherosclerotic	O	O
disease	O	O
.	O	O

Erythropoietin	protein	protein
induces	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
Jak2	protein	protein
,	O	O
STAT5A	protein	protein
,	O	O
and	O	O
STAT5B	protein	protein
in	O	O
primary	cell_type	cell_type
cultured	cell_type	cell_type
human	cell_type	cell_type
erythroid	cell_type	cell_type
precursors	cell_type	cell_type
.	O	O
We	O	O
examined	O	O
signaling	O	O
by	O	O
erythropoietin	protein	protein
in	O	O
highly	cell_type	O
purified	cell_type	O
human	cell_type	O
colony	cell_type	O
forming	cell_type	O
unit-erythroid	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
generated	O	O
in	O	O
vitro	O	O
from	O	O
CD34(+)	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
We	O	O
found	O	O
that	O	O
erythropoietin	protein	protein
induces	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
Jak2	protein	protein
,	O	O
STAT5A	protein	protein
,	O	O
and	O	O
STAT5B	protein	protein
.	O	O
Tyrosine	O	O
phosphorylation	O	O
of	O	O
Jak2	protein	protein
reaches	O	O
a	O	O
peak	O	O
around	O	O
10	O	O
minutes	O	O
after	O	O
stimulation	O	O
and	O	O
is	O	O
maximum	O	O
at	O	O
5	O	O
U/mL	O	O
of	O	O
erythropoietin	protein	protein
.	O	O
Tyrosine	O	O
phosphorylation	O	O
of	O	O
STAT5	protein	protein
is	O	O
accompanied	O	O
by	O	O
the	O	O
translocation	O	O
of	O	O
activated	O	O
STAT5	protein	protein
to	O	O
the	O	O
nucleus	O	O
as	O	O
shown	O	O
by	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assay	O	O
(	O	O
EMSA	O	O
)	O	O
using	O	O
32Pi-labeled	O	DNA
STAT5	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
in	O	O
the	O	O
beta-casein	DNA	DNA
promoter	DNA	DNA
.	O	O
Tyrosine	O	O
phosphorylation	O	O
STAT1	protein	protein
or	O	O
STAT3	protein	protein
was	O	O
not	O	O
detected	O	O
in	O	O
human	cell_type	cell_type
erythroid	cell_type	cell_type
precursors	cell_type	cell_type
after	O	O
stimulation	O	O
with	O	O
erythropoietin	protein	protein
.	O	O
Crkl	protein	O
,	O	O
an	O	O
SH2/SH3	protein	protein
adapter	protein	protein
protein	protein	protein
,	O	O
becomes	O	O
coimmunoprecipitated	O	O
specifically	O	O
with	O	O
STAT5	protein	protein
from	O	O
erythropoietin	cell_type	cell_line
-stimulated	cell_type	cell_line
erythroid	cell_type	cell_line
cells	cell_type	cell_line
;	O	O
although	O	O
it	O	O
was	O	O
shown	O	O
to	O	O
become	O	O
associated	O	O
with	O	O
c-Cbl	protein	protein
in	O	O
the	O	O
studies	O	O
using	O	O
cell	cell_line	O
lines	cell_line	O
.	O	O
Thus,	O	O
human	cell_type	O
erythroid	cell_type	O
precursors	cell_type	O
can	O	O
be	O	O
expanded	O	O
in	O	O
vitro	O	O
in	O	O
sufficient	O	O
numbers	O	O
and	O	O
purity	O	O
to	O	O
allow	O	O
its	O	O
usage	O	O
in	O	O
signal	O	O
transduction	O	O
studies	O	O
.	O	O
This	O	O
report	O	O
sets	O	O
a	O	O
basis	O	O
for	O	O
further	O	O
studies	O	O
on	O	O
signaling	O	O
in	O	O
primary	cell_type	cell_type
cultured	cell_type	cell_type
human	cell_type	cell_type
erythroid	cell_type	cell_type
precursors	cell_type	cell_type
,	O	O
which	O	O
in	O	O
turn	O	O
contribute	O	O
to	O	O
our	O	O
better	O	O
understanding	O	O
in	O	O
the	O	O
differentiation	O	O
processes	O	O
of	O	O
erythrocytes	cell_type	cell_type
and	O	O
their	O	O
precursors.	O	O

Oxidative	O	O
stress	O	O
suppresses	O	O
transcription	protein	O
factor	protein	O
activities	O	O
in	O	O
stimulated	cell_type	O
lymphocytes	cell_type	O
.	O	O
Effects	O	O
of	O	O
oxidative	O	O
stress	O	O
on	O	O
stimulation-dependent	O	O
signal	O	O
transduction	O	O
,	O	O
leading	O	O
to	O	O
IL-2	protein	protein
expression	O	O
,	O	O
were	O	O
studied.	O	O
Purified	cell_type	O
quiescent	cell_type	O
human	cell_type	cell_type
blood	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
were	O	O
subjected	O	O
to:	O	O
(i)	O	O
acute	O	O
exposure	O	O
to	O	O
hydrogen	O	O
peroxide	O	O
;	O	O
(ii)	O	O
chronic	O	O
exposure	O	O
to	O	O
hydrogen	O	O
peroxide	O	O
;	O	O
and	O	O
(iii)	O	O
acute	O	O
exposure	O	O
to	O	O
ionizing	O	O
radiation	O	O
.	O	O
The	O	O
cells	O	O
were	O	O
then	O	O
stimulated	O	O
for	O	O
6	O	O
h.	O	O
DNA-binding	O	O
activities	O	O
(determined	O	O
by	O	O
the	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assay	O	O
)	O	O
of	O	O
three	O	O
transcription	protein	protein
factors	protein	protein
:	O	O
NFkappaB	protein	protein
,	O	O
AP-1	protein	protein
and	O	O
NFAT	protein	protein
,	O	O
were	O	O
abolished	O	O
in	O	O
the	O	O
lymphocytes	cell_type	O
by	O	O
all	O	O
three	O	O
modes	O	O
of	O	O
oxidative	O	O
stress.	O	O
The	O	O
lymphocytes	cell_type	O
exhibited	O	O
lipid	O	O
peroxidation	O	O
only	O	O
upon	O	O
exposure	O	O
to	O	O
the	O	O
lowest	O	O
level	O	O
of	O	O
hydrogen	O	O
peroxide	O	O
used	O	O
(20	O	O
microM).	O	O
All	O	O
three	O	O
modes	O	O
of	O	O
oxidative	O	O
stress	O	O
induced	O	O
catalase	protein	protein
activity	O	O
in	O	O
the	O	O
lymphocytes	cell_type	cell_type
.	O	O
The	O	O
only	O	O
exception	O	O
was	O	O
hydrogen	O	O
peroxide	O	O
at	O	O
20	O	O
microM,	O	O
which	O	O
did	O	O
not	O	O
induce	O	O
catalase	protein	protein
activity	O	O
.	O	O
We	O	O
conclude	O	O
that:	O	O
(i)	O	O
suppression	O	O
of	O	O
specific	O	O
transcription	protein	protein
factor	protein	protein
functions	O	O
can	O	O
potentially	O	O
serve	O	O
as	O	O
a	O	O
marker	O	O
of	O	O
exposure	O	O
to	O	O
oxidative	O	O
stress	O	O
and	O	O
its	O	O
effects	O	O
on	O	O
human	cell_type	cell_type
lymphocytes	cell_type	cell_type
;	O	O
(ii)	O	O
lipid	O	O
peroxidation	O	O
is	O	O
only	O	O
detectable	O	O
in	O	O
human	cell_type	cell_type
lymphocytes	cell_type	cell_type
upon	O	O
exposure	O	O
to	O	O
weak	O	O
oxidative	O	O
stress	O	O
which	O	O
does	O	O
not	O	O
induce	O	O
catalase	protein	protein
activity	O	O
;	O	O
(iii)	O	O
therefore,	O	O
transcription	protein	O
factor	protein	O
DNA-binding	O	O
activities	O	O
are	O	O
more	O	O
sensitive	O	O
to	O	O
oxidative	O	O
stress	O	O
than	O	O
lipid	O	O
peroxidation	O	O
.	O	O

IL-4	protein	protein
-dependent	O	O
regulation	O	O
of	O	O
TGF-alpha	O	protein
and	O	O
TGF-beta1	O	protein
expression	O	O
in	O	O
human	cell_type	cell_type
eosinophils	cell_type	cell_type
.	O	O
TGFs	protein	O
play	O	O
important	O	O
roles	O	O
in	O	O
wound	O	O
healing	O	O
and	O	O
carcinogenesis.	O	O
We	O	O
have	O	O
previously	O	O
demonstrated	O	O
that	O	O
eosinophils	cell_type	cell_type
infiltrating	O	cell_type
into	O	O
different	O	O
pathologic	O	O
processes	O	O
elaborate	O	O
TGF-alpha	protein	protein
and	O	O
TGF-beta1	protein	protein
.	O	O
Eosinophils	cell_type	cell_type
infiltrating	O	cell_type
hamster	O	O
cutaneous	O	O
wounds	O	O
were	O	O
found	O	O
to	O	O
express	O	O
TGFs	protein	O
sequentially.	O	O
In	O	O
this	O	O
study,	O	O
we	O	O
examined	O	O
the	O	O
biologic	O	O
mediators	O	O
that	O	O
may	O	O
regulate	O	O
the	O	O
expression	O	O
of	O	O
TGF	O	protein
-alpha	O	protein
and	O	O
-beta1	O	O
by	O	O
eosinophils	cell_type	cell_type
.	O	O
Eosinophils	cell_type	cell_type
were	O	O
isolated	O	O
from	O	O
the	O	O
peripheral	O	O
blood	O	O
of	O	O
healthy	O	O
donors	O	O
and	O	O
cultured	O	O
in	O	O
the	O	O
absence	O	O
or	O	O
presence	O	O
of	O	O
IL-3	protein	protein
,	O	O
IL-4	protein	protein
,	O	O
and	O	O
IL-5	protein	protein
.	O	O
Cells	O	O
were	O	O
analyzed	O	O
by	O	O
in	O	O
situ	O	O
hybridization	O	O
and	O	O
immunohistochemistry.	O	O
Supernatants	O	O
from	O	O
these	O	O
cultures	O	O
were	O	O
assayed	O	O
for	O	O
secreted	O	O
TGF-alpha	protein	protein
and	O	O
TGF-beta1	protein	protein
using	O	O
TGF	protein	protein
-specific	O	O
ELISAs	O	O
.	O	O
IL-3	protein	protein
,	O	O
IL-4	protein	protein
,	O	O
and	O	O
IL-5	protein	protein
independently	O	O
up-regulated	O	O
TGF-beta1	RNA	RNA
mRNA	RNA	RNA
and	O	O
product	O	O
expression	O	O
by	O	O
eosinophils	cell_type	cell_type
in	O	O
all	O	O
donors.	O	O
Interestingly,	O	O
TGF-alpha	protein	protein
production	O	O
by	O	O
eosinophils	cell_type	cell_type
was	O	O
up-regulated	O	O
by	O	O
IL-3	protein	protein
and	O	O
IL-5	protein	protein
but	O	O
was	O	O
down-regulated	O	O
by	O	O
IL-4	protein	protein
.	O	O
Consistent	O	O
with	O	O
the	O	O
ability	O	O
of	O	O
IL-4	protein	protein
to	O	O
regulate	O	O
eosinophil	O	cell_type
responses	O	O
,	O	O
IL-4	protein	protein
signaling	protein	protein
molecules	protein	protein
are	O	O
present	O	O
in	O	O
human	cell_type	cell_type
eosinophils	cell_type	cell_type
.	O	O
The	O	O
observation	O	O
that	O	O
IL-4	protein	protein
can	O	O
differentially	O	O
regulate	O	O
the	O	O
expression	O	O
of	O	O
TGF-alpha	protein	protein
and	O	O
TGF-beta1	protein	protein
suggests	O	O
that	O	O
IL-4	protein	protein
may	O	O
serve	O	O
as	O	O
a	O	O
physiologic	O	O
molecular	O	O
switch	O	O
of	O	O
TGF	protein	protein
expression	O	O
by	O	O
the	O	O
infiltrating	O	O
eosinophils	cell_type	cell_type
in	O	O
wound	O	O
healing	O	O
and	O	O
carcinogenesis	O	O
.	O	O

MLL	O	O
and	O	O
CALM	DNA	O
are	O	O
fused	O	O
to	O	O
AF10	DNA	protein
in	O	O
morphologically	O	O
distinct	O	O
subsets	O	O
of	O	O
acute	O	O
leukemia	O	O
with	O	O
translocation	DNA	O
t(10;11)	DNA	O
:	O	O
both	O	O
rearrangements	O	O
are	O	O
associated	O	O
with	O	O
a	O	O
poor	O	O
prognosis.	O	O
The	O	O
translocation	DNA	O
t(10;11)	DNA	O
(p13;q14)	DNA	O
has	O	O
been	O	O
observed	O	O
in	O	O
acute	O	O
lymphoblastic	O	O
leukemia	O	O
(	O	O
ALL	O	O
)	O	O
as	O	O
well	O	O
as	O	O
acute	O	O
myeloid	O	O
leukemia	O	O
(	O	O
AML	O	O
).	O	O
A	O	O
recent	O	O
study	O	O
showed	O	O
a	O	O
MLL/	DNA	O
AF10	DNA	protein
fusion	DNA	protein
in	O	O
all	O	O
cases	O	O
of	O	O
AML	O	O
with	O	O
t(10;11)	DNA	O
and	O	O
various	O	O
breakpoints	O	O
on	O	O
chromosome	DNA	DNA
11	DNA	DNA
ranging	O	O
from	O	O
q13	DNA	O
to	O	O
q23	DNA	O
.	O	O
We	O	O
recently	O	O
cloned	O	O
CALM	DNA	protein
(	O	O
Clathrin	DNA	O
Assembly	DNA	O
Lymphoid	DNA	O
Myeloid	DNA	O
leukemia	DNA	O
gene	DNA	O
),	O	O
the	O	O
fusion	O	O
partner	O	O
of	O	O
AF10	DNA	protein
at	O	O
11q14	DNA	O
in	O	O
the	O	O
monocytic	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
U937	cell_line	cell_line
.	O	O
To	O	O
further	O	O
define	O	O
the	O	O
role	O	O
of	O	O
these	O	O
genes	O	O
in	O	O
acute	O	O
leukemias	O	O
,	O	O
10	O	O
cases	O	O
(9	O	O
AML	O	O
and	O	O
1	O	O
ALL	O	O
)	O	O
with	O	O
cytogenetically	O	O
proven	O	O
t(10;11)(p12-14;q13-21)	DNA	O
and	O	O
well-characterized	O	O
morphology,	O	O
immunophenotype,	O	O
and	O	O
clinical	O	O
course	O	O
were	O	O
analyzed.	O	O
Interphase	O	protein
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
was	O	O
performed	O	O
with	O	O
2	O	O
YACs	DNA	O
flanking	O	O
the	O	O
CALM	DNA	DNA
region	DNA	DNA
,	O	O
a	O	O
YAC	DNA	O
contig	DNA	O
of	O	O
the	O	O
MLL	DNA	DNA
region	DNA	DNA
,	O	O
and	O	O
a	O	O
YAC	DNA	O
spanning	O	O
the	O	O
AF10	DNA	protein
breakpoint.	O	O
Rearrangement	O	O
of	O	O
at	O	O
least	O	O
one	O	O
of	O	O
these	O	O
genes	O	O
was	O	O
detected	O	O
in	O	O
all	O	O
cases	O	O
with	O	O
balanced	O	O
t(10;11)	DNA	O
.	O	O
In	O	O
4	O	O
cases,	O	O
including	O	O
3	O	O
AML	O	O
with	O	O
immature	O	O
morphology	O	O
(1	O	O
AML	O	O
-M0	O	O
and	O	O
2	O	O
AML	O	O
-M1	O	O
)	O	O
and	O	O
1	O	O
ALL	O	O
,	O	O
the	O	O
signals	O	O
of	O	O
the	O	O
CALM	DNA	O
YACS	DNA	O
were	O	O
separated	O	O
in	O	O
interphase	O	O
cells,	O	O
indicating	O	O
a	O	O
translocation	O	O
breakpoint	O	O
within	O	O
the	O	O
CALM	DNA	DNA
region	DNA	DNA
.	O	O
MLL	O	O
was	O	O
rearranged	O	O
in	O	O
3	O	O
AML	O	O
with	O	O
myelomonocytic	O	O
differentiation	O	O
(2	O	O
AML-M2	O	O
and	O	O
1	O	O
AML-M5	O	O
),	O	O
including	O	O
1	O	O
secondary	O	O
AML	O	O
.	O	O
In	O	O
all	O	O
3	O	O
cases,	O	O
a	O	O
characteristic	O	O
immunophenotype	O	O
was	O	O
identified	O	O
(	O	O
CD4+	protein	protein
,	O	O
CD13	protein	protein
-,	O	protein
CD33+,	O	protein
CD65s+	O	protein
).	O	O
AF-10	O	protein
was	O	O
involved	O	O
in	O	O
5	O	O
of	O	O
6	O	O
evaluable	O	O
cases,	O	O
including	O	O
1	O	O
case	O	O
without	O	O
detectable	O	O
CALM	DNA	O
or	O	O
MLL	O	O
rearrangement	O	O
.	O	O
In	O	O
2	O	O
complex	O	O
translocations,	O	O
none	O	O
of	O	O
the	O	O
three	O	O
genes	O	O
was	O	O
rearranged.	O	O
All	O	O
cases	O	O
had	O	O
a	O	O
remarkably	O	O
poor	O	O
prognosis,	O	O
with	O	O
a	O	O
mean	O	O
survival	O	O
of	O	O
9.6	O	O
+/-	O	O
6.6	O	O
months.	O	O
For	O	O
the	O	O
7	O	O
AML	O	O
cases	O	O
that	O	O
were	O	O
uniformly	O	O
treated	O	O
according	O	O
to	O	O
the	O	O
AMLCG86/92	O	protein
protocols	O	protein
,	O	O
disease-free	O	O
and	O	O
overall	O	O
survival	O	O
was	O	O
significantly	O	O
worse	O	O
than	O	O
for	O	O
the	O	O
overall	O	O
study	O	O
group	O	O
(P	O	O
=	O	O
.03	O	O
and	O	O
P	O	O
=	O	O
.01,	O	O
respectively).	O	O
We	O	O
conclude	O	O
that	O	O
the	O	O
t(10;11)(p13;q14)	DNA	DNA
indicates	O	O
CALM	O	O
and	O	O
MLL	O	O
rearrangements	O	O
in	O	O
morphologically	O	O
distinct	O	O
subsets	O	O
of	O	O
acute	O	O
leukemia	O	O
and	O	O
may	O	O
be	O	O
associated	O	O
with	O	O
a	O	O
poor	O	O
prognosis	O	O
.	O	O

The	O	O
role	O	O
of	O	O
E-proteins	protein	protein
in	O	O
B-	O	O
and	O	O
T-	O	O
lymphocyte	O	O
development	O	O
.	O	O
Department	O	O
of	O	O
lymphocytes	cell_type	cell_type
from	O	O
hematopoietic	cell_type	cell_type
stem	cell_type	cell_type
cells	cell_type	cell_type
is	O	O
controlled,	O	O
in	O	O
part,	O	O
by	O	O
the	O	O
activity	O	O
of	O	O
transcriptional	protein	protein
regulatory	protein	protein
proteins	protein	protein
.	O	O
In	O	O
particular,	O	O
one	O	O
class	O	O
of	O	O
helix-loop-helix	protein	protein
proteins	protein	protein
,	O	O
termed	O	O
E-proteins	protein	protein
,	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
regulation	O	O
of	O	O
gene	O	O
expression	O	O
during	O	O
B-cell	O	O
development	O	O
.	O	O
Recent	O	O
analysis	O	O
of	O	O
gene-targeted	O	O
mice	O	O
has	O	O
allowed	O	O
a	O	O
direct	O	O
assessment	O	O
of	O	O
the	O	O
functional	O	O
roles	O	O
of	O	O
several	protein	O
E-protein	protein	protein
family	protein	protein
members	protein	protein
in	O	O
hematopoiesis.	O	O
In	O	O
this	O	O
review	O	O
we	O	O
describe	O	O
the	O	O
defects	O	O
in	O	O
B-	O	O
and	O	O
T-	O	O
lymphocyte	O	O
development	O	O
in	O	O
mice	O	O
carrying	O	O
targeted	O	O
mutations	O	O
in	O	O
the	O	O
E-protein	DNA	DNA
genes	DNA	DNA
and	O	O
discuss	O	O
our	O	O
current	O	O
understanding	O	O
of	O	O
the	O	O
role	O	O
of	O	O
these	O	O
proteins	O	O
in	O	O
lymphoid	O	O
development	O	O

Epstein-Barr	protein	O
virus-transforming	protein	O
protein	protein	O
latent	protein	O
infection	protein	O
membrane	protein	O
protein	protein	O
1	protein	O
activates	O	O
transcription	protein	protein
factor	protein	protein
NF-kappaB	protein	protein
through	O	O
a	O	O
pathway	O	O
that	O	O
includes	O	O
the	O	O
NF-kappaB	protein	protein
-inducing	protein	protein
kinase	protein	protein
and	O	O
the	O	O
IkappaB	protein	protein
kinases	protein	protein
IKKalpha	protein	protein
and	O	O
IKKbeta	protein	protein
.	O	O
The	O	O
Epstein-Barr	protein	O
virus	protein	O
oncoprotein	protein	protein
latent	protein	protein
infection	protein	protein
membrane	protein	protein
protein	protein	protein
1	protein	protein
(	O	O
LMP1	protein	protein
)	O	O
is	O	O
a	O	O
constitutively	O	O
aggregated	O	O
pseudo-tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
receptor	protein	protein
(	O	O
TNFR	protein	protein
)	O	O
that	O	O
activates	O	O
transcription	protein	protein
factor	protein	protein
NF-kappaB	protein	protein
through	O	O
two	O	O
sites	O	O
in	O	O
its	O	O
C-terminal	protein	protein
cytoplasmic	protein	protein
domain	protein	protein
.	O	O
One	O	O
site	O	O
is	O	O
similar	O	O
to	O	O
activated	O	O
TNFRII	protein	protein
in	O	O
associating	O	O
with	O	O
TNFR	protein	protein
-associated	protein	protein
factors	protein	protein
TRAF1	protein	protein
and	O	O
TRAF2	protein	protein
,	O	O
and	O	O
the	O	O
second	O	O
site	O	O
is	O	O
similar	O	O
to	O	O
TNFRI	protein	protein
in	O	O
associating	O	O
with	O	O
the	O	O
TNFRI	protein	protein
death	protein	protein
domain	protein	protein
interacting	protein	protein
protein	protein	protein
TRADD	protein	protein
.	O	O
TNFRI	protein	protein
has	O	O
been	O	O
recently	O	O
shown	O	O
to	O	O
activate	O	O
NF-kappaB	protein	protein
through	O	O
association	O	O
with	O	O
TRADD	protein	protein
,	O	O
RIP	protein	protein
,	O	O
and	O	O
TRAF2	protein	protein
;	O	O
activation	O	O
of	O	O
the	O	O
NF-kappaB	protein	protein
-inducing	protein	protein
kinase	protein	protein
(	O	O
NIK	protein	protein
);	O	O
activation	O	O
of	O	O
the	O	O
IkappaB	protein	protein
alpha	protein	protein
kinases	protein	protein
(	O	O
IKKalpha	protein	protein
and	O	O
IKKbeta	protein	protein
);	O	O
and	O	O
phosphorylation	O	O
of	O	O
IkappaB	protein	protein
alpha	protein	protein
.	O	O
IkappaB	protein	protein
alpha	protein	protein
phosphorylation	O	O
on	O	O
Ser-32	O	O
and	O	O
Ser-36	O	O
is	O	O
followed	O	O
by	O	O
its	O	O
degradation	O	O
and	O	O
NF-kappaB	protein	protein
activation	O	O
.	O	O
In	O	O
this	O	O
report,	O	O
we	O	O
show	O	O
that	O	O
NF-kappaB	protein	protein
activation	O	O
by	O	O
LMP1	protein	protein
or	O	O
by	O	O
each	O	O
of	O	O
its	O	O
effector	protein	DNA
sites	protein	DNA
is	O	O
mediated	O	O
by	O	O
a	O	O
pathway	O	O
that	O	O
includes	O	O
NIK	protein	protein
,	O	O
IKKalpha	protein	protein
,	O	O
and	O	O
IKKbeta	protein	protein
.	O	O
Dominant	protein	O
negative	protein	O
mutants	protein	O
of	O	O
NIK	protein	protein
,	O	O
IKKalpha	protein	protein
,	O	O
or	O	O
IKKbeta	protein	protein
substantially	O	O
inhibited	O	O
NF-kappaB	protein	protein
activation	O	O
by	O	O
LMP1	protein	protein
or	O	O
by	O	O
each	O	O
of	O	O
its	O	O
effector	protein	DNA
sites	protein	DNA
.	O	O

Targeted	O	O
disruption	O	O
of	O	O
the	O	O
MyD88	DNA	DNA
gene	DNA	DNA
results	O	O
in	O	O
loss	O	O
of	O	O
IL-1-	O	O
and	O	O
IL-18-	O	O
mediated	O	O
function	O	O
.	O	O
MyD88	protein	protein
,	O	O
originally	O	O
isolated	O	O
as	O	O
a	O	O
myeloid	O	O
differentiation	O	O
primary	DNA	O
response	DNA	O
gene	DNA	O
,	O	O
is	O	O
shown	O	O
to	O	O
act	O	O
as	O	O
an	O	O
adaptor	O	O
in	O	O
interleukin-1	protein	protein
(	O	O
IL-1	protein	protein
)	O	O
signaling	O	O
by	O	O
interacting	O	O
with	O	O
both	O	O
the	O	O
IL-1	protein	protein
receptor	protein	protein
complex	protein	protein
and	O	O
IL-1	protein	protein
receptor-associated	protein	protein
kinase	protein	protein
(	O	O
IRAK	protein	protein
).	O	O
Mice	O	O
generated	O	O
by	O	O
gene	O	O
targeting	O	O
to	O	O
lack	O	O
MyD88	protein	protein
have	O	O
defects	O	O
in	O	O
T	O	O
cell	O	O
proliferation	O	O
as	O	O
well	O	O
as	O	O
induction	O	O
of	O	O
acute	O	O
phase	O	O
proteins	O	O
and	O	O
cytokines	protein	protein
in	O	O
response	O	O
to	O	O
IL-1	protein	protein
.	O	O
Increases	O	O
in	O	O
interferon-gamma	protein	protein
production	O	O
and	O	O
natural	O	O
killer	O	O
cell	O	O
activity	O	O
in	O	O
response	O	O
to	O	O
IL-18	protein	protein
are	O	O
abrogated.	O	O
In	O	O
vivo	O	O
Th1	O	O
response	O	O
is	O	O
also	O	O
impaired.	O	O
Furthermore,	O	O
IL-18	protein	protein
-induced	O	O
activation	O	O
of	O	O
NF-kappaB	protein	protein
and	O	O
c-Jun	protein	protein
N-terminal	protein	protein
kinase	protein	protein
(	O	O
JNK	protein	protein
)	O	O
is	O	O
blocked	O	O
in	O	O
MyD88	cell_line	cell_line
-/-	cell_line	cell_line
Th1-developing	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Taken	O	O
together,	O	O
these	O	O
results	O	O
demonstrate	O	O
that	O	O
MyD88	protein	protein
is	O	O
a	O	O
critical	O	O
component	O	O
in	O	O
the	O	O
signaling	O	O
cascade	O	O
that	O	O
is	O	O
mediated	O	O
by	O	O
IL-1	protein	protein
receptor	protein	protein
as	O	O
well	O	O
as	O	O
IL-18	protein	protein
receptor	protein	protein
.	O	O

Ciprofloxacin	O	O
induces	O	O
an	O	O
immunomodulatory	O	O
stress	O	O
response	O	O
in	O	O
human	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
Exposure	O	O
of	O	O
cells	O	O
to	O	O
adverse	O	O
environmental	O	O
conditions	O	O
invokes	O	O
a	O	O
genetically	O	O
programmed	O	O
series	O	O
of	O	O
events	O	O
resulting	O	O
in	O	O
the	O	O
induction	O	O
of	O	O
specific	DNA	O
genes	DNA	O
.	O	O
The	O	O
fluoroquinolone	O	O
antibiotic	O	O
ciprofloxacin	O	O
has	O	O
recently	O	O
been	O	O
reported	O	O
to	O	O
upregulate	O	O
interleukin-2	protein	protein
(	O	O
IL-2	protein	protein
)	O	O
gene	O	O
induction	O	O
.	O	O
In	O	O
the	O	O
present	O	O
investigation,	O	O
the	O	O
effect	O	O
of	O	O
ciprofloxacin	O	O
at	O	O
supratherapeutic	O	O
concentrations	O	O
on	O	O
immediate-early	O	O
(&lt;2	O	O
h)	O	O
gene	O	O
expression	O	O
in	O	O
primary	cell_type	cell_type
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
lymphocytes	cell_type	cell_type
was	O	O
studied	O	O
with	O	O
Northern	O	O
blots	O	O
.	O	O
In	O	O
addition,	O	O
transcriptional	O	O
activity	O	O
of	O	O
IL-2	protein	protein
and	O	O
metallothionein	O	O
enhancer	O	O
and	O	O
promoter	O	O
regions	O	O
and	O	O
transcription	protein	protein
factors	protein	protein
AP-1	protein	protein
,	O	O
NF-kappaB	protein	protein
,	O	O
and	O	O
NF-AT	protein	protein
were	O	O
analyzed	O	O
by	O	O
chloramphenicol	protein	protein
acetyltransferase	protein	protein
(	O	O
CAT	protein	protein
)	O	O
and	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assays	O	O
,	O	O
respectively.	O	O
The	O	O
concentration	O	O
of	O	O
c-fos	O	DNA
,	O	O
c-jun	O	DNA
,	O	O
c-myc	O	DNA
,	O	O
junB	O	DNA
,	O	O
and	O	O
fra-1	O	O
mRNAs	O	O
was	O	O
increased	O	O
in	O	O
activated	O	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
lymphocytes	cell_type	cell_type
incubated	O	O
with	O	O
ciprofloxacin	O	O
compared	O	O
to	O	O
that	O	O
in	O	O
untreated	O	O
controls.	O	O
Ciprofloxacin	O	O
increased	O	O
CAT	protein	protein
activity	O	O
in	O	O
stimulated	O	O
lymphocytes	O	O
transfected	O	O
with	O	O
plasmids	cell_type	DNA
containing	O	O
either	O	O
the	O	O
IL-2	protein	protein
or	O	O
metallothionein	DNA	O
enhancer	DNA	O
.	O	O
Furthermore,	O	O
among	O	O
the	O	O
transcription	protein	protein
factors	protein	protein
tested,	O	O
AP-1	protein	protein
activity	O	O
was	O	O
increased	O	O
in	O	O
stimulated	cell_type	O
purified	cell_type	O
T	cell_type	cell_type
helper	cell_type	cell_type
lymphocytes	cell_type	cell_type
incubated	O	O
with	O	O
ciprofloxacin	O	O
compared	O	O
to	O	O
drug-free	cell_type	O
controls	cell_type	O
.	O	O
Taken	O	O
together,	O	O
ciprofloxacin	O	O
increased	O	O
the	O	O
levels	O	O
of	O	O
immediate-early	RNA	protein
transcripts	RNA	protein
,	O	O
enhanced	O	O
IL-2	protein	protein
and	O	O
metallothionein	protein	O
promoter	O	O
induction	O	O
,	O	O
and	O	O
upregulated	O	O
AP-1	protein	protein
concentrations	O	O
in	O	O
primary	cell_type	cell_type
lymphocytes	cell_type	cell_type
,	O	O
reflecting	O	O
a	O	O
program	O	O
commonly	O	O
observed	O	O
in	O	O
mammalian	O	O
stress	O	O
responses	O	O
.	O	O

A	O	O
novel	O	O
retinoic	protein	protein
acid	protein	protein
receptor	protein	protein
(	O	O
RAR	protein	protein
)-selective	O	O
antagonist	O	O
inhibits	O	O
differentiation	O	O
and	O	O
apoptosis	O	O
of	O	O
HL-60	cell_line	cell_line
cells	cell_line	cell_line
:	O	O
implications	O	O
of	O	O
RARalpha	protein	protein
-mediated	O	O
signals	O	O
in	O	O
myeloid	cell_type	cell_type
leukemic	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Retinoic	O	O
acid	O	O
(	O	O
RA	O	O
)	O	O
induces	O	O
HL-60	cell_line	cell_line
cells	cell_line	cell_line
to	O	O
differentiate	O	O
terminally	O	O
into	O	O
mature	cell_type	O
granulocytes	cell_type	cell_type
,	O	O
which	O	O
subsequently	O	O
die	O	O
by	O	O
apoptosis	O	O
.	O	O
The	O	O
biological	O	O
effects	O	O
of	O	O
RA	O	O
are	O	O
mediated	O	O
by	O	O
two	O	O
distinct	O	O
families	O	O
of	O	O
transcription	protein	protein
factors	protein	protein
:	O	O
retinoic	protein	O
acid	protein	protein
receptors	protein	protein
(	O	O
RARs	protein	protein
)	O	O
and	O	O
retinoid	protein	protein
X	protein	protein
receptors	protein	protein
(	O	O
RXRs	protein	protein
).	O	O
RARs	protein	protein
and	O	O
RXRs	protein	protein
form	O	protein
heterodimers	protein	protein
and	O	O
regulate	O	O
retinoid-mediated	O	O
gene	O	O
expression	O	O
.	O	O
We	O	O
have	O	O
recently	O	O
developed	O	O
a	O	O
novel	O	O
RAR	protein	protein
-selective	O	O
antagonist	O	O
(	O	O
ER27191	O	protein
)	O	O
which	O	O
prevents	O	O
RAR	protein	protein
activation	O	O
by	O	O
retinoids.	O	O
Using	O	O
this	O	O
RAR-selective	O	O
antagonist	O	O
,	O	O
and	O	O
RXR	protein	protein
and	O	O
RAR	protein	protein
agonist	O	O
,	O	O
we	O	O
demonstrate	O	O
the	O	O
RAR	protein	protein
-mediated	O	O
signaling	O	O
pathway	O	O
is	O	O
important	O	O
for	O	O
differentiation	O	O
and	O	O
apoptosis	O	O
of	O	O
myeloid	cell_type	cell_type
leukemic	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Simple	O	O
activation	O	O
of	O	O
RXRs	protein	protein
is	O	O
not	O	O
sufficient	O	O
to	O	O
induce	O	O
apoptosis	O	O
of	O	O
the	O	O
cells.	O	O
Interestingly,	O	O
the	O	O
combination	O	O
of	O	O
the	O	O
RAR-selective	O	O
antagonist	O	O
and	O	O
9-cis	O	O
RA	O	O
resulted	O	O
in	O	O
partial	O	O
differentiation	O	O
and	O	O
apoptosis	O	O
of	O	O
HL-60	O	O
and	O	O
NB4	O	cell_line
cells	O	cell_line
,	O	O
whereas	O	O
the	O	O
RAR	protein	protein
antagonist	O	O
completely	O	O
blocked	O	O
all-trans	O	O
RA	O	O
-induced	O	O
differentiation	O	O
and	O	O
apoptosis	O	O
of	O	O
the	O	O
cells.	O	O
Additional	O	O
experiments	O	O
showed	O	O
that	O	O
levels	O	O
of	O	O
BCL-2	protein	protein
protein	protein	protein
decreased	O	O
during	O	O
differentiation	O	O
of	O	O
myeloid	cell_type	cell_type
leukemic	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Furthermore,	O	O
HL-60	cell_line	cell_line
cells	cell_line	cell_line
transduced	O	O
with	O	O
a	O	O
bcl-2	DNA	protein
expression	DNA	O
vector	DNA	O
showed	O	O
the	O	O
same	O	O
differentiation	O	O
response	O	O
to	O	O
retinoids	O	O
as	O	O
did	O	O
parental	cell_line	O
HL-60	cell_line	cell_line
cells	cell_line	cell_line
even	O	O
though	O	O
apoptosis	O	O
was	O	O
inhibited	O	O
in	O	O
these	O	O
bcl-2-transduced	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
suggesting	O	O
that	O	O
differentiation	O	O
and	O	O
apoptosis	O	O
are	O	O
regulated	O	O
independently	O	O
in	O	O
myeloid	cell_type	cell_type
leukemic	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Thrombopoietin	protein	protein
supports	O	O
in	O	O
vitro	O	O
erythroid	O	O
differentiation	O	O
via	O	O
its	O	O
specific	O	O
receptor	O	O
c-Mpl	protein	protein
in	O	O
a	O	O
human	cell_line	cell_line
leukemia	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
Thrombopoietin	protein	protein
(	O	O
TPO	protein	protein
)	O	O
acts	O	O
on	O	O
megakaryopoiesis	O	O
and	O	O
erythropoiesis	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo.	O	O
We	O	O
isolated	O	O
a	O	O
novel	O	O
subline,	O	O
UT-7/GMT	cell_line	O
,	O	O
from	O	O
the	O	O
human	cell_line	cell_line
leukemia	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
UT-7/GM	cell_line	cell_line
(N.	O	cell_line
Komatsu,	O	cell_line
et	O	cell_line
al.,	O	cell_line
Blood,	O	cell_line
89:	O	cell_line
4021-4033,	O	cell_line
1997).	O	O
A	O	O
small	O	O
population	O	O
of	O	O
UT-7/GM	cell_line	cell_line
cells	cell_line	cell_line
positively	O	O
stained	O	O
for	O	O
hemoglobin	protein	protein
(	O	O
Hb	protein	protein
)	O	O
after	O	O
a	O	O
7-day	O	O
exposure	O	O
to	O	O
TPO	protein	protein
.	O	O
More	O	O
than	O	O
50%	O	O
of	O	O
TPO	cell_line	protein
-treated	cell_line	O
UT-7/GMT	cell_line	cell_line
cells	cell_line	cell_line
positively	O	O
stained	O	O
for	O	O
Hb	protein	protein
.	O	O
Using	O	O
UT-7/GMT	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
we	O	O
examined	O	O
how	O	O
TPO	protein	protein
promotes	O	O
hemoglobinization	O	O
.	O	O
TPO	protein	protein
induced	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
the	O	O
TPO	protein	protein
receptor	O	protein
but	O	O
not	O	O
the	O	O
erythropoietin	protein	protein
(	protein	O
EPO	protein	protein
)	protein	protein
receptor	protein	protein
.	O	O
There	O	O
was	O	O
no	O	O
competition	O	O
between	O	O
TPO	protein	protein
and	O	O
EPO	protein	protein
for	O	O
binding	O	O
to	O	O
EPO	protein	protein
receptor	protein	protein
.	O	O
These	O	O
findings	O	O
suggest	O	O
that	O	O
TPO	protein	protein
has	O	O
a	O	O
direct	O	O
effect	O	O
on	O	O
hemoglobinization	O	O
via	O	O
a	O	O
specific	O	O
receptor	O	O
on	O	O
UT-7/GMT	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Isoelectric	O	O
focusing	O	O
demonstrated	O	O
that	O	O
TPO	protein	protein
induced	O	O
fetal	O	O
and	O	O
adult	O	O
Hb	O	O
synthesis	O	O
,	O	O
whereas	O	O
EPO	protein	protein
induced	O	O
embryonic	O	O
,	O	O
fetal	O	O
,	O	O
and	O	O
adult	O	O
Hb	O	O
synthesis	O	O
.	O	O
Thus,	O	O
our	O	O
data	O	O
suggest	O	O
that	O	O
TPO	protein	protein
has	O	O
a	O	O
distinct	O	O
action	O	O
on	O	O
erythropoiesis	O	O
.	O	O

Role	O	O
of	O	O
GATA-1	protein	protein
in	O	O
proliferation	O	O
and	O	O
differentiation	O	O
of	O	O
definitive	O	O
erythroid	O	O
and	O	O
megakaryocytic	O	cell_type
cells	O	cell_type
in	O	O
vivo.	O	O
To	O	O
elucidate	O	O
the	O	O
contributions	O	O
of	O	O
GATA-1	protein	protein
to	O	O
definitive	O	O
hematopoiesis	O	O
in	O	O
vivo,	O	O
we	O	O
have	O	O
examined	O	O
adult	O	O
mice	O	O
that	O	O
were	O	O
rendered	O	O
genetically	O	O
defective	O	O
in	O	O
GATA-1	protein	protein
synthesis	O	O
(Takahashi	O	O
et	O	O
al,	O	O
J	O	O
Biol	O	O
Chem	O	O
272:12611,	O	O
1997).	O	O
Because	O	O
the	O	O
GATA-1	DNA	DNA
gene	DNA	DNA
is	O	O
located	O	O
on	O	O
the	O	O
X	DNA	DNA
chromosome	DNA	DNA
,	O	O
which	O	O
is	O	O
randomly	O	O
inactivated	O	O
in	O	O
every	O	O
cell,	O	O
heterozygous	O	O
females	O	O
can	O	O
bear	O	O
either	O	O
an	O	O
active	O	O
wild-type	O	O
or	O	O
mutant	O	O
(referred	O	O
to	O	O
as	O	O
GATA-1.05	DNA	protein
)	O	O
GATA-1	protein	protein
allele,	O	O
consequently	O	O
leading	O	O
to	O	O
variable	O	O
anemic	O	O
severity	O	O
.	O	O
These	O	O
heterozygous	O	O
mutant	O	O
mice	O	O
usually	O	O
developed	O	O
normally,	O	O
but	O	O
they	O	O
began	O	O
to	O	O
die	O	O
after	O	O
5	O	O
months.	O	O
These	O	O
affected	O	O
animals	O	O
displayed	O	O
marked	O	O
splenomegaly	O	O
,	O	O
anemia	O	O
,	O	O
and	O	O
thrombocytopenia	O	O
.	O	O
Proerythroblasts	cell_type	O
and	O	O
megakaryocytes	cell_type	cell_type
massively	O	O
accumulated	O	O
in	O	O
the	O	O
spleens	O	O
of	O	O
the	O	O
heterozygotes	O	O
,	O	O
and	O	O
we	O	O
showed	O	O
that	O	O
the	O	O
neomycin	DNA	O
resistance	DNA	O
gene	DNA	O
(which	O	O
is	O	O
the	O	O
positive	O	O
selection	O	O
marker	O	O
in	O	O
ES	cell_type	cell_type
cells	cell_type	cell_type
)	O	O
was	O	O
expressed	O	O
profusely	O	O
in	O	O
the	O	O
abnormally	O	O
abundant	O	O
cells	O	O
generated	O	O
in	O	O
the	O	O
GATA-1.05	protein	protein
mutant	O	protein
females	O	O
.	O	O
We	O	O
also	O	O
observed	O	O
hematopoiesis	O	O
outside	O	O
of	O	O
the	O	O
bone	O	O
marrow	O	O
in	O	O
the	O	O
affected	O	O
mutant	O	O
mice	O	O
.	O	O
These	O	O
data	O	O
suggest	O	O
that	O	O
a	O	O
small	O	O
number	O	O
of	O	O
GATA-1.05	cell_line	protein
mutant	cell_line	protein
hematopoietic	cell_line	protein
progenitor	cell_line	O
cells	cell_line	O
begin	O	O
to	O	O
proliferate	O	O
vigorously	O	O
during	O	O
early	O	O
adulthood,	O	O
but	O	O
because	O	O
the	O	O
cells	O	O
are	O	O
unable	O	O
to	O	O
terminally	O	O
differentiate,	O	O
this	O	O
leads	O	O
to	O	O
progenitor	O	O
proliferation	O	O
in	O	O
the	O	O
spleen	O	O
and	O	O
consequently	O	O
death.	O	O
Thus,	O	O
GATA-1	protein	protein
plays	O	O
important	O	O
in	O	O
vivo	O	O
roles	O	O
for	O	O
directing	O	O
definitive	O	O
hematopoietic	cell_type	O
progenitors	cell_type	O
to	O	O
differentiate	O	O
along	O	O
both	O	O
the	O	O
erythroid	O	O
and	O	O
megakaryocytic	O	O
pathways	O	O
.	O	O
The	O	O
GATA-1	protein	protein
heterozygous	O	protein
mutant	O	protein
mouse	O	protein
shows	O	O
a	O	O
phenotype	O	O
that	O	O
is	O	O
analogous	O	O
to	O	O
human	O	O
myelodysplastic	O	O
syndrome	O	O
and	O	O
thus	O	O
may	O	O
serve	O	O
as	O	O
a	O	O
useful	O	O
model	O	O
for	O	O
this	O	O
disorder.	O	O

Differential	O	O
regulation	O	O
of	O	O
the	O	O
Janus	protein	protein
kinase	protein	protein
-STAT	protein	protein
pathway	O	O
and	O	O
biologic	O	O
function	O	O
of	O	O
IL-13	protein	protein
in	O	O
primary	O	cell_type
human	O	cell_type
NK	O	cell_type
and	O	O
T	O	cell_type
cells	O	cell_type
:	O	O
a	O	O
comparative	O	O
study	O	O
with	O	O
IL-4	protein	protein
.	O	O
IL-13	protein	protein
,	O	O
a	O	O
cytokine	O	protein
similar	O	O
to	O	O
IL-4	protein	protein
,	O	O
is	O	O
a	O	O
regulator	O	O
of	O	O
human	O	cell_type
B	O	cell_type
cell	O	cell_type
and	O	O
monocyte	O	O
functions	O	O
.	O	O
Biologic	O	O
effects	O	O
of	O	O
IL-13	protein	protein
on	O	O
primary	O	cell_type
human	O	cell_type
NK	O	cell_type
and	O	O
T	O	cell_type
cells	O	cell_type
have	O	O
not	O	O
been	O	O
well	O	O
defined.	O	O
We	O	O
demonstrate	O	O
that,	O	O
in	O	O
primary	cell_type	cell_type
NK	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
IL-13	protein	protein
,	O	O
but	O	O
not	O	O
IL-4	protein	protein
,	O	O
may	O	O
induce	O	O
low	O	O
levels	O	O
of	O	O
IFN-gamma	protein	protein
secretion	O	O
.	O	O
When	O	O
NK	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
costimulated	O	O
with	O	O
IL-13	protein	protein
and	O	O
IL-2	protein	protein
,	O	O
IL-13	protein	protein
generally	O	O
resulted	O	O
in	O	O
two	O	O
types	O	O
of	O	O
reactivity:	O	O
IL-13	protein	protein
synergized	O	O
with	O	O
IL-2	protein	protein
to	O	O
stimulate	O	O
IFN-gamma	protein	protein
production	O	O
or	O	O
it	O	O
modestly	O	O
inhibited	O	O
IL-2	protein	protein
-mediated	O	O
IFN-gamma	protein	protein
production	O	O
.	O	O
In	O	O
both	O	O
types	O	O
of	O	O
donors,	O	O
the	O	O
effect	O	O
of	O	O
IL-13	protein	protein
on	O	O
IL-2	protein	protein
-induced	O	O
IFN-gamma	protein	protein
production	O	O
was	O	O
in	O	O
marked	O	O
contrast	O	O
to	O	O
the	O	O
strong	O	O
inhibition	O	O
seen	O	O
with	O	O
IL-4	protein	protein
in	O	O
NK	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Additionally,	O	O
IL-13	protein	protein
suppresses	O	O
IL-2-induced	O	O
NK	O	O
cytolytic	O	O
and	O	O
proliferative	O	O
activities	O	O
although	O	O
less	O	O
efficiently	O	O
than	O	O
IL-4	protein	protein
.	O	O
In	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
IL-13	protein	protein
inhibits	O	O
anti-CD3	O	protein
mAb/IL-2-	O	protein
or	O	O
PHA-	O	O
mediated	O	O
IFN-gamma	O	protein
production	O	O
and	O	O
enhances	O	O
cytolytic	O	O
potential.	O	O
Furthermore,	O	O
we	O	O
demonstrate	O	O
that	O	O
IL-13	protein	protein
,	O	O
like	O	O
IL-4	protein	protein
,	O	O
induces	O	O
distinct	O	O
STAT6-DNA	protein	protein
binding	protein	protein
complexes	protein	protein
and	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
STAT6	protein	protein
and	O	O
Janus	protein	protein
kinase	protein	protein
3	protein	protein
(	O	O
JAK3	protein	protein
)	O	O
in	O	O
NK	O	O
and	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
We	O	O
observed	O	O
that	O	O
Abs	O	protein
directed	O	O
against	O	O
unique	O	O
domains	O	O
of	O	O
STAT6	protein	protein
have	O	O
differential	O	O
effects	O	O
on	O	O
complexes	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
but	O	O
not	O	O
in	O	O
NK	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
suggesting	O	O
different	O	O
STAT6	protein	protein
isoforms	protein	protein
.	O	O
These	O	O
findings	O	O
show	O	O
that	O	O
IL-13	protein	protein
and	O	O
IL-4	protein	protein
have	O	O
the	O	O
ability	O	O
to	O	O
regulate	O	O
NK	O	O
and	O	O
T	O	O
cell	O	O
activation	O	O
and	O	O
that	O	O
IL-13	protein	protein
is	O	O
a	O	O
potent	O	O
regulator	O	O
of	O	O
STAT6	protein	protein
and	O	O
JAK3	protein	protein
in	O	O
these	O	O
cell	O	O
types.	O	O

The	O	O
human	O	O
toll	O	O
signaling	O	O
pathway	O	O
:	O	O
divergence	O	O
of	O	O
nuclear	protein	protein
factor	protein	protein
kappaB	protein	protein
and	O	O
JNK	protein	protein
/SAPK	protein	protein
activation	O	O
upstream	O	O
of	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
receptor-associated	protein	protein
factor	protein	protein
6	protein	protein
(	O	O
TRAF6	protein	protein
).	O	O
The	O	O
human	O	O
homologue	O	O
of	O	O
Drosophila	protein	protein
Toll	protein	protein
(	O	O
hToll	protein	O
)	O	O
is	O	O
a	O	O
recently	O	O
cloned	O	O
receptor	O	O
of	O	O
the	O	O
interleukin	protein	protein
1	protein	protein
receptor	protein	protein
(	protein	O
IL-1R	protein	protein
)	protein	O
superfamily	protein	O
,	O	O
and	O	O
has	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
activation	O	O
of	O	O
adaptive	O	O
immunity	O	O
.	O	O
Signaling	O	O
by	O	O
hToll	protein	O
is	O	O
shown	O	O
to	O	O
occur	O	O
through	O	O
sequential	O	O
recruitment	O	O
of	O	O
the	O	O
adapter	protein	O
molecule	protein	O
MyD88	protein	O
and	O	O
the	O	O
IL-1R-associated	protein	protein
kinase	protein	protein
.	O	O
Tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
receptor-activated	protein	protein
factor	protein	protein
6	protein	protein
(	O	O
TRAF6	protein	protein
)	O	O
and	O	O
the	O	O
nuclear	protein	protein
factor	protein	protein
kappaB	protein	protein
(	protein	O
NF-kappaB	protein	protein
)-inducing	protein	protein
kinase	protein	protein
(	O	O
NIK	protein	protein
)	O	O
are	O	O
both	O	O
involved	O	O
in	O	O
subsequent	O	O
steps	O	O
of	O	O
NF-kappaB	protein	protein
activation	O	O
.	O	O
Conversely,	O	O
a	O	O
dominant	O	O
negative	O	O
version	O	O
of	O	O
TRAF6	protein	protein
failed	O	O
to	O	O
block	O	O
hToll	protein	O
-induced	O	O
activation	O	O
of	O	O
stress-activated	protein	protein
protein	protein	protein
kinase/c-Jun	protein	protein
NH2-terminal	protein	protein
kinases	protein	protein
,	O	O
thus	O	O
suggesting	O	O
an	O	O
early	O	O
divergence	O	O
of	O	O
the	O	O
two	O	O
pathways.	O	O

Inhibition	O	O
of	O	O
nuclear	protein	protein
factor	protein	protein
kappaB	protein	protein
activation	O	O
attenuates	O	O
apoptosis	O	O
resistance	O	O
in	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Death-inducing	protein	O
ligands	protein	O
(	O	O
DILs	protein	protein
)	O	O
such	O	O
as	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
alpha	protein	protein
(	O	O
TNFalpha	protein	protein
)	O	O
or	O	O
the	O	O
cytotoxic	O	O
drug	O	O
doxorubicin	O	O
have	O	O
been	O	O
shown	O	O
to	O	O
activate	O	O
a	O	O
nuclear	protein	protein
factor	protein	protein
kappaB	protein	protein
(	O	O
NFkappaB	protein	protein
)-dependent	O	O
program	O	O
that	O	O
may	O	O
rescue	O	O
cells	O	O
from	O	O
apoptosis	O	O
induction.	O	O
We	O	O
demonstrate	O	O
here	O	O
that	O	O
TRAIL	protein	protein
(	O	O
TNF-related	protein	O
apoptosis	protein	O
-inducing	protein	O
ligand	protein	O
),	O	O
a	O	O
recently	O	O
identified	O	O
DIL	protein	O
,	O	O
also	O	O
activates	O	O
NFkappaB	protein	protein
in	O	O
lymphoid	O	cell_line
cell	O	cell_line
lines	O	cell_line
in	O	O
a	O	O
kinetic	O	O
similar	O	O
to	O	O
TNFalpha	protein	protein
.	O	O
NFkappaB	protein	protein
activity	O	O
is	O	O
independent	O	O
from	O	O
FADD	protein	O
,	O	O
caspases	protein	protein
,	O	O
and	O	O
apoptosis	O	O
induction	O	O
.	O	O
To	O	O
study	O	O
the	O	O
influence	O	O
of	O	O
NFkappaB	protein	protein
activity	O	O
on	O	O
apoptosis	O	O
mediated	O	O
by	O	O
TRAIL	protein	protein
,	O	O
CD95,	O	protein
TNFalpha	protein	protein
,	O	O
or	O	O
doxorubicin	O	O
,	O	O
NFkappaB	protein	protein
activation	O	O
was	O	O
inhibited	O	O
using	O	O
the	O	O
proteasome	protein	protein
inhibitor	O	O
N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal	O	O
or	O	O
transient	O	O
overexpression	O	O
of	O	O
mutant	protein	protein
IkappaBalpha	protein	protein
.	O	O
Sensitivity	O	O
for	O	O
induction	O	O
of	O	O
apoptosis	O	O
was	O	O
markedly	O	O
increased	O	O
by	O	O
these	O	O
treatments	O	O
in	O	O
apoptosis	O	O
sensitive	O	O
cell	cell_line	O
lines	cell_line	O
.	O	O
Moreover,	O	O
both	O	O
in	O	O
cell	O	O
lines	O	O
and	O	O
in	O	O
primary	O	cell_type
leukemia	O	cell_type
cells	O	cell_type
that	O	O
are	O	O
resistant	O	O
towards	O	O
induction	O	O
of	O	O
apoptosis	O	O
by	O	O
DILs	protein	O
and	O	O
doxorubicin	O	O
,	O	O
antagonization	O	O
of	O	O
NFkappaB	protein	protein
activity	O	O
partially	O	O
restored	O	O
apoptosis	O	O
sensitivity	O	O
.	O	O
These	O	O
data	O	O
suggest	O	O
that	O	O
inhibition	O	O
of	O	O
NFkappaB	protein	protein
activation	O	O
may	O	O
provide	O	O
a	O	O
molecular	O	O
approach	O	O
to	O	O
increase	O	O
apoptosis	O	O
sensitivity	O	O
in	O	O
anticancer	O	O
treatment	O	O
.	O	O

Loss-	O	O
and	O	O
gain-of-function	O	O
mutations	O	O
reveal	O	O
an	O	O
important	O	O
role	O	O
of	O	O
BSAP	protein	protein
(	O	O
Pax-5	protein	protein
)	O	O
at	O	O
the	O	O
start	O	O
and	O	O
end	O	O
of	O	O
B	O	O
cell	O	O
differentiation	O	O
.	O	O
Pax-5	protein	protein
codes	O	O
for	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
BSAP	protein	protein
which	O	O
is	O	O
expressed	O	O
throughout	O	O
B	O	O
cell	O	O
development	O	O
except	O	O
in	O	O
terminally	cell_type	O
differentiated	cell_type	O
plasma	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Gene	O	O
targeting	O	O
experiments	O	O
in	O	O
the	O	O
mouse	O	O
revealed	O	O
a	O	O
differential	O	O
dependency	O	O
of	O	O
fetal	O	O
and	O	O
adult	O	O
B-lymphopoiesis	O	O
on	O	O
this	O	O
transcription	protein	O
factor	protein	O
.	O	O
BSAP	protein	protein
is	O	O
required	O	O
for	O	O
B-lineage	O	O
commitment	O	O
in	O	O
the	O	O
fetal	O	O
liver	O	O
and	O	O
for	O	O
progression	O	O
beyond	O	O
an	O	O
early	O	O
pro-B	O	O
cell	O	O
stage	O	O
in	O	O
adult	O	O
bone	O	O
marrow	O	O
.	O	O
The	O	O
characterization	O	O
of	O	O
Pax-5	cell_type	protein
-deficient	cell_type	O
pro-B	cell_type	cell_type
cells	cell_type	cell_type
demonstrated	O	O
an	O	O
important	O	O
role	O	O
of	O	O
BSAP	protein	protein
in	O	O
the	O	O
regulation	O	O
of	O	O
the	O	O
CD19	protein	protein
,	O	O
mb-1	protein	O
(	O	O
Ig	protein	protein
alpha	protein	protein
)	O	O
and	O	O
N-myc	DNA	DNA
genes	DNA	DNA
as	O	O
well	O	O
as	O	O
in	O	O
the	O	O
developmental	O	O
pathway	O	O
controlling	O	O
VH-to-DHJH	O	O
recombination	O	O
at	O	O
the	O	O
immunoglobulin	protein	DNA
heavy-chain	protein	DNA
(	protein	DNA
IgH	protein	DNA
)	protein	DNA
locus	protein	DNA
.	O	O
The	O	O
human	DNA	DNA
PAX-5	DNA	DNA
gene	DNA	DNA
was	O	O
recently	O	O
shown	O	O
to	O	O
participate	O	O
together	O	O
with	O	O
the	O	O
IgH	DNA	DNA
locus	DNA	DNA
in	O	O
the	O	O
chromosomal	O	O
translocation	O	O
t(9;14)(p13;q32)	DNA	O
.	O	O
This	O	O
translocation	O	O
is	O	O
characteristic	O	O
of	O	O
a	O	O
small	O	O
subset	O	O
of	O	O
non-Hodgkin	O	O
lymphomas	O	O
exhibiting	O	O
plasmacytoid	O	O
differentiation	O	O
.	O	O
The	O	O
translocated	DNA	O
PAX-5	DNA	DNA
gene	DNA	DNA
is	O	O
deregulated	O	O
by	O	O
the	O	O
insertion	O	O
of	O	O
IgH	DNA	DNA
regulatory	DNA	DNA
elements	DNA	DNA
into	O	O
its	O	O
5'	DNA	DNA
region	DNA	DNA
,	O	O
which	O	O
may	O	O
contribute	O	O
to	O	O
tumorigenesis	O	O
by	O	O
interfering	O	O
with	O	O
the	O	O
shut-down	O	O
of	O	O
PAX-5	protein	protein
transcription	O	O
and	O	O
thus	O	O
with	O	O
the	O	O
completion	O	O
of	O	O
plasma	cell_type	O
cell	cell_type	O
differentiation	O	O

Acetylation	O	O
and	O	O
modulation	O	O
of	O	O
erythroid	protein	protein
Kruppel-like	protein	protein
factor	protein	protein
(	O	O
EKLF	protein	protein
)	O	O
activity	O	O
by	O	O
interaction	O	O
with	O	O
histone	protein	protein
acetyltransferases	protein	protein
.	O	O
Erythroid	protein	protein
Kruppel-like	protein	protein
factor	protein	protein
(	O	O
EKLF	protein	protein
)	O	O
is	O	O
a	O	O
red	protein	O
cell-specific	protein	O
transcriptional	protein	O
activator	protein	O
that	O	O
is	O	O
crucial	O	O
for	O	O
consolidating	O	O
the	O	O
switch	O	O
to	O	O
high	O	O
levels	O	O
of	O	O
adult	O	O
beta-globin	protein	O
expression	O	O
during	O	O
erythroid	O	O
ontogeny	O	O
.	O	O
EKLF	protein	protein
is	O	O
required	O	O
for	O	O
integrity	O	O
of	O	O
the	O	O
chromatin	DNA	DNA
structure	DNA	DNA
at	O	O
the	O	O
beta-like	DNA	DNA
globin	DNA	DNA
locus	DNA	DNA
,	O	O
and	O	O
it	O	O
interacts	O	O
with	O	O
a	O	O
positive-acting	protein	protein
factor	protein	protein
in	O	O
vivo.	O	O
We	O	O
find	O	O
that	O	O
EKLF	protein	protein
is	O	O
an	O	O
acetylated	protein	protein
transcription	protein	protein
factor	protein	protein
,	O	O
and	O	O
that	O	O
it	O	O
interacts	O	O
in	O	O
vivo	O	O
with	O	O
CBP	protein	protein
,	O	O
p300	protein	protein
,	O	O
and	O	O
P/CAF	protein	protein
.	O	O
However,	O	O
its	O	O
interactions	O	O
with	O	O
these	O	O
histone	protein	protein
acetyltransferases	protein	protein
are	O	O
not	O	O
equivalent,	O	O
as	O	O
CBP	protein	protein
and	O	O
p300	protein	protein
,	O	O
but	O	O
not	O	O
P/CAF	protein	protein
,	O	O
utilize	O	O
EKLF	protein	protein
as	O	O
a	O	O
substrate	O	O
for	O	O
in	O	O
vitro	O	O
acetylation	O	O
within	O	O
its	O	O
trans-	O	O
activation	protein	O
region	protein	O
.	O	O
The	O	O
functional	O	O
effects	O	O
of	O	O
these	O	O
interactions	O	O
are	O	O
that	O	O
CBP	protein	protein
and	O	O
p300	protein	protein
,	O	O
but	O	O
not	O	O
P/CAF	protein	protein
,	O	O
enhance	O	O
EKLF	protein	protein
's	O	O
transcriptional	O	O
activation	O	O
of	O	O
the	O	O
beta-globin	DNA	DNA
promoter	DNA	DNA
in	O	O
erythroid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
These	O	O
results	O	O
establish	O	O
EKLF	protein	protein
as	O	O
a	O	O
tissue-specific	protein	protein
transcription	protein	protein
factor	protein	protein
that	O	O
undergoes	O	O
post-translational	O	O
acetylation	O	O
and	O	O
suggest	O	O
a	O	O
mechanism	O	O
by	O	O
which	O	O
EKLF	protein	protein
is	O	O
able	O	O
to	O	O
alter	O	O
chromatin	DNA	DNA
structure	O	O
and	O	O
induce	O	O
beta-globin	protein	protein
expression	O	O
within	O	O
the	O	O
beta-like	DNA	DNA
globin	DNA	DNA
cluster	DNA	DNA
.	O	O

Recognition	O	O
of	O	O
herpes	protein	protein
simplex	protein	protein
virus	protein	protein
type	protein	protein
2	protein	protein
tegument	protein	protein
proteins	protein	protein
by	O	O
CD4	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
infiltrating	O	O
human	O	O
genital	O	O
herpes	O	O
lesions	O	O
.	O	O
The	O	O
local	O	O
cellular	O	O
immune	O	O
response	O	O
to	O	O
herpes	O	O
simplex	O	O
virus	O	O
(	O	O
HSV	O	O
)	O	O
is	O	O
important	O	O
in	O	O
the	O	O
control	O	O
of	O	O
recurrent	O	O
HSV	O	O
infection	O	O
.	O	O
The	O	O
antiviral	O	O
functions	O	O
of	O	O
infiltrating	cell_type	O
CD4-bearing	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
may	O	O
include	O	O
cytotoxicity	O	O
,	O	O
inhibition	O	O
of	O	O
viral	O	O
growth	O	O
,	O	O
lymphokine	protein	protein
secretion	O	O
,	O	O
and	O	O
support	O	O
of	O	O
humoral	O	O
and	O	O
CD8	O	protein
responses	O	O
.	O	O
The	O	O
antigens	O	O
recognized	O	O
by	O	O
many	O	O
HSV	cell_type	O
-specific	cell_type	O
CD4	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
localizing	O	O
to	O	O
genital	O	O
HSV	O	O
-2	O	O
lesions	O	O
are	O	O
unknown.	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
recognizing	O	O
antigens	O	O
encoded	O	O
within	O	O
map	O	O
units	O	O
0.67	O	O
to	O	O
0.73	O	O
of	O	O
HSV	DNA	O
DNA	DNA	O
are	O	O
frequently	O	O
recovered	O	O
from	O	O
herpetic	O	O
lesions	O	O
.	O	O
Expression	O	O
cloning	O	O
with	O	O
this	O	O
region	O	O
of	O	O
DNA	O	DNA
now	O	DNA
shows	O	O
that	O	O
tegument	protein	O
protein	protein	O
VP22	protein	O
and	O	O
the	O	O
viral	protein	O
dUTPase	protein	protein
,	O	O
encoded	O	O
by	O	O
genes	O	O
UL49	DNA	O
and	O	O
UL50	DNA	O
,	O	O
respectively,	O	O
are	O	O
T-cell	protein	O
antigens	protein	O
.	O	O
Separate	O	O
epitopes	protein	protein
in	O	O
VP22	protein	O
were	O	O
defined	O	O
for	O	O
T-cell	cell_line	O
clones	cell_line	O
from	O	O
each	O	O
of	O	O
three	O	O
patients	O	O
.	O	O
Reactivity	O	O
with	O	O
the	O	O
tegument	protein	O
protein	protein	O
encoded	O	O
by	O	O
UL21	DNA	protein
was	O	O
identified	O	O
for	O	O
an	O	O
additional	O	O
patient.	O	O
Three	O	O
new	O	O
epitopes	O	protein
were	O	O
identified	O	O
in	O	O
VP16	protein	protein
,	O	O
a	O	O
tegument	protein	O
protein	protein	O
associated	O	O
with	O	O
VP22	protein	protein
.	O	O
Some	O	O
tegument-specific	cell_line	O
CD4	cell_line	protein
T-cell	cell_line	protein
clones	cell_line	protein
exhibited	O	O
cytotoxic	O	O
activity	O	O
against	O	O
HSV	cell_type	cell_line
-infected	cell_type	cell_line
cells	cell_type	cell_line
.	O	O
These	O	O
results	O	O
suggest	O	O
that	O	O
herpes	protein	protein
simplex	protein	protein
tegument	protein	protein
proteins	protein	protein
are	O	O
processed	O	O
for	O	O
antigen	O	O
presentation	O	O
in	O	O
vivo	O	O
and	O	O
are	O	O
possible	O	O
candidate	O	O
compounds	O	O
for	O	O
herpes	O	O
simplex	O	O
vaccines	O	O
.	O	O

Fibrinogen	protein	O
activates	O	O
NF-kappa	protein	protein
B	protein	protein
transcription	protein	protein
factors	protein	protein
in	O	O
mononuclear	cell_type	cell_type
phagocytes	cell_type	cell_type
.	O	O
Adhesion	O	O
to	O	O
extracellular	O	O
matrices	O	O
is	O	O
known	O	O
to	O	O
modulate	O	O
leukocyte	O	O
activation	O	O
,	O	O
although	O	O
the	O	O
mechanisms	O	O
are	O	O
not	O	O
fully	O	O
understood.	O	O
Mononuclear	cell_type	O
phagocytes	cell_type	O
are	O	O
exposed	O	O
to	O	O
fibrinous	O	O
provisional	O	O
matrix	O	O
throughout	O	O
migration	O	O
into	O	O
inflammatory	O	O
foci,	O	O
so	O	O
this	O	O
study	O	O
was	O	O
undertaken	O	O
to	O	O
determine	O	O
whether	O	O
fibrinogen	O	protein
triggers	O	O
activation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
transcription	protein	protein
factors	protein	protein
.	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
differentiated	O	O
with	O	O
PMA	O	O
in	O	O
nonadherent	cell_line	O
culture	cell_line	O
were	O	O
shown	O	O
to	O	O
express	O	O
two	O	O
fibrinogen-binding	protein	protein
integrins	protein	protein
,	O	O
predominately	O	O
CD11b/CD18	protein	protein
,	O	O
and	O	O
to	O	O
a	O	O
lesser	O	O
extent,	O	O
CD11c/CD18	protein	protein
.	O	O
Cells	O	O
stimulated	O	O
with	O	O
fibrinogen	protein	protein
(10-100	O	protein
microg/ml)/Mn2+	O	protein
(50	O	protein
microM)	O	protein
for	O	O
2	O	O
h	O	O
were	O	O
examined	O	O
by	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assay	O	O
.	O	O
NF-kappa	protein	protein
B	protein	protein
activation	O	O
,	O	O
minimal	O	O
in	O	O
unstimulated	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
was	O	O
substantially	O	O
up-regulated	O	O
by	O	O
fibrinogen	protein	protein
.	O	O
Fibrinogen	protein	O
also	O	O
caused	O	O
activation	O	O
of	O	O
AP-1	protein	protein
,	O	O
but	O	O
not	O	O
SP1	protein	protein
or	O	O
cAMP	protein	O
response	protein	O
element-binding	protein	O
protein	protein	O
(CREB)	protein	protein
factors	protein	protein
.	O	O
Blocking	O	O
mAbs	protein	protein
against	O	O
CD18	protein	protein
and	O	O
CD11b	protein	protein
abrogated	O	O
fibrinogen	protein	protein
-induced	O	O
NF-kappa	protein	protein
B	protein	protein
activation	O	O
.	O	O
To	O	O
determine	O	O
the	O	O
effects	O	O
on	O	O
transcriptional	O	O
regulation	O	O
,	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
were	O	O
transfected	O	O
with	O	O
a	O	O
plasmid	O	DNA
containing	O	O
the	O	O
HIV-1	DNA	DNA
enhancer	DNA	DNA
(bearing	O	O
two	O	O
NF-kappa	DNA	DNA
B	DNA	DNA
sites	DNA	DNA
)	O	O
coupled	O	O
to	O	O
a	O	O
chloramphenicol	DNA	DNA
acetyltransferase	DNA	DNA
(	DNA	DNA
CAT	DNA	DNA
)	DNA	DNA
reporter	DNA	DNA
.	O	O
Cells	O	O
were	O	O
subsequently	O	O
stimulated	O	O
with	O	O
1)	O	O
PMA	O	O
for	O	O
24	O	O
h,	O	O
inducing	O	O
CAT	protein	protein
activity	O	O
by	O	O
2.6-fold,	O	O
2)	O	O
fibrinogen	protein	O
/Mn2+	O	O
for	O	O
2	O	O
h,	O	O
inducing	O	O
CAT	protein	protein
activity	O	O
by	O	O
3.2-fold,	O	O
or	O	O
3)	O	O
costimulation	O	O
with	O	O
fibrinogen	protein	O
and	O	O
PMA	O	O
,	O	O
inducing	O	O
5.7-fold	O	O
the	O	O
CAT	protein	protein
activity	O	O
induced	O	O
by	O	O
PMA	O	O
alone.	O	O
We	O	O
conclude	O	O
that	O	O
contact	O	O
with	O	O
fibrinogen	protein	protein
-derived	protein	protein
proteins	protein	protein
may	O	O
contribute	O	O
to	O	O
mononuclear	O	O
phagocyte	O	O
activation	O	O
by	O	O
signaling	O	O
through	O	O
CD11b/CD18	protein	protein
,	O	O
resulting	O	O
in	O	O
selective	O	O
activation	O	O
of	O	O
transcriptional	protein	protein
regulatory	protein	protein
factors	protein	protein
,	O	O
including	O	O
NF-kappa	protein	protein
B	protein	protein
.	O	O

Peripheral	cell_type	cell_type
blood	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
monocytes	cell_type	cell_type
and	O	O
B	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
derived	O	O
from	O	O
patients	O	O
with	O	O
lupus	O	O
express	O	O
estrogen	O	protein
receptor	O	protein
transcripts	O	O
similar	O	O
to	O	O
those	O	O
of	O	O
normal	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
OBJECTIVE:	O	O
To	O	O
identify	O	O
and	O	O
characterize	O	O
estrogen	RNA	O
receptor	RNA	O
(ER)	RNA	O
transcripts	RNA	O
expressed	O	O
in	O	O
immune	cell_type	O
cells	cell_type	O
of	O	O
patients	O	O
with	O	O
systemic	O	O
lupus	O	O
erythematosus	O	O
(	O	O
SLE	O	O
)	O	O
and	O	O
healthy	O	O
donors	O	O
.	O	O
METHODS:	O	O
Peripheral	cell_type	cell_type
blood	cell_type	cell_type
monocytes	cell_type	cell_type
and	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
prepared	O	O
from	O	O
patients	O	O
with	O	O
SLE	O	O
(n	O	O
=	O	O
6)	O	O
and	O	O
healthy	O	O
donors	O	O
(n	O	O
=	O	O
8).	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
separated	O	O
into	O	O
CD4	cell_type	protein
and	O	O
CD8	cell_type	protein
.	O	O
Some	O	O
monocytes	cell_type	cell_type
and	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
stimulated	O	O
with	O	O
estradiol,	O	O
PMA	O	O
,	O	O
and	O	O
ionomycin	O	O
.	O	O
Epstein-Barr	O	O
virus-transformed	O	cell_line
B	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
(n	O	O
=	O	O
7)	O	O
and	O	O
B	cell_line	O
cell	cell_line	O
hybridomas	cell_line	O
(n	O	O
=	O	O
2)	O	O
established	O	O
from	O	O
patients	O	O
with	O	O
SLE	O	O
and	O	O
a	O	O
healthy	O	O
individual	O	O
were	O	O
used	O	O
as	O	O
a	O	O
B	O	O
cell	O	O
source	O	O
.	O	O
These	O	O
cells	O	O
were	O	O
examined	O	O
for	O	O
ER	RNA	RNA
mRNA	RNA	RNA
by	O	O
reverse	O	O
transcription	O	O
nested	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O
Amplified	O	O
cDNA	DNA	O
were	O	O
sequenced	O	O
by	O	O
standard	O	O
methods.	O	O
RESULTS:	O	O
In	O	O
all	O	O
cells	O	O
tested,	O	O
ER	RNA	RNA
mRNA	RNA	RNA
was	O	O
expressed	O	O
without	O	O
prior	O	O
in	O	O
vitro	O	O
stimulation.	O	O
Partial	O	O
sequences	O	O
from	O	O
exons	DNA	DNA
1-8	DNA	DNA
were	O	O
nearly	O	O
identical	O	O
to	O	O
the	O	O
published	O	O
sequence	O	O
of	O	O
the	O	O
human	RNA	O
ER	RNA	RNA
mRNA	RNA	RNA
.	O	O
There	O	O
were	O	O
no	O	O
notable	O	O
differences	O	O
in	O	O
the	O	O
ER	RNA	protein
transcripts	RNA	O
between	O	O
patients	O	O
and	O	O
healthy	O	O
controls	O	O
.	O	O
Variant	O	O
receptor	O	O
transcripts	O	O
lacking	O	O
exon	DNA	RNA
5	DNA	RNA
or	O	O
exon	DNA	RNA
7	DNA	RNA
,	O	O
which	O	O
encodes	O	O
the	O	O
hormone	O	O
binding	O	O
domain,	O	O
were	O	O
identified	O	O
in	O	O
the	O	O
majority	O	O
of	O	O
the	O	O
cells.	O	O
Precise	O	O
deletion	O	O
of	O	O
the	O	O
exons	O	DNA
suggests	O	O
that	O	O
they	O	O
are	O	O
alternatively	O	O
spliced	O	O
transcripts	O	O
.	O	O
Whether	O	O
the	O	O
detected	O	O
transcripts	O	O
are	O	O
translated	O	O
into	O	O
functional	O	protein
receptor	O	protein
proteins	O	protein
remains	O	O
to	O	O
be	O	O
determined.	O	O
In	O	O
vitro	O	O
stimulation	O	O
did	O	O
not	O	O
affect	O	O
ER	RNA	RNA
mRNA	RNA	RNA
expression	O	O
.	O	O
The	O	O
presence	O	O
of	O	O
variants	O	O
did	O	O
not	O	O
correlate	O	O
with	O	O
disease	O	O
activity	O	O
or	O	O
medication.	O	O
CONCLUSION:	O	O
Monocytes	cell_type	cell_type
,	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
and	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
patients	O	O
express	O	O
transcripts	O	O
of	O	O
the	O	O
normal	O	O
wild	protein	O
type	protein	O
ER	protein	O
and	O	O
the	O	O
hormone	protein	O
binding	protein	protein
domain	protein	protein
variants	protein	O
in	O	O
vivo.	O	O

DNA	O	O
damaging	O	O
agents	O	O
induce	O	O
expression	O	O
of	O	O
Fas	protein	protein
ligand	protein	protein
and	O	O
subsequent	O	O
apoptosis	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
via	O	O
the	O	O
activation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
and	O	O
AP-1	protein	protein
.	O	O
Apoptosis	O	O
induced	O	O
by	O	O
DNA	O	O
damage	O	O
and	O	O
other	O	O
stresses	O	O
can	O	O
proceed	O	O
via	O	O
expression	O	O
of	O	O
Fas	protein	protein
ligand	protein	protein
(	O	O
FasL	protein	protein
)	O	O
and	O	O
ligation	O	O
of	O	O
its	O	O
receptor,	O	O
Fas	O	protein
(CD95).	O	O
We	O	O
report	O	O
that	O	O
activation	O	O
of	O	O
the	O	O
two	O	O
transcription	O	protein
factors	O	protein
NF-kappa	O	protein
B	O	protein
and	O	O
AP-1	protein	protein
is	O	O
crucially	O	O
involved	O	O
in	O	O
FasL	protein	protein
expression	O	O
induced	O	O
by	O	O
etoposide	O	O
,	O	O
teniposide	O	O
,	O	O
and	O	O
UV	O	O
irradiation	O	O
.	O	O
A	O	O
nondegradable	O	O
mutant	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
blocked	O	O
both	O	O
FasL	protein	protein
expression	O	O
and	O	O
apoptosis	O	O
induced	O	O
by	O	O
DNA	O	O
damage	O	O
but	O	O
not	O	O
Fas	protein	protein
ligation	O	O
.	O	O
These	O	O
stimuli	O	O
also	O	O
induced	O	O
the	O	O
stress-activated	O	protein
kinase	O	protein
pathway	O	O
(	O	O
SAPK	protein	protein
/JNK	protein	protein
),	O	O
which	O	O
was	O	O
required	O	O
for	O	O
the	O	O
maximal	O	O
induction	O	O
of	O	O
apoptosis	O	O
.	O	O
A	O	O
1.2	O	O
kb	O	O
FasL	DNA	DNA
promoter	DNA	DNA
responded	O	O
to	O	O
DNA	O	O
damage	O	O
,	O	O
as	O	O
well	O	O
as	O	O
coexpression	O	O
with	O	O
p65	protein	protein
Rel	protein	protein
or	O	O
Fos/Jun	protein	O
.	O	O
Mutations	O	O
in	O	O
the	O	O
relevant	O	O
NF-kappa	protein	protein
B	protein	protein
and	O	O
AP-1	DNA	protein
binding	DNA	O
sites	DNA	O
eliminated	O	O
these	O	O
responses.	O	O
Thus,	O	O
activation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
and	O	O
AP-1	protein	protein
contributes	O	O
to	O	O
stress-induced	O	O
apoptosis	O	O
via	O	O
the	O	O
expression	O	O
of	O	O
FasL	protein	protein
.	O	O

A	O	O
small,	O	O
nonpeptidyl	O	O
mimic	O	O
of	O	O
granulocyte-colony-stimulating	protein	protein
factor	protein	protein
[see	O	O
commetns]	O	O
A	O	O
nonpeptidyl	O	O
small	O	O
molecule	O	O
SB	O	O
247464	O	O
,	O	O
capable	O	O
of	O	O
activating	O	O
granulocyte-colony-stimulating	protein	protein
factor	protein	protein
(	O	O
G-CSF	protein	protein
)	O	O
signal	O	O
transduction	O	O
pathways	O	O
,	O	O
was	O	O
identified	O	O
in	O	O
a	O	O
high-throughput	O	O
assay	O	O
in	O	O
cultured	cell_type	cell_line
cells	cell_type	cell_line
.	O	O
Like	O	O
G-CSF	protein	protein
,	O	O
SB	O	O
247464	O	O
induced	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
multiple	protein	protein
signaling	protein	protein
proteins	protein	protein
and	O	O
stimulated	O	O
primary	cell_type	O
murine	cell_type	O
bone	cell_type	O
marrow	cell_type	O
cells	cell_type	O
to	O	O
form	O	O
granulocytic	cell_type	O
colonies	cell_type	O
in	O	O
vitro.	O	O
It	O	O
also	O	O
elevated	O	O
peripheral	cell_type	O
blood	cell_type	O
neutrophil	cell_type	cell_type
counts	O	O
in	O	O
mice.	O	O
The	O	O
extracellular	O	protein
domain	O	protein
of	O	O
the	O	O
murine	protein	protein
G-CSF	protein	protein
receptor	protein	protein
was	O	O
required	O	O
for	O	O
the	O	O
activity	O	O
of	O	O
SB	O	O
247464	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
compound	O	O
acts	O	O
by	O	O
oligomerizing	protein	O
receptor	protein	O
chains	protein	O
.	O	O
The	O	O
results	O	O
indicate	O	O
that	O	O
a	O	O
small	O	protein
molecule	O	protein
can	O	O
activate	O	O
a	O	O
receptor	O	O
that	O	O
normally	O	O
binds	O	O
a	O	O
relatively	O	O
large	O	O
protein	O	O
ligand.	O	O

Minimal	O	O
residual	O	O
disease	O	O
in	O	O
acute	O	O
myelogenous	O	O
leukemia	O	O
with	O	O
PML/RAR	protein	protein
alpha	protein	protein
or	O	O
AML1/ETO	protein	RNA
mRNA	O	RNA
and	O	O
phenotypic	O	O
analysis	O	O
of	O	O
possible	O	O
T	O	O
and	O	O
natural	O	cell_type
killer	O	cell_type
cells	O	cell_type
in	O	O
bone	O	O
marrow	O	O
.	O	O
Here	O	O
we	O	O
studied	O	O
minimal	O	O
residual	O	O
disease	O	O
(	O	O
MRD	O	O
)	O	O
of	O	O
patients	O	O
with	O	O
acute	O	O
myeloid	O	O
leukemia	O	O
(	O	O
AML	O	O
)	O	O
who	O	O
have	O	O
PML/RAR	protein	protein
alpha	protein	protein
or	O	O
AML1/ETO	protein	protein
as	O	O
well	O	O
as	O	O
the	O	O
phenotypic	O	O
analysis	O	O
of	O	O
lymphocyte	cell_type	O
subsets	cell_type	O
involved	O	O
in	O	O
antitumor	O	O
immunity	O	O
.	O	O
Eight	O	O
patients	O	O
in	O	O
long-term	O	O
(LT;	O	O
3	O	O
to	O	O
15	O	O
years)	O	O
and	O	O
15	O	O
patients	O	O
in	O	O
short-term	O	O
(ST;	O	O
up	O	O
to	O	O
3	O	O
years)	O	O
remission	O	O
were	O	O
studied.	O	O
Using	O	O
the	O	O
reverse	O	O
transcription-polymerase	O	O
chain	O	O
reaction	O	O
(RT)	O	O
assay	O	O
,	O	O
the	O	O
limit	O	O
of	O	O
detection	O	O
was	O	O
10(-5)	O	O
to	O	O
10(-6)	O	O
for	O	O
PML/RAR	RNA	protein
alpha	RNA	protein
transcript	RNA	O
and	O	O
10(-4)	O	O
to	O	O
10(-5)	O	O
for	O	O
the	O	O
AML1/ETO	RNA	DNA
transcript	RNA	DNA
.	O	O
Simultaneously,	O	O
T	cell_type	O
lymphocyte	cell_type	O
subsets	cell_type	O
and	O	O
NK	cell_type	cell_type
cells	cell_type	cell_type
from	O	O
the	O	O
peripheral	O	O
blood	O	O
(	O	O
PB	O	cell_type
)	O	O
and	O	O
bone	O	O
marrow	O	O
(	O	O
BM	O	O
)	O	O
were	O	O
investigated	O	O
by	O	O
flow	O	O
cytometric	O	O
analysis	O	O
.	O	O
Four	O	O
of	O	O
the	O	O
eight	O	O
patients	O	O
in	O	O
LT	O	O
and	O	O
7	O	O
of	O	O
the	O	O
15	O	O
patients	O	O
in	O	O
ST	O	O
remission	O	O
were	O	O
MRD	O	O
-positive	O	O
.	O	O
Although	O	O
all	O	O
MRD	O	O
-positive	O	O
patients	O	O
in	O	O
LT	O	O
remission	O	O
are	O	O
still	O	O
until	O	O
now	O	O
event-free,	O	O
3	O	O
of	O	O
the	O	O
7	O	O
MRD	O	O
-positive	O	O
(	O	O
MRD	O	O
+)	O	O
patients	O	O
in	O	O
ST	O	O
remission	O	O
soon	O	O
relapsed.	O	O
The	O	O
total	O	O
populations	O	O
of	O	O
CD4	protein	protein
+,	O	O
CD8	protein	protein
+	O	O
and	O	O
CD56	protein	O
+	O	O
[	O	O
possible	O	O
T-cell	cell_type	O
and	O	O
natural	cell_type	O
killer	cell_type	O
(	O	O
T/NK	cell_type	O
)	O	O
populations	O	O
]	O	O
in	O	O
the	O	O
BM	O	O
of	O	O
ST	O	O
patients	O	O
and	O	O
MRD	O	O
+/LT	O	O
patients	O	O
were	O	O
significantly	O	O
(p	O	O
&lt;	O	O
.01)	O	O
low.	O	O
The	O	O
CD8	protein	protein
+	O	O
CD28	protein	protein
+	O	O
population	O	O
showed	O	O
the	O	O
same	O	O
tendency	O	O
(p	O	O
&lt;	O	O
.01-.02).	O	O
The	O	O
T/NK	cell_type	O
subsets	cell_type	O
in	O	O
the	O	O
BM	O	O
of	O	O
MRD	O	O
-negative	O	O
(	O	O
MRD	O	O
-)	O	O
LT	O	O
(	O	O
MRD	O	O
-/LT)	O	O
patients	O	O
showed	O	O
similar	O	O
numbers	O	O
of	O	O
cells	O	O
as	O	O
normal	O	O
volunteers.	O	O
Basically,	O	O
the	O	O
total	O	O
percentage	O	O
of	O	O
the	O	O
CD4	protein	protein
+	O	O
,	O	O
CD8	protein	protein
+	O	O
and	O	O
CD56	protein	O
+	O	O
cell	O	O
populations	O	O
in	O	O
the	O	O
BM	O	O
was	O	O
increased	O	O
and	O	O
in	O	O
the	O	O
following	O	O
order:	O	O
MRD	O	O
-/LT	O	O
patients	O	O
,	O	O
normal	O	O
volunteers,	O	O
MRD	O	O
+/LT	O	O
patients	O	O
and	O	O
MRD	O	O
+	O	O
or	O	O
-/ST	O	O
patients	O	O
.	O	O
The	O	O
percentages	O	O
of	O	O
the	O	O
T/NK-cell	cell_type	O
subsets	cell_type	O
in	O	O
the	O	O
PB	O	cell_type
were	O	O
not	O	O
significantly	O	O
different	O	O
among	O	O
these	O	O
groups.	O	O
Thus,	O	O
the	O	O
difference	O	O
of	O	O
the	O	O
possible	O	O
T/NK-cell	cell_type	O
phenotype	O	O
in	O	O
the	O	O
BM	O	O
may	O	O
strongly	O	O
influence	O	O
clinical	O	O
and	O	O
molecular	O	O
remission	O	O
.	O	O
These	O	O
results	O	O
still	O	O
remain	O	O
to	O	O
be	O	O
confirmed	O	O
by	O	O
further	O	O
studies	O	O
of	O	O
the	O	O
functional	O	O
anti-tumor	O	O
immunity	O	O
of	O	O
T/NK	cell_type	cell_type
cells	cell_type	cell_type
of	O	O
AML	O	O
in	O	O
remission	O	O
.	O	O

Mycobacterium	O	O
tuberculosis	O	O
mannose-capped	O	O
lipoarabinomannan	O	O
can	O	O
induce	O	O
NF-kappaB	protein	protein
-dependent	O	O
activation	O	O
of	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
type	O	O
1	O	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Tuberculosis	O	O
has	O	O
emerged	O	O
as	O	O
an	O	O
epidemic,	O	O
extended	O	O
by	O	O
the	O	O
large	O	O
number	O	O
of	O	O
individuals	O	O
infected	O	O
with	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
type	O	O
1	O	O
(	O	O
HIV-1	O	O
).	O	O
The	O	O
major	O	O
goal	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
whether	O	O
the	O	O
mycobacterial	cell_type	O
cell	cell_type	O
wall	O	O
component	O	O
mannose-capped	O	O
lipoarabinomannan	O	O
(	O	O
ManLAM	O	protein
)	O	O
of	O	O
Mycobacterium	O	O
tuberculosis	O	O
(	O	O
M.	O	O
tuberculosis	O	O
)	O	O
could	O	O
activate	O	O
transcription	O	O
of	O	O
HIV-1	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
the	O	O
use	O	O
of	O	O
an	O	O
in	O	O
vitro	O	O
cell	O	O
culture	O	O
system	O	O
.	O	O
These	O	O
experiments	O	O
are	O	O
of	O	O
prime	O	O
importance	O	O
considering	O	O
that	O	O
CD4	cell_type	cell_type
-expressing	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
represent	O	O
the	O	O
major	O	O
virus	O	O
reservoir	O	O
in	O	O
the	O	O
peripheral	O	O
blood	O	O
of	O	O
infected	O	O
individuals	O	O
.	O	O
Using	O	O
the	O	O
1G5	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
harbouring	O	O
the	O	O
luciferase	DNA	DNA
reporter	DNA	DNA
gene	DNA	DNA
under	O	O
the	O	O
control	O	O
of	O	O
the	O	O
HIV-1	DNA	DNA
LTR	DNA	DNA
,	O	O
it	O	O
was	O	O
first	O	O
found	O	O
that	O	O
culture	O	O
protein	O	O
filtrates	O	O
(	O	O
CFP	O	O
)	O	O
from	O	O
M.	O	O
tuberculosis	O	O
or	O	O
purified	O	O
ManLAM	O	O
could	O	O
activate	O	O
HIV-1	DNA	DNA
LTR	DNA	DNA
-dependent	DNA	O
gene	DNA	O
expression	O	O
unlike	O	O
similarly	O	O
prepared	O	O
CFP	O	O
extracts	O	O
devoid	O	O
of	O	O
ManLAM	O	protein
.	O	O
The	O	O
implication	O	O
of	O	O
protein	protein	O
tyrosine	protein	O
kinase(s)	protein	O
,	O	O
protein	protein	protein
kinase	protein	protein
A	protein	protein
and/or	O	protein
protein	protein	protein
kinase	protein	protein
C	protein	protein
was	O	O
highlighted	O	O
by	O	O
the	O	O
abrogation	O	O
of	O	O
the	O	O
ManLAM	O	protein
-mediated	O	O
activation	O	O
of	O	O
HIV-1	DNA	DNA
LTR	DNA	DNA
-driven	DNA	O
gene	DNA	O
expression	O	O
using	O	O
herbimycin	O	O
A	O	O
and	O	O
H7	O	O
.	O	O
It	O	O
was	O	O
also	O	O
determined,	O	O
using	O	O
electrophoresis	O	O
mobility	O	O
shift	O	O
assays	O	O
,	O	O
that	O	O
M.	O	O
tuberculosis	O	O
ManLAM	O	O
led	O	O
to	O	O
the	O	O
nuclear	O	O
translocation	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
NF-kappaB	protein	protein
.	O	O
M.	O	O
tuberculosis	O	O
ManLAM	O	O
resulted	O	O
in	O	O
clear	O	O
induction	O	O
of	O	O
the	O	O
luciferase	DNA	DNA
gene	DNA	DNA
placed	O	O
under	O	O
the	O	O
control	O	O
of	O	O
the	O	O
wild-type,	DNA	O
but	DNA	O
not	DNA	O
the	DNA	O
kappaB	DNA	protein
-mutated,	DNA	O
HIV-1	DNA	DNA
LTR	DNA	DNA
region	DNA	DNA
.	O	O
Finally,	O	O
the	O	O
ManLAM	O	protein
-mediated	O	O
activation	O	O
of	O	O
HIV-1	DNA	DNA
LTR	DNA	DNA
transcription	O	O
was	O	O
found	O	O
to	O	O
be	O	O
independent	O	O
of	O	O
the	O	O
autocrine	O	O
or	O	O
paracrine	O	O
action	O	O
of	O	O
endogenous	protein	O
TNF-alpha	protein	protein
.	O	O
The	O	O
results	O	O
suggest	O	O
that	O	O
M.	O	O
tuberculosis	O	O
can	O	O
upregulate	O	O
HIV-1	O	O
expression	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
could	O	O
thus	O	O
have	O	O
the	O	O
potential	O	O
to	O	O
influence	O	O
the	O	O
pathogenesis	O	O
of	O	O
HIV-1	O	O
infection	O	O
.	O	O

Human	DNA	O
immunodeficiency	DNA	O
virus	DNA	O
type	DNA	O
1	DNA	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
quasispecies	DNA	O
differ	O	O
in	O	O
basal	O	O
transcription	O	O
and	O	O
nuclear	protein	O
factor	protein	O
recruitment	O	O
in	O	O
human	O	cell_type
glial	O	cell_type
cells	O	cell_type
and	O	O
lymphocytes	O	cell_type
.	O	O
The	O	O
generation	O	O
of	O	O
genomic	O	O
diversity	O	O
during	O	O
the	O	O
course	O	O
of	O	O
infection	O	O
has	O	O
the	O	O
potential	O	O
to	O	O
affect	O	O
all	O	O
aspects	O	O
of	O	O
HIV-1	O	O
replication	O	O
,	O	O
including	O	O
expression	O	O
of	O	O
the	O	O
proviral	DNA	O
genome	DNA	O
.	O	O
To	O	O
gain	O	O
a	O	O
better	O	O
understanding	O	O
of	O	O
the	O	O
impact	O	O
of	O	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
(	O	O
LTR	DNA	DNA
)	O	O
sequence	O	O
diversity	O	O
on	O	O
LTR	DNA	DNA
-directed	DNA	O
gene	DNA	O
expression	O	O
in	O	O
cells	O	O
of	O	O
the	O	O
central	O	O
nervous	O	O
system	O	O
(	O	O
CNS	O	O
)	O	O
and	O	O
immune	O	O
system	O	O
,	O	O
we	O	O
amplified	O	O
and	O	O
cloned	O	O
LTRs	DNA	O
from	O	O
proviral	DNA	O
DNA	DNA	O
in	O	O
HIV-1	cell_type	O
-infected	cell_type	O
peripheral	cell_type	O
blood	cell_type	O
.	O	O
Sequence	O	O
analysis	O	O
of	O	O
nineteen	O	O
LTRs	DNA	DNA
cloned	O	O
from	O	O
2	O	O
adult	O	O
and	O	O
3	O	O
pediatric	O	O
patients	O	O
revealed	O	O
an	O	O
average	O	O
of	O	O
33	O	O
nucleotide	O	O
changes	O	O
(with	O	O
respect	O	O
to	O	O
the	O	O
sequence	O	O
of	O	O
the	O	O
LAI	DNA	DNA
LTR	DNA	DNA
)	O	O
within	O	O
the	O	O
455-bp	DNA	DNA
U3	DNA	DNA
region	DNA	DNA
.	O	O
Transient	O	O
expression	O	O
analyses	O	O
in	O	O
cells	O	O
of	O	O
neuroglial	O	O
and	O	O
lymphocytic	O	O
origin	O	O
demonstrated	O	O
that	O	O
some	O	O
of	O	O
these	O	O
LTRs	DNA	DNA
had	O	O
activities	O	O
which	O	O
varied	O	O
significantly	O	O
from	O	O
the	O	O
LAI	DNA	DNA
LTR	DNA	DNA
in	O	O
U-373	cell_line	cell_line
MG	cell_line	cell_line
cells	cell_line	cell_line
(an	O	O
astrocytoma	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
)	O	O
as	O	O
well	O	O
as	O	O
in	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
(a	O	O
CD4-positive	cell_line	cell_line
lymphocyte	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
).	O	O
While	O	O
LTRs	DNA	DNA
which	O	O
demonstrated	O	O
the	O	O
highest	O	O
activities	O	O
in	O	O
U-373	cell_line	cell_line
MG	cell_line	cell_line
cells	cell_line	cell_line
also	O	O
yielded	O	O
high	O	O
activities	O	O
in	O	O
Jurkat	O	O
cells,	O	O
the	O	O
LTRs	DNA	DNA
were	O	O
generally	O	O
more	O	O
active	O	O
in	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
when	O	O
compared	O	O
to	O	O
the	O	O
LAI	DNA	DNA
LTR	DNA	DNA
.	O	O
Differences	O	O
in	O	O
LTR	DNA	DNA
sequence	DNA	DNA
also	O	O
resulted	O	O
in	O	O
differences	O	O
in	O	O
transcription	O	O
factor	O	O
recruitment	O	O
to	O	O
cis-acting	DNA	DNA
sites	DNA	DNA
within	O	O
the	O	O
U3	DNA	DNA
region	DNA	DNA
of	O	O
the	O	O
LTR	DNA	DNA
,	O	O
as	O	O
demonstrated	O	O
by	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assays	O	O
.	O	O
In	O	O
particular,	O	O
naturally	O	O
occurring	O	O
sequence	O	O
variation	O	O
impacted	O	O
transcription	protein	O
factor	protein	O
binding	O	O
to	O	O
an	O	O
activating	DNA	O
transcription	DNA	O
factor/	DNA	O
cAMP	DNA	O
response	DNA	O
element	DNA	O
binding	DNA	O
(	DNA	O
ATF/CREB	DNA	protein
)	DNA	O
binding	DNA	O
site	DNA	O
(located	O	O
between	O	O
the	O	O
LEF-1	protein	protein
and	O	O
distal	O	O
NF-kappaB	protein	protein
transcription	O	protein
factor	O	protein
binding	O	protein
sites	O	protein
)	O	O
that	O	O
we	O	O
identified	O	O
in	O	O
previous	O	O
studies	O	O
of	O	O
the	O	O
HIV-1	DNA	DNA
LTR	DNA	DNA
.	O	O
These	O	O
findings	O	O
suggest	O	O
that	O	O
LTR	DNA	DNA
sequence	DNA	DNA
changes	O	O
can	O	O
significantly	O	O
affect	O	O
basal	O	O
LTR	DNA	DNA
function	O	O
and	O	O
transcription	protein	protein
factor	protein	protein
recruitment	O	O
,	O	O
which	O	O
may,	O	O
in	O	O
turn,	O	O
alter	O	O
the	O	O
course	O	O
of	O	O
viral	O	O
replication	O	O
in	O	O
cells	O	O
of	O	O
CNS	O	O
and	O	O
immune	O	O
system	O	O
origin	O	O
.	O	O

HMG	protein	protein
box	protein	protein
containing	O	O
transcription	protein	protein
factors	protein	protein
in	O	O
lymphocyte	cell_type	O
differentiation	O	O
.	O	O
The	O	O
identification	O	O
of	O	O
the	O	O
mammalian	DNA	DNA
sex-determining	DNA	DNA
gene	DNA	DNA
Sry	DNA	DNA
has	O	O
led	O	O
to	O	O
the	O	O
discovery	O	O
of	O	O
a	O	O
large	O	O
family	O	O
of	O	O
related	O	O
('	O	O
HMG	protein	protein
box	protein	protein
')	O	protein
transcription	protein	protein
factors	protein	protein
that	O	O
control	O	O
developmental	O	O
events	O	O
in	O	O
yeast	O	O
,	O	O
C.	O	O
elegans	O	O
,	O	O
Drosophila	O	O
and	O	O
vertebrates	O	O
.	O	O
In	O	O
lymphocyte	cell_type	O
differentiation	O	O
,	O	O
several	O	O
HMG	protein	protein
box	protein	protein
proteins	protein	protein
play	O	O
a	O	O
decisive	O	O
role.	O	O
Sox-4	protein	protein
is	O	O
important	O	O
for	O	O
very	O	O
early	O	O
B-cell	O	O
differentiation	O	O
,	O	O
while	O	O
TCF-1/LEF-1	protein	protein
play	O	O
a	O	O
crucial	O	O
role	O	O
in	O	O
early	O	O
thymocyte	O	O
development	O	O
.	O	O
TCF/LEF	protein	protein
proteins	protein	protein
have	O	O
recently	O	O
been	O	O
found	O	O
to	O	O
constitute	O	O
a	O	O
downstream	O	O
component	O	O
of	O	O
the	O	O
Wingless/Wnt	O	O
signal	O	O
transduction	O	O
pathway	O	O
.	O	O
In	O	O
flies,	O	O
this	O	O
pathway	O	O
controls	O	O
segment	O	O
polarity;	O	O
in	O	O
Xenopus	O	O
it	O	O
controls	O	O
the	O	O
definition	O	O
of	O	O
the	O	O
body	O	O
axis	O	O
.	O	O
Deregulation	O	O
of	O	O
the	O	O
pathway	O	O
occurs	O	O
in	O	O
several	O	O
human	O	O
tumors	O	O
.	O	O
These	O	O
insights	O	O
in	O	O
the	O	O
molecular	O	O
events	O	O
that	O	O
are	O	O
involved	O	O
in	O	O
TCF/LEF	protein	O
function	O	O
in	O	O
these	O	O
organisms	O	O
may	O	O
eventually	O	O
lead	O	O
to	O	O
the	O	O
understanding	O	O
of	O	O
the	O	O
function	O	O
of	O	O
these	O	O
HMG	protein	protein
box	protein	protein
proteins	protein	protein
in	O	O
lymphoid	O	O
development	O	O

Detection	O	O
of	O	O
adenovirus	DNA	DNA
DNA	DNA	DNA
in	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assay	O	O
.	O	O
Adenovirus	O	O
can	O	O
establish	O	O
persistent	O	O
infections	O	O
which	O	O
may	O	O
reactivate	O	O
and	O	O
cause	O	O
disease	O	O
in	O	O
immunocompromised	O	O
hosts	O	O
.	O	O
Lymphocytes	cell_type	cell_type
have	O	O
been	O	O
postulated	O	O
to	O	O
serve	O	O
as	O	O
a	O	O
site	O	O
of	O	O
adenoviral	O	O
persistence	O	O
based	O	O
upon	O	O
the	O	O
ability	O	O
to	O	O
isolate	O	O
adenovirus	O	O
from	O	O
tonsils	O	O
and	O	O
to	O	O
detect	O	O
adenovirus	DNA	O
DNA	DNA	O
by	O	O
Southern	O	O
blot	O	O
hybridization	O	O
in	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
(	O	O
PBMC	cell_type	cell_type
).	O	O
To	O	O
test	O	O
this	O	O
hypothesis,	O	O
a	O	O
more	O	O
sensitive	O	O
and	O	O
specific	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
assay	O	O
was	O	O
developed	O	O
to	O	O
detect	O	O
adenovirus	DNA	O
DNA	DNA	O
.	O	O
Two	O	O
sets	O	O
of	O	O
nested	DNA	O
primers	DNA	O
were	O	O
designed	O	O
to	O	O
conserved	O	O
sequences	O	O
in	O	O
the	O	O
adenovirus	protein	O
E1A	protein	protein
and	O	O
hexon	protein	O
genes	O	O
.	O	O
The	O	O
E1A	protein	protein
and	O	O
hexon	protein	O
primers	O	O
amplified	O	O
DNA	O	O
from	O	O
representative	O	O
adenoviral	O	O
serotypes	O	O
in	O	O
all	O	O
six	O	O
adenoviral	O	O
groups	O	O
(A-F).	O	O
Both	O	O
primers	O	O
detected	O	O
a	O	O
single	O	O
copy	O	O
of	O	O
the	O	O
adenovirus	DNA	DNA
type	DNA	DNA
2	DNA	DNA
genome	DNA	DNA
but	O	O
were	O	O
less	O	O
sensitive	O	O
for	O	O
the	O	O
group	O	O
B	O	O
type	O	O
35.	O	O
None	O	O
of	O	O
33	O	O
PBMC	cell_type	cell_type
specimens	O	cell_type
from	O	O
healthy	O	O
adults	O	O
and	O	O
only	O	O
one	O	O
of	O	O
40	O	O
pediatric	O	O
samples	O	O
was	O	O
positive	O	O
(at	O	O
a	O	O
low	O	O
level)	O	O
for	O	O
adenovirus	DNA	O
DNA	DNA	O
by	O	O
nested	O	O
PCR	O	O
assay	O	O
.	O	O
In	O	O
comparison,	O	O
PBMC	cell_type	cell_type
from	O	O
two	O	O
children	O	O
with	O	O
fatal	O	O
adenoviral	O	O
infection	O	O
were	O	O
both	O	O
strongly	O	O
positive	O	O
for	O	O
adenovirus	DNA	DNA
DNA	DNA	DNA
.	O	O
It	O	O
is	O	O
concluded	O	O
that,	O	O
in	O	O
contrast	O	O
to	O	O
a	O	O
previous	O	O
study,	O	O
PBMC	cell_type	cell_type
are	O	O
not	O	O
a	O	O
common	O	O
site	O	O
of	O	O
persistent	O	O
group	O	O
C	O	O
adenoviral	O	O
infection	O	O
.	O	O
In	O	O
addition,	O	O
assay	O	O
of	O	O
PBMC	cell_type	cell_type
by	O	O
the	O	O
adenovirus	O	O
-specific	O	O
PCR	O	O
may	O	O
help	O	O
detect	O	O
early	O	O
invasive	O	O
disease	O	O
and	O	O
warrants	O	O
further	O	O
evaluation.	O	O

Disruption	O	O
of	O	O
the	O	O
human	DNA	DNA
SCL	DNA	DNA
locus	DNA	DNA
by	O	O
"	O	O
illegitimate"	O	O
V-(D)-J	O	O
recombinase	O	O
activity	O	O
.	O	O
A	O	O
fusion	DNA	O
complementary	DNA	O
DNA	DNA	O
in	O	O
the	O	O
T	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
HSB-2	cell_line	cell_line
elucidates	O	O
a	O	O
provocative	O	O
mechanism	O	O
for	O	O
the	O	O
disruption	O	O
of	O	O
the	O	O
putative	O	protein
hematopoietic	protein	protein
transcription	protein	protein
factor	protein	protein
SCL	protein	protein
.	O	O
The	O	O
fusion	DNA	O
cDNA	DNA	O
results	O	O
from	O	O
an	O	O
interstitial	O	O
deletion	O	O
between	O	O
a	O	O
previously	O	O
unknown	DNA	O
locus	DNA	O
,	O	O
SIL	DNA	O
(	O	O
SCL	DNA	protein
interrupting	DNA	protein
locus	DNA	O
),	O	O
and	O	O
the	O	O
5'	DNA	DNA
untranslated	DNA	DNA
region	DNA	DNA
of	O	O
SCL	protein	protein
.	O	O
Similar	O	O
to	O	O
1;14	O	O
translocations	O	O
,	O	O
this	O	O
deletion	O	O
disrupts	O	O
the	O	O
SCL	DNA	protein
5'	DNA	protein
regulatory	DNA	protein
region	DNA	protein
.	O	O
This	O	O
event	O	O
is	O	O
probably	O	O
mediated	O	O
by	O	O
V-(D)-J	O	protein
recombinase	O	protein
activity	O	O
,	O	O
although	O	O
neither	O	O
locus	O	O
is	O	O
an	O	O
immunoglobulin	protein	protein
or	O	O
a	O	O
T	protein	O
cell	protein	O
receptor	protein	O
.	O	O
Two	O	O
other	O	O
T	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
,	O	O
CEM	cell_line	cell_line
and	O	O
RPMI	cell_line	O
8402	cell_line	O
,	O	O
have	O	O
essentially	O	O
identical	O	O
deletions.	O	O
Thus,	O	O
in	O	O
lymphocytes	cell_type	cell_type
,	O	O
growth-affecting	DNA	O
genes	DNA	O
other	O	O
than	O	O
immune	protein	O
receptors	protein	O
risk	O	O
rearrangements	O	O
.	O	O

Thyroid	protein	protein
hormone	protein	protein
receptors	protein	protein
form	O	protein
distinct	O	O
nuclear	O	O
protein-	O	O
dependent	O	O
and	O	O
independent	O	O
complexes	O	O
with	O	O
a	O	O
thyroid	DNA	O
hormone	DNA	O
response	DNA	O
element	DNA	O
.	O	O
We	O	O
have	O	O
examined	O	O
the	O	O
binding	O	O
of	O	O
nuclear	protein	protein
proteins	protein	protein
and	O	O
recombinant	protein	protein
thyroid	protein	protein
hormone	protein	protein
receptors	protein	protein
(	O	O
TRs	protein	protein
)	O	O
to	O	O
the	O	O
palindromic	DNA	DNA
thyroid	DNA	DNA
hormone	DNA	DNA
responsive	DNA	DNA
element	DNA	DNA
AGGTCATGACCT	O	DNA
(	O	DNA
TREp	DNA	DNA
)	O	O
using	O	O
a	O	O
gel	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assay	O	O
.	O	O
Four	O	O
specific	O	O
protein-DNA	protein	protein
complexes	protein	protein
were	O	O
detected	O	O
after	O	O
incubation	O	O
of	O	O
nuclear	O	O
extracts	O	O
(	O	O
NE	O	protein
)	O	O
from	O	O
T3-responsive	cell_line	cell_line
pituitary	cell_line	cell_line
(GH3)	cell_line	cell_line
cells	cell_line	cell_line
with	O	O
a	O	O
TREp	DNA	DNA
-containing	DNA	DNA
DNA	DNA	DNA
fragment	DNA	DNA
.	O	O
This	O	O
was	O	O
compared	O	O
with	O	O
the	O	O
TREp	DNA	O
binding	O	O
of	O	O
reticulocyte	protein	O
lysate-synthesized	protein	O
TRs	protein	protein
.	O	O
TR	protein	DNA
alpha	protein	DNA
1	protein	DNA
and	O	O
TR	protein	protein
beta	protein	protein
2	protein	protein
each	O	O
formed	O	O
a	O	O
single	O	O
major	O	O
TR	protein	DNA
:	protein	O
TREp	protein	protein
complex	protein	protein
which	O	O
comigrated	O	O
with	O	O
the	O	O
least	O	O
retarded	O	O
complex	O	O
formed	O	O
by	O	O
GH3	O	protein
NE	O	protein
,	O	O
while	O	O
TR	protein	protein
beta	protein	protein
1	protein	protein
formed	O	O
multiple	O	O
complexes	O	O
suggesting	O	O
that	O	O
it	O	O
can	O	O
bind	O	O
to	O	O
TREp	DNA	O
as	O	O
an	O	O
oligomer	protein	O
.	O	O
Interestingly,	O	O
coincubation	O	O
of	O	O
35S-	protein	protein
TR	protein	protein
alpha	protein	protein
1	protein	protein
,	O	O
GH3	O	protein
NE	O	protein
,	O	O
and	O	O
unlabeled	O	O
TREp	DNA	O
resulted	O	O
in	O	O
not	O	O
only	O	O
the	O	O
35S-TR:	protein	protein
TREp	protein	protein
complex	protein	protein
,	O	O
but	O	O
in	O	O
two	O	O
additional	O	O
more	O	O
greatly	O	O
retarded	O	O
complexes	O	O
containing	O	O
35S-	protein	protein
TR	protein	protein
alpha	protein	protein
1	protein	protein
and	O	O
comigrating	O	O
with	O	O
those	O	O
formed	O	O
by	O	O
GH3	O	protein
extract	O	O
alone.	O	O
Incubation	O	O
of	O	O
each	O	O
of	O	O
the	O	O
TRs	protein	protein
with	O	O
NE	O	protein
from	O	O
COS-7	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
which	O	O
do	O	O
not	O	O
possess	O	O
sufficient	O	O
endogenous	O	O
TRs	protein	O
to	O	O
mediate	O	O
T3-responses	O	O
,	O	O
resulted	O	O
in	O	O
formation	O	O
of	O	O
a	O	O
new,	O	O
more	O	O
greatly	protein	O
shifted	protein	O
complex	protein	O
.	O	O
A	O	O
similar,	O	O
heat	O	O
labile	O	O
activity	O	O
which	O	O
altered	O	O
mobility	O	O
of	O	O
the	O	O
TR:TRE	protein	DNA
complex	protein	DNA
was	O	O
also	O	O
present	O	O
in	O	O
NE	O	O
from	O	O
T3-unresponsive	cell_line	cell_line
JEG-3	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
At	O	O
high	O	O
concentration	O	O
of	O	O
NE	O	protein
,	O	O
all	O	O
of	O	O
the	O	O
TR	protein	DNA
bound	O	O
to	O	O
TREp	DNA	O
was	O	O
more	O	O
greatly	O	O
retarded	O	O
than	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
NE	O	protein
.	O	O
Truncation	O	O
of	O	O
TR	protein	DNA
alpha	protein	DNA
1	protein	DNA
at	O	O
amino	protein	O
acid	protein	O
210	protein	O
prevented	O	O
additional	O	O
complex	O	O
formation	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
NE	O	protein
without	O	O
affecting	O	O
DNA	O	O
binding	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
carboxyl-terminus	protein	protein
of	O	O
the	O	O
TRs	protein	protein
is	O	O
essential	O	O
for	O	O
interaction	O	O
with	O	O
nuclear	protein	protein
proteins	protein	protein
.	O	O
(ABSTRACT	O	O
TRUNCATED	O	O
AT	O	O
250	O	O
WORDS)	O	O

Cell-specific	O	O
differences	O	O
in	O	O
activation	O	O
of	O	O
NF-kappa	DNA	protein
B	DNA	protein
regulatory	DNA	protein
elements	DNA	protein
of	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
and	O	O
beta	O	O
interferon	O	O
promoters	O	O
by	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
.	O	O
Three	O	O
aspects	O	O
of	O	O
the	O	O
involvement	O	O
of	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
in	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
(	O	O
HIV	O	O
)	O	O
pathogenesis	O	O
were	O	O
examined.	O	O
Tumor	RNA	protein
necrosis	RNA	protein
factor	RNA	protein
alpha	RNA	protein
(	RNA	O
TNF-alpha	RNA	protein
)	RNA	O
mRNA	RNA	RNA
production	O	O
was	O	O
analyzed	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
amplification	O	O
in	O	O
monocytic	cell_line	cell_line
U937	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
in	O	O
a	O	O
chronically	cell_line	O
HIV	cell_line	O
infected	cell_line	O
U937	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
(	O	O
U9-IIIB	cell_line	cell_line
).	O	O
TNF-alpha	RNA	protein
RNA	RNA	O
was	O	O
undetectable	O	O
in	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
whereas	O	O
a	O	O
low	O	O
constitutive	O	O
level	O	O
was	O	O
detected	O	O
in	O	O
U9-IIIB	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Paramyxovirus	O	O
infection	O	O
induced	O	O
a	O	O
5-	O	O
to	O	O
10-fold	O	O
increase	O	O
in	O	O
the	O	O
steady-state	O	O
level	O	O
of	O	O
TNF-alpha	RNA	protein
RNA	RNA	protein
in	O	O
U9-IIIB	cell_line	cell_line
cells	cell_line	cell_line
compared	O	O
with	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
suggesting	O	O
that	O	O
HIV-infected	cell_line	O
monocytic	cell_line	cell_type
cells	cell_line	cell_type
produced	O	O
higher	O	O
levels	O	O
of	O	O
TNF-alpha	protein	protein
than	O	O
did	O	O
normal	O	cell_type
cells	O	cell_type
after	O	O
a	O	O
secondary	O	O
virus	O	O
infection	O	O
.	O	O
The	O	O
effects	O	O
of	O	O
TNF-alpha	protein	protein
on	O	O
gene	O	O
expression	O	O
were	O	O
examined	O	O
by	O	O
transient	O	O
expression	O	O
assays	O	O
using	O	O
reporter	DNA	O
chloramphenicol	DNA	DNA
acetyltransferase	DNA	DNA
plasmids	DNA	DNA
linked	O	O
to	O	O
regulatory	DNA	DNA
elements	DNA	DNA
from	O	O
the	O	O
HIV	DNA	DNA
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
(	O	O
LTR	DNA	DNA
)	O	O
and	O	O
the	O	O
beta	DNA	O
interferon	DNA	DNA
promoter	DNA	DNA
.	O	O
In	O	O
U937	O	cell_line
and	O	O
Jurkat	O	cell_line
T	O	cell_line
lymphoid	O	cell_line
cells	O	cell_line
,	O	O
the	O	O
inducibility	O	O
of	O	O
the	O	O
different	O	O
hybrid	DNA	DNA
promoters	DNA	DNA
by	O	O
TNF-alpha	protein	protein
or	O	O
phorbol	O	O
ester	O	O
varied	O	O
in	O	O
a	O	O
cell	O	O
type-	O	O
and	O	O
promoter	O	O
context-specific	O	O
manner;	O	O
the	O	O
levels	O	O
of	O	O
gene	O	O
activity	O	O
of	O	O
NF-kappa	DNA	protein
B	DNA	protein
-containing	DNA	protein
plasmids	DNA	protein
correlated	O	O
directly	O	O
with	O	O
induction	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
DNA-binding	O	O
activity	O	O
.	O	O
Although	O	O
the	O	O
intact	O	O
beta	DNA	DNA
interferon	DNA	DNA
promoter	DNA	DNA
was	O	O
only	O	O
weakly	O	O
stimulated	O	O
by	O	O
phorbol	O	O
ester	O	O
or	O	O
TNF-alpha	protein	protein
,	O	O
multimers	O	O
of	O	O
the	O	O
PRDII	DNA	protein
NF-kappa	DNA	protein
B	DNA	protein
-binding	DNA	protein
domain	DNA	protein
were	O	O
inducible	O	O
by	O	O
both	O	O
agents.	O	O
TNF-alpha	protein	protein
was	O	O
able	O	O
to	O	O
increase	O	O
expression	O	O
of	O	O
the	O	O
HIV	DNA	DNA
LTR	DNA	DNA
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
but	O	O
in	O	O
monocytic	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
TNF-alpha	protein	protein
did	O	O
not	O	O
induce	O	O
the	O	O
HIV	DNA	DNA
LTR	DNA	DNA
above	O	O
a	O	O
constitutive	O	O
level	O	O
of	O	O
activity	O	O
.	O	O
This	O	O
level	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
-independent	O	O
activity	O	O
appears	O	O
to	O	O
be	O	O
sufficient	O	O
for	O	O
virus	O	O
multiplication	O	O
,	O	O
since	O	O
TNF-alpha	protein	protein
treatment	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
the	O	O
kinetics	O	O
of	O	O
de	O	O
novo	O	O
HIV	O	O
type	O	O
1	O	O
(	O	O
HIV-1	O	O
)	O	O
infection	O	O
and	O	O
viral	RNA	O
RNA	RNA	O
production	O	O
in	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
However,	O	O
in	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
TNF-alpha	protein	protein
dramatically	O	O
enhanced	O	O
the	O	O
spread	O	O
of	O	O
HIV-1	O	O
through	O	O
the	O	O
cell	O	O
population	O	O
and	O	O
increased	O	O
viral	RNA	O
RNA	RNA	O
synthesis	O	O
,	O	O
indicating	O	O
that	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
HIV-1	O	O
multiplication	O	O
was	O	O
stimulated	O	O
by	O	O
TNF-alpha	protein	protein
treatment	O	O
.	O	O

Functional	O	O
analysis	O	O
of	O	O
cis-linked	DNA	DNA
regulatory	DNA	DNA
sequences	DNA	DNA
in	O	O
the	O	O
HLA	DNA	DNA
DRA	DNA	DNA
promoter	DNA	DNA
by	O	O
transcription	O	O
in	O	O
vitro.	O	O
Two	O	O
consensus	O	O
sequences,	O	O
called	O	O
X	O	O
and	O	O
Y	O	O
boxes	O	O
,	O	O
capable	O	O
of	O	O
binding	O	protein
nuclear	protein	protein
proteins	protein	protein
and	O	O
regulating	O	O
expression	O	O
in	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
have	O	O
been	O	O
defined	O	O
within	O	O
the	O	O
immediate	O	DNA
upstream	O	DNA
region	O	DNA
of	O	O
major	DNA	DNA
histocompatibility	DNA	DNA
complex	DNA	DNA
(MHC)	DNA	DNA
class	DNA	DNA
II	DNA	DNA
promoters	DNA	DNA
.	O	O
Unlike	O	O
other	O	O
class	DNA	DNA
II	DNA	DNA
promoters	DNA	DNA
,	O	O
the	O	O
HLA-DR	DNA	protein
alpha	DNA	protein
(DRA)	DNA	O
promoter	DNA	O
also	O	O
contains	O	O
one	O	O
element	O	O
identical	O	O
to	O	O
the	O	O
"octamer"	DNA	O
motif	DNA	O
of	O	O
immunoglobulin	DNA	DNA
variable	DNA	DNA
region	DNA	DNA
promoters	DNA	DNA
that	O	O
is	O	O
responsible	O	O
for	O	O
B	O	protein
cell-specific	O	protein
transcription	O	protein
.	O	O
This	O	O
"	O	O
octamer	DNA	O
"	O	O
in	O	O
the	O	O
context	O	O
of	O	O
DRA	protein	DNA
appears	O	O
capable	O	O
of	O	O
binding	O	O
both	O	O
the	O	O
ubiquitous	protein	O
(	O	O
OTF-1	protein	protein
)	O	O
and	O	O
lymphoid-specific	protein	O
(	protein	O
OTF-2	protein	protein
)	protein	O
"octamer"	protein	O
binding	protein	O
proteins	protein	O
,	O	O
but	O	O
at	O	O
least	O	O
one	O	O
other	O	O
distinct	O	O
"octamer"	protein	protein
complex	protein	protein
was	O	O
found.	O	O
In	O	O
order	O	O
to	O	O
characterize	O	O
the	O	O
function	O	O
of	O	O
cis-acting	DNA	DNA
elements	DNA	DNA
,	O	O
we	O	O
have	O	O
developed	O	O
an	O	O
in	O	O
vitro	O	O
system	O	O
in	O	O
which	O	O
a	O	O
DRA	DNA	DNA
promoter	DNA	DNA
construct	DNA	DNA
is	O	O
transcribed	O	O
more	O	O
efficiently	O	O
in	O	O
extracts	O	O
from	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
than	O	O
in	O	O
extracts	O	O
from	O	O
class	cell_line	cell_line
II-negative	cell_line	cell_line
HeLa	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
5'	O	DNA
deletion	O	DNA
constructs	O	DNA
which	O	O
lacked	O	O
the	O	O
Y	DNA	DNA
box	DNA	DNA
,	O	O
but	O	O
retained	O	O
the	O	O
"octamer"	DNA	O
motif	DNA	O
and	O	O
TATA	DNA	DNA
box	DNA	DNA
were	O	O
completely	O	O
inactive,	O	O
and	O	O
internal	O	O
deletion	O	O
of	O	O
the	O	O
Y	DNA	DNA
box	DNA	DNA
reduced	O	O
transcription	O	O
by	O	O
95%.	O	O
Using	O	O
supercoiled,	O	O
but	O	O
not	O	O
linear	O	O
templates,	O	O
we	O	O
observed	O	O
differences	O	O
in	O	O
transcription	O	O
efficiencies	O	O
from	O	O
templates	O	O
lacking	O	O
or	O	O
disrupting	O	O
the	O	O
X	DNA	DNA
consensus	DNA	DNA
element	DNA	DNA
that	O	O
reflect	O	O
effects	O	O
of	O	O
random	O	O
replacement	O	O
of	O	O
X	DNA	DNA
box	DNA	DNA
sequences	DNA	DNA
in	O	O
transient	O	O
expression	O	O
assays	O	O
.	O	O
Demonstration	O	O
of	O	O
the	O	O
complete	O	O
dependence	O	O
on	O	O
the	O	O
Y	DNA	DNA
box	DNA	DNA
in	O	O
this	O	O
system	O	O
suggests	O	O
that,	O	O
despite	O	O
its	O	O
demonstrated	O	O
importance	O	O
in	O	O
the	O	O
DRA	DNA	DNA
promoter	DNA	DNA
,	O	O
the	O	O
DRA	DNA	DNA
"octamer"	DNA	DNA
does	O	O
not	O	O
utilize	O	O
OTF-2	protein	protein
in	O	O
a	O	O
manner	O	O
analogous	O	O
to	O	O
immunoglobulin	DNA	DNA
promoters	DNA	DNA
in	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Lipopolysaccharide	O	O
is	O	O
a	O	O
potent	O	O
monocyte/macrophage-specific	O	O
stimulator	O	O
of	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
type	O	O
1	O	O
expression	O	O
.	O	O
Lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
potently	O	O
stimulates	O	O
human	DNA	O
immunodeficiency	DNA	O
virus	DNA	O
type	DNA	O
1-long	DNA	O
terminal	DNA	O
repeat	DNA	O
(	DNA	O
HIV-1-LTR	DNA	DNA
)	DNA	DNA
CAT	DNA	DNA
constructs	DNA	DNA
transfected	O	O
into	O	O
monocyte/macrophage-like	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
but	O	O
not	O	O
a	O	O
T	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
This	O	O
effect	O	O
appears	O	O
to	O	O
be	O	O
mediated	O	O
through	O	O
the	O	O
induction	O	O
of	O	O
nuclear	protein	protein
factor	protein	protein
kappa	protein	protein
B	protein	protein
(	O	O
NF-kappa	protein	protein
B	protein	protein
).	O	O
Electrophoretic	O	O
mobility	O	O
shift	O	O
assays	O	O
demonstrate	O	O
that	O	O
LPS	O	O
induces	O	O
a	O	O
DNA	O	O
binding	O	O
activity	O	O
indistinguishable	O	O
from	O	O
NF-kappa	protein	protein
B	protein	protein
in	O	O
U937	cell_line	cell_line
and	O	O
THP-1	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
LPS	O	O
is	O	O
also	O	O
shown	O	O
to	O	O
dramatically	O	O
increase	O	O
HIV-1	O	O
production	O	O
from	O	O
a	O	O
chronically	cell_line	cell_line
infected	cell_line	cell_line
monocyte/macrophage-like	cell_line	cell_line
cloned	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
,	O	O
U1	cell_line	cell_line
,	O	O
which	O	O
produces	O	O
very	O	O
low	O	O
levels	O	O
of	O	O
HIV-1	O	O
at	O	O
baseline.	O	O
The	O	O
stimulation	O	O
of	O	O
viral	O	O
production	O	O
from	O	O
this	O	O
cell	O	O
line	O	O
occurs	O	O
only	O	O
if	O	O
these	O	O
cells	O	O
are	O	O
treated	O	O
with	O	O
granulocyte/macrophage	protein	protein
colony-stimulating	protein	protein
factor	protein	protein
(	O	O
GM-CSF	protein	protein
)	O	O
before	O	O
treatment	O	O
with	O	O
LPS	O	O
.	O	O
This	O	O
stimulation	O	O
of	O	O
HIV-1	O	O
production	O	O
is	O	O
correlated	O	O
with	O	O
an	O	O
increase	O	O
in	O	O
the	O	O
level	O	O
of	O	O
HIV-1	RNA	O
RNA	RNA	O
and	O	O
and	O	O
activation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
.	O	O
LPS	O	O
is	O	O
not	O	O
able	O	O
to	O	O
induce	O	O
HIV-1	O	O
production	O	O
in	O	O
a	O	O
cloned	O	cell_line
T	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
The	O	O
effect	O	O
of	O	O
LPS	O	O
on	O	O
HIV-1	O	O
replication	O	O
occurs	O	O
at	O	O
picogram	O	O
per	O	O
milliliter	O	O
concentrations	O	O
and	O	O
may	O	O
be	O	O
clinically	O	O
significant	O	O
in	O	O
understanding	O	O
the	O	O
variability	O	O
of	O	O
the	O	O
natural	O	O
history	O	O
of	O	O
HIV-1	O	O
infection	O	O
.	O	O

Steroid	O	O
dose	O	O
sparing	O	O
:	O	O
pharmacodynamic	O	O
responses	O	O
to	O	O
single	O	O
versus	O	O
divided	O	O
doses	O	O
of	O	O
methylprednisolone	O	O
in	O	O
man.	O	O
Inhibitory	O	O
drug	O	O
interactions	O	O
affecting	O	O
the	O	O
metabolism	O	O
of	O	O
methylprednisolone	O	O
(	O	O
MP	O	O
)	O	O
may	O	O
produce	O	O
either	O	O
steroid	O	O
sparing	O	O
or	O	O
adverse	O	O
effects	O	O
partly	O	O
by	O	O
increasing	O	O
the	O	O
exposure	O	O
time	O	O
to	O	O
the	O	O
steroid	O	O
.	O	O
This	O	O
phenomenon	O	O
can	O	O
be	O	O
mimicked	O	O
by	O	O
administering	O	O
MP	O	O
in	O	O
divided	O	O
doses.	O	O
Two	O	O
types	O	O
of	O	O
responses	O	O
were	O	O
compared	O	O
after	O	O
a	O	O
single	O	O
MP	O	O
dose	O	O
(40	O	O
mg	O	O
bolus)	O	O
and	O	O
a	O	O
divided	O	O
regimen	O	O
(20	O	O
mg	O	O
bolus	O	O
and	O	O
a	O	O
5	O	O
mg	O	O
bolus	O	O
8	O	O
hours	O	O
later)	O	O
in	O	O
six	O	O
healthy	O	O
male	O	O
volunteers	O	O
.	O	O
The	O	O
suppression	O	O
of	O	O
basophils	cell_type	cell_type
measured	O	cell_type
as	O	O
whole	O	O
blood	O	O
histamine	O	O
and	O	O
plasma	O	O
cortisol	O	O
concentrations	O	O
was	O	O
assessed	O	O
during	O	O
32	O	O
hours.	O	O
The	O	O
37.5%	O	O
reduction	O	O
in	O	O
dose	O	O
produced	O	O
a	O	O
23%	O	O
overall	O	O
decreased	O	O
blood	O	O
histamine	O	O
response	O	O
.	O	O
A	O	O
pharmacodynamic	O	O
model	O	O
for	O	O
basophil	O	cell_type
cell	O	cell_type
distribution	O	O
to	O	O
and	O	O
from	O	O
an	O	O
extravascular	O	O
compartment	O	O
describes	O	O
the	O	O
effects	O	O
of	O	O
MP	O	O
after	O	O
both	O	O
regimens.	O	O
A	O	O
slower	O	O
initial	O	O
decline	O	O
in	O	O
blood	O	O
histamine	O	O
after	O	O
the	O	O
divided	O	O
regimen	O	O
may	O	O
be	O	O
related	O	O
to	O	O
incomplete	O	O
suppression	O	O
of	O	O
basophil	cell_type	O
cell	cell_type	O
return	O	O
to	O	O
blood	O	O
.	O	O
The	O	O
50%	O	O
inhibitory	O	O
concentrations	O	O
of	O	O
MP	O	O
of	O	O
about	O	O
5	O	O
ng/ml	O	O
were	O	O
similar	O	O
for	O	O
both	O	O
regimens.	O	O
The	O	O
decline	O	O
and	O	O
return	O	O
of	O	O
cortisol	O	O
concentrations	O	O
were	O	O
similar	O	O
between	O	O
MP	O	O
treatments	O	O
with	O	O
suppression	O	O
continuing	O	O
for	O	O
24	O	O
hours.	O	O
The	O	O
50%	O	O
inhibitory	O	O
concentrations	O	O
of	O	O
MP	O	O
values	O	O
for	O	O
adrenal	O	O
suppression	O	O
were	O	O
about	O	O
1	O	O
ng/ml.	O	O
Pharmacodynamic	O	O
modeling	O	O
is	O	O
useful	O	O
in	O	O
quantitating	O	O
corticosteroid	O	O
responses	O	O
and	O	O
generally	O	O
predicted	O	O
the	O	O
"dose-sparing"	O	O
effects	O	O
that	O	O
were	O	O
achieved	O	O
by	O	O
prolonging	O	O
MP	O	O
plasma	O	O
concentrations	O	O
.	O	O
This	O	O
study	O	O
supports	O	O
previous	O	O
clinical	O	O
observations	O	O
that	O	O
patients	O	O
may	O	O
require	O	O
morning	O	O
through	O	O
evening	O	O
exposure	O	O
to	O	O
MP	O	O
to	O	O
optimize	O	O
efficacy	O	O
while	O	O
adrenal	O	O
suppression	O	O
is	O	O
being	O	O
minimized.	O	O

1,25(OH)2D2	O	O
production	O	O
by	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
and	O	O
alveolar	cell_type	cell_type
macrophages	cell_type	cell_type
recovered	O	O
by	O	O
lavage	O	O
from	O	O
normocalcemic	O	O
patients	O	O
with	O	O
tuberculosis.	O	O
To	O	O
compare	O	O
extra-renal	O	O
1,25(OH)2D3	O	O
production	O	O
in	O	O
different	O	O
types	O	O
of	O	O
granulomatous	O	O
disease	O	O
,	O	O
and	O	O
to	O	O
identify	O	O
the	O	O
cell	O	O
types	O	O
responsible,	O	O
we	O	O
have	O	O
evaluated	O	O
the	O	O
conversion	O	O
of	O	O
25(OH)D3	O	O
in	O	O
1,25(OH)2D3	O	O
by	O	O
uncultured	cell_type	cell_type
cells	cell_type	cell_type
recovered	O	O
by	O	O
bronchoalveolar	O	O
lavage	O	O
and	O	O
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
from	O	O
normocalcemic	O	O
patients	O	O
with	O	O
sarcoidosis	O	O
and	O	O
tuberculosis.	O	O
1,25(OH)2D3	O	O
was	O	O
produced	O	O
both	O	O
by	O	O
lavage	cell_type	cell_type
cells	cell_type	cell_type
(12/12	O	O
tuberculosis	O	O
patients	O	O
,	O	O
2/6	O	O
sarcoidosis	O	O
patients	O	O
)	O	O
and	O	O
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
(3/5	O	O
tuberculosis	O	O
patients	O	O
,	O	O
0/3	O	O
sarcoidosis	O	O
patients	O	O
)	O	O
from	O	O
patients	O	O
but	O	O
not	O	O
controls,	O	O
but	O	O
significantly	O	O
greater	O	O
amounts	O	O
were	O	O
produced	O	O
by	O	O
lavage	O	cell_type
cells	O	cell_type
from	O	O
tuberculosis	O	O
patients	O	O
than	O	O
those	O	O
of	O	O
sarcoidosis	O	O
patients	O	O
(P	O	O
less	O	O
than	O	O
0.001).	O	O
1,25(OH)2D3	O	O
production	O	O
by	O	O
lavage	cell_type	cell_type
cells	cell_type	cell_type
from	O	O
tuberculosis	O	O
patients	O	O
correlated	O	O
with	O	O
the	O	O
number	O	O
of	O	O
CD8+	O	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
present	O	O
but	O	O
not	O	O
other	O	O
cell	O	O
types.	O	O
T	cell_type	O
lymphocytes	cell_type	O
appeared	O	O
to	O	O
be	O	O
an	O	O
important	O	O
source	O	O
of	O	O
1,25(OH)2D3	O	O
production	O	O
,	O	O
since	O	O
purified	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
from	O	O
all	O	O
patients	O	O
with	O	O
tuberculosis	O	O
produced	O	O
1,25(OH)2D3	O	O
,	O	O
and	O	O
1,25(OH)2D3	O	O
production	O	O
by	O	O
these	O	O
cells	O	O
correlated	O	O
closely	O	O
with	O	O
that	O	O
produced	O	O
by	O	O
unseparated	O	cell_type
lavage	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Because	O	O
1,25(OH)2D3	O	O
can	O	O
improve	O	O
the	O	O
capacity	O	O
of	O	O
macrophages	cell_type	cell_type
to	O	O
kill	O	O
mycobacteria	O	O
,	O	O
our	O	O
results	O	O
support	O	O
the	O	O
conclusion	O	O
that	O	O
macrophage-lymphocyte	O	cell_type
interactions	O	cell_type
,	O	O
mediated	O	O
at	O	O
least	O	O
in	O	O
part	O	O
by	O	O
1,25(OH)2D3	O	O
,	O	O
may	O	O
be	O	O
an	O	O
important	O	O
component	O	O
of	O	O
a	O	O
successful	O	O
antituberculous	O	O
immune	O	O
response	O	O
.	O	O

Megakaryocytic	O	O
and	O	O
erythrocytic	O	O
lineages	O	O
share	O	O
specific	O	O
transcription	protein	protein
factors	protein	protein
.	O	O
Erythroid-specific	DNA	DNA
genes	DNA	DNA
contain	O	O
binding	O	DNA
sites	O	DNA
for	O	O
NF-E1	protein	protein
(also	O	O
called	O	O
GF-1	protein	protein
and	O	O
Eryf-1	protein	protein
;	O	O
refs	O	O
1-3	O	O
respectively),	O	O
the	O	O
principal	O	O
DNA-binding	protein	O
protein	protein	O
of	O	O
the	O	O
erythrocytic	cell_type	cell_type
lineage	cell_type	cell_type
.	O	O
NF-E1	protein	protein
expression	O	O
seems	O	O
to	O	O
be	O	O
restricted	O	O
to	O	O
the	O	O
erythrocytic	cell_type	cell_type
lineage	cell_type	cell_type
.	O	O
A	O	O
closely	O	O
related	O	O
(if	O	O
not	O	O
identical)	O	O
protein	O	O
is	O	O
found	O	O
in	O	O
both	O	O
a	O	O
human	cell_line	cell_line
megakaryocytic	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
and	O	O
purified	cell_line	O
human	cell_line	O
megakaryocytes	cell_line	cell_type
;	O	O
it	O	O
binds	O	O
to	O	O
promoter	DNA	DNA
regions	DNA	DNA
of	O	O
two	O	O
megakaryocytic-specific	DNA	DNA
genes	DNA	DNA
.	O	O
The	O	O
binding	O	O
sites	O	O
and	O	O
partial	O	O
proteolysis	O	O
profile	O	O
of	O	O
this	O	O
protein	O	O
are	O	O
indistinguishable	O	O
from	O	O
those	O	O
of	O	O
the	O	O
erythroid	protein	protein
protein	protein	protein
;	O	O
also,	O	O
NF-E1	RNA	protein
messenger	RNA	protein
RNA	RNA	protein
is	O	O
the	O	O
same	O	O
size	O	O
in	O	O
both	O	O
the	O	O
megakaryocytic	O	O
and	O	O
erythroid	O	cell_line
cell	O	cell_line
lines	O	cell_line
.	O	O
Furthermore,	O	O
point	O	O
mutations	O	O
that	O	O
abolish	O	O
binding	O	O
of	O	O
NF-E1	protein	protein
result	O	O
in	O	O
a	O	O
70%	O	O
decrease	O	O
in	O	O
the	O	O
transcriptional	O	O
activity	O	O
of	O	O
a	O	O
megakaryocytic-specific	DNA	DNA
promoter	DNA	DNA
.	O	O
We	O	O
also	O	O
find	O	O
that	O	O
NF-E2	protein	protein
,	O	O
another	O	O
trans-acting	protein	protein
factor	protein	protein
of	O	O
the	O	O
erythrocytic	cell_type	cell_type
lineage	cell_type	cell_type
,	O	O
is	O	O
present	O	O
in	O	O
megakaryocytes	cell_line	cell_type
.	O	O
Transcriptional	O	O
effects	O	O
in	O	O
both	O	O
lineages	O	O
might	O	O
then	O	O
be	O	O
mediated	O	O
in	O	O
part	O	O
by	O	O
the	O	O
same	O	O
specific	O	O
trans-acting	protein	protein
factors	protein	protein
.	O	O
Our	O	O
data	O	O
strengthen	O	O
the	O	O
idea	O	O
of	O	O
a	O	O
close	O	O
association	O	O
between	O	O
the	O	O
erythrocytic	O	DNA
and	O	O
the	O	O
megakaryocytic	O	O
lineages	O	O
and	O	O
could	O	O
also	O	O
explain	O	O
the	O	O
expression	O	O
of	O	O
markers	O	O
specific	O	O
to	O	O
the	O	O
erythrocytic	O	O
and	O	O
megakaryocytic	O	O
lineages	O	O
in	O	O
most	O	O
erythroblastic	O	O
and	O	O
megakaryoblastic	O	O
permanent	O	O
cell	O	O
lines	O	O
.	O	O

Transcriptional	O	O
down-regulation	O	O
of	O	O
c-myc	DNA	O
expression	O	O
by	O	O
protein	O	O
synthesis	O	O
-dependent	O	O
and	O	O
-independent	O	O
pathways	O	O
in	O	O
a	O	O
human	cell_line	O
T	cell_line	O
lymphoblastic	cell_line	O
tumor	cell_line	O
cell	cell_line	O
line	cell_line	O
.	O	O
We	O	O
show	O	O
that	O	O
in	O	O
the	O	O
human	cell_line	O
T	cell_line	O
lymphoblastic	cell_line	O
tumor	cell_line	O
cell	cell_line	O
line	cell_line	O
Molt4	RNA	O
c-myc	RNA	RNA
mRNA	RNA	RNA
and	O	O
protein	O	O
expression	O	O
is	O	O
down-regulated	O	O
after	O	O
exposure	O	O
to	O	O
dimethyl	O	O
sulfoxide	O	O
,	O	O
to	O	O
phorbol	O	O
myristate	O	O
acetate	O	O
,	O	O
or	O	O
to	O	O
the	O	O
calcium	O	O
ionophore	O	O
A23187	O	O
,	O	O
which	O	O
raises	O	O
the	O	O
intracellular	O	O
calcium	O	O
concentration	O	O
.	O	O
A	O	O
block	O	O
to	O	O
RNA	O	O
elongation	O	O
is	O	O
largely	O	O
responsible	O	O
for	O	O
decreased	O	O
c-myc	DNA	O
transcription	O	O
.	O	O
Although	O	O
negative	O	O
regulation	O	O
by	O	O
dimethyl	O	O
sulfoxide	O	O
takes	O	O
place	O	O
even	O	O
when	O	O
protein	O	O
synthesis	O	O
is	O	O
inhibited	O	O
by	O	O
cycloheximide	O	O
,	O	O
the	O	O
phorbol	O	O
myristate	O	O
acetate	O	O
effect	O	O
is	O	O
blocked	O	O
to	O	O
some	O	O
extent	O	O
only	O	O
by	O	O
cycloheximide	O	O
.	O	O
The	O	O
calcium	O	O
ionophore-induced	O	O
c-myc	DNA	O
suppression	O	O
,	O	O
however,	O	O
strictly	O	O
requires	O	O
de	O	O
novo	O	O
protein	O	O
synthesis	O	O
.	O	O
Therefore,	O	O
two	O	O
different	O	O
negative	O	O
regulatory	O	O
pathways	O	O
are	O	O
involved	O	O
in	O	O
c-myc	DNA	O
regulation	O	O
:	O	O
one	O	O
which	O	O
is	O	O
independent	O	O
and	O	O
one	O	O
which	O	O
depends	O	O
on	O	O
de	O	O
novo	O	O
protein	O	O
synthesis	O	O
.	O	O
The	O	O
latter	O	O
one	O	O
appears	O	O
to	O	O
be	O	O
mediated	O	O
by	O	O
a	O	O
rapidly	O	O
calcium	protein	O
-dependent	protein	O
induced	protein	O
gene	protein	O
product	protein	O
.	O	O

Oestrogen	protein	protein
receptor	protein	protein
(	O	O
ER	protein	protein
)	O	O
analysis	O	O
in	O	O
B-cell	O	O
chronic	O	O
lymphocytic	O	O
leukemia	O	O
:	O	O
correlation	O	O
of	O	O
biochemical	O	O
and	O	O
immunocytochemical	O	O
methods	O	O
.	O	O
Oestrogen	protein	protein
receptors	protein	protein
(	O	O
ER	protein	protein
)	O	O
are	O	O
present	O	O
in	O	O
neoplastic	cell_type	cell_type
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
have	O	O
been	O	O
considered	O	O
a	O	O
physiological	O	O
marker	O	O
of	O	O
growth	O	O
rate	O	O
or	O	O
differentiation.	O	O
Tamoxifen	O	O
,	O	O
an	O	O
oestrogen	O	O
antagonist	O	O
,	O	O
has	O	O
been	O	O
given	O	O
in	O	O
some	O	O
patients	O	O
with	O	O
CLL	O	O
and	O	O
Hodgkin's	O	O
disease	O	O
,	O	O
with	O	O
dramatic	O	O
response	O	O
in	O	O
single	O	O
cases.	O	O
Until	O	O
now,	O	O
ER	protein	protein
status	O	O
has	O	O
been	O	O
assessed	O	O
using	O	O
a	O	O
steroid	O	O
binding	O	O
assay	O	O
(	O	O
SBA	O	O
)	O	O
which	O	O
has	O	O
many	O	O
inherent	O	O
problems.	O	O
Recently,	O	O
the	O	O
development	O	O
of	O	O
monoclonal	O	protein
antibodies	O	protein
directed	O	O
against	O	O
ER	protein	protein
has	O	O
been	O	O
applied	O	O
to	O	O
the	O	O
study	O	O
of	O	O
breast	O	O
carcinomas	O	O
and	O	O
results	O	O
obtained	O	O
show	O	O
good	O	O
correlation	O	O
with	O	O
the	O	O
quantitative	O	O
SBA	O	O
.	O	O
We	O	O
studied	O	O
49	O	O
cases	O	O
of	O	O
B-cell	O	O
chronic	O	O
lymphocytic	O	O
leukemia	O	O
(	O	O
CLL	O	O
)	O	O
using	O	O
immunostaining	O	O
of	O	O
cytospin	O	protein
preparations	O	O
.	O	O
In	O	O
30	O	O
of	O	O
these	O	O
cases	O	O
ER	protein	protein
enzyme	O	protein
immunoassay	O	protein
(	O	O
ER	protein	protein
-EIA	O	protein
)	O	O
was	O	O
also	O	O
performed.	O	O
Cultured	cell_line	cell_line
MCF-7	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
derived	O	O
from	O	O
a	O	O
pleural	O	O
effusion	O	O
of	O	O
a	O	O
breast	O	O
cancer	O	O
patient	O	O
,	O	O
known	O	O
to	O	O
contain	O	O
high	O	O
levels	O	O
of	O	O
ER	protein	protein
were	O	O
used	O	O
as	O	O
a	O	O
positive	O	O
control	O	O
(40-48%	O	O
ER	cell_type	cell_line
positive	cell_type	cell_line
cells	cell_type	cell_line
by	O	O
immunocytochemistry;	O	O
200	O	O
fmol/mg	O	O
protein	O	O
by	O	O
EIA).	O	O
All	O	O
of	O	O
the	O	O
CLL	O	O
cases	O	O
except	O	O
two	O	O
(96%)	O	O
were	O	O
negative	O	O
for	O	O
ER	protein	protein
(less	O	O
than	O	O
1%	O	O
staining;	O	O
less	O	O
than	O	O
4	O	O
fmol/mg	O	O
protein).	O	O
The	O	O
two	O	O
positive	O	O
cases	O	O
expressed	O	O
granular	O	O
ER	protein	O
staining	O	O
over	O	O
the	O	O
nucleus	O	O
(9.2	O	O
and	O	O
12.1%	O	O
positive	O	O
cells)	O	O
and	O	O
were	O	O
positive	O	O
by	O	O
EIA	O	O
and	O	O
SBA	O	O
.	O	O
It	O	O
is	O	O
concluded	O	O
that	O	O
(i)	O	O
patients	O	O
with	O	O
CLL	O	O
rarely	O	O
express	O	O
ER	protein	protein
and	O	O
(ii)	O	O
immunocytochemical	O	O
staining	O	O
of	O	O
cytospin	O	O
preparations	O	O
is	O	O
a	O	O
valid	O	O
technique	O	O
for	O	O
the	O	O
measurement	O	O
of	O	O
ER	protein	protein
.	O	O
It	O	O
is	O	O
of	O	O
interest	O	O
that	O	O
one	O	O
of	O	O
the	O	O
positive	O	O
cases	O	O
was	O	O
diagnosed	O	O
as	O	O
CLL	O	O
with	O	O
Richter's	O	O
transformation	O	O
confirming	O	O
earlier	O	O
findings.	O	O

Type-II	protein	O
estrogen	protein	O
binding	protein	O
sites	protein	O
in	O	O
a	O	O
lymphoblastoid	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
and	O	O
growth-inhibitory	O	O
effect	O	O
of	O	O
estrogen	O	O
,	O	O
anti-estrogen	O	O
and	O	O
bioflavonoids	O	O
.	O	O
Type-II	protein	O
estrogen	protein	DNA
-binding	protein	DNA
sites	protein	DNA
(	O	O
type-II	protein	protein
EBS	protein	protein
)	O	O
have	O	O
been	O	O
demonstrated	O	O
in	O	O
the	O	O
human	cell_line	cell_line
lymphoblastoid	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
IM-9	cell_line	cell_line
using	O	O
a	O	O
whole-cell	O	O
assay	O	O
with	O	O
(6,7-3H)	O	DNA
estradiol	O	DNA
(	O	DNA
3H-E2	O	DNA
)	O	O
as	O	O
tracer.	O	O
Competition	O	O
analysis	O	O
showed	O	O
that	O	O
the	O	O
anti-estrogen	O	O
tamoxifen	O	O
and	O	O
the	O	O
flavonoids	O	O
quercetin	O	O
and	O	O
rutin	O	O
competed	O	O
for	O	O
(3H)-E2	O	O
binding	O	O
to	O	O
type-II	protein	protein
EBS	protein	protein
.	O	O
Growth	O	O
experiments	O	O
demonstrated	O	O
that	O	O
diethylstilbestrol	O	O
(	O	O
DES	O	O
)	O	O
tamoxifen	O	O
(	O	O
TAM	O	protein
),	O	O
quercetin	O	O
and	O	O
rutin	O	O
exerted	O	O
a	O	O
reversible	O	O
dose-dependent	O	O
inhibition	O	O
of	O	O
cell	O	O
proliferation	O	O
in	O	O
the	O	O
range	O	O
of	O	O
concentrations	O	O
between	O	O
10	O	O
nM	O	O
and	O	O
10	O	O
microM.	O	O
The	O	O
relative	O	O
binding	O	O
affinity	O	O
of	O	O
quercetin	O	protein
,	O	O
rutin	O	O
,	O	O
DES	O	O
and	O	O
TAM	O	O
for	O	O
type-II	protein	protein
EBS	protein	protein
correlated	O	O
well	O	O
with	O	O
their	O	O
potency	O	O
as	O	O
cell	O	O
growth	O	O
inhibitors	O	O
.	O	O
Moreover,	O	O
hesperidin,	O	O
a	O	O
flavonoid	O	O
which	O	O
does	O	O
not	O	O
bind	O	O
to	O	O
type-II	protein	protein
EBS	protein	protein
,	O	O
was	O	O
ineffective	O	O
in	O	O
inhibiting	O	O
cell	O	O
growth	O	O
.	O	O
Cell-cycle	O	O
analysis	O	O
showed	O	O
that	O	O
the	O	O
growth-inhibitory	O	O
effect	O	O
of	O	O
DES	O	O
,	O	O
TAM	O	O
or	O	O
quercetin	O	O
was	O	O
due	O	O
to	O	O
a	O	O
blocking	O	O
effect	O	O
in	O	O
the	O	O
G0-G1	O	O
phases.	O	O
Our	O	O
results	O	O
suggest	O	O
that	O	O
high	O	O
estrogen	O	O
and	O	O
anti-estrogen	O	O
concentrations	O	O
and	O	O
flavonoids	O	O
may	O	O
regulate	O	O
IM-9	cell_line	O
cell	O	O
growth	O	O
through	O	O
a	O	O
common	O	O
mechanism	O	O
involving	O	O
a	O	O
binding	O	O
interaction	O	O
with	O	O
type-II	protein	protein
EBS	protein	protein
.	O	O

[	O	O
Glucocorticoid	protein	protein
receptors	protein	protein
in	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
lymphocytes	cell_type	cell_type
of	O	O
patients	O	O
with	O	O
bronchial	O	O
asthma	O	O
]	O	O
Quantitation	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
(	O	O
GCR	protein	protein
)	O	O
and	O	O
the	O	O
study	O	O
of	O	O
their	O	O
affinity	O	O
for	O	O
glucocorticosteroids	O	O
(	O	O
GCS	O	O
)	O	O
were	O	O
made	O	O
in	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
lymphocytes	cell_type	cell_type
of	O	O
bronchial	O	O
asthma	O	O
(	O	O
BA	O	O
)	O	O
patients	O	O
in	O	O
consideration	O	O
of	O	O
GCR	protein	protein
treatment	O	O
and	O	O
serum	O	O
levels	O	O
of	O	O
endogenous	O	O
cortisol	O	O
.	O	O
It	O	O
is	O	O
stated	O	O
that	O	O
GCR	protein	protein
of	O	O
healthy	O	O
controls	O	O
and	O	O
GCS	O	O
-untreated	O	O
patients	O	O
outnumbered	O	O
those	O	O
of	O	O
cortisol-dependent	O	O
BA	O	O
patients	O	O
on	O	O
hormone	O	O
therapy	O	O
.	O	O
Following	O	O
discontinuation	O	O
of	O	O
glucocorticoid	O	O
drugs	O	O
GCR	protein	O
count	O	O
in	O	O
cortisol	O	O
-dependent	O	O
BA	O	O
tends	O	O
to	O	O
rise.	O	O
Endogenous	O	O
cortisol	O	O
has	O	O
no	O	O
effect	O	O
on	O	O
GCR	protein	O
level	O	O
estimated	O	O
by	O	O
3H-triamcinolone	O	protein
acetonide	O	protein
.	O	O

Two	O	O
glucocorticoid	protein	O
binding	protein	O
sites	protein	O
on	O	O
the	O	O
human	protein	protein
glucocorticoid	protein	protein
receptor	protein	protein
.	O	O
Glucocorticoids	O	O
are	O	O
known	O	O
to	O	O
have	O	O
a	O	O
lytic	O	O
effect	O	O
in	O	O
leukemic	cell_type	cell_type
cells	cell_type	cell_type
via	O	O
interactions	O	O
with	O	O
the	O	O
glucocorticoid	protein	protein
receptor	protein	protein
(	O	O
GR	protein	protein
).	O	O
Cortisol	O	O
and	O	O
various	O	O
synthetic	O	O
glucocorticoids	O	O
bind	O	O
to	O	O
the	O	O
GR	protein	protein
with	O	O
one-site	O	O
kinetics	O	O
.	O	O
Cortivazol	O	O
(	O	O
CVZ	O	O
)	O	O
is	O	O
a	O	O
unique,	O	O
high	O	O
potency	O	O
synthetic	O	O
glucocorticoid	O	O
,	O	O
which	O	O
has	O	O
a	O	O
phenylpyrazol	O	O
fused	O	O
to	O	O
the	O	O
A-ring	O	O
of	O	O
the	O	O
steroid	O	O
nucleus	O	O
and	O	O
displays	O	O
binding	O	O
consistent	O	O
with	O	O
two	O	O
or	O	O
more	O	O
sites	O	O
in	O	O
the	O	O
cytosol	O	O
from	O	O
CEM	cell_line	cell_line
C7	cell_line	cell_line
cells	cell_line	cell_line
(a	O	O
human	cell_line	O
acute	cell_line	O
lymphoblastic	cell_line	O
T-cell	cell_line	O
line	cell_line	O
).	O	O
It	O	O
has	O	O
previously	O	O
been	O	O
shown	O	O
that	O	O
the	O	O
lower	O	O
affinity	O	O
class	O	O
of	O	O
sites	O	O
are	O	O
similar	O	O
in	O	O
affinity	O	O
and	O	O
site	O	O
molarity	O	O
to	O	O
those	O	O
recognized	O	O
by	O	O
dexamethasone	O	O
.	O	O
The	O	O
higher	O	O
affinity	O	O
sites	O	O
bind	O	O
CVZ	O	O
with	O	O
20-	O	O
to	O	O
50-fold	O	O
greater	O	O
affinity	O	O
,	O	O
consistent	O	O
with	O	O
CVZ	O	O
's	O	O
enhanced	O	O
biological	O	O
effects	O	O
.	O	O
In	O	O
mutant	O	cell_line
leukemic	cell_type	cell_line
cells	cell_type	cell_line
resistant	O	O
to	O	O
the	O	O
lytic	O	O
effects	O	O
of	O	O
dexamethasone	O	O
,	O	O
CVZ	O	O
both	O	O
lyses	O	O
the	O	O
cells	O	O
and	O	O
recognizes	O	O
a	O	O
single	O	O
class	O	O
of	O	O
sites	O	O
similar	O	O
to	O	O
the	O	O
high	O	O
affinity	O	O
site	O	O
in	O	O
CEM	cell_line	cell_line
C7	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
We	O	O
have	O	O
carried	O	O
out	O	O
experiments	O	O
to	O	O
define	O	O
the	O	O
nature	O	O
of	O	O
the	O	O
higher	protein	O
affinity	protein	O
CVZ	protein	O
binding	protein	O
site	protein	O
.	O	O
We	O	O
now	O	O
show	O	O
that:	O	O
1)	O	O
CVZ	O	O
has	O	O
more	O	O
than	O	O
one	O	O
binding	O	O
site	O	O
in	O	O
a	O	O
second,	O	O
independent,	O	O
B-cell	cell_line	O
line	cell_line	O
,	O	O
IM-9	cell_line	cell_line
;	O	O
2)	O	O
the	O	O
antiglucocorticoid	O	O
RU	O	O
38486	O	O
is	O	O
able	O	O
to	O	O
block	O	O
both	O	O
CVZ	O	O
's	O	O
higher	O	O
and	O	O
lower	O	O
affinity	O	O
sites;	O	O
3)	O	O
all	O	O
of	O	O
CVZ	protein	O
's	protein	O
binding	protein	O
sites	protein	O
are	O	O
on	O	O
a	O	O
protein	O	O
immunologically	O	O
indistinguishable	O	O
from	O	O
the	O	O
human	O	DNA
GR	protein	DNA
;	O	O
and	O	O
4)	O	O
freshly	O	O
isolated	O	O
clones	O	O
of	O	O
CVZ	O	cell_line
-resistant	O	cell_line
cells	O	cell_line
have	O	O
lost	O	O
all	O	O
binding	O	O
sites	O	O
for	O	O
CVZ	O	O
.	O	O
These	O	O
data	O	O
indicate	O	O
that	O	O
CVZ	O	O
is	O	O
recognizing	O	O
two	O	O
glucocorticoid	protein	O
binding	protein	DNA
sites	protein	DNA
on	O	O
the	O	O
human	O	O
GR	protein	protein
or	O	O
a	O	O
protein	O	O
very	O	O
similar	O	O
to	O	O
it.	O	O

Retroviral	O	O
mediated	O	O
transfer	O	O
and	O	O
expression	O	O
of	O	O
exogenous	DNA	DNA
genes	DNA	DNA
in	O	O
primary	cell_type	cell_type
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
:	O	O
assaying	O	O
for	O	O
a	O	O
viral	O	O
transactivator	protein	O
activity	O	O
in	O	O
normal	O	O
and	O	O
malignant	O	cell_type
cells	O	cell_type
.	O	O
In	O	O
this	O	O
report	O	O
we	O	O
describe	O	O
the	O	O
use	O	O
of	O	O
recombinant	O	O
retroviruses	O	O
to	O	O
characterize	O	O
the	O	O
activity	O	O
of	O	O
an	O	O
exogenous	DNA	DNA
promoter	DNA	DNA
in	O	O
primary	O	cell_type
cells	O	cell_type
obtained	O	O
from	O	O
patients	O	O
with	O	O
lymphoproliferative	O	O
disorders	O	O
.	O	O
The	O	O
infection	O	O
of	O	O
a	O	O
variety	O	O
of	O	O
cultured	O	O
and	O	O
primary	cell_type	cell_type
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
a	O	O
recombinant	O	O
retrovirus	O	O
containing	O	O
a	O	O
histone	DNA	protein
promoter-driven	DNA	O
beta-galactosidase	DNA	DNA
gene	DNA	DNA
is	O	O
shown	O	O
to	O	O
result	O	O
in	O	O
the	O	O
expression	O	O
of	O	O
beta-galactosidase	protein	protein
in	O	O
50%	O	O
to	O	O
100%	O	O
of	O	O
the	O	O
cells.	O	O
A	O	O
similar	O	O
infection	O	O
with	O	O
a	O	O
recombinant	O	O
retrovirus	O	O
containing	O	O
the	O	O
beta-galactosidase	DNA	DNA
gene	DNA	DNA
with	O	O
an	O	O
adenovirus	DNA	DNA
E2	DNA	DNA
promoter	DNA	DNA
,	O	O
results	O	O
in	O	O
beta-galactosidase	protein	protein
activity	O	O
in	O	O
a	O	O
limited	O	O
number	O	O
of	O	O
cultured	cell_line	O
and	O	O
primary	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Since	O	O
the	O	O
adenovirus	DNA	DNA
E2	DNA	DNA
promoter	DNA	DNA
has	O	O
been	O	O
well	O	O
characterized	O	O
and	O	O
is	O	O
known	O	O
to	O	O
be	O	O
regulated	O	O
by	O	O
transactivators	protein	protein
encoded	O	O
by	O	O
many	O	O
viruses	O	O
,	O	O
the	O	O
activity	O	O
of	O	O
this	O	O
promoter	O	O
in	O	O
specific	O	O
cell	O	O
types	O	O
is	O	O
discussed	O	O
in	O	O
reference	O	O
to	O	O
both	O	O
the	O	O
biology	O	O
of	O	O
the	O	O
cell	O	O
and	O	O
the	O	O
possible	O	O
presence	O	O
of	O	O
as	O	O
yet	O	O
undetected	O	O
viral	protein	O
gene	protein	O
products	protein	O
.	O	O

[The	O	O
effect	O	O
of	O	O
24,25-dihydroxyvitamin	O	O
D3	O	O
(	O	O
dioxyvit	O	O
)	O	O
on	O	O
Ca	O	O
metabolism	O	O
and	O	O
immune	O	O
status	O	O
during	O	O
chronic	O	O
kidney	O	O
failure	O	O
]	O	O
Active	O	O
metabolite	O	O
of	O	O
vitamin	O	O
D3	O	O
,	O	O
24R,25	O	O
(OH)2D3	O	O
(	O	O
dioxyvit	O	O
)	O	O
was	O	O
used	O	O
at	O	O
a	O	O
daily	O	O
dose	O	O
of	O	O
100	O	O
micrograms	O	O
in	O	O
treatment	O	O
of	O	O
children	O	O
affected	O	O
with	O	O
tubulointerstitial	O	O
disease	O	O
of	O	O
kidney	O	O
and	O	O
with	O	O
chronic	O	O
glomerulonephritis	O	O
under	O	O
conditions	O	O
of	O	O
kidney	O	O
insufficiency	O	O
.	O	O
The	O	O
drug	O	O
exhibited	O	O
distinct	O	O
normalizing	O	O
effect	O	O
on	O	O
patterns	O	O
of	O	O
calcium	O	O
metabolism	O	O
:	O	O
increase	O	O
of	O	O
total	O	O
and	O	O
ionized	O	O
Ca2+	O	O
and	O	O
of	O	O
25-OHD	O	protein
,	O	O
decrease	O	O
in	O	O
concentration	O	O
of	O	O
parath	O	O
hormone	O	O
and	O	O
osteocalcine	O	O
in	O	O
blood	O	O
serum	O	O
as	O	O
well	O	O
as	O	O
on	O	O
immunological	O	O
parameters	O	O
:	O	O
restoration	O	O
of	O	O
decreased	O	O
content	O	O
of	O	O
T-	O	O
and	O	O
0-	O	O
lymphocytes	O	O
.	O	O
Concentration	O	O
of	O	O
receptors	O	O
of	O	O
hormonal	O	O
form	O	O
of	O	O
1,25(OH)2D3	O	O
was	O	O
found	O	O
to	O	O
be	O	O
minimal	O	O
in	O	O
lymphocytes	cell_type	cell_type
under	O	O
conditions	O	O
of	O	O
chronic	O	O
kidney	O	O
insufficiency	O	O
,	O	O
while	O	O
their	O	O
expression,	O	O
after	O	O
the	O	O
dioxyvit	O	O
action,	O	O
was	O	O
detected	O	O
only	O	O
in	O	O
patients	O	O
with	O	O
glomerulonephritis	O	O
.	O	O
Specific	O	O
calcitropic	O	O
effect	O	O
of	O	O
dioxyvit	O	O
with	O	O
simultaneous	O	O
correction	O	O
of	O	O
vitamin	O	O
D	O	O
deficiency	O	O
were	O	O
apparently	O	O
responsible	O	O
for	O	O
high	O	O
efficacy	O	O
of	O	O
the	O	O
drug	O	O
in	O	O
treatment	O	O
of	O	O
calcium	O	O
metabolism	O	O
and	O	O
immunity	O	O
impairments	O	O
in	O	O
children	O	O
with	O	O
renal	O	O
deteriorations	O	O
at	O	O
the	O	O
step	O	O
of	O	O
chronic	O	O
kidney	O	O
insufficiency	O	O
.	O	O

[The	O	O
role	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
and	O	O
HLA	protein	protein
antigens	protein	protein
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
Cushing's	protein	O
syndrome	protein	O
]	O	O
Lymphocytic	O	O
levels	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
were	O	O
evaluated	O	O
in	O	O
114	O	O
patients	O	O
suffering	O	O
from	O	O
Icenko-	O	O
Cushing's	protein	O
syndrome	protein	O
.	O	O
Incidence	O	O
of	O	O
HLA	protein	protein
antigens	protein	protein
was	O	O
determined	O	O
in	O	O
94	O	O
of	O	O
them.	O	O
A	O	O
significant	O	O
rise	O	O
of	O	O
A10	protein	protein
and	O	O
B27	protein	protein
antigen	protein	protein
incidence	O	O
compared	O	O
to	O	O
that	O	O
in	O	O
normal	O	O
subjects	O	O
allows	O	O
these	O	O
antigens	O	O
to	O	O
be	O	O
considered	O	O
genetic	O	O
markers	O	O
of	O	O
Icenko-	O	O
Cushing's	protein	O
syndrome	protein	O
.	O	O
The	O	O
levels	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
in	O	O
lymphocytes	cell_type	cell_type
of	O	O
the	O	O
patients	O	O
are	O	O
lower	O	O
than	O	O
in	O	O
normal	O	O
subjects	O	O
both	O	O
in	O	O
the	O	O
active	O	O
stage	O	O
of	O	O
the	O	O
disease	O	O
and	O	O
following	O	O
bilateral	O	O
total	O	O
adrenalectomy	O	O
.	O	O
The	O	O
patients	O	O
carrying	O	O
B27	protein	O
antigen	protein	O
had	O	O
lymphocytic	O	O
receptor	O	O
concentrations	O	O
under	O	O
the	O	O
levels	O	O
of	O	O
such	O	O
in	O	O
patients	O	O
free	O	O
of	O	O
the	O	O
antigen	O	O
carriage.	O	O
Antigen	protein	O
B27	protein	O
seems	O	O
to	O	O
be	O	O
a	O	O
cause	O	O
of	O	O
lower	O	O
levels	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
in	O	O
blood	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O

Effects	O	O
of	O	O
1	O	O
alpha,	O	O
25-dihydroxyvitamin	O	O
D3	O	O
on	O	O
the	O	O
human	cell_line	O
chronic	cell_line	O
myelogenous	cell_line	O
leukemia	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
RWLeu-4	cell_line	cell_line
.	O	O
The	O	O
effects	O	O
of	O	O
1	O	O
alpha,	O	O
25-dihydroxyvitamin	O	O
D3	O	O
(	O	O
VD3	O	O
)	O	O
on	O	O
proliferation	O	O
,	O	O
differentiation	O	O
,	O	O
and	O	O
macromolecular	O	O
synthesis	O	O
in	O	O
the	O	O
new	O	O
Philadelphia	cell_line	O
chromosome-positive	cell_line	O
chronic	cell_line	O
myelogenous	cell_line	O
leukemia	cell_line	O
cell	cell_line	O
line	cell_line	O
,	O	O
RWLeu-4	cell_line	cell_line
,	O	O
were	O	O
investigated.	O	O
Binding	O	O
of	O	O
[3H]VD3	O	O
was	O	O
saturable,	O	O
with	O	O
approximately	O	O
2000-3000	O	O
sites/cell,	O	O
and	O	O
half-maximal	O	O
binding	O	O
occurring	O	O
at	O	O
0.21-0.33	O	O
nM.	O	O
Treatment	O	O
of	O	O
RWLeu-4	cell_line	cell_line
cells	cell_line	cell_line
with	O	O
VD3	O	O
induced	O	O
24R-hydroxylase	protein	protein
activity	O	O
,	O	O
a	O	O
marker	O	O
of	O	O
vitamin	O	O
D3	O	O
responsiveness	O	O
in	O	O
many	O	O
tissues.	O	O
Exposure	O	O
of	O	O
RWLeu-4	cell_line	cell_line
cells	cell_line	cell_line
to	O	O
VD3	O	O
also	O	O
inhibited	O	O
proliferation	O	O
and	O	O
DNA	O	O
synthesis	O	O
with	O	O
a	O	O
50%	O	O
effective	O	O
dose	O	O
of	O	O
3.5-10	O	O
nM	O	O
within	O	O
72	O	O
h;	O	O
in	O	O
addition,	O	O
protein	O	O
and	O	O
RNA	O	O
synthesis	O	O
were	O	O
inhibited	O	O
by	O	O
VD3	O	O
treatment	O	O
.	O	O
Exposure	O	O
of	O	O
RWLeu-4	cell_line	cell_line
cells	cell_line	cell_line
to	O	O
5	O	O
nM	O	O
VD3	O	O
for	O	O
72	O	O
h	O	O
caused	O	O
50%	O	O
of	O	O
the	O	O
cells	O	O
to	O	O
differentiate	O	O
into	O	O
macrophage/monocyte	cell_type	cell_type
type	cell_type	cell_type
cells	cell_type	cell_type
as	O	O
judged	O	O
by	O	O
nitroblue	O	O
tetrazolium	O	O
staining	O	O
and	O	O
adherence	O	O
to	O	O
plastic.	O	O
Progressive	O	O
expression	O	O
of	O	O
cell	protein	O
surface	protein	O
maturation-specific	protein	O
antigens	protein	O
of	O	O
the	O	O
monocyte/macrophage	cell_type	cell_type
lineage	cell_type	cell_type
was	O	O
induced	O	O
by	O	O
treatment	O	O
of	O	O
RWLeu-4	cell_line	cell_line
cells	cell_line	cell_line
with	O	O
VD3	O	O
for	O	O
24	O	O
to	O	O
72	O	O
h	O	O
at	O	O
doses	O	O
that	O	O
inhibited	O	O
cellular	O	O
proliferation	O	O
.	O	O
c-myc	RNA	DNA
RNA	RNA	DNA
,	O	O
which	O	O
is	O	O
constitutively	O	O
expressed	O	O
in	O	O
RWLeu-4	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
increased	O	O
after	O	O
0.5	O	O
h	O	O
of	O	O
treatment	O	O
with	O	O
50	O	O
nM	O	O
VD3	O	O
and	O	O
then	O	O
rapidly	O	O
decreased	O	O
to	O	O
barely	O	O
detectable	O	O
levels	O	O
after	O	O
4	O	O
h	O	O
of	O	O
treatment.	O	O
Finally,	O	O
the	O	O
in	O	O
vitro	O	O
tyrosine	O	O
kinase	O	O
activity	O	O
associated	O	O
with	O	O
the	O	O
p210bcr-abl	protein	DNA
oncogene	protein	DNA
product	protein	DNA
was	O	O
decreased	O	O
approximately	O	O
50%	O	O
by	O	O
VD3	O	O
treatment	O	O
.	O	O
Because	O	O
of	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
functional	O	O
receptor-effector	O	O
system	O	O
for	O	O
VD3	O	O
and	O	O
multiple	O	O
biological	O	O
responses	O	O
to	O	O
the	O	O
hormone,	O	O
these	O	O
cells	O	O
provide	O	O
a	O	O
unique	O	O
model	O	O
system	O	O
with	O	O
which	O	O
to	O	O
probe	O	O
the	O	O
specific	O	O
effects	O	O
of	O	O
VD3	O	O
on	O	O
cell	O	O
growth	O	O
and	O	O
differentiation	O	O
in	O	O
chronic	O	O
myelogenous	O	O
leukemia	O	O
.	O	O

A	O	O
new	O	O
member	O	O
of	O	O
the	O	O
leucine	protein	protein
zipper	protein	protein
class	protein	protein
of	O	protein
proteins	O	protein
that	O	O
binds	O	O
to	O	O
the	O	O
HLA	DNA	DNA
DR	DNA	DNA
alpha	DNA	DNA
promoter	DNA	DNA
.	O	O
Several	O	O
mutants	O	O
derived	O	O
from	O	O
transformed	cell_line	cell_line
human	cell_line	cell_line
B	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
are	O	O
defective	O	O
in	O	O
expressing	O	O
major	DNA	protein
histocompatibility	DNA	protein
complex	DNA	protein
(MHC)	DNA	protein
class	DNA	protein
II	DNA	protein
genes	DNA	O
.	O	O
The	O	O
failure	O	O
to	O	O
express	O	O
a	O	O
class	DNA	DNA
II	DNA	DNA
gene	DNA	DNA
in	O	O
at	O	O
least	O	O
one	O	O
such	O	O
mutant	cell_line	O
line	cell_line	O
has	O	O
been	O	O
mapped	O	O
to	O	O
the	O	O
MHC	DNA	protein
class	DNA	protein
II	DNA	protein
X	DNA	protein
box	DNA	protein
,	O	O
a	O	O
conserved	DNA	DNA
transcriptional	DNA	DNA
element	DNA	DNA
in	O	O
the	O	O
promoter	DNA	DNA
region	DNA	DNA
.	O	O
A	O	O
complementary	DNA	O
DNA	DNA	O
encoding	O	O
a	O	O
DNA-binding	protein	protein
protein	protein	protein
(	O	O
human	protein	protein
X	protein	protein
box	protein	protein
binding	protein	protein
protein	protein	protein
,	O	O
hXBP-1	protein	protein
)	O	O
whose	O	O
target	O	O
is	O	O
the	O	O
human	DNA	protein
DR	DNA	protein
alpha	DNA	protein
X	DNA	protein
box	DNA	protein
and	O	O
the	O	O
3'	DNA	DNA
flanking	DNA	DNA
region	DNA	DNA
has	O	O
now	O	O
been	O	O
cloned.	O	O
This	O	O
complementary	DNA	O
DNA	DNA	O
encoded	O	O
a	O	O
protein	O	O
with	O	O
structural	O	O
similarities	O	O
to	O	O
the	O	O
c-jun	protein	DNA
proto-oncogene	protein	DNA
product	protein	DNA
,	O	O
and	O	O
its	O	O
target	O	O
sequence	O	O
was	O	O
closely	O	O
related	O	O
to	O	O
the	O	O
palindromic	DNA	DNA
target	DNA	DNA
sequence	DNA	DNA
of	O	O
c-jun	DNA	DNA
.	O	O
Mutation	O	O
of	O	O
the	O	O
hXBP-1	DNA	DNA
DNA	DNA	DNA
target	DNA	DNA
sequence	DNA	DNA
decreased	O	O
DR	DNA	DNA
alpha	DNA	DNA
promoter	DNA	DNA
activity	O	O
in	O	O
vivo.	O	O
These	O	O
studies	O	O
suggest	O	O
that	O	O
the	O	O
hXBP-1	protein	protein
protein	protein	protein
acts	O	O
as	O	O
a	O	O
transcription	protein	protein
factor	protein	protein
in	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Pseudohypoaldosteronism	O	O
in	O	O
eight	O	O
families:	O	O
different	O	O
forms	O	O
of	O	O
inheritance	O	O
are	O	O
evidence	O	O
for	O	O
various	O	O
genetic	O	O
defects	O	O
.	O	O
Pseudohypoaldosteronism	O	O
is	O	O
a	O	O
rare	O	O
hereditary	O	O
disorder	O	O
presenting	O	O
in	O	O
early	O	O
infancy	O	O
with	O	O
renal	O	O
salt	O	O
loss	O	O
leading	O	O
to	O	O
hyponatremia	O	O
and	O	O
hyperkalemia	O	O
despite	O	O
high	O	O
levels	O	O
of	O	O
plasma	O	O
aldosterone	O	O
.	O	O
The	O	O
patients	O	O
are	O	O
insensitive	O	O
to	O	O
mineralocorticoids	O	O
;	O	O
however,	O	O
sodium	O	O
supplementation	O	O
is	O	O
able	O	O
to	O	O
correct	O	O
electrolyte	O	O
abnormalities	O	O
.	O	O
Absent	O	O
or	O	O
greatly	O	O
diminished	O	O
type	O	O
I	protein	protein
aldosterone	protein	protein
receptors	protein	protein
in	O	O
peripheral	cell_type	cell_type
mononuclear	cell_type	cell_type
leucocytes	cell_type	cell_type
have	O	O
been	O	O
recently	O	O
demonstrated	O	O
and	O	O
explain	O	O
the	O	O
lack	O	O
of	O	O
response	O	O
to	O	O
mineralocorticoids	O	O
.	O	O
We	O	O
have	O	O
studied	O	O
the	O	O
mode	O	O
of	O	O
inheritance	O	O
in	O	O
eight	O	O
families	O	O
with	O	O
a	O	O
total	O	O
of	O	O
nine	O	O
patients	O	O
.	O	O
There	O	O
was	O	O
evidence	O	O
for	O	O
an	O	O
autosomal	O	O
recessive	O	O
form	O	O
of	O	O
inheritance	O	O
in	O	O
four	O	O
families,	O	O
while	O	O
the	O	O
other	O	O
four	O	O
families	O	O
appeared	O	O
to	O	O
have	O	O
an	O	O
autosomal	O	O
dominant	O	O
mode	O	O
of	O	O
transmission	O	O
.	O	O
In	O	O
three	O	O
families	O	O
the	O	O
autosomal	O	O
recessive	O	O
form	O	O
was	O	O
characterized	O	O
by	O	O
normal	protein	O
receptor	protein	O
as	O	O
well	O	O
as	O	O
hormone	O	O
data	O	O
in	O	O
both	O	O
parents,	O	O
while	O	O
in	O	O
one	O	O
family	O	O
receptor	O	O
levels	O	O
in	O	O
both	O	O
parents	O	O
were	O	O
greatly	O	O
reduced,	O	O
but	O	O
hormone	O	O
levels	O	O
were	O	O
normal.	O	O
In	O	O
the	O	O
four	O	O
families	O	O
with	O	O
an	O	O
autosomal	O	O
dominant	O	O
mode	O	O
of	O	O
transmission	O	O
there	O	O
was	O	O
always	O	O
one	O	O
parent	O	O
with	O	O
reduced	O	O
receptor	O	O
binding	O	O
in	O	O
peripheral	cell_type	O
mononuclear	cell_type	O
leucocytes	cell_type	O
and	O	O
elevated	O	O
serum	O	O
hormone	O	O
levels	O	O
.	O	O
These	O	O
parents	O	O
were	O	O
entirely	O	O
asymptomatic	O	O
.	O	O
In	O	O
an	O	O
extended	O	O
family	O	O
we	O	O
were	O	O
able	O	O
to	O	O
study	O	O
an	O	O
aunt	O	O
and	O	O
her	O	O
newborn	O	O
daughter,	O	O
who	O	O
were	O	O
both	O	O
also	O	O
biochemically	O	O
affected	O	O
but	O	O
clinically	O	O
asymptomatic	O	O
.	O	O
It,	O	O
therefore,	O	O
appears	O	O
that	O	O
this	O	O
dual	O	O
pattern	O	O
of	O	O
genetic	O	O
transmission	O	O
may	O	O
indicate	O	O
differing	O	O
genetic	O	O
defects	O	O
which	O	O
cause	O	O
the	O	O
same	O	O
clinical	O	O
picture	O	O
of	O	O
pseudohypoaldosteronism	O	O
.	O	O

Perceived	O	O
social	O	O
support	O	O
and	O	O
tumor	O	O
estrogen/progesterone	protein	O
receptor	protein	O
status	O	O
as	O	O
predictors	O	O
of	O	O
natural	protein	O
killer	protein	O
cell	protein	O
activity	protein	O
in	O	O
breast	O	O
cancer	O	O
patients	O	O
.	O	O
This	O	O
report	O	O
is	O	O
concerned	O	O
with	O	O
the	O	O
prediction	O	O
of	O	O
natural	O	protein
killer	cell_type	protein
(NK)	cell_type	protein
cell	cell_type	protein
activity	O	O
in	O	O
61	O	O
Stage	O	O
I	O	O
and	O	O
II	O	O
breast	O	O
cancer	O	O
patients	O	O
,	O	O
between	O	O
the	O	O
ages	O	O
of	O	O
25	O	O
and	O	O
70,	O	O
who	O	O
were	O	O
accrued	O	O
to	O	O
this	O	O
project.	O	O
All	O	O
baseline	O	O
interview	O	O
and	O	O
testing	O	O
data	O	O
were	O	O
obtained	O	O
either	O	O
just	O	O
before	O	O
patients	O	O
were	O	O
discharged	O	O
from	O	O
the	O	O
hospital,	O	O
or	O	O
at	O	O
their	O	O
first	O	O
outpatient	O	O
visit,	O	O
within	O	O
two	O	O
weeks	O	O
of	O	O
discharge.	O	O
A	O	O
major	O	O
interest	O	O
of	O	O
this	O	O
project	O	O
is	O	O
the	O	O
predictive	O	O
value	O	O
of	O	O
perceived	O	O
social	O	O
support,	O	O
as	O	O
a	O	O
potential	O	O
"stress"	O	O
buffer,	O	O
related	O	O
to	O	O
NK	O	O
activity	O	O
.	O	O
In	O	O
the	O	O
main	O	O
model	O	O
reported	O	O
here,	O	O
we	O	O
found	O	O
that	O	O
a	O	O
significant	O	O
amount	O	O
of	O	O
NK	O	O
activity	O	O
variance	O	O
could	O	O
be	O	O
explained	O	O
by	O	O
five	O	O
variables.	O	O
Higher	O	O
NK	O	O
activity	O	O
could	O	O
be	O	O
predicted	O	O
by	O	O
the	O	O
perception	O	O
of	O	O
high	O	O
quality	O	O
emotional	O	O
support	O	O
from	O	O
a	O	O
spouse	O	O
or	O	O
intimate	O	O
other	O	O
,	O	O
perceived	O	O
social	O	O
support	O	O
from	O	O
the	O	O
patient's	O	O
physician	O	O
,	O	O
estrogen	protein	O
receptor	protein	O
-negative	O	O
tumor	O	O
status	O	O
,	O	O
having	O	O
an	O	O
excisional	protein	O
biopsy	protein	O
as	O	O
surgical	protein	O
treatment	protein	O
,	O	O
and	O	O
actively	O	O
seeking	O	O
social	protein	O
support	protein	O
as	O	O
a	O	O
major	O	O
coping	O	O
strategy	O	O
(R2	O	O
=	O	O
0.33,	O	O
F(5,55)	O	O
=	O	O
5.5,	O	O
p	O	O
less	O	O
than	O	O
0.0004).	O	O
Findings	O	O
are	O	O
discussed	O	O
in	O	O
terms	O	O
of	O	O
host	O	O
interaction	O	O
with	O	O
tumor	protein	O
endocrine	protein	O
status	protein	O
,	O	O
and	O	O
the	O	O
role	O	O
that	O	O
social	protein	O
support	protein	O
might	O	O
play	O	O
in	O	O
modulating	O	O
such	O	O
activity.	O	O

[	O	O
Estrogen	protein	protein
receptor	protein	protein
content	O	O
of	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
lymphocytes	cell_type	cell_type
in	O	O
patients	O	O
with	O	O
systemic	O	O
lupus	O	O
erythematosus	O	O
]	O	O
ER	O	protein
content	O	O
in	O	O
lymphocytes	cell_type	cell_type
of	O	O
peripheral	O	cell_type
blood	O	cell_type
from	O	O
27	O	O
SLE	O	O
patients	O	O
and	O	O
20	O	O
healthy	O	O
controls	O	O
were	O	O
determined	O	O
by	O	O
dextran-coated	O	O
charcoal	O	O
assay	O	O
.	O	O
ER	protein	protein
content	O	O
in	O	O
lymphocytes	cell_type	cell_type
of	O	O
each	O	O
sample	O	O
was	O	O
expressed	O	O
by	O	O
both	O	O
fmol/mg	O	O
of	O	O
lymphocyte	protein	protein
cytosolic	protein	protein
protein	protein	protein
and	O	O
fmol/micrograms	O	O
of	O	O
lymphocyte	DNA	O
DNA	DNA	O
.	O	O
The	O	O
results	O	O
showed	O	O
that	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
between	O	O
the	O	O
ER	protein	protein
content	O	O
of	O	O
lymphocytes	cell_type	cell_type
from	O	O
the	O	O
controls	O	O
and	O	O
that	O	O
from	O	O
patients	O	O
with	O	O
SLE	O	O
.	O	O
But	O	O
the	O	O
logarithmic	O	O
mean	O	O
of	O	O
ER	protein	protein
content	O	O
in	O	O
lymphocytes	cell_type	cell_type
,	O	O
expressed	O	O
by	O	O
fmol/mg	O	O
of	O	O
cytosolic	protein	protein
protein	protein	protein
,	O	O
in	O	O
14	O	O
patients	O	O
with	O	O
active	O	O
SLE	O	O
(0.9356	O	O
+/-	O	O
0.31)	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
that	O	O
in	O	O
13	O	O
patients	O	O
with	O	O
inactive	O	O
SLE	O	O
(0.2979	O	O
+/-	O	O
0.23,	O	O
P	O	O
less	O	O
than	O	O
0.001)	O	O
and	O	O
in	O	O
the	O	O
controls	O	O
(0.6204	O	O
+/-	O	O
0.52,	O	O
P	O	O
less	O	O
than	O	O
0.001).	O	O
The	O	O
normal	O	O
upper	O	O
limit	O	O
of	O	O
ER	protein	protein
content	O	O
in	O	O
lymphocytes	cell_type	cell_type
,	O	O
expressed	O	O
by	O	O
fmol/micrograms	O	O
of	O	O
DNA,	O	O
was	O	O
0.136.	O	O
The	O	O
elevated	O	O
rate	O	O
of	O	O
ER	protein	protein
content	O	O
in	O	O
lymphocytes	cell_type	cell_type
in	O	O
14	O	O
active	O	O
SLE	O	O
(92.9%)	O	O
was	O	O
also	O	O
higher	O	O
than	O	O
that	O	O
in	O	O
quieiescent	O	O
patients	O	O
(23.1%,	O	O
P	O	O
less	O	O
than	O	O
0.001)	O	O
and	O	O
in	O	O
the	O	O
controls	O	O
(10%,	O	O
P	O	O
less	O	O
than	O	O
0.001).	O	O
Moreover,	O	O
the	O	O
elevated	O	O
level	O	O
of	O	O
ER	protein	protein
content	O	O
was	O	O
found	O	O
to	O	O
be	O	O
related	O	O
to	O	O
the	O	O
positive	O	O
antidsDNA	protein	O
antibody	protein	O
and	O	O
hypocomplementemia	O	O
.	O	O

An	O	O
in	O	O
vitro	O	O
globin	DNA	DNA
gene	DNA	DNA
switching	O	O
model	O	O
based	O	O
on	O	O
differentiated	cell_type	O
embryonic	cell_type	cell_type
stem	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
We	O	O
used	O	O
mouse	cell_type	O
embryonic	cell_type	O
stem	cell_type	O
(ES)	cell_type	O
cells	cell_type	O
to	O	O
study	O	O
globin	DNA	O
gene	DNA	O
expression	O	O
and	O	O
switching	O	O
in	O	O
vitro.	O	O
We	O	O
show	O	O
that	O	O
ES-derived	cell_type	O
embryoid	cell_type	O
bodies	cell_type	O
express	O	O
the	O	O
full	O	O
complement	O	O
of	O	O
mouse	DNA	O
embryonic	DNA	DNA
globin	DNA	DNA
genes	DNA	DNA
in	O	O
the	O	O
correct	O	O
temporal	O	O
order	O	O
and	O	O
that	O	O
on	O	O
further	O	O
differentiation	O	O
,	O	O
a	O	O
switch	O	O
occurs	O	O
to	O	O
the	O	O
fetal/adult	DNA	DNA
genes	DNA	DNA
.	O	O
In	O	O
addition,	O	O
the	O	O
erythroid-specific	protein	protein
transcription	protein	protein
factor	protein	protein
NF-E1	protein	protein
was	O	O
shown	O	O
to	O	O
be	O	O
expressed	O	O
coordinately	O	O
with	O	O
that	O	O
of	O	O
globin	protein	O
in	O	O
embryoid	cell_type	O
bodies	cell_type	O
.	O	O
We	O	O
conclude	O	O
from	O	O
these	O	O
experiments	O	O
that	O	O
the	O	O
ES	O	O
cell	O	O
system	O	O
provides	O	O
a	O	O
good	O	O
model	O	O
to	O	O
study	O	O
hematopoietic	O	O
development	O	O
.	O	O
When	O	O
the	O	O
human	O	O
epsilon-	O	O
or	O	O
beta-	O	O
globin	O	O
genes	O	O
driven	O	O
by	O	O
the	O	O
dominant	DNA	DNA
control	DNA	DNA
region	DNA	DNA
(	O	O
DCR	DNA	DNA
)	O	O
are	O	O
introduced	O	O
into	O	O
this	O	O
system,	O	O
the	O	O
human	DNA	DNA
epsilon-	DNA	DNA
globin	DNA	DNA
gene	DNA	DNA
,	O	O
in	O	O
contrast	O	O
to	O	O
the	O	O
beta-	DNA	O
globin	DNA	DNA
gene	DNA	DNA
,	O	O
is	O	O
not	O	O
deregulated	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
DCR	DNA	O
and	O	O
is	O	O
expressed	O	O
strictly	O	O
as	O	O
an	O	O
embryonic	DNA	DNA
gene	DNA	DNA
.	O	O
We	O	O
conclude	O	O
from	O	O
this	O	O
that	O	O
the	O	O
epsilon-	DNA	DNA
globin	DNA	DNA
gene	DNA	DNA
is	O	O
not	O	O
regulated	O	O
by	O	O
competition	O	O
with	O	O
other	O	O
genes	O	O
in	O	O
the	O	O
human	DNA	DNA
beta-globin	DNA	DNA
locus	DNA	DNA
.	O	O

Cloning	O	O
of	O	O
a	O	O
mitogen-inducible	DNA	DNA
gene	DNA	DNA
encoding	O	O
a	O	O
kappa	protein	DNA
B	protein	DNA
DNA-binding	protein	DNA
protein	protein	DNA
with	O	O
homology	O	O
to	O	O
the	O	O
rel	DNA	O
oncogene	DNA	O
and	O	O
to	O	O
cell-cycle	DNA	O
motifs	DNA	O
.	O	O
We	O	O
have	O	O
cloned	O	O
and	O	O
characterized	O	O
a	O	O
mitogen-inducible	DNA	DNA
gene	DNA	DNA
isolated	O	O
from	O	O
human	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
that	O	O
predicts	O	O
a	O	O
protein	O	O
of	O	O
968	protein	protein
amino	protein	protein
acids	protein	protein
.	O	O
The	O	O
amino-terminal	protein	protein
domain	protein	protein
has	O	O
regions	O	O
homologous	O	O
to	O	O
the	O	O
oncogene	DNA	DNA
rel	DNA	O
and	O	O
to	O	O
the	O	O
developmentally	O	O
important	O	O
gene	O	O
dorsal	DNA	O
of	O	O
Drosophila	O	O
.	O	O
The	O	O
carboxy-terminal	protein	protein
domain	protein	protein
contains	O	O
repeat	O	O
structures	O	O
found	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
proteins	O	O
that	O	O
are	O	O
involved	O	O
in	O	O
cell-cycle	O	O
control	O	O
of	O	O
yeast	O	O
and	O	O
in	O	O
tissue	O	O
differentiation	O	O
in	O	O
Drosophila	O	O
and	O	O
Ceanorhabditis	O	O
elegans	O	O
,	O	O
as	O	O
well	O	O
as	O	O
in	O	O
the	O	O
putative	DNA	O
human	DNA	O
oncogene	DNA	DNA
bcl-3	DNA	DNA
and	O	O
in	O	O
the	O	O
ankyrin	protein	protein
protein	protein	protein
.	O	O
A	O	O
truncated	O	O
form	O	O
of	O	O
the	O	O
product	O	O
of	O	O
this	O	O
gene	O	O
translated	O	O
in	O	O
vitro	O	O
is	O	O
a	O	O
DNA-binding	protein	protein
protein	protein	protein
which	O	O
interacts	O	O
specifically	O	O
with	O	O
the	O	O
kappa	DNA	DNA
B	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
found	O	O
in	O	O
many	O	O
inducible	DNA	DNA
genes	DNA	DNA
,	O	O
including	O	O
the	O	O
enhancer	O	O
in	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
.	O	O
This	O	O
gene	O	O
is	O	O
yet	O	O
another	O	O
in	O	O
a	O	O
growing	O	O
list	O	O
of	O	O
important	O	O
regulatory	O	protein
molecules	O	protein
whose	O	O
expression	O	O
is	O	O
transcriptionally	O	O
induced	O	O
upon	O	O
cellular	O	O
activation	O	O
.	O	O

Extrarenal	O	O
receptor-effector-mechanisms	O	O
for	O	O
aldosterone	O	O
:	O	O
the	O	O
sequence	O	O
of	O	O
effects	O	O
on	O	O
the	O	O
cellular	O	O
electrolyte	O	O
transport	O	O
in	O	O
human	cell_type	cell_type
lymphocytes	cell_type	cell_type
and	O	O
their	O	O
implications	O	O
for	O	O
disorders	O	O
of	O	O
the	O	O
water	O	O
and	O	O
electrolyte	O	O
balances	O	O
.	O	O
High	O	O
affinity	O	O
aldosterone	O	O
binding	O	O
sites	O	O
have	O	O
not	O	O
only	O	O
been	O	O
described	O	O
in	O	O
the	O	O
classic	O	O
target	O	O
tissues	O	O
such	O	O
as	O	O
the	O	O
renal	O	O
tubules	O	O
,	O	O
but	O	O
also	O	O
in	O	O
non-classic	O	O
target	O	O
tissues	O	O
such	O	O
as	O	O
the	O	O
hippocampus	O	O
,	O	O
mammary	O	O
gland	O	O
,	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
and,	O	O
recently,	O	O
human	cell_type	O
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
.	O	O
An	O	O
in	O	O
vitro	O	O
effect	O	O
of	O	O
aldosterone	O	O
on	O	O
intracellular	O	O
sodium	O	O
,	O	O
potassium	O	O
and	O	O
calcium	O	O
concentrations	O	O
and	O	O
cell	O	O
volume	O	O
was	O	O
shown	O	O
in	O	O
human	cell_type	cell_type
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
.	O	O
In	O	O
the	O	O
absence	O	O
of	O	O
aldosterone	O	O
,	O	O
the	O	O
intracellular	O	O
Na+	O	O
,	O	O
K+	O	O
and	O	O
Ca2+	O	O
concentrations	O	O
and	O	O
the	O	O
cell	O	O
volume	O	O
decreased	O	O
significantly,	O	O
but	O	O
remained	O	O
constant	O	O
when	O	O
aldosterone	O	O
(1.4	O	O
nmol/l)	O	O
was	O	O
added	O	O
to	O	O
the	O	O
incubation	O	O
medium	O	O
.	O	O
These	O	O
effects	O	O
of	O	O
aldosterone	O	O
were	O	O
blocked	O	O
by	O	O
the	O	O
aldosterone	O	O
antagonist	O	O
canrenone	O	O
(140	O	O
nmol/l).	O	O
The	O	O
sodium/proton	protein	O
exchanger	protein	O
of	O	O
the	O	O
cell	O	O
membrane	O	O
could	O	O
be	O	O
identified	O	O
as	O	O
the	O	O
primary	O	O
target	O	O
of	O	O
the	O	O
aldosterone	O	O
action,	O	O
possibly	O	O
non-genomically	O	O
mediated	O	O
through	O	O
membrane	protein	protein
receptors	protein	protein
.	O	O
The	O	O
clinical	O	O
significance	O	O
of	O	O
this	O	O
model	O	O
was	O	O
underlined	O	O
by	O	O
the	O	O
demonstration	O	O
of	O	O
absent	O	O
or	O	O
a	O	O
decreased	O	O
number	O	O
of	O	O
mineralocorticoid	protein	protein
receptors	protein	protein
and	O	O
the	O	O
lack	O	O
of	O	O
electrolyte	O	O
response	O	O
to	O	O
aldosterone	O	O
in	O	O
human	cell_type	cell_type
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
of	O	O
patients	O	O
with	O	O
pseudohypoaldosteronism	O	O
and	O	O
aldosteronism	O	O
.	O	O
Additionally,	O	O
an	O	O
abnormal	O	O
effector	O	O
mechanism	O	O
could	O	O
be	O	O
demonstrated	O	O
in	O	O
human	cell_type	cell_type
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
from	O	O
essential	O	O
hypertensives	O	O
.	O	O
These	O	O
studies	O	O
are	O	O
the	O	O
first	O	O
to	O	O
demonstrate	O	O
the	O	O
significance	O	O
of	O	O
extrarenal,	protein	O
nonepithelial	protein	O
mineralocorticoid	protein	O
receptors	protein	O
and	O	O
the	O	O
related	O	O
effector	O	O
mechanism	O	O
in	O	O
different	O	O
disorders	O	O
of	O	O
the	O	O
water	O	O
and	O	O
electrolyte	O	O
balance	O	O
in	O	O
man	O	O
.	O	O

Immunohistochemical	O	O
study	O	O
of	O	O
steroid	O	O
hormones	O	O
and	O	O
an	O	O
estrogen	O	O
binding	O	O
assay	O	O
in	O	O
malignant	cell_type	O
soft	cell_type	O
tissue	cell_type	O
tumors	cell_type	O
.	O	O
Immunohistochemically,	O	O
the	O	O
immunoreaction	O	O
against	O	O
5	O	O
steroid	O	O
hormone	O	O
anti-sera	O	O
(	O	O
estradiol	O	O
,	O	O
estriol	O	O
,	O	O
cortisol	O	O
,	O	O
progesterone	O	O
and	O	O
testosterone	O	O
)	O	O
was	O	O
examined	O	O
in	O	O
39	O	O
cases	O	O
with	O	O
the	O	O
malignant	cell_type	O
soft	cell_type	O
tissue	cell_type	O
tumors	cell_type	O
(	O	O
fibrosarcoma	O	O
:	O	O
8,	O	O
malignant	O	O
fibrous	O	O
histiocytoma	O	O
:	O	O
6,	O	O
rhabdomyosarcoma	O	O
:	O	O
10,	O	O
leiomyosarcoma	O	O
:	O	O
10,	O	O
liposarcoma	O	O
:	O	O
5).	O	O
Seventeen	O	O
cases	O	O
revealed	O	O
distinct	O	O
immunostaining	O	O
against	O	O
at	O	O
least	O	O
1	O	O
of	O	O
the	O	O
5	O	O
steroid	O	O
hormones	O	O
.	O	O
Immunostained	cell_type	O
tumor	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
more	O	O
frequently	O	O
distributed	O	O
in	O	O
the	O	O
area	O	O
where	O	O
tumor	O	O
cell	O	O
infiltration	O	O
was	O	O
more	O	O
invasive.	O	O
The	O	O
majority	O	O
of	O	O
the	O	O
positive	O	O
cases	O	O
occurred	O	O
in	O	O
female	O	O
cases.	O	O
Furthermore,	O	O
the	O	O
existence	O	O
of	O	O
estrogen	protein	O
receptor	protein	O
(estrogen	O	O
binding	O	O
activity)	O	O
was	O	O
examined	O	O
histochemically	O	O
in	O	O
39	O	O
cases	O	O
and	O	O
it	O	O
was	O	O
detected	O	O
in	O	O
8.	O	O
We	O	O
concluded	O	O
that	O	O
steroid	O	O
hormones	O	O
might	O	O
be	O	O
closely	O	O
related	O	O
to	O	O
tumor	O	O
cell	O	O
infiltration	O	O
of	O	O
some	O	O
malignant	cell_type	O
soft	cell_type	O
tissue	cell_type	O
tumors	cell_type	O
.	O	O

Involvement	O	O
of	O	O
cyclic	protein	protein
AMP-dependent	protein	protein
protein	protein	protein
kinases	protein	protein
in	O	O
the	O	O
signal	O	O
transduction	O	O
pathway	O	O
for	O	O
interleukin-1	protein	protein
.	O	O
Expression	O	O
of	O	O
a	O	O
highly	O	O
specific	O	O
protein	O	O
inhibitor	O	O
for	O	O
cyclic	protein	protein
AMP-dependent	protein	protein
protein	protein	protein
kinases	protein	protein
in	O	O
interleukin-1	cell_line	cell_line
(IL-1)-responsive	cell_line	cell_line
cells	cell_line	cell_line
blocked	O	O
IL-1-induced	DNA	O
gene	DNA	O
transcription	O	O
that	O	O
was	O	O
driven	O	O
by	O	O
the	O	O
kappa	DNA	DNA
immunoglobulin	DNA	DNA
enhancer	DNA	DNA
or	O	O
the	O	O
human	DNA	O
immunodeficiency	DNA	O
virus	DNA	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
.	O	O
This	O	O
inhibitor	O	O
did	O	O
not	O	O
affect	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
-mediated	O	O
gene	O	O
transcription	O	O
,	O	O
suggesting	O	O
that	O	O
cyclic	protein	protein
AMP-dependent	protein	protein
protein	protein	protein
kinases	protein	protein
are	O	O
involved	O	O
in	O	O
the	O	O
signal	O	O
transduction	O	O
pathway	O	O
for	O	O
IL-1	protein	protein
in	O	O
a	O	O
number	O	O
of	O	O
responsive	cell_type	O
cell	cell_type	O
types	cell_type	O
.	O	O

The	O	O
Epstein-Barr	DNA	O
virus	DNA	O
(	DNA	O
EBV	DNA	O
)	DNA	O
ORI1yt	DNA	DNA
enhancer	DNA	DNA
is	O	O
not	O	O
B-cell	O	O
specific	O	O
and	O	O
does	O	O
not	O	O
respond	O	O
synergistically	O	O
to	O	O
the	O	O
EBV	O	protein
transcription	O	protein
factors	O	protein
R	O	O
and	O	O
Z	O	O
.	O	O
The	O	O
Epstein-Barr	DNA	O
virus	DNA	O
DR	DNA	DNA
promoter	DNA	DNA
is	O	O
located	O	O
upstream	O	O
of	O	O
the	O	O
PstI	DNA	O
repeats	DNA	O
,	O	O
and	O	O
in	O	O
addition	O	O
to	O	O
the	O	O
TATA	DNA	DNA
box	DNA	DNA
,	O	O
it	O	O
contains	O	O
an	O	O
upstream	DNA	DNA
region	DNA	DNA
(positions	O	O
-69	O	O
to	O	O
-220)	O	O
responsive	O	O
to	O	O
EB1	protein	protein
(Z)	protein	protein
(the	O	O
BZLF1-encoded	protein	protein
transcription	protein	protein
factor	protein	protein
)	O	O
and	O	O
an	O	O
enhancer	DNA	O
with	O	O
two	O	O
functionally	O	O
distinct	O	O
domains,	O	O
A	DNA	O
and	O	O
B	DNA	O
.	O	O
Domain	DNA	protein
B	DNA	protein
has	O	O
been	O	O
described	O	O
as	O	O
a	O	O
B-cell-specific	DNA	O
EB1	DNA	DNA
-responsive	DNA	DNA
element	DNA	DNA
(P.M.Lieberman,	O	O
J.M.Hardwick,	O	O
and	O	O
S.D.Hayward,	O	O
J.Virol.63:3040-3050,	O	O
1989)	O	O
activated	O	O
synergistically	O	O
by	O	O
EB1	protein	protein
and	O	O
R	protein	O
,	O	O
an	O	O
EBV	protein	O
early	protein	O
product	protein	O
encoded	O	O
by	O	O
the	O	O
open	DNA	DNA
reading	DNA	DNA
frame	DNA	DNA
BRLF1	DNA	DNA
(M.A.	O	DNA
Cox,	O	DNA
J.Leahy,	O	DNA
and	O	O
J.M.Hardwick,	O	O
J.Virol.64:313-321,	O	O
1990).	O	O
We	O	O
show	O	O
here	O	O
that	O	O
domain	DNA	O
B	DNA	O
is	O	O
an	O	O
R-responsive	DNA	DNA
element	DNA	DNA
in	O	O
HeLa	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
is	O	O
therefore	O	O
not	O	O
an	O	O
EB1	DNA	DNA
-responsive	DNA	DNA
B-cell-specific	DNA	DNA
element	DNA	DNA
.	O	O
However,	O	O
there	O	O
is	O	O
an	O	O
EB1	DNA	DNA
-binding	DNA	DNA
site	DNA	DNA
(	O	O
ZRE-B	DNA	protein
)	O	O
located	O	O
within	O	O
the	O	O
R-responsive	DNA	DNA
enhancer	DNA	DNA
region	DNA	DNA
.	O	O
ZRE-B	DNA	protein
can	O	O
be	O	O
deleted	O	O
without	O	O
affecting	O	O
the	O	O
R-dependent	O	DNA
enhancer	O	DNA
activity	O	O
.	O	O
Moreover,	O	O
there	O	O
is	O	O
no	O	O
cooperation	O	O
or	O	O
synergy	O	O
between	O	O
R	protein	O
and	O	O
EB1	protein	protein
when	O	O
activating	O	O
the	O	O
B	DNA	protein
domain	DNA	protein
(	O	O
ZRE-B	DNA	protein
plus	O	O
the	O	O
R-responsive	DNA	DNA
element	DNA	DNA
)	O	O
positioned	O	O
as	O	O
an	O	O
enhancer	DNA	O
.	O	O
ZRE-B	DNA	O
is	O	O
therefore	O	O
not	O	O
part	O	O
of	O	O
the	O	O
R-	DNA	DNA
inducible	DNA	DNA
enhancer	DNA	DNA
.	O	O
We	O	O
have	O	O
tested	O	O
several	O	O
subregions	O	O
of	O	O
the	O	O
DR	DNA	DNA
enhancer	DNA	DNA
B	DNA	DNA
domain	DNA	DNA
,	O	O
either	O	O
alone	O	O
or	O	O
in	O	O
combination,	O	O
for	O	O
their	O	O
capacity	O	O
to	O	O
transmit	O	O
the	O	O
R-activating	O	O
signal	O	O
to	O	O
the	O	O
rabbit	DNA	O
beta-globin	DNA	DNA
promoter	DNA	DNA
.	O	O
We	O	O
found	O	O
that	O	O
the	O	O
R-responsive	DNA	DNA
element	DNA	DNA
is	O	O
composed	O	O
of	O	O
four	O	O
protoenhancers	DNA	O
that	O	O
span	O	O
the	O	O
whole	O	O
B	DNA	protein
domain	DNA	protein
.	O	O
These	O	O
protoenhancers	DNA	O
alone	O	O
are	O	O
weakly	O	O
or	O	O
not	O	O
responsive	O	O
to	O	O
R	protein	O
.	O	O
One	O	O
of	O	O
the	O	O
protoenhancers	DNA	DNA
contains	O	O
the	O	O
overlapping	DNA	O
palindromes	DNA	O
5'-TTGTCCcgtGGACAAaTGTCC-3'	O	O
.	O	O
However,	O	O
one	O	O
palindrome	DNA	O
,	O	O
either	O	O
alone	O	O
or	O	O
duplicated,	O	O
or	O	O
the	O	O
overlapping	DNA	O
palindromes	DNA	O
did	O	O
not	O	O
respond	O	O
to	O	O
R.	O	O

Nuclear	O	protein
3,5,3'-triiodothyronine	protein	protein
receptors	protein	protein
(	O	O
T3R	protein	protein
)	O	O
of	O	O
circulating	cell_type	cell_type
human	cell_type	cell_type
lymphocytes	cell_type	cell_type
in	O	O
hyper-	O	O
and	O	O
hypo	O	O
thyroidism	O	O
and	O	O
nonthyroidal	O	O
diseases	O	O
.	O	O
The	O	O
clinical	O	O
implications	O	O
of	O	O
nuclear	O	O
T3R	protein	protein
alterations	O	O
of	O	O
circulating	cell_type	cell_type
lymphocytes	cell_type	cell_type
in	O	O
hyperthyroidism	O	O
,	O	O
hypothyroidism	O	O
and	O	O
nonthyroidal	O	O
diseases	O	O
were	O	O
investigated.	O	O
Nuclear	O	O
T3R	protein	O
in	O	O
lymphocytes	cell_type	cell_type
was	O	O
determined	O	O
by	O	O
radio-ligand	O	O
binding	O	O
analysis	O	O
.	O	O
The	O	O
results	O	O
showed	O	O
that	O	O
in	O	O
hyper-	O	O
and	O	O
hypo	O	O
thyroid	O	O
patients	O	O
the	O	O
nuclear	O	O
affinity	O	O
(	O	O
Ka	O	O
)	O	O
for	O	O
T3	O	protein
was	O	O
similar	O	O
to	O	O
that	O	O
of	O	O
normal	O	O
subjects	O	O
.	O	O
In	O	O
hyperthyroidism	O	O
nuclear	O	O
T3	O	protein
maximal	O	protein
binding	O	O
capacity	O	O
(	O	O
MBC	O	O
)	O	O
was	O	O
unaltered,	O	O
whereas	O	O
in	O	O
hypothyroidism	O	O
the	O	O
MBC	O	O
was	O	O
significantly	O	O
increased.	O	O
In	O	O
the	O	O
patients	O	O
with	O	O
diabetes	O	O
mellitus	O	O
,	O	O
chronic	O	O
renal	O	O
failure	O	O
and	O	O
hepatic	O	O
cirrhosis	O	O
,	O	O
the	O	O
nuclear	protein	O
T3R	protein	protein
MBC	O	protein
of	O	O
lymphocytes	cell_type	cell_type
was	O	O
about	O	O
1.5-1.6	O	O
times	O	O
of	O	O
the	O	O
normal	O	O
controls	O	O
.	O	O
It	O	O
was	O	O
concluded	O	O
that	O	O
there	O	O
existed	O	O
hormonal	O	O
regulation	O	O
of	O	O
nuclear	protein	O
T3R	protein	protein
,	O	O
and	O	O
up-regulation	O	O
was	O	O
seen	O	O
in	O	O
hypothyroidism	O	O
and	O	O
low	O	O
T3	O	O
syndrome	O	O
.	O	O

Lymphocyte	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
from	O	O
vitamin	O	cell_line
D-dependent	O	cell_line
rickets	O	cell_line
type	O	cell_line
II	O	cell_line
show	O	O
functional	O	O
defects	O	O
in	O	O
the	O	O
1	protein	O
alpha,25-dihydroxyvitamin	protein	protein
D3	protein	protein
receptor	protein	protein
.	O	O
Lymphocyte	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
were	O	O
established	O	O
from	O	O
five	O	O
patients	O	O
with	O	O
vitamin	O	O
D-dependent	O	O
rickets	O	O
,	O	O
type	O	protein
II	O	protein
(	O	O
VDDR-II	O	protein
).	O	O
These	O	O
lines	O	O
were	O	O
established	O	O
by	O	O
infection	O	O
with	O	O
human	O	O
T-lymphotrophic	O	O
virus	O	O
type	O	O
I	O	O
(	O	O
HTLV-I	O	O
).	O	O
Binding	O	O
of	O	O
[3H]1	O	O
alpha,25-dihydroxyvitamin	O	O
D3	O	O
(	O	O
1,25(OH)2D3	O	O
)	O	O
to	O	O
its	O	O
receptor	O	O
in	O	O
these	O	O
cell	O	cell_line
lines	O	cell_line
was	O	O
compared	O	O
to	O	O
binding	O	O
studies	O	O
using	O	O
a	O	O
T-lymphocyte	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
(	O	O
S-LB1	cell_line	cell_line
)	O	O
from	O	O
a	O	O
normal	O	O
individual.	O	O
The	O	O
1,25(OH)2D3	O	O
receptor	O	O
of	O	O
S-LB1	cell_line	protein
was	O	O
comparable	O	O
to	O	O
the	O	O
well-characterized	O	O
chick	protein	protein
intestinal	protein	protein
1,25(OH)2D3	protein	O
receptor	protein	O
in	O	O
terms	O	O
of	O	O
its	O	O
ligand	O	O
binding	O	O
affinity	O	O
and	O	O
capacity,	O	O
its	O	O
mobility	O	O
on	O	O
5-20%	O	O
sucrose	O	O
gradients,	O	O
and	O	O
its	O	O
adsorption	O	O
to	O	O
and	O	O
elution	O	O
properties	O	O
from	O	O
DNA-cellulose	O	O
.	O	O
Three	O	O
cell	cell_line	cell_line
lines	cell_line	cell_line
established	O	O
from	O	O
patients	O	O
with	O	O
VDDR-II	O	O
(	O	O
Rh-	O	protein
VDR	protein	protein
,	O	O
Sh-	O	O
VDR	protein	protein
,	O	O
and	O	O
Ab-	O	protein
VDR	protein	protein
)	O	O
showed	O	O
no	O	O
specific	O	O
binding	O	O
of	O	O
1,25(OH)2D3	O	O
to	O	O
a	O	O
receptor	protein	O
and	O	O
treatment	O	O
of	O	O
the	O	O
cultured	cell_line	cell_line
cells	cell_line	cell_line
with	O	O
1,25(OH)2D3	O	O
did	O	O
not	O	O
stimulate	O	O
production	O	O
of	O	O
24,25-dihydroxy-vitamin	O	O
D3	O	O
(	O	O
24,25(OH)2D3	O	O
),	O	O
a	O	O
response	O	O
which	O	O
is	O	O
diagnostic	O	O
of	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
functional	protein	O
1,25(OH)2D3	protein	O
receptor	protein	O
.	O	O
In	O	O
a	O	O
fourth	O	O
cell	cell_line	O
line	cell_line	O
,	O	O
A1-VDR	cell_line	protein
,	O	O
the	O	O
receptor	O	O
for	O	O
1,25(OH)2D3	O	O
had	O	O
a	O	O
low	O	O
binding	O	O
capacity	O	O
and	O	O
25(OH)D3-24-hydroxylase	protein	protein
activity	O	O
was	O	O
not	O	O
detectable.	O	O
Induction	O	O
of	O	O
24,25-(OH)2D3	O	O
synthesis	O	O
by	O	O
1,25(OH)2D3	O	O
was	O	O
observed	O	O
in	O	O
the	O	O
fifth	O	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
,	O	O
designated	O	O
Ro-VDR	cell_line	protein
,	O	O
although	O	O
the	O	O
sensitivity	O	O
to	O	O
hormone	O	O
treatment	O	O
was	O	O
lower	O	O
than	O	O
in	O	O
the	O	O
control	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
from	O	O
a	O	O
normal	O	O
donor	O	O
.	O	O
The	O	O
capacity	O	O
of	O	O
the	O	O
receptor	protein	O
for	O	O
1,25(OH)2D3	O	O
was	O	O
low	O	O
in	O	O
Ro-VDR	cell_line	O
.	O	O
In	O	O
all	O	O
cell	cell_line	O
lines	cell_line	O
where	O	O
1,25(OH)2D3	O	O
binding	O	O
to	O	O
a	O	O
receptor	protein	O
was	O	O
detectable,	O	O
the	O	O
receptor	protein	O
had	O	O
the	O	O
typical	O	O
sedimentation	O	O
coefficient	O	O
of	O	O
3.7	O	O
S	O	O
on	O	O
sucrose	O	O
density	O	O
gradient	O	O
analysis	O	O
.	O	O
Binding	O	O
and	O	O
elution	O	O
properties	O	O
to	O	O
DNA-cellulose	O	O
,	O	O
however,	O	O
differed	O	O
from	O	O
normal	O	O
in	O	O
both	O	O
Ro-VDR	cell_line	O
and	O	O
A1-VDR	cell_line	cell_line
cells	cell_line	cell_line
where	O	O
elution	O	O
from	O	O
DNA-cellulose	O	O
occurred	O	O
at	O	O
a	O	O
lower	O	O
salt	O	O
concentration	O	O
than	O	O
is	O	O
typical	O	O
of	O	O
the	O	O
1,25(OH)2D3	protein	O
receptor	protein	O
.	O	O
While	O	O
Ro-VDR	cell_line	cell_line
cells	cell_line	cell_line
showed	O	O
typical	O	O
nuclear	O	O
localization	O	O
of	O	O
the	O	O
unoccupied	protein	O
1,25(OH)2D3	protein	O
receptor	protein	O
,	O	O
neither	O	O
the	O	O
unoccupied	O	O
nor	O	O
the	O	O
occupied	O	O
receptor	protein	O
from	O	O
A1-VDR	cell_line	cell_line
cells	cell_line	cell_line
was	O	O
completely	O	O
localized	O	O
in	O	O
the	O	O
nucleus	O	O
.	O	O
In	O	O
a	O	O
series	O	O
of	O	O
functional	O	O
studies	O	O
we	O	O
found	O	O
that	O	O
modulation	O	O
of	O	O
the	O	O
level	O	O
of	O	O
the	O	O
mRNAs	RNA	RNA
coding	O	O
for	O	O
both	O	O
the	O	O
c-myc	DNA	DNA
oncogene	DNA	DNA
and	O	O
the	O	O
growth	O	protein
factor	O	protein
known	O	O
as	O	O
granulocyte-monocyte	O	O
colony	O	O
stimulating	O	O
activity	O	O
by	O	O
1,25(OH)2D3	O	O
correlated	O	O
with	O	O
the	O	O
1,25(OH)2D3	protein	O
receptor	protein	O
status	O	O
of	O	O
these	O	O
cells.	O	O
Use	O	O
of	O	O
these	O	O
cell	cell_line	O
lines	cell_line	O
will	O	O
facilitate	O	O
further	O	O
study	O	O
of	O	O
the	O	O
molecular	O	O
defect(s)	O	O
in	O	O
the	O	O
receptor	protein	O
for	O	O
1,25(OH)2D3	O	O
in	O	O
vitamin	O	O
D-dependent	O	O
rickets	O	O
type	O	O
II	O	O
and	O	O
will	O	O
allow	O	O
a	O	O
correlation	O	O
with	O	O
impairment	O	O
of	O	O
cellular	O	O
functions	O	O
.	O	O

Transcriptional	O	O
and	O	O
post-transcriptional	O	O
regulation	O	O
of	O	O
c-jun	DNA	DNA
expression	O	O
during	O	O
monocytic	O	O
differentiation	O	O
of	O	O
human	cell_line	cell_type
myeloid	cell_line	cell_type
leukemic	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
AP-1	protein	protein
,	O	O
the	O	O
polypeptide	O	O
product	O	O
of	O	O
c-jun	DNA	DNA
,	O	O
recognizes	O	O
and	O	O
binds	O	O
to	O	O
specific	DNA	O
DNA	DNA	DNA
sequences	DNA	DNA
and	O	O
stimulates	O	O
transcription	O	O
of	O	O
genes	DNA	O
responsive	O	O
to	O	O
certain	O	O
growth	O	protein
factors	O	protein
and	O	O
phorbol	O	O
esters	O	O
such	O	O
as	O	O
12-O-tetradecanoylphorbol-13-acetate	O	O
(	O	O
TPA	O	O
).	O	O
We	O	O
studied	O	O
the	O	O
effects	O	O
of	O	O
TPA	O	O
on	O	O
the	O	O
regulation	O	O
of	O	O
c-jun	DNA	DNA
gene	O	DNA
expression	O	O
in	O	O
HL-60	cell_line	cell_line
cells	cell_line	cell_line
during	O	O
monocytic	O	O
differentiation	O	O
.	O	O
Low	O	O
levels	O	O
of	O	O
c-jun	RNA	DNA
transcripts	RNA	DNA
were	O	O
detectable	O	O
in	O	O
untreated	cell_line	O
HL-60	cell_line	cell_line
leukemic	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
increased	O	O
significantly	O	O
by	O	O
6	O	O
h,	O	O
and	O	O
reached	O	O
near	O	O
maximal	O	O
levels	O	O
by	O	O
24	O	O
h	O	O
of	O	O
exposure	O	O
to	O	O
32	O	O
nM	O	O
TPA	O	O
.	O	O
Similar	O	O
kinetics	O	O
of	O	O
c-jun	DNA	O
induction	O	O
by	O	O
TPA	O	O
were	O	O
observed	O	O
in	O	O
human	cell_line	O
U-937	cell_line	cell_line
and	O	O
THP-1	cell_line	cell_line
monocytic	cell_line	cell_line
leukemia	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Similar	O	O
findings	O	O
were	O	O
obtained	O	O
with	O	O
bryostatin	O	O
1	O	O
(10	O	O
nM),	O	O
another	O	O
activator	O	O
of	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
and	O	O
inducer	O	O
of	O	O
monocytic	O	O
differentiation	O	O
.	O	O
Furthermore,	O	O
1,25-dihydroxyvitamin	O	O
D3	O	O
(0.5	O	O
microM),	O	O
a	O	O
structurally	O	O
distinct	O	O
agent	O	O
which	O	O
also	O	O
induces	O	O
HL-60	O	O
monocytic	O	O
differentiation	O	O
,	O	O
increased	O	O
c-jun	DNA	DNA
expression	O	O
.	O	O
TPA	O	O
treatment	O	O
of	O	O
HL-60	cell_line	cell_line
cells	cell_line	cell_line
in	O	O
the	O	O
presence	O	O
of	O	O
cycloheximide	O	O
was	O	O
associated	O	O
with	O	O
superinduction	O	O
of	O	O
c-jun	DNA	DNA
transcripts.	O	O
Run-on	O	O
analysis	O	O
demonstrated	O	O
detectable	O	O
levels	O	O
of	O	O
c-jun	DNA	DNA
gene	O	DNA
transcription	O	O
in	O	O
untreated	cell_line	O
HL-60	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
and	O	O
that	O	O
exposure	O	O
to	O	O
TPA	O	O
increases	O	O
this	O	O
rate	O	O
3.3-fold.	O	O
Treatment	O	O
of	O	O
HL-60	cell_line	cell_line
cells	cell_line	cell_line
with	O	O
both	O	O
TPA	O	O
and	O	O
cycloheximide	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
the	O	O
rates	O	O
of	O	O
c-jun	DNA	DNA
transcription	O	O
.	O	O
The	O	O
half-life	O	O
of	O	O
c-jun	RNA	DNA
RNA	RNA	DNA
as	O	O
determined	O	O
by	O	O
treating	O	O
HL-60	cell_line	cell_line
cells	cell_line	cell_line
with	O	O
TPA	O	O
and	O	O
actinomycin	O	O
D	O	O
was	O	O
30	O	O
min.	O	O
In	O	O
contrast,	O	O
the	O	O
half-life	O	O
of	O	O
c-jun	RNA	DNA
RNA	RNA	DNA
in	O	O
TPA	cell_line	O
-treated	cell_line	O
HL-60	cell_line	cell_line
cells	cell_line	cell_line
exposed	O	O
to	O	O
cycloheximide	O	O
and	O	O
actinomycin	O	O
D	O	O
was	O	O
greater	O	O
than	O	O
2	O	O
h.	O	O
These	O	O
findings	O	O
suggested	O	O
that	O	O
the	O	O
increase	O	O
in	O	O
c-jun	RNA	DNA
RNA	RNA	DNA
observed	O	O
during	O	O
TPA	O	O
-induced	O	O
monocytic	O	O
differentiation	O	O
is	O	O
mediated	O	O
by	O	O
both	O	O
transcriptional	O	O
and	O	O
post-transcriptional	O	O
mechanisms	O	O
.	O	O

[	O	O
Hormonal	O	O
interactions	O	O
and	O	O
glucocorticoid	protein	protein
receptors	protein	protein
in	O	O
patients	O	O
with	O	O
the	O	O
nephrotic	O	O
syndrome	O	O
]	O	O
As	O	O
many	O	O
as	O	O
27	O	O
children	O	O
aged	O	O
6	O	O
to	O	O
15	O	O
years	O	O
with	O	O
morphologically	O	O
verified	O	O
nephropathies	O	O
were	O	O
examined.	O	O
Four	O	O
variants	O	O
of	O	O
changes	O	O
in	O	O
the	O	O
thyroid	O	O
status	O	O
,	O	O
characteristic	O	O
of	O	O
children	O	O
with	O	O
different	O	O
variants	O	O
of	O	O
nephrotic	O	O
syndrome	O	O
were	O	O
distinguished:	O	O
1)	O	O
biochemical	O	O
signs	O	O
of	O	O
primary	O	O
hypothyroidism	O	O
,	O	O
2)	O	O
biochemical	O	O
signs	O	O
of	O	O
secondary	O	O
hypothyroidism	O	O
,	O	O
3)	O	O
low	O	O
content	O	O
of	O	O
T3,	O	O
4)	O	O
dysfunction	O	O
of	O	O
the	O	O
hypophyseal	O	O
and	O	O
thyroid	O	O
system	O	O
.	O	O
It	O	O
is	O	O
shown	O	O
that	O	O
the	O	O
low	O	O
level	O	O
of	O	O
steroid	protein	protein
receptors	protein	protein
,	O	O
thyroid	O	O
hormones	O	O
that	O	O
the	O	O
low	O	O
level	O	O
of	O	O
steroid	protein	protein
receptors	protein	protein
,	O	O
thyroid	O	O
hormones	O	O
(T3	O	O
and	O	O
T4)	O	O
and	O	O
cortisol	O	O
is	O	O
typical	O	O
of	O	O
children	O	O
with	O	O
the	O	O
signs	O	O
of	O	O
renal	O	O
dysplasia	O	O
.	O	O
It	O	O
is	O	O
assumed	O	O
that	O	O
superaddition	O	O
under	O	O
such	O	O
conditions	O	O
of	O	O
immune	O	O
glomerulopathy	O	O
(	O	O
glomerulonephritis	O	O
and	O	O
nephrotic	O	O
syndrome	O	O
)	O	O
gives	O	O
rise	O	O
to	O	O
the	O	O
resistance	O	O
to	O	O
the	O	O
treatment	O	O
with	O	O
glucocorticoids	O	O
.	O	O

Lymphoid	O	O
specific	O	O
gene	O	O
expression	O	O
of	O	O
the	O	O
adenovirus	DNA	DNA
early	DNA	DNA
region	DNA	DNA
3	DNA	DNA
promoter	DNA	DNA
is	O	O
mediated	O	O
by	O	O
NF-kappa	DNA	protein
B	DNA	protein
binding	DNA	O
motifs	DNA	O
.	O	O
A	O	O
primary	O	O
site	O	O
of	O	O
infection	O	O
by	O	O
human	O	O
adenoviruses	O	O
is	O	O
lymphoid	cell_type	O
cells	cell_type	O
.	O	O
However,	O	O
analysis	O	O
of	O	O
the	O	O
viral	DNA	DNA
control	DNA	DNA
elements	DNA	DNA
and	O	O
the	O	O
cellular	protein	protein
factors	protein	protein
that	O	O
regulate	O	O
adenoviral	O	O
gene	O	O
expression	O	O
in	O	O
lymphocytes	cell_type	cell_type
has	O	O
not	O	O
been	O	O
reported.	O	O
The	O	O
adenovirus	protein	DNA
early	protein	DNA
region	protein	DNA
3	protein	DNA
(	protein	DNA
ES	protein	DNA
)	protein	DNA
gene	protein	DNA
products	protein	DNA
are	O	O
involved	O	O
in	O	O
the	O	O
maintenance	O	O
of	O	O
viral	O	O
persistence	O	O
by	O	O
complexing	O	O
with	O	O
the	O	O
class	protein	DNA
I	protein	DNA
MHC	protein	DNA
antigens	protein	DNA
,	O	O
thus	O	O
preventing	O	O
their	O	O
cell	O	O
surface	O	O
expression	O	O
with	O	O
a	O	O
resultant	O	O
decrease	O	O
in	O	O
host	O	O
immunologic	O	O
destruction	O	O
.	O	O
To	O	O
determine	O	O
whether	O	O
different	O	O
cellular	protein	protein
factors	protein	protein
were	O	O
involved	O	O
in	O	O
E3	O	O
regulation	O	O
in	O	O
lymphocytes	cell_type	cell_type
as	O	O
compared	O	O
with	O	O
HeLa	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
both	O	O
DNA	O	O
binding	O	O
and	O	O
transfection	O	O
analysis	O	O
with	O	O
the	O	O
E3	DNA	DNA
promoter	DNA	DNA
in	O	O
both	O	O
cell	O	O
types	O	O
were	O	O
performed.	O	O
These	O	O
studies	O	O
detected	O	O
two	O	O
novel	DNA	protein
domains	DNA	protein
referred	O	O
to	O	O
as	O	O
L1	DNA	protein
and	O	O
L2	DNA	O
with	O	O
a	O	O
variety	O	O
of	O	O
lymphoid	O	O
but	O	O
not	O	O
HeLa	O	cell_line
extracts	O	cell_line
.	O	O
Each	O	O
of	O	O
these	O	O
domains	O	O
possessed	O	O
strong	O	O
homology	O	O
to	O	O
motifs	O	O
previously	O	O
found	O	O
to	O	O
bind	O	O
the	O	O
cellular	protein	protein
factor	protein	protein
NF-kappa	protein	protein
B	protein	protein
.	O	O
Transfections	O	O
of	O	O
E3	DNA	DNA
constructs	DNA	DNA
linked	O	O
to	O	O
the	O	O
chloramphenicol	DNA	DNA
acetyltransferase	DNA	DNA
gene	DNA	DNA
revealed	O	O
that	O	O
mutagenesis	O	O
of	O	O
the	O	O
distal	DNA	DNA
NF-kappa	DNA	DNA
B	DNA	DNA
motif	DNA	DNA
(	O	O
L2	DNA	protein
)	O	O
had	O	O
minimal	O	O
effects	O	O
on	O	O
promoter	O	O
expression	O	O
in	O	O
HeLa	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
but	O	O
resulted	O	O
in	O	O
dramatic	O	O
decreases	O	O
in	O	O
expression	O	O
by	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
contrast,	O	O
mutagenesis	O	O
of	O	O
proximal	DNA	O
NF-kappa	DNA	protein
B	DNA	protein
motif	DNA	protein
(	O	O
L1	DNA	protein
)	O	O
had	O	O
minimal	O	O
effects	O	O
on	O	O
gene	O	O
expression	O	O
in	O	O
both	O	O
HeLa	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
but	O	O
resulted	O	O
in	O	O
a	O	O
small,	O	O
but	O	O
reproducible,	O	O
increase	O	O
in	O	O
gene	O	O
expression	O	O
in	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
when	O	O
coupled	O	O
to	O	O
the	O	O
L2	DNA	protein
mutation	O	protein
.	O	O
Reversing	O	O
the	O	O
position	O	O
and	O	O
subsequent	O	O
mutagenesis	O	O
of	O	O
the	O	O
L1	DNA	protein
and	O	O
L2	DNA	protein
domains	DNA	protein
indicated	O	O
that	O	O
the	O	O
primary	DNA	O
sequence	DNA	O
of	O	O
these	O	O
motifs	O	O
rather	O	O
than	O	O
their	O	O
position	O	O
in	O	O
the	O	O
E3	DNA	DNA
promoter	DNA	DNA
was	O	O
critical	O	O
for	O	O
regulating	O	O
gene	O	O
expression	O	O
.	O	O
(ABSTRACT	O	O
TRUNCATED	O	O
AT	O	O
250	O	O
WORDS)	O	O

Characterization	O	O
of	O	O
defensin	protein	O
resistance	O	O
phenotypes	O	O
associated	O	O
with	O	O
mutations	O	O
in	O	O
the	O	O
phoP	DNA	O
virulence	DNA	O
regulon	DNA	O
of	O	O
Salmonella	O	O
typhimurium	O	O
.	O	O
The	O	O
defensin	protein	O
sensitivities	O	O
of	O	O
Salmonella	O	O
typhimurium	O	O
strains	O	O
with	O	O
mutations	O	O
in	O	O
the	O	O
phoP/phoQ	DNA	O
two-component	DNA	O
virulence	DNA	O
regulon	DNA	O
were	O	O
tested	O	O
by	O	O
using	O	O
purified	protein	O
defensins	protein	O
NP-1	protein	protein
and	O	O
NP-2	protein	protein
.	O	O
Strains	O	O
with	O	O
mutations	O	O
in	O	O
either	O	O
gene	O	O
of	O	O
the	O	O
regulatory	DNA	DNA
pair	DNA	DNA
(	O	O
phoP	DNA	protein
[	O	protein
transcriptional	DNA	protein
activator	DNA	protein
]	O	protein
or	O	O
phoQ	DNA	O
[	O	O
membrane	protein	O
sensor	protein	O
kinase	protein	O
])	O	O
had	O	O
increased	O	O
sensitivities	O	O
to	O	O
defensin	protein	O
.	O	O
The	O	O
predicted	O	O
periplasmic	protein	protein
domain	protein	protein
of	O	O
the	O	O
PhoQ	protein	protein
protein	protein	protein
contained	O	O
a	O	O
markedly	O	O
anionic	O	O
domain	O	O
that	O	O
could	O	O
interact	O	O
with	O	O
cationic	protein	O
proteins	protein	O
and	O	O
that	O	O
could	O	O
be	O	O
responsible	O	O
for	O	O
resistance	O	O
to	O	O
defensin	protein	O
.	O	O
Because	O	O
insertion	O	O
mutations	O	O
in	O	O
phoP	DNA	O
are	O	O
polar	O	O
on	O	O
phoQ	DNA	O
,	O	O
we	O	O
constructed	O	O
strains	O	O
that	O	O
expressed	O	O
the	O	O
PhoQ	protein	protein
protein	protein	protein
in	O	O
the	O	O
absence	O	O
of	O	O
PhoP	protein	O
to	O	O
test	O	O
whether	O	O
resistance	O	O
to	O	O
defensin	O	O
requires	O	O
only	O	O
the	O	O
phoQ	protein	DNA
gene	protein	DNA
product	protein	O
.	O	O
We	O	O
found	O	O
that	O	O
resistance	O	O
to	O	O
defensin	O	O
requires	O	O
the	O	O
function	O	O
of	O	O
both	O	O
components	O	O
of	O	O
this	O	O
regulatory	O	O
system	O	O
,	O	O
because	O	O
strains	O	O
expressing	O	O
PhoQ	protein	O
without	O	O
PhoP	protein	O
were	O	O
still	O	O
markedly	O	O
sensitive	O	O
to	O	O
defensins	protein	O
.	O	O
This	O	O
implied	O	O
that	O	O
a	O	O
pag	protein	O
(	protein	O
phoP	protein	DNA
-activated	protein	DNA
gene	protein	DNA
)	protein	O
product	protein	O
is	O	O
responsible	O	O
for	O	O
defensin	protein	O
resistance	O	O
.	O	O
We	O	O
also	O	O
tested	O	O
for	O	O
the	O	O
ability	O	O
of	O	O
defensins	protein	O
NP-1	protein	protein
,	O	O
NP-5	protein	protein
,	O	O
and	O	O
HNP-1	protein	protein
to	O	O
activate	O	O
pag	DNA	O
expression	O	O
and	O	O
found	O	O
that	O	O
these	O	O
peptides	O	O
have	O	O
no	O	O
effect.	O	O
Defensin	O	O
resistance	O	O
is	O	O
not	O	O
the	O	O
only	O	O
virulence	O	O
characteristic	O	O
controlled	O	O
by	O	O
the	O	O
PhoP	protein	O
-PhoQ	protein	O
regulon	protein	O
because	O	O
mutations	O	O
in	O	O
pagC	DNA	O
,	O	O
as	O	O
well	O	O
as	O	O
ones	O	O
in	O	O
the	O	O
phoP	DNA	O
locus	DNA	O
that	O	O
resulted	O	O
in	O	O
constitutive	O	O
pag	DNA	O
activation	O	O
(phenotype	O	O
PhoPc	protein	O
),	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
defensin	protein	O
resistance	O	O
,	O	O
even	O	O
though	O	O
they	O	O
rendered	O	O
the	O	O
organism	O	O
avirulent	O	O
and	O	O
deficient	O	O
in	O	O
survival	O	O
within	O	O
macrophages	cell_type	cell_type
.	O	O
The	O	O
virulence	O	O
defect	O	O
conferred	O	O
by	O	O
mutations	O	O
in	O	O
the	O	O
phoP	DNA	O
-phoQ	DNA	O
two-component	O	O
regulatory	O	O
system	O	O
is	O	O
not	O	O
completely	O	O
explained	O	O
by	O	O
alterations	O	O
in	O	O
resistance	O	O
to	O	O
cationic	protein	O
proteins	protein	O
and	O	O
involves	O	O
the	O	O
control	O	O
of	O	O
other	O	O
proteins	O	O
necessary	O	O
for	O	O
S.	O	O
typhimurium	O	O
survival	O	O
within	O	O
macrophages	cell_type	cell_type
.	O	O

Stimulation	O	O
of	O	O
a	O	O
human	cell_line	cell_line
T-cell	cell_line	cell_line
clone	cell_line	cell_line
with	O	O
anti-CD3	protein	protein
or	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
induces	O	O
NF-kappa	protein	protein
B	protein	protein
translocation	O	O
but	O	O
not	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
1	O	O
enhancer-dependent	O	O
transcription	O	O
.	O	O
The	O	O
expression	O	O
of	O	O
transiently	O	O
transfected	O	O
expression	O	O
vectors	O	O
under	O	O
the	O	O
control	O	O
of	O	O
the	O	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
(	O	O
LTR	DNA	DNA
)	O	O
of	O	O
the	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
(	O	O
HIV	O	O
)	O	O
or	O	O
its	O	O
enhancer	DNA	DNA
sequence	DNA	DNA
and	O	O
the	O	O
translocation	O	O
of	O	O
the	O	O
HIV	protein	O
enhancer-binding	protein	O
protein	protein	O
NF-kappa	protein	protein
B	protein	protein
were	O	O
analyzed	O	O
in	O	O
two	O	O
human	O	cell_line
T-cell	cell_line	cell_line
clones	cell_line	cell_line
stimulated	O	O
through	O	O
their	O	O
T-cell	protein	protein
receptor	protein	protein
complex	protein	protein
or	O	O
by	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
or	O	O
phorbol	O	O
12-myristate	O	O
13-acetate	O	O
.	O	O
We	O	O
found	O	O
a	O	O
dissociation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
translocation	O	O
from	O	O
transactivation	O	O
of	O	O
either	O	O
the	O	O
HIV	DNA	DNA
LTR	DNA	DNA
or	O	O
the	O	O
HIV	DNA	DNA
enhancer	DNA	DNA
.	O	O
Interleukin	protein	protein
2	protein	protein
induced	O	O
proliferation	O	O
but	O	O
not	O	O
NF-kappa	protein	protein
B	protein	protein
translocation	O	O
or	O	O
LTR	DNA	DNA
transactivation	O	O
.	O	O
Phorbol	O	O
ester	O	O
or	O	O
specific	O	O
antigen	O	O
recognition	O	O
induced	O	O
HIV	DNA	O
LTR	DNA	DNA
transactivation	O	O
,	O	O
whereas	O	O
stimulation	O	O
with	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
or	O	O
antibody	O	O
to	O	O
CD3	protein	protein
did	O	O
not.	O	O
The	O	O
two	O	O
latter	O	O
signals	O	O
were	O	O
nevertheless	O	O
able	O	O
to	O	O
induce	O	O
NF-kappa	protein	protein
B	protein	protein
translocation	O	O
with	O	O
a	O	O
pattern	O	O
in	O	O
the	O	O
band-shift	O	O
assay	O	O
indistinguishable	O	O
from	O	O
that	O	O
observed	O	O
using	O	O
phorbol	O	O
ester	O	O
.	O	O
Our	O	O
finding	O	O
that	O	O
induction	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
by	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
or	O	O
antibody	protein	O
to	protein	O
CD3	protein	protein
is	O	O
not	O	O
sufficient	O	O
to	O	O
induce	O	O
HIV	DNA	DNA
enhancer	DNA	DNA
-dependent	O	O
transcription	O	O
in	O	O
cloned	cell_line	O
T	cell_line	cell_type
cells	cell_line	cell_type
contrasts	O	O
with	O	O
results	O	O
obtained	O	O
in	O	O
most	O	O
lymphoblastoid	cell_line	cell_line
T-cell	cell_line	cell_line
lines	cell_line	cell_line
and	O	O
indicates	O	O
that	O	O
normal	O	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
differ	O	O
from	O	O
tumoral	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
terms	O	O
of	O	O
requirements	O	O
for	O	O
HIV	DNA	O
LTR	DNA	DNA
activation	O	O
.	O	O
Furthermore,	O	O
our	O	O
results	O	O
suggest	O	O
that	O	O
events	O	O
linked	O	O
to	O	O
T-cell	O	O
activation	O	O
,	O	O
in	O	O
addition	O	O
to	O	O
NF-kappa	protein	protein
B	protein	protein
translocation	O	O
per	O	O
se,	O	O
induce	O	O
functional	O	O
interactions	O	O
of	O	O
the	O	O
NF-kappa	protein	protein
B	protein	protein
complex	protein	protein
with	O	O
the	O	O
HIV	DNA	DNA
enhancer	DNA	DNA
.	O	O

Decreased	O	O
concentration	O	O
of	O	O
1,25-dihydroxyvitamin	protein	O
D3	protein	O
receptors	protein	O
in	O	O
peripheral	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
of	O	O
patients	O	O
with	O	O
X-linked	O	O
hypophosphatemic	O	O
rickets	O	O
:	O	O
effect	O	O
of	O	O
phosphate	O	O
supplementation	O	O
.	O	O
Abnormal	O	O
renal	O	O
tubular	O	O
phosphate	O	O
transport	O	O
is	O	O
considered	O	O
to	O	O
be	O	O
the	O	O
primary	O	O
defect	O	O
in	O	O
X-linked	O	O
hypophosphatemic	O	O
rickets	O	O
(	O	O
XLH	O	O
).	O	O
However,	O	O
the	O	O
resistance	O	O
to	O	O
vitamin	O	O
D	O	O
treatment	O	O
in	O	O
XLH	O	O
cannot	O	O
be	O	O
explained	O	O
by	O	O
hypophosphatemia	O	O
alone.	O	O
Since	O	O
most	O	O
of	O	O
the	O	O
actions	O	O
of	O	O
vitamin	O	O
D	O	O
are	O	O
mediated	O	O
by	O	O
its	O	O
receptors	O	protein
(	O	O
VDR	protein	protein
),	O	O
abnormalities	O	O
of	O	O
VDR	protein	protein
have	O	O
been	O	O
postulated	O	O
in	O	O
XLH	O	O
.	O	O
In	O	O
order	O	O
to	O	O
investigate	O	O
this	O	O
possibility,	O	O
we	O	O
measured	O	O
the	O	O
concentration	O	O
of	O	O
VDR	protein	protein
in	O	O
PHA-activated	cell_line	cell_line
peripheral	cell_line	cell_line
mononuclear	cell_line	cell_line
cells	cell_line	cell_line
from	O	O
10	O	O
XLH	O	O
patients	O	O
.	O	O
Patients	O	O
without	O	O
phosphate	O	O
supplementation	O	O
showed	O	O
significantly	O	O
lower	O	O
concentration	O	O
(21.7	O	O
+/-	O	O
5.1	O	O
fmol/mg	O	O
protein,	O	O
mean	O	O
+/-	O	O
SEM)	O	O
compared	O	O
to	O	O
the	O	O
normal	O	O
controls	O	O
(60.7	O	O
+/-	O	O
4.0).	O	O
On	O	O
the	O	O
contrary,	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
between	O	O
the	O	O
phosphate-supplemented	O	O
patients	O	O
(58.3	O	O
+/-	O	O
2.7)	O	O
and	O	O
controls	O	O
.	O	O
There	O	O
was	O	O
a	O	O
significant	O	O
positive	O	O
correlation	O	O
between	O	O
VDR	protein	protein
concentration	O	O
and	O	O
serum	O	O
phosphate	O	O
(P	O	O
less	O	O
than	O	O
0.05).	O	O
In	O	O
two	O	O
patients	O	O
,	O	O
VDR	protein	protein
was	O	O
increased	O	O
after	O	O
daily	O	O
phosphate	O	O
supplementation	O	O
was	O	O
started.	O	O
These	O	O
results	O	O
indicate	O	O
that	O	O
a	O	O
decreased	O	O
concentration	O	O
of	O	O
VDR	protein	protein
secondary	O	O
to	O	O
persistent	O	O
hypophosphatemia	O	O
is	O	O
one	O	O
of	O	O
the	O	O
causes	O	O
of	O	O
vitamin	O	O
D	O	O
resistance	O	O
in	O	O
XLH	O	O
.	O	O

Two	O	O
distinct	O	O
forms	O	O
of	O	O
active	protein	O
transcription	protein	protein
factor	protein	protein
CREB	protein	protein
(	O	O
cAMP	protein	DNA
response	protein	DNA
element	protein	DNA
binding	protein	O
protein	protein	O
).	O	O
Mammalian	cell_type	cell_type
cells	cell_type	cell_type
express	O	O
two	O	O
distinct	O	O
forms	O	O
of	O	O
transcription	protein	protein
factor	protein	protein
CREB	protein	protein
(	O	O
cAMP	protein	DNA
response	protein	DNA
element	protein	DNA
binding	protein	O
protein	protein	O
)	O	O
that	O	O
are	O	O
apparently	O	O
the	O	O
products	O	O
of	O	O
alternative	O	O
splicing	O	O
of	O	O
the	O	O
CREB	RNA	DNA
gene	RNA	DNA
transcript	RNA	O
.	O	O
The	O	O
two	O	O
proteins	O	O
differ	O	O
by	O	O
a	O	O
14-amino	protein	O
acid	protein	O
serine-rich	protein	O
insertion	protein	O
present	O	O
in	O	O
one	O	O
of	O	O
the	O	O
CREB	protein	protein
isoforms	protein	protein
.	O	O
We	O	O
show	O	O
that	O	O
both	O	O
CREB	protein	protein
isoforms	protein	protein
are	O	O
expressed	O	O
in	O	O
many	cell_type	O
cell	cell_type	O
types	cell_type	O
and	O	O
mammalian	O	O
species	O	O
.	O	O
Both	O	O
encode	O	O
proteins	O	O
that	O	O
bind	O	O
specifically	O	O
to	O	O
a	O	O
cAMP	DNA	DNA
response	DNA	DNA
element	DNA	DNA
in	DNA	O
vitro	DNA	O
.	O	O
As	O	O
expected	O	O
for	O	O
proteins	O	O
of	O	O
this	O	O
class,	O	O
the	O	O
CREB	protein	protein
proteins	protein	protein
bind	O	O
DNA	O	O
as	O	O
dimers.	O	O
Both	O	O
proteins	O	O
impart	O	O
cAMP	O	O
-regulated	O	O
transcriptional	O	O
activity	O	O
to	O	O
a	O	O
heterologous	DNA	protein
DNA-binding	DNA	protein
domain	DNA	protein
,	O	O
showing	O	O
that	O	O
cAMP	O	O
directly	O	O
modulates	O	O
the	O	O
transcriptional	O	O
stimulatory	O	O
activity	O	O
of	O	O
CREB	protein	protein
.	O	O
The	O	O
presence	O	O
of	O	O
multiple	O	O
CREB	protein	protein
isoforms	protein	protein
with	O	O
identical	O	O
DNA-binding	O	O
specificities	O	O
but	O	O
differences	O	O
in	O	O
the	O	O
presumed	O	O
regulatory	protein	protein
domain	protein	protein
raises	O	O
the	O	O
possibility	O	O
that	O	O
CREB	protein	protein
proteins	protein	protein
may	O	O
be	O	O
able	O	O
to	O	O
integrate	O	O
distinct	O	O
regulatory	O	O
signals	O	O
at	O	O
the	O	O
level	O	O
of	O	O
gene	O	O
transcription	O	O
.	O	O

Human	protein	O
immunodeficiency	protein	O
virus	protein	O
vpr	protein	O
product	protein	O
is	O	O
a	O	O
virion-associated	protein	protein
regulatory	protein	protein
protein	protein	protein
.	O	O
The	O	O
vpr	protein	O
product	protein	O
of	O	O
the	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
type	O	O
1	O	O
(	O	O
HIV-1	O	O
)	O	O
acts	O	O
in	O	O
trans	O	O
to	O	O
accelerate	O	O
virus	O	O
replication	O	O
and	O	O
cytopathic	O	O
effect	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Here	O	O
it	O	O
is	O	O
shown	O	O
that	O	O
the	O	O
HIV-1	O	DNA
viral	O	DNA
particle	O	O
contains	O	O
multiple	O	O
copies	O	O
of	O	O
the	O	O
vpr	protein	O
protein	protein	O
.	O	O
The	O	O
vpr	protein	O
product	protein	O
is	O	O
the	O	O
first	O	O
regulatory	O	O
protein	O	O
of	O	O
HIV-1	O	O
to	O	O
be	O	O
found	O	O
in	O	O
the	O	O
virus	O	O
particle	O	O
.	O	O
This	O	O
observation	O	O
raises	O	O
the	O	O
possibility	O	O
that	O	O
vpr	DNA	O
acts	O	O
to	O	O
facilitate	O	O
the	O	O
early	O	O
steps	O	O
of	O	O
infection	O	O
before	O	O
de	O	O
novo	O	O
viral	O	O
protein	O	O
synthesis	O	O
occurs.	O	O

A	O	O
novel	O	O
B-cell	protein	O
lineage-specific	protein	O
transcription	protein	O
factor	protein	O
present	O	O
at	O	O
early	O	O
but	O	O
not	O	O
late	O	O
stages	O	O
of	O	O
differentiation	protein	O
.	O	O
A	O	O
novel	O	O
B-cell-specific	protein	protein
transcription	protein	protein
factor	protein	protein
,	O	O
BSAP	protein	protein
,	O	O
was	O	O
identified	O	O
as	O	O
a	O	O
mammalian	protein	DNA
homolog	protein	DNA
of	O	O
the	O	O
sea	protein	protein
urchin	protein	protein
protein	protein	protein
TSAP	protein	protein
,	O	O
which	O	O
interacts	O	O
with	O	O
the	O	O
promoters	DNA	DNA
of	O	O
four	O	O
tissue-specific	O	O
late	O	O
histone	O	protein
H2A-2	O	protein
and	O	O
H2B-2	O	DNA
genes	O	DNA
.	O	O
As	O	O
shown	O	O
by	O	O
mobility-shift	O	O
,	O	O
methylation	O	O
interference	O	O
,	O	O
and	O	O
mutational	O	O
analyses	O	O
,	O	O
the	O	O
mammalian	protein	protein
protein	protein	protein
BSAP	protein	protein
recognizes	O	O
all	O	O
four	O	O
sea	DNA	O
urchin	DNA	O
binding	DNA	O
sites	DNA	O
in	O	O
a	O	O
manner	O	O
indistinguishable	O	O
from	O	O
TSAP	protein	O
;	O	O
however,	O	O
the	O	O
two	O	O
proteins	O	O
differ	O	O
in	O	O
molecular	O	O
weight.	O	O
BSAP	protein	protein
is	O	O
exclusively	O	O
restricted	O	O
to	O	O
the	O	O
B-cell	O	cell_type
lineage	O	cell_type
of	O	O
lymphoid	O	O
differentiation	O	O
.	O	O
Its	O	O
expression	O	O
appears	O	O
to	O	O
be	O	O
activated	O	O
during	O	O
pro-B-cell	O	O
development	O	O
,	O	O
is	O	O
abundant	O	O
at	O	O
the	O	O
pre-B-	O	O
and	O	O
mature	O	O
B-	O	O
cell	O	O
stages	O	O
,	O	O
but	O	O
is	O	O
absent	O	O
in	O	O
terminally	cell_type	O
differentiated	cell_type	O
plasma	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Moreover,	O	O
BSAP	protein	protein
is	O	O
clearly	O	O
a	O	O
B-cell-specific	protein	protein
transcription	protein	protein
factor	protein	protein
,	O	O
as	O	O
a	O	O
wild-type	DNA	O
but	O	O
not	O	O
a	O	O
mutant	DNA	O
TSAP	DNA	DNA
-binding	DNA	DNA
site	DNA	DNA
of	O	O
the	O	O
sea	O	O
urchin	O	O
functions	O	O
only	O	O
in	O	O
transfected	cell_line	cell_line
B	cell_line	cell_line
cells	cell_line	cell_line
as	O	O
an	O	O
upstream	DNA	DNA
promoter	DNA	DNA
element	DNA	DNA
.	O	O
Competition	O	O
experiments	O	O
did	O	O
not	O	O
reveal	O	O
any	O	O
high-affinity	DNA	O
binding	DNA	O
site	DNA	O
for	O	O
BSAP	protein	protein
in	O	O
known	O	O
regulatory	DNA	O
regions	DNA	O
of	O	O
immunoglobulin	O	protein
and	O	O
class	O	DNA
II	O	DNA
major	O	DNA
histocompatibility	O	DNA
(MHC)	O	DNA
genes	O	DNA
,	O	O
suggesting	O	O
that	O	O
BSAP	protein	protein
is	O	O
a	O	O
regulator	O	O
of	O	O
a	O	O
different	O	O
set	O	O
of	O	O
B-lymphoid-specific	DNA	DNA
genes	DNA	DNA
.	O	O

Octamer	protein	protein
transcription	protein	protein
factors	protein	protein
and	O	O
the	O	O
cell	DNA	O
type-specificity	DNA	O
of	DNA	O
immunoglobulin	DNA	DNA
gene	DNA	DNA
expression	O	O
.	O	O
Antibodies	protein	O
are	O	O
produced	O	O
exclusively	O	O
in	O	O
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
The	O	O
expression	O	O
of	O	O
the	O	O
antibody-encoding	DNA	DNA
genes	DNA	DNA
,	O	O
the	O	O
immunoglobulin	DNA	DNA
(Ig)	DNA	DNA
genes	DNA	DNA
,	O	O
is	O	O
also	O	O
restricted	O	O
to	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
The	O	O
octamer	DNA	DNA
sequence	DNA	DNA
ATGCAAAT	O	DNA
is	O	O
present	O	O
in	O	O
the	O	O
promoter	DNA	O
and	O	O
the	O	O
enhancer	DNA	O
of	O	O
Ig	DNA	DNA
genes	DNA	DNA
,	O	O
and	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
its	O	O
tissue-specific	O	O
expression	O	O
.	O	O
This	O	O
sequence	DNA	O
motif	DNA	O
is	O	O
a	O	O
binding	O	O
site	O	O
for	O	O
nuclear	protein	protein
proteins	protein	protein
,	O	O
the	O	O
so-called	O	O
octamer	protein	protein
transcription	protein	protein
factors	protein	protein
(	O	O
Oct	protein	O
or	O	O
OTF	protein	protein
factors	protein	protein
).	O	O
The	O	O
Oct-1	protein	protein
protein	protein	protein
is	O	O
present	O	O
in	O	O
all	O	O
cell	O	O
types	O	O
analyzed	O	O
so	O	O
far,	O	O
whereas	O	O
Oct-2A	protein	protein
and	O	O
Oct-2B	protein	protein
are	O	O
found	O	O
mainly	O	O
in	O	O
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
All	O	O
three	O	O
proteins	O	O
show	O	O
the	O	O
same	O	O
sequence	O	O
specificity	O	O
and	O	O
binding	O	O
affinity	O	O
.	O	O
It	O	O
appears	O	O
that	O	O
the	O	O
B	O	protein
cell-specific	O	protein
expression	O	O
of	O	O
Ig	DNA	DNA
genes	DNA	DNA
is	O	O
mediated	O	O
at	O	O
least	O	O
in	O	O
part	O	O
by	O	O
cell	O	O
type-specific	protein	O
Oct	protein	protein
factors	protein	protein
,	O	O
and	O	O
that	O	O
there	O	O
are	O	O
both	O	O
quantitative	O	O
and	O	O
qualitative	O	O
differences	O	O
between	O	O
Oct-1	protein	protein
and	O	O
Oct-2	protein	protein
factors	protein	protein
.	O	O
Recently,	O	O
a	O	O
number	O	O
of	O	O
other	O	O
octamer	protein	protein
factor	protein	protein
variants	protein	protein
were	O	O
identified.	O	O
Many	O	O
of	O	O
these	O	O
may	O	O
be	O	O
created	O	O
by	O	O
alternative	O	O
splicing	O	O
of	O	O
a	O	O
primary	RNA	O
transcript	RNA	O
of	O	O
one	O	O
Oct	O	protein
factor	O	protein
gene	O	O
and	O	O
may	O	O
serve	O	O
a	O	O
specific	O	O
function	O	O
in	O	O
the	O	O
fine	O	O
tuning	O	O
of	O	O
gene	O	O
expression	O	O
.	O	O

A	O	O
factor	O	O
known	O	O
to	O	O
bind	O	O
to	O	O
endogenous	DNA	protein
Ig	DNA	protein
heavy	DNA	protein
chain	DNA	protein
enhancer	DNA	O
only	O	O
in	O	O
lymphocytes	cell_type	cell_type
is	O	O
a	O	O
ubiquitously	protein	O
active	protein	O
transcription	protein	O
factor	protein	O
.	O	O
The	O	O
transcriptional	DNA	DNA
enhancer	DNA	DNA
located	O	O
in	O	O
the	O	O
first	O	O
intron	O	O
of	O	O
the	O	O
immunoglobulin	DNA	DNA
heavy	DNA	DNA
chain	DNA	DNA
constant	DNA	DNA
region	DNA	DNA
is	O	O
a	O	O
major	O	O
determinant	O	O
of	O	O
B-cell-specific	O	O
expression	O	O
of	O	O
immunoglobulin	DNA	DNA
genes	DNA	DNA
.	O	O
Like	O	O
other	O	O
enhancers	DNA	DNA
,	O	O
the	O	O
Ig	DNA	DNA
heavy	DNA	DNA
chain	DNA	DNA
enhancer	DNA	DNA
contains	O	O
several	O	O
short	O	DNA
sequence	DNA	DNA
motifs	DNA	DNA
that	O	O
bind	O	O
specific	protein	O
transcription	protein	protein
factors	protein	protein
.	O	O
Each	O	O
binding	DNA	O
site	DNA	O
contributes	O	O
to	O	O
the	O	O
overall	O	O
activity	O	O
of	O	O
the	O	O
enhancer	DNA	DNA
,	O	O
however	O	O
no	O	O
single	O	O
element	O	O
seems	O	O
absolutely	O	O
required	O	O
for	O	O
activity.	O	O
For	O	O
a	O	O
better	O	O
understanding	O	O
of	O	O
the	O	O
Ig	DNA	DNA
heavy	DNA	DNA
chain	DNA	DNA
enhancer	DNA	DNA
components	DNA	O
,	O	O
we	O	O
have	O	O
cloned	O	O
and	O	O
analyzed	O	O
individual	O	O
sequence	DNA	O
elements	DNA	O
.	O	O
We	O	O
find	O	O
that	O	O
the	O	O
factor	O	O
that	O	O
binds	O	O
to	O	O
the	O	O
E3	DNA	DNA
enhancer	DNA	DNA
motif	DNA	DNA
,	O	O
CATGTGGC	O	O
,	O	O
is	O	O
a	O	O
ubiquitous	protein	protein
transcription	protein	protein
factor	protein	protein
.	O	O
It	O	O
is	O	O
present	O	O
in	O	O
an	O	O
active	O	O
form	O	O
in	O	O
both	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
non-	cell_type	cell_type
B	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
where	O	O
it	O	O
can	O	O
mediate	O	O
transcriptional	O	O
activation	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo.	O	O
However,	O	O
despite	O	O
its	O	O
ability	O	O
to	O	O
activate	O	O
transcription	O	O
of	O	O
a	O	O
transfected	DNA	O
reporter	DNA	DNA
gene	DNA	DNA
,	O	O
the	O	O
factor	O	O
is	O	O
apparently	O	O
unable	O	O
to	O	O
bind	O	O
to	O	O
the	O	O
endogenous	DNA	protein
Ig	DNA	protein
heavy	DNA	protein
chain	DNA	protein
enhancer	DNA	O
in	O	O
non-	cell_type	cell_type
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
:	O	O
In	O	O
previous	O	O
experiments	O	O
by	O	O
others,	O	O
the	O	O
characteristic	O	O
in	O	O
vivo	O	O
footprint	O	O
of	O	O
this	O	O
factor,	O	O
designated	O	O
NF-muE3	protein	protein
,	O	O
was	O	O
detected	O	O
in	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
but	O	O
not	O	O
in	O	O
non-B	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
From	O	O
this	O	O
and	O	O
other	O	O
findings	O	O
the	O	O
picture	O	O
emerges	O	O
that	O	O
there	O	O
are	O	O
at	O	O
least	O	O
three	O	O
categories	O	O
of	O	O
factors	O	O
which	O	O
mediate	O	O
cell-type-specific	O	O
transcription	O	O
in	O	O
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
:	O	O
(a)	O	O
cell-specific	protein	protein
factors	protein	protein
such	O	O
as	O	O
Oct-2A	protein	protein
and	O	O
Oct-2B	protein	protein
that	O	O
are	O	O
not	O	O
expressed	O	O
in	O	O
most	O	O
other	O	O
cell	O	O
types:	O	O
(b)	O	O
ubiquitous	protein	protein
factors	protein	protein
such	O	O
as	O	O
NF-kappa	protein	protein
B	protein	protein
that	O	O
are	O	O
constitutively	O	O
active	O	O
in	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
but	O	O
are	O	O
sequestered	O	O
in	O	O
an	O	O
inactive	O	O
form	O	O
in	O	O
other	O	O
cells;	O	O
(c)	O	O
ubiquitously	protein	O
active	protein	protein
factors	protein	protein
,	O	O
exemplified	O	O
by	O	O
the	O	O
one	O	O
binding	O	O
to	O	O
the	O	O
E3	DNA	DNA
sequence	DNA	DNA
motif	DNA	DNA
.	O	O
This	O	O
factor	O	O
is	O	O
present	O	O
in	O	O
an	O	O
active	O	O
form	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
cell	O	O
types	O	O
but	O	O
is	O	O
apparently	O	O
unable	O	O
to	O	O
bind	O	O
to	O	O
the	O	O
endogenous	DNA	protein
Ig	DNA	protein
heavy	DNA	protein
chain	DNA	protein
enhancer	DNA	O
in	O	O
non-B	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
perhaps	O	O
due	O	O
to	O	O
a	O	O
non-permissive	O	DNA
chromatin	DNA	DNA
structure	O	O
of	O	O
the	O	O
Ig	DNA	DNA
heavy	DNA	DNA
chain	DNA	DNA
locus	DNA	DNA
.	O	O

[	O	O
Endocrine	O	O
status	O	O
changes	O	O
in	O	O
children	O	O
with	O	O
bronchial	O	O
asthma	O	O
]	O	O
A	O	O
study	O	O
was	O	O
made	O	O
of	O	O
adrenocortical	O	O
function	O	O
by	O	O
measuring	O	O
blood	O	O
plasma	O	O
cortisol	O	O
concentration	O	O
and	O	O
amount	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
in	O	O
lymphocytes	cell_type	cell_type
as	O	O
well	O	O
as	O	O
thyroid	O	O
function	O	O
by	O	O
measuring	O	O
blood	O	O
plasma	O	O
triidothyronine	O	O
and	O	O
thyroxine	O	O
concentration	O	O
in	O	O
58	O	O
bronchial	O	O
asthma	O	O
children	O	O
aged	O	O
1	O	O
to	O	O
14	O	O
years.	O	O
The	O	O
authors	O	O
revealed	O	O
alterations	O	O
in	O	O
the	O	O
functional	O	O
activity	O	O
of	O	O
the	O	O
indicated	O	O
endocrine	O	O
glands	O	O
depending	O	O
on	O	O
the	O	O
intensity	O	O
of	O	O
bronchial	O	O
patency	O	O
disorders	O	O
and	O	O
the	O	O
nature	O	O
of	O	O
the	O	O
therapeutic	O	O
measures	O	O
carried	O	O
out.	O	O

TAR	DNA	DNA
independent	O	O
activation	O	O
of	O	O
the	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
in	O	O
phorbol	O	O
ester	O	O
stimulated	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
Multiple	DNA	O
regulatory	DNA	O
elements	DNA	O
in	O	O
the	O	O
human	DNA	O
immunodeficiency	DNA	O
virus	DNA	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
(	O	O
HIV	DNA	DNA
LTR	DNA	DNA
)	O	O
are	O	O
required	O	O
for	O	O
activation	O	O
of	O	O
HIV	O	DNA
gene	O	DNA
expression	O	O
.	O	O
Previous	O	O
transfection	O	O
studies	O	O
of	O	O
HIV	DNA	DNA
LTR	DNA	DNA
constructs	DNA	DNA
linked	O	O
to	O	O
the	O	O
chloramphenicol	DNA	DNA
acetyltransferase	DNA	DNA
gene	DNA	DNA
indicated	O	O
that	O	O
multiple	O	O
regulatory	DNA	O
regions	DNA	O
including	O	O
the	O	O
enhancer	DNA	DNA
,	O	O
SP1	DNA	protein
,	O	O
TATA	DNA	DNA
and	O	O
TAR	DNA	DNA
regions	DNA	DNA
were	O	O
important	O	O
for	O	O
HIV	O	O
gene	O	O
expression	O	O
.	O	O
To	O	O
characterize	O	O
these	O	O
regulatory	DNA	DNA
elements	DNA	DNA
further,	O	O
mutations	O	O
in	O	O
these	O	O
regions	O	O
were	O	O
inserted	O	O
into	O	O
both	O	O
the	O	O
5'	O	DNA
and	O	DNA
3'	O	DNA
HIV	DNA	DNA
LTRs	DNA	DNA
and	O	O
infectious	O	O
proviral	O	O
constructs	O	O
were	O	O
assembled.	O	O
These	O	O
constructs	O	O
were	O	O
transfected	O	O
into	O	O
either	O	O
HeLa	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
or	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
in	O	O
both	O	O
the	O	O
presence	O	O
and	O	O
absence	O	O
of	O	O
phorbol	O	O
esters	O	O
which	O	O
have	O	O
previously	O	O
been	O	O
demonstrated	O	O
to	O	O
activate	O	O
HIV	O	O
gene	O	O
expression	O	O
.	O	O
Viral	O	O
gene	O	O
expression	O	O
was	O	O
assayed	O	O
by	O	O
the	O	O
level	O	O
of	O	O
p24	protein	protein
gag	protein	protein
protein	protein	protein
released	O	O
from	O	O
cultures	O	O
transfected	O	O
with	O	O
the	O	O
proviral	O	O
constructs	O	O
.	O	O
Results	O	O
in	O	O
all	O	O
cell	O	O
lines	O	O
indicated	O	O
that	O	O
mutations	O	O
of	O	O
the	O	O
SP1	DNA	protein
,	O	O
TATA	DNA	DNA
and	O	O
the	O	O
TAR	DNA	DNA
loop	DNA	DNA
and	O	O
stem	DNA	O
secondary	DNA	O
structure	DNA	O
resulted	O	O
in	O	O
marked	O	O
decreases	O	O
in	O	O
gene	O	O
expression	O	O
while	O	O
mutations	O	O
of	O	O
the	O	O
enhancer	DNA	DNA
motif	DNA	DNA
or	O	O
TAR	DNA	DNA
primary	DNA	DNA
sequence	DNA	DNA
resulted	O	O
in	O	O
only	O	O
slight	O	O
decreases.	O	O
However,	O	O
viruses	O	O
containing	O	O
mutations	O	O
in	O	O
either	O	O
the	O	O
TAR	DNA	DNA
loop	DNA	DNA
sequences	DNA	DNA
or	O	O
stem	DNA	O
secondary	DNA	O
structure	DNA	O
which	O	O
were	O	O
very	O	O
defective	O	O
for	O	O
gene	O	O
expression	O	O
in	O	O
untreated	O	cell_line
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
gave	O	O
nearly	O	O
wild-type	O	O
levels	O	O
of	O	O
gene	O	O
expression	O	O
in	O	O
phorbol	cell_line	O
ester	cell_line	O
-treated	cell_line	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
but	O	O
not	O	O
in	O	O
phorbol	cell_line	O
ester	cell_line	O
-treated	cell_line	O
HeLa	cell_line	cell_line
or	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
High	O	O
level	O	O
gene	O	O
expression	O	O
of	O	O
these	O	O
TAR	DNA	DNA
mutant	DNA	DNA
constructs	DNA	DNA
in	O	O
phorbol	cell_line	O
ester	cell_line	O
-treated	cell_line	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
was	O	O
eliminated	O	O
by	O	O
second	O	O
site	O	O
mutations	O	O
in	O	O
the	O	O
enhancer	DNA	DNA
region	DNA	DNA
or	O	O
by	O	O
disruption	O	O
of	O	O
the	O	O
tat	DNA	DNA
gene	DNA	DNA
.	O	O
(ABSTRACT	O	O
TRUNCATED	O	O
AT	O	O
250	O	O
WORDS)	O	O

A	O	O
case	O	O
of	O	O
hypersensitivity	O	O
to	O	O
thyroid	O	O
hormones	O	O
with	O	O
normally	O	O
functioning	O	O
thyroid	O	O
gland	O	O
and	O	O
increased	O	O
nuclear	O	protein
triiodothyronine	protein	protein
receptors	protein	protein
.	O	O
A	O	O
52-year-old	O	O
male	O	O
presented	O	O
himself	O	O
with	O	O
tachycardia	O	O
crises	O	O
which	O	O
appeared	O	O
first	O	O
during	O	O
childhood,	O	O
increased	O	O
in	O	O
frequency	O	O
without	O	O
goiter	O	O
or	O	O
exophthalmos	O	O
.	O	O
Cardiac	O	O
and	O	O
adrenergic	O	O
diseases	O	O
were	O	O
excluded.	O	O
The	O	O
thyroid	O	O
function	O	O
was	O	O
normal	O	O
regarding	O	O
T4	O	O
,	O	O
free	O	O
T4	O	O
and	O	O
T3	O	protein
,	O	O
TBG	O	protein
,	O	O
radioiodine	O	O
uptake	O	O
,	O	O
TSH	O	O
and	O	O
T3	O	protein
suppressibility	O	O
;	O	O
however	O	O
the	O	O
TSH	O	O
response	O	O
to	O	O
TRH	O	protein
was	O	O
decreased.	O	O
The	O	O
lymphocyte	protein	O
nuclear	protein	O
T3	protein	protein
receptor	protein	protein
was	O	O
found	O	O
with	O	O
an	O	O
affinity	O	O
close	O	O
to	O	O
that	O	O
of	O	O
normal	O	O
volunteers	O	O
(Ka:	O	O
1.42	O	O
x	O	O
10(10)	O	O
M-1	O	O
vs	O	O
1.95	O	O
+/-	O	O
0.35	O	O
x	O	O
10(10)	O	O
M-1)	O	O
and	O	O
a	O	O
binding	O	O
capacity	O	O
markedly	O	O
increased	O	O
(9.9	O	O
vs	O	O
3.7	O	O
+/-	O	O
0.4	O	O
fmol	O	O
T3	O	O
/100	O	O
micrograms	O	O
DNA).	O	O
Pindolol	O	O
was	O	O
inefficient	O	O
on	O	O
the	O	O
dysrhythmia	O	O
which	O	O
disappeared	O	O
with	O	O
carbimazole	O	O
and	O	O
relapsed	O	O
after	O	O
withdrawal	O	O
of	O	O
the	O	O
antithyroid	O	O
drug.	O	O
Under	O	O
carbimazole	O	O
,	O	O
the	O	O
plasma	O	O
T4	O	O
markedly	O	O
decreased	O	O
(27.7	O	O
+/-	O	O
3.6	O	O
nmol/l)	O	O
but	O	O
the	O	O
patient	O	O
remained	O	O
euthyroid	O	O
.	O	O
The	O	O
clinical	O	O
course	O	O
and	O	O
the	O	O
laboratory	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
tachycardia	O	O
crises	O	O
are	O	O
the	O	O
consequence	O	O
of	O	O
a	O	O
hypersensitivity	O	O
of	O	O
the	O	O
heart	O	O
to	O	O
thyroid	O	O
hormones	O	O
,	O	O
associated	O	O
with	O	O
an	O	O
increased	O	O
number	O	O
of	O	O
T3	protein	protein
nuclear	protein	protein
receptor	protein	protein
sites	O	protein
in	O	O
lymphocytes	cell_type	cell_type
.	O	O

Induction	O	O
of	O	O
immediate	DNA	O
early	DNA	O
response	DNA	O
genes	DNA	O
by	O	O
macrophage	protein	protein
colony-stimulating	protein	protein
factor	protein	protein
in	O	O
normal	cell_type	cell_type
human	cell_type	cell_type
monocytes	cell_type	cell_type
.	O	O
A	O	O
group	O	O
of	O	O
coordinately	O	O
induced	O	O
protooncogenes	DNA	O
,	O	O
cytoskeletal	O	O
,	O	O
and	O	O
extracellular	O	O
matrix	O	O
genes	O	O
have	O	O
been	O	O
termed	O	O
immediate	DNA	O
early	DNA	O
response	DNA	O
genes	DNA	O
,	O	O
and	O	O
their	O	O
induction	O	O
has	O	O
been	O	O
associated	O	O
with	O	O
growth	protein	protein
factor	protein	protein
-stimulated	O	O
cell	O	O
proliferation	O	O
.	O	O
We	O	O
have	O	O
investigated	O	O
the	O	O
induction	O	O
of	O	O
these	O	O
genes	O	O
by	O	O
macrophage-CSF	protein	protein
(	O	O
M-CSF	protein	protein
)	O	O
in	O	O
human	cell_type	cell_type
monocytes	cell_type	cell_type
that	O	O
do	O	O
not	O	O
proliferate	O	O
in	O	O
response	O	O
to	O	O
M-CSF	protein	protein
but	O	O
require	O	O
the	O	O
factor	O	O
for	O	O
optimal	O	O
cell	O	O
differentiation	O	O
.	O	O
Normal	O	cell_type
human	cell_type	cell_type
monocytes	cell_type	cell_type
were	O	O
isolated,	O	O
carefully	O	O
washed,	O	O
and	O	O
incubated	O	O
for	O	O
36	O	O
to	O	O
48	O	O
h	O	O
in	O	O
fetal	O	O
bovine	O	O
serum-containing	O	O
medium	O	O
.	O	O
At	O	O
the	O	O
end	O	O
of	O	O
this	O	O
incubation	O	O
the	O	O
resting	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
stimulated	O	O
with	O	O
M-CSF	protein	protein
,	O	O
and	O	O
RNA	RNA	O
was	O	O
isolated	O	O
for	O	O
analysis	O	O
by	O	O
Northern	O	O
blotting	O	O
.	O	O
RNA	RNA	O
from	O	O
control	O	O
resting	cell_type	cell_type
cells	cell_type	cell_type
contained	O	O
low	O	O
to	O	O
undetectable	O	O
levels	O	O
of	O	O
c-jun	RNA	DNA
,	O	O
fibronectin	RNA	protein
receptor	RNA	protein
,	O	O
and	O	O
actin	RNA	RNA
mRNA	RNA	RNA
.	O	O
Within	O	O
15	O	O
to	O	O
30	O	O
min	O	O
of	O	O
addition	O	O
of	O	O
M-CSF	protein	protein
,	O	O
however,	O	O
there	O	O
was	O	O
a	O	O
dramatic	O	O
coordinate	O	O
induction	O	O
of	O	O
these	O	O
genes.	O	O
The	O	O
c-jun	DNA	DNA
gene	DNA	DNA
expression	O	O
was	O	O
very	O	O
transient	O	O
and	O	O
was	O	O
not	O	O
detectable	O	O
by	O	O
60	O	O
min	O	O
after	O	O
M-CSF	protein	O
addition	O	O
.	O	O
In	O	O
contrast,	O	O
the	O	O
expression	O	O
of	O	O
actin	O	protein
and	O	O
fibronectin	O	protein
receptor	O	protein
mRNA	O	O
was	O	O
more	O	O
sustained,	O	O
and	O	O
the	O	O
expression	O	O
of	O	O
these	O	O
genes	O	O
remained	O	O
elevated	O	O
at	O	O
24	O	O
to	O	O
48	O	O
h	O	O
after	O	O
M-CSF	protein	O
addition	O	O
.	O	O
We	O	O
also	O	O
observed	O	O
the	O	O
induction	O	O
of	O	O
the	O	O
myelomonocytic	DNA	O
specific	DNA	O
tyrosine	DNA	protein
kinase	DNA	protein
hck	DNA	protein
gene	DNA	O
simultaneously	O	O
with	O	O
the	O	O
other	O	O
immediate	DNA	protein
early	DNA	O
response	DNA	O
genes	DNA	O
.	O	O
The	O	O
protein	O	O
synthesis	O	O
inhibitor	O	O
cycloheximide	O	O
did	O	O
not	O	O
block	O	O
the	O	O
induction	O	O
of	O	O
any	O	O
of	O	O
these	O	O
genes,	O	O
and	O	O
in	O	O
fact,	O	O
super-induced	O	O
the	O	O
expression	O	O
of	O	O
c-jun	DNA	O
and	O	O
hck	DNA	O
.	O	O
Nuclear	O	O
run	O	O
on	O	O
transcription	O	O
of	O	O
the	O	O
c-jun	DNA	DNA
,	O	O
hck	DNA	O
,	O	O
and	O	O
actin	DNA	DNA
genes	DNA	DNA
.	O	O
Therefore,	O	O
in	O	O
normal	cell_type	cell_type
human	cell_type	cell_type
monocytes	cell_type	cell_type
M-CSF	protein	O
induces	O	O
immediate	DNA	O
early	DNA	O
response	DNA	O
genes	DNA	O
without	O	O
inducing	O	O
cell	O	O
proliferation.	O	O
These	O	O
genes	O	O
may	O	O
then	O	O
play	O	O
a	O	O
role	O	O
in	O	O
altering	O	O
the	O	O
physiologic	O	O
status	O	O
of	O	O
the	O	O
cells	O	O
in	O	O
response	O	O
to	O	O
CSF	protein	protein
.	O	O

Inducible	O	O
nuclear	protein	protein
factor	protein	protein
binding	O	O
to	O	O
the	O	O
kappa	DNA	DNA
B	DNA	DNA
elements	DNA	DNA
of	O	O
the	O	O
human	DNA	O
immunodeficiency	DNA	O
virus	DNA	O
enhancer	DNA	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
can	O	O
be	O	O
blocked	O	O
by	O	O
cyclosporin	O	O
A	O	O
in	O	O
a	O	O
signal-dependent	O	O
manner	O	O
.	O	O
Cyclosporin	O	O
A	O	O
(	O	O
CsA	O	O
)	O	O
is	O	O
thought	O	O
to	O	O
exert	O	O
its	O	O
immunosuppressive	O	O
effects	O	O
by	O	O
inhibiting	O	O
the	O	O
expression	O	O
of	O	O
a	O	O
distinct	O	O
set	O	O
of	O	O
lymphokine	DNA	DNA
genes	DNA	DNA
which	O	O
are	O	O
induced	O	O
upon	O	O
T-cell	O	O
activation	O	O
,	O	O
among	O	O
them	O	O
the	O	O
gene	O	O
coding	O	O
for	O	O
interleukin-2	protein	protein
.	O	O
In	O	O
addition,	O	O
the	O	O
activation	O	O
of	O	O
the	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
(	O	O
HIV	O	O
)	O	O
is	O	O
partially	O	O
suppressed.	O	O
To	O	O
better	O	O
understand	O	O
the	O	O
molecular	O	O
mechanisms	O	O
underlying	O	O
suppression	O	O
by	O	O
CsA	O	O
,	O	O
we	O	O
have	O	O
investigated	O	O
the	O	O
effects	O	O
of	O	O
this	O	O
drug	O	O
on	O	O
transcription	protein	protein
factors	protein	protein
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Here	O	O
we	O	O
report	O	O
that	O	O
the	O	O
formation	O	O
of	O	O
two	O	O
distinct	O	O
mitogen-inducible	protein	protein
DNA-binding	protein	protein
complexes	protein	protein
,	O	O
the	O	O
kappa	protein	protein
B	protein	protein
complex	protein	protein
within	O	O
the	O	O
HIV	DNA	DNA
enhancer	DNA	DNA
and	O	O
the	O	O
NFAT-1	protein	protein
complex	protein	protein
within	O	O
the	O	O
interleukin-2	DNA	DNA
enhancer	DNA	DNA
,	O	O
is	O	O
inhibited	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
CsA	O	O
.	O	O
The	O	O
kappa	O	O
B-binding	O	O
activity	O	O
with	O	O
the	O	O
HIV	DNA	DNA
enhancer	DNA	DNA
is	O	O
inhibited	O	O
only	O	O
if	O	O
it	O	O
is	O	O
activated	O	O
via	O	O
the	O	O
mitogen	protein	protein
phytohemagglutinin	protein	protein
whereas	O	O
phorbol	O	O
myristate	O	O
acetate	O	O
-mediated	O	O
activation	O	O
is	O	O
completely	O	O
insensitive	O	O
to	O	O
the	O	O
drug.	O	O
This	O	O
suggests	O	O
a	O	O
model	O	O
in	O	O
which	O	O
functionally	O	O
indistinguishable	O	O
kappa	protein	protein
B	protein	protein
complexes	protein	protein
can	O	O
be	O	O
activated	O	O
via	O	O
two	O	O
separate	O	O
pathways	O	O
of	O	O
signal	O	O
transduction	O	O
distinguishable	O	O
by	O	O
CsA	O	O
.	O	O

Purification	O	O
of	O	O
TCF-1	protein	protein
alpha	protein	protein
,	O	O
a	O	O
T-cell-specific	protein	protein
transcription	protein	protein
factor	protein	protein
that	O	O
activates	O	O
the	O	O
T-cell	DNA	protein
receptor	DNA	protein
C	DNA	protein
alpha	DNA	protein
gene	DNA	O
enhancer	DNA	O
in	O	O
a	O	O
context-dependent	O	O
manner.	O	O
The	O	O
differentiation	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
into	O	O
functionally	O	O
diverse	O	O
subpopulations	O	O
is	O	O
controlled	O	O
in	O	O
part,	O	O
by	O	O
transcriptional	O	O
activation	O	O
and	O	O
silencing	O	O
;	O	O
however,	O	O
little	O	O
is	O	O
known	O	O
in	O	O
detail	O	O
about	O	O
the	O	O
proteins	O	O
that	O	O
influence	O	O
this	O	O
developmental	O	O
process	O	O
.	O	O
We	O	O
have	O	O
purified	O	O
a	O	O
new	O	O
T-cell-specific	protein	protein
factor	protein	protein
,	O	O
TCF-1	protein	protein
alpha	protein	protein
,	O	O
that	O	O
is	O	O
implicated	O	O
in	O	O
the	O	O
activation	O	O
of	O	O
genes	O	O
encoding	O	O
a	O	O
major	O	O
component	O	O
of	O	O
the	O	O
human	protein	protein
T-cell	protein	protein
receptor	protein	protein
(	O	O
TCR	protein	protein
).	O	O
TCF-1	protein	protein
alpha	protein	protein
,	O	O
originally	O	O
identified	O	O
and	O	O
purified	O	O
through	O	O
its	O	O
binding	O	O
sites	O	O
on	O	O
the	O	O
HIV-1	DNA	DNA
promoter	DNA	DNA
,	O	O
was	O	O
found	O	O
to	O	O
bind	O	O
to	O	O
the	O	O
TCR	DNA	DNA
alpha	DNA	DNA
enhancer	DNA	DNA
and	O	O
to	O	O
promoters	DNA	O
for	O	O
several	O	O
genes	DNA	O
expressed	O	O
at	O	O
significantly	O	O
earlier	O	O
stages	O	O
of	O	O
T-cell	O	O
development	O	O
than	O	O
the	O	O
TCR	DNA	DNA
alpha	DNA	DNA
gene	DNA	DNA
(e.g.,	O	O
p56lck	DNA	protein
and	O	O
CD3	DNA	protein
delta	DNA	protein
).	O	O
Sequences	O	O
related	O	O
to	O	O
the	O	O
TCF-1	DNA	protein
alpha	DNA	protein
binding	DNA	protein
motif	DNA	protein
(	O	O
5'-GGCACCCTTTGA-3'	O	DNA
)	O	O
are	O	O
also	O	O
found	O	O
in	O	O
the	O	O
human	DNA	O
TCR	DNA	protein
delta	DNA	protein
(and	O	O
possibly	O	O
TCR	DNA	protein
beta	DNA	protein
)	O	O
enhancers	DNA	DNA
.	O	O
Southwestern	O	O
and	O	O
gel	O	O
renaturation	O	O
experiments	O	O
with	O	O
the	O	O
use	O	O
of	O	O
purified	O	O
protein	O	O
fractions	O	O
revealed	O	O
that	O	O
TCF-1	protein	protein
alpha	protein	protein
activity	O	O
is	O	O
derived	O	O
from	O	O
a	O	O
family	O	O
of	O	O
57-	protein	O
to	protein	O
53-kD	protein	protein
proteins	protein	protein
that	O	O
are	O	O
abundantly	O	O
expressed	O	O
in	O	O
mature	O	O
and	O	O
immature	O	cell_line
T-cell	O	cell_line
lines	O	cell_line
(	O	O
Jurkat	cell_line	cell_line
,	O	O
CCRF-CEM	cell_line	O
)	O	O
and	O	O
not	O	O
in	O	O
mature	cell_line	cell_type
B	cell_line	cell_type
cells	cell_line	cell_type
(	O	O
JY	cell_line	O
,	O	O
Namalwa	cell_line	O
)	O	O
or	O	O
nonlymphoid	cell_line	O
(HeLa)	cell_line	O
cell	cell_line	O
lines	cell_line	O
.	O	O
A	O	O
small	O	O
95-bp	O	DNA
fragment	O	DNA
of	O	O
the	O	O
TCR	DNA	protein
alpha	DNA	protein
control	DNA	O
region	DNA	O
that	O	O
contains	O	O
the	O	O
TCF-1	DNA	DNA
alpha	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
juxtaposed	O	O
between	O	O
a	O	O
cAMP-response	DNA	DNA
element	DNA	DNA
(the	O	O
CRE	DNA	DNA
or	O	O
T	DNA	O
alpha	DNA	O
1	DNA	O
motif	DNA	O
)	O	O
and	O	O
the	O	O
binding	DNA	O
site	DNA	O
for	O	O
a	O	O
distinct	O	O
lymphoid-specific	protein	protein
protein	protein	protein
(	O	O
TCF-2	protein	protein
alpha	protein	protein
)	O	O
behaved	O	O
as	O	O
a	O	O
potent	O	O
T-cell-specific	DNA	DNA
enhancer	DNA	DNA
in	O	O
vivo.	O	O
Tandem	O	O
copies	O	O
of	O	O
this	O	O
enhancer	O	O
functioned	O	O
synergistically	O	O
in	O	O
mature	cell_line	O
(Jurkat)	cell_line	cell_line
T-cell	cell_line	cell_line
lines	cell_line	cell_line
as	O	O
well	O	O
as	O	O
resting	O	O
and	O	O
activated	O	O
immature	cell_line	O
(CCRF-CEM)	cell_line	cell_line
T-cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
Mutation	O	O
of	O	O
the	O	O
TCF-1	DNA	protein
alpha	DNA	protein
binding	DNA	O
site	DNA	O
diminished	O	O
enhancer	O	O
activity	O	O
and	O	O
disrupted	O	O
the	O	O
synergism	O	O
observed	O	O
in	O	O
vivo	O	O
between	O	O
tandem	DNA	DNA
enhancer	DNA	DNA
repeats	DNA	DNA
.	O	O
The	O	O
TCF-1	DNA	protein
alpha	DNA	protein
binding	DNA	O
site	DNA	O
was	O	O
also	O	O
required	O	O
for	O	O
TCR	protein	protein
alpha	O	protein
enhancer	O	O
activity	O	O
in	O	O
transcriptionally	O	O
active	O	O
extracts	O	O
from	O	O
Jurkat	cell_line	cell_line
but	O	O
not	O	O
HeLa	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
confirming	O	O
that	O	O
TCF-1	protein	protein
alpha	protein	protein
is	O	O
a	O	O
T-cell-specific	protein	protein
transcription	protein	protein
factor	protein	protein
.	O	O
Curiously,	O	O
the	O	O
TCF-1	protein	protein
alpha	protein	protein
binding	O	protein
element	O	protein
was	O	O
inactive	O	O
in	O	O
vivo	O	O
when	O	O
removed	O	O
from	O	O
its	O	O
neighboring	O	O
elements	O	O
on	O	O
the	O	O
TCR	DNA	DNA
alpha	DNA	DNA
enhancer	DNA	DNA
and	O	O
positioned	O	O
in	O	O
one	O	O
or	O	O
more	O	O
copies	O	O
upstream	O	O
of	O	O
a	O	O
heterologous	DNA	DNA
promoter	DNA	DNA
.	O	O
Thus,	O	O
the	O	O
transcriptional	O	O
activity	O	O
of	O	O
TCF-1	protein	protein
alpha	protein	protein
appears	O	O
to	O	O
depend	O	O
on	O	O
the	O	O
TCF-2	protein	DNA
alpha	protein	DNA
and	O	O
T	protein	O
alpha	protein	O
1	protein	O
(	O	O
CREB	protein	protein
)	O	protein
transcription	protein	protein
factors	protein	protein
and	O	O
the	O	O
context	O	O
of	O	O
its	O	O
binding	O	O
site	O	O
within	O	O
the	O	O
TCR	DNA	DNA
alpha	DNA	DNA
enhancer	DNA	DNA
.	O	O

Tandem	DNA	O
AP-1-binding	DNA	DNA
sites	DNA	DNA
within	O	O
the	O	O
human	DNA	DNA
beta-globin	DNA	DNA
dominant	DNA	DNA
control	DNA	DNA
region	DNA	DNA
function	O	O
as	O	O
an	O	O
inducible	DNA	DNA
enhancer	DNA	DNA
in	O	O
erythroid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
A	O	O
powerful	O	DNA
enhancer	O	DNA
has	O	O
been	O	O
mapped	O	O
to	O	O
an	O	O
18-bp	DNA	DNA
DNA	DNA	DNA
segment	DNA	DNA
located	O	O
11	O	O
kb	O	O
5'	O	O
to	O	O
the	O	O
human	DNA	DNA
epsilon-globin	DNA	DNA
gene	DNA	DNA
within	O	O
the	O	O
dominant	DNA	O
control	DNA	O
or	O	O
locus-activating	DNA	O
region	DNA	O
.	O	O
This	O	O
enhancer	DNA	O
is	O	O
inducible	O	O
in	O	O
K562	cell_line	cell_line
human	cell_line	cell_line
erythroleukemia	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
increasing	O	O
linked	O	O
gamma-globin	DNA	DNA
promoter	DNA	DNA
/luciferase	protein	DNA
gene	O	DNA
expression	O	O
to	O	O
170-fold	O	O
over	O	O
an	O	O
enhancerless	DNA	O
construct	DNA	O
.	O	O
The	O	O
enhancer	DNA	O
consists	O	O
of	O	O
tandem	DNA	DNA
AP-1-binding	DNA	DNA
sites	DNA	DNA
,	O	O
phased	O	O
10	O	O
bp	O	O
apart,	O	O
which	O	O
are	O	O
both	O	O
required	O	O
for	O	O
full	O	O
activity.	O	O
DNA-protein	O	O
binding	O	O
assays	O	O
with	O	O
nuclear	O	O
extracts	O	O
from	O	O
induced	O	O
cells	O	O
demonstrate	O	O
a	O	O
high	protein	O
molecular	protein	O
weight	protein	O
complex	protein	O
on	O	O
the	O	O
enhancer	DNA	DNA
.	O	O
The	O	O
formation	O	O
of	O	O
this	O	O
complex	O	O
also	O	O
requires	O	O
both	O	O
AP-1	DNA	DNA
sites	DNA	DNA
and	O	O
correlates	O	O
with	O	O
maximal	O	O
enhancer	DNA	O
activity	O	O
.	O	O
Induction	O	O
of	O	O
the	O	O
enhancer	DNA	O
may	O	O
have	O	O
a	O	O
role	O	O
in	O	O
the	O	O
increase	O	O
in	O	O
globin	DNA	DNA
gene	DNA	DNA
transcription	O	O
that	O	O
characterizes	O	O
erythroid	O	O
maturation	O	O
.	O	O
Enhancer	O	O
activity	O	O
appears	O	O
to	O	O
be	O	O
mediated	O	O
by	O	O
the	O	O
binding	O	O
of	O	O
a	O	O
complex	O	O
of	O	O
proteins	O	O
from	O	O
the	O	O
jun	DNA	O
and	DNA	O
fos	DNA	O
families	DNA	O
to	O	O
tandem	DNA	O
AP-1	DNA	DNA
consensus	DNA	DNA
sequences	DNA	DNA
.	O	O

Identification	O	O
of	O	O
a	O	O
novel	protein	O
factor	protein	O
that	O	O
interacts	O	O
with	O	O
an	O	O
immunoglobulin	DNA	DNA
heavy-chain	DNA	DNA
promoter	DNA	DNA
and	O	O
stimulates	O	O
transcription	O	O
in	O	O
conjunction	O	O
with	O	O
the	O	O
lymphoid	protein	protein
cell-specific	protein	protein
factor	protein	protein
OTF2	protein	protein
.	O	O
The	O	O
tissue-specific	O	O
expression	O	O
of	O	O
the	O	O
MOPC	DNA	O
141	DNA	O
immunoglobulin	DNA	DNA
heavy-chain	DNA	DNA
gene	DNA	DNA
was	O	O
studied	O	O
by	O	O
using	O	O
in	O	O
vitro	O	O
transcription	O	O
.	O	O
B-cell-specific	O	O
transcription	O	O
of	O	O
this	O	O
gene	O	O
was	O	O
dependent	O	O
on	O	O
the	O	O
octamer	DNA	DNA
element	DNA	DNA
5'-ATGCAAAG-3'	O	DNA
,	O	O
located	O	O
in	O	O
the	O	O
upstream	DNA	O
region	DNA	O
of	O	O
this	O	O
promoter	DNA	O
and	O	O
in	O	O
the	O	O
promoters	DNA	O
of	O	O
all	O	O
other	O	O
immunoglobulin	O	protein
heavy-	O	protein
and	O	O
light-	O	O
chain	O	O
genes	O	O
.	O	O
The	O	O
interaction	O	O
of	O	O
purified	O	protein
octamer	protein	protein
transcription	protein	protein
factors	protein	protein
1	O	protein
and	O	O
2	O	O
(	O	O
OTF1	protein	protein
and	O	O
OTF2	protein	protein
)	O	O
with	O	O
the	O	O
MOPC	DNA	DNA
141	DNA	DNA
promoter	DNA	DNA
was	O	O
studied	O	O
by	O	O
using	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assays	O	O
and	O	O
DNase	protein	protein
I	protein	protein
footprinting	O	O
.	O	O
Purified	O	O
OTF1	protein	O
from	O	O
HeLa	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
OTF1	protein	protein
and	O	O
OTF2	protein	O
from	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
bound	O	O
to	O	O
identical	O	O
sequences	O	O
within	O	O
the	O	O
heavy-chain	DNA	DNA
promoter	DNA	DNA
.	O	O
The	O	O
OTF	O	O
interactions	O	O
we	O	O
observed	O	O
extended	O	O
over	O	O
the	O	O
heptamer	DNA	DNA
element	DNA	DNA
5'-CTCAGGA-3'	O	DNA
,	O	O
and	O	O
it	O	O
seems	O	O
likely	O	O
that	O	O
the	O	O
binding	O	O
of	O	O
the	O	O
purified	protein	protein
factors	protein	protein
involves	O	O
cooperation	O	O
between	O	O
octamer	O	O
and	O	O
heptamer	O	DNA
sites	O	DNA
in	O	O
this	O	O
promoter	DNA	O
.	O	O
In	O	O
addition	O	O
to	O	O
these	O	O
elements,	O	O
we	O	O
identified	O	O
a	O	O
second	O	DNA
regulatory	DNA	DNA
element	DNA	DNA
,	O	O
the	O	O
N	DNA	DNA
element	DNA	DNA
with	O	O
the	O	O
sequence	O	O
5'-GGAACCTCCCCC-3'	O	O
.	O	O
The	O	O
N	DNA	DNA
element	DNA	DNA
could	O	O
independently	O	O
mediate	O	O
low	O	O
levels	O	O
of	O	O
transcription	O	O
in	O	O
both	O	O
B-cell	O	O
and	O	O
HeLa-cell	O	O
extracts	O	O
,	O	O
and,	O	O
in	O	O
conjunction	O	O
with	O	O
the	O	O
octamer	DNA	DNA
element	DNA	DNA
,	O	O
it	O	O
can	O	O
promote	O	O
high	O	O
levels	O	O
of	O	O
transcription	O	O
in	O	O
B-cell	O	O
extracts	O	O
.	O	O
The	O	O
N	DNA	DNA
element	DNA	DNA
bound	O	O
a	O	O
transcription	protein	protein
factor	protein	protein
,	O	O
NTF	protein	protein
,	O	O
that	O	O
is	O	O
ubiquitous	O	O
in	O	O
cell-type	protein	O
distribution	protein	O
,	O	O
and	O	O
NTF	protein	O
was	O	O
distinct	O	O
from	O	O
any	O	O
of	O	O
the	O	O
previously	protein	O
described	protein	O
proteins	protein	O
that	O	O
bind	O	O
to	O	O
similar	O	O
sequences.	O	O
Based	O	O
on	O	O
these	O	O
results,	O	O
we	O	O
propose	O	O
that	O	O
NTF	protein	O
and	O	O
OTF2	protein	O
interactions	O	O
(both	O	O
with	O	O
their	O	O
cognate	DNA	DNA
DNA	DNA	DNA
elements	DNA	DNA
and	O	O
possibly	O	O
at	O	O
the	O	O
protein-protein	O	O
level	O	O
)	O	O
may	O	O
be	O	O
critical	O	O
to	O	O
B-cell-specific	O	O
expression	O	O
and	O	O
that	O	O
these	O	O
interactions	O	O
provide	O	O
additional	O	O
pathways	O	O
for	O	O
regulating	O	O
gene	O	O
expression	O	O
.	O	O

NF-kappa	protein	protein
B	protein	protein
as	O	O
inducible	O	O
transcriptional	protein	protein
activator	protein	protein
of	O	O
the	O	O
granulocyte-macrophage	DNA	protein
colony-stimulating	DNA	protein
factor	DNA	protein
gene	DNA	O
.	O	O
The	O	O
expression	O	O
of	O	O
the	O	O
gene	O	O
encoding	O	O
the	O	O
granulocyte-	protein	protein
macrophage	protein	protein
colony-stimulating	protein	protein
factor	protein	protein
(	O	O
GM-CSF	protein	protein
)	O	O
is	O	O
induced	O	O
upon	O	O
activation	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
phytohemagglutinin	protein	protein
and	O	O
active	O	O
phorbolester	O	O
and	O	O
upon	O	O
expression	O	O
of	O	O
tax1	protein	protein
,	O	O
a	O	O
transactivating	protein	O
protein	protein	O
of	O	O
the	O	O
human	O	O
T-cell	O	O
leukemia	O	O
virus	O	O
type	O	O
I	O	O
.	O	O
The	O	O
same	O	O
agents	O	O
induce	O	O
transcription	O	O
from	O	O
the	O	O
interleukin-2	O	protein
receptor	O	protein
alpha-chain	O	protein
and	O	O
interleukin-2	O	DNA
genes	O	DNA
,	O	O
depending	O	O
on	O	O
promoter	DNA	DNA
elements	DNA	DNA
that	O	O
bind	O	O
the	O	O
inducible	protein	protein
transcription	protein	protein
factor	protein	protein
NF-kappa	protein	protein
B	protein	protein
(or	O	O
an	O	O
NF-kappa	protein	protein
B	protein	protein
-like	protein	protein
factor	protein	protein
).	O	O
We	O	O
therefore	O	O
tested	O	O
the	O	O
possibility	O	O
that	O	O
the	O	O
GM-CSF	DNA	DNA
gene	DNA	DNA
is	O	O
also	O	O
regulated	O	O
by	O	O
a	O	O
cognate	O	DNA
motif	O	DNA
for	O	O
the	O	O
NF-kappa	protein	protein
B	protein	protein
transcription	protein	protein
factor	protein	protein
.	O	O
A	O	O
recent	O	O
functional	O	O
analysis	O	O
by	O	O
Miyatake	O	O
et	O	O
al.	O	O
(S.	O	O
Miyatake,	O	O
M.	O	O
Seiki,	O	O
M.	O	O
Yoshida,	O	O
and	O	O
K.	O	O
Arai,	O	O
Mol.	O	O
Cell.	O	O
Biol.	O	O
8:5581-5587,	O	O
1988)	O	O
described	O	O
a	O	O
short	DNA	DNA
promoter	DNA	DNA
region	DNA	DNA
in	O	O
the	O	O
GM-CSF	DNA	DNA
gene	DNA	DNA
that	O	O
conferred	O	O
strong	O	O
inducibility	O	O
by	O	O
T-cell-activating	O	O
signals	O	O
and	O	O
tax1	protein	protein
,	O	O
but	O	O
no	O	O
NF-kappa	DNA	protein
B	DNA	protein
-binding	DNA	O
motifs	DNA	O
were	O	O
identified.	O	O
Using	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assays	O	O
,	O	O
we	O	O
showed	O	O
binding	O	O
of	O	O
purified	O	O
human	protein	O
NF-kappa	protein	protein
B	protein	protein
and	O	O
of	O	O
the	O	O
NF-kappa	protein	protein
B	protein	protein
activated	O	protein
in	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
to	O	O
an	O	O
oligonucleotide	O	O
comprising	O	O
the	O	O
GM-CSF	DNA	DNA
promoter	DNA	DNA
element	DNA	DNA
responsible	O	O
for	O	O
mediating	O	O
responsiveness	O	O
to	O	O
T-cell-activating	O	O
signals	O	O
and	O	O
tax1	protein	protein
.	O	O
As	O	O
shown	O	O
by	O	O
a	O	O
methylation	O	O
interference	O	O
analysis	O	O
and	O	O
oligonucleotide	O	O
competition	O	O
experiments,	O	O
purified	O	O
NF-kappa	protein	protein
B	protein	protein
binds	O	O
at	O	O
positions	DNA	O
-82	DNA	O
to	DNA	O
-91	DNA	O
(	O	O
GGGAACTACC	O	O
)	O	O
of	O	O
the	O	O
GM-CSF	DNA	DNA
promoter	DNA	DNA
sequence	O	O
with	O	O
an	O	O
affinity	O	O
similar	O	O
to	O	O
that	O	O
with	O	O
which	O	O
it	O	O
binds	O	O
to	O	O
the	O	O
biologically	DNA	O
functional	DNA	O
kappa	DNA	DNA
B	DNA	DNA
motif	DNA	DNA
in	O	O
the	O	O
beta	DNA	DNA
interferon	DNA	DNA
promoter	DNA	DNA
(	O	O
GGGAAATTCC	O	O
).	O	O
Two	O	O
kappa	DNA	O
B-like	DNA	O
motifs	DNA	O
at	O	O
positions	DNA	O
-98	DNA	O
to	DNA	O
-108	DNA	O
of	O	O
the	O	O
GM-CSF	DNA	DNA
promoter	DNA	DNA
were	O	O
also	O	O
recognized	O	O
but	O	O
with	O	O
much	O	O
lower	O	O
affinities.	O	O
Our	O	O
data	O	O
provide	O	O
strong	O	O
evidence	O	O
that	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
GM-CSF	DNA	DNA
gene	DNA	DNA
following	O	O
T-cell	O	O
activation	O	O
is	O	O
controlled	O	O
by	O	O
binding	O	O
of	O	O
the	O	O
NF-kappa	protein	protein
B	protein	protein
transcription	protein	protein
factor	protein	protein
to	O	O
a	O	O
high-affinity	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
in	O	O
the	O	O
GM-CSF	DNA	DNA
promoter	DNA	DNA
.	O	O

Effects	O	O
of	O	O
mitogenic	O	O
agents	O	O
upon	O	O
glucocorticoid	O	O
action	O	O
in	O	O
human	cell_type	cell_type
tonsillar	cell_type	cell_type
T-	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
The	O	O
treatment	O	O
of	O	O
human	cell_type	O
tonsillar	cell_type	O
T-	cell_type	O
lymphocytes	cell_type	O
with	O	O
4-phorbol	O	O
12-myristate	O	O
13-acetate	O	O
(	O	O
PMA	O	O
),	O	O
resulted	O	O
in	O	O
about	O	O
two	O	O
fold	O	O
increase	O	O
in	O	O
glucocorticoid	protein	protein
receptor	protein	protein
(	O	O
GR	protein	protein
)	O	O
number	O	O
,	O	O
without	O	O
any	O	O
significant	O	O
change	O	O
in	O	O
the	O	O
receptor	O	O
affinity	O	O
.	O	O
This	O	O
increase	O	O
disappeared	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
cycloheximide	O	O
.	O	O
Alone,	O	O
PMA	O	O
and	O	O
calcium	O	O
ionophore	O	O
A23187	O	O
did	O	O
not	O	O
affect,	O	O
but	O	O
together	O	O
stimulated,	O	O
like	O	O
phytohaemagglutinin	protein	protein
(	O	O
PHA	protein	protein
),	O	O
leucine	O	protein
and,	O	O
in	O	O
particular,	O	O
thymidine	O	O
incorporation	O	O
.	O	O
PMA	O	O
enhanced	O	O
slightly	O	O
the	O	O
stimulatory	O	O
effect	O	O
of	O	O
PHA	protein	protein
.	O	O
Alone,	O	O
these	O	O
agents	O	O
failed	O	O
to	O	O
alter	O	O
the	O	O
suppressive	O	O
effect	O	O
of	O	O
dexamethasone	O	O
on	O	O
thymidine	O	O
and	O	O
leucine	O	O
incorporation	O	O
;	O	O
however,	O	O
PMA	O	O
-A23187	O	O
and	O	O
PMA	O	O
-PHA	protein	O
combinations	O	O
appeared	O	O
to	O	O
antagonize	O	O
the	O	O
suppression	O	O
by	O	O
dexamethasone	O	O
.	O	O

To	O	O
be	O	O
or	O	O
not	O	O
to	O	O
be	O	O
a	O	O
responder	O	O
in	O	O
T-cell	O	O
responses	O	O
:	O	O
ubiquitous	O	O
oligopeptides	O	O
in	O	O
all	O	O
proteins.	O	O
Amino	O	O
acid	O	O
sequences	O	O
of	O	O
all	O	O
proteins	O	O
are	O	O
essays	O	O
written	O	O
in	O	O
the	O	O
same	O	O
language.	O	O
Accordingly,	O	O
the	O	O
same	O	O
set	O	O
of	O	O
words	O	O
and	O	O
phrases	O	O
(	O	O
oligopeptides	O	O
)	O	O
appear	O	O
in	O	O
totally	O	O
unrelated	protein	O
proteins	protein	O
.	O	O
The	O	O
reason	O	O
that	O	O
only	O	O
certain	O	O
individuals	O	O
of	O	O
particular	O	O
major	protein	protein
histocompatibility	protein	protein
complex	protein	protein
(MHC)	protein	protein
haplotypes	protein	O
can	O	O
mount	O	O
T-cell	O	O
responses	O	O
against	O	O
a	O	O
given	O	O
antigen	O	O
of	O	O
pathogens	O	O
is	O	O
found	O	O
in	O	O
the	O	O
fact	O	O
that	O	O
T-cell	protein	protein
receptors	protein	protein
are	O	O
designed	O	O
to	O	O
recognize	O	O
18-20	O	O
residue-long	O	O
peptide	O	O
fragments	O	O
sandwiched	O	O
between	O	O
two	O	O
alpha-helices	protein	O
of	O	O
class	protein	protein
I	protein	protein
or	O	O
class	protein	protein
II	protein	protein
MHC	protein	protein
molecules	protein	protein
.	O	O
At	O	O
this	O	O
range	O	O
of	O	O
peptide	O	O
lengths	O	O
,	O	O
most	O	O
would	O	O
appear	O	O
as	O	O
self,	O	O
while	O	O
nonselfness	O	O
of	O	O
the	O	O
remainders	O	O
are	O	O
destined	O	O
to	O	O
be	O	O
quite	O	O
ambiguous,	O	O
hence	O	O
creating	O	O
responders	O	O
and	O	O
nonresponders.	O	O

Two	O	O
distinct	O	O
signal	O	O
transmission	O	O
pathways	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
are	O	O
inhibited	O	O
by	O	O
complexes	O	O
formed	O	O
between	O	O
an	O	O
immunophilin	protein	protein
and	O	O
either	O	O
FK506	O	O
or	O	O
rapamycin	O	O
.	O	O
Proliferation	O	O
and	O	O
immunologic	O	O
function	O	O
of	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
are	O	O
initiated	O	O
by	O	O
signals	O	O
from	O	O
the	O	O
antigen	protein	O
receptor	protein	O
that	O	O
are	O	O
inhibited	O	O
by	O	O
the	O	O
immunosuppressant	O	O
FK506	O	O
but	O	O
not	O	O
by	O	O
its	O	O
structural	O	O
analog,	O	O
rapamycin	O	O
.	O	O
On	O	O
the	O	O
other	O	O
hand,	O	O
interleukin	protein	protein
2	protein	protein
(	O	O
IL-2	protein	protein
)-induced	O	O
signals	O	O
are	O	O
blocked	O	O
by	O	O
rapamycin	O	O
but	O	O
not	O	O
by	O	O
FK506	O	O
.	O	O
Remarkably,	O	O
these	O	O
two	O	O
drugs	O	O
inhibit	O	O
each	O	O
other's	O	O
actions,	O	O
raising	O	O
the	O	O
possibility	O	O
that	O	O
both	O	O
act	O	O
by	O	O
means	O	O
of	O	O
a	O	O
common	O	O
immunophilin	protein	protein
(	O	O
immunosuppressant	protein	O
binding	protein	O
protein	protein	O
).	O	O
We	O	O
find	O	O
that	O	O
the	O	O
dissociation	O	O
constant	O	O
of	O	O
rapamycin	O	O
to	O	O
the	O	O
FK506	protein	O
binding	protein	O
protein	protein	O
FKBP	protein	O
(Kd	O	O
=	O	O
0.2	O	O
nM)	O	O
is	O	O
close	O	O
to	O	O
the	O	O
dissociation	O	O
constant	O	O
of	O	O
FK506	O	O
to	O	O
FKBP	protein	protein
(Kd	O	O
=	O	O
0.4	O	O
nM)	O	O
and	O	O
to	O	O
their	O	O
effective	O	O
biologic	O	O
inhibitory	O	O
concentrations	O	O
.	O	O
However,	O	O
an	O	O
excess	O	O
of	O	O
rapamycin	O	O
is	O	O
needed	O	O
to	O	O
revert	O	O
FK506	O	O
-mediated	O	O
inhibition	O	O
of	O	O
IL-2	protein	protein
production	O	O
,	O	O
apoptosis	O	O
,	O	O
and	O	O
transcriptional	O	O
activation	O	O
of	O	O
NF-AT	protein	protein
,	O	O
a	O	O
T-cell-specific	protein	protein
transcription	protein	protein
factor	protein	protein
necessary	O	O
for	O	O
IL-2	DNA	DNA
gene	DNA	DNA
activation	O	O
.	O	O
Similarly,	O	O
an	O	O
excess	O	O
of	O	O
FK506	O	O
is	O	O
needed	O	O
to	O	O
revert	O	O
rapamycin	O	O
-mediated	O	O
inhibition	O	O
of	O	O
IL-2	protein	protein
-induced	O	O
proliferation	O	O
.	O	O
The	O	O
drug	O	O
concentrations	O	O
required	O	O
for	O	O
antagonism	O	O
may	O	O
be	O	O
explained	O	O
by	O	O
the	O	O
relative	O	O
affinity	O	O
of	O	O
the	O	O
drugs	O	O
to,	O	O
and	O	O
by	O	O
the	O	O
abundance	O	O
of,	O	O
the	O	O
immunophilin	protein	protein
FKBP	protein	protein
.	O	O
FKBP	protein	protein
has	O	O
been	O	O
shown	O	O
to	O	O
catalyze	O	O
the	O	O
interconversion	O	O
of	O	O
the	O	O
cis-	O	O
and	O	O
trans-	O	O
rotamers	O	O
of	O	O
the	O	O
peptidyl-prolyl	protein	O
amide	protein	O
bond	protein	O
of	O	O
peptide	O	O
substrates	O	O
;	O	O
here	O	O
we	O	O
show	O	O
that	O	O
rapamycin	O	O
,	O	O
like	O	O
FK506	O	O
,	O	O
is	O	O
a	O	O
potent	O	O
inhibitor	O	O
of	O	O
the	O	O
rotamase	O	O
activity	O	O
of	O	O
FKBP	protein	protein
(Ki	O	protein
=	O	O
0.2	O	O
nM).	O	O
Neither	O	O
FKBP	protein	protein
binding	O	O
nor	O	O
inhibition	O	O
of	O	O
rotamase	O	O
activity	O	O
of	O	O
FKBP	protein	protein
alone	O	O
is	O	O
sufficient	O	O
to	O	O
explain	O	O
the	O	O
biologic	O	O
actions	O	O
of	O	O
these	O	O
drugs.	O	O
Rather,	O	O
these	O	O
findings	O	O
suggest	O	O
that	O	O
immunophilin	protein	protein
bound	O	O
to	O	O
FK506	O	O
interferes	O	O
with	O	O
antigen	protein	O
receptor	protein	O
-induced	O	O
signals	O	O
,	O	O
while	O	O
rapamycin	O	O
bound	O	O
to	O	O
the	O	O
immunophilin	protein	protein
interferes	O	O
with	O	O
IL-2	protein	protein
-induced	O	O
signals	O	O
.	O	O

Adherence-dependent	O	O
increase	O	O
in	O	O
human	RNA	O
monocyte	RNA	O
PDGF(B)	RNA	O
mRNA	RNA	O
is	O	O
associated	O	O
with	O	O
increases	O	O
in	O	O
c-fos	O	DNA
,	O	O
c-jun	O	O
,	O	O
and	O	O
EGR2	O	RNA
mRNA	O	RNA
.	O	O
Adherence	O	O
is	O	O
an	O	O
important	O	O
initial	O	O
step	O	O
in	O	O
the	O	O
transition	O	O
of	O	O
a	O	O
circulating	cell_type	O
monocyte	cell_type	O
to	O	O
a	O	O
tissue	cell_type	O
macrophage	cell_type	O
.	O	O
This	O	O
differentiation	O	O
is	O	O
accompanied	O	O
by	O	O
an	O	O
augmented	O	O
capacity	O	O
to	O	O
generate	O	O
growth	protein	protein
factors	protein	protein
.	O	O
We	O	O
hypothesized	O	O
that	O	O
adherence	O	O
itself	O	O
might	O	O
be	O	O
an	O	O
important	O	O
trigger	O	O
for	O	O
a	O	O
sequence	O	O
of	O	O
gene	O	O
activation	O	O
culminating	O	O
in	O	O
cells	O	O
with	O	O
increased	O	O
mRNA	RNA	O
encoding	O	O
profibrotic	O	O
growth	protein	protein
factors	protein	protein
such	O	O
as	O	O
platelet-derived	protein	protein
growth	protein	protein
factor	protein	protein
B	protein	protein
subunit	protein	protein
(	O	O
PDGF[B]	protein	O
)	O	O
and	O	O
transforming	protein	protein
growth	protein	protein
factor-beta	protein	protein
(	O	O
TGF-beta	protein	protein
).	O	O
After	O	O
in	O	O
vitro	O	O
adherence,	O	O
human	O	cell_type
monocytes	O	cell_type
had	O	O
a	O	O
biphasic	O	O
increase	O	O
in	O	O
PDGF(B)	RNA	RNA
mRNA	RNA	RNA
with	O	O
peaks	O	O
at	O	O
6	O	O
h	O	O
and	O	O
13	O	O
d.	O	O
No	O	O
increase	O	O
in	O	O
TGF-beta	RNA	RNA
mRNA	RNA	RNA
was	O	O
observed.	O	O
The	O	O
6-h	O	O
increase	O	O
in	O	O
PDGF(B)	RNA	RNA
mRNA	RNA	RNA
was	O	O
adherence	O	O
dependent,	O	O
and	O	O
in	O	O
addition,	O	O
was	O	O
abrogated	O	O
when	O	O
the	O	O
cytoskeletal	O	O
integrity	O	O
was	O	O
compromised	O	O
by	O	O
cytochalasin	O	protein
D	O	protein
.	O	O
The	O	O
6-h	O	O
increase	O	O
in	O	O
PDGF(B)	RNA	RNA
mRNA	RNA	RNA
was	O	O
unaltered	O	O
by	O	O
adherence	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
monocyte	O	O
stimulus	O	O
lipopolysaccharide	O	O
.	O	O
Adherence	O	O
to	O	O
either	O	O
fibronectin	O	protein
or	O	O
collagen-coated	O	O
plastic	O	O
had	O	O
little	O	O
consistent	O	O
effect	O	O
on	O	O
PDGF(B)	RNA	RNA
mRNA	RNA	RNA
accumulation	O	O
.	O	O
The	O	O
increased	O	O
PDGF(B)	RNA	O
mRNA	RNA	O
observed	O	O
in	O	O
adherent	cell_type	cell_type
monocytes	cell_type	cell_type
was	O	O
accompanied	O	O
by	O	O
increases	O	O
in	O	O
mRNAs	RNA	RNA
of	O	O
the	O	O
early	DNA	O
growth	DNA	O
response	DNA	O
genes	DNA	O
c-fos	DNA	O
(maximal	O	O
at	O	O
20	O	O
min),	O	O
c-jun,	O	O
and	O	O
EGR2	O	O
(maximal	O	O
at	O	O
6-24	O	O
h).	O	O
The	O	O
increase	O	O
in	O	O
c-jun	O	O
and	O	O
EGR2,	O	O
but	O	O
not	O	O
c-fos	DNA	DNA
,	O	O
mRNA	O	O
was	O	O
also	O	O
abrogated	O	O
by	O	O
cytochalasin	O	protein
D	O	protein
.	O	O
These	O	O
observations	O	O
suggest	O	O
that	O	O
adherence	O	O
results	O	O
in	O	O
increases	O	O
of	O	O
c-fos	O	DNA
,	O	O
c-jun	O	DNA
,	O	O
EGR2	O	protein
,	O	O
and	O	O
PDGF(B)	O	RNA
mRNA	O	RNA
.	O	O
In	O	O
addition,	O	O
the	O	O
increases	O	O
in	O	O
c-jun	DNA	DNA
,	O	O
EGR2	DNA	protein
,	O	O
and	O	O
PDGF(B)	protein	O
may	O	O
depend	O	O
on	O	O
cytoskeletal	O	O
rearrangement	O	O
.	O	O
Modulation	O	O
of	O	O
these	O	O
events	O	O
at	O	O
the	O	O
time	O	O
of	O	O
adherence	O	O
offers	O	O
a	O	O
mechanism	O	O
by	O	O
which	O	O
differential	O	O
priming	O	O
of	O	O
the	O	O
cells	O	O
may	O	O
be	O	O
accomplished.	O	O

Single	O	O
cell	O	O
assay	O	O
of	O	O
a	O	O
transcription	protein	protein
factor	protein	protein
reveals	O	O
a	O	O
threshold	O	O
in	O	O
transcription	O	O
activated	O	O
by	O	O
signals	O	O
emanating	O	O
from	O	O
the	O	O
T-cell	protein	protein
antigen	protein	protein
receptor	protein	protein
.	O	O
Stimulation	O	O
of	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
through	O	O
their	O	O
antigen	protein	O
receptor	protein	O
leads	O	O
to	O	O
the	O	O
appearance	O	O
of	O	O
several	O	O
transcription	protein	protein
factors	protein	protein
,	O	O
including	O	O
NF-AT	protein	protein
and	O	O
NF-kappa	protein	protein
B	protein	protein
,	O	O
which	O	O
are	O	O
involved	O	O
in	O	O
regulating	O	O
genes	O	O
required	O	O
for	O	O
immunologic	O	O
activation.	O	O
To	O	O
investigate	O	O
the	O	O
activity	O	O
of	O	O
a	O	O
single	O	O
transcription	protein	protein
factor	protein	protein
in	O	O
individual	cell_type	O
viable	cell_type	O
cells	cell_type	O
,	O	O
we	O	O
have	O	O
applied	O	O
an	O	O
assay	O	O
that	O	O
uses	O	O
the	O	O
fluorescence-activated	O	O
cell	O	O
sorter	O	O
to	O	O
quantitate	O	O
beta-galactosidase	protein	protein
(	O	O
beta-gal	protein	O
).	O	O
We	O	O
have	O	O
analyzed	O	O
the	O	O
distribution	O	O
of	O	O
NF-AT	protein	protein
transcriptional	O	O
activity	O	O
among	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
undergoing	O	O
activation	O	O
by	O	O
using	O	O
a	O	O
construct	O	O
in	O	O
which	O	O
three	O	O
tandem	O	O
copies	O	O
of	O	O
the	O	O
NF-AT	DNA	DNA
-binding	DNA	DNA
site	DNA	DNA
directs	O	O
transcription	O	O
of	O	O
the	O	O
lacZ	DNA	DNA
gene	DNA	DNA
.	O	O
Unexpectedly,	O	O
stimulation	O	O
of	O	O
cloned	cell_line	O
stably	cell_line	O
transfected	cell_line	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
leads	O	O
to	O	O
a	O	O
bimodal	O	O
pattern	O	O
of	O	O
beta-gal	O	O
expression	O	O
in	O	O
which	O	O
some	O	O
cells	O	O
express	O	O
no	O	O
beta-gal	protein	O
and	O	O
others	O	O
express	O	O
high	O	O
levels.	O	O
This	O	O
expression	O	O
pattern	O	O
cannot	O	O
be	O	O
accounted	O	O
for	O	O
by	O	O
cell-cycle	O	O
position	O	O
or	O	O
heritable	O	O
variation.	O	O
Further	O	O
results,	O	O
in	O	O
which	O	O
beta-gal	protein	O
activity	O	O
is	O	O
correlated	O	O
with	O	O
NF-AT	protein	protein
-binding	O	O
activity	O	O
,	O	O
indicate	O	O
that	O	O
the	O	O
concentration	O	O
of	O	O
NF-AT	protein	protein
must	O	O
exceed	O	O
a	O	O
critical	O	O
threshold	O	O
before	O	O
transcription	O	O
initiates.	O	O
This	O	O
threshold	O	O
likely	O	O
reflects	O	O
the	O	O
NF-AT	protein	protein
concentration-dependent	O	O
assembly	O	O
of	O	O
transcription	protein	O
complexes	protein	O
at	O	O
the	O	O
promoter	DNA	DNA
.	O	O
Similar	O	O
constructs	O	O
controlled	O	O
by	O	O
NF-kappa	protein	protein
B	protein	protein
or	O	O
the	O	O
entire	O	O
interleukin-2	DNA	DNA
enhancer	DNA	DNA
show	O	O
bimodal	O	O
expression	O	O
patterns	O	O
during	O	O
induction,	O	O
suggesting	O	O
that	O	O
thresholds	O	O
set	O	O
by	O	O
the	O	O
concentration	O	O
of	O	O
transcription	protein	protein
factors	protein	protein
may	O	O
be	O	O
a	O	O
common	O	O
property	O	O
of	O	O
inducible	DNA	DNA
genes	DNA	DNA
.	O	O

The	O	O
Epstein-Barr	DNA	O
virus	DNA	O
(	DNA	O
EBV	DNA	O
)	DNA	O
BMRF1	DNA	DNA
promoter	DNA	DNA
for	O	O
early	protein	O
antigen	protein	O
(	O	O
EA-D	protein	protein
)	O	O
is	O	O
regulated	O	O
by	O	O
the	O	O
EBV	protein	O
transactivators	protein	protein
,	O	O
BRLF1	protein	O
and	O	O
BZLF1	protein	protein
,	O	O
in	O	O
a	O	O
cell-specific	O	O
manner	O	O
.	O	O
The	O	O
Epstein-Barr	protein	O
virus	protein	O
early	protein	O
antigen	protein	O
diffuse	protein	O
component	protein	O
(	O	O
EA-D	protein	O
)	O	O
is	O	O
essential	O	O
for	O	O
Epstein-Barr	O	O
virus	DNA	O
DNA	DNA	O
polymerase	O	O
activity	O	O
,	O	O
and	O	O
its	O	O
activity	O	O
is	O	O
suppressed	O	O
during	O	O
latent	O	O
infection.	O	O
We	O	O
investigated	O	O
the	O	O
regulation	O	O
of	O	O
the	O	O
promoter	DNA	DNA
(	O	O
BMRF1	DNA	protein
)	O	O
for	O	O
this	O	O
early	O	O
gene	O	O
by	O	O
studying	O	O
its	O	O
responsiveness	O	O
in	O	O
vitro	O	O
to	O	O
two	O	O
immediate-early	protein	protein
viral	protein	protein
transactivators	protein	protein
,	O	O
BZLF1	protein	protein
(	O	O
Z	protein	O
)	O	O
and	O	O
BRLF1	protein	protein
(	O	O
R	protein	O
),	O	O
focusing	O	O
on	O	O
the	O	O
differences	O	O
in	O	O
response	O	O
in	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
epithelial	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
Z	protein	O
or	O	O
R	protein	O
alone	O	O
produced	O	O
only	O	O
small	O	O
increases	O	O
in	O	O
EA-D	DNA	O
promoter	DNA	O
activity	O	O
,	O	O
whereas	O	O
both	O	O
transactivators	protein	protein
together	O	O
produced	O	O
a	O	O
large	O	O
stimulatory	O	O
effect.	O	O
In	O	O
epithelial	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
the	O	O
Z	protein	protein
transactivator	protein	protein
alone	O	O
produced	O	O
maximal	O	O
stimulation	O	O
of	O	O
the	O	O
EA-D	DNA	DNA
promoter	DNA	DNA
;	O	O
the	O	O
effect	O	O
of	O	O
R	protein	O
and	O	O
Z	protein	O
together	O	O
was	O	O
no	O	O
greater	O	O
than	O	O
that	O	O
of	O	O
Z	protein	O
alone.	O	O
Deletional	O	O
analysis	O	O
and	O	O
site-directed	O	O
mutagenesis	O	O
of	O	O
the	O	O
EA-D	DNA	DNA
promoter	DNA	DNA
demonstrated	O	O
that	O	O
in	O	O
epithelial	cell_type	cell_type
cells	cell_type	cell_type
the	O	O
potential	O	O
AP-1	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
plays	O	O
an	O	O
essential	O	O
role	O	O
in	O	O
Z	protein	O
responsiveness,	O	O
although	O	O
sequences	O	O
further	O	O
upstream	O	O
are	O	O
also	O	O
important.	O	O
In	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
only	O	O
the	O	O
upstream	DNA	DNA
sequences	DNA	DNA
are	O	O
required	O	O
for	O	O
transactivation	O	O
by	O	O
the	O	O
Z/R	protein	O
combination,	O	O
and	O	O
the	O	O
AP-1	protein	DNA
site	protein	DNA
is	O	O
dispensable.	O	O
These	O	O
data	O	O
suggest	O	O
that	O	O
EA-D	DNA	protein
(	DNA	O
BMRF1	DNA	DNA
)	DNA	DNA
promoter	DNA	DNA
regulation	O	O
by	O	O
Z	protein	O
and	O	O
R	protein	O
is	O	O
cell	O	O
type	O	O
specific	O	O
and	O	O
appears	O	O
to	O	O
involve	O	O
different	O	O
mechanisms	O	O
in	O	O
each	O	O
cell	O	O
type.	O	O

Complementary	DNA	O
DNA	DNA	O
encoding	O	O
the	O	O
human	protein	protein
T-cell	protein	protein
FK506	protein	protein
-binding	protein	protein
protein	protein	protein
,	O	O
a	O	O
peptidylprolyl	protein	O
cis-trans	protein	DNA
isomerase	protein	DNA
distinct	O	O
from	O	O
cyclophilin	protein	protein
.	O	O
The	O	O
recently	O	O
discovered	O	O
macrolide	O	O
FK506	O	O
has	O	O
been	O	O
demonstrated	O	O
to	O	O
have	O	O
potent	O	O
immunosuppressive	O	O
activity	O	O
at	O	O
concentrations	O	O
100-fold	O	O
lower	O	O
than	O	O
cyclosporin	O	O
A	O	O
,	O	O
a	O	O
cyclic	O	protein
undecapeptide	O	O
that	O	O
is	O	O
used	O	O
to	O	O
prevent	O	O
rejection	O	O
after	O	O
transplantation	O	O
of	O	O
bone	O	O
marrow	O	O
and	O	O
organs	O	O
,	O	O
such	O	O
as	O	O
kidney	O	O
,	O	O
heart	O	O
,	O	O
and	O	O
liver	O	O
.	O	O
After	O	O
the	O	O
recent	O	O
discovery	O	O
that	O	O
the	O	O
cyclosporin	protein	O
A	protein	O
-binding	protein	O
protein	protein	O
cyclophilin	protein	protein
is	O	O
identical	O	O
to	O	O
peptidylprolyl	protein	O
cis-trans	protein	DNA
isomerase	protein	DNA
,	O	O
a	O	O
cellular	protein	O
binding	protein	O
protein	protein	O
for	O	O
FK506	O	O
was	O	O
found	O	O
to	O	O
be	O	O
distinct	O	O
from	O	O
cyclophilin	protein	protein
but	O	O
to	O	O
have	O	O
the	O	O
same	O	O
enzymatic	O	O
activity	O	O
.	O	O
In	O	O
this	O	O
study,	O	O
we	O	O
isolated	O	O
a	O	O
cDNA	DNA	DNA
coding	O	DNA
for	O	O
FK506	O	O
-binding	O	O
protein	O	O
(	O	O
FKBP	protein	protein
)	O	O
from	O	O
human	O	cell_type
peripheral	O	cell_type
blood	O	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
using	O	O
mixed	O	O
20-mer	O	O
oligonucleotide	O	O
probes	O	O
synthesized	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
the	O	O
sequence,	O	O
Glu-Asp-Gly-Lys-Lys-Phe-Asp	O	O
,	O	O
reported	O	O
for	O	O
bovine	protein	O
FKBP	protein	protein
.	O	O
The	O	O
DNA	O	O
isolated	O	O
contained	O	O
an	O	O
open	O	DNA
reading	O	DNA
frame	O	DNA
encoding	O	O
108	O	protein
amino	O	protein
acid	O	protein
residues	O	protein
.	O	O
The	O	O
first	O	O
40	O	O
residues	O	O
of	O	O
the	O	O
deduced	O	O
amino	protein	O
acid	protein	O
sequence	protein	O
were	O	O
identical	O	O
to	O	O
those	O	O
of	O	O
the	O	O
reported	O	O
amino-terminal	O	O
sequence	O	O
of	O	O
bovine	O	O
FKBP	protein	protein
,	O	O
indicating	O	O
that	O	O
the	O	O
DNA	O	DNA
sequence	O	DNA
isolated	O	O
represents	O	O
the	O	O
gene	O	O
coding	O	O
for	O	O
FKBP	protein	protein
.	O	O
Computer-assisted	O	O
analysis	O	O
of	O	O
the	O	O
deduced	O	O
amino	O	O
acid	O	O
sequence	O	O
indicates	O	O
that	O	O
FKBP	protein	protein
exhibits	O	O
no	O	O
internal	O	O
homology	O	O
and	O	O
does	O	O
not	O	O
have	O	O
significant	O	O
sequence	O	O
similarity	O	O
to	O	O
any	O	O
other	O	O
amino	O	O
acid	O	O
sequences	O	O
of	O	O
known	O	O
proteins,	O	O
including	O	O
cyclophilin	protein	protein
.	O	O
This	O	O
result	O	O
suggests	O	O
that	O	O
two	O	O
catalytically	O	O
similar	O	O
proteins,	O	O
cyclophilin	protein	protein
and	O	O
FKBP	protein	protein
,	O	O
evolved	O	O
independently.	O	O
In	O	O
Northern	O	O
blot	O	O
analysis	O	O
,	O	O
mRNA	RNA	O
species	RNA	O
of	O	O
approximately	O	O
1.8	O	O
kilobases	O	O
that	O	O
hybridized	O	O
with	O	O
human	DNA	DNA
FKBP	DNA	DNA
cDNA	DNA	DNA
were	O	O
detected	O	O
in	O	O
poly(A)+	RNA	O
RNAs	RNA	O
from	O	O
brain	O	O
,	O	O
lung	O	O
,	O	O
liver	O	O
,	O	O
and	O	O
placental	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
leukocytes	cell_type	cell_type
.	O	O
Induction	O	O
of	O	O
Jurkat	cell_line	cell_line
leukemic	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
with	O	O
phorbol	O	O
12-myristate	O	O
13-acetate	O	O
and	O	O
ionomycin	O	O
did	O	O
not	O	O
affect	O	O
the	O	O
level	O	O
of	O	O
FKBP	RNA	RNA
mRNA	RNA	RNA
.	O	O
Southern	O	O
blot	O	O
analysis	O	O
of	O	O
human	DNA	DNA
genomic	DNA	DNA
DNA	DNA	DNA
digested	O	O
with	O	O
different	O	O
restriction	protein	O
enzymes	protein	O
suggests	O	O
the	O	O
existence	O	O
of	O	O
only	O	O
a	O	O
few	O	O
copies	O	O
of	O	O
the	O	O
DNA	O	DNA
sequence	O	DNA
encoding	O	O
FKBP	protein	protein
.	O	O
This	O	O
is	O	O
in	O	O
contrast	O	O
to	O	O
the	O	O
result	O	O
that	O	O
as	O	O
many	O	O
as	O	O
20	O	O
copies	O	O
of	O	O
the	O	O
cyclophilin	DNA	DNA
gene	DNA	DNA
and	O	O
possible	O	O
pseudogenes	O	O
may	O	O
be	O	O
present	O	O
in	O	O
the	O	O
mammalian	DNA	DNA
genome	DNA	DNA
.	O	O

Involvement	O	O
of	O	O
a	O	O
second	O	O
lymphoid-specific	DNA	DNA
enhancer	DNA	DNA
element	DNA	DNA
in	O	O
the	O	O
regulation	O	O
of	O	O
immunoglobulin	DNA	DNA
heavy-chain	DNA	DNA
gene	DNA	DNA
expression	O	O
.	O	O
To	O	O
determine	O	O
whether	O	O
enhancer	DNA	DNA
elements	DNA	DNA
in	O	O
addition	O	O
to	O	O
the	O	O
highly	O	O
conserved	O	O
octamer	DNA	DNA
(OCTA)-nucleotide	DNA	DNA
motif	DNA	DNA
are	O	O
important	O	O
for	O	O
lymphoid-specific	O	O
expression	O	O
of	O	O
the	O	O
immunoglobulin	DNA	DNA
heavy-chain	DNA	DNA
(IgH)	DNA	DNA
gene	DNA	DNA
,	O	O
we	O	O
have	O	O
investigated	O	O
the	O	O
effect	O	O
of	O	O
mutating	O	O
the	O	O
binding	DNA	DNA
site	DNA	DNA
for	O	O
a	O	O
putative	protein	O
additional	protein	O
lymphoid-specific	protein	protein
transcription	protein	protein
factor	protein	protein
,	O	O
designated	O	O
NF-microB	protein	protein
,	O	O
in	O	O
the	O	O
murine	DNA	DNA
IgH	DNA	DNA
enhancer	DNA	DNA
.	O	O
We	O	O
demonstrate	O	O
that	O	O
the	O	O
NF-microB-binding	DNA	DNA
site	DNA	DNA
plays	O	O
a	O	O
critical	O	O
role	O	O
in	O	O
the	O	O
IgH	DNA	DNA
enhancer	DNA	DNA
,	O	O
because	O	O
mutation	O	O
of	O	O
the	O	O
microB	O	DNA
DNA	O	DNA
motif	O	DNA
decreased	O	O
transcriptional	O	O
activity	O	O
of	O	O
the	O	O
IgH	DNA	DNA
enhancer	DNA	DNA
in	O	O
cells	O	O
of	O	O
the	O	O
B-cell	cell_type	cell_type
lineage	cell_type	cell_type
but	O	O
not	O	O
in	O	O
nonlymphoid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
This	O	O
effect	O	O
was	O	O
comparable	O	O
to	O	O
or	O	O
even	O	O
stronger	O	O
than	O	O
the	O	O
effect	O	O
of	O	O
a	O	O
mutation	O	O
in	O	O
the	O	O
OCTA	DNA	DNA
site	DNA	DNA
.	O	O
Moreover,	O	O
combined	O	O
mutation	O	O
of	O	O
both	O	O
microB	DNA	O
and	O	O
OCTA	DNA	DNA
sites	DNA	DNA
further	O	O
reduced	O	O
enhancer	O	O
activity	O	O
in	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Interestingly,	O	O
alteration	O	O
of	O	O
either	O	O
the	O	O
microB	DNA	O
or	O	O
E3	DNA	DNA
site	DNA	DNA
in	O	O
a	O	O
70-base-pair	DNA	DNA
fragment	DNA	DNA
of	O	O
the	O	O
IgH	DNA	DNA
enhancer	DNA	DNA
that	O	O
lacks	O	O
the	O	O
binding	O	DNA
site	O	DNA
for	O	O
OCTA	O	DNA
abolished	O	O
enhancer	O	O
activity	O	O
in	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
completely.	O	O
Nevertheless,	O	O
a	O	O
multimer	O	O
of	O	O
the	O	O
microB	DNA	DNA
motif	DNA	DNA
alone	O	O
showed	O	O
no	O	O
enhancer	O	O
activity	O	O
.	O	O
DNase	O	protein
footprinting	O	O
analysis	O	O
corroborated	O	O
the	O	O
functional	O	O
data	O	O
showing	O	O
that	O	O
a	O	O
lymphoid-specific	protein	protein
protein	protein	protein
binds	O	O
to	O	O
the	O	O
microB	DNA	DNA
DNA	DNA	DNA
motif	DNA	DNA
.	O	O
Our	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
microB	DNA	DNA
element	DNA	DNA
is	O	O
a	O	O
new	O	O
crucial	O	O
element	O	O
important	O	O
for	O	O
lymphoid-specific	O	O
expression	O	O
of	O	O
the	O	O
IgH	O	DNA
gene	O	DNA
but	O	O
that	O	O
interaction	O	O
with	O	O
another	O	O
enhancer	DNA	DNA
element	DNA	DNA
is	O	O
essential	O	O
for	O	O
its	O	O
activity.	O	O

Stimulation	O	O
of	O	O
the	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
type	O	O
2	O	O
(	O	O
HIV-2	O	DNA
)	O	DNA
gene	O	DNA
expression	O	O
by	O	O
the	O	O
cytomegalovirus	O	O
and	O	O
HIV-2	DNA	O
transactivator	DNA	O
gene	DNA	O
.	O	O
Human	O	O
immunodeficiency	O	O
virus	O	O
(	O	O
HIV	O	O
)	O	O
often	O	O
causes	O	O
latent	O	O
infection.	O	O
Transactivation	O	O
by	O	O
some	O	O
DNA	O	O
viruses	O	O
has	O	O
been	O	O
implicated	O	O
in	O	O
inducing	O	O
HIV-1	O	O
replication	O	O
and	O	O
pathogenesis.	O	O
The	O	O
transactivator	DNA	DNA
(IE-2)	DNA	DNA
gene	DNA	DNA
of	O	O
the	O	O
human	O	protein
cytomegalovirus	O	protein
(	O	O
CMV	O	O
)	O	O
can	O	O
enhance	O	O
HIV-2	O	O
as	O	O
well	O	O
as	O	O
HIV-1	O	DNA
gene	O	DNA
expression	O	O
in	O	O
vitro.	O	O
This	O	O
inducer	O	O
can	O	O
act	O	O
in	O	O
concert	O	O
with	O	O
the	O	O
HIV-2	DNA	DNA
tat	DNA	DNA
gene	DNA	DNA
and	O	O
T-cell	O	O
activation	O	O
in	O	O
enhancing	O	O
gene	O	O
expression	O	O
in	O	O
human	cell_type	cell_type
CD4+	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
While	O	O
the	O	O
HIV-2	O	O
and	O	O
HIV-1	DNA	DNA
tat	DNA	DNA
genes	DNA	DNA
and	O	O
T-cell	protein	O
activators	protein	O
apparently	O	O
employ	O	O
independent	O	O
modes	O	O
of	O	O
action,	O	O
the	O	O
CMV	DNA	O
transactivator	DNA	O
in	O	O
combination	O	O
with	O	O
the	O	O
HIV-2	DNA	O
tat	DNA	O
or	O	O
T-cell	protein	O
activators	protein	O
may	O	O
employ	O	O
a	O	O
gene	O	O
activation	O	O
pathway	O	O
with	O	O
some	O	O
common	O	O
and	O	O
some	O	O
distinct	O	O
components.	O	O
Both	O	O
HIV-2	O	O
and	O	O
CMV	DNA	O
transactivators	DNA	O
enhance	O	O
HIV-2	O	DNA
gene	O	DNA
expression	O	O
by	O	O
transcriptional	O	O
activation	O	O
involving	O	O
transcript	O	O
initiation	O	O
as	O	O
well	O	O
as	O	O
elongation	O	O
,	O	O
with	O	O
CMV	DNA	O
transactivator	DNA	O
affecting	O	O
elongation	O	O
more	O	O
than	O	O
the	O	O
initiation	O	O
.	O	O
A	O	O
significant	O	O
proportion	O	O
of	O	O
transcripts	RNA	O
appear	O	O
to	O	O
terminate	O	O
prematurely	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
transactivators	protein	protein
.	O	O
Deletion	O	O
mutation	O	O
analysis	O	O
of	O	O
the	O	O
HIV-2	DNA	DNA
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
(	O	O
LTR	DNA	DNA
)	O	O
suggests	O	O
that	O	O
the	O	O
element	O	O
that	O	O
responds	O	O
to	O	O
CMV	O	O
transactivation	O	O
in	O	O
human	cell_type	cell_type
CD4+	cell_type	cell_type
lymphocytes	cell_type	cell_type
is	O	O
either	O	O
a	O	O
diffuse	O	O
one	O	O
or	O	O
located	O	O
downstream	O	O
of	O	O
the	O	O
HIV-2	DNA	DNA
enhancer	DNA	DNA
element	DNA	DNA
.	O	O

Quantitative	O	O
immunohistochemical	O	O
analysis	O	O
of	O	O
mononuclear	cell_type	cell_type
infiltrates	cell_type	O
in	O	O
breast	O	O
carcinomas	O	O
--correlation	O	O
with	O	O
tumour	O	O
differentiation	O	O
.	O	O
Inflammatory	cell_type	O
infiltrates	cell_type	O
were	O	O
analysed	O	O
in	O	O
tissue	O	O
sections	O	O
of	O	O
76	O	O
breast	O	O
carcinomas	O	O
by	O	O
counting	O	O
the	O	O
percentage	O	O
of	O	O
macrophages	cell_type	cell_type
,	O	O
IgA+	O	protein
and	O	O
IgG+	O	cell_line
plasma	O	cell_line
cells	O	cell_line
,	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
their	O	O
subpopulations,	O	O
and	O	O
natural	cell_type	cell_type
killer	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
and	O	O
by	O	O
measuring	O	O
postcapillary	O	O
venules	O	O
(	O	O
PCVs	O	O
,	O	O
found	O	O
in	O	O
12	O	O
cases)	O	O
within	O	O
the	O	O
infiltrates.	O	O
These	O	O
parameters	O	O
were	O	O
correlated	O	O
with	O	O
nuclear	O	O
grade	O	O
and	O	O
biochemically	O	O
determined	O	O
hormone	O	O
receptor	O	O
status	O	O
,	O	O
known	O	O
markers	O	O
of	O	O
tumour	O	O
differentiation	O	O
.	O	O
A	O	O
direct	O	O
correlation	O	O
was	O	O
found	O	O
between	O	O
the	O	O
extent	O	O
of	O	O
inflammation	O	O
and	O	O
nuclear	O	O
grade	O	O
(P	O	O
less	O	O
than	O	O
0.0001),	O	O
and	O	O
an	O	O
inverse	O	O
correlation	O	O
between	O	O
inflammation	O	O
and	O	O
oestrogen	protein	protein
receptor	protein	protein
(	O	O
OR	protein	protein
)	O	O
positivity	O	O
(P	O	O
less	O	O
than	O	O
0.05)	O	O
as	O	O
well	O	O
as	O	O
inflammation	O	O
and	O	O
progesterone	protein	protein
receptor	protein	protein
(	O	O
PR	protein	protein
)	O	O
positivity	O	O
(P	O	O
less	O	O
than	O	O
0.05).	O	O
The	O	O
percentage	O	O
of	O	O
the	O	O
OKT8+	cell_line	cell_line
suppressor/cytotoxic	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
increased	O	O
when	O	O
the	O	O
inflammation	O	O
expanded	O	O
from	O	O
scanty	O	O
to	O	O
moderate	O	O
(P	O	O
less	O	O
than	O	O
0.02).	O	O
The	O	O
diameter	O	O
of	O	O
the	O	O
PCVs	O	O
also	O	O
increased	O	O
with	O	O
increasing	O	O
inflammatory	O	O
infiltrate	O	O
(P	O	O
less	O	O
than	O	O
0.02).	O	O
In	O	O
addition,	O	O
a	O	O
direct	O	O
correlation	O	O
exists	O	O
between	O	O
the	O	O
diameter	O	O
of	O	O
the	O	O
PCVs	O	O
and	O	O
both	O	O
the	O	O
percentage	O	O
of	O	O
the	O	O
OKT8+	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
(P	O	O
less	O	O
than	O	O
0.04)	O	O
and	O	O
the	O	O
Leu-7+	O	protein
natural	cell_type	protein
killer	cell_type	O
cells	cell_type	O
(P	O	O
less	O	O
than	O	O
0.03).	O	O

Reactivity	O	O
of	O	O
lymphocytes	cell_line	O
to	O	O
a	O	O
progesterone	protein	O
receptor-specific	protein	O
monoclonal	protein	protein
antibody	protein	protein
.	O	O
In	O	O
this	O	O
study	O	O
we	O	O
present	O	O
evidence	O	O
for	O	O
reactivity	O	O
of	O	O
pregnancy	cell_type	O
lymphocytes	cell_type	O
,	O	O
but	O	O
not	O	O
nonpregnancy	cell_type	O
lymphocytes	cell_type	O
,	O	O
with	O	O
the	O	O
progesterone	protein	O
receptor-specific	protein	O
monoclonal	protein	protein
antibody	protein	protein
mPRI	protein	protein
.	O	O
Using	O	O
an	O	O
avidin	protein	O
-biotin	protein	O
peroxidase	protein	O
detection	O	O
system	O	O
,	O	O
we	O	O
found	O	O
a	O	O
nuclear	O	O
staining	O	O
in	O	O
14.6	O	O
+/-	O	O
3.7%	O	O
(mean	O	O
+/-	O	O
SEM,	O	O
N	O	O
=	O	O
27)	O	O
of	O	O
pregnancy	cell_type	O
lymphocytes	cell_type	cell_type
,	O	O
while	O	O
only	O	O
0.47	O	O
+/-	O	O
0.33%	O	O
(mean	O	O
+/-	O	O
SEM,	O	O
N	O	O
=	O	O
15)	O	O
of	O	O
nonpregnancy	cell_type	O
lymphocytes	cell_type	O
reacted	O	O
with	O	O
the	O	O
antibody.	O	O
To	O	O
characterize	O	O
the	O	O
receptor-bearing	O	O
subset,	O	O
CD8+	O	O
and	O	O
CD4+	O	cell_type
cells	O	cell_type
were	O	O
depleted	O	O
by	O	O
complement-dependent	O	O
lysis.	O	O
Depletion	O	O
of	O	O
CD8+	cell_line	cell_type
cells	cell_line	cell_type
was	O	O
accompanied	O	O
by	O	O
62	O	O
+/-	O	O
18%	O	O
loss	O	O
of	O	O
progesterone	cell_line	protein
receptor	cell_line	protein
-bearing	cell_line	O
cells	cell_line	O
,	O	O
while	O	O
depletion	O	O
of	O	O
CD4+	cell_line	cell_type
cells	cell_line	cell_type
resulted	O	O
in	O	O
a	O	O
twofold	O	O
increase	O	O
in	O	O
the	O	O
number	O	O
of	O	O
positively	O	O
staining	O	O
lymphocytes	cell_line	O
.	O	O
In	O	O
nonpregnancy	cell_line	O
lymphocytes	cell_line	O
a	O	O
3-day	O	O
PHA	protein	protein
treatment	O	O
,	O	O
as	O	O
well	O	O
as	O	O
allogeneic	O	O
stimulation,	O	O
resulted	O	O
in	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
the	O	O
number	O	O
of	O	O
receptor-containing	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
These	O	O
results	O	O
suggest	O	O
that	O	O
pregnancy	O	O
,	O	O
but	O	O
not	O	O
nonpregnancy	O	O
,	O	O
lymphocytes	cell_line	cell_type
contain	O	O
progesterone	protein	O
binding	protein	O
structures	protein	O
,	O	O
and	O	O
that	O	O
these	O	O
are	O	O
inducible	O	O
by	O	O
mitogenic	O	O
or	O	O
alloantigenic	O	O
stimuli	O	O
.	O	O

Activation	O	O
of	O	O
human	cell_line	cell_type
CD4	cell_line	cell_type
T	cell_line	cell_type
lymphocytes	cell_line	cell_type
.	O	O
Interaction	O	O
of	O	O
fibronectin	protein	protein
with	O	O
VLA-5	protein	protein
receptor	protein	protein
on	O	O
CD4	cell_line	cell_type
cells	cell_line	cell_type
induces	O	O
the	O	O
AP-1	protein	protein
transcription	protein	protein
factor	protein	protein
.	O	O
Fibronectin	protein	protein
synergized	O	O
with	O	O
anti-CD3	protein	protein
antibody	protein	protein
to	O	O
promote	O	O
CD4	protein	cell_type
cell	O	cell_type
proliferation	O	O
in	O	O
a	O	O
serum-free	O	cell_line
culture	O	cell_line
system	O	cell_line
whereas	O	O
no	O	O
proliferation	O	O
was	O	O
observed	O	O
when	O	O
CD4	cell_line	cell_type
cells	cell_line	cell_type
were	O	O
cultured	O	O
with	O	O
anti-CD3	protein	protein
alone	O	O
or	O	O
fibronectin	protein	protein
alone.	O	O
In	O	O
addition,	O	O
anti-CD29	protein	protein
(	O	O
integrin	protein	protein
beta	protein	protein
1	protein	protein
)	O	O
as	O	O
well	O	O
as	O	O
anti-VLA-5	protein	protein
(	O	O
human	protein	protein
fibronectin	protein	protein
receptor	protein	protein
)	O	protein
antibodies	O	protein
blocked	O	O
this	O	O
CD4	cell_line	protein
cell	cell_line	protein
activation	O	O
in	O	O
this	O	O
system.	O	O
Although	O	O
anti-CD3	protein	protein
alone	O	O
or	O	O
fibronectin	protein	protein
alone	O	O
cannot	O	O
induce	O	O
IL-2	protein	protein
message	O	O
by	O	O
CD4	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
the	O	O
combination	O	O
of	O	O
anti-CD3	protein	protein
plus	O	O
fibronectin	protein	protein
induced	O	O
IL-2	protein	protein
message	O	O
by	O	O
CD4	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
In	O	O
an	O	O
analysis	O	O
of	O	O
the	O	O
molecular	O	O
mechanism	O	O
by	O	O
which	O	O
IL-2	protein	protein
message	O	O
was	O	O
generated,	O	O
we	O	O
showed	O	O
that	O	O
a	O	O
fibronectin	protein	protein
-VLA-5	O	protein
fibronectin	protein	protein
receptor	protein	protein
interaction	O	O
may	O	O
contribute	O	O
an	O	O
independent	O	O
signal	O	O
distinct	O	O
from	O	O
the	O	O
CD3	protein	protein
pathway	O	O
of	O	O
activation	O	O
by	O	O
the	O	O
induction	O	O
of	O	O
an	O	O
AP-1	protein	protein
transcriptional	protein	protein
factor	protein	protein
.	O	O
Thus	O	O
the	O	O
VLA-5	protein	protein
fibronectin	protein	protein
receptor	protein	protein
on	O	O
CD4	cell_line	cell_type
cells	cell_line	cell_type
can	O	O
play	O	O
a	O	O
complementary	O	O
role	O	O
in	O	O
CD3	protein	protein
-	O	O
TCR	protein	protein
-mediated	O	O
signal	O	O
transduction	O	O
through	O	O
its	O	O
interaction	O	O
with	O	O
fibronectin	protein	protein
.	O	O

Glucocorticoid	protein	protein
receptors	protein	protein
on	O	O
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
in	O	O
Alzheimer's	O	O
disease	O	O
.	O	O
Several	O	O
lines	O	O
of	O	O
evidence	O	O
suggest	O	O
disturbances	O	O
of	O	O
the	O	O
hypothalamic-pituitary-adrenal	O	O
(	O	O
HPA	O	O
)	O	O
system	O	O
in	O	O
Alzheimer's	O	O
disease	O	O
(	O	O
AD	O	O
).	O	O
In	O	O
an	O	O
exploration	O	O
of	O	O
the	O	O
potential	O	O
role	O	O
of	O	O
the	O	O
glucocorticoid	O	protein
receptor	O	protein
(GR)	O	protein
in	O	O
AD	O	O
,	O	O
GR	O	protein
density	O	O
and	O	O
affinity	O	O
were	O	O
assessed	O	O
on	O	O
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
of	O	O
12	O	O
AD	O	O
patients	O	O
and	O	O
12	O	O
healthy	O	O
controls	O	O
.	O	O
GR	O	protein
binding	O	O
characteristics	O	O
did	O	O
not	O	O
differ	O	O
between	O	O
patients	O	O
and	O	O
controls	O	O
or	O	O
between	O	O
patients	O	O
subdivided	O	O
according	O	O
to	O	O
diagnosis	O	O
or	O	O
associated	O	O
clinical	O	O
features.	O	O
These	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
abnormalities	O	O
of	O	O
the	O	O
HPA	O	O
system	O	O
in	O	O
AD	O	O
are	O	O
not	O	O
related	O	O
to	O	O
a	O	O
GR	protein	protein
deficiency	O	O
.	O	O

Oncogene	O	O
amplification	O	O
correlates	O	O
with	O	O
dense	O	O
lymphocyte	O	O
infiltration	O	O
in	O	O
human	O	O
breast	O	O
cancers	O	O
:	O	O
a	O	O
role	O	O
for	O	O
hematopoietic	protein	protein
growth	protein	protein
factor	protein	protein
release	O	O
by	O	O
tumor	cell_type	cell_type
cells	cell_type	cell_type
?	O	O
One	O	O
hundred	O	O
six	O	O
primary	O	O
breast	O	O
cancer	O	O
samples	O	O
were	O	O
analysed	O	O
for	O	O
c-erbB2	O	protein
,	O	O
int-2	O	O
,	O	O
and	O	O
c-myc	O	DNA
gene	O	DNA
amplification	O	O
.	O	O
Surgically	O	O
confirmed	O	O
nodal	O	O
involvement	O	O
was	O	O
observed	O	O
in	O	O
42%.	O	O
Level	O	O
of	O	O
gene	O	O
amplification	O	O
was	O	O
studied	O	O
by	O	O
Southern	O	O
and/or	O	O
slot	O	O
blot	O	O
techniques	O	O
.	O	O
Amplified	O	O
c-erbB2	DNA	DNA
gene	DNA	DNA
sequences	DNA	DNA
were	O	O
present	O	O
in	O	O
21.5%	O	O
of	O	O
all	O	O
samples.	O	O
Int-2	DNA	O
was	O	O
amplified	O	O
in	O	O
13.1%	O	O
and	O	O
c-myc	DNA	O
was	O	O
amplified	O	O
in	O	O
10.3%.	O	O
In	O	O
a	O	O
non-parametric	O	O
test	O	O
(Kruskal-Wallis)	O	O
a	O	O
strong	O	O
negative	O	O
association	O	O
was	O	O
found	O	O
between	O	O
high	O	O
levels	O	O
of	O	O
c-erbB2	DNA	protein
amplification	O	O
and	O	O
absence	O	O
of	O	O
estrogen	O	O
receptor	O	O
(ER)	O	O
(P	O	O
=	O	O
.0009)	O	O
or	O	O
progesterone	protein	protein
receptor	protein	protein
(	O	O
PR	protein	protein
)	O	O
(P	O	O
=	O	O
.011)	O	O
expression.	O	O
No	O	O
correlations	O	O
were	O	O
found	O	O
between	O	O
all	O	O
or	O	O
high	O	O
levels	O	O
of	O	O
amplification	O	O
of	O	O
each	O	O
oncogene	O	DNA
separately	O	O
or	O	O
combined	O	O
with	O	O
T,	O	O
N,	O	O
grade,	O	O
multifocality	O	O
of	O	O
tumor	O	O
,	O	O
or	O	O
associated	O	O
carcinoma	O	O
in	O	O
situ.	O	O
There	O	O
was	O	O
a	O	O
trend	O	O
approaching	O	O
statistical	O	O
significance	O	O
for	O	O
patients	O	O
with	O	O
c-erbB2	DNA	protein
amplifications	O	O
to	O	O
have	O	O
positive	O	O
lymph	O	O
nodes	O	O
at	O	O
surgery	O	O
(P	O	O
=	O	O
0.09).	O	O
A	O	O
somewhat	O	O
surprising	O	O
finding	O	O
however	O	O
was	O	O
a	O	O
very	O	O
strong	O	O
association	O	O
between	O	O
oncogene	DNA	DNA
amplification	O	O
and	O	O
dense	O	O
lymphocyte	O	O
infiltration	O	O
of	O	O
the	O	O
tumor	O	O
(P	O	O
=	O	O
.05).	O	O
This	O	O
correlation	O	O
is	O	O
even	O	O
stronger	O	O
when	O	O
only	O	O
high	O	O
levels	O	O
of	O	O
amplification	O	O
are	O	O
considered,	O	O
either	O	O
for	O	O
each	O	O
oncogene	O	O
separately	O	O
(P	O	O
=	O	O
.0048)	O	O
or	O	O
in	O	O
combination	O	O
(P	O	O
=	O	O
.0007).	O	O
We	O	O
propose	O	O
that	O	O
malignant	O	O
cell	O	O
cytokine	protein	protein
production	O	O
may	O	O
help	O	O
explain	O	O
this	O	O
observation.	O	O

Suppression	O	O
of	O	O
signals	O	O
required	O	O
for	O	O
activation	O	O
of	O	O
transcription	protein	protein
factor	protein	protein
NF-kappa	protein	protein
B	protein	protein
in	O	O
cells	O	O
constitutively	O	O
expressing	O	O
the	O	O
HTLV-I	protein	protein
Tax	protein	protein
protein	protein	protein
.	O	O
Transient	O	O
short-term	O	O
expression	O	O
of	O	O
the	O	O
Tax	protein	protein
protein	protein	protein
of	O	O
human	O	protein
T-cell	O	protein
leukemia	O	protein
virus	O	protein
type-I	O	protein
(	O	O
HTLV-I	O	O
)	O	O
leads	O	O
to	O	O
activation	O	O
of	O	O
the	O	O
pleiotropic	O	protein
transcription	protein	protein
factor	protein	protein
NF-kappa	protein	protein
B	protein	protein
.	O	O
Consistent	O	O
with	O	O
findings	O	O
obtained	O	O
with	O	O
transient	O	O
expression	O	O
assays	O	O
,	O	O
we	O	O
observed	O	O
marked	O	O
accumulation	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
NF-kappa	protein	protein
B	protein	protein
in	O	O
the	O	O
nucleus	O	O
of	O	O
Namalwa	cell_line	protein
B	cell_line	protein
lymphoid	cell_line	O
cells	cell_line	O
,	O	O
which	O	O
constitutively	O	O
express	O	O
Tax	protein	protein
.	O	O
In	O	O
contrast,	O	O
NF-kappa	protein	protein
B	protein	protein
activity	O	O
was	O	O
not	O	O
detected	O	O
in	O	O
the	O	O
nucleus	O	O
following	O	O
long-term	O	O
expression	O	O
of	O	O
Tax	protein	protein
in	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
lymphocytes	cell_line	cell_line
.	O	O
The	O	O
ability	O	O
of	O	O
both	O	O
mitogens	O	O
and	O	O
cytokines	protein	protein
to	O	O
activate	O	O
NF-kappa	protein	protein
B	protein	protein
was	O	O
also	O	O
blocked	O	O
in	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
constitutively	O	O
expressing	O	O
Tax	protein	protein
.	O	O
However,	O	O
the	O	O
activation	O	O
of	O	O
other	O	O
mitogen-inducible	protein	protein
transcription	protein	protein
factors	protein	protein
,	O	O
such	O	O
as	O	O
Fos	protein	protein
and	O	O
Jun	protein	protein
,	O	O
was	O	O
unaffected.	O	O
Thus,	O	O
depending	O	O
on	O	O
the	O	O
cellular	O	O
environment	O	O
,	O	O
the	O	O
short-	O	O
and	O	O
long-term	O	O
effects	O	O
of	O	O
Tax	protein	protein
expression	O	O
can	O	O
be	O	O
quite	O	O
different.	O	O
Consequently,	O	O
one	O	O
function	O	O
of	O	O
Tax	protein	protein
in	O	O
cells	O	O
infected	O	O
with	O	O
HTLV-I	O	O
might	O	O
involve	O	O
cell-type-specific	O	O
suppression	O	O
,	O	O
as	O	O
opposed	O	O
to	O	O
activation,	O	O
of	O	O
distinct	O	O
signal	O	O
pathways	O	O
.	O	O
The	O	O
cells	O	O
lines	O	O
described	O	O
here	O	O
should	O	O
be	O	O
useful	O	O
for	O	O
the	O	O
delineation	O	O
of	O	O
signaling	O	O
pathways	O	O
utilized	O	O
in	O	O
the	O	O
selective	O	O
regulation	O	O
of	O	O
gene	O	O
expression	O	O
.	O	O

Interferon-gamma	protein	protein
and	O	O
the	O	O
sexual	O	O
dimorphism	O	O
of	O	O
autoimmunity	O	O
.	O	O
The	O	O
sexual	O	O
difference	O	O
in	O	O
the	O	O
incidence	O	O
of	O	O
autoimmune	O	O
diseases	O	O
has	O	O
remained	O	O
an	O	O
enigma	O	O
for	O	O
many	O	O
years.	O	O
In	O	O
the	O	O
examination	O	O
of	O	O
the	O	O
induction	O	O
of	O	O
autoimmunity	O	O
in	O	O
transgenic	O	O
mice	O	O
,	O	O
evidence	O	O
has	O	O
been	O	O
obtained	O	O
further	O	O
implicating	O	O
the	O	O
lymphokine	protein	protein
interferon-gamma	protein	protein
in	O	O
the	O	O
etiology	O	O
of	O	O
autoimmunity	O	O
.	O	O
Sex	O	O
steroid	O	O
regulation	O	O
of	O	O
the	O	O
production	O	O
of	O	O
this	O	O
molecule,	O	O
as	O	O
well	O	O
as	O	O
other	O	O
cytokines	protein	protein
,	O	O
may	O	O
help	O	O
explain	O	O
the	O	O
gender-specific	O	O
differences	O	O
in	O	O
the	O	O
immune	O	O
system	O	O
,	O	O
including	O	O
autoimmunity	O	O
.	O	O

Cloning	O	O
of	O	O
a	O	O
transcriptionally	protein	O
active	protein	O
human	protein	O
TATA	protein	DNA
binding	protein	DNA
factor	protein	DNA
.	O	O
Transcription	protein	protein
factor	protein	protein
IID	protein	protein
(	O	protein
TFIID	protein	protein
)	O	O
binds	O	O
to	O	O
the	O	O
TATA	DNA	DNA
box	DNA	DNA
promoter	DNA	DNA
element	DNA	DNA
and	O	O
regulates	O	O
the	O	O
expression	O	O
of	O	O
most	O	O
eukaryotic	DNA	O
genes	DNA	O
transcribed	O	O
by	O	O
RNA	protein	protein
polymerase	protein	protein
II	protein	protein
.	O	O
Complementary	DNA	O
DNA	DNA	O
(	O	O
cDNA	DNA	DNA
)	O	O
encoding	O	O
a	O	O
human	protein	protein
TFIID	protein	protein
protein	protein	protein
has	O	O
been	O	O
cloned.	O	O
The	O	O
human	protein	O
TFIID	protein	O
polypeptide	protein	O
has	O	O
339	O	O
amino	O	O
acids	O	O
and	O	O
a	O	O
molecular	O	O
size	O	O
of	O	O
37,745	O	O
daltons	O	O
.	O	O
The	O	O
carboxyl-terminal	protein	protein
181	protein	protein
amino	protein	protein
acids	protein	protein
of	O	O
the	O	O
human	protein	protein
TFIID	protein	protein
protein	protein	protein
shares	O	O
80%	O	O
identity	O	O
with	O	O
the	O	O
TFIID	protein	protein
protein	O	protein
from	O	O
Saccharomyces	O	O
cerevisiae	O	O
.	O	O
The	O	O
amino	protein	protein
terminus	protein	protein
contains	O	O
an	O	O
unusual	O	O
repeat	O	O
of	O	O
38	O	O
consecutive	O	O
glutamine	O	O
residues	O	O
and	O	O
an	O	O
X-Thr-Pro	protein	DNA
repeat	protein	DNA
.	O	O
Expression	O	O
of	O	O
DNA	DNA	O
in	O	O
reticulocyte	O	O
lysates	O	O
or	O	O
in	O	O
Escherichia	O	O
coli	O	O
yielded	O	O
a	O	O
protein	O	O
that	O	O
was	O	O
competent	O	O
for	O	O
both	O	O
DNA	O	O
binding	O	O
and	O	O
transcription	O	O
activation	O	O
.	O	O

A	O	O
novel	O	O
T-cell	protein	O
trans-activator	protein	O
that	O	O
recognizes	O	O
a	O	O
phorbol	DNA	O
ester-inducible	DNA	O
element	DNA	O
of	O	O
the	O	O
interleukin-2	DNA	DNA
promoter	DNA	DNA
.	O	O
The	O	O
interleukin	DNA	protein
2	DNA	protein
(	DNA	O
IL-2	DNA	protein
)	DNA	O
gene	DNA	O
promoter	DNA	O
is	O	O
recognized	O	O
by	O	O
several	O	O
cell-type-specific	O	O
and	O	O
ubiquitous	O	O
transcriptional	O	O
regulators	O	O
that	O	O
integrate	O	O
information	O	O
transmitted	O	O
by	O	O
various	O	O
signaling	O	O
systems	O	O
leading	O	O
to	O	O
IL-2	protein	protein
production	O	O
and	O	O
T-cell	cell_type	O
activation	O	O
.	O	O
Using	O	O
a	O	O
combination	O	O
of	O	O
transfection	O	O
,	O	O
protein-DNA	O	O
binding,	O	O
and	O	O
in	O	O
vitro	O	O
transcription	O	O
methods	O	O
,	O	O
we	O	O
have	O	O
discovered	O	O
the	O	O
novel	protein	O
T-cell-specific	protein	protein
transcriptional	protein	protein
activator	protein	protein
TCF-1	protein	protein
(for	O	O
T-Cell	protein	O
Factor-1	protein	protein
),	O	O
which	O	O
recognizes	O	O
a	O	O
T-cell-specific	DNA	DNA
response	DNA	DNA
element	DNA	DNA
(	O	O
TCE	DNA	DNA
)	O	O
located	O	O
within	O	O
the	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
.	O	O
Although	O	O
the	O	O
TCE	DNA	O
is	O	O
similar	O	O
in	O	O
sequence	O	O
to	O	O
a	O	O
consensus	DNA	DNA
NF	DNA	DNA
kappa	DNA	DNA
B	DNA	DNA
site	DNA	DNA
,	O	O
several	O	O
criteria	O	O
indicate	O	O
that	O	O
TCF-1	protein	protein
is	O	O
distinct	O	O
from	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
.	O	O
However,	O	O
like	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
,	O	O
TCF-1	protein	protein
activity	O	O
is	O	O
induced	O	O
by	O	O
phorbol	O	O
esters	O	O
and	O	O
other	O	O
T-cell	O	O
activators	O	O
.	O	O

Risk	O	protein
factors	O	protein
for	O	O
breast	O	O
recurrence	O	O
in	O	O
premenopausal	O	O
and	O	O
postmenopausal	O	O
patients	O	O
with	O	O
ductal	O	O
cancers	O	O
treated	O	O
by	O	O
conservation	O	O
therapy	O	O
.	O	O
Risk	O	protein
factors	O	protein
for	O	O
local	O	O
failure	O	O
were	O	O
evaluated	O	O
for	O	O
496	O	O
clinical	O	O
Stage	O	O
I-II	O	O
patients	O	O
with	O	O
infiltrating	O	O
ductal	O	O
carcinomas	O	O
(median	O	O
follow-up,	O	O
71	O	O
months)	O	O
treated	O	O
by	O	O
conservative	O	O
surgery	O	O
and	O	O
radiotherapy	O	O
.	O	O
Monofactorial	O	O
analysis	O	O
identified	O	O
the	O	O
following	O	O
factors	O	O
to	O	O
be	O	O
correlated	O	O
with	O	O
increased	O	O
risk:	O	O
moderate/marked	O	O
mononuclear	O	O
cell	O	O
reaction	O	O
(	O	O
MCR	O	O
),	O	O
high	O	O
histologic	O	O
grade	O	O
(G),	O	O
extensive	O	O
intraductal	O	O
component	O	O
(	O	O
EIC	O	O
),	O	O
tumor	O	protein
necrosis	O	protein
,	O	O
macroscopic	O	O
multiplicity	O	O
,	O	O
estrogen	protein	O
receptor	protein	O
negativity	O	O
,	O	O
anatomic	O	O
tumor	O	O
size	O	O
,	O	O
age	O	O
younger	O	O
than	O	O
40	O	O
years,	O	O
and	O	O
vascular	O	O
invasion	O	O
.	O	O
Only	O	O
MCR	O	O
,	O	O
G	O	O
,	O	O
and	O	O
EIC	O	O
proved	O	O
significant	O	O
in	O	O
Cox	O	O
multivariate	O	O
analysis	O	O
.	O	O
These	O	O
risk	O	protein
factors	O	protein
were	O	O
highly	O	O
age	O	O
dependent,	O	O
with	O	O
EIC	O	O
markedly	O	O
more	O	O
prevalent	O	O
in	O	O
women	O	O
younger	O	O
than	O	O
50,	O	O
MCR	O	O
and	O	O
G	O	O
in	O	O
women	O	O
younger	O	O
than	O	O
40.	O	O
Separate	O	O
Cox	O	O
analysis	O	O
for	O	O
premenopausal	O	O
patients	O	O
showed	O	O
that	O	O
MCR	O	O
/EIC	O	O
determined	O	O
risk	O	O
independent	O	O
of	O	O
resection	O	O
margins:	O	O
tumors	O	O
with	O	O
MCR	O	O
had	O	O
a	O	O
28%,	O	O
and	O	O
with	O	O
EIC	O	O
a	O	O
22%	O	O
probability	O	O
of	O	O
recurring	O	O
locally	O	O
by	O	O
5	O	O
years.	O	O
Premenopausal	O	O
patients	O	O
with	O	O
neither	O	O
risk	O	O
factor	O	O
had	O	O
a	O	O
very	O	O
low	O	O
failure	O	O
rate	O	O
(2.6%	O	O
at	O	O
5	O	O
years),	O	O
regardless	O	O
of	O	O
age.	O	O
For	O	O
postmenopausal	O	O
patients	O	O
risk	O	O
of	O	O
breast	O	O
recurrence	O	O
was	O	O
determined	O	O
both	O	O
by	O	O
adequacy	O	O
of	O	O
resection	O	O
margins	O	O
and	O	O
grade,	O	O
with	O	O
a	O	O
high	O	O
local	O	O
failure	O	O
rate	O	O
for	O	O
patients	O	O
having	O	O
G3	O	O
tumors	O	O
with	O	O
positive	O	O
or	O	O
indeterminate	O	O
margins	O	O
(31%	O	O
at	O	O
5	O	O
years).	O	O
The	O	O
authors	O	O
conclude	O	O
that	O	O
the	O	O
microscopic	O	O
examination	O	O
is	O	O
the	O	O
only	O	O
useful	O	O
tool	O	O
for	O	O
assessing	O	O
the	O	O
risk	O	O
of	O	O
local	O	O
failure,	O	O
which	O	O
is	O	O
quite	O	O
low	O	O
for	O	O
the	O	O
majority	O	O
of	O	O
patients	O	O
treated	O	O
with	O	O
breast	O	O
conservation	O	O
.	O	O
High-risk	O	O
patients	O	O
can	O	O
be	O	O
recognized	O	O
morphologically.	O	O
The	O	O
age	O	O
dependence	O	O
of	O	O
morphologic	O	O
risk	O	protein
factors	O	protein
appears	O	O
to	O	O
explain	O	O
the	O	O
high	O	O
local	O	O
failure	O	O
rate	O	O
seen	O	O
in	O	O
patients	O	O
younger	O	O
than	O	O
40.	O	O

Tax	protein	protein
-independent	O	O
binding	O	O
of	O	O
multiple	O	O
cellular	protein	protein
factors	protein	protein
to	O	O
Tax	DNA	DNA
-response	DNA	DNA
element	DNA	DNA
DNA	DNA	O
of	O	O
HTLV-I	O	O
.	O	O
The	O	O
human	DNA	cell_line
T-cell	DNA	cell_line
leukemia	DNA	cell_line
virus	DNA	cell_line
type	DNA	cell_line
I	DNA	cell_line
(	DNA	cell_line
HTLV-I	DNA	cell_line
)	DNA	O
promoter	DNA	O
contains	O	O
three	O	O
copies	O	O
of	O	O
imperfect	O	O
repeats	O	O
of	O	O
a	O	O
21-base	O	DNA
pair	O	DNA
sequence	O	DNA
designated	O	O
here	O	O
as	O	O
TRE	DNA	DNA
(	O	O
Tax	DNA	DNA
-response	DNA	DNA
element	DNA	DNA
)	O	O
that	O	O
is	O	O
responsive	O	O
to	O	O
the	O	O
virally	protein	O
encoded	protein	O
transactivator	protein	protein
protein	protein	protein
Tax	protein	protein
.	O	O
We	O	O
have	O	O
identified	O	O
and	O	O
separated	O	O
four	O	O
nuclear	protein	O
proteins	protein	O
from	O	O
C81-66-45	O	protein
cells,	O	O
an	O	O
HTLV-I	cell_line	O
immortalized	cell_line	O
Tax	cell_line	protein
-expressing	cell_line	O
human	cell_line	cell_line
T-lymphocyte	cell_line	cell_line
line	cell_line	cell_line
(Salahuddin	O	cell_line
et	O	cell_line
al.,	O	cell_line
1983),	O	O
that	O	O
interact	O	O
with	O	O
the	O	O
TRE	DNA	DNA
-DNA	DNA	DNA
,	O	O
none	O	O
of	O	O
which	O	O
are	O	O
identical	O	O
with	O	O
the	O	O
Tax	protein	protein
-protein	protein	protein
.	O	O
The	O	O
proteins	O	O
identified	O	O
have	O	O
molecular	O	O
weights	O	O
of	O	O
about	O	O
32,	O	O
36	O	O
to	O	O
42,	O	O
50	O	O
and	O	O
110	O	O
kD.	O	O
Four	O	O
different	O	O
methods	O	O
were	O	O
used	O	O
to	O	O
identify	O	O
the	O	O
proteins.	O	O
First,	O	O
from	O	O
different	O	O
cell	O	cell_line
lines	O	cell_line
three	O	O
or	O	O
all	O	O
four	O	O
of	O	O
the	O	O
nuclear	protein	protein
proteins	protein	protein
were	O	O
specifically	O	O
cross-linked	O	O
by	O	O
UV	O	O
irradiation	O	O
to	O	O
the	O	O
radioactively	O	O
labeled	O	O
TRE	DNA	DNA
-DNA	DNA	DNA
fragment	DNA	DNA
.	O	O
Second,	O	O
TRE	protein	DNA
-DNA	protein	DNA
binding	protein	DNA
proteins	protein	DNA
sedimented	O	O
through	O	O
a	O	O
glycerol	O	O
density	O	O
gradient	O	O
at	O	O
rates	O	O
corresponding	O	O
to	O	O
proteins	O	O
of	O	O
native	O	O
molecular	O	O
weights	O	O
of	O	O
35	O	O
to	O	O
50	O	O
kD	O	O
and	O	O
110	O	O
kD.	O	O
Third,	O	O
only	O	O
the	O	O
50	protein	protein
kD	protein	protein
protein	protein	protein
was	O	O
retained	O	O
on	O	O
a	O	O
biotinylated	O	O
DNA-streptavidin	O	O
matrix	O	O
when	O	O
the	O	O
DNA	O	DNA
fragment	O	DNA
contained	O	O
the	O	O
TRE	DNA	DNA
-DNA	DNA	DNA
.	O	O
Fourth,	O	O
extensive	O	O
purification	O	O
by	O	O
several	O	O
cycles	O	O
of	O	O
TRE	DNA	DNA
-DNA	O	DNA
affinity	O	O
chromatography	O	O
resulted	O	O
in	O	O
the	O	O
32	O	O
,	O	O
36	O	O
to	O	O
42	O	O
and	O	O
110	O	protein
kD	O	protein
proteins	O	protein
and	O	O
to	O	O
less	O	O
extent	O	O
the	O	O
50	protein	protein
kD	protein	protein
factor	protein	protein
.	O	O
Two	O	O
abundant	O	O
proteins	O	O
of	O	O
75	O	O
and	O	O
80	O	O
kD	O	O
were	O	O
competed	O	O
out	O	O
by	O	O
poly[d(I-C)]	O	O
in	O	O
all	O	O
reactions.	O	O
The	O	O
cAMP-response	DNA	DNA
element	DNA	DNA
CRE	DNA	DNA
,	O	O
TGACGTCA	O	O
,	O	O
present	O	O
in	O	O
the	O	O
21	DNA	DNA
base-pair	DNA	DNA
sequence	DNA	DNA
,	O	O
appears	O	O
to	O	O
be	O	O
essential	O	O
for	O	O
specific	O	O
protein-	O	O
TRE	DNA	DNA
-DNA	O	DNA
interactions	O	DNA
because	O	O
mutation	O	O
of	O	O
the	O	O
two	O	O
G	O	O
's	O	O
destroys	O	O
this	O	O
complex.	O	O
This	O	O
result	O	O
suggests	O	O
that	O	O
the	O	O
cAMP	protein	DNA
response	protein	DNA
element	protein	DNA
binding	protein	O
protein	protein	O
,	O	O
CREB	protein	protein
,	O	O
is	O	O
involved	O	O
in	O	O
the	O	O
protein-	protein	O
TRE	protein	DNA
-DNA	protein	DNA
complex	protein	O
and	O	O
in	O	O
mediating	O	O
the	O	O
Tax	protein	protein
response	O	O
.	O	O

Two	O	O
distinct	O	O
transcription	protein	protein
factors	protein	protein
that	O	O
bind	O	O
the	O	O
immunoglobulin	DNA	DNA
enhancer	DNA	DNA
microE5/kappa	DNA	DNA
2	DNA	DNA
motif	DNA	DNA
.	O	O
Activity	O	O
of	O	O
the	O	O
immunoglobulin	O	DNA
heavy	O	DNA
and	O	DNA
kappa	O	DNA
light	O	DNA
chain	O	DNA
gene	O	DNA
enhancers	O	DNA
depends	O	O
on	O	O
a	O	O
complex	O	O
interplay	O	O
of	O	O
ubiquitous	protein	O
and	protein	O
developmentally	protein	O
regulated	protein	O
proteins	protein	O
.	O	O
Two	O	O
complementary	DNA	O
DNAs	DNA	O
were	O	O
isolated	O	O
that	O	O
encode	O	O
proteins,	O	O
denoted	O	O
ITF-1	protein	protein
and	O	O
ITF-2	protein	protein
,	O	O
that	O	O
are	O	O
expressed	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
cell	O	O
types	O	O
and	O	O
bind	O	O
the	O	O
microE5/kappa	DNA	DNA
2	DNA	DNA
motif	DNA	DNA
found	O	O
in	O	O
both	O	O
heavy	O	O
and	O	O
kappa	O	O
light	O	O
chain	O	O
enhancers	O	O
.	O	O
The	O	O
complementary	DNA	O
DNAs	DNA	O
are	O	O
the	O	O
products	O	O
of	O	O
distinct	O	O
genes,	O	O
yet	O	O
both	O	O
ITF-1	protein	protein
and	O	O
ITF-2	protein	protein
are	O	O
structurally	O	O
and	O	O
functionally	O	O
similar.	O	O
The	O	O
two	O	O
proteins	O	O
interact	O	O
with	O	O
one	O	O
another	O	O
through	O	O
their	O	O
putative	O	O
helix-loop-helix	protein	protein
motifs	protein	protein
and	O	O
each	O	O
possesses	O	O
a	O	O
distinct	O	O
domain	O	O
that	O	O
dictates	O	O
transcription	O	O
activation	O	O
.	O	O

Elevated	O	protein
glucocorticoid	protein	protein
receptor	protein	protein
concentrations	O	O
before	O	O
and	O	O
after	O	O
glucocorticoid	O	O
therapy	O	O
in	O	O
peripheral	cell_type	cell_type
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
of	O	O
patients	O	O
with	O	O
atopic	O	O
dermatitis	O	O
.	O	O
The	O	O
number	O	O
and	O	O
affinity	O	O
of	O	O
glucocorticoid	O	O
binding	O	O
sites	O	O
in	O	O
peripheral	cell_type	cell_type
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
of	O	O
patients	O	O
with	O	O
atopic	O	O
dermatitis	O	O
(	O	O
AD	O	O
)	O	O
and	O	O
healthy	O	O
controls	O	O
were	O	O
determined	O	O
under	O	O
baseline	O	O
conditions	O	O
and	O	O
after	O	O
a	O	O
defined	O	O
oral	O	O
glucocorticoid	O	O
treatment	O	O
.	O	O
Patients	O	O
with	O	O
AD	O	O
(n	O	O
=	O	O
15)	O	O
exhibited	O	O
significantly	O	O
more	O	O
glucocorticoid	protein	protein
receptors	protein	protein
(	O	O
GR	protein	protein
)	O	O
per	O	O
cell	O	O
than	O	O
the	O	O
control	O	O
group	O	O
(n	O	O
=	O	O
22),	O	O
while	O	O
the	O	O
GR	protein	protein
affinity	O	O
did	O	O
not	O	O
differ.	O	O
Methylprednisolone	O	O
treatment	O	O
resulted	O	O
in	O	O
a	O	O
significant	O	O
reduction	O	O
of	O	O
the	O	O
GR	protein	DNA
sites	O	DNA
per	O	O
cell	O	O
in	O	O
the	O	O
steroid-treated	O	O
control	O	O
group	O	O
(n	O	O
=	O	O
10)	O	O
in	O	O
contrast	O	O
to	O	O
the	O	O
patients	O	O
.	O	O
The	O	O
dissociation	O	O
constant	O	O
was	O	O
not	O	O
affected	O	O
by	O	O
methylprednisolone	O	O
treatment	O	O
in	O	O
either	O	O
group.	O	O
In	O	O
view	O	O
of	O	O
the	O	O
therapeutic	O	O
efficiency	O	O
of	O	O
glucocorticoids	O	O
in	O	O
AD	O	O
and	O	O
findings	O	O
of	O	O
abnormal	O	O
cAMP	O	O
and	O	O
cAMP-phosphodiesterase	O	protein
activity	O	O
,	O	O
the	O	O
elevated	O	O
GR	protein	protein
concentrations	O	O
in	O	O
AD	O	O
lend	O	O
support	O	O
to	O	O
the	O	O
hypothesis	O	O
of	O	O
a	O	O
compensatory	O	O
GR	protein	protein
upregulation	O	O
due	O	O
to	O	O
an	O	O
insufficient	O	O
action	O	O
of	O	O
endogenous	O	O
cortisol	O	O
or	O	O
to	O	O
altered	O	O
cAMP	O	O
-induced	O	O
GR	protein	protein
expression	O	O
.	O	O

The	O	O
actions	O	O
of	O	O
cyclosporin	O	O
A	O	O
and	O	O
FK506	O	O
suggest	O	O
a	O	O
novel	O	O
step	O	O
in	O	O
the	O	O
activation	O	O
of	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
Cyclosporin	O	O
A	O	O
and	O	O
FK506	O	O
are	O	O
immunosuppressive	O	O
compounds	O	O
that	O	O
have	O	O
similar	O	O
inhibitory	O	O
effects	O	O
on	O	O
the	O	O
expression	O	O
of	O	O
several	O	O
lymphokines	protein	O
produced	O	O
by	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
Despite	O	O
their	O	O
similar	O	O
effects	O	O
the	O	O
drugs	O	O
bind	O	O
to	O	O
two	O	O
different	O	O
cytosolic	protein	protein
protein	protein	protein
,	O	O
cyclophilin	protein	protein
and	O	O
FKBP	protein	protein
respectively,	O	O
which	O	O
raises	O	O
the	O	O
possibility	O	O
that	O	O
they	O	O
have	O	O
different	O	O
modes	O	O
of	O	O
action.	O	O
Using	O	O
constructs	O	O
in	O	O
which	O	O
mRNA	RNA	O
production	O	O
controlled	O	O
by	O	O
a	O	O
specific	O	O
transcription	protein	protein
factor	protein	protein
could	O	O
be	O	O
readily	O	O
measured	O	O
we	O	O
found	O	O
that	O	O
both	O	O
cyclosporin	O	O
A	O	O
and	O	O
FK506	O	O
completely	O	O
inhibited	O	O
transcription	O	O
activated	O	O
by	O	O
NF-AT	protein	protein
,	O	O
NFIL2	protein	protein
A	protein	protein
,	O	O
NFIL2	protein	protein
B	protein	protein
and	O	O
partially	O	O
inhibited	O	O
transcription	O	O
activated	O	O
by	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
.	O	O
Cyclosporin	O	O
A	O	O
and	O	O
FK506	O	O
inhibited	O	O
only	O	O
transcriptional	O	O
activation	O	O
that	O	O
was	O	O
dependent	O	O
on	O	O
Ca2+	O	O
mobilization	O	O
.	O	O
However,	O	O
cyclosporin	O	O
A	O	O
and	O	O
FK506	O	O
did	O	O
not	O	O
inhibit	O	O
Ca2+	O	O
mobilization	O	O
dependent	O	O
expression	O	O
of	O	O
c-fos	RNA	RNA
mRNA	RNA	RNA
indicating	O	O
that	O	O
only	O	O
a	O	O
subset	O	O
of	O	O
signalling	O	O
pathways	O	O
regulated	O	O
by	O	O
Ca2+	O	O
is	O	O
sensitive	O	O
to	O	O
these	O	O
drugs.	O	O
Furthermore,	O	O
we	O	O
did	O	O
not	O	O
observe	O	O
any	O	O
qualitative	O	O
differences	O	O
between	O	O
the	O	O
effect	O	O
of	O	O
cyclosporin	O	O
A	O	O
and	O	O
FK506	O	O
on	O	O
six	O	O
different	O	O
transcription	protein	protein
factors	protein	protein
which	O	O
suggests	O	O
that	O	O
these	O	O
drugs	O	O
may	O	O
interfere	O	O
with	O	O
the	O	O
activity	O	O
of	O	O
a	O	O
novel	O	O
Ca2+	O	O
dependent	O	O
step	O	O
that	O	O
regulates	O	O
several	O	O
transcription	protein	protein
factors	protein	protein
.	O	O

The	O	O
internal	O	O
methionine	O	O
codons	O	O
of	O	O
human	DNA	O
T-cell	DNA	O
leukemia	DNA	O
virus	DNA	O
type	DNA	O
II	DNA	O
rex	DNA	O
gene	DNA	O
are	O	O
not	O	O
required	O	O
for	O	O
p24rex	protein	protein
production	O	O
or	O	O
virus	O	O
replication	O	O
and	O	O
transformation	O	O
.	O	O
Human	O	O
T-cell	O	O
leukemia	O	O
virus	O	O
types	O	O
I	O	O
(	O	O
HTLV-I	O	O
)	O	O
and	O	O
II	O	O
(	O	O
HTLV-II	O	O
)	O	O
have	O	O
two	O	O
nonstructural	DNA	O
trans-acting	DNA	DNA
regulatory	DNA	DNA
genes	DNA	DNA
,	O	O
tax	DNA	O
and	O	O
rex	DNA	O
,	O	O
located	O	O
in	O	O
the	O	O
3'	DNA	DNA
region	DNA	DNA
of	O	O
the	O	O
viral	DNA	DNA
genome	DNA	DNA
.	O	O
The	O	O
tax	protein	DNA
gene	protein	DNA
product	protein	DNA
(	O	O
HTLV-I	protein	O
p40tax	protein	O
and	O	O
HTLV-II	protein	O
p37tax	protein	O
)	O	O
is	O	O
the	O	O
transcriptional	O	protein
activator	O	protein
of	O	O
the	O	O
viral	DNA	DNA
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
.	O	O
The	O	O
rex	DNA	O
gene	DNA	O
encodes	O	O
two	O	O
protein	O	O
products,	O	O
p27rex	protein	O
/p21rex	protein	O
and	O	O
p26rex	protein	O
/p24rex	protein	O
in	O	O
HTLV-I	O	O
and	O	O
HTLV-II	O	O
,	O	O
respectively.	O	O
Rex	protein	O
acts	O	O
posttranscriptionally	O	O
to	O	O
facilitate	O	O
accumulation	O	O
of	O	O
full-length	O	O
gag/pol	protein	O
and	O	O
singly	O	O
spliced	O	O
env	RNA	O
mRNA	RNA	O
in	O	O
the	O	O
cytoplasm	O	O
of	O	O
HTLV-infected	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Previous	O	O
studies	O	O
showed	O	O
that	O	O
the	O	O
first	O	O
ATG	O	O
of	O	O
the	O	O
rex	DNA	DNA
gene	DNA	DNA
is	O	O
critical	O	O
for	O	O
Rex	protein	O
production	O	O
and	O	O
function.	O	O
The	O	O
importance	O	O
of	O	O
the	O	O
internal	O	O
ATGs	O	O
to	O	O
Rex	protein	O
function	O	O
is	O	O
not	O	O
known.	O	O
However,	O	O
in	O	O
vitro	O	O
mutagenesis	O	O
of	O	O
the	O	O
HTLV-I	O	DNA
rex	DNA	DNA
gene	DNA	DNA
has	O	O
provided	O	O
indirect	O	O
evidence	O	O
which	O	O
suggests	O	O
that	O	O
p21rex	protein	protein
,	O	O
and	O	O
by	O	O
analogy	O	O
HTLV-II	O	O
p24rex	protein	O
,	O	O
results	O	O
from	O	O
initiation	O	O
at	O	O
an	O	O
internal	O	O
AUG	O	O
of	O	O
the	O	O
tax	RNA	RNA
/rex	RNA	RNA
mRNA	RNA	RNA
.	O	O
By	O	O
using	O	O
an	O	O
infectious	O	O
molecular	O	O
clone	O	O
of	O	O
HTLV-II	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
importance	O	O
of	O	O
the	O	O
internal	O	O
ATGs	O	O
of	O	O
the	O	O
rex	DNA	DNA
gene	DNA	DNA
on	O	O
Rex	protein	protein
protein	O	protein
production	O	O
and	O	O
function.	O	O
Our	O	O
results	O	O
indicate	O	O
that	O	O
p24rex	protein	protein
of	O	O
HTLV-II	O	O
is	O	O
not	O	O
initiated	O	O
at	O	O
an	O	O
internal	O	O
AUG	O	O
and	O	O
that	O	O
the	O	O
internal	O	O
methionine	O	O
codons	O	O
are	O	O
not	O	O
crucial	O	O
to	O	O
the	O	O
function	O	O
of	O	O
the	O	O
rex	DNA	DNA
gene	DNA	DNA
and,	O	O
ultimately,	O	O
the	O	O
transforming	O	O
properties	O	O
of	O	O
the	O	O
virus	O	O
.	O	O

Astrocytes	cell_type	O
and	O	O
glioblastoma	cell_type	cell_type
cells	cell_type	cell_type
express	O	O
novel	O	O
octamer-DNA	protein	protein
binding	protein	protein
proteins	protein	protein
distinct	O	O
from	O	O
the	O	O
ubiquitous	protein	O
Oct-1	protein	protein
and	protein	O
B	protein	O
cell	protein	O
type	protein	O
Oct-2	protein	protein
proteins	protein	protein
.	O	O
The	O	O
'octamer'	DNA	O
sequence	DNA	O
,	O	O
ATGCAAAT	O	O
or	O	O
its	O	O
complement	O	O
ATTTGCAT	O	protein
,	O	O
is	O	O
a	O	O
key	O	O
element	O	O
for	O	O
the	O	O
transcriptional	O	O
regulation	O	O
of	O	O
immunoglobulin	DNA	DNA
genes	DNA	DNA
in	O	O
B-lymphocytes	cell_type	cell_type
as	O	O
well	O	O
as	O	O
a	O	O
number	O	O
of	O	O
housekeeping	DNA	DNA
genes	DNA	DNA
in	O	O
all	O	O
cell	O	O
types.	O	O
In	O	O
lymphocytes	cell_type	cell_type
,	O	O
the	O	O
octamer-binding	protein	protein
protein	protein	protein
Oct-2A	protein	protein
and	O	O
variants	O	O
thereof	O	O
are	O	O
thought	O	O
to	O	O
contribute	O	O
to	O	O
the	O	O
B-cell	DNA	O
specific	DNA	O
gene	DNA	O
expression	O	O
,	O	O
while	O	O
the	O	O
ubiquitous	O	protein
protein	O	protein
Oct-1	O	protein
seems	O	O
to	O	O
control	O	O
general	O	O
octamer	DNA	DNA
site	DNA	DNA
-dependent	O	O
transcription	O	O
.	O	O
Various	O	O
other	O	O
genes,	O	O
for	O	O
example	O	O
interleukin-1	O	protein
and	O	O
MHC	O	protein
class	O	protein
II	O	protein
genes	O	O
,	O	O
contain	O	O
an	O	O
octamer	DNA	DNA
sequence	DNA	DNA
in	O	O
the	O	O
promoter	DNA	O
and	O	O
are	O	O
expressed	O	O
in	O	O
cells	O	O
of	O	O
both	O	O
the	O	O
immune	O	O
and	O	O
nervous	O	O
systems	O	O
.	O	O
This	O	O
prompted	O	O
us	O	O
to	O	O
analyze	O	O
the	O	O
octamer-binding	protein	protein
proteins	protein	protein
in	O	O
the	O	O
latter	O	O
cells.	O	O
Using	O	O
the	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assay	O	O
,	O	O
at	O	O
least	O	O
six	O	O
novel	O	O
octamer	protein	protein
binding	protein	protein
proteins	protein	protein
were	O	O
detected	O	O
in	O	O
nuclear	O	O
extracts	O	O
of	O	O
cultured	cell_type	O
mouse	cell_type	O
astrocytes	cell_type	cell_type
.	O	O
These	O	O
proteins	O	O
are	O	O
differentially	O	O
expressed	O	O
in	O	O
human	O	O
glioblastoma	O	O
and	O	O
neuroblastoma	O	cell_line
cell	O	cell_line
lines	O	cell_line
.	O	O
The	O	O
nervous	protein	O
system-derived	protein	O
(N-Oct)	protein	protein
proteins	protein	protein
bound	O	O
to	O	O
the	O	O
octamer	DNA	DNA
DNA	DNA	DNA
sequence	DNA	DNA
in	O	O
a	O	O
manner	O	O
which	O	O
is	O	O
indistinguishable	O	O
from	O	O
the	O	O
Oct-1	protein	protein
and	O	O
Oct-2A	protein	protein
proteins	protein	protein
.	O	O
The	O	O
relationship	O	O
of	O	O
the	O	O
N-Oct	protein	protein
proteins	protein	protein
to	O	O
Oct-1	protein	protein
and	O	O
Oct-2A	protein	protein
was	O	O
analyzed	O	O
by	O	O
proteolytic	O	O
clipping	O	O
bandshift	O	O
assays	O	O
and	O	O
by	O	O
their	O	O
reactivity	O	O
towards	O	O
antisera	O	O
raised	O	O
against	O	O
recombinant	O	O
Oct-1	protein	protein
and	O	O
Oct-2A	protein	protein
proteins.	O	O
On	O	O
the	O	O
basis	O	O
of	O	O
these	O	O
assays,	O	O
all	O	O
N-Oct-factors	protein	O
were	O	O
found	O	O
to	O	O
be	O	O
distinct	O	O
from	O	O
the	O	O
ubiquitous	protein	O
Oct-1	protein	protein
and	O	O
the	O	O
lymphoid-specific	protein	O
Oct-2A	protein	protein
proteins.	O	O
In	O	O
melanoma	cell_type	O
cells	cell_type	O
that	O	O
contain	O	O
the	O	O
N-Oct-3	protein	protein
factor	protein	protein
,	O	O
a	O	O
transfected	O	O
lymphocyte-specific	O	DNA
promoter	O	DNA
was	O	O
neither	O	O
activated	O	O
nor	O	O
was	O	O
it	O	O
repressed	O	O
upon	O	O
contransfection	O	O
with	O	O
an	O	O
Oct-2A	DNA	protein
expression	DNA	O
vector	DNA	O
.	O	O
We	O	O
therefore	O	O
speculate	O	O
that	O	O
N-Oct-3	protein	protein
and	O	O
other	O	O
N-Oct	protein	protein
factors	protein	protein
have	O	O
a	O	O
specific	O	O
role	O	O
in	O	O
gene	O	O
expression	O	O
in	O	O
cells	O	O
of	O	O
the	O	O
nervous	O	O
system	O	O
.	O	O

Detection	O	O
in	O	O
non-erythroid	cell_type	cell_type
cells	cell_type	cell_type
of	O	O
a	O	O
factor	O	O
with	O	O
the	O	O
binding	O	O
characteristics	O	O
of	O	O
the	O	O
erythroid	protein	protein
cell	protein	protein
transcription	protein	protein
factor	protein	protein
EF1	protein	protein
.	O	O
The	O	O
erythroid	protein	protein
transcription	protein	protein
factor	protein	protein
erythroid	protein	protein
factor-1	protein	protein
(	O	O
EF1	protein	protein
)	O	O
plays	O	O
a	O	O
critical	O	O
role	O	O
in	O	O
the	O	O
transcription	O	O
of	O	O
erythroid-specific	DNA	DNA
genes	DNA	DNA
.	O	O
Here	O	O
we	O	O
report	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
factor	O	O
with	O	O
the	O	O
mobility	O	O
and	O	O
sequence-specific	O	O
DNA-binding	O	O
characteristics	O	O
of	O	O
EF1	protein	protein
at	O	O
low	O	O
abundance	O	O
in	O	O
a	O	O
wide	O	O
variety	O	O
of	O	O
non-erythroid	cell_type	O
cell	cell_type	O
types	cell_type	O
.	O	O
This	O	O
is	O	O
the	O	O
first	O	O
report	O	O
of	O	O
an	O	O
EF1	protein	protein
-like	O	O
activity	O	O
in	O	O
non-erythroid	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
indicates	O	O
that	O	O
this	O	O
factor	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
regulation	O	O
of	O	O
genes	DNA	O
expressed	O	O
in	O	O
such	O	O
cells.	O	O

Protein	O	O
kinase	O	O
inhibitor	O	O
H-7	O	O
blocks	O	O
accumulation	O	O
of	O	O
unspliced	RNA	O
mRNA	RNA	RNA
of	O	O
human	O	O
T-cell	O	O
leukemia	O	O
virus	O	O
type	O	O
I	O	O
(	O	O
HTLV-I	O	O
).	O	O
Rex	protein	O
,	O	O
the	O	O
post-transcriptional	protein	O
regulator	protein	O
of	O	O
human	O	O
T-cell	O	O
leukemia	O	O
virus	O	O
type	O	O
I	O	O
(	O	O
HTLV-I	O	O
),	O	O
is	O	O
known	O	O
to	O	O
induce	O	O
accumulation	O	O
of	O	O
the	O	O
unspliced	RNA	O
viral	RNA	O
gag-pol	RNA	RNA
mRNA	RNA	RNA
.	O	O
Rex	protein	O
is	O	O
a	O	O
phosphoprotein	protein	O
found	O	O
in	O	O
the	O	O
cell	O	O
nucleolus	O	O
,	O	O
whose	O	O
function	O	O
may	O	O
be	O	O
regulated	O	O
by	O	O
its	O	O
localization	O	O
and	O	O
phosphorylation	O	O
.	O	O
We	O	O
have	O	O
examined	O	O
the	O	O
role	O	O
of	O	O
phosphorylation	O	O
on	O	O
Rex	protein	O
function	O	O
by	O	O
using	O	O
a	O	O
protein	O	protein
kinase	O	protein
inhibitor	O	O
,	O	O
H-7	O	O
[	O	O
1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine	O	O
].	O	O
Treatment	O	O
of	O	O
an	O	O
HTLV-I	cell_line	cell_line
infected	cell_line	cell_line
human	cell_line	cell_line
T-cell	cell_line	cell_line
line	cell_line	cell_line
with	O	O
H-7	O	O
blocked	O	O
specifically	O	O
accumulation	O	O
of	O	O
the	O	O
unspliced	RNA	O
gag-pol	RNA	RNA
mRNA	RNA	RNA
,	O	O
resulting	O	O
in	O	O
the	O	O
decreased	O	O
Gag	protein	O
protein	protein	O
synthesis	O	O
that	O	O
corresponds	O	O
with	O	O
the	O	O
decreased	O	O
in	O	O
vivo	O	O
phosphorylation	O	O
of	O	O
Rex	protein	protein
.	O	O
In	O	O
contrast,	O	O
other	O	O
viral	O	O
and	O	O
cellular	O	O
products	O	O
have	O	O
not	O	O
been	O	O
influenced	O	O
by	O	O
the	O	O
level	O	O
of	O	O
H-7	O	O
used.	O	O
Therefore,	O	O
the	O	O
phosphorylation	O	O
of	O	O
Rex	protein	protein
is	O	O
required	O	O
for	O	O
the	O	O
viral	O	O
RNA	O	O
partition	O	O
of	O	O
HTLV-I	O	O
.	O	O

Increased	O	O
glucocorticoid	O	O
responsiveness	O	O
of	O	O
CD4+	cell_line	protein
T-cell	cell_line	protein
clonal	cell_line	protein
lines	cell_line	protein
grown	O	O
in	O	O
serum-free	O	O
media	O	O
.	O	O
CEM-C7	cell_line	protein
,	O	O
a	O	O
human	cell_line	cell_line
leukemic	cell_line	cell_line
CD4+	cell_line	cell_line
T-lymphocyte	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
and	O	O
three	O	O
of	O	O
its	O	O
subclones,	O	O
CEM-4R4	cell_line	protein
,	O	O
CEM-3R43	cell_line	protein
,	O	O
and	O	O
ICR-27	cell_line	protein
,	O	O
previously	O	O
cultured	O	O
in	O	O
a	O	O
medium	O	O
supplemented	O	O
with	O	O
5	O	O
to	O	O
10%	O	O
fetal	O	O
bovine	O	O
serum	O	O
,	O	O
have	O	O
been	O	O
adapted	O	O
to	O	O
serum-free	O	O
media	O	O
.	O	O
The	O	O
best	O	O
medium	O	O
of	O	O
those	O	O
tested	O	O
was	O	O
RPMI	O	O
1640	O	O
supplemented	O	O
with	O	O
5	O	O
micrograms/ml	O	O
each	O	O
transferrin	protein	O
and	O	O
insulin	protein	O
+	O	O
5	O	O
ng/ml	O	O
sodium	O	O
selenite	O	O
+/-	O	O
0.1%	O	O
bovine	protein	O
serum	protein	O
albumin	protein	O
.	O	O
While	O	O
growing	O	O
either	O	O
with	O	O
or	O	O
without	O	O
albumin,	O	O
the	O	O
several	O	O
clonal	cell_line	O
lines	cell_line	O
of	O	O
CEM	cell_line	cell_line
cells	O	cell_line
displayed	O	O
growth	O	O
similar	O	O
to	O	O
serum-supplemented	O	O
cultures.	O	O
Cell	O	O
proliferation	O	O
of	O	O
CEM-C7	cell_line	cell_line
cells	O	cell_line
cultured	O	O
in	O	O
both	O	O
serum-free	O	O
media	O	O
has	O	O
been	O	O
sustained	O	O
for	O	O
3	O	O
mo.	O	O
with	O	O
culture	O	O
doubling	O	O
times	O	O
of	O	O
about	O	O
25	O	O
h	O	O
for	O	O
both	O	O
serum-supplemented	O	O
and	O	O
serum-free	O	O
cultures	O	O
(viability	O	O
greater	O	O
than	O	O
or	O	O
equal	O	O
to	O	O
90%).	O	O
Cell	O	O
morphology	O	O
remained	O	O
essentially	O	O
the	O	O
same	O	O
in	O	O
serum-free	O	O
or	O	O
serum	O	O
containing	O	O
media	O	O
.	O	O
The	O	O
expression	O	O
of	O	O
CD4	protein	protein
,	O	O
a	O	O
marker	O	O
for	O	O
T-derived	cell_type	cell_type
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
was	O	O
not	O	O
significantly	O	O
different	O	O
in	O	O
serum-free	O	O
medium	O	O
.	O	O
When	O	O
grown	O	O
in	O	O
serum-free	O	O
medium,	O	O
CEM-C7	cell_line	cell_line
cells	O	cell_line
exhibited	O	O
increased	O	O
steroid	O	O
responsiveness	O	O
as	O	O
evidenced	O	O
by	O	O
increased	O	O
glucocorticoid	protein	protein
receptor	protein	protein
binding	O	O
sites	O	O
,	O	O
increased	O	O
induction	O	O
of	O	O
glutamine	protein	O
synthetase	protein	O
,	O	O
and	O	O
cell	O	O
lysis	O	O
at	O	O
lower	O	O
concentrations	O	O
of	O	O
steroid	O	O
.	O	O
Receptor	O	O
mutant	O	O
subclones	O	O
of	O	O
CEM-C7	cell_line	protein
,	O	O
which	O	O
are	O	O
proven	O	O
to	O	O
be	O	O
completely	O	O
unresponsive	O	O
to	O	O
micromolar	O	O
concentrations	O	O
of	O	O
dexamethasone	O	O
when	O	O
grown	O	O
in	O	O
serum-supplemented	O	O
medium	O	O
,	O	O
become	O	O
partially	O	O
sensitive	O	O
to	O	O
the	O	O
hormone	O	O
after	O	O
growth	O	O
in	O	O
defined	O	O
medium.	O	O
The	O	O
increased	O	O
sensitivity	O	O
of	O	O
CEM-C7	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
its	O	O
subclones	O	O
to	O	O
dexamethasone	O	O
in	O	O
serum-free	O	O
medium	O	O
returned	O	O
to	O	O
previous	O	O
levels	O	O
when	O	O
these	O	O
cells	O	O
were	O	O
recultured	O	O
in	O	O
serum-containing	O	O
medium	O	O
.	O	O
Our	O	O
results	O	O
suggest	O	O
that	O	O
substances	O	O
in	O	O
serum	O	O
influence	O	O
steroid	O	O
effects	O	O
on	O	O
these	O	O
cells	O	O
and	O	O
that	O	O
the	O	O
molecular	O	O
details	O	O
of	O	O
glucocorticoid	O	O
hormone	O	O
action	O	O
may	O	O
be	O	O
pursued	O	O
more	O	O
precisely	O	O
in	O	O
a	O	O
clearly	O	O
defined	O	O
culture	O	O
medium.	O	O

[	O	O
Glucocorticoid	protein	protein
receptors	protein	protein
on	O	O
human	O	cell_type
peripheral	O	cell_type
mononuclear	O	cell_type
and	O	O
polymorphonuclear	O	O
leucocytes	O	O
:	O	O
changes	O	O
in	O	O
patients	O	O
with	O	O
yang-deficiency	O	O
]	O	O
It	O	O
was	O	O
found	O	O
that,	O	O
in	O	O
former	O	O
works,	O	O
the	O	O
glucocorticoid	protein	protein
receptors	protein	protein
(	O	O
GCR	protein	protein
)	O	O
on	O	O
peripheral	cell_type	O
mixed	cell_type	O
leucocytes	cell_type	O
in	O	O
patients	O	O
with	O	O
Yang-deficiency	O	O
were	O	O
decreased.	O	O
In	O	O
this	O	O
work,	O	O
the	O	O
mixed	cell_type	O
leucocytes	cell_type	cell_type
were	O	O
further	O	O
separated	O	O
into	O	O
mononuclear	O	O
(MNL)	O	O
and	O	O
polymorphonuclear	O	O
(PML)	O	O
leucocytes	O	O
,	O	O
and	O	O
GCR	protein	protein
were	O	O
determined	O	O
in	O	O
each	O	O
part	O	O
of	O	O
leucocytes	cell_type	cell_type
.	O	O
GCR	protein	O
on	O	O
MNL	cell_type	cell_type
and	O	O
PML	cell_type	protein
in	O	O
6	O	O
Yang	O	O
deficient	O	O
patients	O	O
were	O	O
3473	O	O
+/-	O	O
413	O	O
and	O	O
4433	O	O
+/-	O	O
651	O	O
sites/cell	O	O
respectively,	O	O
statistically	O	O
significant	O	O
from	O	O
the	O	O
normal	O	O
control	O	O
group	O	O
(4462	O	O
+/-	O	O
962	O	O
and	O	O
5622	O	O
+/-	O	O
782	O	O
sites/cell	O	O
respectively,	O	O
P	O	O
less	O	O
than	O	O
0.05).	O	O
GCR	protein	O
on	O	O
MNL	cell_type	cell_type
,	O	O
PML	cell_type	protein
and	O	O
mixed	cell_type	O
leucocytes	cell_type	O
in	O	O
5	O	O
patients	O	O
were	O	O
determined	O	O
simultaneously,	O	O
and	O	O
all	O	O
lowered	O	O
from	O	O
the	O	O
control	O	O
group	O	O
.	O	O
The	O	O
results	O	O
were	O	O
3369	O	O
+/-	O	O
370,	O	O
4986	O	O
+/-	O	O
419	O	O
and	O	O
4524	O	O
+/-	O	O
852	O	O
sites/cell	O	O
respectively,	O	O
with	O	O
the	O	O
lowest	O	O
GCR	protein	protein
on	O	O
MNL	cell_type	cell_type
and	O	O
highest	O	O
on	O	O
PML	cell_type	DNA
.	O	O

The	O	O
ubiquitous	protein	protein
octamer-binding	protein	protein
protein	protein	protein
(s)	O	O
is	O	O
sufficient	O	O
for	O	O
transcription	O	O
of	O	O
immunoglobulin	DNA	DNA
genes	DNA	DNA
.	O	O
All	O	DNA
immunoglobulin	DNA	DNA
genes	DNA	DNA
contain	O	O
a	O	O
conserved	O	O
octanucleotide	DNA	DNA
promoter	DNA	DNA
element	DNA	DNA
,	O	O
ATGCAAAT	O	O
,	O	O
which	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
be	O	O
required	O	O
for	O	O
their	O	O
normal	O	O
B-cell-specific	O	O
transcription	O	O
.	O	O
Proteins	O	O
that	O	O
bind	O	O
this	O	O
octamer	O	O
have	O	O
been	O	O
purified,	O	O
and	O	O
cDNAs	DNA	DNA
encoding	O	O
octamer-binding	protein	protein
proteins	protein	protein
have	O	O
been	O	O
cloned.	O	O
Some	O	O
of	O	O
these	O	O
proteins	O	O
(referred	O	O
to	O	O
as	O	O
OTF-2	protein	protein
)	O	O
are	O	O
lymphoid	O	O
specific,	O	O
whereas	O	O
at	O	O
least	O	O
one	O	O
other,	O	O
and	O	O
possibly	O	O
more	O	O
(referred	O	O
to	O	O
as	O	O
OTF-1	protein	protein
),	O	O
is	O	O
found	O	O
ubiquitously	O	O
in	O	O
all	O	O
cell	O	O
types.	O	O
The	O	O
exact	O	O
role	O	O
of	O	O
these	O	O
different	O	O
proteins	O	O
in	O	O
directing	O	O
the	O	O
tissue-specific	O	O
expression	O	O
of	O	O
immunoglobulin	DNA	DNA
genes	DNA	DNA
is	O	O
unclear.	O	O
We	O	O
have	O	O
identified	O	O
two	O	O
human	cell_line	cell_line
pre-B-cell	cell_line	cell_line
lines	cell_line	cell_line
that	O	O
contain	O	O
extremely	O	O
low	O	O
levels	O	O
of	O	O
OTF-2	protein	protein
yet	O	O
still	O	O
express	O	O
high	O	O
levels	O	O
of	O	O
steady-state	RNA	O
immunoglobulin	RNA	RNA
heavy-chain	RNA	RNA
mRNA	RNA	RNA
in	O	O
vivo	O	O
and	O	O
efficiently	O	O
transcribe	O	O
an	O	O
immunoglobulin	DNA	DNA
gene	DNA	DNA
in	O	O
vitro.	O	O
Addition	O	O
of	O	O
a	O	O
highly	O	O
enriched	O	O
preparation	O	O
of	O	O
OTF-1	protein	protein
made	O	O
from	O	O
one	O	O
of	O	O
these	O	O
pre-B	cell_line	cell_type
cells	cell_line	cell_type
or	O	O
from	O	O
HeLa	cell_line	cell_line
cells	cell_line	cell_line
specifically	O	O
stimulated	O	O
in	O	O
vitro	O	O
transcription	O	O
of	O	O
an	O	O
immunoglobulin	DNA	DNA
gene	DNA	DNA
.	O	O
Furthermore,	O	O
OFT-1	O	protein
appeared	O	O
to	O	O
have	O	O
approximately	O	O
the	O	O
same	O	O
transactivation	O	O
ability	O	O
as	O	O
OTF-2	protein	protein
when	O	O
normalized	O	O
for	O	O
binding	O	O
activity.	O	O
These	O	O
results	O	O
suggest	O	O
that	O	O
OTF-1	protein	protein
,	O	O
without	O	O
OTF-2	protein	protein
,	O	O
is	O	O
sufficient	O	O
for	O	O
transcription	O	O
of	O	O
immunoglobulin	DNA	DNA
genes	DNA	DNA
and	O	O
that	O	O
OTF-2	protein	protein
alone	O	O
is	O	O
not	O	O
responsible	O	O
for	O	O
the	O	O
B-cell-specific	O	O
regulation	O	O
of	O	O
immunoglobulin	DNA	DNA
gene	DNA	DNA
expression	O	O
.	O	O

Effects	O	O
of	O	O
aldosterone	O	O
on	O	O
intralymphocytic	O	O
sodium	O	O
and	O	O
potassium	O	O
in	O	O
patients	O	O
with	O	O
essential	O	O
hypertension	O	O
.	O	O
In	O	O
vitro	O	O
binding	O	O
of	O	O
aldosterone	O	O
to	O	O
mineralocorticoid	protein	protein
receptors	protein	protein
on	O	O
human	cell_type	cell_type
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
(	O	O
HML	cell_type	cell_type
)	O	O
and	O	O
its	O	O
effects	O	O
on	O	O
the	O	O
intracellular	O	O
sodium	O	O
and	O	O
potassium	O	O
concentrations	O	O
of	O	O
HML	cell_type	protein
have	O	O
already	O	O
been	O	O
described.	O	O
In	O	O
the	O	O
present	O	O
paper	O	O
this	O	O
easily	O	O
accessible	O	O
human	O	O
cell	O	O
model	O	O
was	O	O
investigated	O	O
in	O	O
13	O	O
patients	O	O
with	O	O
essential	O	O
hypertension	O	O
.	O	O
In	O	O
only	O	O
four	O	O
patients	O	O
sodium	O	O
in	O	O
HML	cell_type	cell_type
without	O	O
incubation	O	O
was	O	O
elevated	O	O
compared	O	O
with	O	O
the	O	O
range	O	O
for	O	O
normal	O	O
persons	O	O
.	O	O
A	O	O
decrease	O	O
of	O	O
intracellular	O	O
sodium	O	O
or	O	O
potassium	O	O
occurred	O	O
during	O	O
incubation	O	O
without	O	O
aldosterone	O	O
(P	O	O
less	O	O
than	O	O
0.02).	O	O
The	O	O
addition	O	O
of	O	O
1.4	O	O
nM	O	O
aldosterone	O	O
did	O	O
not	O	O
prevent	O	O
this	O	O
loss	O	O
of	O	O
electrolytes	O	O
as	O	O
observed	O	O
in	O	O
normal	O	O
persons	O	O
.	O	O
Plasma	protein	O
renin	protein	protein
activity	O	O
and	O	O
aldosterone	O	O
were	O	O
not	O	O
correlated	O	O
with	O	O
the	O	O
electrolyte	O	O
response	O	O
and	O	O
were	O	O
within	O	O
the	O	O
normal	O	O
limits.	O	O
The	O	O
number	O	O
of	O	O
mineralocorticoid	protein	protein
receptors	protein	protein
/cell	O	O
were	O	O
within	O	O
or	O	O
close	O	O
to	O	O
the	O	O
normal	O	O
range	O	O
(n	O	O
=	O	O
9).	O	O
The	O	O
independence	O	O
of	O	O
intracellular	O	O
electrolytes	O	O
from	O	O
aldosterone	O	O
despite	O	O
a	O	O
normal	O	O
number	O	O
of	O	O
mineralocorticoid	protein	protein
receptors	protein	protein
may	O	O
reflect	O	O
an	O	O
impairment	O	O
of	O	O
the	O	O
mineralocorticoid	O	O
effector	O	O
mechanism	O	O
in	O	O
the	O	O
HML	cell_type	O
of	O	O
patients	O	O
with	O	O
essential	O	O
hypertension	O	O
.	O	O

[Differential	O	O
diagnostic	O	O
value	O	O
of	O	O
receptors	O	O
of	O	O
1,25-dihydroxyvitamin	O	O
D3	O	O
(	O	O
calcitriol	O	O
)	O	O
determination	O	O
in	O	O
lymphocytes	cell_type	cell_type
of	O	O
children	O	O
with	O	O
rickets	O	O
and	O	O
rickets	O	O
-like	O	O
diseases	O	O
]	O	O
The	O	O
authors	O	O
provide	O	O
the	O	O
results	O	O
of	O	O
studying	O	O
1,25-dihydroxyvitamin	O	O
D3	O	O
(	O	O
calcitriol	O	O
)	O	O
in	O	O
lymphocytes	cell_type	cell_type
of	O	O
children	O	O
with	O	O
rickets	O	O
and	O	O
rickets	O	O
-like	O	O
diseases	O	O
.	O	O
It	O	O
is	O	O
proposed	O	O
that	O	O
the	O	O
character	O	O
of	O	O
their	O	O
expression	O	O
under	O	O
the	O	O
influence	O	O
of	O	O
vitamin	O	O
D	O	O
may	O	O
be	O	O
used	O	O
with	O	O
differential	O	O
diagnostic	O	O
purposes	O	O
in	O	O
view.	O	O

Regulation	O	O
of	O	O
gene	O	O
expression	O	O
with	O	O
double-stranded	O	O
phosphorothioate	O	O
oligonucleotides	O	O
.	O	O
Alteration	O	O
of	O	O
gene	O	O
transcription	O	O
by	O	O
inhibition	O	O
of	O	O
specific	O	O
transcriptional	protein	protein
regulatory	protein	protein
proteins	protein	protein
is	O	O
necessary	O	O
for	O	O
determining	O	O
how	O	O
these	O	O
factors	O	O
participate	O	O
in	O	O
cellular	O	O
differentiation	O	O
.	O	O
The	O	O
functions	O	O
of	O	O
these	O	O
proteins	O	O
can	O	O
be	O	O
antagonized	O	O
by	O	O
several	O	O
methods,	O	O
each	O	O
with	O	O
specific	O	O
limitations.	O	O
Inhibition	O	O
of	O	O
sequence-specific	protein	protein
DNA-binding	protein	protein
proteins	protein	protein
was	O	O
achieved	O	O
with	O	O
double-stranded	O	O
(ds)	O	O
phosphorothioate	O	O
oligonucleotides	O	O
that	O	O
contained	O	O
octamer	O	O
or	O	O
kappa	O	O
B	O	O
consensus	O	DNA
sequences	O	DNA
.	O	O
The	O	O
phosphorothioate	O	O
oligonucleotides	O	O
specifically	O	O
bound	O	O
either	O	O
octamer	protein	protein
transcription	protein	protein
factor	protein	protein
or	O	O
nuclear	protein	protein
factor	protein	protein
(NF)-kappa	protein	protein
B	protein	protein
.	O	O
The	O	O
modified	O	O
oligonucleotides	O	O
accumulated	O	O
in	O	O
cells	O	O
more	O	O
effectively	O	O
than	O	O
standard	O	O
ds	O	O
oligonucleotides	O	O
and	O	O
modulated	O	O
gene	O	O
expression	O	O
in	O	O
a	O	O
specific	O	O
manner.	O	O
Octamer-dependent	O	O
activation	O	O
of	O	O
a	O	O
reporter	DNA	O
plasmid	DNA	O
or	O	O
NF-kappa	protein	protein
B	protein	protein
-dependent	O	O
activation	O	O
of	O	O
the	O	O
human	DNA	O
immunodeficiency	DNA	O
virus	DNA	O
(	DNA	O
HIV	DNA	O
)	DNA	O
enhancer	DNA	O
was	O	O
inhibited	O	O
when	O	O
the	O	O
appropriate	O	O
phosphorothioate	O	O
oligonucleotide	O	O
was	O	O
added	O	O
to	O	O
a	O	O
transiently	cell_line	O
transfected	cell_line	O
B	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
Addition	O	O
of	O	O
phosphorothioate	O	O
oligonucleotides	O	O
that	O	O
contained	O	O
the	O	O
octamer	DNA	DNA
consensus	DNA	DNA
to	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
leukemia	cell_line	cell_line
cells	cell_line	cell_line
inhibited	O	O
interleukin-2	protein	protein
(	O	O
IL-2	protein	protein
)	O	O
secretion	O	O
to	O	O
a	O	O
degree	O	O
similar	O	O
to	O	O
that	O	O
observed	O	O
with	O	O
a	O	O
mutated	DNA	DNA
octamer	DNA	DNA
site	DNA	DNA
in	O	O
the	O	O
IL-2	DNA	DNA
enhancer	DNA	DNA
.	O	O
The	O	O
ds	O	O
phosphorothioate	O	O
oligonucleotides	O	O
probably	O	O
compete	O	O
for	O	O
binding	O	O
of	O	O
specific	O	O
transcription	O	protein
factors	O	protein
and	O	O
may	O	O
provide	O	O
anti-viral	O	O
,	O	O
immunosuppressive	O	O
,	O	O
or	O	O
other	O	O
therapeutic	O	O
effects	O	O
.	O	O

[Effect	O	O
of	O	O
the	O	O
regimen	O	O
of	O	O
kidney-tonifying	O	O
and	O	O
qi-invigorating	O	O
on	O	O
aging	O	O
changes	O	O
of	O	O
glucocorticoid	protein	protein
receptor	protein	protein
]	O	O
The	O	O
plasma	O	O
cortisol	O	O
concentration	O	O
and	O	O
the	O	O
sites	O	O
of	O	O
glucocorticoid	protein	protein
receptor	protein	protein
(	O	O
GCR	protein	protein
)	O	O
in	O	O
the	O	O
peripheral	cell_type	cell_type
lymphocytes	cell_type	cell_type
were	O	O
measured	O	O
in	O	O
32	O	O
healthy	O	O
aged	O	O
persons	O	O
and	O	O
13	O	O
young	O	O
adults	O	O
.	O	O
In	O	O
animal	O	O
experiment	O	O
,	O	O
GCR	protein	O
of	O	O
spleen	cell_type	O
lymphocytic	cell_type	O
cell	cell_type	O
was	O	O
also	O	O
measured	O	O
in	O	O
18	O	O
aged	O	O
rats	O	O
and	O	O
9	O	O
young	O	O
rats	O	O
.	O	O
The	O	O
results	O	O
showed	O	O
that	O	O
GCR	protein	protein
was	O	O
significantly	O	O
lower	O	O
in	O	O
the	O	O
aged	O	O
persons	O	O
or	O	O
rats	O	O
than	O	O
that	O	O
in	O	O
the	O	O
young	O	O
while	O	O
the	O	O
plasma	O	O
cortisol	O	O
level	O	O
didn't	O	O
change	O	O
with	O	O
aging.	O	O
So	O	O
we	O	O
think	O	O
that	O	O
GCR	protein	protein
is	O	O
more	O	O
sensitive	O	O
than	O	O
the	O	O
plasma	O	O
cortisol	O	O
level	O	O
to	O	O
reflect	O	O
the	O	O
aging	O	O
change	O	O
of	O	O
the	O	O
adrenal	O	O
cortex	O	O
function	O	O
.	O	O
After	O	O
the	O	O
treatment	O	O
with	O	O
the	O	O
regimen	O	O
of	O	O
Kidney-tonifying	O	O
and	O	O
Qi-invigorating	O	O
,	O	O
the	O	O
GCR	protein	protein
of	O	O
the	O	O
aged	O	O
persons	O	O
and	O	O
rats	O	O
was	O	O
enhanced,	O	O
and	O	O
in	O	O
this	O	O
way,	O	O
the	O	O
function	O	O
of	O	O
the	O	O
aged	O	O
adrenal	O	O
cortex	O	O
was	O	O
improved.	O	O

Interferon	O	protein
affects	O	O
nuclear	protein	O
proteins	protein	O
in	O	O
cells	O	O
of	O	O
clinically	O	O
sensitive	O	O
chronic	O	O
myelogenous	O	O
leukemia	O	O
patients	O	O
.	O	O
Cytoplasmic	O	protein
protein	O	protein
extracts	O	O
from	O	O
chronic	cell_type	O
myelogenous	cell_type	O
leukemia	cell_type	O
(	cell_type	O
CML	cell_type	cell_type
)	cell_type	cell_type
cells	cell_type	cell_type
contained	O	O
an	O	O
activity	O	O
that	O	O
altered	O	O
the	O	O
electrophoretic	O	O
mobility	O	O
of	O	O
complexes	O	O
formed	O	O
between	O	O
nuclear	protein	protein
proteins	protein	protein
and	O	O
the	O	O
transcriptional	O	O
enhancers	O	O
of	O	O
interferon	O	protein
(IFN)-inducible	O	protein
genes.	O	O
Exposure	O	O
of	O	O
CML	cell_type	cell_type
cells	cell_type	cell_type
to	O	O
IFN-alpha	protein	protein
diminished	O	O
the	O	O
effect	O	O
of	O	O
the	O	O
CML	protein	protein
cytoplasmic	protein	protein
proteins	protein	protein
on	O	O
these	O	O
nuclear	protein	O
protein-DNA	protein	protein
complexes	protein	protein
.	O	O
The	O	O
presence	O	O
of	O	O
clinical	O	O
responsiveness	O	O
to	O	O
IFN-alpha	protein	protein
correlated	O	O
with	O	O
the	O	O
sensitivity	O	O
to	O	O
the	O	O
IFN	protein	protein
-induced	O	O
change	O	O
in	O	O
the	O	O
electrophoretic	O	O
mobility	O	O
of	O	O
nuclear	protein	protein
protein-DNA	protein	protein
complexes	protein	protein
.	O	O
These	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
action	O	O
of	O	O
IFN-alpha	protein	protein
in	O	O
CML	O	O
may	O	O
be	O	O
linked	O	O
to	O	O
a	O	O
pathway	O	O
that	O	O
can	O	O
result	O	O
in	O	O
posttranslational	O	O
modification	O	O
of	O	O
nuclear	protein	protein
proteins	protein	protein
.	O	O

Epstein-Barr	protein	O
virus	protein	O
nuclear	protein	protein
antigen	protein	protein
2	protein	protein
transactivates	O	O
latent	protein	O
membrane	protein	O
protein	protein	O
LMP1	protein	protein
.	O	O
Several	O	O
lines	O	O
of	O	O
evidence	O	O
are	O	O
compatible	O	O
with	O	O
the	O	O
hypothesis	O	O
that	O	O
Epstein-Barr	protein	protein
virus	protein	protein
(	protein	protein
EBV	protein	protein
)	protein	protein
nuclear	protein	protein
antigen	protein	protein
2	protein	protein
(	O	O
EBNA-2	protein	protein
)	O	O
or	O	O
leader	protein	O
protein	protein	O
(	O	O
EBNA-LP	protein	protein
)	O	O
affects	O	O
expression	O	O
of	O	O
the	O	O
EBV	protein	O
latent	protein	O
infection	protein	O
membrane	protein	O
protein	protein	O
LMP1	protein	protein
.	O	O
We	O	O
now	O	O
demonstrate	O	O
the	O	O
following.	O	O
(i)	O	O
Acute	O	O
transfection	O	O
and	O	O
expression	O	O
of	O	O
EBNA-2	protein	protein
under	O	O
control	O	O
of	O	O
simian	O	O
virus	O	O
40	O	O
or	O	O
Moloney	O	O
murine	O	O
leukemia	O	O
virus	O	O
promoters	O	O
resulted	O	O
in	O	O
increased	O	O
LMP1	protein	protein
expression	O	O
in	O	O
P3HR-1-infected	cell_line	cell_line
Burkitt's	cell_line	cell_line
lymphoma	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
the	O	O
P3HR-1	cell_line	O
or	O	O
Daudi	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
(ii)	O	O
Transfection	O	O
and	O	O
expression	O	O
of	O	O
EBNA-LP	protein	protein
alone	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
LMP1	protein	protein
expression	O	O
and	O	O
did	O	O
not	O	O
act	O	O
synergistically	O	O
with	O	O
EBNA-2	protein	protein
to	O	O
affect	O	O
LMP1	protein	protein
expression	O	O
.	O	O
(iii)	O	O
LMP1	protein	protein
expression	O	O
in	O	O
Daudi	cell_line	cell_line
and	O	O
P3HR-1-infected	cell_line	cell_line
cells	cell_line	cell_line
was	O	O
controlled	O	O
at	O	O
the	O	O
mRNA	RNA	O
level	O	O
,	O	O
and	O	O
EBNA-2	protein	protein
expression	O	O
in	O	O
Daudi	cell_line	cell_line
cells	cell_line	cell_line
increased	O	O
LMP1	RNA	RNA
mRNA	RNA	RNA
.	O	O
(iv)	O	O
No	O	O
other	O	O
EBV	DNA	DNA
genes	DNA	DNA
were	O	O
required	O	O
for	O	O
EBNA-2	protein	protein
transactivation	O	O
of	O	O
LMP1	protein	protein
since	O	O
cotransfection	O	O
of	O	O
recombinant	DNA	protein
EBNA-2	DNA	protein
expression	DNA	O
vectors	DNA	O
and	O	O
genomic	O	O
LMP1	DNA	protein
DNA	DNA	O
fragments	DNA	O
enhanced	O	O
LMP1	protein	protein
expression	O	O
in	O	O
the	O	O
EBV-negative	cell_line	cell_line
B-lymphoma	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
BJAB	cell_line	cell_line
,	O	O
Louckes	cell_line	O
,	O	O
and	O	O
BL30	cell_line	protein
.	O	O
(v)	O	O
An	O	O
EBNA-2	DNA	DNA
-responsive	DNA	DNA
element	DNA	DNA
was	O	O
found	O	O
within	O	O
the	O	O
-512	DNA	DNA
to	DNA	DNA
+40	DNA	DNA
LMP1	DNA	DNA
DNA	DNA	DNA
since	O	O
this	O	O
DNA	O	O
linked	O	O
to	O	O
a	O	O
chloramphenicol	DNA	DNA
acetyltransferase	DNA	DNA
reporter	DNA	DNA
gene	DNA	DNA
was	O	O
transactivated	O	O
by	O	O
cotransfection	O	O
with	O	O
an	O	O
EBNA-2	DNA	protein
expression	DNA	O
vector	DNA	O
.	O	O
(vi)	O	O
The	O	O
EBV	O	O
type	O	O
2	O	O
EBNA-2	protein	protein
transactivated	O	protein
LMP1	protein	protein
as	O	O
well	O	O
as	O	O
the	O	O
EBV	protein	O
type	protein	O
1	protein	O
EBNA-2	protein	protein
.	O	O
(vii)	O	O
Two	O	O
deletions	O	O
within	O	O
the	O	O
EBNA-2	protein	DNA
gene	O	DNA
which	O	O
rendered	O	O
EBV	O	O
transformation	O	O
incompetent	O	O
did	O	O
not	O	O
transactivate	O	O
LMP1	protein	protein
,	O	O
whereas	O	O
a	O	O
transformation-competent	DNA	O
EBNA-2	DNA	protein
deletion	DNA	protein
mutant	DNA	protein
did	O	O
transactivate	O	O
LMP1	protein	protein
.	O	O
LMP1	protein	protein
is	O	O
a	O	O
potent	O	O
effector	O	O
of	O	O
B-lymphocyte	O	O
activation	O	O
and	O	O
can	O	O
act	O	O
synergistically	O	O
with	O	O
EBNA-2	protein	protein
to	O	O
induce	O	O
cellular	O	O
CD23	O	protein
gene	O	O
expression	O	O
.	O	O
Thus,	O	O
EBNA-2	protein	protein
transactivation	O	O
of	O	O
LMP1	protein	protein
amplifies	O	O
the	O	O
biological	O	O
impact	O	O
of	O	O
EBNA-2	protein	protein
and	O	O
underscores	O	O
its	O	O
central	O	O
role	O	O
in	O	O
EBV-induced	O	O
growth	O	O
transformation	O	O
.	O	O

The	O	O
expression	O	O
of	O	O
c-fos	DNA	DNA
,	O	O
c-jun	DNA	O
,	O	O
and	O	O
c-myc	DNA	DNA
genes	DNA	DNA
is	O	O
regulated	O	O
by	O	O
heat	O	O
shock	O	O
in	O	O
human	cell_type	cell_type
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
The	O	O
effect	O	O
of	O	O
heat	O	O
shock	O	O
on	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
nuclear	DNA	O
protooncogenes	DNA	DNA
c-fos	DNA	DNA
,	O	O
c-jun	DNA	O
,	O	O
and	O	O
c-myc	DNA	O
was	O	O
studied	O	O
in	O	O
human	cell_type	cell_type
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Heat	O	O
shock	O	O
caused	O	O
an	O	O
increase	O	O
in	O	O
c-fos	O	O
and	O	O
c-jun	O	O
mRNA	O	O
levels	O	O
and	O	O
a	O	O
decrease	O	O
in	O	O
c-myc	RNA	RNA
mRNA	RNA	RNA
levels	O	O
in	O	O
pre-B	O	O
(Hyon)	O	O
and	O	O
T	O	O
(DND-41)	O	cell_line
cell	O	cell_line
lines	O	cell_line
as	O	O
well	O	O
as	O	O
in	O	O
freshly	O	O
isolated	O	O
normal	O	O
human	O	O
thymocytes.	O	O
The	O	O
changes	O	O
in	O	O
the	O	O
mRNA	O	O
levels	O	O
of	O	O
these	O	O
protooncogenes	DNA	O
in	O	O
Hyon	cell_line	cell_type
cells	cell_line	cell_type
were	O	O
most	O	O
pronounced	O	O
at	O	O
42	O	O
and	O	O
43	O	O
degrees	O	O
C;	O	O
kinetic	O	O
analysis	O	O
demonstrated	O	O
that	O	O
the	O	O
changes	O	O
could	O	O
be	O	O
detected	O	O
within	O	O
30	O	O
min	O	O
of	O	O
heat	O	O
shock	O	O
.	O	O
Altered	O	O
transcription	O	O
of	O	O
c-fos	DNA	DNA
and	O	DNA
c-myc	DNA	DNA
genes	DNA	DNA
was	O	O
the	O	O
primary	O	O
effect	O	O
of	O	O
heat	O	O
shock	O	O
.	O	O
Secondarily,	O	O
heat	O	O
shock	O	O
of	O	O
Hyon	cell_line	cell_type
cells	cell_line	cell_type
stabilized	O	O
the	O	O
c-myc	RNA	RNA
mRNA	RNA	RNA
level	O	O
by	O	O
increasing	O	O
its	O	O
half-life	O	O
from	O	O
24	O	O
to	O	O
45	O	O
min.	O	O
The	O	O
overall	O	O
effect	O	O
of	O	O
heat	O	O
shock	O	O
on	O	O
c-myc	RNA	RNA
mRNA	RNA	RNA
level	O	O
,	O	O
however,	O	O
was	O	O
a	O	O
marked	O	O
inhibition	O	O
of	O	O
its	O	O
transcription	O	O
.	O	O
These	O	O
results	O	O
demonstrate	O	O
that	O	O
the	O	O
transcription	O	O
of	O	O
nuclear	DNA	O
protooncogenes	DNA	O
is	O	O
regulated	O	O
by	O	O
heat	O	O
shock	O	O
indicating	O	O
a	O	O
role	O	O
for	O	O
nuclear	DNA	O
protooncogenes	DNA	O
in	O	O
the	O	O
stress	O	O
response	O	O
of	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Mapping	O	O
of	O	O
B-cell	protein	O
epitopes	protein	O
of	O	O
the	O	O
human	protein	DNA
hepatitis	protein	DNA
B	protein	DNA
virus	protein	DNA
X	protein	DNA
protein	protein	DNA
.	O	O
The	O	O
immune	O	O
response	O	O
to	O	O
the	O	O
X	protein	protein
protein	protein	protein
of	O	O
human	O	protein
hepatitis	O	protein
B	O	protein
virus	O	protein
(	O	O
HBV	O	O
)	O	O
was	O	O
studied	O	O
by	O	O
epitope	O	O
mapping	O	O
by	O	O
using	O	O
a	O	O
set	O	O
of	O	O
MS2-HBx	protein	protein
fusion	protein	protein
proteins	protein	protein
and	O	O
synthetic	O	O
peptides	O	O
.	O	O
Antibodies	O	O
in	O	O
sera	O	O
of	O	O
patients	O	O
with	O	O
acute	O	O
and	O	O
chronic	O	O
HBV	O	O
infection	O	O
showed	O	O
a	O	O
multispecific	O	O
immune	O	O
response	O	O
.	O	O
Each	O	O
serum	O	O
contained	O	O
antibodies	protein	O
to	O	O
a	O	O
different	O	O
set	O	O
of	O	O
epitopes	protein	protein
,	O	O
which	O	O
taken	O	O
together	O	O
cover	O	O
most	O	O
of	O	O
the	O	O
HBx	protein	DNA
sequence	protein	DNA
.	O	O
Some	O	O
of	O	O
the	O	O
epitopes	O	protein
were	O	O
detectable	O	O
only	O	O
by	O	O
immunoblotting	O	O
with	O	O
fusion	protein	protein
proteins	protein	protein
;	O	O
others	O	O
were	O	O
detectable	O	O
only	O	O
by	O	O
an	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
(	O	O
ELISA	O	O
)	O	O
with	O	O
synthetic	O	O
peptides	O	O
.	O	O
The	O	O
carboxy-terminal	protein	protein
half	protein	protein
of	O	O
the	O	O
HBx	protein	protein
protein	protein	protein
was	O	O
preferentially	O	O
recognized	O	O
by	O	O
antibodies	protein	O
from	O	O
patients	O	O
with	O	O
chronic	O	O
hepatitis	O	O
and	O	O
contained	O	O
a	O	O
short	O	DNA
immunodominant	protein	DNA
antigenic	protein	DNA
region	protein	DNA
with	O	O
at	O	O
least	O	O
two	O	O
major	O	O
nonoverlapping	protein	O
epitopes	protein	protein
.	O	O
Anti-	O	protein
HBx	protein	protein
antibody	O	protein
titers	O	O
as	O	O
revealed	O	O
by	O	O
peptide	O	O
ELISAs	O	O
were	O	O
highest	O	O
and	O	O
most	O	O
frequent	O	O
in	O	O
patients	O	O
with	O	O
chronic	O	O
hepatitis	O	O
and	O	O
usually	O	O
low	O	O
in	O	O
acutely	O	O
infected	O	O
patients	O	O
and	O	O
asymptomatic	O	O
carriers	O	O
.	O	O
The	O	O
data	O	O
demonstrate	O	O
a	O	O
remarkable	O	O
qualitative	O	O
and	O	O
quantitative	O	O
heterogeneity	O	O
of	O	O
the	O	O
humoral	O	O
HBx	protein	O
immune	O	O
response	O	O
which	O	O
can	O	O
be	O	O
monitored	O	O
by	O	O
HBx	protein	protein
-specific	O	O
peptide	O	O
ELISAs	O	O
.	O	O
Such	O	O
tests	O	O
may	O	O
become	O	O
useful	O	O
diagnostic	O	O
tools	O	O
.	O	O

[The	O	O
inhibitory	O	O
effect	O	O
of	O	O
hydrocortisone	O	O
on	O	O
the	O	O
chemotactic	O	O
migration	O	O
of	O	O
human	cell_type	cell_type
leukocytes	cell_type	cell_type
]	O	O
Random	O	protein
migration	O	O
(	O	O
RM	O	O
)	O	O
and	O	O
chemotactic	O	protein
migration	O	O
(	O	O
ChtM	O	O
)	O	O
of	O	O
human	cell_type	cell_type
leukocytes	cell_type	cell_type
to	O	O
yeast	O	protein
activated	O	protein
serum	O	protein
were	O	O
studied	O	O
with	O	O
the	O	O
modified	O	O
Boyden	O	O
chamber	O	O
method	O	O
.	O	O
Both	O	O
RM	O	O
and	O	O
ChtM	O	O
showed	O	O
circadian	O	O
rhythm	O	O
.	O	O
Leukocytes	cell_type	cell_type
migrated	O	cell_type
most	O	O
rapidly	O	O
at	O	O
night.	O	O
The	O	O
difference	O	O
between	O	O
the	O	O
peak	O	O
(0:00)	O	O
and	O	O
trough	O	O
values	O	O
(8:00)	O	O
of	O	O
RM	O	O
and	O	O
ChtM	O	O
was	O	O
significant	O	O
statistically	O	O
(P	O	O
less	O	O
than	O	O
0.01).	O	O
ChtM	O	O
was	O	O
inhibited	O	O
by	O	O
hydrocortisone	O	O
(F)	O	O
of	O	O
physiological	O	O
concentration	O	O
(10(-9)-10(-7)	O	O
mol/L)	O	O
which	O	O
was	O	O
dose-dependent	O	O
and	O	O
completely	O	O
antagonized	O	O
by	O	O
the	O	O
competitive	O	O
antagonist	O	O
,	O	O
RU38486	O	O
.	O	O
The	O	O
inhibitory	O	O
effect	O	O
was	O	O
much	O	O
more	O	O
evident	O	O
with	O	O
higher	O	O
dose	O	O
(more	O	O
than	O	O
10(-5)	O	O
mol/L)	O	O
and	O	O
it	O	O
was	O	O
also	O	O
reversed	O	O
by	O	O
RU38486	O	O
,	O	O
but	O	O
only	O	O
partially.	O	O
It	O	O
is	O	O
suggested	O	O
that	O	O
glucocorticoids	O	O
(	O	O
GC	O	O
)	O	O
may	O	O
be	O	O
a	O	O
physiological	O	O
regulator	O	O
of	O	O
the	O	O
activity	O	O
of	O	O
leukocytes	cell_type	cell_type
and	O	O
its	O	O
inhibitory	O	O
action	O	O
on	O	O
ChtM	O	O
may	O	O
be	O	O
involved	O	O
in	O	O
antiinflammatory	O	O
mechanisms	O	O
of	O	O
GC	O	O
of	O	O
pharmacological	O	O
doses	O	O
.	O	O
The	O	O
action	O	O
of	O	O
physiological	O	O
and	O	O
pharmacological	O	O
concentration	O	O
of	O	O
GC	O	O
may	O	O
be	O	O
mediated	O	O
by	O	O
low	protein	O
affinity	protein	O
specific	protein	O
binding	protein	O
sites	protein	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
.	O	O

Heterogeneity	O	O
of	O	O
antigen	protein	protein
molecules	protein	protein
recognized	O	O
by	O	O
anti-tax1	protein	protein
monoclonal	protein	protein
antibody	protein	protein
Lt-4	protein	protein
in	O	O
cell	O	cell_line
lines	O	cell_line
bearing	O	cell_line
human	O	cell_line
T	O	cell_line
cell	O	cell_line
leukemia	O	cell_line
virus	O	cell_line
type	O	cell_line
I	O	cell_line
and	O	O
related	O	O
retroviruses	O	O
.	O	O
Using	O	O
a	O	O
monoclonal	protein	protein
antibody	protein	protein
,	O	O
Lt-4	protein	protein
,	O	O
directed	O	O
against	O	O
human	protein	O
T	protein	O
cell	protein	O
leukemia	protein	O
virus	protein	O
type	protein	O
I	protein	O
(	protein	O
HTLV-I	protein	O
)	protein	O
trans-activator	protein	protein
(	protein	O
tax1	protein	protein
)	protein	protein
antigen	protein	protein
,	O	O
we	O	O
examined	O	O
the	O	O
expression	O	O
of	O	O
tax1	protein	protein
and	O	O
related	O	O
antigens	protein	O
in	O	O
a	O	O
variety	O	O
of	O	O
T	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
bearing	O	O
HTLV-I	O	O
and	O	O
related	O	O
retroviruses	O	O
,	O	O
simian	O	O
T	O	O
cell	O	O
leukemia	O	O
virus	O	O
type	O	O
I	O	O
(	O	O
STLV-I	O	protein
)	O	O
and	O	O
HTLV-II	O	O
,	O	O
by	O	O
immunofluorescence	O	O
and	O	O
immunoblot	O	O
assays	O	O
.	O	O
Lt-4	protein	O
reacted	O	O
with	O	O
all	O	O
HTLV-I	cell_line	cell_line
-bearing	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
tested	O	O
and	O	O
five	O	O
out	O	O
of	O	O
eight	O	O
simian	cell_line	O
cell	cell_line	O
lines	cell_line	O
bearing	O	O
STLV-I	O	protein
,	O	O
but	O	O
not	O	O
with	O	O
an	O	O
HTLV-II	cell_line	O
-bearing	cell_line	O
cell	cell_line	O
line	cell_line	O
.	O	O
Lt-4	protein	O
detected	O	O
40	O	O
kd	O	O
tax1	protein	protein
antigen	protein	protein
molecules	protein	protein
in	O	O
most	O	O
HTLV-I	cell_line	cell_line
-bearing	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
except	O	O
one	O	O
cell	O	O
line	O	O
that	O	O
expressed	O	O
39	protein	O
kd	protein	O
tax1	protein	protein
antigen	protein	protein
.	O	O
In	O	O
the	O	O
STLV-I	cell_line	cell_line
-bearing	cell_line	cell_line
T	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
,	O	O
tax1	protein	protein
-related	protein	protein
antigen	protein	protein
molecules	protein	protein
detected	O	O
by	O	O
Lt-4	protein	protein
were	O	O
heterogeneous,	O	O
having	O	O
molecular	O	O
weights	O	O
in	O	O
the	O	O
range	O	O
of	O	O
36-41	O	O
kd.	O	O

Characterization	O	O
of	O	O
the	O	O
human	protein	O
immunodeficiency	protein	O
virus	protein	O
type	protein	O
1	protein	O
enhancer	protein	O
-binding	protein	O
proteins	protein	O
from	O	O
the	O	O
human	cell_line	cell_line
T-cell	cell_line	cell_line
line	cell_line	cell_line
Jurkat	cell_line	cell_line
.	O	O
The	O	O
transcription	O	O
of	O	O
the	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
type	O	O
1	O	O
(	O	O
HIV-1	O	O
)	O	O
is	O	O
under	O	O
the	O	O
control	O	O
of	O	O
cellular	protein	O
proteins	protein	O
that	O	O
bind	O	O
to	O	O
the	O	O
viral	DNA	DNA
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
(	O	O
LTR	DNA	DNA
).	O	O
Among	O	O
the	O	O
protein-binding	O	DNA
regions	O	DNA
of	O	O
the	O	O
HIV-1	DNA	DNA
LTR	DNA	DNA
is	O	O
the	O	O
transcription-enhancer	DNA	DNA
region	DNA	DNA
.	O	O
We	O	O
show	O	O
that	O	O
at	O	O
least	O	O
one	O	O
inducible	protein	O
,	O	O
C1	protein	protein
,	O	O
and	O	O
one	O	O
constitutive,	protein	O
C2	protein	protein
,	protein	O
protein	protein	O
can	O	O
bind	O	O
to	O	O
the	O	O
HIV	DNA	DNA
enhancer	DNA	DNA
in	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
The	O	O
two	O	O
proteins	O	O
differ	O	O
in	O	O
their	O	O
surface	O	O
charge	O	O
,	O	O
since	O	O
they	O	O
are	O	O
separable	O	O
by	O	O
anion-exchange	O	O
chromatography	O	O
.	O	O
Bivalent	O	O
cations	O	O
such	O	O
as	O	O
Mg2+	O	O
and	O	O
Zn2+	O	O
differentially	O	O
affect	O	O
their	O	O
binding	O	O
to	O	O
oligonucleotides	O	O
which	O	O
contain	O	O
the	O	O
HIV-enhancer	DNA	protein
domain	DNA	protein
.	O	O
Both	O	O
C1	protein	O
and	O	O
C2	protein	protein
proteins	protein	protein
also	O	O
bind	O	O
to	O	O
a	O	O
similar	O	O
sequence	O	O
found	O	O
in	O	O
the	O	O
interleukin-2	DNA	DNA
-receptor	DNA	DNA
alpha-subunit	DNA	DNA
enhancer	DNA	DNA
.	O	O
The	O	O
inducible	protein	O
C1	protein	protein
protein	protein	protein
was	O	O
partially	O	O
purified	O	O
by	O	O
three	O	O
chromatographic	O	O
steps	O	O
and	O	O
characterized	O	O
by	O	O
u.v.	O	O
cross-linking	O	O
as	O	O
a	O	O
47	protein	protein
kDa	protein	protein
protein	protein	protein
.	O	O

Differences	O	O
in	O	O
transcriptional	DNA	O
enhancers	DNA	O
of	O	O
HIV-1	O	O
and	O	O
HIV-2	O	O
.	O	O
Response	O	O
to	O	O
T	cell_type	O
cell	cell_type	O
activation	O	O
signals	O	O
.	O	O
T	cell_type	O
cell	cell_type	O
activation	O	O
results	O	O
in	O	O
high	O	O
levels	O	O
of	O	O
HIV	O	O
replication	O	O
and	O	O
is	O	O
thought	O	O
to	O	O
be	O	O
one	O	O
mechanism	O	O
leading	O	O
to	O	O
the	O	O
conversion	O	O
from	O	O
latent	O	O
to	O	O
active	O	O
viral	O	O
infection	O	O
.	O	O
In	O	O
HIV-1	O	O
,	O	O
the	O	O
sequences	O	O
that	O	O
respond	O	O
to	O	O
these	O	O
signaling	O	O
events	O	O
are	O	O
found	O	O
in	O	O
the	O	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
(	O	O
LTR	DNA	DNA
)	O	O
and	O	O
comprise	O	O
the	O	O
transcriptional	DNA	DNA
enhancer	DNA	DNA
,	O	O
which	O	O
contains	O	O
two	O	O
conserved	DNA	DNA
binding	DNA	DNA
sites	DNA	DNA
for	O	O
the	O	O
nuclear	protein	protein
factor	protein	protein
kappa	protein	protein
B	protein	protein
(	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
).	O	O
The	O	O
corresponding	O	O
region	O	O
in	O	O
the	O	O
second	O	O
AIDS	O	O
retrovirus	O	O
,	O	O
HIV-2	O	O
,	O	O
contains	O	O
a	O	O
conserved	O	O
and	O	O
a	O	O
divergent	O	O
NF	DNA	protein
kappa	DNA	protein
B	DNA	protein
binding	DNA	O
site	DNA	O
.	O	O
We	O	O
demonstrate	O	O
that	O	O
the	O	O
HIV-1	DNA	DNA
LTR	DNA	DNA
responds	O	O
better	O	O
than	O	O
the	O	O
HIV-2	DNA	DNA
LTR	DNA	DNA
to	O	O
T	O	O
cell	O	O
activation	O	O
signals.	O	O
These	O	O
qualitative	O	O
differences	O	O
in	O	O
the	O	O
response	O	O
to	O	O
T	cell_type	O
cell	cell_type	O
activation	O	O
are	O	O
reproduced	O	O
not	O	O
only	O	O
when	O	O
HIV-1	O	O
or	O	O
HIV-2	O	O
enhancers	O	O
are	O	O
placed	O	O
upstream	O	O
of	O	O
a	O	O
heterologous	DNA	DNA
promoter	DNA	DNA
but	O	O
also	O	O
when	O	O
these	O	O
enhancers	DNA	DNA
are	O	O
switched	O	O
between	O	O
their	O	O
respective	O	O
LTR	DNA	DNA
.	O	O
In	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assays,	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
binds	O	O
to	O	O
both	O	O
conserved	O	DNA
sites	O	DNA
in	O	O
the	O	O
HIV-1	DNA	DNA
transcriptional	DNA	DNA
enhancer	DNA	DNA
and	O	O
only	O	O
to	O	O
the	O	O
single	O	DNA
conserved	O	DNA
site	O	DNA
in	O	O
the	O	O
HIV-2	DNA	DNA
transcriptional	DNA	DNA
enhancer	DNA	DNA
.	O	O
Instead	O	O
of	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
,	O	O
the	O	O
activator	protein	protein
protein	protein	protein
3	protein	protein
binds	O	O
to	O	O
the	O	O
divergent	O	DNA
site	O	DNA
in	O	O
HIV-2	O	O
.	O	O
In	O	O
conclusion,	O	O
HIV-1	O	O
and	O	O
HIV-2	O	O
are	O	O
differentially	O	O
regulated	O	O
by	O	O
T	O	O
cell	O	O
activation	O	O
signals,	O	O
and	O	O
this	O	O
difference	O	O
may	O	O
account	O	O
for	O	O
the	O	O
longer	O	O
period	O	O
of	O	O
viral	O	O
latency	O	O
observed	O	O
with	O	O
HIV-2	O	O
than	O	O
with	O	O
HIV-1	O	O
infection	O	O
.	O	O

NF-X2	protein	DNA
that	O	O
binds	O	O
to	O	O
the	O	O
DRA	DNA	DNA
X2-box	DNA	DNA
is	O	O
activator	protein	O
protein	protein	O
1	protein	O
.	O	O
Expression	O	O
cloning	O	O
of	O	O
c-Jun	protein	protein
.	O	O
Human	protein	protein
class	protein	protein
II	protein	protein
MHC	protein	protein
Ag	protein	protein
are	O	O
a	O	O
family	O	O
of	O	O
cell	protein	O
surface	protein	O
glycoproteins	protein	protein
.	O	O
Their	O	O
constitutive	O	O
expression	O	O
is	O	O
limited	O	O
to	O	O
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
and	O	O
thymic	cell_type	cell_type
epithelial	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
many	O	O
other	O	O
cells	O	O
their	O	O
expression	O	O
can	O	O
be	O	O
induced	O	O
by	O	O
IFN-gamma	protein	protein
.	O	O
Conserved	O	O
upstream	O	DNA
promoter	O	DNA
sequences	O	DNA
regulate	O	O
this	O	O
tissue-specific	O	O
expression	O	O
of	O	O
class	DNA	DNA
II	DNA	DNA
genes	DNA	DNA
.	O	O
In	O	O
the	O	O
DRA	DNA	DNA
promoter	DNA	DNA
,	O	O
one	O	O
of	O	O
these	O	O
cis-acting	DNA	DNA
regulatory	DNA	DNA
motifs	DNA	DNA
is	O	O
the	O	O
X2-box	DNA	DNA
to	O	DNA
which	O	O
nuclear	protein	protein
factor	protein	protein
X2	protein	protein
(	O	protein
NF-X2	protein	protein
)	O	O
binds.	O	O
Here,	O	O
we	O	O
present	O	O
the	O	O
isolation	O	O
and	O	O
characterization	O	O
of	O	O
the	O	O
full-length	DNA	DNA
cDNA	DNA	DNA
clone	DNA	DNA
encoding	O	O
NF-X2	protein	protein
.	O	O
This	O	O
cDNA	DNA	O
clone	DNA	O
was	O	O
isolated	O	O
by	O	O
expression	O	O
cDNA	DNA	O
cloning	O	O
,	O	O
and	O	O
encodes	O	O
the	O	O
human	protein	protein
c-Jun	protein	protein
protein	protein	protein
,	O	O
which	O	O
together	O	O
with	O	O
c-Fos	protein	protein
forms	O	O
the	O	O
heterodimeric	protein	protein
activator	protein	protein
protein-1	protein	protein
transcription	protein	protein
complex	protein	protein
.	O	O
Whereas	O	O
c-Fos	protein	protein
/c-Jun	protein	protein
heterodimers	protein	protein
do	O	O
not	O	O
exist	O	O
in	O	O
B	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
they	O	O
form	O	O
and	O	O
bind	O	O
to	O	O
the	O	O
X2-box	DNA	DNA
in	O	O
class	cell_line	cell_line
II	cell_line	cell_line
nonexpressing	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Thus,	O	O
c-Fos	protein	protein
/c-Jun	protein	protein
heterodimers	protein	protein
might	O	O
contribute	O	O
to	O	O
the	O	O
repression	O	O
of	O	O
DRA	DNA	DNA
gene	DNA	DNA
expression	O	O
.	O	O

Synthesis	O	O
of	O	O
4,19-disubstituted	O	O
derivatives	O	O
of	O	O
DOC	O	O
.	O	O
Radioreceptor	O	O
assay	O	O
of	O	O
some	O	O
corticosteroid	O	O
derivatives	O	O
in	O	O
human	cell_type	cell_type
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
.	O	O
Several	O	O
new	O	O
4,19-substituted	O	O
steroids	O	O
and	O	O
previously	O	O
synthesized	O	O
corticosteroids	O	O
were	O	O
assayed	O	O
for	O	O
affinity	O	O
to	O	O
type	protein	protein
1	protein	protein
receptors	protein	protein
in	O	O
human	cell_type	cell_type
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
.	O	O
11	O	O
beta,19-epoxy-4,21-dihydroxypregn-4-ene-3,20-dione	O	protein
(2)	O	O
was	O	O
hydrogenated	O	O
with	O	O
Pd-C	O	O
to	O	O
yield	O	O
a	O	O
mixture	O	O
of	O	O
all	O	O
four	O	O
dihydro	O	O
derivatives	O	O
5,	O	O
accompanied	O	O
by	O	O
4,21-diacetoxy-11	O	O
beta,19-epoxy-3-hydroxypregnan-20-one	O	O
(6)	O	O
and	O	O
21-acetoxy-11	O	O
beta,19-epoxy-4-hydroxypregnane-3,20-dione	O	O
(7).	O	O
With	O	O
hot	O	O
acetic	O	O
+	O	O
p-toluenesulfonic	O	O
acid	O	O
5	O	O
underwent	O	O
rearrangement	O	O
to	O	O
21-acetoxy-11	O	protein
beta,19-epoxypregn-5-ene-4,20-dione	O	protein
(8)	O	protein
Pd-C	O	protein
hydrogenation	O	O
of	O	O
3,21-diacetoxy-5	O	protein
beta,19-cyclopregna-2,9(11)-diene-4,20-dione	O	protein
(10)	O	O
gave	O	O
3,21-diacetoxy-5	O	O
beta,19-cyclopregn-5-ene-4,20-dione	O	O
(11)	O	O
and	O	O
the	O	O
9,11-dihydro	O	O
derivative	O	O
of	O	O
the	O	O
latter.	O	O
Treatment	O	O
of	O	O
10	O	O
with	O	O
warm	O	O
HCl	O	O
furnished	O	O
19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione	O	O
(13).	O	O
Pd-C	O	O
hydrogenation	O	O
of	O	O
its	O	O
diacetate	O	O
14	O	O
afforded	O	O
the	O	O
4,5-dihydro	O	O
derivative	O	O
18,	O	O
19-chloro-21-acetoxypregn-9(11)-en-20-one	O	O
(15),	O	O
its	O	O
4-acetoxy	O	O
derivative	O	O
16	O	O
and	O	O
the	O	O
3,4-diacetoxy	O	O
derivative	O	O
17.	O	O
When	O	O
tested	O	O
in	O	O
a	O	O
radioreceptor	O	O
assay	O	O
in	O	O
human	cell_type	cell_type
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
the	O	O
synthesized	O	O
compounds	O	O
showed	O	O
only	O	O
low	O	O
relative	O	O
binding	O	O
affinities	O	O
(	O	O
RBA	O	O
)	O	O
to	O	O
type	protein	protein
1	protein	protein
receptor	protein	protein
,	O	O
the	O	O
highest	O	O
being	O	O
0.72%	O	O
for	O	O
13	O	O
(	O	O
aldosterone	O	O
=	O	O
100%).	O	O
For	O	O
comparison,	O	O
other	O	O
RBA	O	O
in	O	O
this	O	O
system	O	O
were:	O	O
19-noraldosterone	O	O
,	O	O
20%;	O	O
18-deoxyaldosterone	O	O
,	O	O
5.8%;	O	O
18-deoxy-19-noraldosterone	O	O
,	O	O
4.7%;	O	O
18,21-anhydroaldosterone	O	O
,	O	O
0.37%;	O	O
17-isoaldosterone	O	O
,	O	O
7.6%	O	O
and	O	O
apoaldosterone	O	O
,	O	O
4.3%	O	O

Cell	O	O
type	O	O
specificity	O	O
and	O	O
activation	O	O
requirements	O	O
for	O	O
NFAT-1	protein	protein
(	O	protein
nuclear	protein	protein
factor	protein	protein
of	O	protein
activated	cell_type	protein
T-cells	cell_type	protein
)	O	O
transcriptional	O	O
activity	O	O
determined	O	O
by	O	O
a	O	O
new	O	O
method	O	O
using	O	O
transgenic	O	O
mice	O	O
to	O	O
assay	O	O
transcriptional	O	O
activity	O	O
of	O	O
an	O	O
individual	O	O
nuclear	protein	protein
factor	protein	protein
.	O	O
Nuclear	protein	protein
factor	protein	protein
of	O	protein
activated	cell_type	protein
T-cells	cell_type	protein
(	O	O
NFAT-1	protein	protein
)	O	O
is	O	O
a	O	O
transcription	protein	protein
factor	protein	protein
which	O	O
is	O	O
considered	O	O
to	O	O
be	O	O
an	O	O
important	O	O
regulator	O	O
in	O	O
early	O	O
T-cell	O	O
activation	O	O
.	O	O
We	O	O
have	O	O
developed	O	O
a	O	O
system	O	O
to	O	O
monitor	O	O
the	O	O
transcriptional	O	O
activity	O	O
of	O	O
NFAT-1	protein	protein
at	O	O
the	O	O
single	O	O
cell	O	O
level	O	O
in	O	O
whole	O	O
animals	O	O
.	O	O
The	O	O
system	O	O
is	O	O
based	O	O
on	O	O
the	O	O
use	O	O
of	O	O
an	O	O
oligomerized	O	O
NFAT-1	protein	DNA
binding	O	DNA
motif	O	DNA
that	O	O
directs	O	O
transcription	protein	O
of	protein	O
SV40	protein	O
T-antigen	protein	O
in	O	O
transgenic	O	O
mice	O	O
.	O	O
This	O	O
report	O	O
represents	O	O
the	O	O
first	O	O
demonstration	O	O
that	O	O
a	O	O
multimerized	O	O
short	O	O
binding	O	O
motif	O	O
can	O	O
function	O	O
appropriately	O	O
in	O	O
transgenic	O	O
mice	O	O
.	O	O
NFAT-1	protein	protein
activity	O	O
had	O	O
previously	O	O
been	O	O
thought	O	O
to	O	O
be	O	O
confined	O	O
to	O	O
activated	cell_type	O
T-lymphocytes	cell_type	cell_type
upon	O	O
release	O	O
of	O	O
intracellular	cell_type	O
calcium	cell_type	O
.	O	O
By	O	O
targeting	O	O
NFAT-1	protein	DNA
-dependent	O	DNA
gene	O	DNA
expression	O	O
in	O	O
transgenic	O	O
mice	O	O
we	O	O
discovered	O	O
new	O	O
sites	O	O
of	O	O
NFAT-1	protein	protein
activity	O	O
.	O	O
Besides	O	O
in	O	O
T-lymphocytes	cell_type	cell_type
NFAT-1	protein	cell_type
activity	O	O
could	O	O
also	O	O
be	O	O
induced	O	O
in	O	O
T-lymphocyte-depleted	cell_type	cell_type
spleen	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
purified	cell_type	O
B-lymphocytes	cell_type	O
and	O	O
requires	O	O
agents	O	O
that	O	O
both	O	O
release	O	O
intracellular	O	O
calcium	O	O
and	O	O
activate	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
.	O	O
A	O	O
difference	O	O
in	O	O
the	O	O
time	O	O
course	O	O
of	O	O
appearance	O	O
of	O	O
NFAT-1	protein	protein
activity	O	O
between	O	O
T-lymphocytes	cell_type	cell_type
and	O	O
non-T-lymphocytes	cell_type	cell_type
was	O	O
revealed.	O	O
Constitutive	O	O
expression	O	O
was	O	O
observed	O	O
in	O	O
a	O	O
small	O	O
population	O	O
of	O	O
cells	O	O
in	O	O
the	O	O
dermis	O	O
and	O	O
some	O	O
mice	O	O
have	O	O
developed	O	O
skin	O	O
lesions	O	O
.	O	O
Interestingly,	O	O
the	O	O
tissue	O	O
pattern	O	O
of	O	O
expression	O	O
of	O	O
the	O	O
NFAT-1	protein	protein
activity	O	O
resembles	O	O
the	O	O
expression	O	O
pattern	O	O
described	O	O
for	O	O
HIV-LTR/tat	O	O
transgenic	O	O
mice	O	O
(Vogel,	O	O
J.,	O	O
Hinrichs,	O	O
S.	O	O
H.,	O	O
Reynolds,	O	O
R.	O	O
K.,	O	O
Luciw,	O	O
P.	O	O
A.,	O	O
and	O	O
Jay,	O	O
G.	O	O
(1988)	O	O
Nature	O	O
335,	O	O
606-611).	O	O
This	O	O
similarity	O	O
in	O	O
expression	O	O
and	O	O
the	O	O
fact	O	O
that	O	O
NFAT-1	protein	protein
has	O	O
been	O	O
shown	O	O
to	O	O
bind	O	O
functional	DNA	O
sequences	DNA	O
in	O	O
HIV-LTR	DNA	DNA
suggest	O	O
a	O	O
role	O	O
for	O	O
NFAT-1	protein	protein
in	O	O
dermal	O	O
activation	O	O
of	O	O
the	O	O
HIV-LTR	DNA	DNA
.	O	O

A	O	O
novel	O	O
T-cell	protein	O
protein	protein	O
which	O	O
recognizes	O	O
a	O	O
palindromic	DNA	DNA
sequence	DNA	DNA
in	O	O
the	O	O
negative	DNA	DNA
regulatory	DNA	DNA
element	DNA	DNA
of	O	O
the	O	O
human	DNA	DNA
immunodeficiency	DNA	DNA
virus	DNA	DNA
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
.	O	O
Two	O	O
major	DNA	DNA
protein-binding	DNA	DNA
sites	DNA	DNA
within	O	O
the	O	O
negative	DNA	DNA
regulatory	DNA	DNA
element	DNA	DNA
of	O	O
the	O	O
human	DNA	DNA
immunodeficiency	DNA	DNA
virus	DNA	DNA
type	DNA	DNA
1	DNA	DNA
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
have	O	O
been	O	O
identified.	O	O
One	O	O
(	O	O
site	DNA	O
B	DNA	O
)	O	O
contained	O	O
a	O	O
palindromic	DNA	DNA
sequence	DNA	DNA
with	O	O
homology	O	O
to	O	O
steroid/thyroid	DNA	O
hormone	DNA	O
response	DNA	O
elements	DNA	O
but	O	O
was	O	O
distinct	O	O
from	O	O
previously	O	O
described	O	O
binding	O	O
sites	O	O
of	O	O
this	O	O
class.	O	O
A	O	O
novel	O	O
T-cell	protein	O
protein	protein	O
recognized	O	O
the	O	O
palindromic	DNA	DNA
sequence	DNA	DNA
within	O	O
site	DNA	O
B	DNA	O
and	O	O
also	O	O
bound	O	O
estrogen-	O	O
or	O	O
thyroid	O	O
hormone-	O	O
response	O	O
elements	O	O
with	O	O
lower	O	O
affinity.	O	O
A	O	O
7-base-pair	O	O
mutation	O	O
in	O	O
the	O	O
site	DNA	O
B	DNA	O
palindrome	DNA	O
,	O	O
which	O	O
destroyed	O	O
protein	O	O
binding,	O	O
resulted	O	O
in	O	O
increased	O	O
expression	O	O
from	O	O
the	O	O
human	DNA	DNA
immunodeficiency	DNA	DNA
virus	DNA	DNA
type	DNA	DNA
1	DNA	DNA
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Progesterone	O	O
suppression	O	O
of	O	O
pregnancy	cell_type	O
lymphocytes	cell_type	O
is	O	O
not	O	O
mediated	O	O
by	O	O
glucocorticoid	O	protein
effect.	O	O
This	O	O
study	O	O
investigated	O	O
whether	O	O
the	O	O
suppressive	O	O
effect	O	O
of	O	O
progesterone	O	O
on	O	O
pregnancy	cell_type	O
lymphocytes	cell_type	O
is	O	O
mediated	O	O
by	O	O
specific	O	protein
progesterone	protein	protein
receptors	protein	protein
.	O	O
The	O	O
effects	O	O
of	O	O
a	O	O
competitive	O	O
progesterone	O	O
antagonist	O	O
(	O	O
RU486	O	O
)	O	O
and	O	O
a	O	O
specific	O	O
glucocorticoid	protein	protein
receptor	protein	protein
blocker	O	O
(	O	O
RU43044	O	O
)	O	O
were	O	O
tested	O	O
on	O	O
the	O	O
release	O	O
of	O	O
a	O	O
blocking	protein	O
factor	protein	O
by	O	O
progesterone	cell_line	O
-treated	cell_line	O
pregnancy	cell_line	O
lymphocytes	cell_line	O
.	O	O
RU	O	O
486	O	O
tested	O	O
at	O	O
an	O	O
equal	O	O
concentration	O	O
as	O	O
progesterone	O	O
significantly	O	O
inhibited	O	O
the	O	O
production	O	O
of	O	O
the	O	O
blocking	protein	O
factor	protein	O
,	O	O
while	O	O
RU	O	O
43044	O	O
was	O	O
without	O	O
effect.	O	O
These	O	O
data	O	O
suggest	O	O
that	O	O
in	O	O
pregnancy,	O	O
lymphocyte	O	O
progesterone	O	O
acts	O	O
on	O	O
specific	O	O
progesterone	protein	protein
receptors	protein	protein
and	O	O
glucocorticoid	protein	O
binding	protein	O
sites	protein	O
are	O	O
not	O	O
involved.	O	O

The	O	O
56-59-kilodalton	protein	O
protein	protein	O
identified	O	O
in	O	O
untransformed	protein	O
steroid	protein	O
receptor	protein	O
complexes	protein	O
is	O	O
a	O	O
unique	protein	O
protein	protein	O
that	O	O
exists	O	O
in	O	O
cytosol	O	O
in	O	O
a	O	O
complex	O	O
with	O	O
both	O	O
the	O	O
70-	O	O
and	O	O
90-	O	O
kilodalton	O	O
heat	O	protein
shock	O	protein
proteins	O	protein
.	O	O
It	O	O
has	O	O
previously	O	O
been	O	O
shown	O	O
that	O	O
9S	protein	protein
,	O	O
untransformed	O	O
progestin	O	O
,	O	O
estrogen	O	O
,	O	O
androgen	O	O
,	O	O
and	O	O
glucocorticoid	O	protein
receptor	O	protein
complexes	O	protein
in	O	O
rabbit	O	O
uterine	O	O
and	O	O
liver	O	O
cytosols	O	O
contain	O	O
a	O	O
59-kDa	protein	protein
protein	protein	protein
[Tai,	O	protein
P.K.,	O	protein
Maeda,	O	protein
Y.,	O	protein
Nakao,	O	protein
K.,	O	protein
Wakim,	O	protein
N.G.,	O	protein
Duhring,	O	protein
J.L.,	O	protein
&amp;	O	O
Faber,	O	O
L.E.(1986)	O	O
Biochemistry	O	O
25,	O	O
5269-5275].	O	O
In	O	O
this	O	O
work	O	O
we	O	O
show	O	O
that	O	O
the	O	O
monoclonal	protein	protein
antibody	protein	protein
KN	protein	protein
382/EC1	protein	protein
raised	O	O
against	O	O
the	O	O
rabbit	protein	O
59-kDa	protein	protein
protein	protein	protein
reacts	O	O
with	O	O
9S	protein	protein
,	O	O
untransformed	protein	O
glucocorticoid	protein	protein
receptor	protein	protein
complexes	protein	protein
in	O	O
cytosol	O	O
prepared	O	O
from	O	O
human	cell_line	cell_type
IM-9	cell_line	cell_type
lymphocytes	cell_line	cell_type
but	O	O
not	O	O
with	O	O
4S	protein	protein
salt-transformed	protein	protein
receptors	protein	protein
.	O	O
The	O	O
human	O	protein
protein	O	protein
recognized	O	O
by	O	O
the	O	O
EC1	protein	protein
antibody	protein	protein
is	O	O
a	O	O
56-kDa	protein	protein
protein	protein	protein
(	O	O
p56	protein	protein
)	O	O
of	O	O
moderate	O	O
abundance	O	O
located	O	O
predominantly	O	O
in	O	O
the	O	O
cytoplasm	O	O
by	O	O
indirect	O	O
immunofluorescence	O	O
.	O	O
There	O	O
are	O	O
at	O	O
least	O	O
six	O	O
isomorphs	protein	O
of	O	O
p56	protein	protein
by	O	O
two-dimensional	O	O
gel	O	O
analysis	O	O
.	O	O
N-Terminal	O	O
sequencing	O	O
(	O	O
20	O	O
amino	O	protein
acids	O	protein
)	O	O
shows	O	O
that	O	O
p56	protein	protein
is	O	O
a	O	O
unique	protein	O
human	protein	protein
protein	protein	protein
.	O	O
When	O	O
p56	protein	protein
is	O	O
immunoadsorbed	O	O
from	O	O
IM-9	cell_line	cell_line
cell	cell_line	cell_line
cytosol	O	cell_line
,	O	O
both	O	O
the	O	O
70-	O	O
and	O	O
90-	O	O
kDa	O	O
heat	O	protein
shock	O	protein
proteins	O	protein
are	O	O
coadsorbed	O	O
in	O	O
an	O	O
immune-specific	O	O
manner	O	O
.	O	O
Neither	O	O
heat	protein	protein
shock	protein	protein
protein	protein	protein
reacts	O	O
directly	O	O
with	O	O
the	O	O
EC1	protein	protein
antibody	protein	protein
.	O	O
We	O	O
conclude	O	O
that	O	O
p56	protein	protein
exists	O	O
in	O	O
cytosol	O	O
in	O	O
a	O	O
higher	O	O
order	O	O
complex	O	O
containing	O	O
hsp70	protein	protein
and	O	O
hsp90	protein	protein
,	O	O
both	O	O
of	O	O
which	O	O
in	O	O
turn	O	O
have	O	O
been	O	O
found	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
untransformed	protein	O
steroid	protein	O
receptors	protein	O
.	O	O

Sequence-specific	O	O
DNA	O	O
binding	O	O
of	O	O
the	O	O
proto-oncoprotein	protein	protein
ets-1	protein	protein
defines	O	O
a	O	O
transcriptional	DNA	DNA
activator	DNA	DNA
sequence	DNA	DNA
within	O	O
the	O	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
of	O	O
the	O	O
Moloney	O	O
murine	O	O
sarcoma	O	O
virus	O	O
.	O	O
The	O	O
ets	DNA	protein
proto-oncogene	DNA	protein
family	DNA	protein
is	O	O
a	O	O
group	O	O
of	O	O
sequence-related	DNA	DNA
genes	DNA	DNA
whose	O	O
normal	O	O
cellular	O	O
function	O	O
is	O	O
unknown.	O	O
In	O	O
a	O	O
study	O	O
of	O	O
cellular	protein	protein
proteins	protein	protein
involved	O	O
in	O	O
the	O	O
transcriptional	O	O
regulation	O	O
of	O	O
murine	O	O
retroviruses	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
,	O	O
we	O	O
have	O	O
discovered	O	O
that	O	O
a	O	O
member	O	O
of	O	O
the	O	O
ets	DNA	DNA
gene	DNA	DNA
family	DNA	DNA
encodes	O	O
a	O	O
sequence-specific	protein	protein
DNA-binding	protein	protein
protein	protein	protein
.	O	O
A	O	O
mouse	DNA	O
ets-1	DNA	DNA
cDNA	DNA	DNA
clone	DNA	DNA
was	O	O
obtained	O	O
by	O	O
screening	O	O
a	O	O
mouse	DNA	O
thymus	DNA	O
cDNA	DNA	O
expression	DNA	O
library	DNA	O
with	O	O
a	O	O
double-stranded	DNA	O
oligonucleotide	DNA	O
probe	DNA	O
representing	O	O
20	O	O
bp	O	O
of	O	O
the	O	O
Moloney	O	O
murine	O	O
sarcoma	O	O
virus	O	O
(	O	O
MSV	O	O
)	O	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
(	O	O
LTR	DNA	DNA
).	O	O
The	O	O
cDNA	DNA	DNA
sequence	DNA	DNA
has	O	O
an	O	O
813-bp	DNA	DNA
open	DNA	DNA
reading	DNA	DNA
frame	DNA	DNA
(	O	O
ORF	DNA	DNA
)	O	O
whose	O	O
predicted	O	O
amino	protein	O
acid	protein	O
sequence	protein	O
is	O	O
97.6%	O	O
identical	O	O
to	O	O
the	O	O
272	protein	O
carboxy-terminal	protein	protein
amino	protein	protein
acids	protein	protein
of	O	O
the	O	O
human	protein	protein
ets-1	protein	protein
protein	protein	protein
.	O	O
The	O	O
ORF	DNA	DNA
was	O	O
expressed	O	O
in	O	O
bacteria	O	O
,	O	O
and	O	O
the	O	O
30-kD	protein	protein
protein	protein	protein
product	protein	protein
was	O	O
shown	O	O
to	O	O
bind	O	O
DNA	DNA	O
in	O	O
a	O	O
sequence-specific	O	O
manner	O	O
by	O	O
mobility-shift	O	O
assays	O	O
,	O	O
Southwestern	O	O
blot	O	O
analysis	O	O
,	O	O
and	O	O
methylation	O	O
interference	O	O
.	O	O
A	O	O
mutant	DNA	DNA
LTR	DNA	DNA
containing	O	O
four	O	O
base	O	O
pair	O	O
substitutions	O	O
in	O	O
the	O	O
ets-1	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
was	O	O
constructed	O	O
and	O	O
was	O	O
shown	O	O
to	O	O
have	O	O
reduced	O	O
binding	O	O
in	O	O
vitro.	O	O
Transcriptional	O	O
efficiency	O	O
of	O	O
the	O	O
MSV	DNA	DNA
LTR	DNA	DNA
promoter	DNA	DNA
containing	O	O
this	O	O
disrupted	O	O
ets-1	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
was	O	O
compared	O	O
to	O	O
the	O	O
activity	O	O
of	O	O
a	O	O
wild-type	DNA	DNA
promoter	DNA	DNA
in	O	O
mouse	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
in	O	O
culture,	O	O
and	O	O
15-	O	O
to	O	O
20-fold	O	O
reduction	O	O
in	O	O
expression	O	O
of	O	O
a	O	O
reporter	DNA	DNA
gene	DNA	DNA
was	O	O
observed.	O	O
We	O	O
propose	O	O
that	O	O
ets-1	protein	protein
functions	O	O
as	O	O
a	O	O
transcriptional	O	protein
activator	O	protein
of	O	protein
mammalian	O	protein
type-C	O	protein
retroviruses	O	O
and	O	O
speculate	O	O
that	O	O
ets-related	DNA	DNA
genes	DNA	DNA
constitute	O	O
a	O	O
new	O	O
group	O	O
of	O	O
eukaryotic	protein	protein
DNA-binding	protein	protein
proteins	protein	protein
.	O	O

Type	protein	protein
II	protein	protein
estrogen	protein	protein
binding	protein	protein
sites	protein	protein
in	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
:	O	O
variations	O	O
during	O	O
the	O	O
menstrual	O	O
cycle	O	O
.	O	O
We	O	O
have	O	O
previously	O	O
reported	O	O
that	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
(	O	O
PBMC	cell_type	cell_type
)	O	O
contain	O	O
type	O	protein
II	protein	protein
estrogen	protein	protein
binding	protein	protein
sites	protein	protein
(	O	O
type	protein	protein
II	protein	protein
EBS	protein	protein
).	O	O
In	O	O
this	O	O
study,	O	O
the	O	O
fluctuations	O	O
of	O	O
type	protein	protein
II	protein	protein
EBS	protein	protein
during	O	O
the	O	O
menstrual	O	O
cycle	O	O
were	O	O
analyzed	O	O
in	O	O
6	O	O
normally	O	O
menstruating	O	O
women	O	O
.	O	O
Approximately	O	O
3	O	O
times	O	O
higher	O	O
levels	O	O
of	O	O
type	protein	protein
II	protein	protein
EBS	protein	protein
were	O	O
found	O	O
in	O	O
the	O	O
periovulatory	O	O
period	O	O
with	O	O
respect	O	O
to	O	O
both	O	O
follicular	O	O
and	O	O
luteal	O	O
phases	O	O
.	O	O
In	O	O
postmenopausal	O	O
women	O	O
the	O	O
mean	O	O
type	protein	O
II	protein	O
EBS	protein	O
levels	O	O
were	O	O
similar	O	O
to	O	O
those	O	O
observed	O	O
in	O	O
the	O	O
follicular	O	O
phase	O	O
of	O	O
the	O	O
cycle.	O	O
However,	O	O
in	O	O
3	O	O
postmenopausal	O	O
patients	O	O
a	O	O
short	O	O
course	O	O
of	O	O
estrogen	O	O
or	O	O
tamoxifen	O	O
resulted	O	O
in	O	O
a	O	O
marked	O	O
increase	O	O
of	O	O
type	protein	protein
II	protein	protein
EBS	protein	protein
levels.	O	O
Tamoxifen	O	O
was	O	O
also	O	O
found	O	O
to	O	O
compete	O	O
with	O	O
17	O	O
beta-estradiol	O	O
for	O	O
type	protein	O
II	protein	O
EBS	protein	O
in	O	O
PBMC	cell_type	cell_type
,	O	O
although	O	O
to	O	O
a	O	O
lesser	O	O
extent	O	O
than	O	O
diethylstilbestrol	O	O
.	O	O

Mononuclear	cell_type	O
leukocyte	cell_type	protein
glucocorticoid	protein	protein
receptor	protein	protein
binding	O	O
characteristics	O	O
and	O	O
down-regulation	O	O
in	O	O
major	O	O
depression	O	O
.	O	O
Some	O	O
patients	O	O
with	O	O
major	O	O
depressive	O	O
disorder	O	O
(	O	O
MDD	O	O
)	O	O
have	O	O
elevated	O	O
plasma	O	O
cortisol	O	O
concentrations	O	O
and	O	O
show	O	O
failure	O	O
to	O	O
suppress	O	O
cortisol	O	O
secretion	O	O
upon	O	O
administration	O	O
of	O	O
dexamethasone	O	O
(	O	O
DEX	O	O
),	O	O
yet	O	O
they	O	O
do	O	O
not	O	O
have	O	O
Cushingoid	O	O
features	O	O
.	O	O
To	O	O
study	O	O
whether	O	O
this	O	O
represents	O	O
glucocorticoid	O	O
(	O	O
GC	O	O
)	O	O
resistance	O	O
,	O	O
[3H]-DEX-binding	O	O
assays	O	O
were	O	O
used	O	O
to	O	O
measure,	O	O
in	O	O
vitro,	O	O
the	O	O
GC	protein	O
receptor	protein	O
affinity	O	O
(1/Kd)	O	O
and	O	O
number	O	O
(	O	O
Bmax	O	O
)	O	O
in	O	O
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
of	O	O
11	O	O
MDD	O	O
patients	O	O
and	O	O
15	O	O
control	O	O
subjects	O	O
.	O	O
No	O	O
receptor	O	O
abnormalities	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
MDD	O	O
group;	O	O
thus	O	O
any	O	O
cellular	O	O
defect	O	O
leading	O	O
to	O	O
a	O	O
lack	O	O
of	O	O
responsiveness	O	O
to	O	O
GC	O	O
in	O	O
the	O	O
MDD	O	O
patients	O	O
,	O	O
if	O	O
present,	O	O
probably	O	O
lies	O	O
beyond	O	O
the	O	O
initial	O	O
receptor	O	O
binding	O	O
.	O	O
DEX	O	O
(1.0	O	O
mg	O	O
orally)	O	O
was	O	O
administered	O	O
to	O	O
study	O	O
in	O	O
vivo	protein	O
GC	protein	O
receptor	protein	O
down-regulation	O	O
.	O	O
Compared	O	O
to	O	O
the	O	O
control	O	O
group	O	O
,	O	O
fewer	O	O
depressed	O	O
subjects	O	O
down-regulated	O	O
Bmax	O	O
after	O	O
DEX	O	O
.	O	O
By	O	O
paired	O	O
t-test	O	O
,	O	O
Bmax	O	O
decreased	O	O
significantly	O	O
in	O	O
the	O	O
control	O	O
group	O	O
but	O	O
not	O	O
in	O	O
the	O	O
depressed	O	O
group	O	O
.	O	O
Receptor	O	O
number	O	O
on	O	O
the	O	O
control	O	O
day	O	O
did	O	O
not	O	O
correlate	O	O
significantly	O	O
with	O	O
the	O	O
degree	O	O
of	O	O
receptor	O	O
down-regulation	O	O
,	O	O
severity	O	O
of	O	O
depression	O	O
or	O	O
cortisol	O	O
concentrations	O	O
across	O	O
all	O	O
the	O	O
subjects.	O	O
These	O	O
results	O	O
do	O	O
not	O	O
lend	O	O
support	O	O
to	O	O
previous	O	O
reports	O	O
suggesting	O	O
that	O	O
GC	O	O
resistance	O	O
in	O	O
MDD	O	O
results	O	O
from	O	O
a	O	O
GC	O	O
receptor-binding	O	O
abnormality	O	O
,	O	O
and	O	O
they	O	O
emphasize	O	O
the	O	O
importance	O	O
of	O	O
considering	O	O
receptor	O	O
studies	O	O
in	O	O
the	O	O
context	O	O
of	O	O
GC	O	O
-mediated	O	O
cell	O	O
processes	O	O
in	O	O
order	O	O
to	O	O
identify	O	O
the	O	O
exact	O	O
cellular	O	O
defect(s)	O	O
leading	O	O
to	O	O
GC	O	O
resistance	O	O
.	O	O

Ras-related	protein	protein
GTP-binding	protein	protein
proteins	protein	protein
and	O	O
leukocyte	cell_type	O
signal	O	O
transduction	O	O
.	O	O
Many	O	O
aspects	O	O
of	O	O
leukocyte	cell_type	O
function	O	O
are	O	O
regulated	O	O
by	O	O
both	O	O
heterotrimeric	protein	O
and	O	O
Ras-related	protein	protein
GTP-binding	protein	protein
proteins	protein	protein
,	O	O
but	O	O
there	O	O
is	O	O
little	O	O
definite	O	O
information	O	O
about	O	O
their	O	O
roles	O	O
in	O	O
the	O	O
specialized	O	O
processes	O	O
utilized	O	O
by	O	O
leukocytes	cell_type	cell_type
for	O	O
cell	O	O
killing.	O	O
Recent	O	O
progress	O	O
in	O	O
understanding	O	O
the	O	O
regulation	O	O
of	O	O
the	O	O
phagocyte	protein	O
NADPH	protein	O
oxidase	protein	O
by	O	O
the	O	O
Rac	protein	protein
GTP-binding	protein	protein
proteins	protein	protein
provides	O	O
a	O	O
basis	O	O
for	O	O
defining	O	O
the	O	O
operational	O	O
characteristics	O	O
of	O	O
one	O	O
such	O	O
phagocyte	O	O
system	O	O
.	O	O
It	O	O
is	O	O
clear	O	O
from	O	O
various	O	O
studies	O	O
that	O	O
the	O	O
activity	O	O
of	O	O
the	O	O
NADPH	protein	protein
oxidase	protein	protein
can	O	O
be	O	O
modulated	O	O
through	O	O
the	O	O
regulation	O	O
of	O	O
the	O	O
GTP-GDP	protein	O
state	protein	O
of	O	O
Rac	protein	protein
.	O	O
Proteins	O	O
exist	O	O
in	O	O
leukocytes	cell_type	cell_type
able	O	O
to	O	O
modify	O	O
GTP-binding	protein	protein
protein	protein	protein
function	O	O
in	O	O
this	O	O
manner,	O	O
and	O	O
their	O	O
activity	O	O
may	O	O
be	O	O
regulated	O	O
by	O	O
signals	O	O
generated	O	O
on	O	O
phagocyte	O	O
stimulation	O	O
.	O	O
Proteins	O	O
of	O	O
the	O	O
Ras	protein	protein
superfamily	protein	protein
are	O	O
likely	O	O
to	O	O
be	O	O
involved	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
normal	O	O
phagocyte	O	O
functions	O	O
through	O	O
their	O	O
ability	O	O
to	O	O
modulate	O	O
the	O	O
assembly	O	O
of	O	O
actin	protein	protein
filaments	protein	protein
,	O	O
direct	O	O
vesicle	O	O
trafficking	O	O
and	O	O
fusion,	O	O
and	O	O
so	O	O
forth.	O	O

BSAP	protein	protein
:	O	O
a	O	O
key	O	O
regulator	O	O
of	O	O
B-cell	cell_type	O
development	O	O
and	O	O
differentiation	O	O
.	O	O
B-cell-specific	protein	protein
activator	protein	protein
protein	protein	protein
(	O	O
BSAP	protein	protein
)	O	O
is	O	O
a	O	O
recently	O	O
identified	O	O
member	O	O
of	O	O
the	O	O
Pax-gene	DNA	DNA
family	DNA	DNA
of	O	O
transcription	protein	protein
factors	protein	protein
;	O	O
in	O	O
the	O	O
lymphoid	O	O
system	O	O
,	O	O
BSAP	protein	protein
is	O	O
produced	O	O
only	O	O
in	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Here,	O	O
Markus	O	O
Neurath,	O	O
Eckhard	O	O
Stuber	O	O
and	O	O
Warren	O	O
Strober	O	O
describe	O	O
the	O	O
molecular	O	O
structure	O	O
of	O	O
BSAP	protein	protein
and	O	O
focus	O	O
on	O	O
the	O	O
ability	O	O
of	O	O
this	O	O
protein	O	O
to	O	O
regulate	O	O
the	O	O
expression	O	O
of	O	O
B-cell-specific	DNA	DNA
genes	DNA	DNA
.	O	O
They	O	O
propose	O	O
that	O	O
BSAP	protein	protein
is	O	O
a	O	O
key	protein	O
protein	protein	O
of	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
that	O	O
it	O	O
not	O	O
only	O	O
influence	O	O
B-cell	O	O
development	O	O
but	O	O
also	O	O
influences	O	O
the	O	O
balance	O	O
between	O	O
B-cell	O	O
proliferation	O	O
and	O	O
immunoglobulin	protein	protein
secretion	O	O
at	O	O
later	O	O
stages	O	O
of	O	O
B-cell	O	O
differentiation	O	O
.	O	O

Down-regulation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
protein	protein	protein
levels	O	O
in	O	O
activated	O	cell_type
human	O	cell_type
lymphocytes	O	cell_type
by	O	O
1,25-dihydroxyvitamin	O	O
D3	O	O
[published	O	O
erratum	O	O
appears	O	O
in	O	O
Proc	O	O
Natl	O	O
Acad	O	O
Sci	O	O
U	O	O
S	O	O
A	O	O
1996	O	O
Jan	O	O
9;93(1):524]	O	O
The	O	O
effect	O	O
of	O	O
1,25-dihydroxyvitamin	O	O
D3	O	O
[	O	O
1,25(OH)2)D3	O	O
],	O	O
a	O	O
steroid	O	O
hormone	O	O
with	O	O
immunomodulating	O	O
properties,	O	O
on	O	O
nuclear	protein	protein
factor	protein	protein
kappa	protein	protein
B	protein	protein
(	O	O
NF-kappa	protein	protein
B	protein	protein
)	O	O
proteins	O	O
was	O	O
examined	O	O
in	O	O
in	cell_line	O
vitro	cell_line	O
activated	cell_line	O
normal	cell_line	cell_type
human	cell_line	cell_type
lymphocytes	cell_line	cell_type
by	O	O
Western	O	O
blot	O	O
analysis	O	O
.	O	O
Over	O	O
a	O	O
72-hr	O	O
period	O	O
of	O	O
activation,	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
50-kDa	protein	protein
NF-kappa	protein	protein
B	protein	protein
,	O	O
p50	protein	protein
,	O	O
and	O	O
its	O	O
precursor,	O	O
p105	protein	protein
,	O	O
was	O	O
increased	O	O
progressively.	O	O
When	O	O
cells	O	O
were	O	O
activated	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
1,25(OH)2D3	O	O
,	O	O
the	O	O
levels	O	O
of	O	O
the	O	O
mature	O	O
protein	O	O
as	O	O
well	O	O
as	O	O
its	O	O
precursor	O	O
were	O	O
decreased.	O	O
The	O	O
effect	O	O
of	O	O
the	O	O
hormone	O	O
on	O	O
the	O	O
levels	O	O
of	O	O
p50	protein	protein
was	O	O
demonstrable	O	O
in	O	O
the	O	O
cytosolic	O	protein
and	O	O
nuclear	O	O
compartments	O	O
;	O	O
it	O	O
required	O	O
between	O	O
4	O	O
and	O	O
8	O	O
hr	O	O
and	O	O
was	O	O
specific,	O	O
as	O	O
25-hydroxyvitamin	O	O
D3	O	O
and	O	O
24,25-dihydroxyvitamin	O	O
D3	O	O
were	O	O
ineffective.	O	O
Besides	O	O
p50	protein	protein
,	O	O
1,25(OH)2D3	O	O
decreased	O	O
the	O	O
levels	O	O
of	O	O
another	O	O
NF-kappa	protein	protein
B	protein	protein
protein	protein	protein
,	O	O
namely	O	O
c-rel	protein	protein
.	O	O
In	O	O
addition,	O	O
1,25(OH)2D3	O	O
decreased	O	O
the	O	O
abundance	O	O
of	O	O
a	O	O
specific	protein	O
DNA-protein	protein	protein
complex	protein	protein
formed	O	O
upon	O	O
incubation	O	O
of	O	O
nuclear	O	O
extracts	O	O
from	O	O
activated	O	cell_type
lymphocytes	O	cell_type
with	O	O
a	O	O
labeled	O	O
NF-kappa	protein	protein
B	protein	protein
DNA	protein	O
binding	protein	O
motif	protein	O
.	O	O
Further,	O	O
1,25(OH)2D3	O	O
inhibited	O	O
the	O	O
transcriptional	O	O
activity	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
in	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
transiently	O	O
transfected	O	O
with	O	O
a	O	O
construct	DNA	O
containing	O	O
four	O	O
tandem	DNA	O
repeats	DNA	O
of	O	O
the	O	O
NF-kappa	DNA	protein
B	DNA	protein
binding	DNA	O
sequence	DNA	O
of	O	O
the	O	O
immunoglobulin	DNA	DNA
kappa	DNA	DNA
light	DNA	DNA
chain	DNA	DNA
gene	DNA	DNA
linked	O	O
to	O	O
the	O	O
chloramphenicol	DNA	DNA
acetyltransferase	DNA	DNA
reporter	DNA	DNA
gene	DNA	DNA
.	O	O
These	O	O
observations	O	O
demonstrate	O	O
directly	O	O
that	O	O
there	O	O
is	O	O
de	O	O
novo	O	O
synthesis	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
during	O	O
human	O	O
lymphocyte	O	O
activation	O	O
and	O	O
suggest	O	O
that	O	O
this	O	O
process	O	O
is	O	O
hormonally	O	O
regulated.	O	O

The	O	O
myeloid	DNA	O
zinc	DNA	O
finger	DNA	O
gene	DNA	O
,	O	O
MZF-1	DNA	protein
,	O	O
regulates	O	O
the	O	O
CD34	DNA	DNA
promoter	DNA	DNA
in	O	O
vitro.	O	O
MZF-1	DNA	O
is	O	O
a	O	O
C2H2	DNA	protein
zinc	DNA	protein
finger	DNA	protein
gene	DNA	O
encoding	O	O
a	O	O
putative	protein	protein
transcriptional	protein	protein
regulator	protein	protein
of	O	O
myeloid	O	O
differentiation	O	O
.	O	O
The	O	O
MZF-1	DNA	protein
protein	O	protein
contains	O	O
13	O	O
C2H2	protein	protein
zinc	protein	protein
fingers	protein	protein
arranged	O	O
in	O	O
bipartite	O	O
DNA	protein	O
binding	protein	protein
domains	protein	protein
containing	O	O
zinc	protein	protein
fingers	protein	protein
through	O	O
4	O	O
and,	O	O
in	O	O
the	O	O
carboxy-terminus	protein	protein
,	O	O
5	O	O
through	O	O
13.	O	O
We	O	O
previously	O	O
identified	O	O
the	O	O
DNA	DNA	DNA
consensus	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
recognized	O	O
by	O	O
the	O	O
two	O	O
DNA	protein	DNA
binding	protein	DNA
domains	protein	DNA
.	O	O
To	O	O
assess	O	O
the	O	O
transcription	O	O
regulatory	O	O
function	O	O
of	O	O
MZF-1	DNA	protein
,	O	O
the	O	O
full-length	O	O
MZF-1	DNA	DNA
coding	O	DNA
region	O	DNA
was	O	O
fused	O	O
to	O	O
the	O	O
DNA	protein	protein
binding	protein	protein
domain	protein	protein
of	O	O
the	O	O
yeast	protein	protein
transactivator	protein	protein
GAL4	protein	protein
.	O	O
The	O	O
expression	O	O
vector	O	O
was	O	O
cotransfected	O	O
with	O	O
the	O	O
chloramphenicol	DNA	DNA
acetyl	DNA	DNA
transferase	DNA	DNA
(CAT)	DNA	DNA
reporter	DNA	DNA
gene	DNA	DNA
regulated	O	O
by	O	O
the	O	O
thymidine	DNA	DNA
kinase	DNA	DNA
promoter	DNA	DNA
containing	O	O
GAL4	DNA	DNA
DNA	DNA	DNA
binding	DNA	DNA
sites	DNA	DNA
into	O	O
NIH	cell_line	DNA
3T3	cell_line	DNA
,	O	O
293	cell_line	O
,	O	O
K562	cell_line	cell_line
,	O	O
and	O	O
Jurkat	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
MZF-1	DNA	O
represses	O	O
CAT	DNA	DNA
reporter	DNA	DNA
gene	DNA	DNA
expression	O	O
via	O	O
GAL4	protein	DNA
binding	O	DNA
sites	O	DNA
in	O	O
the	O	O
nonhematopoietic	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
NIH	cell_line	cell_line
3T3	cell_line	cell_line
and	O	O
293	cell_line	O
.	O	O
In	O	O
contrast,	O	O
MZF-1	DNA	protein
activates	O	O
CAT	DNA	DNA
reporter	DNA	DNA
gene	DNA	DNA
expression	O	O
in	O	O
the	O	O
hematopoietic	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
K562	cell_line	cell_line
and	O	O
Jurkat	cell_line	O
.	O	O
The	O	O
MZF-1	DNA	DNA
binding	DNA	DNA
sites	DNA	DNA
are	O	O
present	O	O
in	O	O
the	O	O
promoters	DNA	DNA
of	O	DNA
several	O	DNA
genes	DNA	DNA
expressed	O	O
during	O	O
myeloid	O	O
differentiation	O	O
,	O	O
including	O	O
the	O	O
CD34	DNA	DNA
promoter	DNA	DNA
.	O	O
MZF-1	DNA	protein
transcriptional	O	O
regulation	O	O
of	O	O
this	O	O
physiologically	DNA	O
relevant	DNA	O
promoter	DNA	O
was	O	O
assessed	O	O
in	O	O
both	O	O
hematopoietic	cell_line	O
and	O	O
nonhematopoietic	cell_line	O
cell	cell_line	O
lines	cell_line	O
.	O	O
Recombinant	protein	protein
MZF-1	protein	protein
protein	protein	protein
specifically	O	O
binds	O	O
to	O	O
the	O	O
consensus	DNA	DNA
binding	DNA	DNA
sites	DNA	DNA
in	O	O
the	O	O
CD34	DNA	DNA
promoter	DNA	DNA
in	O	O
mobility	O	O
shift	O	O
assays	O	O
.	O	O
MZF-1	DNA	O
expression	O	O
vectors	O	O
were	O	O
cotransfected	O	O
with	O	O
the	O	O
luciferase	DNA	DNA
reporter	DNA	DNA
plasmids	DNA	DNA
regulated	O	O
by	O	O
the	O	O
CD34	DNA	DNA
promoter	DNA	DNA
into	O	O
both	O	O
nonhematopoietic	O	O
and	O	O
hematopoietic	O	cell_line
cell	O	cell_line
lines	O	cell_line
.	O	O
As	O	O
with	O	O
the	O	O
heterologous	O	DNA
DNA	protein	DNA
binding	protein	DNA
domain	protein	DNA
,	O	O
MZF-1	DNA	DNA
represses	O	DNA
reporter	DNA	DNA
gene	DNA	DNA
expression	O	O
in	O	O
nonhematopoietic	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
and	O	O
activates	O	O
expression	O	O
in	O	O
hematopoietic	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
Activation	O	O
of	O	O
CD34	protein	protein
expression	O	O
in	O	O
hematopoietic	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
is	O	O
dependent	O	O
on	O	O
the	O	O
presence	O	O
of	O	O
intact	O	O
MZF-1	DNA	DNA
binding	DNA	DNA
sites	DNA	DNA
.	O	O
The	O	O
cell	O	O
type-specific	O	O
regulation	O	O
of	O	O
the	O	O
CD34	DNA	DNA
promoter	DNA	DNA
by	O	O
MZF-1	DNA	protein
suggests	O	O
the	O	O
presence	O	O
of	O	O
tissue-specific	O	O
regulators/adapters	O	O
or	O	O
differential	O	O
MZF-1	DNA	O
modifications	O	O
that	O	O
determine	O	O
MZF-1	DNA	protein
transcriptional	O	protein
regulatory	O	protein
function	O	O
.	O	O

The	O	O
murine	O	DNA
BCL6	DNA	DNA
gene	DNA	DNA
is	O	O
induced	O	O
in	O	O
activated	cell_type	cell_type
lymphocytes	cell_type	cell_type
as	O	O
an	O	O
immediate	DNA	O
early	DNA	O
gene	DNA	O
.	O	O
The	O	O
chromosomal	O	O
translocation	O	O
involving	O	O
3q27	DNA	O
is	O	O
often	O	O
detected	O	O
in	O	O
human	cell_type	O
B-cell	cell_type	O
lymphomas	cell_type	O
,	O	O
especially	O	O
diffuse	O	O
lymphomas	O	O
with	O	O
a	O	O
large-cell	O	O
component	O	O
.	O	O
The	O	O
BCL6	DNA	DNA
gene	DNA	DNA
has	O	O
been	O	O
isolated	O	O
from	O	O
the	O	O
chromosomal	O	O
breakpoint	O	O
in	O	O
these	O	O
lymphomas	O	O
.	O	O
Here	O	O
we	O	O
cloned	O	O
the	O	O
murine	DNA	DNA
BCL6	DNA	DNA
(mBCL6)	DNA	DNA
cDNA	DNA	DNA
from	O	O
the	O	O
muscle	DNA	DNA
cDNA	DNA	DNA
library	DNA	DNA
using	O	O
the	O	O
human	DNA	DNA
BCL6	DNA	DNA
(hBCL6)	DNA	DNA
cDNA	DNA	DNA
as	O	O
a	O	O
probe.	O	O
The	O	O
predicted	O	O
amino	O	O
acid	O	O
sequence	O	O
was	O	O
95%	O	O
identical	O	O
to	O	O
that	O	O
of	O	O
hBCL6	protein	protein
.	O	O
It	O	O
contains	O	O
six	O	O
repeats	O	O
of	O	O
the	O	O
Kruppel-like	protein	DNA
zinc-finger	protein	DNA
motif	protein	DNA
that	O	O
are	O	O
completely	O	O
identical	O	O
to	O	O
those	O	O
of	O	O
hBCL6	protein	protein
,	O	O
indicating	O	O
that	O	O
the	O	O
BCL6	DNA	DNA
gene	DNA	DNA
is	O	O
well	O	O
conserved	O	O
between	O	O
humans	O	O
and	O	O
mice	O	O
.	O	O
Expression	O	O
of	O	O
the	O	O
mBCL6	DNA	DNA
gene	DNA	DNA
was	O	O
ubiquitously	O	O
detected	O	O
in	O	O
adult	O	O
mouse	O	O
tissues	O	O
including	O	O
lymphatic	O	O
organs	O	O
.	O	O
Furthermore,	O	O
it	O	O
was	O	O
induced	O	O
in	O	O
lymphocytes	cell_type	cell_type
activated	O	O
with	O	O
phorbol	O	O
ester	O	O
and	O	O
Ca2+	O	O
ionophore	O	O
within	O	O
30	O	O
min	O	O
after	O	O
stimulation.	O	O
This	O	O
induction	O	O
was	O	O
not	O	O
inhibited	O	O
by	O	O
treatment	O	O
of	O	O
the	O	O
cells	O	O
with	O	O
a	O	O
protein	O	O
synthesis	O	O
inhibitor	O	O
,	O	O
cycloheximide	O	O
.	O	O
These	O	O
results	O	O
suggest	O	O
that	O	O
BCL6	protein	protein
plays	O	O
a	O	O
role	O	O
in	O	O
activated	cell_type	cell_type
lymphocytes	cell_type	cell_type
as	O	O
an	O	O
immediate	O	O
early	O	O
gene.	O	O

The	O	O
role	O	O
of	O	O
BSAP	protein	protein
(	O	O
Pax-5	protein	protein
)	O	O
in	O	O
B-cell	O	cell_type
development	O	O
.	O	O
The	O	O
hierarchy	O	O
of	O	O
transcriptional	O	O
control	O	O
in	O	O
B-cell	O	O
development	O	O
has	O	O
recently	O	O
been	O	O
analyzed	O	O
by	O	O
targeted	O	O
gene	O	O
inactivation	O	O
in	O	O
the	O	O
mouse	O	O
.	O	O
In	O	O
this	O	O
manner,	O	O
the	O	O
paired	DNA	DNA
box	DNA	DNA
containing	DNA	O
gene	DNA	O
Pax-5	DNA	protein
,	O	O
encoding	O	O
the	O	O
B	protein	protein
cell	protein	protein
specific	protein	protein
transcription	protein	protein
factor	protein	protein
BSAP	protein	protein
,	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
play	O	O
a	O	O
key	O	O
role	O	O
in	O	O
early	O	O
B	O	O
lymphopoiesis	O	O
.	O	O
Other	O	O
experimental	O	O
strategies	O	O
have	O	O
implicated	O	O
BSAP	protein	protein
in	O	O
the	O	O
control	O	O
of	O	O
cell	O	O
proliferation	O	O
,	O	O
isotype	O	O
switching	O	O
and	O	O
transcription	O	O
of	O	O
the	O	O
immunoglobulin	DNA	DNA
heavy-chain	DNA	DNA
gene	DNA	DNA
at	O	O
late	O	O
stages	O	O
of	O	O
B-cell	O	O
differentiation	O	O
.	O	O

The	O	O
DNA-binding	O	O
properties	O	O
of	O	O
two	protein	O
heat	protein	protein
shock	protein	protein
factors	protein	protein
,	O	O
HSF1	protein	protein
and	O	O
HSF3	protein	protein
,	O	O
are	O	O
induced	O	O
in	O	O
the	O	O
avian	cell_line	O
erythroblast	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
HD6	cell_line	cell_line
.	O	O
Avian	O	cell_type
cells	O	cell_type
express	O	O
three	O	O
heat	DNA	protein
shock	DNA	protein
transcription	DNA	protein
factor	DNA	protein
(	DNA	O
HSF	DNA	DNA
)	DNA	DNA
genes	DNA	DNA
corresponding	O	O
to	O	O
a	O	O
novel	protein	protein
factor	protein	protein
,	O	O
HSF3	protein	protein
,	O	O
and	O	O
homologs	O	O
of	O	O
mouse	O	O
and	O	O
human	O	O
HSF1	protein	protein
and	O	O
HSF2	protein	protein
.	O	O
Analysis	O	O
of	O	O
the	O	O
biochemical	O	O
and	O	O
cell	O	O
biological	O	O
properties	O	O
of	O	O
these	O	O
HSFs	protein	DNA
reveals	O	O
that	O	O
HSF3	protein	protein
has	O	O
properties	O	O
in	O	O
common	O	O
with	O	O
both	O	O
HSF1	protein	protein
and	O	O
HSF2	protein	protein
and	O	O
yet	O	O
has	O	O
features	O	O
which	O	O
are	O	O
distinct	O	O
from	O	O
both.	O	O
HSF3	protein	protein
is	O	O
constitutively	O	O
expressed	O	O
in	O	O
the	O	O
erythroblast	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
HD6	cell_line	cell_line
,	O	O
the	O	O
lymphoblast	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
MSB	cell_line	cell_line
,	O	O
and	O	O
embryo	cell_line	O
fibroblasts	cell_line	cell_type
,	O	O
and	O	O
yet	O	O
its	O	O
DNA-binding	O	O
activity	O	O
is	O	O
induced	O	O
only	O	O
upon	O	O
exposure	O	O
of	O	O
HD6	O	cell_type
cells	O	cell_type
to	O	O
heat	O	O
shock.	O	O
Acquisition	O	O
of	O	O
HSF3	protein	protein
DNA-binding	O	O
activity	O	O
in	O	O
HD6	cell_line	cell_line
cells	cell_line	cell_line
is	O	O
accompanied	O	O
by	O	O
oligomerization	O	O
from	O	O
a	O	O
non-DNA-binding	protein	cell_line
dimer	protein	cell_line
to	O	O
a	O	O
DNA-binding	protein	O
trimer	protein	O
,	O	O
whereas	O	O
the	O	O
effect	O	O
of	O	O
heat	O	O
shock	O	O
on	O	O
HSF1	protein	protein
is	O	O
oligomerization	O	O
of	O	O
an	O	O
inert	protein	O
monomer	protein	O
to	O	O
a	O	O
DNA-binding	protein	O
trimer	protein	O
.	O	O
Induction	O	O
of	O	O
HSF3	protein	protein
DNA-binding	O	O
activity	O	O
is	O	O
delayed	O	O
compared	O	O
with	O	O
that	O	O
of	O	O
HSF1	protein	protein
.	O	O
As	O	O
occurs	O	O
for	O	O
HSF1	protein	protein
,	O	O
heat	O	O
shock	O	O
leads	O	O
to	O	O
the	O	O
translocation	O	O
of	O	O
HSF3	protein	protein
to	O	O
the	O	O
nucleus.	O	O
HSF	O	protein
exhibits	O	O
the	O	O
properties	O	O
of	O	O
a	O	O
transcriptional	protein	protein
activator	protein	protein
,	O	O
as	O	O
judged	O	O
from	O	O
the	O	O
stimulatory	O	O
activity	O	O
of	O	O
transiently	protein	O
overexpressed	protein	O
HSF3	protein	protein
measured	O	O
by	O	O
using	O	O
a	O	O
heat	DNA	O
shock	DNA	O
element-containing	DNA	O
reporter	DNA	O
construct	DNA	O
and	O	O
as	O	O
independently	O	O
assayed	O	O
by	O	O
the	O	O
activity	O	O
of	O	O
a	O	O
chimeric	protein	O
GAL4	protein	protein
-HSF3	protein	protein
protein	protein	protein
on	O	O
a	O	O
GAL4	DNA	DNA
reporter	DNA	DNA
construct	DNA	DNA
.	O	O
These	O	O
results	O	O
reveal	O	O
that	O	O
HSF3	protein	protein
is	O	O
negatively	O	O
regulated	O	O
in	O	O
avian	cell_type	O
cells	cell_type	O
and	O	O
acquires	O	O
DNA-binding	O	O
activity	O	O
in	O	O
certain	O	O
cells	O	O
upon	O	O
heat	O	O
shock	O	O
.	O	O

Direct	O	O
demonstration	O	O
of	O	O
NFATp	protein	protein
dephosphorylation	O	O
and	O	O
nuclear	O	O
localization	O	O
in	O	O
activated	cell_line	cell_type
HT-2	cell_line	cell_type
cells	cell_line	cell_type
using	O	O
a	O	O
specific	O	O
NFATp	protein	protein
polyclonal	protein	protein
antibody	protein	protein
.	O	O
Nuclear	protein	protein
factor	protein	protein
of	protein	protein
activated	protein	protein
T	protein	protein
cells	protein	protein
(	O	O
NFAT	protein	protein
)	O	O
regulates	O	O
transcription	O	O
of	O	O
a	O	O
number	O	O
of	O	O
cytokine	protein	DNA
genes	protein	DNA
,	O	O
and	O	O
NFAT	protein	protein
DNA	O	O
binding	O	O
activity	O	O
is	O	O
stimulated	O	O
following	O	O
T	O	O
cell	O	O
activation	O	O
.	O	O
Several	O	O
lines	O	O
of	O	O
evidence	O	O
have	O	O
suggested	O	O
that	O	O
NFAT	protein	protein
is	O	O
a	O	O
substrate	O	O
for	O	O
calcineurin	protein	protein
,	O	O
a	O	O
serine/threonine	protein	O
phosphatase	protein	O
.	O	O
Using	O	O
a	O	O
polyclonal	O	O
antibody	O	O
to	O	O
murine	protein	O
NFATp	protein	protein
,	O	O
Western	O	O
blot	O	O
analysis	O	O
of	O	O
various	O	O
mouse	O	O
tissues	O	O
demonstrated	O	O
that	O	O
the	O	O
110-130-kDa	O	protein
NFATp	protein	protein
protein	protein	protein
was	O	O
highly	O	O
expressed	O	O
in	O	O
thymus	O	O
and	O	O
spleen	O	O
.	O	O
Treatment	O	O
of	O	O
immunoprecipitated	O	O
NFATp	protein	protein
from	O	O
untreated	O	cell_line
HT-2	cell_line	cell_line
cells	cell_line	cell_line
with	O	O
calcineurin	protein	protein
resulted	O	O
in	O	O
the	O	O
dephosphorylation	O	O
of	O	O
NFATp	protein	protein
,	O	O
demonstrating	O	O
that	O	O
NFATp	protein	protein
is	O	O
an	O	O
in	O	O
vitro	O	O
substrate	O	O
for	O	O
calcineurin	protein	protein
.	O	O
NFATp	protein	protein
immunoprecipitated	O	protein
from	O	O
32P-labeled	cell_line	cell_line
HT-2	cell_line	cell_line
cells	cell_line	cell_line
migrated	O	O
as	O	O
an	O	O
approximately	O	O
120-kDa	O	protein
protein	O	protein
that	O	O
was	O	O
localized	O	O
to	O	O
the	O	O
cytosol	O	O
of	O	O
the	O	O
cells.	O	O
Treatment	O	O
of	O	O
the	O	O
cells	O	O
with	O	O
ionomycin	O	O
resulted	O	O
in	O	O
a	O	O
decrease	O	O
in	O	O
the	O	O
molecular	O	O
weight	O	O
of	O	O
NFATp	protein	protein
and	O	O
a	O	O
loss	O	O
of	O	O
32P	O	protein
,	O	O
consistent	O	O
with	O	O
NFATp	protein	protein
dephosphorylation	O	O
.	O	O
The	O	O
dephosphorylation	O	O
of	O	O
NFATp	protein	protein
was	O	O
accompanied	O	O
by	O	O
localization	O	O
of	O	O
the	O	O
protein	O	O
to	O	O
the	O	O
nuclear	O	O
fraction	O	O
.	O	O
Both	O	O
of	O	O
these	O	O
events	O	O
were	O	O
blocked	O	O
by	O	O
preincubation	O	O
of	O	O
the	O	O
cells	O	O
with	O	O
FK506	O	O
,	O	O
a	O	O
calcineurin	protein	protein
inhibitor	O	protein
,	O	O
consistent	O	O
with	O	O
the	O	O
hypothesis	O	O
that	O	O
NFATp	protein	protein
is	O	O
a	O	O
calcineurin	protein	protein
substrate	O	protein
in	O	O
cells.	O	O

Activation	O	O
and	O	O
expression	O	O
of	O	O
the	O	O
nuclear	protein	protein
factors	protein	protein
of	O	O
activated	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
NFATp	protein	protein
and	O	O
NFATc	protein	protein
,	O	O
in	O	O
human	cell_type	cell_type
natural	cell_type	cell_type
killer	cell_type	cell_type
cells	cell_type	cell_type
:	O	O
regulation	O	O
upon	O	O
CD16	protein	protein
ligand	O	protein
binding	O	O
.	O	O
The	O	O
putative	O	protein
factors	O	protein
that	O	O
couple	O	O
the	O	O
signal	O	O
transduction	O	O
from	O	O
surface	O	O
receptors	O	O
to	O	O
the	O	O
activation	O	O
of	O	O
cytokine	protein	protein
synthesis	O	O
in	O	O
natural	cell_type	cell_type
killer	cell_type	cell_type
(NK)	cell_type	cell_type
cells	cell_type	cell_type
have	O	O
not	O	O
been	O	O
elucidated.	O	O
We	O	O
report	O	O
here	O	O
that	O	O
the	O	O
nuclear	protein	protein
factor	protein	protein
of	O	protein
activated	cell_type	protein
T	cell_type	protein
cells	cell_type	protein
(	O	O
NFATp	protein	protein
),	O	O
a	O	O
cyclosporin	protein	O
A	protein	O
(	protein	O
CsA	protein	O
)-sensitive	protein	O
factor	protein	O
that	O	O
regulates	O	O
the	O	O
transcription	O	O
of	O	O
several	O	O
cytokines	protein	protein
,	O	O
mediates	O	O
CD16	protein	protein
-induced	O	O
activation	O	O
of	O	O
cytokine	protein	DNA
genes	protein	DNA
in	O	O
human	cell_type	cell_type
NK	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
CD16	protein	protein
(	O	O
Fc	protein	protein
gamma	protein	protein
RIIIA	protein	protein
)-induced	O	O
expression	O	O
of	O	O
cytokine	RNA	RNA
mRNA	RNA	RNA
in	O	O
NK	cell_type	cell_type
cells	cell_type	cell_type
occurs	O	O
via	O	O
a	O	O
CsA	O	O
-sensitive	O	O
and	O	O
Ca(2+)-dependent	O	O
mechanism	O	O
.	O	O
Stimulation	O	O
of	O	O
NK	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
CD16	protein	protein
ligands	O	protein
induces	O	O
NFAT	protein	protein
-like	O	O
DNA	O	O
binding	O	O
activity	O	O
in	O	O
the	O	O
nuclear	O	O
extracts	O	O
from	O	O
these	O	O
cells,	O	O
as	O	O
detected	O	O
in	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assays	O	O
.	O	O
This	O	O
occurs	O	O
with	O	O
fast	O	O
kinetics	O	O
after	O	O
stimulation,	O	O
via	O	O
a	O	O
CsA	O	O
-sensitive	O	O
and	O	O
Ca(2+)-dependent	O	O
mechanism	O	O
that	O	O
does	O	O
not	O	O
require	O	O
de	O	O
novo	O	O
protein	O	O
synthesis.	O	O
NK	protein	O
cell	protein	O
NFAT	protein	protein
is	O	O
present	O	O
in	O	O
the	O	O
cytosol	O	O
of	O	O
nonstimulated	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
migrates	O	O
to	O	O
the	O	O
nucleus	O	O
upon	O	O
stimulation,	O	O
and	O	O
can	O	O
associate	O	O
with	O	O
AP-1	protein	protein
.	O	O
Two	O	O
distinct	O	O
molecules,	O	O
NFATp	protein	protein
and	O	O
NFATc	protein	protein
,	O	O
have	O	O
been	O	O
reported	O	O
to	O	O
mediate	O	O
NFAT	protein	protein
activity	O	O
.	O	O
The	O	O
results	O	O
of	O	O
supershift	O	O
assays	O	O
using	O	O
NFATp-	O	protein
and	O	O
NFATc-	O	protein
specific	O	protein
antibodies	O	protein
indicate	O	O
that	O	O
NK	O	O
cell	O	O
activation	O	O
early	O	O
after	O	O
CD16	protein	protein
ligand	O	protein
binding	O	O
involves	O	O
primarily,	O	O
if	O	O
not	O	O
exclusively,	O	O
NFATp	protein	protein
,	O	O
and	O	O
Western	O	O
blot	O	O
analysis	O	O
shows	O	O
that	O	O
this	O	O
has	O	O
the	O	O
same	O	O
electrophoretic	O	O
mobility	O	O
(approximately	O	O
120	O	O
kD)	O	O
as	O	O
that	O	O
of	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
NK	cell_type	cell_type
cells	cell_type	cell_type
do	O	O
not	O	O
express	O	O
NFATc	protein	protein
constitutively,	O	O
but	O	O
NFATc	RNA	RNA
mRNA	RNA	RNA
accumulation	O	O
is	O	O
induced	O	O
in	O	O
these	O	O
cells	O	O
within	O	O
2	O	O
h	O	O
of	O	O
stimulation	O	O
with	O	O
CD16	O	protein
ligands	O	O
.	O	O
However,	O	O
supershift	O	O
assays	O	O
using	O	O
the	O	O
available	O	O
mAb	protein	protein
recognizing	O	O
the	O	O
T	protein	O
cell	protein	O
NFATc	protein	protein
revealed	O	O
no	O	O
detectable	O	O
NFATc	protein	protein
protein	O	protein
in	O	O
nuclear	O	O
and	O	O
cytoplasmic	O	O
extracts	O	O
from	O	O
CD16-	O	O
or	O	O
phorbol	cell_line	O
ester	cell_line	O
-stimulated	cell_line	O
cells	cell_line	O
at	O	O
any	O	O
time	O	O
tested,	O	O
up	O	O
to	O	O
4	O	O
h.	O	O
These	O	O
results	O	O
provide	O	O
the	O	O
first	O	O
direct	O	O
evidence	O	O
that	O	O
both	O	O
CsA	protein	O
-sensitive	protein	O
transcription	protein	protein
factors	protein	protein
,	O	O
NFATp	protein	protein
and	O	O
NFATc	protein	protein
,	O	O
are	O	O
expressed	O	O
in	O	O
human	O	cell_type
NK	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
and	O	O
that	O	O
their	O	O
activation	O	O
and/or	O	O
expression	O	O
can	O	O
be	O	O
regulated	O	O
in	O	O
primary	O	cell_type
cells	O	cell_type
by	O	O
a	O	O
single	O	O
stimulus,	O	O
that,	O	O
in	O	O
the	O	O
case	O	O
of	O	O
CD16	O	protein
in	O	O
NK	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
results	O	O
in	O	O
early	O	O
activation	O	O
of	O	O
NFATp	protein	protein
and	O	O
subsequently	O	O
induced	O	O
expression	O	O
of	O	O
NFATc	RNA	RNA
mRNA	RNA	RNA
.	O	O

Interleukin	O	protein
2	O	protein
signaling	O	O
involves	O	O
the	O	O
phosphorylation	O	O
of	O	O
Stat	protein	protein
proteins	protein	protein
.	O	O
One	O	O
of	O	O
the	O	O
most	O	O
important	O	O
cytokines	protein	protein
involved	O	O
in	O	O
immune	O	O
response	O	O
regulation	O	O
is	O	O
interleukin	O	O
2	O	O
(IL-2),	O	O
a	O	O
potent	O	O
activator	O	O
of	O	O
the	O	O
proliferation	O	O
and	O	O
function	O	O
of	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
and	O	O
natural	cell_type	cell_type
killer	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
The	O	O
mechanisms	O	O
by	O	O
which	O	O
the	O	O
effects	O	O
of	O	O
IL-2	protein	protein
are	O	O
propagated	O	O
within	O	O
cells	O	O
are	O	O
not	O	O
understood.	O	O
While	O	O
the	O	O
binding	O	O
of	O	O
IL-2	protein	protein
to	O	O
its	O	O
receptor	O	O
was	O	O
recently	O	O
shown	O	O
to	O	O
lead	O	O
to	O	O
the	O	O
activation	O	O
of	O	O
two	O	O
kinases	protein	protein
,	O	O
Jak-1	protein	protein
and	O	O
Jak-3	protein	protein
,	O	O
subsequent	O	O
steps	O	O
in	O	O
the	O	O
signaling	O	O
pathway	O	O
to	O	O
the	O	O
nucleus	O	O
that	O	O
lead	O	O
to	O	O
the	O	O
activation	O	O
of	O	O
specific	O	O
genes	O	O
had	O	O
not	O	O
been	O	O
characterized.	O	O
Since	O	O
many	O	O
cytokines	protein	protein
that	O	O
activate	O	O
Jak	protein	protein
kinases	protein	protein
also	O	O
lead	O	O
to	O	O
the	O	O
tyrosine	O	O
phosphorylation	O	O
and	O	O
activation	O	O
of	O	O
members	O	O
of	O	O
the	O	O
Stat	protein	protein
family	protein	protein
of	O	O
transcription	protein	protein
factors	protein	protein
,	O	O
the	O	O
ability	O	O
of	O	O
IL-2	protein	protein
to	O	O
trigger	O	O
Stat	O	O
phosphorylation	O	O
was	O	O
examined.	O	O
Exposure	O	O
of	O	O
activated	O	cell_type
human	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
or	O	O
of	O	O
a	O	O
natural	cell_line	protein
killer	cell_line	protein
cell	cell_line	protein
line	cell_line	protein
(	O	O
NKL	cell_line	O
)	O	O
to	O	O
IL-2	protein	protein
leads	O	O
to	O	O
the	O	O
phosphorylation	O	O
of	O	O
Stat1	protein	protein
alpha	protein	protein
,	O	O
Stat1	protein	protein
beta	protein	protein
,	O	O
and	O	O
Stat3	protein	protein
,	O	O
as	O	O
well	O	O
as	O	O
of	O	O
two	O	O
Stat-related	protein	protein
proteins	protein	protein
,	O	O
p94	protein	O
and	O	O
p95	protein	protein
.	O	O
p94	protein	O
and	O	O
p95	protein	protein
share	O	O
homology	O	O
with	O	O
Stat1	protein	protein
at	O	O
the	O	O
phosphorylation	protein	O
site	protein	O
and	O	O
in	O	O
the	O	O
Src	protein	protein
homology	protein	protein
2	protein	protein
(SH2)	protein	protein
domain	protein	protein
,	O	O
but	O	O
otherwise	O	O
are	O	O
immunologically	O	O
distinct	O	O
from	O	O
Stat1	protein	protein
.	O	O
These	O	O
Stat	protein	protein
proteins	protein	protein
were	O	O
found	O	O
to	O	O
translocate	O	O
to	O	O
the	O	O
nucleus	O	O
and	O	O
to	O	O
bind	O	O
to	O	O
a	O	O
specific	DNA	DNA
DNA	DNA	DNA
sequence	DNA	DNA
.	O	O
These	O	O
findings	O	O
suggest	O	O
a	O	O
mechanism	O	O
by	O	O
which	O	O
IL-2	protein	protein
binding	O	O
to	O	O
its	O	O
receptor	O	O
may	O	O
activate	O	O
specific	DNA	O
genes	DNA	O
involved	O	O
in	O	O
immune	O	O
cell	O	O
function	O	O
.	O	O

Expression	O	O
of	O	O
c-fos	DNA	DNA
correlates	O	O
with	O	O
IFN-alpha	protein	protein
responsiveness	O	O
in	O	O
Philadelphia	O	O
chromosome	O	O
positive	O	O
chronic	O	O
myelogenous	O	O
leukemia	O	O
.	O	O
This	O	O
study	O	O
evaluates	O	O
(i)	O	O
constitutive	O	O
levels	O	O
of	O	O
oncogene	DNA	O
and	O	O
p53	RNA	protein
transcripts	RNA	protein
in	O	O
chronic	O	O
phase	O	O
CML	O	O
patients	O	O
and	O	O
(ii)	O	O
their	O	O
modulations	O	O
subsequent	O	O
to	O	O
in	O	O
vivo	O	O
therapy	O	O
with	O	O
rIFN-alpha	protein	protein
2c	protein	protein
.	O	O
Peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
(	O	O
pbmc	cell_type	O
)	O	O
and	O	O
bone	cell_type	cell_type
marrow	cell_type	cell_type
cells	cell_type	cell_type
of	O	O
26	O	O
patients	O	O
were	O	O
examined	O	O
for	O	O
c-fos	O	DNA
,	O	O
c-myc	O	DNA
,	O	O
p53	O	protein
and	O	O
the	O	O
hybrid	O	O
bcr/abl	O	O
mRNA	O	O
levels	O	O
.	O	O
Results	O	O
indicated	O	O
that	O	O
(i)	O	O
constitutive	O	O
c-fos	RNA	O
transcript	RNA	O
levels	O	O
are	O	O
significantly	O	O
higher	O	O
in	O	O
patients	O	O
subsequently	O	O
responding	O	O
to	O	O
IFN-alpha	protein	protein
therapy	O	O
(p	O	O
&lt;	O	O
0.01)	O	O
and	O	O
positively	O	O
correlated	O	O
with	O	O
the	O	O
proportion	O	O
of	O	O
lymphocytes	cell_type	cell_type
(r	O	O
=	O	O
0.6895,	O	O
p	O	O
&lt;	O	O
0.01)	O	O
and	O	O
negatively	O	O
with	O	O
the	O	O
proportion	O	O
of	O	O
immature	cell_type	cell_type
cells	cell_type	cell_type
(r	O	O
=	O	O
-0.568,	O	O
p	O	O
&lt;	O	O
0.01)	O	O
contained	O	O
in	O	O
the	O	O
pbmc	cell_type	O
preparations	O	O
tested,	O	O
(ii)	O	O
constitutive	RNA	O
mRNA	RNA	O
levels	O	O
of	O	O
the	O	O
hybrid	DNA	DNA
bcr/abl	DNA	DNA
,	O	O
c-myc	DNA	O
and	O	O
p53	DNA	protein
are	O	O
positively	O	O
correlated	O	O
with	O	O
each	O	O
other,	O	O
but	O	O
failed	O	O
to	O	O
relate	O	O
to	O	O
disease	O	O
parameters,	O	O
and	O	O
(iii)	O	O
acute	O	O
and	O	O
chronic	O	O
in	O	O
vivo	O	O
exposure	O	O
to	O	O
IFN-alpha	protein	protein
is	O	O
accompanied	O	O
by	O	O
upregulation	O	O
of	O	O
c-fos	DNA	DNA
and	O	O
downregulation	O	O
of	O	O
c-myc	RNA	RNA
mRNA	RNA	RNA
levels	O	O
in	O	O
responder	O	O
patients	O	O
.	O	O

Menopause	O	O
is	O	O
associated	O	O
with	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
blood	O	O
monocyte	O	O
number	O	O
and	O	O
a	O	O
relative	O	O
decrease	O	O
in	O	O
the	O	O
expression	O	O
of	O	O
estrogen	protein	protein
receptors	protein	protein
in	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
monocytes	cell_type	cell_type
.	O	O
PROBLEM:	O	O
The	O	O
clinical	O	O
significance	O	O
of	O	O
the	O	O
differential	O	O
expression	O	O
of	O	O
estrogen	protein	protein
receptor	protein	protein
(	O	O
ER	protein	protein
)	O	O
in	O	O
human	cell_type	cell_type
monocytes	cell_type	cell_type
was	O	O
evaluated.	O	O
METHOD:	O	O
Two	O	O
color	O	O
flow	O	O
cytometry	O	O
analysis	O	O
was	O	O
used	O	O
on	O	O
peripheral	O	O
blood	O	O
samples	O	O
of	O	O
young	O	O
and	O	O
postmenopausal	O	O
females	O	O
and	O	O
postmenopausal	O	O
females	O	O
treated	O	O
with	O	O
estrogen	O	O
replacement	O	O
therapy	O	O
.	O	O
In	O	O
addition,	O	O
the	O	O
monocyte	O	O
and	O	O
lymphocyte	O	O
counts	O	O
and	O	O
the	O	O
blood	O	O
estrogen	O	O
levels	O	O
of	O	O
each	O	O
patient	O	O
were	O	O
determine.	O	O
RESULTS:	O	O
During	O	O
menopause	O	O
there	O	O
is	O	O
a	O	O
significant	O	O
decrease	O	O
in	O	O
the	O	O
percentage	O	O
of	O	O
ER	cell_type	protein
positive	cell_type	protein
monocytes	cell_type	protein
,	O	O
and	O	O
an	O	O
increase	O	O
in	O	O
blood	cell_type	O
monocyte	cell_type	O
number	O	O
,	O	O
which	O	O
declines	O	O
following	O	O
estrogen	O	O
replacement	O	O
therapy	O	O
to	O	O
values	O	O
of	O	O
the	O	O
young.	O	O
CONCLUSIONS:	O	O
These	O	O
findings	O	O
suggest	O	O
that	O	O
estrogen	O	O
modulates	O	O
the	O	O
monocyte	cell_type	O
numbers	O	O
and	O	O
its	O	O
effects	O	O
may	O	O
be	O	O
mediated	O	O
through	O	O
the	O	O
ER	protein	protein
in	O	O
the	O	O
monocytes	cell_type	cell_type
.	O	O

Staphylococcal	protein	O
enterotoxins	protein	O
modulate	O	O
interleukin	protein	protein
2	protein	protein
receptor	protein	protein
expression	O	O
and	O	O
ligand-induced	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
the	O	O
Janus	protein	protein
protein-	protein	protein
tyrosine	protein	protein
kinase	protein	protein
3	protein	protein
(	O	O
Jak3	protein	protein
)	O	O
and	O	O
signal	protein	protein
transducers	protein	protein
and	protein	protein
activators	protein	protein
of	protein	protein
transcription	protein	protein
(	O	protein
Stat	protein	protein
proteins	protein	protein
).	O	O
Staphylococcal	protein	protein
enterotoxins	protein	protein
(	O	O
SE	protein	protein
)	O	O
stimulate	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
expressing	O	O
the	O	O
appropriate	O	O
variable	protein	O
region	protein	O
beta	protein	O
chain	protein	O
of	protein	O
(	protein	O
V	protein	protein
beta	protein	protein
)	protein	protein
T-cell	protein	protein
receptors	protein	protein
and	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
several	O	O
autoimmune	O	O
diseases	O	O
.	O	O
Depending	O	O
on	O	O
costimulatory	O	O
signals	O	O
,	O	O
SE	protein	O
induce	O	O
either	O	O
proliferation	O	O
or	O	O
anergy	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
addition,	O	O
SE	protein	protein
can	O	O
induce	O	O
an	O	O
interleukin-2	protein	protein
(	O	O
IL-2	protein	protein
)	O	O
nonresponsive	O	O
state	O	O
and	O	O
apoptosis	O	O
.	O	O
Here,	O	O
we	O	O
show	O	O
that	O	O
SE	protein	O
induce	O	O
dynamic	O	O
changes	O	O
in	O	O
the	O	O
expression	O	O
of	O	O
and	O	O
signal	O	O
transduction	O	O
through	O	O
the	O	O
IL-2	O	protein
receptor	O	protein
(IL-2R)	O	protein
beta	O	protein
and	O	O
gamma	O	protein
chains	O	protein
(	O	O
IL-2R	protein	protein
beta	protein	protein
and	O	O
IL-2R	protein	protein
gamma	protein	protein
)	O	O
in	O	O
human	cell_line	cell_line
antigen-specific	cell_line	cell_line
CD4+	cell_line	cell_line
T-cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
Thus,	O	O
after	O	O
4	O	O
hr	O	O
of	O	O
exposure	O	O
to	O	O
SEA	protein	protein
and	O	O
SEB	protein	protein
,	O	O
the	O	O
expression	O	O
of	O	O
IL-2R	protein	protein
beta	protein	protein
was	O	O
down-regulated,	O	O
IL-2R	protein	protein
gamma	protein	protein
was	O	O
slightly	O	O
up-regulated,	O	O
while	O	O
IL-2R	protein	protein
alpha	protein	protein
remained	O	O
largely	O	O
unaffected.	O	O
The	O	O
changes	O	O
in	O	O
the	O	O
composition	O	O
of	O	O
IL-2Rs	protein	protein
were	O	O
accompanied	O	O
by	O	O
inhibition	O	O
of	O	O
IL-2	protein	protein
-induced	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
the	O	O
Janus	protein	protein
protein-	protein	protein
tyrosine	protein	protein
kinase	protein	protein
3	protein	protein
(	O	O
Jak3	protein	protein
)	O	O
and	O	O
signal	protein	protein
transducers	protein	protein
and	protein	protein
activators	protein	protein
of	protein	O
transcription	protein	O
called	O	O
Stat3	protein	protein
and	O	O
Stat5	protein	protein
.	O	O
In	O	O
parallel	O	O
experiments,	O	O
IL-2	protein	protein
-driven	O	O
proliferation	O	O
was	O	O
inhibited	O	O
significantly.	O	O
After	O	O
16	O	O
hr	O	O
of	O	O
exposure	O	O
to	O	O
SE	protein	O
,	O	O
the	O	O
expression	O	O
of	O	O
IL-2R	protein	protein
beta	protein	protein
remained	O	O
low,	O	O
while	O	O
that	O	O
of	O	O
IL2R	protein	protein
alpha	protein	protein
and	O	O
IL2R	protein	protein
gamma	protein	protein
was	O	O
further	O	O
up-regulated,	O	O
and	O	O
ligand-induced	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
Jak3	protein	protein
and	O	O
Stat	protein	protein
proteins	protein	protein
was	O	O
partly	O	O
normalized.	O	O
Yet,	O	O
IL-2	protein	protein
-driven	O	O
proliferation	O	O
remained	O	O
profoundly	O	O
inhibited,	O	O
suggesting	O	O
that	O	O
signaling	O	O
events	O	O
other	O	O
than	O	O
Jak3	protein	protein
/Stat	protein	protein
activation	O	O
had	O	O
also	O	O
been	O	O
changed	O	O
following	O	O
SE	protein	O
stimulation	O	O
.	O	O
In	O	O
conclusion,	O	O
our	O	O
data	O	O
suggest	O	O
that	O	O
SE	protein	protein
can	O	O
modulate	O	O
IL-2R	protein	O
expression	O	O
and	O	O
signal	O	O
transduction	O	O
involving	O	O
the	O	O
Jak/Stat	protein	protein
pathway	O	O
in	O	O
CD4+	cell_line	cell_line
T-cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O

Constitutive	O	O
NF-kappa	protein	protein
B	protein	protein
activation	O	O
,	O	O
enhanced	O	O
granulopoiesis	O	O
,	O	O
and	O	O
neonatal	O	O
lethality	O	O
in	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
-deficient	O	O
mice	O	O
.	O	O
Transcription	protein	protein
factors	protein	protein
belonging	O	O
to	O	O
the	O	O
NF-kappa	protein	protein
B	protein	protein
family	protein	protein
are	O	O
controlled	O	O
by	O	O
inhibitory	protein	protein
I	protein	protein
kappa	protein	protein
B	protein	protein
proteins	protein	protein
,	O	O
mainly	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
and	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
beta	protein	protein
.	O	O
Apparently	O	O
normal	O	O
at	O	O
birth,	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
-/-	O	O
mice	O	O
exhibit	O	O
severe	O	O
runting,	O	O
skin	O	O
defects	O	O
,	O	O
and	O	O
extensive	O	O
granulopoiesis	O	O
postnatally,	O	O
typically	O	O
dying	O	O
by	O	O
8	O	O
days.	O	O
Hematopoietic	O	O
tissues	O	O
from	O	O
these	O	O
mice	O	O
display	O	O
elevated	O	O
levels	O	O
of	O	O
both	O	O
nuclear	protein	O
NF-kappa	protein	protein
B	protein	protein
and	O	O
mRNAs	RNA	O
of	O	O
some,	O	O
but	O	O
not	O	O
all,	O	O
genes	O	O
thought	O	O
to	O	O
be	O	O
regulated	O	O
by	O	O
NF-kappa	protein	protein
B	protein	protein
.	O	O
NF-kappa	protein	protein
B	protein	protein
elevation	O	O
results	O	O
in	O	O
these	O	O
phenotypic	O	O
abnormalities	O	O
because	O	O
mice	O	O
lacking	O	O
both	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
and	O	O
the	O	O
p50	protein	protein
subunit	protein	protein
of	O	O
NF-kappa	protein	protein
B	protein	protein
show	O	O
a	O	O
dramatically	O	O
delayed	O	O
onset	O	O
of	O	O
abnormalities	O	O
.	O	O
In	O	O
contrast	O	O
to	O	O
hematopoietic	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
I	cell_line	protein
kappa	cell_line	protein
B	cell_line	protein
alpha	cell_line	protein
-/-	cell_line	O
embryonic	cell_line	O
fibroblasts	cell_line	cell_type
show	O	O
minimal	O	O
constitutive	protein	O
NF-kappa	protein	protein
B	protein	protein
,	O	O
as	O	O
well	O	O
as	O	O
normal	O	O
signal-dependent	O	O
NF-kappa	protein	protein
B	protein	protein
activation	O	O
that	O	O
is	O	O
concomitant	O	O
with	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
beta	protein	protein
degradation	O	O
.	O	O
Our	O	O
results	O	O
indicate	O	O
that	O	O
I	O	protein
kappa	O	protein
b	O	O
beta,	O	O
but	O	O
not	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
,	O	O
is	O	O
required	O	O
for	O	O
the	O	O
signal-dependent	O	O
activation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
in	O	O
fibroblasts	cell_type	cell_type
.	O	O
However,	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
is	O	O
required	O	O
for	O	O
the	O	O
postinduction	O	O
repression	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
in	O	O
fibroblasts	cell_type	cell_type
.	O	O
These	O	O
results	O	O
define	O	O
distinct	O	O
roles	O	O
for	O	O
the	O	O
two	O	O
forms	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
and	O	O
demonstrate	O	O
the	O	O
necessity	O	O
for	O	O
stringent	O	O
control	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
.	O	O

Interleukin-7	protein	protein
can	O	O
induce	O	O
the	O	O
activation	O	O
of	O	O
Jak	protein	protein
1	protein	protein
,	O	O
Jak	protein	protein
3	protein	protein
and	O	O
STAT	protein	protein
5	protein	protein
proteins	protein	protein
in	O	O
murine	O	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
The	O	O
activation	O	O
of	O	O
Janus	protein	protein
protein	protein	protein
tyrosine	protein	protein
kinases	protein	protein
(	O	O
Jak	protein	protein
)	O	O
and	O	O
STAT	protein	protein
(	protein	O
signal	protein	protein
transducer	protein	protein
and	protein	protein
activator	protein	protein
of	protein	protein
transcription	protein	protein
)	protein	protein
proteins	protein	protein
has	O	O
recently	O	O
been	O	O
linked	O	O
to	O	O
the	O	O
signal	O	O
transduction	O	O
mechanism	O	O
of	O	O
several	O	O
cytokines	protein	protein
.	O	O
IL-7	protein	protein
was	O	O
observed	O	O
to	O	O
induce	O	O
a	O	O
rapid	O	O
and	O	O
dose-dependent	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
Jak	protein	protein
1	protein	protein
and	O	O
Jak	protein	protein
3	protein	protein
and	O	O
concomitantly,	O	O
the	O	O
tyrosine	O	O
phosphorylation	O	O
and	O	O
DNA	O	O
binding	O	O
activity	O	O
of	O	O
multiple	O	O
STAT	protein	protein
proteins	protein	protein
.	O	O
The	O	O
STAT	protein	protein
proteins	protein	protein
utilized	O	O
by	O	O
IL-7	protein	protein
were	O	O
identical	O	O
to	O	O
those	O	O
induced	O	O
by	O	O
IL-2	protein	protein
and	O	O
could	O	O
be	O	O
identified	O	O
as	O	O
various	O	O
STAT	protein	protein
5	protein	protein
isoforms	protein	protein
.	O	O
Moreover,	O	O
the	O	O
induction	O	O
of	O	O
both	O	O
Jak	O	protein
1	O	protein
and	O	O
3	O	O
,	O	O
and	O	O
STAT	protein	protein
5	protein	protein
activity	O	O
strongly	O	O
correlated	O	O
with	O	O
the	O	O
growth-promoting	O	O
effects	O	O
of	O	O
IL-7	protein	protein
,	O	O
suggesting	O	O
that	O	O
this	O	O
signal	O	O
transduction	O	O
mechanism	O	O
may	O	O
play	O	O
a	O	O
key	O	O
role	O	O
in	O	O
IL-7	protein	protein
-induced	O	O
proliferation	O	O
.	O	O

Cytokine	protein	protein
-modulating	O	O
activity	O	O
of	O	O
tepoxalin	O	O
,	O	O
a	O	O
new	O	O
potential	O	O
antirheumatic	O	O
.	O	O
Tepoxalin	O	O
is	O	O
a	O	O
new	O	O
dual	O	O
cyclooxygenase/5-lipoxygenase	O	protein
anti-inflammatory	O	protein
compound	O	protein
currently	O	O
under	O	O
clinical	O	O
investigation.	O	O
It	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
possess	O	O
anti-inflammatory	O	O
activity	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
animal	O	O
models	O	O
and	O	O
more	O	O
recently	O	O
to	O	O
inhibit	O	O
IL-2	protein	protein
induced	O	O
signal	O	O
transduction	O	O
.	O	O
The	O	O
current	O	O
study	O	O
was	O	O
conducted	O	O
to	O	O
evaluate	O	O
the	O	O
cytokine	protein	protein
modulating	O	O
activity	O	O
of	O	O
tepoxalin	O	O
and	O	O
the	O	O
role	O	O
of	O	O
iron	O	O
in	O	O
these	O	O
effects.	O	O
In	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
(	O	O
PBMC	cell_type	cell_type
)	O	O
stimulated	O	O
with	O	O
OKT3/PMA	O	protein
,	O	O
tepoxalin	O	O
inhibited	O	O
lymphocyte	cell_type	O
proliferation	O	O
with	O	O
an	O	O
IC50	O	O
of	O	O
6	O	O
microM.	O	O
Additionally,	O	O
it	O	O
inhibited	O	O
the	O	O
production	O	O
of	O	O
LTB4	protein	O
(IC50	O	O
=	O	O
0.5	O	O
microM)	O	O
and	O	O
the	O	O
cytokines	protein	protein
IL-2	protein	protein
,	O	O
IL-6	protein	protein
and	O	O
TNF	protein	protein
alpha	protein	protein
(IC50	O	O
=	O	O
10-12	O	O
microM).	O	O
Cytotoxicity	O	protein
was	O	O
not	O	O
demonstrated	O	O
at	O	O
these	O	O
concentrations.	O	O
Add-back	O	O
experiments	O	O
with	O	O
either	O	O
cytokines	protein	protein
(	O	O
IL-2	protein	protein
or	O	O
IL-6	protein	protein
),	O	O
LTB4	protein	O
or	O	O
conditioned	O	O
media	O	O
failed	O	O
to	O	O
restore	O	O
the	O	O
proliferative	O	O
response	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
tepoxalin	O	O
.	O	O
However,	O	O
the	O	O
concurrent	O	O
addition	O	O
of	O	O
iron	O	O
(in	O	O
the	O	O
form	O	O
of	O	O
ferrous	O	O
or	O	O
ferric	O	O
chloride	O	O
and	O	O
other	O	O
iron	O	O
salts	O	O
)	O	O
reversed	O	O
the	O	O
inhibition	O	O
of	O	O
proliferation	O	O
caused	O	O
by	O	O
tepoxalin	O	O
.	O	O
Tepoxalin	O	O
also	O	O
inhibits	O	O
the	O	O
activation	O	O
of	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
,	O	O
a	O	O
transcription	protein	protein
factor	protein	protein
which	O	O
acts	O	O
on	O	O
several	O	O
cytokine	DNA	DNA
genes	DNA	DNA
.	O	O
Tepoxalin	O	O
's	O	O
effect	O	O
on	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
is	O	O
also	O	O
reversed	O	O
by	O	O
the	O	O
addition	O	O
of	O	O
iron	O	O
salts	O	O
.	O	O
These	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
action	O	O
of	O	O
tepoxalin	O	O
to	O	O
inhibit	O	O
proliferation	O	O
in	O	O
PBMC	cell_type	cell_type
may	O	O
be	O	O
at	O	O
least	O	O
in	O	O
part	O	O
due	O	O
to	O	O
its	O	O
ability	O	O
to	O	O
reduce	O	O
the	O	O
amount	O	O
of	O	O
available	O	O
iron	O	O
resulting	O	O
in	O	O
decreased	O	O
activation	O	O
of	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
and	O	O
subsequent	O	O
inhibition	O	O
of	O	O
cytokine	protein	protein
production	O	O
.	O	O

N-	protein	O
and	protein	O
C-terminal	protein	O
sequences	protein	O
control	O	O
degradation	O	O
of	O	O
MAD3/	protein	protein
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
in	O	O
response	O	O
to	O	O
inducers	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
activity	O	O
.	O	O
The	O	O
proteolytic	O	O
degradation	O	O
of	O	O
the	O	O
inhibitory	protein	protein
protein	protein	protein
MAD3/	protein	protein
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
in	O	O
response	O	O
to	O	O
extracellular	O	O
stimulation	O	O
is	O	O
a	O	O
prerequisite	O	O
step	O	O
in	O	O
the	O	O
activation	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
NF-kappa	protein	protein
B	protein	protein
.	O	O
Analysis	O	O
of	O	O
the	O	O
expression	O	O
of	O	O
human	protein	protein
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
protein	protein	protein
in	O	O
stable	O	O
transfectants	O	O
of	O	O
mouse	cell_line	cell_line
70Z/3	cell_line	cell_line
cells	cell_line	cell_line
shows	O	O
that,	O	O
as	O	O
for	O	O
the	O	O
endogenous	O	protein
murine	O	protein
protein,	O	O
exogenous	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
is	O	O
degraded	O	O
in	O	O
response	O	O
to	O	O
inducers	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
activity	O	O
,	O	O
such	O	O
as	O	O
phorbol	O	O
myristate	O	O
acetate	O	O
or	O	O
lipopolysaccharide	O	O
.	O	O
In	O	O
addition,	O	O
pretreatment	O	O
of	O	O
the	O	O
cells	O	O
with	O	O
the	O	O
proteasome	protein	protein
inhibitor	O	O
N-Ac-Leu-Leu-norleucinal	O	O
inhibits	O	O
this	O	O
ligand-induced	O	O
degradation	O	O
and,	O	O
in	O	O
agreement	O	O
with	O	O
previous	O	O
studies,	O	O
stabilizes	O	O
a	O	O
hyperphosphorylated	O	O
form	O	O
of	O	O
the	O	O
human	protein	DNA
I	protein	DNA
kappa	protein	DNA
B	protein	DNA
alpha	protein	DNA
protein	protein	DNA
.	O	O
By	O	O
expressing	O	O
mutant	O	O
forms	O	O
of	O	O
the	O	O
human	O	protein
protein	O	protein
in	O	O
this	O	O
cell	cell_line	O
line	cell_line	O
,	O	O
we	O	O
have	O	O
been	O	O
able	O	O
to	O	O
delineate	O	O
the	O	O
sequences	O	O
responsible	O	O
for	O	O
both	O	O
the	O	O
ligand-induced	O	O
phosphorylation	O	O
and	O	O
the	O	O
degradation	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
.	O	O
Our	O	O
results	O	O
show	O	O
that	O	O
deletion	O	O
of	O	O
the	O	O
C	protein	protein
terminus	protein	protein
of	O	O
the	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
molecule	O	protein
up	O	O
to	O	O
amino	protein	O
acid	protein	O
279	protein	O
abolishes	O	O
constitutive	O	O
but	O	O
not	O	O
ligand-inducible	O	O
phosphorylation	O	O
and	O	O
inhibits	O	O
ligand-inducible	O	O
degradation	O	O
.	O	O
Further	O	O
analysis	O	O
reveals	O	O
that	O	O
the	O	O
inducible	O	O
phosphorylation	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
maps	O	O
to	O	O
two	O	O
serines	O	O
in	O	O
the	O	O
N	protein	protein
terminus	protein	protein
of	O	O
the	O	O
protein	O	O
(residues	O	O
32	O	O
and	O	O
36)	O	O
and	O	O
that	O	O
the	O	O
mutation	O	O
of	O	O
either	O	O
residue	O	O
is	O	O
sufficient	O	O
to	O	O
abolish	O	O
ligand-induced	O	O
degradation,	O	O
whereas	O	O
both	O	O
residues	O	O
must	O	O
be	O	O
mutated	O	O
to	O	O
abolish	O	O
inducible	O	O
phosphorylation	O	O
of	O	O
the	O	O
protein.	O	O
(ABSTRACT	O	O
TRUNCATED	O	O
AT	O	O
250	O	O
WORDS)	O	O

Microtubules	protein	O
mediate	O	O
cellular	O	O
25-hydroxyvitamin	O	O
D3	O	O
trafficking	O	O
and	O	O
the	O	O
genomic	O	O
response	O	O
to	O	O
1,25-dihydroxyvitamin	O	O
D3	O	O
in	O	O
normal	O	cell_type
human	cell_type	cell_type
monocytes	cell_type	cell_type
.	O	O
The	O	O
genomic	O	O
actions	O	O
of	O	O
1,25-dihydroxyvitamin	O	O
D3	O	O
(1,25(OH)2D3)	O	O
are	O	O
mediated	O	O
by	O	O
the	O	O
intracellular	O	O
vitamin	protein	protein
D	protein	protein
receptor	protein	protein
(	O	O
VDR	protein	protein
).	O	O
Although	O	O
immunocytochemistry	O	O
has	O	O
shown	O	O
that	O	O
disruption	O	O
of	O	O
microtubular	O	O
assembly	O	O
prevents	O	O
nuclear	O	O
access	O	O
of	O	O
the	O	O
sterol-	protein	protein
VDR	protein	protein
complex	protein	protein
,	O	O
the	O	O
role	O	O
of	O	O
microtubules	protein	O
in	O	O
the	O	O
response	O	O
to	O	O
1,25(OH)2D3	O	O
has	O	O
not	O	O
been	O	O
studied	O	O
in	O	O
viable	cell_type	O
cells	cell_type	O
.	O	O
Our	O	O
studies	O	O
examined	O	O
this	O	O
interaction	O	O
in	O	O
normal	O	cell_type
human	cell_type	cell_type
monocytes	cell_type	cell_type
.	O	O
Monocytes	O	cell_type
convert	O	O
25(OH)D3	O	O
to	O	O
1,25(OH)2D3	O	O
and	O	O
to	O	O
24-hydroxylated	O	O
metabolites	O	O
more	O	O
polar	O	O
than	O	O
1,25(OH)2D3	O	O
.	O	O
Microtubule	O	O
disruption	O	O
totally	O	O
abolished	O	O
the	O	O
ability	O	O
of	O	O
exogenous	O	O
1,25(OH)2D3	O	O
to	O	O
suppress	O	O
its	O	O
own	O	O
synthesis	O	O
and	O	O
to	O	O
induce	O	O
24-hydroxylase	RNA	protein
mRNA	RNA	O
and	O	O
activity,	O	O
without	O	O
affecting	O	O
either	O	O
total	O	O
1,25(OH)2D3	O	O
uptake	O	O
or	O	O
maximal	O	O
1,25(OH)2D3	O	O
-VDR	protein	protein
binding	O	protein
.	O	O
Thus,	O	O
intact	O	O
microtubules	protein	O
are	O	O
essential	O	O
for	O	O
1,25(OH)2D3	O	O
-dependent	O	O
modulation	O	O
of	O	O
gene	O	O
transcription	O	O
.	O	O
Interestingly,	O	O
microtubule	protein	O
disruption	O	O
also	O	O
decreased	O	O
monocyte	cell_type	O
1,25(OH)2D3	O	O
synthesis	O	O
,	O	O
not	O	O
by	O	O
decreasing	O	O
the	O	O
Vmax	O	O
of	O	O
monocyte	protein	protein
mitochondrial	protein	protein
1	protein	protein
alpha-hydroxylase	protein	protein
but	O	O
through	O	O
an	O	O
increase	O	O
in	O	O
the	O	O
Km	O	O
for	O	O
25(OH)2D3	O	O
.	O	O
We	O	O
examined	O	O
25(OH)D3	O	O
transport	O	O
.	O	O
Microtubule	O	O
disruption	O	O
did	O	O
not	O	O
affect	O	O
total	O	O
cellular	O	O
25(OH)D3	O	O
uptake	O	O
but	O	O
reduced	O	O
its	O	O
intracellular	O	O
trafficking	O	O
to	O	O
the	O	O
mitochondria	O	O
.	O	O
Thus,	O	O
microtubules	protein	O
participate	O	O
in	O	O
intracellular	O	O
25(OH)D3	O	O
transport	O	O
,	O	O
and	O	O
their	O	O
integrity	O	O
determines	O	O
normal	O	O
1,25(OH)2D3	O	O
synthesis	O	O
.	O	O

Relationship	O	O
between	O	O
Rap1	protein	protein
protein	protein	protein
phosphorylation	O	O
and	O	O
regulation	O	O
of	O	O
Ca2+	O	O
transport	O	O
in	O	O
platelets	cell_type	cell_type
:	O	O
a	O	O
new	O	O
approach.	O	O
Although	O	O
the	O	O
interrelationship	O	O
between	O	O
the	O	O
two	O	O
messengers	O	O
Ca2+	O	O
and	O	O
cyclic	O	O
AMP	O	O
in	O	O
platelet	O	O
function	O	O
is	O	O
well	O	O
documented,	O	O
its	O	O
mechanism	O	O
of	O	O
action	O	O
still	O	O
remains	O	O
to	O	O
be	O	O
established.	O	O
We	O	O
investigated	O	O
here	O	O
the	O	O
question	O	O
of	O	O
the	O	O
regulation	O	O
of	O	O
platelet	protein	O
Ca(2+)-ATPases	protein	protein
by	O	O
cyclic	O	O
AMP	O	O
through	O	O
the	O	O
phosphorylation	O	O
of	O	O
the	O	O
Rap1	protein	protein
protein	protein	protein
using	O	O
a	O	O
pathological	O	O
model	O	O
.	O	O
We	O	O
first	O	O
found	O	O
experimental	O	O
conditions	O	O
where	O	O
Ca(2+)-transport	O	O
by	O	O
platelet	O	O
membrane	O	O
vesicles	O	O
appeared	O	O
to	O	O
be	O	O
dependent	O	O
on	O	O
the	O	O
phosphorylation	O	O
of	O	O
the	O	O
Rap1	protein	protein
protein	protein	protein
.	O	O
Then,	O	O
we	O	O
studied	O	O
platelets	cell_type	cell_type
of	O	O
patients	O	O
with	O	O
congestive	O	O
heart	O	O
failure	O	O
for	O	O
their	O	O
expression	O	O
of	O	O
the	O	O
potential	O	O
97	protein	O
kDa	protein	O
Ca(2+)-ATPase	protein	protein
target	protein	O
of	O	O
regulation	O	O
through	O	O
the	O	O
Rap1	protein	protein
protein	protein	protein
as	O	O
well	O	O
as	O	O
the	O	O
phosphorylation	O	O
of	O	O
the	O	O
Rap1	protein	protein
protein	protein	protein
using	O	O
the	O	O
catalytic	protein	protein
subunit	protein	protein
of	O	O
the	O	O
cyclic	protein	protein
AMP	protein	protein
-dependent	protein	protein
protein	protein	protein
kinase	protein	protein
(	O	O
C.	protein	O
Sub.	protein	O
).	O	O
In	O	O
the	O	O
first	O	O
patients	O	O
studied,	O	O
we	O	O
found	O	O
no	O	O
significant	O	O
modification	O	O
in	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
97	protein	protein
kDa	protein	protein
Ca(2+)-ATPase	protein	protein
by	O	O
Western	O	O
blotting	O	O
using	O	O
the	O	O
PL/IM	protein	protein
430	protein	protein
monoclonal	protein	protein
antibody	protein	protein
which	O	O
specifically	O	O
recognized	O	O
this	O	O
isoform.	O	O
In	O	O
contrast,	O	O
the	O	O
Rap1	protein	protein
protein	protein	protein
was	O	O
differentially	O	O
phosphorylated	O	O
when	O	O
using	O	O
15	O	O
micrograms/ml	O	O
of	O	O
the	O	O
C.	protein	O
Sub.	protein	O
These	O	O
results	O	O
allowed	O	O
us	O	O
to	O	O
use	O	O
these	O	O
pathological	O	O
platelets	cell_type	O
to	O	O
study	O	O
the	O	O
relationship	O	O
between	O	O
the	O	O
expression	O	O
of	O	O
Rap1	protein	protein
protein	protein	protein
and	O	O
the	O	O
regulation	O	O
of	O	O
Ca2+	O	O
transport	O	O
by	O	O
selecting	O	O
a	O	O
patient	O	O
with	O	O
severe	O	O
heart	O	O
failure	O	O
.	O	O
We	O	O
could	O	O
show	O	O
a	O	O
decrease	O	O
in	O	O
the	O	O
expression	O	O
as	O	O
well	O	O
as	O	O
in	O	O
the	O	O
phosphorylation	O	O
of	O	O
Rap1	protein	protein
protein	protein	protein
and	O	O
demonstrate	O	O
a	O	O
lower	O	O
effect	O	O
of	O	O
C.	protein	O
Sub.	protein	O
on	O	O
Ca2+	O	O
transport	O	O
.	O	O
Finally,	O	O
by	O	O
studying	O	O
a	O	O
further	O	O
series	O	O
of	O	O
patients	O	O
,	O	O
we	O	O
could	O	O
confirm	O	O
that	O	O
the	O	O
decrease	O	O
in	O	O
Rap1	protein	protein
protein	protein	protein
expression	O	O
in	O	O
heart	O	O
failure,	O	O
whatever	O	O
its	O	O
extent,	O	O
was	O	O
variable,	O	O
and	O	O
could	O	O
strictly	O	O
correlate	O	O
the	O	O
expression	O	O
of	O	O
Rap1	protein	protein
protein	protein	protein
with	O	O
the	O	O
stimulatory	O	O
effect	O	O
of	O	O
C.	protein	O
Sub.	protein	O
on	O	O
Ca2+	O	O
transport	O	O
.	O	O
Besides	O	O
the	O	O
evidence	O	O
for	O	O
regulation	O	O
of	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
Rap1	protein	protein
protein	protein	protein
in	O	O
platelets	cell_type	cell_type
from	O	O
patients	O	O
with	O	O
heart	O	O
failure	O	O
,	O	O
these	O	O
findings	O	O
constitute	O	O
a	O	O
new	O	O
approach	O	O
in	O	O
favour	O	O
of	O	O
the	O	O
regulation	O	O
of	O	O
platelet	O	O
Ca2+	O	O
transport	O	O
through	O	O
the	O	O
phosphorylation	O	O
of	O	O
the	O	O
Rap1	protein	protein
protein	protein	protein
.	O	O

An	O	O
IRF-1	protein	protein
-dependent	O	O
pathway	O	O
of	O	O
DNA	O	O
damage-induced	O	O
apoptosis	O	O
in	O	O
mitogen-activated	cell_line	cell_type
T	cell_line	cell_type
lymphocytes	cell_line	cell_type
.	O	O
Lymphocytes	cell_line	cell_type
are	O	O
particularly	O	O
susceptible	O	O
to	O	O
DNA	O	O
damage-induced	O	O
apoptosis	O	O
,	O	O
a	O	O
response	O	O
which	O	O
may	O	O
serve	O	O
as	O	O
a	O	O
form	O	O
of	O	O
'	O	O
altruistic	O	O
suicide	O	O
'	O	O
to	O	O
counter	O	O
their	O	O
intrinsic	O	O
high	O	O
potential	O	O
for	O	O
mutation	O	O
and	O	O
clonal	O	O
expansion	O	O
.	O	O
The	O	O
tumour	protein	O
suppressor	protein	O
p53	protein	protein
has	O	O
been	O	O
shown	O	O
to	O	O
regulate	O	O
this	O	O
type	O	O
of	O	O
apoptosis	O	O
in	O	O
thymocytes	cell_type	cell_type
,	O	O
but	O	O
an	O	O
as	O	O
yet	O	O
unknown,	O	O
p53	protein	protein
-independent	O	O
pathway	O	O
(s)	O	O
appears	O	O
to	O	O
mediate	O	O
the	O	O
same	O	O
event	O	O
in	O	O
mitogen-activated	cell_line	cell_line
mature	cell_line	cell_line
T	cell_line	cell_line
lymphocytes	cell_line	cell_line
.	O	O
Here	O	O
we	O	O
show	O	O
DNA	O	O
damage-induced	O	O
apoptosis	O	O
in	O	O
these	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
is	O	O
dependent	O	O
on	O	O
the	O	O
antioncogenic	protein	O
transcription	protein	protein
factor	protein	protein
interferon	protein	protein
regulatory	protein	protein
factor	protein	protein
(IRF)-1	protein	protein
.	O	O
Thus	O	O
two	O	O
different	O	O
anti-onco-genic	protein	protein
transcription	protein	protein
factors	protein	protein
,	O	O
p53	protein	protein
and	O	O
IRF-1	protein	protein
,	O	O
are	O	O
required	O	O
for	O	O
distinct	O	O
apoptotic	O	O
pathways	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
We	O	O
also	O	O
show	O	O
that	O	O
mitogen	O	protein
induction	O	O
of	O	O
the	O	O
interleukin-1	DNA	protein
beta	DNA	protein
converting	DNA	protein
enzyme	DNA	protein
(	DNA	O
ICE	DNA	DNA
)	DNA	DNA
gene	DNA	DNA
,	O	O
a	O	O
mammalian	protein	DNA
homologue	protein	DNA
of	O	O
the	O	O
Caenorhabditis	DNA	O
elegans	DNA	O
cell	DNA	O
death	DNA	O
gene	DNA	O
ced-3	DNA	O
,	O	O
is	O	O
IRF-1	protein	protein
-dependent	O	O
.	O	O
Ectopic	O	O
overexpression	O	O
of	O	O
IRF-1	protein	protein
results	O	O
in	O	O
the	O	O
activation	O	O
of	O	O
the	O	O
endogenous	DNA	DNA
gene	DNA	DNA
for	O	O
ICE	protein	O
and	O	O
enhances	O	O
the	O	O
sensitivity	O	O
of	O	O
cells	O	O
to	O	O
radiation-induced	O	O
apoptosis	O	O
.	O	O

Circadian	O	O
rhythm	O	O
of	O	O
glucocorticoid	protein	protein
receptors	protein	protein
in	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
leukocytes	cell_type	cell_type
and	O	O
their	O	O
reactivity	O	O
to	O	O
glucocorticoids	O	O
.	O	O
1)	O	O
There	O	O
exists	O	O
a	O	O
CR	O	O
of	O	O
GR	protein	protein
in	O	O
human	cell_type	cell_type
leukocytes	cell_type	cell_type
,	O	O
PMN	cell_type	cell_type
,	O	O
and	O	O
monocytes	cell_type	cell_type
with	O	O
the	O	O
peak	O	O
values	O	O
from	O	O
0400	O	O
to	O	O
0800	O	O
hr	O	O
and	O	O
the	O	O
trough	O	O
values	O	O
between	O	O
2300	O	O
and	O	O
0000	O	O
hr.	O	O
The	O	O
difference	O	O
between	O	O
them	O	O
was	O	O
significant	O	O
statistically.	O	O
2)	O	O
The	O	O
FI	O	O
of	O	O
the	O	O
chemotactic	O	O
migration	O	O
rate	O	O
of	O	O
PMN	cell_type	cell_type
by	O	O
cortisol	O	O
also	O	O
showed	O	O
diurnal	O	O
changes	O	O
which	O	O
were	O	O
synchronous	O	O
with	O	O
that	O	O
of	O	O
GR	protein	protein
.	O	O
This	O	O
indicates	O	O
that	O	O
the	O	O
CR	O	O
of	O	O
GR	protein	protein
may	O	O
be	O	O
of	O	O
functional	O	O
significance.	O	O
3)	O	O
In	O	O
Cushing's	O	O
syndrome	O	O
,	O	O
the	O	O
CR	O	O
of	O	O
GR	protein	protein
was	O	O
normal	O	O
in	O	O
spite	O	O
of	O	O
the	O	O
fact	O	O
that	O	O
the	O	O
CR	O	O
of	O	O
plasma	O	O
cortisol	O	O
was	O	O
disturbed.	O	O
This	O	O
indicates	O	O
the	O	O
independency	O	O
of	O	O
the	O	O
CR	O	O
of	O	O
GR	protein	protein
from	O	O
that	O	O
of	O	O
cortisol	O	O
.	O	O
4)	O	O
In	O	O
apoplexy	O	O
caused	O	O
by	O	O
brain	O	O
ischemia	O	O
,	O	O
the	O	O
CR	O	O
of	O	O
GR	protein	protein
was	O	O
abolished	O	O
in	O	O
patients	O	O
with	O	O
basal	O	O
lesions	O	O
but	O	O
preserved	O	O
when	O	O
the	O	O
lesions	O	O
were	O	O
located	O	O
in	O	O
the	O	O
cerebral	O	O
cortex	O	O
.	O	O
These	O	O
results	O	O
strongly	O	O
suggest	O	O
that	O	O
the	O	O
main	O	O
"	O	O
circadian	O	O
pacemaker	O	O
"	O	O
of	O	O
GR	protein	protein
is	O	O
located	O	O
in	O	O
the	O	O
basal	O	O
brain	O	O
,	O	O
most	O	O
probably	O	O
in	O	O
the	O	O
suprachiasmatic	O	O
nuclei	O	O
as	O	O
has	O	O
been	O	O
suggested	O	O
for	O	O
rodents	O	O
.	O	O

B-lymphoblastoid	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
from	O	O
multiple	O	O
sclerosis	O	O
patients	O	O
and	O	O
a	O	O
healthy	O	O
control	O	O
producing	O	O
a	O	O
putative	O	O
new	O	O
human	O	O
retrovirus	O	O
and	O	O
Epstein-Barr	O	O
virus	O	O
.	O	O
On	O	O
several	O	O
occasions	O	O
we	O	O
have	O	O
observed	O	O
retrovirus-like	O	O
particles	O	O
(	O	O
RVLPs	O	protein
)	O	O
by	O	O
transmission	O	O
electron	O	O
microscopy	O	O
(	O	O
EM	O	O
)	O	O
of	O	O
cultured	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
from	O	O
a	O	O
patient	O	O
with	O	O
MS	O	O
.	O	O
Later	O	O
we	O	O
established	O	O
spontaneously	O	O
formed	O	O
B-lymphoblastoid	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
(	O	O
LCLs	cell_line	cell_line
)	O	O
from	O	O
a	O	O
patient	O	O
with	O	O
an	O	O
MS	O	O
-like	O	O
disease	O	O
and	O	O
from	O	O
another	O	O
patient	O	O
with	O	O
MS	O	O
who	O	O
had	O	O
a	O	O
reactivated	O	O
Epstein-Barr	O	O
virus	O	O
(EBV)	O	O
infection	O	O
.	O	O
Both	O	O
LCLs	cell_line	cell_line
were	O	O
found	O	O
by	O	O
EM	O	O
to	O	O
produce	O	O
RVLP	O	O
and	O	O
EBV	O	O
particles	O	O
.	O	O
Reverse	O	O
transcriptase	O	O
(RT)	O	O
assays	O	O
were	O	O
positive	O	O
in	O	O
purified	O	O
viral	O	O
material	O	O
from	O	O
both	O	O
LCLs	cell_line	cell_line
.	O	O
To	O	O
substantiate	O	O
these	O	O
findings	O	O
we	O	O
initiated	O	O
an	O	O
intensified	O	O
culturing	O	O
procedure	O	O
and	O	O
were	O	O
able	O	O
to	O	O
establish	O	O
LCLs	cell_line	O
from	O	O
5	O	O
out	O	O
of	O	O
21	O	O
consecutive	O	O
MS	O	O
patients	O	O
and	O	O
1	O	O
out	O	O
of	O	O
13	O	O
consecutive	O	O
healthy	O	O
controls	O	O
.	O	O
All	O	O
LCLs	cell_line	cell_line
were	O	O
found	O	O
to	O	O
produce	O	O
both	O	O
RVLP	O	O
and	O	O
EBV	O	O
particles	O	O
by	O	O
EM	O	O
.	O	O
Whether	O	O
the	O	O
putative	O	O
new	O	O
retrovirus	O	O
(es)	O	O
and	O	O
EBV	O	O
have	O	O
any	O	O
causal	O	O
relationship	O	O
to	O	O
MS	O	O
is	O	O
still	O	O
not	O	O
known,	O	O
but	O	O
the	O	O
findings	O	O
support	O	O
this	O	O
possibility.	O	O

Identification	O	O
of	O	O
an	O	O
ionomycin	DNA	O
/cyclosporin	DNA	O
A	DNA	O
-responsive	DNA	DNA
element	DNA	DNA
within	O	O
the	O	O
human	DNA	cell_line
T	DNA	cell_line
cell	DNA	cell_line
receptor	DNA	cell_line
gamma	DNA	cell_line
enhancer	DNA	cell_line
.	O	O
Activation	O	O
through	O	O
the	O	O
Ca2+	O	O
/	O	O
calcineurin	protein	protein
pathway	O	O
is	O	O
essential	O	O
to	O	O
the	O	O
transcription	O	O
of	O	O
many	O	O
cytokine	DNA	DNA
genes	DNA	DNA
.	O	O
The	O	O
conserved	DNA	O
cis-acting	DNA	DNA
sequence	DNA	DNA
,	O	O
GGAAAA	O	O
,	O	O
and	O	O
transcription	protein	protein
factors	protein	protein
binding	O	O
to	O	O
this	O	O
sequence	O	O
are	O	O
involved	O	O
in	O	O
the	O	O
response	O	O
to	O	O
increased	O	O
intracellular	O	O
Ca2+	O	O
concentrations	O	O
.	O	O
Here	O	O
we	O	O
report	O	O
the	O	O
identification	O	O
and	O	O
importance	O	O
of	O	O
the	O	O
same	O	O
sequence	O	O
in	O	O
a	O	O
non-cytokine	DNA	DNA
gene	DNA	DNA
,	O	O
the	O	O
human	DNA	cell_line
T	DNA	cell_line
cell	DNA	cell_line
receptor	DNA	cell_line
gamma	DNA	cell_line
(	DNA	cell_line
TCRG	DNA	cell_line
)	DNA	O
enhancer	DNA	O
.	O	O
Results	O	O
from	O	O
site-directed	O	O
mutations	O	O
and	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assays	O	O
strongly	O	O
suggest	O	O
that	O	O
this	O	O
sequence	O	O
mediates	O	O
the	O	O
ionomycin	O	O
-induced	O	O
activation	O	O
of	O	O
the	O	O
TCRG	DNA	DNA
enhancer	DNA	DNA
.	O	O
Our	O	O
studies	O	O
provide	O	O
an	O	O
explanation	O	O
for	O	O
a	O	O
previous	O	O
observation	O	O
that	O	O
TCRG	RNA	RNA
mRNA	RNA	RNA
levels	O	O
,	O	O
but	O	O
not	O	O
mRNA	O	O
levels	O	O
for	O	O
T	O	protein
cell	O	protein
receptor	O	protein
alpha	O	protein
and	O	O
-beta	O	O
,	O	O
are	O	O
increased	O	O
by	O	O
ionomycin	O	O
treatment	O	O
.	O	O

Coexpression	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
/Rel	protein	protein
and	O	O
Sp1	protein	protein
transcription	protein	protein
factors	protein	protein
in	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
1	O	O
-induced,	O	O
dendritic	O	O
cell-T-cell	O	O
syncytia	O	O
.	O	O
Productive	O	O
infection	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
1	O	O
(	O	O
HIV-1	O	O
)	O	O
typically	O	O
requires	O	O
that	O	O
the	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
be	O	O
stimulated	O	O
with	O	O
antigens	O	O
or	O	O
mitogens	O	O
.	O	O
This	O	O
requirement	O	O
has	O	O
been	O	O
attributed	O	O
to	O	O
the	O	O
activation	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
NF-kappa	protein	protein
B	protein	protein
,	O	O
which	O	O
synergizes	O	O
with	O	O
the	O	O
constitutive	protein	O
transcription	protein	O
factor	protein	O
Sp1	protein	O
to	O	O
drive	O	O
the	O	O
HIV-1	DNA	DNA
promoter	DNA	DNA
.	O	O
Recently,	O	O
we	O	O
have	O	O
found	O	O
that	O	O
vigorous	O	O
replication	O	O
of	O	O
HIV-1	O	O
takes	O	O
place	O	O
in	O	O
nonactivated	O	O
memory	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
after	O	O
syncytium	O	O
formation	O	O
with	O	O
dendritic	cell_type	cell_type
cells	cell_type	cell_type
(	O	O
DCs	cell_type	cell_type
).	O	O
These	O	O
syncytia	O	O
lack	O	O
activated	cell_type	O
cells	cell_type	O
as	O	O
determined	O	O
by	O	O
an	O	O
absence	O	O
of	O	O
staining	O	O
for	O	O
Ki-67	O	O
cell	O	O
cycle	O	O
antigen.	O	O
The	O	O
expression	O	O
and	O	O
activity	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
and	O	O
Sp1	protein	protein
were,	O	O
therefore,	O	O
analyzed	O	O
in	O	O
isolated	O	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
DCs	cell_type	cell_type
from	O	O
humans	O	O
and	O	O
mice	O	O
.	O	O
We	O	O
have	O	O
used	O	O
immunolabeling	O	O
,	O	O
Western	O	O
blot	O	O
analysis	O	O
,	O	O
and	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
and	O	O
supershift	O	O
assays	O	O
.	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
lack	O	O
active	O	O
NF-kappa	protein	protein
B	protein	protein
but	O	O
express	O	O
Sp1	protein	protein
as	O	O
expected.	O	O
DCs	cell_type	O
express	O	O
high	O	O
levels	O	O
of	O	O
all	O	O
known	O	O
NF-kappa	protein	protein
B	protein	protein
and	O	O
Rel	protein	protein
proteins	protein	protein
,	O	O
with	O	O
activity	O	O
residing	O	O
primarily	O	O
within	O	O
RelB	protein	protein
,	O	O
p50	protein	protein
,	O	O
and	O	O
p65	protein	protein
.	O	O
However,	O	O
DCs	cell_type	cell_type
lack	O	cell_type
Sp1	protein	cell_type
,	O	O
which	O	O
may	O	O
explain	O	O
the	O	O
failure	O	O
of	O	O
HIV-1	O	O
to	O	O
replicate	O	O
in	O	O
purified	O	O
DCs	cell_type	cell_type
.	O	O
Coexpression	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
and	O	O
Sp1	protein	protein
occurs	O	O
in	O	O
the	O	O
heterologous	cell_type	O
DC-T-cell	cell_type	O
syncytia	cell_type	O
that	O	O
are	O	O
induced	O	O
by	O	O
HIV-1	O	O
.	O	O
Therefore,	O	O
HIV-1	O	O
-induced	O	O
cell	O	O
fusion	O	O
brings	O	O
together	O	O
factors	O	O
that	O	O
upregulate	O	O
virus	O	O
transcription	O	O
.	O	O
Since	O	O
DCs	cell_type	O
and	O	O
memory	O	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
frequently	O	O
traffic	O	O
together	O	O
in	O	O
situ,	O	O
these	O	O
unusual	O	O
heterologous	cell_type	O
syncytia	cell_type	O
could	O	O
develop	O	O
in	O	O
infected	O	O
individuals	O	O
and	O	O
lead	O	O
to	O	O
chronic	O	O
HIV-1	O	O
replication	O	O
without	O	O
ostensible	O	O
immune	O	O
stimulation	O	O
.	O	O

Cupric	O	O
ion	O	O
blocks	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
activation	O	O
through	O	O
inhibiting	O	O
the	O	O
signal-induced	O	O
phosphorylation	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
.	O	O
A	O	O
transcription	protein	protein
factor	protein	protein
NF	protein	protein
kappa	protein	protein
B	protein	protein
,	O	O
which	O	O
regulates	O	O
expression	O	O
of	O	O
various	O	O
cellular	O	O
genes	O	O
involved	O	O
in	O	O
immune	O	O
responses	O	O
and	O	O
viral	DNA	O
genes	DNA	O
including	O	O
HIV	O	O
,	O	O
is	O	O
sequestered	O	O
in	O	O
the	O	O
cytoplasm	O	O
as	O	O
a	O	O
complex	O	O
with	O	O
an	O	O
inhibitory	protein	protein
protein	protein	protein
I	protein	protein
kappa	protein	protein
B	protein	protein
.	O	O
Various	O	O
extracellular	O	O
signals	O	O
induce	O	O
phosphorylation	O	O
and	O	O
rapid	O	O
degradation	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
to	O	O
release	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
.	O	O
Cu2+	O	O
was	O	O
found	O	O
to	O	O
inhibit	O	O
the	O	O
activation	O	O
of	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
induced	O	O
by	O	O
TNF-alpha	protein	protein
,	O	O
TPA	O	O
,	O	O
or	O	O
H2O2	O	O
.	O	O
Deoxycholate	O	O
treatment	O	O
of	O	O
the	O	O
cytoplasmic	O	O
extract	O	O
prepared	O	O
from	O	O
cells	O	O
stimulated	O	O
by	O	O
TNF-alpha	protein	protein
in	O	O
the	O	O
presence	O	O
of	O	O
Cu2+	O	O
resulted	O	O
in	O	O
the	O	O
release	O	O
of	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
from	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
,	O	O
indicating	O	O
that	O	O
Cu2+	O	O
interferes	O	O
with	O	O
the	O	O
dissociation	O	O
of	O	O
the	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
-I	protein	protein
kappa	protein	protein
B	protein	protein
complex	protein	protein
.	O	O
Neither	O	O
phosphorylation	O	O
nor	O	O
degradation	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
was	O	O
observed	O	O
upon	O	O
TNF-alpha	protein	protein
stimulation	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
Cu2+	O	protein
.	O	O
These	O	O
results	O	O
indicate	O	O
that	O	O
Cu2+	O	O
inhibits	O	O
the	O	O
release	O	O
of	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
by	O	O
blockade	O	O
of	O	O
a	O	O
signal	O	O
leading	O	O
to	O	O
the	O	O
phosphorylation	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
.	O	O

Cloning	O	O
a	O	O
cDNA	DNA	O
from	O	O
human	O	cell_type
NK/	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
which	O	O
codes	O	O
for	O	O
a	O	O
protein	O	O
with	O	O
high	O	O
proline	O	O
content	O	O
.	O	O
A	O	O
cDNA	DNA	DNA
clone	DNA	DNA
,	O	O
B4-2	DNA	protein
,	O	O
was	O	O
isolated	O	O
from	O	O
a	O	O
natural	DNA	O
killer	DNA	O
(NK)	DNA	O
minus	DNA	O
T	DNA	O
cell	DNA	O
subtractive	DNA	O
library	DNA	O
.	O	O
The	O	O
B4-2	DNA	DNA
clone	O	DNA
coded	O	O
for	O	O
an	O	O
mRNA	RNA	O
of	O	O
2061	O	O
bp	O	O
in	O	O
length.	O	O
It	O	O
encodes	O	O
a	O	O
deduced	O	O
327	protein	O
aa	protein	O
protein	protein	O
with	O	O
a	O	O
calculated	O	O
molecular	O	O
mass	O	O
of	O	O
35.2	O	O
kDa.	O	O
Searching	O	O
of	O	O
B4-2	DNA	DNA
DNA	DNA	DNA
and	O	O
protein	O	O
sequences	O	O
against	O	O
various	O	O
databases	O	O
revealed	O	O
no	O	O
high	O	O
homology	O	O
to	O	O
other	O	O
sequences.	O	O
However,	O	O
B4-2	DNA	protein
has	O	O
an	O	O
unusually	O	O
high	O	O
proline	O	O
content	O	O
(13%),	O	O
contains	O	O
a	O	O
putative	O	O
nuclear	protein	O
targeting	protein	O
sequence	protein	O
,	O	O
and	O	O
has	O	O
several	O	O
SPXX	protein	protein
motifs	protein	protein
which	O	O
are	O	O
frequently	O	O
found	O	O
in	O	O
gene	protein	O
regulatory	protein	O
proteins	protein	O
.	O	O
One	O	O
of	O	O
the	O	O
stretches	O	O
of	O	O
prolines	O	O
in	O	O
B4-2	DNA	cell_line
closely	O	cell_line
resembles	O	O
the	O	O
ligand	O	O
for	O	O
proteins	O	O
with	O	O
SH3	protein	protein
domains	protein	protein
.	O	O
Northern	O	O
hybridization	O	O
data	O	O
showed	O	O
that	O	O
B4-2	DNA	protein
is	O	O
not	O	O
a	O	O
lymphoid	DNA	O
specific	DNA	O
gene	DNA	O
and	O	O
is	O	O
expressed	O	O
in	O	O
a	O	O
hepatoma	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
and	O	O
also	O	O
weakly	O	O
transcribed	O	O
or	O	O
absent	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
other	O	O
cells.	O	O
A	O	O
polyclonal	O	O
antiserum	O	O
raised	O	O
against	O	O
recombinant	protein	protein
B4-2	protein	protein
recognizes	O	O
a	O	O
32-34	protein	protein
kDa	protein	protein
protein	protein	protein
in	O	O
lymphocytes	cell_type	cell_type
.	O	O

Activation	O	O
of	O	O
JAK3	protein	protein
,	O	O
but	O	O
not	O	O
JAK1	protein	protein
,	O	O
is	O	O
critical	O	O
for	O	O
IL-2	protein	protein
-induced	O	O
proliferation	O	O
and	O	O
STAT5	protein	protein
recruitment	O	O
by	O	O
a	O	O
COOH-terminal	protein	protein
region	protein	protein
of	O	O
the	O	O
IL-2	protein	protein
receptor	protein	protein
beta-chain	protein	protein
.	O	O
A	O	O
number	O	O
of	O	O
cytokines	protein	protein
and	O	O
growth	protein	protein
factors	protein	protein
use	O	O
the	O	O
JAK	protein	protein
-STAT	protein	protein
pathway	O	O
to	O	O
signal	O	O
from	O	O
the	O	O
cell	O	O
membrane	O	O
to	O	O
the	O	O
nucleus	O	O
.	O	O
While	O	O
homodimerizing	protein	protein
cytokine	protein	protein
receptors	protein	protein
may	O	O
transmit	O	O
signal	O	O
via	O	O
a	O	O
single	O	O
form	O	O
of	O	O
JAK	protein	protein
(i.e.	O	protein
growth	protein	protein
hormone	protein	protein
receptors	protein	protein
),	O	O
several	O	O
multicomponent	protein	protein
cytokine	protein	protein
receptors	protein	protein
have	O	O
been	O	O
shown	O	O
to	O	O
require	O	O
simultaneous	O	O
activation	O	O
of	O	O
pairs	O	O
of	O	O
different	O	O
JAK	protein	protein
kinases	protein	protein
(i.e.	O	protein
interferon	protein	protein
receptors	protein	protein
).	O	O
Recent	O	O
evidence	O	O
for	O	O
a	O	O
preferential	O	O
coupling	O	O
of	O	O
JAK3	protein	protein
to	O	O
interleukin-2	protein	protein
receptor-gamma	protein	protein
(	O	O
IL-2R	protein	protein
gamma	protein	protein
)	O	O
and	O	O
JAK1	protein	protein
to	O	O
IL-2R	protein	protein
beta	protein	protein
supports	O	O
the	O	O
concept	O	O
of	O	O
heterotrans-activation	O	O
of	O	O
JAK1	protein	protein
and	O	O
JAK3	protein	protein
caused	O	O
by	O	O
IL-2	protein	protein
-induced	O	O
heterodimerization	O	O
of	O	O
their	O	O
receptor	O	O
partners	O	O
.	O	O
The	O	O
present	O	O
study	O	O
verified	O	O
the	O	O
ability	O	O
of	O	O
IL-2	protein	protein
to	O	O
cause	O	O
tyrosine	O	O
phosphorylation	O	O
and	O	O
activation	O	O
of	O	O
JAK1	protein	protein
and	O	O
JAK3	protein	protein
,	O	O
but	O	O
demonstrated	O	O
that	O	O
IL-2	protein	protein
stimulated	O	O
JAK3	protein	protein
to	O	O
a	O	O
significantly	O	O
larger	O	O
extent	O	O
than	O	O
JAK1	protein	protein
in	O	O
human	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
and	O	O
the	O	O
YT	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
This	O	O
conclusion	O	O
was	O	O
based	O	O
upon	O	O
several	O	O
independent	O	O
criteria,	O	O
including	O	O
more	O	O
vigorous	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
JAK3	protein	protein
,	O	O
more	O	O
marked	O	O
enzymatic	O	O
activation	O	O
of	O	O
JAK3	protein	protein
as	O	O
well	O	O
as	O	O
higher	O	O
abundance	O	O
of	O	O
JAK3	protein	protein
in	O	O
activated	O	O
IL-2	protein	protein
receptor	protein	protein
complexes	protein	protein
.	O	O
Furthermore,	O	O
when	O	O
human	protein	O
IL-2R	protein	protein
beta	protein	protein
was	O	O
stably	O	O
expressed	O	O
in	O	O
murine	cell_line	cell_type
BA/F3	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
robust	O	O
IL-2	protein	protein
-induced	O	O
proliferation	O	O
and	O	O
JAK3	protein	protein
activation	O	O
occurred	O	O
without	O	O
detectable	O	O
involvement	O	O
of	O	O
either	O	O
JAK1	protein	protein
,	O	O
JAK2	protein	protein
or	O	O
TYK2	protein	protein
.	O	O
We	O	O
therefore	O	O
propose	O	O
that	O	O
IL-2	protein	protein
receptor	protein	protein
signal	O	O
transduction	O	O
does	O	O
not	O	O
depend	O	O
on	O	O
equimolar	O	O
heterodimerization	O	O
of	O	O
JAK1	protein	protein
and	O	O
JAK3	protein	protein
following	O	O
IL-2	protein	protein
-induced	O	O
heterodimerization	O	O
of	O	O
IL-2R	protein	protein
beta	protein	protein
and	O	O
IL-2R	protein	protein
gamma	protein	protein
.	O	O
Nonetheless,	O	O
a	O	O
membrane-proximal	protein	protein
region	protein	protein
of	O	O
human	O	DNA
IL-2R	protein	DNA
beta	protein	DNA
(	O	DNA
Asn240-Leu335	protein	DNA
)	O	O
was	O	O
critical	O	O
for	O	O
JAK3	protein	protein
activation,	O	O
and	O	O
the	O	O
amount	O	O
of	O	O
JAK3	protein	protein
present	O	O
in	O	O
activated	O	O
IL-2	protein	protein
receptor	protein	protein
complexes	protein	protein
increased	O	O
with	O	O
time,	O	O
suggesting	O	O
that	O	O
stabilization	O	O
of	O	O
JAK3	protein	protein
binding	O	O
to	O	O
the	O	O
receptor	protein	protein
complex	protein	protein
relies	O	O
on	O	O
both	O	O
IL-2R	protein	protein
beta	protein	protein
and	O	O
IL-2R	protein	protein
gamma	protein	protein
.	O	O
Moreover,	O	O
STAT5	protein	protein
was	O	O
found	O	O
to	O	O
be	O	O
the	O	O
predominant	O	O
STAT	protein	protein
transcription	protein	protein
factor	protein	protein
used	O	O
by	O	O
IL-2	protein	protein
in	O	O
human	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
and	O	O
specifically	O	O
required	O	O
a	O	O
COOH-terminal	protein	protein
region	protein	protein
of	O	O
IL-2R	protein	protein
beta	protein	protein
(	O	O
Ser386-Val525	protein	O
),	O	O
while	O	O
STAT5	protein	protein
recruitment	O	O
was	O	O
not	O	O
correlated	O	O
to	O	O
activation	O	O
of	O	O
IL-2R	protein	protein
gamma	protein	protein
or	O	O
JAK3	protein	protein
.	O	O

Up-regulation	O	O
of	O	O
high-affinity	O	O
dehydroepiandrosterone	O	O
binding	O	O
activity	O	O
by	O	O
dehydroepiandrosterone	O	O
in	O	O
activated	O	cell_type
human	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
Although	O	O
evidence	O	O
indicates	O	O
that	O	O
dehydroepiandrosterone	O	O
(	O	O
DHEA	O	O
)	O	O
exerts	O	O
direct	O	O
physiological	O	O
effects	O	O
,	O	O
its	O	O
mechanism	O	O
of	O	O
action	O	O
remains	O	O
unknown.	O	O
DHEA	O	O
binding	O	O
sites	O	O
were	O	O
examined	O	O
using	O	O
a	O	O
whole-cell	O	O
binding	O	O
assay	O	O
in	O	O
a	O	O
human	cell_line	O
T	cell_line	O
lymphoid	cell_line	O
cell	cell_line	O
line	cell_line	O
,	O	O
PEER	cell_line	cell_line
,	O	O
revealing	O	O
that	O	O
a	O	O
single	O	O
class	O	O
of	O	O
high-affinity	O	O
binding	O	O
sites	O	O
for	O	O
DHEA	O	O
(dissociation	O	O
constant	O	O
=	O	O
7.4	O	O
+/-	O	O
0.53	O	O
nmol/L,	O	O
mean	O	O
+/-	O	O
SE,	O	O
n	O	O
=	O	O
4)	O	O
was	O	O
greatly	O	O
increased	O	O
when	O	O
treated	O	O
with	O	O
DHEA	O	O
,	O	O
phorbol-12-myristate-13-acetate	O	O
,	O	O
and	O	O
the	O	O
Ca2+	O	O
ionophore	O	O
A23187.	O	O
Bound	O	O
[3H]	O	O
DHEA	O	O
was	O	O
displaced	O	O
sensitively	O	O
by	O	O
DHEA	O	O
and	O	O
secondarily	O	O
by	O	O
dihydrotestosterone	O	O
,	O	O
but	O	O
not	O	O
effectively	O	O
by	O	O
other	O	O
steroids	O	O
,	O	O
including	O	O
DHEA	O	O
sulfate	O	O
.	O	O
These	O	O
results	O	O
not	O	O
only	O	O
indicate	O	O
the	O	O
existence	O	O
of	O	O
a	O	O
DHEA	protein	O
receptor	protein	O
,	O	O
but	O	O
also	O	O
suggest	O	O
that	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
become	O	O
susceptible	O	O
to	O	O
regulation	O	O
by	O	O
DHEA	O	O
during	O	O
the	O	O
process	O	O
of	O	O
signal-induced	O	O
activation	O	O
.	O	O

Ubiquitin-mediated	O	O
processing	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
transcriptional	protein	protein
activator	protein	protein
precursor	protein	protein
p105	protein	protein
.	O	O
Reconstitution	O	O
of	O	O
a	O	O
cell-free	O	O
system	O	O
and	O	O
identification	O	O
of	O	O
the	O	O
ubiquitin-carrier	protein	protein
protein	protein	protein
,	O	O
E2	protein	O
,	O	O
and	O	O
a	O	O
novel	O	O
ubiquitin-protein	protein	protein
ligase	protein	protein
,	O	O
E3	protein	protein
,	O	O
involved	O	O
in	O	O
conjugation.	O	O
In	O	O
most	O	O
cases,	O	O
the	O	O
transcriptional	protein	protein
factor	protein	protein
NF-kappa	protein	protein
B	protein	protein
is	O	O
a	O	O
heterodimer	protein	O
consisting	O	O
of	O	O
two	O	O
subunits,	O	O
p50	protein	protein
and	O	O
p65	protein	protein
,	O	O
which	O	O
are	O	O
encoded	O	O
by	O	O
two	O	O
distinct	O	O
genes	O	O
of	O	O
the	O	O
Rel	DNA	protein
family	DNA	protein
.	O	O
p50	protein	protein
is	O	O
translated	O	O
as	O	O
a	O	O
precursor	O	O
of	O	O
105	protein	protein
kDa	protein	protein
.	O	O
The	O	O
C-terminal	protein	protein
domain	protein	protein
of	O	O
the	O	O
precursor	O	O
is	O	O
rapidly	O	O
degraded,	O	O
forming	O	O
the	O	O
mature	protein	O
p50	protein	protein
subunit	protein	protein
consisted	O	O
of	O	O
the	O	O
N-terminal	protein	protein
region	protein	protein
of	O	O
the	O	O
molecule.	O	O
The	O	O
mechanism	O	O
of	O	O
generation	O	O
of	O	O
p50	protein	protein
is	O	O
not	O	O
known.	O	O
It	O	O
has	O	O
been	O	O
suggested	O	O
that	O	O
the	O	O
ubiquitin	protein	protein
-proteasome	protein	protein
system	O	protein
is	O	O
involved	O	O
in	O	O
the	O	O
process;	O	O
however,	O	O
the	O	O
specific	O	O
enzymes	protein	O
involved	O	O
and	O	O
the	O	O
mechanism	O	O
of	O	O
limited	O	O
proteolysis	O	O
,	O	O
in	O	O
which	O	O
half	O	O
of	O	O
the	O	O
molecule	O	O
is	O	O
spared,	O	O
have	O	O
been	O	O
obscure.	O	O
Palombella	O	O
and	O	O
colleagues	O	O
(Palombella,	O	O
V.J.,	O	O
Rando,	O	O
O.J.,	O	O
Goldberg,	O	O
A.L.,	O	O
and	O	O
Maniatis,	O	O
T.(1994)	O	O
Cell	O	O
78,	O	O
773-785)	O	O
have	O	O
shown	O	O
that	O	O
ubiquitin	protein	protein
is	O	O
required	O	O
for	O	O
the	O	O
processing	O	O
in	O	O
a	O	O
cell-free	O	O
system	O	O
of	O	O
a	O	O
truncated,	O	O
artificially	O	O
constructed,	O	O
60-kDa	protein	protein
precursor	protein	protein
.	O	O
They	O	O
have	O	O
also	O	O
shown	O	O
that	O	O
proteasome	protein	protein
inhibitors	O	O
block	O	O
the	O	O
processing	O	O
both	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo.	O	O
In	O	O
this	O	O
study,	O	O
we	O	O
demonstrate	O	O
reconstitution	O	O
of	O	O
a	O	O
cell-free	O	O
processing	O	O
system	O	O
and	O	O
demonstrate	O	O
directly	O	O
that:	O	O
(a)	O	O
the	O	O
ubiquitin	protein	protein
-proteasome	protein	protein
system	O	protein
is	O	O
involved	O	O
in	O	O
processing	O	O
of	O	O
the	O	O
intact	O	O
p105	protein	protein
precursor,	O	O
(b)	O	O
conjugation	O	O
of	O	O
ubiquitin	protein	protein
to	O	O
the	O	O
precursor	O	O
is	O	O
an	O	O
essential	O	O
intermediate	O	O
step	O	O
in	O	O
the	O	O
processing,	O	O
(c)	O	O
the	O	O
recently	O	O
discovered	O	O
novel	O	O
species	O	O
of	O	O
the	O	O
ubiquitin	protein	protein
-carrier	protein	protein
protein	protein	protein
,	O	O
E2-F1	protein	protein
,	O	O
that	O	O
is	O	O
involved	O	O
in	O	O
the	O	O
conjugation	O	O
and	O	O
degradation	O	O
of	O	O
p53	protein	protein
,	O	O
is	O	O
also	O	O
required	O	O
for	O	O
the	O	O
limited	O	O
processing	O	O
of	O	O
the	O	O
p105	protein	protein
precursor	protein	protein
,	O	O
and	O	O
(d)	O	O
a	O	O
novel,	O	O
approximately	O	O
320-kDa	protein	O
species	protein	O
of	O	O
ubiquitin	protein	protein
-protein	protein	protein
ligase	protein	protein
,	O	O
is	O	O
involved	O	O
in	O	O
the	O	O
process.	O	O
This	O	O
novel	O	O
enzyme	O	O
is	O	O
distinct	O	O
from	O	O
E6-AP	protein	protein
,	O	O
the	O	O
p53	protein	protein
-conjugating	protein	protein
ligase	protein	protein
,	O	O
and	O	O
from	O	O
E3	protein	O
alpha	protein	O
,	O	O
the	O	O
"N-end	protein	protein
rule"	protein	protein
ligase	protein	protein
.	O	O

Flutamide	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
hirsutism	O	O
:	O	O
long-term	O	O
clinical	O	O
effects	O	O
,	O	O
endocrine	O	O
changes	O	O
,	O	O
and	O	O
androgen	protein	protein
receptor	protein	protein
behavior	O	O
.	O	O
OBJECTIVE:	O	O
To	O	O
investigate	O	O
the	O	O
long-term	O	O
effects	O	O
of	O	O
treatment	O	O
with	O	O
low	O	O
doses	O	O
of	O	O
flutamide	O	O
on	O	O
clinical	O	O
and	O	O
hormonal	O	O
parameters	O	O
,	O	O
as	O	O
well	O	O
as	O	O
on	O	O
the	O	O
androgen	protein	protein
receptor	protein	protein
status,	O	O
in	O	O
hirsute	O	O
women	O	O
.	O	O
DESIGN:	O	O
Eighteen	O	O
hirsute	O	O
patients	O	O
with	O	O
regular	O	O
menses	O	O
were	O	O
studied	O	O
basally	O	O
and	O	O
during	O	O
treatment	O	O
with	O	O
125	O	O
mg	O	O
flutamide	O	O
,	O	O
three	O	O
times	O	O
per	O	O
day	O	O
for	O	O
12	O	O
months.	O	O
Barrier	O	O
or	O	O
intrauterine	O	O
contraception	O	O
was	O	O
used	O	O
during	O	O
the	O	O
study	O	O
in	O	O
sexually	O	O
active	O	O
women	O	O
.	O	O
Safety	O	O
parameters	O	O
were	O	O
assessed	O	O
throughout	O	O
the	O	O
study.	O	O
Hirsutism	O	O
,	O	O
graded	O	O
by	O	O
the	O	O
modified	O	O
Ferriman-Gallwey	O	O
score	O	O
,	O	O
and	O	O
hormonal	O	O
parameters	O	O
were	O	O
evaluated	O	O
basally	O	O
and	O	O
at	O	O
4-month	O	O
intervals	O	O
during	O	O
treatment.	O	O
Gonadotropin-releasing	O	O
hormone	O	O
and	O	O
ACTH	O	O
stimulation	O	O
tests	O	O
were	O	O
performed	O	O
before	O	O
and	O	O
after	O	O
3	O	O
to	O	O
4	O	O
months	O	O
of	O	O
therapy	O	O
.	O	O
In	O	O
addition,	O	O
the	O	O
concentration	O	O
of	O	O
androgen	protein	protein
receptors	protein	protein
in	O	O
mononuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
was	O	O
measured,	O	O
in	O	O
both	O	O
the	O	O
follicular	O	O
and	O	O
luteal	O	O
phases	O	O
of	O	O
the	O	O
menstrual	O	O
cycle	O	O
,	O	O
basally	O	O
and	O	O
after	O	O
4	O	O
months	O	O
of	O	O
flutamide	O	O
treatment.	O	O
RESULTS:	O	O
Flutamide	O	O
was	O	O
well	O	O
tolerated	O	O
in	O	O
all	O	O
women	O	O
,	O	O
with	O	O
the	O	O
noticeable	O	O
exception	O	O
of	O	O
one	O	O
patient	O	O
who	O	O
presented	O	O
increased	O	O
serum	protein	O
transaminase	protein	O
after	O	O
8	O	O
months	O	O
of	O	O
therapy	protein	O
.	O	O
Hirsutism	O	O
markedly	O	O
improved	O	O
in	O	O
all	O	O
women	O	O
during	O	O
the	O	O
treatment	O	O
(	O	O
Ferriman-Gallwey	O	O
score	O	O
after	O	O
1	O	O
year:	O	O
4.1	O	O
+/-	O	O
0.5	O	O
versus	O	O
14.1	O	O
+/-	O	O
0.9).	O	O
A	O	O
reduction	O	O
of	O	O
serum	O	O
androgens	O	O
was	O	O
found,	O	O
whereas	O	O
no	O	O
change	O	O
was	O	O
observed	O	O
in	O	O
either	O	O
basal	O	O
or	O	O
GnRH-stimulated	O	O
gonadotropins	O	O
or	O	O
in	O	O
the	O	O
cortisol	O	O
and	O	O
17	O	O
alpha-hydroxyprogesterone	O	O
response	O	O
to	O	O
ACTH	O	protein
.	O	O
Cycles	O	O
remained	O	O
ovulatory.	O	O
Before	O	O
treatment,	O	O
the	O	O
number	O	O
of	O	O
androgen	protein	protein
receptors	protein	protein
was	O	O
higher	O	O
in	O	O
the	O	O
luteal	O	O
than	O	O
in	O	O
the	O	O
follicular	O	O
phase	O	O
.	O	O
This	O	O
rhythmic	O	O
differentiation	O	O
disappeared	O	O
after	O	O
the	O	O
patients	O	O
had	O	O
been	O	O
given	O	O
the	O	O
antiandrogen	O	O
drug	O	O
.	O	O
CONCLUSIONS:	O	O
Flutamide	O	O
is	O	O
effective	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
hirsutism	O	O
but	O	O
requires	O	O
constant	O	O
surveillance	O	O
of	O	O
liver	O	O
function	O	O
.	O	O
Androgen	O	protein
receptor	O	protein
blockade	O	O
might	O	O
be	O	O
potentiated	O	O
by	O	O
a	O	O
reduction	O	O
of	O	O
serum	O	O
androgens	O	O
.	O	O
Flutamide	O	O
affects	O	O
androgen	protein	protein
receptor	protein	protein
behavior	O	O
during	O	O
the	O	O
menstrual	O	O
cycle	O	O
.	O	O
The	O	O
meaning	O	O
of	O	O
this	O	O
finding	O	O
remains	O	O
to	O	O
be	O	O
elucidated	O	O
.	O	O

Constitutive	O	O
expression	O	O
of	O	O
HIV-1	protein	protein
tat	protein	protein
protein	protein	protein
in	O	O
human	cell_line	cell_line
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
using	O	O
a	O	O
BK	O	O
virus	O	O
vector	O	O
.	O	O
The	O	O
production	O	O
and	O	O
characterization	O	O
of	O	O
Jurkat	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
that	O	O
constitutively	O	O
express	O	O
functional	O	O
human	protein	O
immune	protein	O
deficiency	protein	O
virus	protein	O
type	protein	O
1	protein	O
(	protein	O
HIV-1	protein	O
)	protein	O
tat	protein	protein
protein	protein	protein
,	O	O
using	O	O
a	O	O
BK	O	O
virus	O	O
plasmid	O	O
expression	O	O
vector	O	O
and	O	O
HIV-1	DNA	O
tat	DNA	DNA
cDNA	DNA	DNA
,	O	O
is	O	O
described.	O	O
An	O	O
increased	O	O
growth	O	O
rate	O	O
of	O	O
these	O	O
Jurkat-tat	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
as	O	O
compared	O	O
with	O	O
control	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
was	O	O
observed.	O	O

A	O	O
PEBP2	protein	protein
alpha/AML-1-related	protein	protein
factor	protein	protein
increases	O	O
osteocalcin	DNA	O
promoter	DNA	O
activity	O	O
through	O	O
its	O	O
binding	O	O
to	O	O
an	O	O
osteoblast-specific	DNA	DNA
cis-acting	DNA	DNA
element	DNA	DNA
.	O	O
To	O	O
identify	O	O
osteoblast-specific	DNA	O
cis-acting	DNA	DNA
elements	DNA	DNA
and	O	O
trans-acting	protein	protein
factors	protein	protein
,	O	O
we	O	O
initiated	O	O
an	O	O
analysis	O	O
of	O	O
the	O	O
promoter	DNA	O
of	O	O
a	O	O
mouse	DNA	DNA
osteocalcin	DNA	DNA
gene	DNA	DNA
,	O	O
an	O	O
osteoblast-specific	DNA	DNA
gene	DNA	DNA
.	O	O
In	O	O
this	O	O
promoter,	O	O
we	O	O
identified	O	O
two	O	O
osteoblast-specific	DNA	DNA
cis-acting	DNA	DNA
elements	DNA	DNA
(Ducy,	O	O
P.and	O	O
Karsenty,	O	O
G.(1995)	O	O
Mol.Cell.Biol.15,	O	O
1858-1869).	O	O
The	O	O
sequence	O	O
of	O	O
one	O	O
of	O	O
these	O	O
elements	DNA	O
,	O	O
OSE2	DNA	protein
,	O	O
is	O	O
identical	O	O
to	O	O
the	O	O
DNA-binding	DNA	DNA
site	DNA	DNA
of	O	O
the	O	O
PEBP2	protein	protein
alpha/AML-1	protein	protein
transcription	protein	protein
factors	protein	protein
,	O	O
the	O	O
mammalian	protein	DNA
homologues	protein	DNA
of	O	O
the	O	O
Drosophila	protein	protein
Runt	protein	protein
protein	protein	protein
.	O	O
Here	O	O
we	O	O
show,	O	O
using	O	O
nuclear	O	O
extracts	O	O
,	O	O
recombinant	protein	protein
protein	protein	protein
,	O	O
and	O	O
a	O	O
specific	O	O
antiserum	O	O
against	O	O
AML-1	protein	protein
proteins	protein	protein
in	O	O
DNA-binding	O	O
assays	O	O
,	O	O
that	O	O
one	O	O
member	O	O
of	O	O
this	O	O
family,	O	O
AML-1B	protein	DNA
,	O	O
binds	O	O
specifically	O	O
to	O	O
OSE2	DNA	O
and	O	O
is	O	O
immunologically	O	O
related	O	O
to	O	O
OSF2	protein	protein
,	O	O
the	O	O
factor	O	O
present	O	O
in	O	O
osteoblast	O	O
nuclear	O	O
extracts	O	O
that	O	O
binds	O	O
to	O	O
OSE2	DNA	protein
.	O	O
By	O	O
DNA	O	O
cotransfection	O	O
experiments	O	O
,	O	O
we	O	O
also	O	O
demonstrate	O	O
that	O	O
AML-1B	protein	protein
can	O	O
increase	O	O
the	O	O
activity	O	O
of	O	O
a	O	O
short	O	DNA
osteocalcin	DNA	DNA
promoter	DNA	DNA
through	O	O
its	O	O
binding	O	O
to	O	O
OSE2	DNA	protein
.	O	O
Lastly,	O	O
the	O	O
different	O	O
mobilities	O	O
of	O	O
osteoblast	protein	protein
nuclear	protein	protein
extract-DNA	protein	protein
complexes	protein	protein
compared	O	O
with	O	O
T-cell	protein	O
nuclear	protein	O
extract-DNA	protein	protein
complexes	protein	protein
,	O	O
along	O	O
with	O	O
the	O	O
inability	O	O
of	O	O
OSF2	protein	protein
to	O	O
be	O	O
upregulated	O	O
by	O	O
retinoic	O	O
acid	O	O
,	O	O
unlike	O	O
the	O	O
other	O	O
PEBP2	protein	protein
alpha	protein	protein
factors	protein	protein
,	O	O
suggest	O	O
that	O	O
OSF2	protein	protein
is	O	O
a	O	O
new	O	O
member	O	O
of	O	O
this	O	O
family	O	O
of	O	O
transcription	protein	protein
factors	protein	protein
.	O	O
Thus,	O	O
this	O	O
study	O	O
demonstrates	O	O
that	O	O
AML-1B	protein	protein
can	O	O
increase	O	O
gene	O	O
expression	O	O
of	O	O
an	O	O
osteoblast-specific	DNA	DNA
gene	DNA	DNA
through	O	O
its	O	O
binding	O	O
to	O	O
an	O	O
osteoblast-specific	DNA	DNA
cis-acting	DNA	DNA
element	DNA	DNA
and	O	O
presents	O	O
evidence	O	O
that	O	O
OSF2	protein	protein
is	O	O
a	O	O
member	O	O
of	O	O
the	O	O
PEBP2	protein	protein
alpha/AML-1	protein	protein
family	protein	protein
of	O	O
transcription	protein	protein
factors	protein	protein
.	O	O

Initiation	protein	O
binding	protein	O
repressor	protein	O
,	O	O
a	O	O
factor	O	O
that	O	O
binds	O	O
to	O	O
the	O	O
transcription	DNA	DNA
initiation	DNA	DNA
site	DNA	DNA
of	O	O
the	O	O
histone	DNA	DNA
h5	DNA	DNA
gene	DNA	DNA
,	O	O
is	O	O
a	O	O
glycosylated	protein	O
member	protein	O
of	O	O
a	O	O
family	O	O
of	O	O
cell	protein	O
growth	protein	O
regulators	protein	O
[corrected]	O	O
[published	O	O
erratum	O	O
appears	O	O
in	O	O
Mol	O	O
Cell	O	O
Biol	O	O
1996	O	O
Feb;16(2):735]	O	O
Initiation	protein	O
binding	protein	O
repressor	protein	protein
[corrected]	O	protein
(	O	O
IBR	protein	O
)	O	O
is	O	O
a	O	O
chicken	protein	protein
erythrocyte	protein	protein
factor	protein	protein
(apparent	O	O
molecular	O	O
mass,	O	O
70	O	O
to	O	O
73	O	O
kDa)	O	O
that	O	O
binds	O	O
to	O	O
the	O	O
sequences	O	O
spanning	O	O
the	O	O
transcription	DNA	DNA
initiation	DNA	DNA
site	DNA	DNA
of	O	O
the	O	O
histone	DNA	DNA
h5	DNA	DNA
gene	DNA	DNA
,	O	O
repressing	O	O
its	O	O
transcription	O	O
.	O	O
A	O	O
variety	O	O
of	O	O
other	O	O
cells,	O	O
including	O	O
transformed	cell_type	O
erythroid	cell_type	O
precursors	cell_type	O
,	O	O
do	O	O
not	O	O
have	O	O
IBR	protein	O
but	O	O
a	O	O
factor	O	O
referred	O	O
to	O	O
as	O	O
IBF	protein	O
(68	O	O
to	O	O
70	O	O
kDa)	O	O
that	O	O
recognizes	O	O
the	O	O
same	O	O
IBR	protein	O
sites.	O	O
We	O	O
have	O	O
cloned	O	O
the	O	O
IBR	DNA	DNA
cDNA	DNA	DNA
and	O	O
studied	O	O
the	O	O
relationship	O	O
of	O	O
IBR	protein	O
and	O	O
IBF	protein	O
.	O	O
IBR	protein	O
is	O	O
a	O	O
503-amino-acid-long	protein	protein
acidic	protein	protein
protein	protein	protein
which	O	O
is	O	O
99.0%	O	O
identical	O	O
to	O	O
the	O	O
recently	O	O
reported	O	O
human	protein	protein
NRF-1/alpha-Pal	protein	protein
factor	protein	protein
and	O	O
highly	O	O
related	O	O
to	O	O
the	O	O
invertebrate	O	O
transcription	protein	protein
factors	protein	protein
P3A2	protein	protein
and	O	O
erected	protein	O
wing	protein	O
gene	protein	O
product	protein	O
(	O	O
EWG	protein	O
).	O	O
We	O	O
present	O	O
evidence	O	O
that	O	O
IBR	protein	O
and	O	O
IBF	protein	O
are	O	O
most	O	O
likely	O	O
identical	O	O
proteins,	O	O
differing	O	O
in	O	O
their	O	O
degree	O	O
of	O	O
glycosylation	O	O
.	O	O
We	O	O
have	O	O
analyzed	O	O
several	O	O
molecular	O	O
aspects	O	O
of	O	O
IBR/F	protein	O
and	O	O
shown	O	O
that	O	O
the	O	O
factor	O	O
associates	O	O
as	O	O
stable	O	O
homodimers	protein	O
and	O	O
that	O	O
the	O	O
dimer	protein	O
is	O	O
the	O	O
relevant	protein	O
DNA-binding	protein	O
species	protein	O
.	O	O
The	O	O
evolutionarily	O	O
conserved	O	O
N-terminal	protein	O
half	protein	O
of	O	O
IBR/F	protein	O
harbors	O	O
the	O	O
DNA-binding/dimerization	protein	protein
domain	protein	protein
(outer	O	O
limits,	O	O
127	O	O
to	O	O
283),	O	O
one	O	O
or	O	O
several	O	O
casein	protein	protein
kinase	protein	protein
II	protein	protein
sites	protein	protein
(37	O	O
to	O	O
67),	O	O
and	O	O
a	O	O
bipartite	protein	O
nuclear	protein	O
localization	protein	O
signal	protein	O
(89	O	O
to	O	O
106)	O	O
which	O	O
appears	O	O
to	O	O
be	O	O
necessary	O	O
for	O	O
nuclear	O	O
targeting	O	O
.	O	O
Binding	O	O
site	O	O
selection	O	O
revealed	O	O
that	O	O
the	O	O
alternating	protein	O
RCGCRYGCGY	protein	O
consensus	protein	O
constitutes	O	O
high-affinity	O	O
IBR/F	DNA	O
binding	DNA	O
sites	DNA	O
and	O	O
that	O	O
the	O	O
direct-repeat	DNA	O
palindrome	DNA	O
TGCGCATGCGCA	O	O
is	O	O
the	O	O
optimal	DNA	DNA
site	DNA	DNA
.	O	O
A	O	O
survey	O	O
of	O	O
genes	DNA	O
potentially	O	O
regulated	O	O
by	O	O
this	O	O
family	O	O
of	O	O
factors	protein	O
primarily	O	O
revealed	O	O
genes	DNA	O
involved	O	O
in	O	O
growth-related	O	O
metabolism	O	O
.	O	O

Triggering	O	O
of	O	O
the	O	O
human	O	DNA
interleukin-6	O	DNA
gene	O	DNA
by	O	O
interferon-gamma	O	protein
and	O	O
tumor	O	protein
necrosis	O	protein
factor-alpha	O	protein
in	O	O
monocytic	O	cell_type
cells	O	cell_type
involves	O	O
cooperation	O	O
between	O	O
interferon	protein	protein
regulatory	protein	protein
factor-1	protein	protein
,	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
,	O	O
and	O	O
Sp1	protein	protein
transcription	protein	protein
factors	protein	protein
.	O	O
We	O	O
investigated	O	O
the	O	O
molecular	O	O
basis	O	O
of	O	O
the	O	O
synergistic	O	O
induction	O	O
by	O	O
interferon-gamma	protein	protein
(	O	O
IFN-gamma	protein	protein
)/	O	protein
tumor	protein	protein
necrosis	protein	protein
factor-alpha	protein	protein
(	O	O
TNF-alpha	protein	protein
)	O	O
of	O	O
human	DNA	DNA
interleukin-6	DNA	DNA
(IL-6)	DNA	DNA
gene	DNA	DNA
in	O	O
THP-1	cell_type	cell_line
monocytic	cell_type	cell_line
cells	cell_type	cell_line
,	O	O
and	O	O
compared	O	O
it	O	O
with	O	O
the	O	O
basis	O	O
of	O	O
this	O	O
induction	O	O
by	O	O
lipopolysaccharide	O	O
(	O	O
LPS	O	O
).	O	O
Functional	O	O
studies	O	O
with	O	O
IL-6	DNA	DNA
promoter	DNA	DNA
demonstrated	O	O
that	O	O
three	O	O
regions	O	O
are	O	O
the	O	O
targets	O	O
of	O	O
the	O	O
IFN-gamma	protein	protein
and/or	O	O
TNF-alpha	protein	protein
action,	O	O
whereas	O	O
only	O	O
one	O	O
of	O	O
these	O	O
regions	O	O
seemed	O	O
to	O	O
be	O	O
implicated	O	O
in	O	O
LPS	O	O
activation	O	O
.	O	O
The	O	O
three	O	O
regions	O	O
concerned	O	O
are:	O	O
1)	O	O
a	O	O
region	O	O
between	O	O
-73	O	DNA
and	O	O
-36,	O	O
which	O	O
is	O	O
the	O	O
minimal	DNA	DNA
element	DNA	DNA
inducible	O	O
by	O	O
LPS	O	O
or	O	O
TNF-alpha	protein	protein
;	O	O
2)	O	O
an	O	O
element	O	O
located	O	O
between	O	O
-181	O	DNA
and	O	O
-73,	O	O
which	O	O
appeared	O	O
to	O	O
regulate	O	O
the	O	O
response	O	O
to	O	O
IFN-gamma	protein	protein
and	O	O
TNF-alpha	protein	protein
negatively;	O	O
and	O	O
3)	O	O
a	O	O
distal	DNA	DNA
element	DNA	DNA
upstream	DNA	O
of	O	O
-224,	O	O
which	O	O
was	O	O
inducible	O	O
by	O	O
IFN-gamma	protein	protein
alone.	O	O
LPS	O	O
signaling	O	O
was	O	O
found	O	O
to	O	O
involve	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
activation	O	O
by	O	O
the	O	O
p50/p65	protein	protein
heterodimers	protein	protein
.	O	O
Synergistic	O	O
induction	O	O
of	O	O
the	O	O
IL-6	DNA	DNA
gene	DNA	DNA
by	O	O
IFN-gamma	protein	protein
and	O	O
TNF-alpha	protein	protein
,	O	O
in	O	O
monocytic	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
involved	O	O
cooperation	O	O
between	O	O
the	O	O
IRF-1	protein	DNA
and	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
p65	protein	protein
homodimers	protein	protein
with	O	O
concomitant	O	O
removal	O	O
of	O	O
the	O	O
negative	O	O
effect	O	O
of	O	O
the	O	O
retinoblastoma	DNA	DNA
control	DNA	DNA
element	DNA	DNA
present	O	O
in	O	O
the	O	O
IL-6	DNA	DNA
promoter	DNA	DNA
.	O	O
This	O	O
removal	O	O
occurred	O	O
by	O	O
activation	O	O
of	O	O
the	O	O
constitutive	protein	O
Sp1	protein	protein
factor	protein	protein
,	O	O
whose	O	O
increased	O	O
binding	O	O
activity	O	O
and	O	O
phosphorylation	O	O
were	O	O
mediated	O	O
by	O	O
IFN-gamma	protein	protein
.	O	O

Mutation	O	O
of	O	O
Jak3	protein	protein
in	O	O
a	O	O
patient	O	O
with	O	O
SCID	O	O
:	O	O
essential	O	O
role	O	O
of	O	O
Jak3	protein	protein
in	O	O
lymphoid	O	O
development	O	O
.	O	O
Males	O	O
with	O	O
X-linked	O	O
severe	O	O
combined	O	O
immunodeficiency	O	O
(	O	O
XSCID	O	O
)	O	O
have	O	O
defects	O	O
in	O	O
the	O	O
common	O	protein
cytokine	DNA	protein
receptor	DNA	protein
gamma	DNA	protein
chain	DNA	protein
(	DNA	O
gamma	DNA	protein
c	DNA	protein
)	DNA	O
gene	DNA	O
that	O	O
encodes	O	O
a	O	O
shared,	O	O
essential	O	O
component	O	O
of	O	O
the	O	O
receptors	O	O
of	O	O
interleukin-2	protein	protein
(	O	O
IL-2	protein	protein
),	O	O
IL-4	protein	protein
,	O	O
IL-7	protein	protein
,	O	O
IL-9	protein	protein
,	O	O
and	O	O
IL-15	protein	protein
.	O	O
The	O	O
Janus	protein	protein
family	protein	protein
tyrosine	protein	protein
kinase	protein	protein
Jak3	protein	protein
is	O	O
the	O	O
only	O	O
signaling	O	protein
molecule	O	protein
known	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
gamma	protein	protein
c	protein	protein
,	O	O
so	O	O
it	O	O
was	O	O
hypothesized	O	O
that	O	O
defects	O	O
in	O	O
Jak3	protein	protein
might	O	O
cause	O	O
an	O	O
XSCID	O	O
-like	O	O
phenotype	O	O
.	O	O
A	O	O
girl	O	O
with	O	O
immunological	O	O
features	O	O
indistinguishable	O	O
from	O	O
those	O	O
of	O	O
XSCID	O	O
was	O	O
therefore	O	O
selected	O	O
for	O	O
analysis.	O	O
An	O	O
Epstein-Barr	cell_line	O
virus	cell_line	O
(	cell_line	O
EBV	cell_line	cell_line
)-transformed	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
derived	O	O
from	O	O
her	O	O
lymphocytes	cell_type	O
had	O	O
normal	O	O
gamma	protein	O
c	protein	O
expression	O	O
but	O	O
lacked	O	O
Jak3	protein	protein
protein	protein	protein
and	O	O
had	O	O
greatly	O	O
diminished	O	O
Jak3	RNA	protein
messenger	RNA	protein
RNA	RNA	protein
.	O	O
Sequencing	O	O
revealed	O	O
a	O	O
different	O	O
mutation	O	O
on	O	O
each	O	O
allele:	O	O
a	O	O
single	O	O
nucleotide	O	O
insertion	O	O
resulting	O	O
in	O	O
a	O	O
frame	O	O
shift	O	O
and	O	O
premature	O	O
termination	O	O
in	O	O
the	O	O
Jak3	protein	protein
JH4	protein	protein
domain	protein	protein
and	O	O
a	O	O
nonsense	O	O
mutation	O	O
in	O	O
the	O	O
Jak3	protein	protein
JH2	O	protein
domain	O	protein
.	O	O
The	O	O
lack	O	O
of	O	O
Jak3	protein	protein
expression	O	O
correlated	O	O
with	O	O
impaired	O	O
B	O	O
cell	O	O
signaling	O	O
,	O	O
as	O	O
demonstrated	O	O
by	O	O
the	O	O
inability	O	O
of	O	O
IL-4	protein	protein
to	O	O
activate	O	O
Stat6	protein	protein
in	O	O
the	O	O
EBV	cell_line	cell_line
-transformed	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
from	O	O
the	O	O
patient.	O	O
These	O	O
observations	O	O
indicate	O	O
that	O	O
the	O	O
functions	O	O
of	O	O
gamma	protein	O
c	protein	O
are	O	O
dependent	O	O
on	O	O
Jak3	protein	O
and	O	O
that	O	O
Jak3	protein	protein
is	O	O
essential	O	O
for	O	O
lymphoid	O	O
development	O	O
and	O	O
signaling.	O	O

Constitutive	O	O
overexpression	O	O
of	O	O
the	O	O
L-selectin	DNA	DNA
gene	DNA	DNA
in	O	O
fresh	O	cell_type
leukemic	cell_type	cell_type
cells	cell_type	cell_type
of	O	O
adult	O	O
T-cell	O	O
leukemia	O	O
that	O	O
can	O	O
be	O	O
transactivated	O	O
by	O	O
human	protein	O
T-cell	protein	O
lymphotropic	protein	O
virus	protein	O
type	protein	O
1	protein	O
Tax	protein	protein
.	O	O
L-selectin	protein	protein
is	O	O
an	O	O
adhesion	O	protein
molecule	O	protein
of	O	O
the	O	O
selectin	O	protein
family	O	protein
that	O	O
mediates	O	O
the	O	O
initial	O	O
step	O	O
of	O	O
leukocyte	O	O
adhesion	O	O
to	O	O
vascular	O	protein
endothelium	O	protein
.	O	O
Upon	O	O
cellular	O	O
activation	O	O
,	O	O
expression	O	O
of	O	O
the	O	O
L-selectin	DNA	DNA
gene	DNA	DNA
is	O	O
downregulated	O	O
at	O	O
both	O	O
the	O	O
protein	O	O
and	O	O
mRNA	O	O
levels	O	O
.	O	O
To	O	O
understand	O	O
the	O	O
mechanism	O	O
of	O	O
leukemic	cell_type	O
cell	cell_type	O
infiltration	O	O
into	O	O
organs	O	O
,	O	O
we	O	O
studied	O	O
the	O	O
expression	O	O
and	O	O
regulation	O	O
of	O	O
L-selectin	RNA	RNA
mRNA	RNA	RNA
in	O	O
fresh	O	cell_type
leukemic	cell_type	cell_type
cells	cell_type	cell_type
of	O	O
adult	O	O
T-cell	O	O
leukemia	O	O
(	O	O
ATL	O	O
)	O	O
patients	O	O
and	O	O
investigated	O	O
the	O	O
response	O	O
of	O	O
the	O	O
L-selectin	DNA	DNA
promoter	DNA	DNA
to	O	O
human	protein	O
T-cell	protein	O
lymphotropic	protein	O
virus	protein	O
type	protein	O
1	protein	O
(	protein	O
HTLV-1	protein	O
)	protein	O
Tax	protein	protein
,	O	O
which	O	O
is	O	O
a	O	O
viral	protein	protein
transcriptional	protein	protein
transactivator	protein	protein
.	O	O
Flow	O	O
cytometry	O	O
showed	O	O
that	O	O
L-selectin	protein	protein
was	O	O
expressed	O	O
on	O	O
fresh	O	cell_type
ATL	cell_line	cell_type
cells	cell_line	cell_type
along	O	O
with	O	O
other	O	O
activation	protein	O
antigens	protein	O
.	O	O
Northern	O	O
blot	O	O
analysis	O	O
showed	O	O
that	O	O
ATL	cell_line	O
cells	cell_line	O
overexpressed	O	O
that	O	O
L-selectin	RNA	RNA
mRNA	RNA	RNA
and	O	O
that	O	O
the	O	O
level	O	O
was	O	O
aberrantly	O	O
upregulated	O	O
after	O	O
PMA	O	O
stimulation	O	O
.	O	O
Studies	O	O
using	O	O
in	O	O
situ	O	O
hybridization	O	O
showed	O	O
expression	O	O
of	O	O
the	O	O
L-selectin	RNA	RNA
mRNA	RNA	RNA
in	O	O
the	O	O
infiltrating	O	O
leukemic	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
the	O	O
liver	O	O
of	O	O
two	O	O
ATL	O	O
patients	O	O
.	O	O
Intravenous	O	O
injection	O	O
of	O	O
a	O	O
rat	cell_line	cell_line
T-cell	cell_line	cell_line
line	cell_line	cell_line
that	O	O
overexpresses	O	O
L-selectin	protein	protein
showed	O	O
increased	O	O
organ	O	O
infiltration	O	O
.	O	O
The	O	O
induction	O	O
of	O	O
Tax	protein	protein
expression	O	O
in	O	O
JPX9	cell_line	cell_line
cells	cell_line	cell_line
resulted	O	O
in	O	O
about	O	O
a	O	O
twofold	O	O
increase	O	O
in	O	O
the	O	O
mRNA	RNA	O
expression	O	O
levels	O	O
compared	O	O
with	O	O
the	O	O
basal	O	O
level	O	O
.	O	O
Chloramphenicol	protein	DNA
acetyltransferase	protein	DNA
(	O	DNA
CAT	protein	DNA
)	O	O
assay	O	O
after	O	O
transient	O	O
cotransfection	O	O
showed	O	O
about	O	O
a	O	O
fivefold	O	O
transactivation	O	O
of	O	O
the	O	O
L-selectin	DNA	DNA
promoter	DNA	DNA
by	O	O
Tax	protein	protein
.	O	O
The	O	O
serum	O	O
level	O	O
of	O	O
the	O	O
shed	O	O
form	O	O
of	O	O
L-selectin	protein	protein
was	O	O
significantly	O	O
increased	O	O
in	O	O
ATL	O	O
patients	O	O
(mean	O	O
+/-	O	O
SD,	O	O
4,215.4	O	O
+/-	O	O
4,111	O	O
ng/mL)	O	O
compared	O	O
with	O	O
those	O	O
of	O	O
asymptomatic	O	O
carriers	O	O
and	O	O
healthy	O	O
blood	O	O
donors	O	O
(mean	O	O
+/-	O	O
SD,	O	O
1,148.0	O	O
+/-	O	O
269.0	O	O
ng/mL	O	O
and	O	O
991.9	O	O
+/-	O	O
224	O	O
ng/mL,	O	O
respectively).	O	O
These	O	O
results	O	O
indicated	O	O
that	O	O
ATL	cell_line	O
cells	cell_line	O
constitutively	O	O
overexpress	O	O
the	O	O
L-selectin	DNA	DNA
gene	DNA	DNA
that	O	O
can	O	O
be	O	O
transactivated	O	O
by	O	O
HTLV-1	O	O
Tax	protein	protein
.	O	O
The	O	O
overexpression	O	O
of	O	O
L-selectin	protein	protein
,	O	O
as	O	O
well	O	O
as	O	O
of	O	O
inflammatory	protein	protein
cytokines	protein	protein
,	O	O
by	O	O
ATL	cell_line	O
cells	cell_line	O
may	O	O
provide	O	O
a	O	O
basis	O	O
for	O	O
ATL	cell_line	O
cells	cell_line	O
to	O	O
attach	O	O
the	O	O
vascular	O	protein
endothelium	O	protein
,	O	O
leading	O	O
to	O	O
transmigration	O	O
and	O	O
organ	O	O
infitration	O	O
.	O	O

Human	O	O
herpesvirus	O	O
6	O	O
variant	O	O
A	O	O
,	O	O
but	O	O
not	O	O
variant	O	O
B	O	O
,	O	O
infects	O	O
EBV	cell_line	O
-positive	cell_line	O
B	cell_line	cell_type
lymphoid	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
activating	O	O
the	O	O
latent	DNA	O
EBV	DNA	O
genome	DNA	O
through	O	O
a	O	O
BZLF-1	protein	DNA
-dependent	O	O
mechanism	O	O
.	O	O
Human	O	O
herpesvirus	O	O
6	O	O
,	O	O
a	O	O
predominantly	O	O
T	O	O
lymphotropic	O	O
virus	O	O
,	O	O
has	O	O
been	O	O
recently	O	O
shown	O	O
to	O	O
infect	O	O
some	O	O
EBV	cell_line	O
-positive	cell_line	O
B	cell_line	O
cell	cell_line	O
lines	cell_line	O
,	O	O
and	O	O
to	O	O
induce	O	O
in	O	O
them	O	O
the	O	O
activation	O	O
of	O	O
the	O	O
EBV	O	O
lytic	O	O
cycle	O	O
.	O	O
Here	O	O
we	O	O
have	O	O
confirmed	O	O
and	O	O
extended	O	O
such	O	O
observations,	O	O
showing	O	O
that	O	O
(1)	O	O
this	O	O
phenomenon	O	O
is	O	O
restricted	O	O
to	O	O
the	O	O
variant	O	O
A	O	O
of	O	O
HHV-6	O	O
:	O	O
in	O	O
fact	O	O
two	O	O
isolates	O	O
belonging	O	O
to	O	O
the	O	O
HHV-6	O	O
variant	O	O
B	O	O
(	O	O
BA92	O	O
and	O	O
Z29	O	O
)	O	O
were	O	O
neither	O	O
able	O	O
to	O	O
infect	O	O
any	O	O
B	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
,	O	O
independently	O	O
of	O	O
the	O	O
EBV	O	O
status	O	O
,	O	O
nor	O	O
to	O	O
induce	O	O
the	O	O
EBV	O	O
genome	O	O
expression	O	O
.	O	O
The	O	O
only	O	O
exception	O	O
is	O	O
represented	O	O
by	O	O
the	O	O
P3HR1	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
in	O	O
which,	O	O
however,	O	O
the	O	O
infection	O	O
by	O	O
the	O	O
variant	O	O
B	O	O
does	O	O
not	O	O
determine	O	O
induction	O	O
of	O	O
EBV	protein	protein
antigens	protein	protein
;	O	O
(2)	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
EBV	DNA	DNA
genome	DNA	DNA
contributes	O	O
to	O	O
the	O	O
susceptibility	O	O
of	O	O
the	O	O
B	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
to	O	O
HHV-6	O	O
infection	O	O
,	O	O
increasing	O	O
the	O	O
binding	O	DNA
sites	O	DNA
and	O	O
the	O	O
percentage	O	O
of	O	O
infectable	cell_type	O
cells	cell_type	O
,	O	O
as	O	O
detected	O	O
by	O	O
immunoelectron	O	O
microscopy	O	O
;	O	O
and	O	O
(3)	O	O
HHV-6	cell_line	O
infected	cell_line	O
T	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
transfected	O	O
with	O	O
plasmids	DNA	DNA
bearing	O	O
the	O	O
promoter	DNA	DNA
regions	DNA	DNA
of	O	O
the	O	O
EBV	O	DNA
early	O	DNA
genes	O	DNA
BZLF1	DNA	DNA
and	O	O
BMRF1	DNA	protein
,	O	O
show	O	O
a	O	O
strong	O	O
transactivation	O	O
of	O	O
these	O	O
promoters	DNA	DNA
.	O	O

Evidence	O	O
for	O	O
normal	O	O
vitamin	RNA	O
D	RNA	O
receptor	RNA	O
messenger	RNA	O
ribonucleic	RNA	O
acid	RNA	O
and	O	O
genotype	O	O
in	O	O
absorptive	O	O
hypercalciuria	O	O
.	O	O
Absorptive	O	O
hypercalciuria	O	O
(a	O	O
stone-forming	O	O
condition	O	O
)	O	O
is	O	O
characterized	O	O
by	O	O
gut	O	O
hyperabsorption	O	O
of	O	O
calcium	O	O
,	O	O
hypercalciuria	O	O
,	O	O
and	O	O
reduced	O	O
bone	O	O
density	O	O
.	O	O
Inasmuch	O	O
as	O	O
these	O	O
features	O	O
implicate	O	O
enhanced	O	O
calcitriol	O	O
action	O	O
in	O	O
gut	O	O
and	O	O
bone	O	O
,	O	O
we	O	O
analyzed	O	O
the	O	O
vitamin	DNA	protein
D	DNA	protein
receptor	DNA	protein
(	DNA	O
VDR	DNA	protein
)	DNA	O
gene	DNA	O
to	O	O
ascertain	O	O
whether	O	O
an	O	O
abnormality	O	O
of	O	O
this	O	O
gene	O	O
marks	O	O
patients	O	O
with	O	O
intestinal	O	O
hyperabsorption	O	O
of	O	O
calcium	O	O
.	O	O
We	O	O
have	O	O
compared	O	O
the	O	O
frequency	O	O
of	O	O
a	O	O
restriction	DNA	O
fragment	DNA	O
length	DNA	O
polymorphism	DNA	O
(	O	O
Bsm	DNA	DNA
I	DNA	DNA
)	O	O
associated	O	O
with	O	O
different	O	O
alleles	O	O
of	O	O
the	O	O
VDR	DNA	DNA
gene	DNA	DNA
in	O	O
a	O	O
group	O	O
of	O	O
33	O	O
well	O	O
characterized	O	O
absorptive	O	O
hypercalciuric	O	O
patients	O	O
and	O	O
a	O	O
group	O	O
of	O	O
36	O	O
normal	O	O
race-	O	O
and	O	O
age-matched	O	O
control	O	O
subjects	O	O
.	O	O
There	O	O
was	O	O
no	O	O
difference	O	O
between	O	O
the	O	O
distribution	O	O
of	O	O
the	O	O
VDR	protein	protein
alleles	O	O
in	O	O
the	O	O
patient	O	O
population	O	O
when	O	O
compared	O	O
with	O	O
the	O	O
normal	O	O
population	O	O
.	O	O
The	O	O
coding	O	O
region	O	O
of	O	O
VDR	RNA	protein
messenger	RNA	protein
RNA	RNA	protein
was	O	O
also	O	O
normal,	O	O
as	O	O
determined	O	O
by	O	O
both	O	O
DNA	DNA	DNA
sequence	DNA	DNA
analysis	O	O
and	O	O
chemical	O	O
mismatch	O	O
cleavage	O	O
analysis	O	O
of	O	O
copy	O	O
DNA	O	O
from	O	O
11	O	O
index	O	O
absorptive	O	O
hypercalciuric	O	O
patients	O	O
.	O	O
On	O	O
the	O	O
basis	O	O
of	O	O
these	O	O
results,	O	O
we	O	O
propose	O	O
that	O	O
the	O	O
enhanced	O	O
intestinal	O	O
calcium	O	O
absorption	O	O
invariably	O	O
seen	O	O
in	O	O
absorptive	O	O
hypercalciuria	O	O
and	O	O
attendant	O	O
symptoms	O	O
of	O	O
this	O	O
disorder	O	O
are	O	O
not	O	O
attributable	O	O
to	O	O
mutations	O	O
of	O	O
the	O	O
VDR	protein	protein
and	O	O
are	O	O
not	O	O
linked	O	O
to	O	O
a	O	O
common	O	O
VDR	DNA	protein
genotype	DNA	O
.	O	O

Transcriptional	O	O
regulation	O	O
of	O	O
the	O	O
gene	O	O
encoding	O	O
the	O	O
human	protein	protein
C-type	protein	protein
lectin	protein	protein
leukocyte	protein	protein
receptor	protein	protein
AIM/CD69	protein	protein
and	O	O
functional	O	O
characterization	O	O
of	O	O
its	O	O
tumor	DNA	protein
necrosis	DNA	protein
factor-alpha	DNA	protein
-responsive	DNA	O
elements	DNA	O
.	O	O
The	O	O
human	protein	protein
activation	protein	O
antigen	protein	O
CD69	protein	protein
is	O	O
a	O	O
member	O	O
of	O	O
the	O	O
C-type	protein	protein
animal	protein	protein
lectin	protein	protein
superfamily	protein	protein
that	O	O
functions	O	O
as	O	O
a	O	O
signal-transmitting	protein	O
receptor	protein	O
.	O	O
Although	O	O
the	O	O
expression	O	O
of	O	O
CD69	protein	protein
can	O	O
be	O	O
induced	O	O
in	O	O
vitro	O	O
on	O	O
cells	O	O
of	O	O
most	O	O
hematopoietic	O	O
lineages	O	O
with	O	O
a	O	O
wide	O	O
variety	O	O
of	O	O
stimuli,	O	O
in	O	O
vivo	O	O
it	O	O
is	O	O
mainly	O	O
expressed	O	O
by	O	O
T-	cell_type	cell_type
lymphocytes	cell_type	cell_type
located	O	O
in	O	O
the	O	O
inflammatory	O	O
infiltrates	O	O
of	O	O
several	O	O
human	O	O
diseases	O	O
.	O	O
To	O	O
elucidate	O	O
the	O	O
mechanisms	O	O
that	O	O
regulate	O	O
the	O	O
constitutive	O	O
and	O	O
inducible	O	O
expression	O	O
of	O	O
CD69	protein	protein
by	O	O
leukocytes	cell_type	cell_type
,	O	O
we	O	O
isolated	O	O
the	O	O
promoter	DNA	DNA
region	DNA	DNA
of	O	O
the	O	O
CD69	protein	DNA
gene	O	DNA
and	O	O
carried	O	O
out	O	O
its	O	O
functional	O	O
characterization	O	O
.	O	O
Sequence	O	O
analysis	O	O
of	O	O
the	O	O
5'-flanking	DNA	DNA
region	DNA	DNA
of	O	O
the	O	O
CD69	DNA	DNA
gene	DNA	DNA
revealed	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
potential	O	DNA
TATA	DNA	DNA
element	DNA	DNA
30	DNA	DNA
base	DNA	DNA
pairs	DNA	DNA
upstream	DNA	O
of	O	O
the	O	O
major	O	O
transcription	DNA	DNA
initiation	DNA	DNA
site	DNA	DNA
and	O	O
several	O	O
putative	O	O
binding	O	O
sequences	O	O
for	O	O
inducible	O	O
transcription	protein	protein
factors	protein	protein
(	O	O
NF-kappa	protein	protein
B	protein	protein
,	O	O
Egr-1	protein	protein
,	O	O
AP-1	protein	protein
),	O	O
which	O	O
might	O	O
mediate	O	O
the	O	O
inducible	O	O
expression	O	O
of	O	O
this	O	O
gene.	O	O
Transient	O	O
expression	O	O
of	O	O
CD69	DNA	protein
promoter-based	DNA	O
reporter	DNA	DNA
gene	DNA	DNA
constructs	DNA	DNA
in	O	O
K562	cell_line	cell_line
cells	cell_line	cell_line
indicated	O	O
that	O	O
the	O	O
proximal	DNA	DNA
promoter	DNA	DNA
region	DNA	DNA
spanning	O	O
positions	O	O
-78	O	O
to	O	O
+16	O	O
contained	O	O
the	O	O
cis-acting	DNA	DNA
sequences	DNA	DNA
necessary	O	O
for	O	O
basal	O	O
and	O	O
phorbol	O	O
12-myristate	O	O
13-acetate	O	O
-inducible	O	O
transcription	O	O
of	O	O
the	O	O
CD69	DNA	DNA
gene	DNA	DNA
.	O	O
Removal	O	O
of	O	O
the	O	O
upstream	O	DNA
sequences	O	DNA
located	O	O
between	O	O
positions	O	DNA
-78	O	DNA
and	O	O
-38	O	O
resulted	O	O
in	O	O
decreased	O	O
promoter	O	O
strength	O	O
and	O	O
abolished	O	O
the	O	O
response	O	O
to	O	O
phorbol	O	O
12-myristate	O	O
13-acetate.	O	O
We	O	O
also	O	O
found	O	O
that	O	O
tumor	protein	protein
necrosis	protein	protein
factor-alpha	protein	protein
(	O	O
TNF-alpha	protein	protein
)	O	O
is	O	O
capable	O	O
of	O	O
inducing	O	O
the	O	O
surface	O	O
expression	O	O
of	O	O
the	O	O
CD69	protein	protein
molecule	O	protein
as	O	O
well	O	O
as	O	O
the	O	O
promoter	O	O
activity	O	O
of	O	O
fusion	O	O
plasmids	O	O
that	O	O
contain	O	O
5'-flanking	O	DNA
sequences	O	DNA
of	O	O
the	O	O
CD69	protein	protein
gene,	O	O
suggesting	O	O
that	O	O
this	O	O
cytokine	O	protein
may	O	O
regulate	O	O
in	O	O
vivo	O	O
the	O	O
expression	O	O
of	O	O
CD69	protein	protein
.	O	O
(ABSTRACT	O	O
TRUNCATED	O	O
AT	O	O
250	O	O
WORDS)	O	O

Characterization	O	O
of	O	O
5'	DNA	DNA
end	DNA	DNA
of	DNA	O
human	DNA	protein
thromboxane	DNA	protein
receptor	DNA	protein
gene	DNA	O
.	O	O
Organizational	O	O
analysis	O	O
and	O	O
mapping	O	O
of	O	O
protein	DNA	protein
kinase	DNA	protein
C--responsive	DNA	protein
elements	DNA	protein
regulating	O	O
expression	O	O
in	O	O
platelets	cell_type	cell_type
.	O	O
Platelet	protein	protein
thromboxane	protein	protein
receptors	protein	protein
are	O	O
acutely	O	O
and	O	O
reversibly	O	O
upregulated	O	O
after	O	O
acute	O	O
myocardial	O	O
infarction	O	O
.	O	O
To	O	O
determine	O	O
if	O	O
platelet	O	protein
thromboxane	protein	protein
receptors	protein	protein
are	O	O
under	O	O
transcriptional	O	O
control	O	O
,	O	O
we	O	O
isolated	O	O
and	O	O
characterized	O	O
human	DNA	O
genomic	DNA	DNA
DNA	DNA	DNA
clones	DNA	DNA
containing	O	O
the	O	O
5'	DNA	DNA
flanking	DNA	DNA
region	DNA	DNA
of	O	O
the	O	O
thromboxane	DNA	O
receptor	DNA	O
gene	DNA	O
.	O	O
The	O	O
exon-intron	DNA	DNA
structure	DNA	DNA
of	O	O
the	O	O
5'	DNA	DNA
portion	DNA	DNA
of	O	O
the	O	O
thromboxane	DNA	O
receptor	DNA	O
gene	DNA	O
was	O	O
determined	O	O
initially	O	O
by	O	O
comparing	O	O
the	O	O
nucleotide	DNA	DNA
sequence	DNA	DNA
of	O	O
the	O	O
5'	DNA	DNA
flanking	DNA	DNA
genomic	DNA	DNA
clone	DNA	DNA
with	O	O
that	O	O
of	O	O
a	O	O
novel	DNA	O
human	DNA	O
uterine	DNA	O
thromboxane	DNA	O
receptor	DNA	O
cDNA	DNA	O
that	O	O
extended	O	O
the	O	O
mRNA	RNA	RNA
141	DNA	RNA
bp	DNA	RNA
further	DNA	O
upstream	DNA	O
than	O	O
the	O	O
previously	DNA	O
identified	DNA	O
human	DNA	O
placental	DNA	DNA
cDNA	DNA	DNA
.	O	O
A	O	O
major	O	O
transcription	DNA	DNA
initiation	DNA	DNA
site	DNA	DNA
was	O	O
located	O	O
in	O	O
three	O	O
human	O	O
tissues	O	O
approximately	O	O
560	DNA	O
bp	DNA	O
upstream	DNA	O
from	O	O
the	O	O
translation	DNA	O
initiation	DNA	O
codon	DNA	O
and	O	O
380	DNA	O
bp	DNA	O
upstream	DNA	O
from	O	O
any	O	O
previously	O	O
identified	O	O
transcription	DNA	DNA
initiation	DNA	DNA
site	DNA	DNA
.	O	O
The	O	O
thromboxane	DNA	O
receptor	DNA	O
gene	DNA	O
has	O	O
neither	O	O
a	O	O
TATA	DNA	DNA
nor	O	O
a	O	O
CAAT	DNA	DNA
consensus	DNA	DNA
site	DNA	DNA
.	O	O
Promoter	O	O
function	O	O
of	O	O
the	O	O
5'	DNA	DNA
flanking	DNA	DNA
region	DNA	DNA
of	O	O
the	O	O
thromboxane	DNA	O
receptor	DNA	O
gene	DNA	O
was	O	O
evaluated	O	O
by	O	O
transfection	O	O
of	O	O
thromboxane	DNA	O
receptor	DNA	O
gene	DNA	O
promoter/	DNA	O
chloramphenicol	DNA	DNA
acetyltransferase	DNA	DNA
(	DNA	DNA
CAT	DNA	DNA
)	DNA	O
chimera	DNA	protein
plasmids	DNA	protein
into	O	O
platelet-like	O	cell_type
K562	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
Thromboxane	O	O
receptor	DNA	O
promoter	DNA	O
activity	O	O
,	O	O
as	O	O
assessed	O	O
by	O	O
CAT	protein	protein
expression	O	O
,	O	O
was	O	O
relatively	O	O
weak	O	O
but	O	O
was	O	O
significantly	O	O
enhanced	O	O
by	O	O
phorbol	O	O
ester	O	O
treatment	O	O
.	O	O
Functional	O	O
analysis	O	O
of	O	O
5'	DNA	DNA
deletion	DNA	DNA
constructs	DNA	DNA
in	O	O
transfected	O	cell_line
K562	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
gel	O	O
mobility	O	O
shift	O	O
localized	O	O
the	O	O
major	O	O
phorbol	O	O
ester	O	O
-responsive	O	O
motifs	O	O
in	O	O
the	O	O
thromboxane	DNA	O
receptor	DNA	DNA
gene	DNA	DNA
promoter	O	DNA
to	O	O
a	O	O
cluster	O	O
of	O	O
activator	DNA	protein
protein-2	DNA	protein
(	DNA	O
AP-2	DNA	protein
)	DNA	O
binding	DNA	O
consensus	DNA	DNA
sites	DNA	DNA
located	O	O
approximately	O	O
1.8	O	DNA
kb	O	DNA
5'	O	DNA
from	O	O
the	O	O
transcription	DNA	DNA
initiation	DNA	DNA
site	DNA	DNA
.	O	O
These	O	O
studies	O	O
are	O	O
the	O	O
first	O	O
to	O	O
determine	O	O
the	O	O
structure	O	O
and	O	O
organization	O	O
of	O	O
the	O	O
5'	O	DNA
end	O	DNA
of	O	O
the	O	O
thromboxane	DNA	O
receptor	DNA	O
gene	DNA	O
and	O	O
demonstrate	O	O
that	O	O
thromboxane	DNA	O
receptor	DNA	O
gene	DNA	O
expression	O	O
can	O	O
be	O	O
regulated	O	O
by	O	O
activation	O	O
of	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
via	O	O
induction	O	O
of	O	O
an	O	O
AP-2	protein	protein
-like	protein	protein
nuclear	protein	protein
factor	protein	protein
binding	O	O
to	O	O
upstream	DNA	DNA
promoter	DNA	DNA
elements	DNA	DNA
.	O	O
These	O	O
findings	O	O
strongly	O	O
suggest	O	O
that	O	O
the	O	O
mechanism	O	O
for	O	O
previously	O	O
described	O	O
upregulation	O	O
of	O	O
platelet	protein	protein
thromboxane	protein	protein
receptors	protein	protein
after	O	O
acute	O	O
myocardial	O	O
infarction	O	O
is	O	O
increased	O	O
thromboxane	DNA	O
receptor	DNA	O
gene	DNA	O
transcription	O	O
in	O	O
platelet-progenitor	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Estrogen	protein	protein
receptor	protein	protein
concentration	O	O
and	O	O
social	O	O
factors	O	O
as	O	O
predictors	O	O
of	O	O
natural	O	O
killer	O	O
cell	O	O
activity	O	O
in	O	O
early-stage	O	O
breast	O	O
cancer	O	O
patients	O	O
.	O	O
Confirmation	O	O
of	O	O
a	O	O
model.	O	O
Previous	O	O
work	O	O
of	O	O
ours	O	O
has	O	O
demonstrated	O	O
that	O	O
a	O	O
significant	O	O
amount	O	O
of	O	O
natural	O	protein
killer	O	protein
(NK)	O	protein
activity	O	O
variance	O	O
after	O	O
surgery	O	O
in	O	O
stage	O	O
I	O	O
and	O	O
II	O	O
breast	O	O
cancer	O	O
patients	O	O
could	O	O
be	O	O
accounted	O	O
for	O	O
by	O	O
both	O	O
the	O	O
estrogen	protein	protein
receptor	protein	protein
(	O	O
ER	protein	protein
)	O	O
status	O	O
of	O	O
the	O	O
tumor	O	O
and	O	O
by	O	O
social	O	protein
factors	O	protein
,	O	O
namely,	O	O
perceived	O	O
social	O	O
support	O	O
and	O	O
seeking	O	O
social	O	O
support	O	O
as	O	O
a	O	O
general	O	O
coping	O	O
strategy	O	O
.	O	O
As	O	O
considerable	O	O
evidence	O	O
has	O	O
accumulated	O	O
that	O	O
social	O	O
support	O	O
in	O	O
both	O	O
animal	O	O
and	O	O
human	O	O
populations	O	O
may	O	O
have	O	O
survival	O	O
value,	O	O
we	O	O
sought	O	O
to	O	O
test	O	O
the	O	O
reliability	O	O
of	O	O
this	O	O
regression	O	O
model	O	O
,	O	O
using	O	O
coping	O	O
and	O	O
perceived	O	O
support	O	O
factor	O	O
values	O	O
obtained	O	O
at	O	O
3	O	O
months	O	O
after	O	O
surgery	O	O
to	O	O
account	O	O
for	O	O
concurrent	O	O
follow-up	O	O
NK	O	O
activity	O	O
in	O	O
this	O	O
serially	O	O
assessed	O	O
group	O	O
of	O	O
patients	O	O
.	O	O
It	O	O
was	O	O
found	O	O
that	O	O
the	O	O
most	O	O
significant	O	O
variable	O	O
predicting	O	O
NK	O	O
activity	O	O
at	O	O
follow-up	O	O
was	O	O
tumor	O	O
ER	protein	protein
concentration	O	O
,	O	O
with	O	O
higher	O	O
NK	O	O
activity	O	O
associated	O	O
with	O	O
ER	protein	protein
-status	O	O
.	O	O
In	O	O
addition,	O	O
seeking	O	O
social	O	O
support	O	O
as	O	O
a	O	O
coping	O	O
strategy,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
perceived	O	O
quality	O	O
of	O	O
support,	O	O
also	O	O
entered	O	O
the	O	O
model	O	O
to	O	O
account	O	O
for	O	O
a	O	O
significant	O	O
amount	O	O
of	O	O
NK	O	O
activity	O	O
variance	O	O
(multivariate	O	O
F	O	O
=	O	O
5.25,	O	O
p	O	O
less	O	O
than	O	O
0.001).	O	O
If,	O	O
as	O	O
the	O	O
literature	O	O
suggests,	O	O
NK	O	O
activity	O	O
is	O	O
relevant	O	O
to	O	O
breast	O	O
cancer	O	O
control	O	O
,	O	O
and	O	O
since	O	O
ER	protein	protein
-tumors	O	protein
have	O	O
a	O	O
worse	O	O
prognosis,	O	O
we	O	O
suggest	O	O
here	O	O
that	O	O
perhaps	O	O
such	O	O
tumors	O	O
are	O	O
resistant	O	O
to	O	O
control	O	O
by	O	O
NK	cell_type	cell_type
cells	cell_type	cell_type
because	O	O
they	O	O
lack	O	O
the	O	O
ability	O	O
to	O	O
attract	O	O
an	O	O
accumulation	O	O
of	O	O
effector	cell_type	cell_type
cells	cell_type	cell_type
to	O	O
the	O	O
tumor	O	DNA
site	O	DNA
,	O	O
or	O	O
because	O	O
blocking	O	O
factors	O	O
at	O	O
the	O	O
site	O	O
of	O	O
the	O	O
tumor	O	O
prevent	O	O
local	O	O
tumor	O	O
control	O	O
at	O	O
the	O	O
site	O	O
of	O	O
action.	O	O
The	O	O
finding	O	O
related	O	O
to	O	O
social	O	O
support	O	O
also	O	O
replicates	O	O
results	O	O
from	O	O
an	O	O
independent	O	O
sample	O	O
of	O	O
breast	O	O
cancer	O	O
patients	O	O
.	O	O
This	O	O
finding,	O	O
taken	O	O
together	O	O
with	O	O
other	O	O
evidence	O	O
that	O	O
this	O	O
social	O	O
variable	O	O
is	O	O
associated	O	O
with	O	O
longer	O	O
survival	O	O
in	O	O
breast	O	O
cancer	O	O
populations	O	O
,	O	O
underscores	O	O
the	O	O
potential	O	O
importance	O	O
of	O	O
this	O	O
social	O	O
support	O	O
variable	O	O
.	O	O
Our	O	O
findings	O	O
also	O	O
suggest	O	O
one	O	O
possible	O	O
immunological	O	O
variable	O	O
involved	O	O
,	O	O
with	O	O
potential	O	O
clinical	O	O
significance	O	O
,	O	O
for	O	O
this	O	O
patient	O	O
population	O	O
.	O	O

Solution	O	O
structure	O	O
of	O	O
the	O	O
sequence-specific	DNA	DNA
HMG	DNA	DNA
box	DNA	DNA
of	O	O
the	O	O
lymphocyte	protein	protein
transcriptional	protein	protein
activator	protein	protein
Sox-4	protein	protein
.	O	O
Two	O	O
groups	O	O
of	O	O
HMG	protein	protein
box	protein	protein
proteins	protein	protein
are	O	O
distinguished.	O	O
Proteins	O	O
in	O	O
the	O	O
first	O	O
group	O	O
contain	O	O
multiple	O	O
HMG	protein	protein
boxes	protein	protein
,	O	O
are	O	O
non-sequence-specific	O	O
,	O	O
and	O	O
recognize	O	O
structural	O	O
features	O	O
as	O	O
found	O	O
in	O	O
cruciform	DNA	O
DNA	DNA	O
and	O	O
cross-over	DNA	O
DNA	DNA	O
.	O	O
The	O	O
abundant	O	O
chromosomal	protein	O
protein	protein	O
HMG-1	protein	protein
belongs	O	O
to	O	O
this	O	O
subgroup.	O	O
Proteins	O	O
in	O	O
the	O	O
second	O	O
group	O	O
carry	O	O
a	O	O
single	protein	O
HMG	protein	protein
box	protein	protein
with	O	O
affinity	O	O
for	O	O
the	O	O
minor	DNA	O
groove	DNA	O
of	O	O
the	O	O
heptamer	DNA	DNA
motif	DNA	DNA
AACAAAG	O	DNA
or	O	O
variations	O	O
thereof.	O	O
A	O	O
solution	O	O
structure	O	O
for	O	O
the	O	O
non-sequence-specific	O	O
C-terminal	protein	O
HMG	protein	protein
box	protein	protein
of	O	O
HMG-1	protein	protein
has	O	O
recently	O	O
been	O	O
proposed.	O	O
Now,	O	O
we	O	O
report	O	O
the	O	O
solution	O	O
structure	O	O
of	O	O
the	O	O
sequence-specific	protein	DNA
HMG-box	protein	DNA
of	O	O
the	O	O
SRY-related	protein	protein
protein	protein	protein
Sox-4	protein	protein
.	O	O
NMR	O	O
analysis	O	O
demonstrated	O	O
the	O	O
presence	O	O
of	O	O
three	O	O
alpha-helices	protein	O
(	O	O
Val10-Gln22	protein	protein
,	O	O
Glu30-Leu41	protein	O
and	O	O
Phe50-Tyr65	protein	protein
)	O	O
connected	O	O
by	O	O
loop	protein	protein
regions	protein	protein
(	O	O
Ser23-Ala49	protein	O
and	O	O
Leu42-Pro49	protein	protein
).	O	O
Helices	O	O
I	O	O
and	O	O
II	O	O
are	O	O
positioned	O	O
in	O	O
an	O	O
antiparallel	protein	O
mode	protein	O
and	O	O
form	O	O
one	O	O
arm	O	O
of	O	O
the	O	O
HMG	protein	protein
box	protein	protein
.	O	O
Helix	protein	O
III	protein	O
is	O	O
less	O	O
rigid,	O	O
makes	O	O
an	O	O
average	O	O
angle	O	O
of	O	O
about	O	O
90	O	O
degrees	O	O
with	O	O
helices	O	O
I	O	O
and	O	O
II	O	O
,	O	O
and	O	O
constitutes	O	O
the	O	O
other	O	O
arm	O	O
of	O	O
the	O	O
molecule.	O	O
As	O	O
in	O	O
HMG1B	protein	protein
,	O	O
the	O	O
overall	O	O
structure	O	O
of	O	O
the	O	O
Sox-4	protein	protein
HMG	protein	protein
box	protein	protein
is	O	O
L-shaped	O	O
and	O	O
is	O	O
maintained	O	O
by	O	O
a	O	O
cluster	O	O
of	O	O
conserved,	O	O
mainly	O	O
aromatic	O	O
residues	O	O
.	O	O

Nuclear	protein	O
factor-IL6	protein	O
activates	O	O
the	O	O
human	DNA	DNA
IL-4	DNA	DNA
promoter	DNA	DNA
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Positive	DNA	DNA
regulatory	DNA	DNA
element	DNA	DNA
I	DNA	DNA
(	O	DNA
PRE-I	DNA	DNA
)	O	O
is	O	O
a	O	O
strong	O	DNA
enhancer	DNA	DNA
element	DNA	DNA
essential	O	O
for	O	O
expression	O	O
of	O	O
the	O	O
human	DNA	DNA
IL-4	DNA	DNA
gene	DNA	DNA
.	O	O
To	O	O
identify	O	O
transcription	protein	protein
factors	protein	protein
binding	O	O
to	O	O
PRE-I	DNA	DNA
,	O	O
we	O	O
screened	O	O
a	O	O
cDNA	DNA	DNA
expression	DNA	DNA
library	DNA	DNA
from	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
isolated	O	O
a	O	O
cDNA	DNA	DNA
encoding	O	O
nuclear	protein	protein
factor	protein	protein
(NF)-IL6	protein	protein
(also	O	O
known	O	O
as	O	O
C/EBP	protein	protein
beta	protein	protein
).	O	O
NF-IL6	RNA	RNA
mRNA	RNA	RNA
was	O	O
found	O	O
in	O	O
human	cell_line	cell_line
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
and	O	O
in	O	O
the	O	O
mouse	cell_line	cell_line
Th2	cell_line	cell_line
clone	cell_line	cell_line
D10	cell_line	cell_line
,	O	O
but	O	O
not	O	O
in	O	O
Th1	cell_line	cell_line
clone	cell_line	cell_line
29	cell_line	cell_line
.	O	O
rNF-IL6	protein	protein
expressed	O	O
in	O	O
bacteria	O	O
was	O	O
shown	O	O
to	O	O
specifically	O	O
bind	O	O
to	O	O
PRE-I	DNA	DNA
.	O	O
PRE-I	DNA	O
forms	O	O
multiple	protein	O
DNA-protein	protein	protein
complexes	protein	protein
with	O	O
nuclear	O	O
extracts	O	O
from	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Some	O	O
of	O	O
these	O	O
complexes	O	O
were	O	O
demonstrated	O	O
to	O	O
contain	O	O
NF-IL6	protein	protein
by	O	O
using	O	O
anti-	protein	O
C/EBP	protein	protein
beta	protein	protein
Abs	protein	protein
.	O	O
Overexpression	O	O
of	O	O
NF-IL6	protein	protein
enhanced	O	O
expression	O	O
of	O	O
the	O	O
chloramphenicol	DNA	DNA
acetyl	DNA	DNA
transferase	DNA	DNA
reporter	DNA	DNA
gene	DNA	DNA
linked	O	O
to	O	O
the	O	O
PRE-I	protein	DNA
-thymidine	protein	DNA
kinase	protein	DNA
or	O	O
the	O	O
human	DNA	DNA
IL-4	DNA	DNA
promoter	DNA	DNA
more	O	O
than	O	O
10-fold	O	O
in	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Promoter	O	O
deletion	O	O
studies	O	O
revealed	O	O
two	O	O
additional	O	O
NF-IL6	DNA	DNA
binding	DNA	DNA
sites	DNA	DNA
located	O	O
at	O	O
positions	O	O
-44	O	O
to	O	O
-36	O	O
(	O	O
C/EBP	protein	protein
proximal	protein	protein
)	O	O
and	O	O
-87	O	O
to	O	O
-79	O	O
(	O	O
C/EBP	protein	protein
medial	protein	protein
),	O	O
respectively.	O	O
Our	O	O
results	O	O
demonstrate	O	O
that	O	O
NF-IL6	protein	protein
is	O	O
involved	O	O
in	O	O
transcriptional	O	O
activation	O	O
of	O	O
the	O	O
human	DNA	DNA
IL-4	DNA	DNA
promoter	DNA	DNA
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Identification	O	O
of	O	O
an	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha-associated	protein	protein
protein	protein	protein
kinase	protein	protein
in	O	O
a	O	O
human	cell_line	cell_line
monocytic	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
and	O	O
determination	O	O
of	O	O
its	O	O
phosphorylation	protein	O
sites	protein	O
on	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
.	O	O
Nuclear	protein	protein
factor	protein	protein
kappa	protein	protein
B	protein	protein
(	O	O
NF-kappa	protein	protein
B	protein	protein
)	O	O
is	O	O
stored	O	O
in	O	O
the	O	O
cytoplasm	O	O
as	O	O
an	O	O
inactive	O	O
form	O	O
through	O	O
interaction	O	O
with	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
.	O	O
Stimulation	O	O
of	O	O
cells	O	O
leads	O	O
to	O	O
a	O	O
rapid	O	O
phosphorylation	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
,	O	O
which	O	O
is	O	O
presumed	O	O
to	O	O
be	O	O
important	O	O
for	O	O
the	O	O
subsequent	O	O
degradation	O	O
.	O	O
We	O	O
have	O	O
recently	O	O
reported	O	O
the	O	O
establishment	O	O
of	O	O
a	O	O
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)-dependent	O	O
cell-free	O	O
activation	O	O
system	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
in	O	O
association	O	O
with	O	O
the	O	O
induction	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
phosphorylation	O	O
.	O	O
In	O	O
this	O	O
study,	O	O
we	O	O
have	O	O
identified	O	O
a	O	O
kinase	protein	O
in	O	O
cell	O	O
extracts	O	O
from	O	O
the	O	O
LPS	cell_line	cell_line
-stimulated	cell_line	cell_line
human	cell_line	cell_line
monocytic	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
,	O	O
THP-1	cell_line	cell_line
,	O	O
that	O	O
specifically	O	O
binds	O	O
and	O	O
phosphorylates	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
.	O	O
LPS	O	O
stimulation	O	O
transiently	O	O
enhanced	O	O
the	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
-bound	protein	protein
kinase	protein	protein
activity	O	O
in	O	O
THP-1	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Mutational	O	O
analyses	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	O	protein
and	O	O
competition	O	O
experiments	O	O
with	O	O
the	O	O
synthetic	O	O
peptides	O	O
identified	O	O
major	O	O
phosphorylation	protein	O
sites	protein	O
by	O	O
the	O	O
bound	O	O
kinase	protein	O
as	O	O
Ser	O	O
and	O	O
Thr	O	O
residues	O	O
in	O	O
the	O	O
C-terminal	protein	protein
acidic	protein	protein
domain	protein	protein
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
.	O	O
Moreover,	O	O
we	O	O
show	O	O
that	O	O
the	O	O
peptide	O	O
,	O	O
corresponding	O	O
to	O	O
the	O	O
C-terminal	protein	protein
acidic	protein	protein
domain	protein	protein
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
,	O	O
blocked	O	O
the	O	O
LPS	O	O
-induced	O	O
NF-kappa	protein	protein
B	protein	protein
activation	O	O
as	O	O
well	O	O
as	O	O
inducible	O	O
phosphorylation	O	O
of	O	O
endogenous	O	protein
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
in	O	O
a	O	O
cell-free	O	O
system	O	O
using	O	O
THP-1	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
These	O	O
results	O	O
suggested	O	O
that	O	O
the	O	O
bound	protein	O
kinase	protein	O
is	O	O
involved	O	O
in	O	O
the	O	O
signaling	O	O
pathway	O	O
of	O	O
LPS	O	O
by	O	O
inducing	O	O
the	O	O
phosphorylation	O	O
of	O	O
the	O	O
C-terminal	protein	protein
region	protein	protein
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
and	O	O
subsequent	O	O
dissociation	O	O
of	O	O
the	O	O
NF-kappa	protein	protein
B	protein	protein
.	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
complex	protein	protein
.	O	O

Bik	protein	O
,	O	O
a	O	O
novel	O	O
death-inducing	protein	protein
protein	protein	protein
shares	O	O
a	O	O
distinct	O	O
sequence	O	O
motif	O	O
with	O	O
Bcl-2	protein	protein
family	protein	protein
proteins	protein	protein
and	O	O
interacts	O	O
with	O	O
viral	O	O
and	O	O
cellular	protein	O
survival-promoting	protein	O
proteins	protein	O
.	O	O
The	O	O
survival-promoting	O	O
activity	O	O
of	O	O
the	O	O
Bcl-2	protein	protein
family	protein	protein
of	O	O
proteins	O	O
appears	O	O
to	O	O
be	O	O
modulated	O	O
by	O	O
interactions	O	O
between	O	O
various	O	O
cellular	protein	protein
proteins	protein	protein
.	O	O
We	O	O
have	O	O
identified	O	O
a	O	O
novel	O	O
cellular	protein	protein
protein	protein	protein
,	O	O
Bik	protein	O
,	O	O
that	O	O
interacts	O	O
with	O	O
the	O	O
cellular	protein	protein
survival-promoting	protein	protein
proteins	protein	protein
,	O	O
Bcl-2	protein	protein
and	O	O
Bcl-xL	protein	protein
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
viral	protein	protein
survival-promoting	protein	protein
proteins	protein	protein
,	O	O
Epstein	protein	protein
Barr	protein	protein
virus	protein	protein
-BHRF1	protein	protein
and	O	O
adenovirus	protein	O
E1B-19	protein	protein
kDa	protein	protein
.	O	O
In	O	O
transient	O	O
transfection	O	O
assays	O	O
,	O	O
Bik	protein	O
promotes	O	O
cell	O	O
death	O	O
in	O	O
a	O	O
manner	O	O
similar	O	O
to	O	O
the	O	O
death-promoting	protein	O
members	protein	O
of	O	O
the	O	O
Bcl-2	protein	protein
family	protein	protein
,	O	O
Bax	protein	protein
and	O	O
Bak	protein	protein
.	O	O
This	O	O
death-promoting	O	O
activity	O	O
of	O	O
Bik	protein	protein
can	O	O
be	O	O
suppressed	O	O
by	O	O
coexpression	O	O
of	O	O
Bcl-2	protein	protein
,	O	O
Bcl-XL	protein	protein
,	O	O
EBV-BHRF1	protein	protein
and	O	O
E1B-19	protein	protein
kDa	protein	protein
proteins	O	protein
suggesting	O	O
that	O	O
Bik	protein	O
may	O	O
be	O	O
a	O	O
common	O	O
target	O	O
for	O	O
both	O	O
cellular	O	O
and	O	O
viral	O	protein
anti-apoptotic	O	protein
proteins	O	protein
.	O	O
While	O	O
Bik	protein	O
does	O	O
not	O	O
show	O	O
overt	O	O
homology	O	O
to	O	O
the	O	O
BH1	protein	protein
and	O	O
BH2	protein	protein
conserved	O	protein
domains	O	protein
characteristic	O	O
of	O	O
the	O	O
Bcl-2	protein	protein
family	protein	protein
,	O	O
it	O	O
does	O	O
share	O	O
a	O	O
9	O	O
amino	protein	protein
acid	protein	protein
domain	protein	protein
(	O	O
BH3	protein	protein
)	O	O
with	O	O
Bax	protein	protein
and	O	O
Bak	protein	O
which	O	O
may	O	O
be	O	O
a	O	O
critical	O	O
determinant	O	O
for	O	O
the	O	O
death-promoting	O	O
activity	O	O
of	O	O
these	O	O
proteins.	O	O

The	O	O
human	DNA	DNA
TCF-1	DNA	DNA
gene	DNA	DNA
encodes	O	O
a	O	O
nuclear	protein	protein
DNA-binding	protein	protein
protein	protein	protein
uniquely	O	O
expressed	O	O
in	O	O
normal	O	O
and	O	O
neoplastic	O	O
T-lineage	O	cell_type
lymphocytes	O	cell_type
.	O	O
The	O	O
TCF-1	DNA	DNA
gene	DNA	DNA
encodes	O	O
a	O	O
putative	protein	protein
transcription	protein	protein
factor	protein	protein
with	O	O
affinity	O	O
for	O	O
a	O	O
sequence	DNA	O
motif	DNA	O
occurring	O	O
in	O	O
a	O	O
number	O	O
of	O	O
T-cell	DNA	O
enhancers	DNA	DNA
.	O	O
TCF-1	RNA	RNA
mRNA	RNA	RNA
was	O	O
originally	O	O
found	O	O
to	O	O
be	O	O
expressed	O	O
in	O	O
a	O	O
T	O	O
cell-specific	O	O
fashion	O	O
within	O	O
a	O	O
set	O	O
of	O	O
human	cell_line	O
and	cell_line	O
mouse	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
In	O	O
contrast,	O	O
expression	O	O
reportedly	O	O
occurs	O	O
in	O	O
multiple	O	O
nonlymphoid	O	O
tissues	O	O
during	O	O
murine	O	O
embryogenesis	O	O
.	O	O
We	O	O
have	O	O
now	O	O
raised	O	O
a	O	O
monoclonal	protein	protein
antibody	protein	protein
to	O	O
document	O	O
expression	O	O
and	O	O
biochemistry	O	O
of	O	O
the	O	O
human	protein	protein
TCF-1	protein	protein
protein	protein	protein
.	O	O
As	O	O
expected,	O	O
the	O	O
TCF-1	protein	protein
protein	protein	protein
was	O	O
detectable	O	O
only	O	O
in	O	O
cell	cell_line	O
lines	cell_line	O
of	cell_line	O
T	cell_line	cell_type
lineage	cell_line	cell_type
.	O	O
Its	O	O
expression	O	O
was	O	O
always	O	O
restricted	O	O
to	O	O
the	O	O
nucleus	O	O
.	O	O
Immunohistochemistry	O	O
on	O	O
a	O	O
panel	O	O
of	O	O
human	O	O
tissues	O	O
revealed	O	O
that	O	O
the	O	O
TCF-1	protein	protein
protein	protein	protein
was	O	O
found	O	O
exclusively	O	O
in	O	O
thymocytes	O	cell_type
and	O	O
in	O	O
CD3+	cell_line	cell_type
T	cell_line	cell_type
cells	cell_line	cell_type
in	O	O
peripheral	O	O
lymphoid	O	O
tissues	O	O
.	O	O
Western	O	O
blotting	O	O
yielded	O	O
a	O	O
set	O	O
of	O	O
bands	O	O
ranging	O	O
from	O	O
25	O	O
kD	O	O
to	O	O
55	O	O
kD,	O	O
resulting	O	O
from	O	O
extensive	O	O
alternative	O	O
splicing	O	O
.	O	O
The	O	O
TCF-1	protein	protein
protein	O	protein
was	O	O
detectable	O	O
in	O	O
all	O	O
samples	O	O
of	O	O
a	O	O
set	O	O
of	O	O
22	O	O
T-cell	cell_type	O
malignancies	cell_type	O
of	O	O
various	O	O
stages	O	O
of	O	O
maturation,	O	O
but	O	O
was	O	O
absent	O	O
from	O	O
a	O	O
large	O	O
number	O	O
of	O	O
other	O	O
hematologic	cell_type	O
neoplasms	cell_type	O
.	O	O
These	O	O
observations	O	O
imply	O	O
a	O	O
T	O	O
cell-specific	O	O
function	O	O
for	O	O
TCF-1	protein	protein
,	O	O
a	O	O
notion	O	O
corroborated	O	O
by	O	O
recent	O	O
observations	O	O
on	O	O
Tcf-1	O	protein
knock-out	O	O
mice	O	O
.	O	O
In	O	O
addition,	O	O
these	O	O
results	O	O
indicate	O	O
that	O	O
nuclear	O	O
TCF-1	protein	protein
expression	O	O
can	O	O
serve	O	O
as	O	O
a	O	O
pan-T-lineage	O	O
marker	O	O
in	O	O
the	O	O
diagnosis	O	O
of	O	O
lymphoid	O	O
malignancies	O	O
.	O	O

Cross-linking	O	O
of	O	O
Fc	protein	protein
gamma	protein	protein
receptors	protein	protein
activates	O	O
HIV-1	DNA	DNA
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
-driven	O	O
transcription	O	O
in	O	O
human	cell_type	cell_type
monocytes	cell_type	cell_type
.	O	O
Elevation	O	O
of	O	O
the	O	O
levels	O	O
of	O	O
circulating	protein	O
immune	protein	O
complexes	protein	O
frequently	O	O
accompanies	O	O
HIV-1	O	O
infection	O	O
and	O	O
is	O	O
a	O	O
prognostic	O	O
indicator	O	O
of	O	O
clinical	O	O
progression	O	O
from	O	O
asymptomatic	O	O
infection	O	O
to	O	O
AIDS	O	O
.	O	O
Here	O	O
we	O	O
report	O	O
that	O	O
cross-linking	O	O
of	O	O
Fc	protein	protein
gamma	protein	protein
RI	protein	protein
or	O	O
Fc	protein	protein
gamma	protein	protein
RII	protein	protein
by	O	O
adherent	protein	O
human	protein	O
IgG	protein	O
or	O	O
by	O	O
specific	O	O
anti-Fc	protein	protein
gamma	protein	protein
R	protein	protein
mAb	protein	protein
activates	O	O
HIV-1	O	DNA
gene	O	DNA
expression	O	O
in	O	O
the	O	O
human	cell_line	cell_line
monocytic	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
BF24	cell_line	cell_line
and	O	O
increased	O	O
HIV	RNA	O
RNA	RNA	O
expression	O	O
in	O	O
monocytes	cell_type	cell_type
from	O	O
HIV	O	O
infected	O	O
patients	O	O
as	O	O
assayed	O	O
by	O	O
reverse	O	O
transcription-PCR	O	O
.	O	O
In	O	O
THP-1	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
Fc	protein	protein
gamma	protein	protein
R	protein	protein
cross-linking	O	O
induced	O	O
NF-kappa	protein	protein
B	protein	protein
,	O	O
which	O	O
is	O	O
known	O	O
to	O	O
bind	O	O
to	O	O
the	O	O
regulatory	DNA	DNA
region	DNA	DNA
of	O	O
the	O	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
(	O	O
LTR	DNA	DNA
)	O	O
of	O	O
HIV-1	O	O
and	O	O
to	O	O
activate	O	O
HIV-1	O	O
transcription	O	O
.	O	O
Anti-TNF-alpha	protein	protein
antibody	protein	protein
but	O	O
not	O	O
anti-IL-1	protein	protein
beta	protein	protein
antibody	protein	protein
strongly	O	O
inhibited	O	O
both	O	O
the	O	O
induction	O	O
of	O	O
HIV-1	O	O
-	O	O
LTR	DNA	DNA
-driven	O	O
transcription	O	O
and	O	O
the	O	O
induction	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
by	O	O
Fc	protein	protein
gamma	protein	protein
R	protein	protein
cross-linking	O	O
.	O	O
These	O	O
results	O	O
indicate	O	O
that	O	O
Fc	protein	protein
gamma	protein	protein
R	protein	protein
can	O	O
mediate	O	O
a	O	O
TNF-alpha	protein	protein
-dependent	O	O
induction	O	O
of	O	O
HIV-1	DNA	DNA
gene	DNA	DNA
transcription	O	O
and	O	O
suggest	O	O
that	O	O
immune	protein	protein
complexes	protein	protein
may	O	O
contribute	O	O
to	O	O
the	O	O
pathophysiology	O	O
of	O	O
HIV-1	O	O
infection	O	O
by	O	O
augmenting	O	O
viral	O	O
replication	O	O
in	O	O
monocytes	cell_type	cell_type
.	O	O

Signalling	O	O
via	O	O
CD28	protein	protein
of	O	O
human	cell_line	O
naive	cell_line	O
neonatal	cell_line	O
T	cell_line	cell_type
lymphocytes	cell_line	cell_type
.	O	O
Accessory	O	protein
molecules	O	protein
play	O	O
a	O	O
crucial	O	O
role	O	O
in	O	O
the	O	O
development	O	O
of	O	O
the	O	O
T	O	O
cell	O	O
response	O	O
to	O	O
antigenic	O	O
challenge.	O	O
We	O	O
have	O	O
examined	O	O
the	O	O
role	O	O
of	O	O
CD28	protein	protein
in	O	O
modulating	O	O
the	O	O
'	O	O
naive'	O	O
neonatal	O	O
T	O	O
cell	O	O
response	O	O
to	O	O
anti-CD2	protein	protein
-mediated	O	O
activation	O	O
.	O	O
To	O	O
compare	O	O
the	O	O
role	O	O
of	O	O
CD28	protein	protein
,	O	O
neonatal	cell_type	O
and	O	O
adult	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
stimulated	O	O
with	O	O
a	O	O
pair	O	O
of	O	O
mitogenic	protein	O
anti-CD2	protein	protein
antibodies	protein	protein
in	O	O
the	O	O
presence	O	O
or	O	O
absence	O	O
of	O	O
anti-	protein	O
CD28	protein	protein
MoAb	protein	protein
.	O	O
With	O	O
anti-CD2	protein	protein
alone,	O	O
neonatal	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
proliferated	O	O
slightly	O	O
but	O	O
produced	O	O
no	O	O
detectable	O	O
IL-2	protein	protein
,	O	O
whereas	O	O
adult	O	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
proliferated	O	O
vigorously,	O	O
with	O	O
significant	O	O
IL-2	protein	protein
production	O	O
.	O	O
Costimulation	O	O
with	O	O
anti-	protein	protein
CD28	protein	protein
MoAb	protein	protein
greatly	O	O
enhanced	O	O
the	O	O
proliferative	O	O
response	O	O
of	O	O
neonatal	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
to	O	O
levels	O	O
equivalent	O	O
to	O	O
those	O	O
of	O	O
adult	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
whereas	O	O
adult	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
showed	O	O
only	O	O
slight	O	O
increases.	O	O
Although	O	O
IL-2	protein	protein
secretion	O	O
was	O	O
increased	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
anti-	protein	protein
CD28	protein	protein
MoAb	protein	protein
,	O	O
neonatal	cell_type	O
T	cell_type	O
cell	cell_type	O
IL-2	protein	protein
production	O	O
remained	O	O
lower	O	O
than	O	O
in	O	O
adults	O	O
.	O	O
In	O	O
contrast,	O	O
enhancement	O	O
of	O	O
IL-2	RNA	RNA
mRNA	RNA	RNA
expression	O	O
in	O	O
neonates	O	O
was	O	O
similar	O	O
to	O	O
adult	O	O
levels	O	O
.	O	O
Anti-	O	O
CD28	protein	protein
MoAb	protein	protein
costimulation	O	O
increased	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
levels	O	O
in	O	O
neonates	O	O
,	O	O
albeit	O	O
to	O	O
levels	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
adults	O	O
.	O	O
The	O	O
cellular	O	O
mechanism	O	O
governing	O	O
the	O	O
diminished	O	O
proliferative	O	O
response	O	O
of	O	O
neonatal	cell_type	cell_type
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
to	O	O
anti-CD2	protein	protein
may	O	O
therefore	O	O
be	O	O
due	O	O
to	O	O
decreased	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
induction	O	O
,	O	O
reduced	O	O
IL-2	RNA	RNA
mRNA	RNA	RNA
expression	O	O
and	O	O
deficient	O	O
IL-2	protein	protein
production	O	O
.	O	O
Although	O	O
anti-	protein	O
CD28	protein	protein
MoAb	protein	protein
costimulation	O	O
enhances	O	O
all	O	O
of	O	O
the	O	O
above	O	O
signals,	O	O
NF	O	protein
kappa	O	protein
B	O	protein
and	O	O
IL-2	O	protein
levels	O	O
remain	O	O
lower	O	O
than	O	O
in	O	O
adults	O	O
,	O	O
suggesting	O	O
the	O	O
need	O	O
for	O	O
further	O	O
activation	O	O
requirements	O	O
in	O	O
the	O	O
neonate	O	O
.	O	O

TCL1	O	protein
oncogene	O	protein
activation	O	O
in	O	O
preleukemic	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
from	O	O
a	O	O
case	O	O
of	O	O
ataxia-telangiectasia	O	O
.	O	O
The	O	O
TCL1	DNA	DNA
oncogene	DNA	DNA
on	O	O
human	DNA	DNA
chromosome	DNA	DNA
14q32.1	DNA	DNA
is	O	O
involved	O	O
in	O	O
chromosome	O	O
translocations	O	O
[	O	O
t(14;14)(q11;q32.1)	DNA	O
and	O	O
t(7;14)(q35;q32.1)	DNA	O
]	O	O
and	O	O
inversions	O	O
[	O	O
inv14(q11;q32.1)	DNA	O
]	O	O
with	O	O
TCR	DNA	protein
alpha/beta	DNA	protein
loci	DNA	O
in	O	O
T-cell	O	O
leukemias	O	O
,	O	O
such	O	O
as	O	O
T-prolymphocytic	O	O
(	O	O
T-PLL	O	O
).	O	O
It	O	O
is	O	O
also	O	O
involved	O	O
in	O	O
T-	O	O
acute	O	O
and-	O	O
chronic	O	O
leukemias	O	O
arising	O	O
in	O	O
cases	O	O
of	O	O
ataxia-telangiectasia	O	O
(	O	O
AT	O	O
),	O	O
an	O	O
immunodeficiency	O	O
syndrome	O	O
.	O	O
Similar	O	O
chromosomal	O	O
rearrangements	O	O
occur	O	O
also	O	O
in	O	O
the	O	O
clonally	O	cell_line
expanded	O	cell_line
T	cell_type	cell_line
cells	cell_type	cell_line
in	O	O
AT	O	O
patients	O	O
before	O	O
the	O	O
appearance	O	O
of	O	O
the	O	O
overt	O	O
leukemia	O	O
.	O	O
We	O	O
have	O	O
analyzed	O	O
the	O	O
expression	O	O
of	O	O
TCL1	RNA	RNA
mRNA	RNA	RNA
and	O	O
protein	protein	O
in	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
lymphocytes	cell_type	cell_type
(	O	O
PBLs	cell_type	cell_type
)	O	O
from	O	O
four	O	O
AT	O	O
cases	O	O
and	O	O
from	O	O
healthy	O	O
controls	O	O
.	O	O
We	O	O
found	O	O
that	O	O
the	O	O
TCL1	DNA	DNA
gene	DNA	DNA
was	O	O
overexpressed	O	O
in	O	O
the	O	O
PBLs	cell_type	cell_type
of	O	O
an	O	O
AT	O	O
patient	O	O
with	O	O
a	O	O
large	cell_line	O
clonal	cell_line	O
T-cell	cell_line	O
population	cell_line	O
exhibiting	O	O
the	O	O
t(14;14)	O	O
translocation	O	O
but	O	O
not	O	O
in	O	O
the	O	O
lymphocytes	cell_type	O
of	O	O
the	O	O
other	O	O
cases.	O	O
Fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
of	O	O
the	O	O
TCL1	DNA	DNA
genomic	DNA	DNA
locus	DNA	DNA
to	O	DNA
lymphocyte	O	DNA
metaphases	O	DNA
from	O	O
the	O	O
AT	O	O
patient	O	O
with	O	O
the	O	O
T-cell	O	O
clonal	O	O
expansion	O	O
showed	O	O
that	O	O
the	O	O
breakpoint	O	O
of	O	O
the	O	O
t(14;14)	O	O
translocation	O	O
lies	O	O
within	O	O
the	O	O
TCL1	DNA	DNA
locus	DNA	DNA
and	O	O
is	O	O
accompanied	O	O
by	O	O
an	O	O
inverted	DNA	O
duplication	DNA	O
of	O	O
the	O	O
distal	DNA	O
part	DNA	O
of	O	O
chromosome	DNA	DNA
14	DNA	DNA
.	O	O
These	O	O
data	O	O
indicate	O	O
that	O	O
TCL1	DNA	protein
is	O	O
activated	O	O
in	O	O
preleukemic	cell_line	cell_type
clonal	cell_line	cell_type
cells	cell_line	cell_type
as	O	O
a	O	O
consequence	O	O
of	O	O
chromosome	O	O
translocation	O	O
involving	O	O
sequences	O	O
from	O	O
the	O	O
TCR	DNA	DNA
locus	DNA	DNA
at	O	O
14q11	DNA	O
.	O	O
Deregulation	O	O
of	O	O
TCL1	DNA	protein
is	O	O
the	O	O
first	O	O
event	O	O
in	O	O
the	O	O
initiation	O	O
of	O	O
malignancy	O	O
in	O	O
these	O	O
types	O	O
of	O	O
leukemias	O	O
and	O	O
represents	O	O
a	O	O
potential	O	O
tool	O	O
for	O	O
clinical	O	O
evaluation	O	O
.	O	O

C/EBP	protein	protein
proteins	protein	protein
activate	O	O
transcription	O	O
from	O	O
the	O	O
human	DNA	DNA
immunodeficiency	DNA	DNA
virus	DNA	DNA
type	DNA	DNA
1	DNA	DNA
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
in	O	O
macrophages/	O	cell_type
monocytes	cell_type	cell_type
.	O	O
Three	O	O
binding	O	O
sites	O	O
for	O	O
C/EBP	protein	protein
proteins	protein	protein
are	O	O
found	O	O
in	O	O
the	O	O
human	DNA	O
immunodeficiency	DNA	O
virus	DNA	O
type	DNA	O
1	DNA	O
(	DNA	O
HIV-1	DNA	O
)	DNA	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
(	O	O
LTR	DNA	DNA
)	O	O
(V.M.	O	O
Tesmer,	O	O
A.Rajadhyaksha,	O	O
J.Babin,	O	O
and	O	O
M.Bina,	O	O
Proc.Natl.Acad.Sci.	O	O
USA	O	O
90:7298-7302,	O	O
1993).	O	O
We	O	O
have	O	O
determined	O	O
the	O	O
functional	O	O
role	O	O
of	O	O
C/EBP	protein	protein
proteins	protein	protein
and	O	O
C/EBP	DNA	DNA
sites	DNA	DNA
in	O	O
regulating	O	O
transcription	O	O
from	O	O
the	O	O
HIV-	DNA	O
1	DNA	O
LTR	DNA	DNA
in	O	O
monocytes	cell_type	cell_type
/macrophages	cell_type	cell_type
.	O	O
Inhibition	O	O
of	O	O
endogenous	protein	protein
C/EBP	protein	protein
proteins	protein	protein
,	O	O
using	O	O
either	O	O
an	O	O
excess	O	O
of	O	O
C/EBP	DNA	DNA
binding	DNA	DNA
sites	DNA	DNA
or	O	O
a	O	O
trans-	DNA	O
dominant	DNA	O
negative	DNA	O
inhibitor	DNA	O
,	O	O
demonstrated	O	O
that	O	O
C/EBP	protein	protein
proteins	protein	protein
are	O	O
required	O	O
for	O	O
basal	O	O
and	O	O
activated	O	O
levels	O	O
of	O	O
HIV-1	DNA	DNA
LTR	DNA	DNA
transcription	O	O
in	O	O
the	O	O
promonocytic	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
U937	cell_line	cell_line
.	O	O
Northern	O	O
(RNA)	O	O
blots	O	O
and	O	O
binding	O	O
assays	O	O
showed	O	O
that	O	O
NF-IL6	protein	protein
is	O	O
the	O	O
only	O	O
known	O	O
C/EBP	protein	protein
family	protein	protein
member	protein	protein
which	O	O
is	O	O
increased	O	O
when	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
are	O	O
activated.	O	O
Mutational	O	O
analyses	O	O
of	O	O
the	O	O
HIV-1	DNA	DNA
LTR	DNA	DNA
showed	O	O
that	O	O
one	O	O
C/EBP	DNA	DNA
site	DNA	DNA
is	O	O
required	O	O
for	O	O
normal	O	O
LTR	DNA	DNA
transcription	O	O
both	O	O
before	O	O
and	O	O
after	O	O
cellular	O	O
activation	O	O
and	O	O
that	O	O
the	O	O
two	O	O
3'	O	DNA
C/EBP	DNA	DNA
sites	DNA	DNA
are	O	O
functionally	O	O
equivalent.	O	O
However,	O	O
transcription	O	O
from	O	O
crippled	DNA	O
HIV-1	DNA	O
LTRs	DNA	DNA
lacking	O	DNA
C/EBP	DNA	DNA
sites	DNA	DNA
can	O	O
still	O	O
be	O	O
induced	O	O
following	O	O
activation	O	O
of	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Several	O	O
models	O	O
are	O	O
suggested	O	O
for	O	O
how	O	O
elevated	O	O
NF-IL6	protein	protein
may	O	O
participate	O	O
in	O	O
an	O	O
autostimulatory	O	O
loop	O	O
involving	O	O
HIV	O	O
infection	O	O
,	O	O
macrophage	O	O
activation	O	O
,	O	O
cytokine	protein	protein
expression	O	O
,	O	O
and	O	O
HIV	O	O
replication	O	O
.	O	O

Human	O	O
immunodeficiency	O	O
virus	O	O
type-2	O	O
gene	O	O
expression	O	O
:	O	O
two	O	O
enhancers	DNA	DNA
and	O	O
their	O	O
activation	O	O
by	O	O
T-cell	cell_type	O
activators	O	O
.	O	O
The	O	O
human	O	O
immunodeficiency	O	O
viruses	O	O
(	O	O
HIVs	O	O
)	O	O
may	O	O
include	O	O
a	O	O
spectrum	O	O
of	O	O
retroviruses	O	O
with	O	O
varying	O	O
potential	O	O
to	O	O
infect	O	O
their	O	O
host,	O	O
undergo	O	O
long	O	O
periods	O	O
of	O	O
latent	O	O
infection	O	O
,	O	O
and	O	O
induce	O	O
pathology	O	O
.	O	O
Since	O	O
expression	O	O
of	O	O
the	O	O
viruses	O	O
is	O	O
in	O	O
large	O	O
part	O	O
regulated	O	O
by	O	O
the	O	O
sequence	DNA	DNA
elements	DNA	DNA
in	O	O
their	O	O
long	DNA	O
terminal	DNA	O
repeats	DNA	O
(	O	O
LTRs	DNA	DNA
),	O	O
this	O	O
study	O	O
was	O	O
directed	O	O
to	O	O
an	O	O
analysis	O	O
of	O	O
the	O	O
regulatory	DNA	DNA
elements	DNA	DNA
in	O	O
the	O	O
HIV-2	DNA	DNA
LTR	DNA	DNA
.	O	O
The	O	O
HIV-2	DNA	DNA
LTR	DNA	DNA
was	O	O
found	O	O
to	O	O
contain	O	O
two	O	O
enhancers	DNA	DNA
.	O	O
One	O	O
of	O	O
these	O	O
enhancers	DNA	DNA
is,	O	O
in	O	O
part,	O	O
identical	O	O
to	O	O
the	O	O
HIV-1	DNA	DNA
enhancer	DNA	DNA
.	O	O
This	O	O
enhancer	DNA	O
in	O	O
HIV-1	O	O
is	O	O
the	O	O
T-cell	DNA	O
activation	DNA	O
response	DNA	O
element	DNA	O
;	O	O
in	O	O
HIV-2	O	O
,	O	O
however,	O	O
it	O	O
is	O	O
the	O	O
second	DNA	O
enhancer	DNA	O
that	O	O
is	O	O
mainly	O	O
responsible	O	O
for	O	O
activation	O	O
in	O	O
response	O	O
to	O	O
T-cell	O	O
activators	O	O
.	O	O
The	O	O
second	O	O
enhancer	DNA	O
interacts	O	O
with	O	O
two	O	O
nuclear	protein	protein
binding	protein	protein
proteins	protein	protein
(85	O	protein
kD	O	protein
and	O	O
27	O	O
kD	O	O
mobility)	O	O
that	O	O
appear	O	O
to	O	O
be	O	O
required	O	O
for	O	O
optimal	O	O
enhancer	O	O
function	O	O
and	O	O
activation.	O	O
Observations	O	O
such	O	O
as	O	O
these	O	O
encourage	O	O
the	O	O
speculation	O	O
that	O	O
there	O	O
may	O	O
be	O	O
subtle	O	O
differences	O	O
in	O	O
the	O	O
regulation	O	O
of	O	O
HIV-1	O	O
and	O	O
HIV-2	O	O
expression	O	O
that	O	O
may	O	O
be	O	O
relevant	O	O
to	O	O
the	O	O
possible	O	O
longer	O	O
latency	O	O
and	O	O
reduced	O	O
pathogenicity	O	O
of	O	O
HIV-2	O	O
.	O	O

NF-M	protein	protein
(	O	O
chicken	protein	protein
C/EBP	protein	protein
beta	protein	protein
)	O	O
induces	O	O
eosinophilic	O	O
differentiation	O	O
and	O	O
apoptosis	O	O
in	O	O
a	O	O
hematopoietic	cell_line	cell_line
progenitor	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
.	O	O
CAAT/enhancer	protein	protein
binding	protein	protein
proteins	protein	protein
(	O	O
C/EBPs	protein	protein
)	O	O
are	O	O
transcriptional	O	O
activators	O	O
implicated	O	O
in	O	O
the	O	O
differentiation	O	O
processes	O	O
of	O	O
various	O	O
cell	O	O
lineages.	O	O
We	O	O
have	O	O
shown	O	O
earlier	O	O
that	O	O
NF-M	protein	protein
,	O	O
the	O	O
chicken	protein	protein
homolog	protein	protein
of	O	O
C/EBP	protein	protein
beta	protein	protein
,	O	O
is	O	O
specifically	O	O
expressed	O	O
in	O	O
myelomonocytic	O	O
and	O	O
eosinophilic	O	O
cells	O	O
of	O	O
the	O	O
hematopoietic	O	O
system.	O	O
To	O	O
investigate	O	O
the	O	O
role	O	O
of	O	O
NF-M	protein	protein
in	O	O
hematopoietic	cell_line	cell_type
cell	cell_line	cell_type
lineage	cell_line	cell_type
commitment,	O	O
we	O	O
constructed	O	O
a	O	O
conditional	O	O
form	O	O
of	O	O
the	O	O
protein	O	O
by	O	O
fusing	O	O
it	O	O
to	O	O
the	O	O
hormone	protein	protein
binding	protein	protein
domain	protein	protein
of	O	O
the	O	O
human	protein	protein
estrogen	protein	protein
receptor	protein	protein
.	O	O
This	O	O
construct	O	O
was	O	O
stably	O	O
expressed	O	O
in	O	O
a	O	O
multipotent	cell_line	O
progenitor	cell_line	O
cell	cell_line	O
line	cell_line	O
transformed	O	O
by	O	O
the	O	O
Myb-Ets	protein	protein
oncoprotein	protein	protein
.	O	O
We	O	O
report	O	O
here	O	O
that	O	O
both	O	O
NF-M	DNA	DNA
-dependent	DNA	DNA
promoter	DNA	DNA
constructs	DNA	DNA
and	O	DNA
resident	O	DNA
genes	O	DNA
could	O	O
be	O	O
activated	O	O
by	O	O
addition	O	O
of	O	O
beta-estradiol	O	O
to	O	O
the	O	O
NF-M	cell_line	protein
-estrogen	cell_line	protein
receptor	cell_line	protein
expressing	cell_line	O
progenitors	cell_line	protein
.	O	O
At	O	O
the	O	O
same	O	O
time,	O	O
we	O	O
observed	O	O
a	O	O
down-regulation	O	O
of	O	O
progenitor-specific	protein	protein
surface	protein	protein
markers	protein	protein
and	O	O
the	O	O
up-regulation	O	O
of	O	O
differentiation	protein	O
markers	protein	O
restricted	O	O
to	O	O
the	O	O
eosinophil	cell_type	protein
and	O	O
myeloid	cell_type	O
lineages	cell_type	O
.	O	O
In	O	O
addition	O	O
to	O	O
the	O	O
onset	O	O
of	O	O
differentiation	O	O
,	O	O
cell	O	O
death	O	O
was	O	O
induced	O	O
with	O	O
typical	O	O
apoptotic	O	O
features.	O	O
Our	O	O
results	O	O
suggest	O	O
that	O	O
NF-M	protein	protein
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
commitment	O	O
along	O	O
the	O	O
eosinophil	cell_type	cell_type
lineage	cell_type	cell_type
and	O	O
in	O	O
the	O	O
induction	O	O
of	O	O
apoptosis	O	O
.	O	O

Prolactin	protein	O
and	O	O
interleukin-2	protein	protein
receptors	protein	protein
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
signal	O	O
through	O	O
a	O	O
MGF-STAT5-like	protein	protein
transcription	protein	protein
factor	protein	protein
.	O	O
The	O	O
cell	O	protein
surface	O	protein
receptors	O	protein
for	O	O
PRL	protein	protein
and	O	O
interleukin-2	protein	protein
(	O	O
IL-2	protein	protein
)	O	O
are	O	O
structurally	O	O
distinct,	O	O
but	O	O
share	O	O
regulatory	O	O
tasks	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
They	O	O
can	O	O
stimulate	O	O
proliferation	O	O
and	O	O
activate	O	O
transcription	O	O
of	O	O
over-lapping	O	O
sets	O	O
of	O	O
genes	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
PRL	protein	O
and	O	O
IL-2	protein	protein
receptor	O	protein
activation	O	O
are	O	O
both	O	O
linked	O	O
to	O	O
the	O	O
Jak/Stat	protein	protein
(	O	O
signal	protein	protein
transducer	protein	protein
and	protein	protein
activator	protein	protein
of	protein	protein
transcription	protein	protein
)	O	O
pathway	O	O
.	O	O
We	O	O
investigated	O	O
the	O	O
ability	O	O
of	O	O
PRL	protein	protein
and	O	O
IL-2	protein	protein
to	O	O
activate	O	O
Stat	protein	protein
proteins	protein	protein
in	O	O
different	O	O
T	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
The	O	O
DNA	O	O
binding	O	O
specificities,	O	O
the	O	O
reactivities	O	O
toward	O	O
Stat-specific	O	O
antisera	O	O
,	O	O
and	O	O
the	O	O
mol	O	O
wt	O	O
of	O	O
IL-2	protein	protein
-and	O	O
PRL	protein	protein
-induced	protein	protein
DNA-binding	protein	protein
proteins	protein	protein
in	O	O
Nb2	O	O
and	O	O
C196	O	cell_line
T	O	cell_line
cell	O	cell_line
lines	O	cell_line
were	O	O
investigated.	O	O
A	O	O
comparison	O	O
with	O	O
the	O	O
Stat	protein	protein
proteins	protein	protein
induced	O	O
by	O	O
interferon-gamma	protein	protein
,	O	O
PRL	protein	protein
,	O	O
and	O	O
IL-6	protein	protein
in	O	O
T47D	cell_line	cell_line
mammary	cell_line	cell_line
tumor	cell_line	cell_line
cells	cell_line	cell_line
was	O	O
made.	O	O
We	O	O
found	O	O
that	O	O
these	O	O
parameters	O	O
were	O	O
indistinguishable	O	O
for	O	O
one	O	O
of	O	O
the	O	O
PRL-	O	O
and	O	O
IL-2-	O	O
induced	O	O
factors	O	O
.	O	O
A	O	O
transcription	O	O
factor	O	O
closely	O	O
related	O	O
to	O	O
mammary	protein	O
gland	protein	O
factor-Stat5	protein	protein
is	O	O
rapidly	O	O
activated	O	O
upon	O	O
interaction	O	O
of	O	O
IL-2	protein	protein
and	O	O
PRL	protein	O
with	O	O
their	O	O
respective	O	O
receptors.	O	O
Activation	O	O
of	O	O
a	O	O
second	O	O
protein	O	O
related	O	O
to	O	O
Stat1	protein	protein
was	O	O
also	O	O
observed.	O	O
Our	O	O
results	O	O
emphasize	O	O
the	O	O
role	O	O
of	O	O
PRL	protein	protein
as	O	O
a	O	O
regulator	O	O
of	O	O
the	O	O
immune	O	O
response	O	O
and	O	O
indicate	O	O
that	O	O
the	O	O
Stat	protein	protein
factors	protein	protein
mammary	protein	O
gland	protein	O
factor-Stat5	protein	O
and	O	O
Stat1	protein	protein
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
regulation	O	O
of	O	O
gene	O	O
expression	O	O
during	O	O
T	O	O
cell	O	O
development	O	O
.	O	O

ETS1	protein	protein
transactivates	O	O
the	O	O
human	DNA	DNA
GM-CSF	DNA	DNA
promoter	DNA	DNA
in	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
stimulated	O	O
with	O	O
PMA	O	O
and	O	O
ionomycin	O	O
.	O	O
Activation	O	O
of	O	O
T	cell_type	cell_type
helper	cell_type	cell_type
cells	cell_type	cell_type
results	O	O
in	O	O
coordinate	O	O
expression	O	O
of	O	O
a	O	O
number	O	O
of	O	O
cytokines	protein	protein
involved	O	O
in	O	O
differentiation	O	O
,	O	O
proliferation	O	O
and	O	O
activation	O	O
of	O	O
the	O	O
haematopoietic	O	O
system	O	O
.	O	O
Granulocyte-macrophage	protein	protein
colony-stimulating	protein	protein
factor	protein	protein
(	O	O
GM-CSF	protein	protein
)	O	O
is	O	O
one	O	O
such	O	O
cytokine	protein	protein
whose	O	O
increased	O	O
expression	O	O
results	O	O
partly	O	O
from	O	O
increases	O	O
in	O	O
transcription	O	O
.	O	O
Cis-acting	DNA	DNA
elements	DNA	DNA
with	O	O
NF	protein	protein
kappa	protein	protein
B	protein	protein
,	O	O
AP-1	protein	protein
and	O	O
ETS-like	DNA	O
motifs	DNA	O
have	O	O
been	O	O
identified	O	O
in	O	O
the	O	O
promoter	O	DNA
region	O	DNA
of	O	O
the	O	O
GM-CSF	DNA	DNA
gene	DNA	DNA
,	O	O
which	O	O
are	O	O
important	O	O
for	O	O
transcriptional	O	O
activity	O	O
following	O	O
PMA	O	O
and	O	O
ionomycin	O	O
stimulation.	O	O
A	O	O
number	O	O
of	O	O
the	O	O
ETS	protein	protein
family	protein	protein
of	O	O
transcription	protein	protein
factors	protein	protein
are	O	O
expressed	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
including	O	O
ETS1	protein	protein
and	O	O
ELF1	protein	protein
.	O	O
Here	O	O
we	O	O
describe	O	O
the	O	O
ability	O	O
of	O	O
these	O	O
factors	O	O
to	O	O
interact	O	O
with	O	O
a	O	O
site	O	O
(	O	O
GM5	DNA	DNA
),	O	O
located	O	O
within	O	O
the	O	O
CLE0	DNA	DNA
element	DNA	DNA
,	O	O
-47	DNA	O
to	DNA	O
-40	DNA	O
upstream	DNA	O
of	O	O
the	O	O
GM-CSF	DNA	protein
transcription	DNA	O
initiation	DNA	O
site	DNA	O
.	O	O
Exogenous	O	O
ETS1	protein	protein
,	O	O
but	O	O
not	O	O
ELF1	protein	protein
,	O	O
can	O	O
transactivate	O	O
GM-CSF	protein	protein
,	O	O
through	O	O
the	O	O
GM5	DNA	O
site,	O	O
in	O	O
a	O	O
PMA	O	O
/	O	O
ionomycin	O	O
dependent	O	O
manner	O	O
.	O	O
Other	O	O
unidentified	O	O
ETS-like	protein	protein
factors	protein	protein
present	O	O
in	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
are	O	O
also	O	O
capable	O	O
of	O	O
binding	O	O
GM5	DNA	protein
.	O	O
Mutation	O	O
of	O	O
the	O	O
core	O	O
ETS	DNA	O
binding	DNA	O
site	DNA	O
from	O	O
-GGAA-	DNA	O
to	DNA	O
-GGAT-	DNA	O
prevents	O	O
the	O	O
binding	O	O
of	O	O
ETS-like	protein	protein
factors	protein	protein
with	O	O
the	O	O
exception	O	O
of	O	O
ETS1	protein	protein
.	O	O
The	O	O
GM-CSF	DNA	DNA
promoter	DNA	DNA
,	O	O
modified	O	O
in	O	O
this	O	O
way	O	O
to	O	O
be	O	O
ETS1	protein	protein
specific	O	O
,	O	O
is	O	O
fully	O	O
responsive	O	O
to	O	O
PMA	O	O
/	O	O
ionomycin	O	O
induction,	O	O
in	O	O
addition	O	O
to	O	O
ETS1	protein	protein
transactivation	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
PMA	O	O
and	O	O
ionomycin	O	O
.	O	O
Together	O	O
these	O	O
data	O	O
suggest	O	O
that	O	O
ETS1	protein	protein
may	O	O
be	O	O
involved	O	O
in	O	O
mediating	O	O
the	O	O
increased	O	O
GM-CSF	protein	protein
production	O	O
associated	O	O
with	O	O
T	cell_type	O
cell	cell_type	O
activation	O	O
.	O	O

Quantitation	O	O
of	O	O
beta	RNA	O
1	RNA	O
triiodothyronine	RNA	O
receptor	RNA	O
mRNA	RNA	O
in	O	O
human	O	O
tissues	O	O
by	O	O
competitive	O	O
reverse	O	O
transcription	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O
Thyroid	O	O
hormones	O	O
act	O	O
by	O	O
binding	O	O
to	O	O
nuclear	protein	protein
receptor	protein	protein
proteins	protein	protein
,	O	O
the	O	O
thyroid	protein	protein
hormone	protein	protein
receptors	protein	protein
(	O	O
TR	protein	protein
)	O	O
alpha	O	O
and	O	O
beta	O	O
.	O	O
Data	O	O
from	O	O
cell	O	O
culture	O	O
and	O	O
animal	O	O
studies	O	O
indicate	O	O
that	O	O
TR	protein	DNA
expression	O	O
may	O	O
be	O	O
regulated	O	O
to	O	O
modulate	O	O
target	O	O
organ	O	O
responsiveness	O	O
to	O	O
thyroid	O	O
hormone	O	O
.	O	O
To	O	O
investigate	O	O
whether	O	O
such	O	O
adaptive	O	O
changes	O	O
in	O	O
TR	protein	O
expression	O	O
occur	O	O
in	O	O
humans,	O	O
we	O	O
determined	O	O
the	O	O
mRNA	O	O
levels	O	O
of	O	O
the	O	O
hTR	protein	DNA
beta	protein	DNA
1	protein	DNA
in	O	O
various	O	O
thyroid	O	O
states	O	O
.	O	O
Patients	O	O
with	O	O
overt	O	O
hypo	O	O
-or	O	O
hyper	O	O
thyroidism	O	O
were	O	O
enrolled	O	O
in	O	O
the	O	O
study.	O	O
Total	RNA	O
RNA	RNA	O
was	O	O
isolated	O	O
from	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
hTR	RNA	O
beta	RNA	O
1	RNA	O
mRNA	RNA	O
levels	O	O
determined	O	O
by	O	O
quantitative	O	O
competitive	O	O
reverse	O	O
transcription	O	O
PCR	O	O
.	O	O
For	O	O
comparison,	O	O
hTR	RNA	O
beta	RNA	O
1	RNA	O
mRNA	RNA	O
levels	O	O
were	O	O
determined	O	O
in	O	O
lymphocytes	cell_type	cell_type
and	O	O
normal	O	O
thyroid	O	O
tissue	O	O
of	O	O
euthyroid	O	O
patients	O	O
.	O	O
Human	RNA	O
TR	RNA	DNA
beta	RNA	DNA
1	RNA	DNA
mRNA	RNA	O
levels	O	O
in	O	O
lymphocytes	cell_type	cell_type
were	O	O
1.8	O	O
+/-	O	O
0.4,	O	O
1.9	O	O
+/-	O	O
0.5,	O	O
1.1	O	O
+/-	O	O
0.4	O	O
10(-18)	O	O
mol/microgram	O	O
RNA	O	O
in	O	O
hypo	O	O
-,	O	O
eu	O	O
-and	O	O
hyper	O	O
thyroid	O	O
patients	O	O
,	O	O
respectively,	O	O
corresponding	O	O
to	O	O
an	O	O
estimated	O	O
0.5	O	O
-2	O	protein
molecules	O	protein
per	O	O
cell.	O	O
Although	O	O
the	O	O
mean	O	O
hTR	RNA	O
beta	RNA	O
1	RNA	O
mRNA	RNA	O
levels	O	O
were	O	O
40%	O	O
lower	O	O
in	O	O
hyperthyroid	O	O
than	O	O
in	O	O
euthyroid	O	O
subjects,	O	O
this	O	O
difference	O	O
did	O	O
not	O	O
reach	O	O
statistical	O	O
significance	O	O
.	O	O
Similar	O	O
levels	O	O
of	O	O
hTR	RNA	DNA
beta	RNA	DNA
1	RNA	DNA
mRNA	RNA	O
levels	O	O
were	O	O
detected	O	O
in	O	O
thyroid	O	O
gland	O	O
from	O	O
euthyroid	O	O
patients	O	O
.	O	O
In	O	O
summary,	O	O
we	O	O
developed	O	O
an	O	O
assay	O	O
for	O	O
the	O	O
quantitative	O	O
determination	O	O
of	O	O
hTR	RNA	DNA
beta	RNA	DNA
1	RNA	DNA
mRNA	RNA	O
levels	O	O
in	O	O
small	O	O
human	O	O
tissue	O	O
samples	O	O
,	O	O
containing	O	O
as	O	O
little	O	O
as	O	O
50	O	O
ng	O	O
of	O	O
total	O	O
RNA.	O	O
Absolute	O	O
hTR	RNA	O
beta	RNA	O
1	RNA	O
mRNA	RNA	O
levels	O	O
are	O	O
very	O	O
low	O	O
with	O	O
an	O	O
estimated	O	O
one	O	O
molecule	O	O
of	O	O
mRNA	RNA	RNA
being	O	O
present	O	O
in	O	O
a	O	O
mononuclear	cell_type	cell_line
blood	cell_type	cell_line
cell	cell_type	cell_line
or	O	O
thyrocyte	cell_type	O
.	O	O
No	O	O
up-regulation	O	O
of	O	O
hTR	protein	DNA
beta	protein	DNA
1	protein	DNA
was	O	O
seen	O	O
in	O	O
hypothyroid	O	O
relative	O	O
to	O	O
euthyroid	O	O
patients	O	O
.	O	O
However,	O	O
there	O	O
is	O	O
a	O	O
non-significant	O	O
trend	O	O
towards	O	O
a	O	O
down-regulation	O	O
of	O	O
hTR	RNA	DNA
beta	RNA	DNA
1	RNA	DNA
mRNA	RNA	O
levels	O	O
in	O	O
hyperthyroid	O	O
patients	O	O
.	O	O

Multiple	O	O
proteins	protein	O
interact	O	O
with	O	O
the	O	O
nuclear	DNA	protein
inhibitory	DNA	protein
protein	DNA	protein
repressor	DNA	protein
element	DNA	protein
in	O	O
the	O	O
human	DNA	DNA
interleukin-3	DNA	DNA
promoter	DNA	DNA
.	O	O
T	O	O
cell	O	O
expression	O	O
of	O	O
interleukin	protein	protein
3	protein	protein
(	O	O
IL-3	protein	protein
)	O	O
is	O	O
directed	O	O
by	O	O
positive	O	O
and	O	O
negative	O	O
cis-acting	O	DNA
DNA	O	DNA
elements	O	DNA
clustered	O	O
within	O	O
300	O	O
base	O	O
pairs	O	O
of	O	O
the	O	O
transcriptional	DNA	DNA
start	DNA	DNA
site	DNA	DNA
.	O	O
A	O	O
strong	O	DNA
repressor	protein	DNA
element	protein	DNA
,	O	O
termed	O	O
nuclear	protein	protein
inhibitory	protein	protein
protein	protein	protein
(	O	O
NIP	protein	protein
),	O	O
was	O	O
previously	O	O
mapped	O	O
to	O	O
a	O	O
segment	O	O
of	O	O
the	O	O
IL-3	DNA	DNA
promoter	DNA	DNA
between	O	O
nucleotides	DNA	DNA
-271	DNA	DNA
and	DNA	O
-250	DNA	O
.	O	O
Functional	O	O
characterization	O	O
of	O	O
this	O	O
element	O	O
demonstrates	O	O
that	O	O
it	O	O
can	O	O
mediate	O	O
repression	O	O
when	O	O
linked	O	O
in	O	O
cis	O	O
to	O	O
a	O	O
heterologous	DNA	DNA
promoter	DNA	DNA
.	O	O
DNA	O	O
binding	O	O
experiments	O	O
were	O	O
carried	O	O
out	O	O
to	O	O
characterize	O	O
the	O	O
repressor	O	O
activity	O	O
.	O	O
Using	O	O
varying	O	O
conditions,	O	O
three	O	O
distinct	O	O
complexes	O	O
were	O	O
shown	O	O
to	O	O
interact	O	O
specifically	O	O
with	O	O
the	O	O
NIP	DNA	protein
region	DNA	protein
,	O	O
although	O	O
only	O	O
one	O	O
correlates	O	O
with	O	O
repressor	O	O
activity	O	O
.	O	O
Complex	protein	O
1	protein	O
results	O	O
from	O	O
binding	O	O
of	O	O
a	O	O
ubiquitous	O	O
polypeptide	O	O
that	O	O
recognizes	O	O
the	O	O
3'	DNA	O
portion	DNA	O
of	O	O
this	O	O
sequence	O	O
and	O	O
is	O	O
not	O	O
required	O	O
for	O	O
repression	O	O
.	O	O
Complex	protein	O
2	protein	O
corresponds	O	O
to	O	O
binding	O	O
of	O	O
transcription	protein	protein
factor	protein	protein
(	O	O
upstream	protein	protein
stimulatory	protein	protein
factor	protein	protein
)	O	O
to	O	O
an	O	O
E-box	DNA	DNA
motif	DNA	DNA
in	O	O
the	O	O
5'	DNA	DNA
portion	DNA	DNA
of	O	O
the	O	O
NIP	DNA	protein
region	DNA	protein
.	O	O
DNA	O	O
binding	O	O
specificity	O	O
of	O	O
complex	O	O
3	O	O
overlaps	O	O
with	O	O
that	O	O
of	O	O
upstream	protein	protein
stimulatory	protein	protein
factor	protein	protein
but	O	O
is	O	O
clearly	O	O
distinct.	O	O
To	O	O
determine	O	O
which	O	O
of	O	O
the	O	O
latter	O	O
two	O	O
complexes	O	O
represents	O	O
NIP	protein	O
activity	O	O
,	O	O
we	O	O
incorporated	O	O
small	O	O
alterations	O	O
into	O	O
the	O	O
NIP	DNA	DNA
site	DNA	DNA
of	O	O
an	O	O
IL-3	DNA	DNA
promoter	DNA	DNA
-linked	DNA	DNA
reporter	DNA	DNA
construct	DNA	DNA
and	O	O
examined	O	O
their	O	O
effects	O	O
on	O	O
NIP	protein	protein
-mediated	O	O
repression	O	O
.	O	O
Functional	O	O
specificity	O	O
for	O	O
repression	O	O
matches	O	O
the	O	O
DNA	O	O
binding	O	O
specificity	O	O
of	O	O
complex	protein	O
3	protein	O
;	O	O
both	O	O
repressor	O	O
activity	O	O
and	O	O
complex	protein	O
3	protein	O
binding	O	O
require	O	O
the	O	O
consensus	DNA	DNA
sequence	DNA	DNA
CTCACNTNC	O	DNA
.	O	O

The	O	O
hematopoietic	protein	protein
transcription	protein	protein
factor	protein	protein
PU.1	protein	protein
is	O	O
downregulated	O	O
in	O	O
human	cell_line	O
multiple	cell_line	O
myeloma	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
PU.1	protein	protein
is	O	O
a	O	O
hematopoietic	protein	protein
transcription	protein	protein
factor	protein	protein
belonging	O	O
to	O	O
the	O	O
Ets-family	protein	protein
.	O	O
It	O	O
is	O	O
identical	O	O
to	O	O
the	O	O
Spi-1	DNA	DNA
oncogene	DNA	DNA
,	O	O
which	O	O
is	O	O
implicated	O	O
in	O	O
spleen	O	O
focus-forming	O	O
virus-induced	O	O
murine	O	O
erythroleukemias	O	O
.	O	O
PU.1	protein	protein
seems	O	O
to	O	O
be	O	O
required	O	O
for	O	O
early	O	O
development	O	O
of	O	O
multiple	cell_type	O
hematopoietic	cell_type	O
lineages	cell_type	O
,	O	O
but	O	O
its	O	O
expression	O	O
in	O	O
mature	cell_type	cell_type
cells	cell_type	cell_type
is	O	O
preferentially	O	O
observed	O	O
in	O	O
cells	O	O
of	O	O
the	O	O
B-cell-and	cell_type	O
monocyte/macrophage-	cell_type	O
differentiation	cell_type	O
lineage	cell_type	O
.	O	O
It	O	O
binds	O	O
the	O	O
so-called	O	O
Pu	DNA	DNA
box	DNA	DNA
,	O	O
an	O	O
important	O	O
tissue-specific	DNA	O
regulatory	DNA	DNA
DNA	DNA	DNA
element	DNA	DNA
present	O	O
in	O	O
a	O	O
number	O	O
of	O	O
genes	O	O
expressed	O	O
in	O	O
these	O	O
cell	cell_type	O
lineages	cell_type	O
.	O	O
We	O	O
have	O	O
analyzed	O	O
the	O	O
expression	O	O
and	O	O
activity	O	O
of	O	O
PU.1	protein	protein
during	O	O
human	O	O
B-cell	O	O
development	O	O
using	O	O
a	O	O
panel	O	O
of	O	O
B-cell	cell_line	cell_line
lines	cell_line	cell_line
representing	O	O
different	O	O
stages	O	O
of	O	O
maturation,	O	O
from	O	O
early	cell_line	O
precursors	cell_line	O
to	O	O
differentiated	cell_line	O
plasma	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
PU.1	RNA	RNA
mRNA	RNA	RNA
expression	O	O
and	O	O
PU.1	protein	protein
DNA	O	O
binding	O	O
activity	O	O
,	O	O
as	O	O
measured	O	O
by	O	O
Northern	O	O
blot	O	O
analysis	O	O
and	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assay	O	O
,	O	O
respectively,	O	O
were	O	O
evident	O	O
in	O	O
cell	cell_line	cell_line
lines	cell_line	cell_line
representing	O	O
pro-B	O	O
,	O	O
pre-B	O	O
,	O	O
and	O	O
mature	O	cell_type
B	O	cell_type
cells	O	cell_type
.	O	O
We	O	O
could	O	O
also	O	O
show	O	O
Pu	DNA	DNA
box	DNA	DNA
-dependent	O	O
transactivation	O	O
of	O	O
a	O	O
reporter	O	DNA
gene	O	DNA
in	O	O
transient	O	O
transfections	O	O
in	O	O
these	O	O
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
In	O	O
contrast,	O	O
in	O	O
a	O	O
number	O	O
of	O	O
multiple	cell_line	O
myeloma	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
,	O	O
representing	O	O
differentiated,	cell_type	O
plasma	cell_type	O
cell-like	cell_type	O
B	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
PU.1	protein	protein
DNA	O	O
binding	O	O
activity	O	O
,	O	O
mRNA	O	O
expression	O	O
,	O	O
and	O	O
Pu	DNA	protein
box	DNA	protein
-dependent	O	O
transactivation	O	O
were	O	O
absent	O	O
or	O	O
detectable	O	O
at	O	O
a	O	O
very	O	O
low	O	O
level.	O	O
In	O	O
lymphoblastoid	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
,	O	O
which	O	O
exemplify	O	O
an	O	O
intermediate	O	O
stage	O	O
of	O	O
B-cell	O	O
differentiation	O	O
,	O	O
a	O	O
reduced	O	O
expression	O	O
and	O	O
activity	O	O
were	O	O
observed.	O	O
The	O	O
findings	O	O
in	O	O
the	O	O
human	cell_line	O
multiple	cell_line	O
myeloma	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
represent	O	O
the	O	O
first	O	O
examples	O	O
of	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
downregulated	O	O
PU.1	protein	protein
expression	O	O
and	O	O
apparently	O	O
contradict	O	O
observations	O	O
in	O	O
the	O	O
murine	O	O
system	O	O
in	O	O
which	O	O
PU.1	protein	protein
is	O	O
expressed	O	O
and	O	O
active	O	O
in	O	O
plasmacytoma	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
At	O	O
present,	O	O
it	O	O
is	O	O
unclear	O	O
whether	O	O
the	O	O
lack	O	O
of	O	O
PU.1	protein	protein
expression	O	O
and	O	O
activity	O	O
in	O	O
human	cell_line	O
multiple	cell_line	O
myeloma	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
represents	O	O
a	O	O
malignancy-associated	O	O
defect	O	O
in	O	O
these	O	O
cells	O	O
or	O	O
exemplifies	O	O
a	O	O
normal	O	O
developmental	O	O
regulation	O	O
in	O	O
terminally	cell_type	cell_type
differentiated	cell_type	cell_type
B	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Regulation	O	O
of	O	O
granulocyte-macrophage	protein	protein
colony-stimulating	protein	protein
factor	protein	protein
and	O	O
E-selectin	protein	protein
expression	O	O
in	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
cyclosporin	O	O
A	O	O
and	O	O
the	O	O
T-cell	protein	O
transcription	protein	protein
factor	protein	protein
NFAT	protein	protein
.	O	O
Nuclear	protein	protein
factor	protein	protein
of	protein	protein
activated	protein	protein
T	protein	protein
cells	protein	protein
(	O	O
NFAT	protein	protein
)	O	O
was	O	O
originally	O	O
described	O	O
as	O	O
a	O	O
T-cell-specific	protein	protein
transcription	protein	protein
factor	protein	protein
athat	O	O
supported	O	O
the	O	O
activation	O	O
of	O	O
cytokine	protein	DNA
gene	O	DNA
expression	O	O
and	O	O
mediated	O	O
the	O	O
immunoregulatory	protein	protein
effects	O	O
of	O	O
cyclosporin	O	O
A	O	O
(	O	O
CsA	O	O
).	O	O
As	O	O
we	O	O
observed	O	O
that	O	O
activated	cell_type	cell_type
endothelial	cell_type	cell_type
cells	cell_type	cell_type
also	O	O
expressed	O	O
NFAT	protein	protein
,	O	O
we	O	O
tested	O	O
the	O	O
antiinflammatory	O	O
properties	O	O
of	O	O
CsA	O	O
in	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Significantly,	O	O
CsA	O	O
completely	O	O
suppressed	O	O
the	O	O
induction	O	O
of	O	O
NFAT	protein	protein
in	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
inhibited	O	O
the	O	O
activity	O	O
of	O	O
granulocyte-macrophage	DNA	protein
colony-stimulating	DNA	protein
factor	DNA	protein
(	DNA	O
GM-CSF	DNA	protein
)	DNA	O
gene	DNA	O
regulatory	DNA	O
elements	DNA	O
that	O	O
use	O	O
NFAT	protein	protein
by	O	O
60%.	O	O
CsA	O	O
similarly	O	O
mediated	O	O
a	O	O
reduction	O	O
of	O	O
up	O	O
to	O	O
65%	O	O
in	O	O
GM-CSF	RNA	RNA
mRNA	RNA	RNA
and	O	O
protein	O	O
expression	O	O
in	O	O
activated	cell_type	cell_type
endothelial	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
CsA	O	O
also	O	O
suppressed	O	O
E-selectin	protein	protein
,	O	O
but	O	O
not	O	O
vascular	protein	protein
cell	protein	protein
adhesion	protein	protein
molecule-1	protein	protein
(	O	O
VCAM-1	protein	protein
)	O	O
expression	O	O
in	O	O
endothelial	O	O
cells,	O	O
even	O	O
though	O	O
the	O	O
E-selectin	DNA	DNA
promoter	DNA	DNA
is	O	O
activated	O	O
by	O	O
NF-kappa	protein	protein
B	protein	protein
rather	O	O
than	O	O
NFAT	protein	protein
.	O	O
Hence,	O	O
induction	O	O
of	O	O
cell	O	O
surface	O	O
expression	O	O
of	O	O
this	O	O
leukocyte	protein	protein
adhesion	protein	protein
molecule	protein	protein
by	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
(TNF)-alpha	protein	protein
was	O	O
reduced	O	O
by	O	O
40%	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
CsA	O	O
,	O	O
and	O	O
this	O	O
was	O	O
reflected	O	O
by	O	O
a	O	O
29%	O	O
decrease	O	O
in	O	O
neutrophil	cell_type	cell_type
adhesion	O	O
.	O	O
The	O	O
effects	O	O
of	O	O
CsA	O	O
on	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
also	O	O
detected	O	O
at	O	O
the	O	O
chromatin	DNA	DNA
structure	O	DNA
level	O	O
,	O	O
as	O	O
DNasel	DNA	DNA
hypersensitive	DNA	DNA
sites	DNA	DNA
within	O	O
both	O	O
the	O	O
GM-CSF	protein	DNA
enhancer	O	DNA
and	O	O
the	O	O
E-selectin	DNA	DNA
promoter	DNA	DNA
were	O	O
suppressed	O	O
by	O	O
CsA	O	O
.	O	O
This	O	O
represents	O	O
the	O	O
first	O	O
report	O	O
of	O	O
NFAT	protein	protein
in	O	O
endothelial	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
suggests	O	O
mechanisms	O	O
by	O	O
which	O	O
CsA	O	O
could	O	O
function	O	O
as	O	O
an	O	O
antiinflammatory	O	O
agent	O	O
.	O	O

Costimulation	O	O
requirement	O	O
for	O	O
AP-1	protein	protein
and	O	O
NF-kappa	protein	protein
B	protein	protein
transcription	O	protein
factor	O	protein
activation	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
The	O	O
transcriptional	O	O
activity	O	O
of	O	O
the	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
requires	O	O
T-cell	cell_type	O
costimulation	O	O
delivered	O	O
by	O	O
the	O	O
TCR	protein	protein
and	O	O
the	O	O
auxiliary	protein	O
receptor	protein	O
CD28	protein	protein
.	O	O
Several	O	O
transcription	protein	protein
factors	protein	protein
participate	O	O
in	O	O
IL-2	protein	DNA
promoter	O	DNA
activation	O	O
,	O	O
among	O	O
which	O	O
are	O	O
AP-1	protein	protein
-like	protein	protein
factors	protein	protein
and	O	O
NF-kappa	protein	protein
B	protein	protein
.	O	O
Protein	O	O
phosphorylation	O	O
has	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
regulation	O	O
of	O	O
these	O	O
two	O	O
factors:	O	O
(1)	O	O
it	O	O
induces	O	O
the	O	O
transactivating	O	O
capacity	O	O
of	O	O
the	O	O
AP-1	protein	protein
protein	protein	protein
c-Jun	protein	protein
;	O	O
and	O	O
(2)	O	O
it	O	O
is	O	O
involved	O	O
in	O	O
the	O	O
release	O	O
of	O	O
the	O	O
cytoplasmic	protein	O
inhibitor	protein	O
,	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
,	O	O
from	O	O
NF-kappa	protein	protein
B	protein	protein
,	O	O
allowing	O	O
translocation	O	O
of	O	O
the	O	O
latter	O	O
into	O	O
the	O	O
nucleus	O	O
.	O	O
We	O	O
have	O	O
recently	O	O
shown	O	O
that	O	O
both	O	O
phosphorylation	O	O
processes	O	O
require	O	O
T-cell	O	O
costimulation	O	O
.	O	O
Furthermore,	O	O
in	O	O
activated	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
the	O	O
kinetics	O	O
of	O	O
the	O	O
two	O	O
phosphorylation	O	O
events	O	O
are	O	O
essentially	O	O
similar.	O	O
According	O	O
to	O	O
our	O	O
results,	O	O
however,	O	O
the	O	O
kinases	O	protein
responsible	O	O
for	O	O
the	O	O
two	O	O
processes	O	O
are	O	O
distinct	O	O
entities.	O	O
Whereas	O	O
TPCK	protein	O
inhibits	O	O
phosphorylation	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
and,	O	O
consequently,	O	O
activation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
,	O	O
it	O	O
markedly	O	O
enhances	O	O
the	O	O
activity	O	O
of	O	O
JNK	protein	protein
,	O	O
the	O	O
MAP	protein	protein
kinase-related	protein	protein
kinase	protein	protein
that	O	O
phosphorylates	O	O
the	O	O
transactivation	protein	protein
domain	protein	protein
of	O	O
c-Jun	protein	protein
.	O	O
We,	O	O
therefore,	O	O
propose	O	O
the	O	O
activation	O	O
scheme	O	O
presented	O	O
in	O	O
FIGURE	O	O
3	O	O
for	O	O
T-cell	O	O
costimulation	O	O
.	O	O
Costimulation	O	O
results	O	O
in	O	O
the	O	O
activation	O	O
of	O	O
a	O	O
signaling	O	O
pathway	O	O
that	O	O
leads	O	O
to	O	O
the	O	O
simultaneous	O	O
induction	O	O
of	O	O
the	O	O
two	O	O
transcription	protein	protein
factors	protein	protein
,	O	O
AP-1	protein	protein
and	O	O
NF-kappa	protein	protein
B	protein	protein
.	O	O
Integration	O	O
of	O	O
the	O	O
signals	O	O
generated	O	O
by	O	O
TCR	protein	protein
and	O	O
CD28	protein	protein
engagement	O	O
occurs	O	O
along	O	O
this	O	O
pathway,	O	O
which	O	O
then	O	O
bifurcates	O	O
to	O	O
induce	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
phosphorylation	O	O
and	O	O
NF-kappa	protein	protein
B	protein	protein
activation	O	O
on	O	O
the	O	O
one	O	O
hand,	O	O
and	O	O
JNK	protein	protein
activation	O	O
and	O	O
c-Jun	protein	O
phosphorylation	O	O
on	O	O
the	O	O
other.	O	O
We	O	O
are	O	O
currently	O	O
engaged	O	O
in	O	O
defining	O	O
where	O	O
the	O	O
two	O	O
signals	O	O
integrate	O	O
along	O	O
the	O	O
AP-1	protein	protein
/	O	O
NF-kappa	protein	protein
B	protein	protein
pathway	O	O
.	O	O

Regulation	O	O
of	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
type	O	O
1	O	O
and	O	O
cytokine	O	DNA
gene	O	DNA
expression	O	O
in	O	O
myeloid	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
NF-kappa	protein	protein
B	protein	protein
/Rel	protein	protein
transcription	protein	protein
factors	protein	protein
.	O	O
CD4+	cell_line	cell_type
macrophages	cell_line	cell_type
in	O	O
tissues	O	O
such	O	O
as	O	O
lung	O	O
,	O	O
skin	O	O
,	O	O
and	O	O
lymph	O	O
nodes	O	O
,	O	O
promyelocytic	cell_type	cell_type
cells	cell_type	cell_type
in	O	O
bone	O	O
marrow	O	O
,	O	O
and	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
monocytes	cell_type	cell_type
serve	O	O
as	O	O
important	O	O
targets	O	O
and	O	O
reservoirs	O	O
for	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
type	O	O
1	O	O
(	O	O
HIV-1	O	O
)	O	O
replication	O	O
.	O	O
HIV-1	O	O
-infected	O	cell_type
myeloid	cell_type	cell_type
cells	cell_type	cell_type
are	O	O
often	O	O
diminished	O	O
in	O	O
their	O	O
ability	O	O
to	O	O
participate	O	O
in	O	O
chemotaxis	O	O
,	O	O
phagocytosis	O	O
,	O	O
and	O	O
intracellular	O	O
killing	O	O
.	O	O
HIV-1	O	O
infection	O	O
of	O	O
myeloid	cell_type	cell_type
cells	cell_type	cell_type
can	O	O
lead	O	O
to	O	O
the	O	O
expression	O	O
of	O	O
surface	protein	protein
receptors	protein	protein
associated	O	O
with	O	O
cellular	O	O
activation	O	O
and/or	O	O
differentiation	O	O
that	O	O
increase	O	O
the	O	O
responsiveness	O	O
of	O	O
these	O	O
cells	O	O
to	O	O
cytokines	protein	protein
secreted	O	O
by	O	O
neighboring	O	O
cells	O	O
as	O	O
well	O	O
as	O	O
to	O	O
bacteria	O	O
or	O	O
other	O	O
pathogens.	O	O
Enhancement	O	O
of	O	O
HIV-1	O	O
replication	O	O
is	O	O
related	O	O
in	O	O
part	O	O
to	O	O
increased	O	O
DNA-binding	O	O
activity	O	O
of	O	O
cellular	protein	protein
transcription	protein	protein
factors	protein	protein
such	O	O
as	O	O
NF-kappa	protein	protein
B	protein	protein
.	O	O
NF-kappa	protein	protein
B	protein	protein
binds	O	O
to	O	O
the	O	O
HIV-1	DNA	DNA
enhancer	DNA	DNA
region	O	DNA
of	O	O
the	O	O
long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
and	O	O
contributes	O	O
to	O	O
the	O	O
inducibility	O	O
of	O	O
HIV-1	O	DNA
gene	O	DNA
expression	O	O
in	O	O
response	O	O
to	O	O
multiple	O	O
activating	O	O
agents.	O	O
Phosphorylation	O	O
and	O	O
degradation	O	O
of	O	O
the	O	O
cytoplasmic	protein	protein
inhibitor	protein	protein
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	O	protein
are	O	O
crucial	O	O
regulatory	O	O
events	O	O
in	O	O
the	O	O
activation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
DNA-binding	O	O
activity	O	O
.	O	O
Both	O	O
N-	O	O
and	O	O
C-	O	O
terminal	O	O
residues	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	O	protein
are	O	O
required	O	O
for	O	O
inducer-mediated	O	O
degradation	O	O
.	O	O
Chronic	O	O
HIV-1	O	O
infection	O	O
of	O	O
myeloid	cell_type	cell_type
cells	cell_type	cell_type
leads	O	O
to	O	O
constitutive	O	O
NF-kappa	protein	protein
B	protein	protein
DNA-binding	O	O
activity	O	O
and	O	O
provides	O	O
an	O	O
intranuclear	O	O
environment	O	O
capable	O	O
of	O	O
perpetuating	O	O
HIV-1	O	O
replication	O	O
.	O	O
Increased	O	O
intracellular	O	O
stores	O	O
of	O	O
latent	protein	O
NF-kappa	protein	protein
B	protein	protein
may	O	O
also	O	O
result	O	O
in	O	O
rapid	O	O
inducibility	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
-dependent	O	O
cytokine	protein	DNA
gene	O	DNA
expression	O	O
.	O	O
In	O	O
response	O	O
to	O	O
secondary	O	O
pathogenic	O	O
infections	O	O
or	O	O
antigenic	O	O
challenge,	O	O
cytokine	protein	DNA
gene	O	DNA
expression	O	O
is	O	O
rapidly	O	O
induced,	O	O
enhanced,	O	O
and	O	O
sustained	O	O
over	O	O
prolonged	O	O
periods	O	O
in	O	O
HIV-1	cell_line	O
-infected	cell_line	cell_type
myeloid	cell_line	cell_type
cells	cell_line	cell_type
compared	O	O
with	O	O
uninfected	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Elevated	O	O
levels	O	O
of	O	O
several	O	O
inflammatory	protein	protein
cytokines	protein	protein
have	O	O
been	O	O
detected	O	O
in	O	O
the	O	O
sera	O	O
of	O	O
HIV-1	O	O
-infected	O	O
individuals	O	O
.	O	O
Secretion	O	O
of	O	O
myeloid	protein	O
cell-derived	protein	O
cytokines	protein	protein
may	O	O
both	O	O
increase	O	O
virus	O	O
production	O	O
and	O	O
contribute	O	O
to	O	O
AIDS-associated	O	O
disorders	O	O
.	O	O

Steroid	O	O
mediated	O	O
lysis	O	O
of	O	O
lymphoblasts	cell_type	cell_type
requires	O	O
the	O	O
DNA	O	DNA
binding	O	DNA
region	O	DNA
of	O	O
the	O	O
steroid	O	O
hormone	O	O
receptor.	O	O
Glucocorticoids	O	O
kill	O	O
certain	O	O
types	O	O
of	O	O
lymphoblasts	cell_type	cell_type
,	O	O
but	O	O
the	O	O
mechanisms	O	O
are	O	O
unknown.	O	O
It	O	O
is	O	O
clear	O	O
that	O	O
sufficient	O	O
numbers	O	O
of	O	O
functional	O	O
glucocorticoid	protein	protein
receptors	protein	protein
are	O	O
required	O	O
to	O	O
mediate	O	O
lysis,	O	O
but	O	O
whether	O	O
they	O	O
do	O	O
so	O	O
through	O	O
the	O	O
classical	O	O
model	O	O
of	O	O
steroid	O	O
hormone	O	O
activation	O	O
and	O	O
modulation	O	O
of	O	O
gene	O	O
expression	O	O
has	O	O
not	O	O
been	O	O
established.	O	O
In	O	O
this	O	O
report	O	O
we	O	O
have	O	O
asked	O	O
which	O	O
region(s)	O	O
of	O	O
the	O	O
steroid	protein	O
receptor	protein	O
are	O	O
important	O	O
for	O	O
mediating	O	O
lysis	O	O
in	O	O
leukemic	cell_type	O
T	cell_type	O
lymphoblasts	cell_type	O
.	O	O
CEM-ICR	cell_line	O
27	cell_line	O
leukemic	cell_line	O
lymphoblasts	cell_line	O
,	O	O
a	O	O
clone	O	O
of	O	O
CEM	cell_line	cell_line
cells	cell_line	cell_line
which	O	O
lack	O	O
functional	O	O
glucocorticoid	protein	protein
receptors	protein	protein
and	O	O
therefore	O	O
are	O	O
neither	O	O
lysed	O	O
by	O	O
dexamethasone	O	O
nor	O	O
capable	O	O
of	O	O
showing	O	O
glutamine	protein	O
synthetase	protein	O
induction	O	O
,	O	O
were	O	O
provided	O	O
with	O	O
steroid	protein	protein
receptors	protein	protein
by	O	O
DNA	O	O
transfections	O	O
of	O	O
various	O	O
receptor	O	O
gene	O	O
constructs.	O	O
We	O	O
measured	O	O
steroid	O	O
mediated	O	O
lysis	O	O
,	O	O
receptor	O	O
number	O	O
and	O	O
induction	O	O
of	O	O
glutamine	protein	O
synthetase	protein	O
in	O	O
the	O	O
transfected	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Our	O	O
results	O	O
provide	O	O
evidence	O	O
that	O	O
the	O	O
lysis	O	O
mechanism	O	O
in	O	O
the	O	O
ICR27	cell_line	DNA
lymphoblasts	cell_line	DNA
is	O	O
restored	O	O
when	O	O
functional	O	O
receptor	O	O
number	O	O
is	O	O
restored.	O	O
The	O	O
DNA	protein	DNA
binding	protein	DNA
region	protein	DNA
specifying	O	O
high	O	O
affinity	O	O
for	O	O
GRE	DNA	DNA
sites	DNA	DNA
is	O	O
required.	O	O
Lysis	O	O
is	O	O
mediated	O	O
by	O	O
any	O	O
steroid	O	O
that	O	O
allows	O	O
for	O	O
activation	O	O
of	O	O
the	O	O
receptor	O	O
containing	O	O
such	O	O
a	O	O
region.	O	O
Our	O	O
data	O	O
support	O	O
the	O	O
view	O	O
that	O	O
steroid	O	O
-mediated	O	O
cell	O	O
death	O	O
occurs	O	O
by	O	O
a	O	O
process	O	O
requiring	O	O
direct	O	O
interaction	O	O
of	O	O
steroid	protein	O
-receptor	protein	O
complexes	protein	O
with	O	O
the	O	O
genome.	O	O

Functional	O	O
characterization	O	O
of	O	O
the	O	O
murine	protein	O
homolog	protein	O
of	O	O
the	O	O
B	protein	protein
cell-specific	protein	protein
coactivator	protein	protein
BOB.1/OBF.1	protein	protein
.	O	O
B	O	O
cell-specific	O	O
transcriptional	O	O
promoter	O	O
activity	O	O
mediated	O	O
by	O	O
the	O	O
octamer	DNA	DNA
motif	DNA	DNA
requires	O	O
the	O	O
Oct1	protein	protein
or	O	O
Oct2	protein	protein
protein	protein	protein
and	O	O
additional	O	O
B	protein	O
cell-restricted	protein	O
cofactors	protein	O
.	O	O
One	O	O
such	O	O
cofactor	protein	O
,	O	O
BOB.1/OBF.1	protein	protein
,	O	O
was	O	O
recently	O	O
isolated	O	O
from	O	O
human	cell_type	cell_type
B	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Here,	O	O
we	O	O
describe	O	O
the	O	O
isolation	O	O
and	O	O
detailed	O	O
characterization	O	O
of	O	O
the	O	O
murine	protein	DNA
homolog	protein	DNA
.	O	O
Full-length	O	O
cDNAs	DNA	DNA
and	O	O
genomic	DNA	O
clones	DNA	O
were	O	O
isolated,	O	O
and	O	O
the	O	O
gene	O	O
structure	O	O
was	O	O
determined.	O	O
Comparison	O	O
of	O	O
the	O	O
deduced	O	O
amino	O	O
acids	O	O
shows	O	O
88%	O	O
sequence	O	O
identity	O	O
between	O	O
mouse	O	O
and	O	O
human	O	O
BOB.1/OBF.1	O	protein
.	O	O
The	O	O
NH2-terminal	protein	protein
126	protein	protein
amino	protein	protein
acids	protein	protein
of	O	O
BOB.1/OBF.1	protein	protein
are	O	O
both	O	O
essential	O	O
and	O	O
sufficient	O	O
for	O	O
interaction	O	O
with	O	O
the	O	O
POU	protein	protein
domains	protein	protein
of	O	O
either	O	O
Oct1	protein	protein
or	O	O
Oct2	protein	protein
.	O	O
This	O	O
protein-protein	O	O
interaction	O	O
does	O	O
not	O	O
require	O	O
the	O	O
simultaneous	O	O
binding	O	O
of	O	O
Oct	protein	protein
proteins	protein	protein
to	O	O
DNA,	O	O
and	O	O
high	O	O
resolution	O	O
footprinting	O	O
of	O	O
the	O	O
Oct	DNA	O
-DNA	O	O
interaction	O	O
reveals	O	O
that	O	O
binding	O	O
of	O	O
BOB.1/OBF.1	protein	protein
to	O	O
Oct1	protein	protein
or	O	O
Oct2	protein	protein
does	O	O
not	O	O
alter	O	O
the	O	O
interaction	O	O
with	O	O
DNA.	O	O
BOB.1/OBF.1	protein	protein
can	O	O
efficiently	O	O
activate	O	O
octamer-dependent	O	O
promoters	O	O
in	O	O
fibroblasts	cell_type	cell_type
;	O	O
however,	O	O
it	O	O
fails	O	O
to	O	O
stimulate	O	O
octamer-dependent	DNA	O
enhancer	DNA	O
activity	O	O
.	O	O
Fusion	O	O
of	O	O
subdomains	O	O
of	O	O
BOB.1/OBF.1	protein	protein
with	O	O
the	O	O
GAL4	protein	protein
DNA	protein	protein
binding	protein	protein
domain	protein	protein
reveals	O	O
that	O	O
both	O	O
NH2-	O	O
and	O	O
COOH-	O	protein
terminal	O	protein
domains	O	protein
of	O	O
BOB.1/OBF.1	protein	protein
contribute	O	O
to	O	O
full	O	O
transactivation	O	O
function,	O	O
the	O	O
COOH-terminal	protein	protein
domain	protein	protein
is	O	O
more	O	O
efficient	O	O
in	O	O
this	O	O
transactivation	O	O
assay	O	O
.	O	O
Consistent	O	O
with	O	O
the	O	O
failure	O	O
of	O	O
full-length	protein	O
BOB.1/OBF.1	protein	protein
to	O	O
stimulate	O	O
octamer-dependent	DNA	DNA
enhancer	DNA	DNA
elements	DNA	DNA
in	O	O
non	cell_type	cell_type
B	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
the	O	O
GAL4	protein	protein
fusions	protein	protein
likewise	O	O
only	O	O
stimulate	O	O
from	O	O
a	O	O
promoter-proximal	O	DNA
position	O	DNA
.	O	O

Anti-immunoglobulin	protein	O
M	protein	O
activates	O	O
nuclear	protein	O
calcium/calmodulin-dependent	protein	protein
protein	protein	protein
kinase	protein	protein
II	protein	protein
in	O	O
human	cell_type	cell_type
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
We	O	O
and	O	O
others	O	O
have	O	O
previously	O	O
shown	O	O
that	O	O
the	O	O
nuclear	protein	protein
protein	protein	protein
,	O	O
Ets-1	protein	protein
,	O	O
is	O	O
phosphorylated	O	O
in	O	O
a	O	O
calcium-dependent	O	O
manner	O	O
after	O	O
ligation	O	O
of	O	O
immunoglobulin	protein	protein
(Ig)	protein	protein
M	protein	protein
on	O	O
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
As	O	O
this	O	O
phosphorylation	O	O
was	O	O
independent	O	O
of	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
activity	O	O
,	O	O
we	O	O
tested	O	O
whether	O	O
a	O	O
calcium/calmodulin-dependent	protein	protein
protein	protein	protein
kinase	protein	protein
(	O	O
CaM	protein	protein
kinase	protein	protein
)	O	O
might	O	O
phosphorylate	O	O
the	O	O
Ets-1	protein	protein
protein	protein	protein
after	O	O
elevation	O	O
of	O	O
intracellular	O	O
free	O	O
calcium	O	O
concentrations	O	O
.	O	O
The	O	O
dephosphorylated	O	O
form	O	O
of	O	O
Ets-1	protein	protein
has	O	O
been	O	O
shown	O	O
to	O	O
bind	O	O
to	O	O
chromatin	DNA	DNA
,	O	O
suggesting	O	O
that	O	O
the	O	O
operative	protein	O
kinase	protein	O
should	O	O
be	O	O
detectable	O	O
in	O	O
the	O	O
nucleus	O	O
.	O	O
We	O	O
prepared	O	O
nuclear	O	O
extracts	O	O
from	O	O
two	O	O
human	cell_line	cell_line
B	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
in	O	O
which	O	O
increased	O	O
intracellular	O	O
free	O	O
calcium	O	O
levels	O	O
correlated	O	O
with	O	O
increased	O	O
phosphorylation	O	O
of	O	O
the	O	O
Ets-1	protein	protein
protein.	O	O
Activity	O	O
of	O	O
the	O	O
CaM	protein	protein
kinases	protein	protein
was	O	O
determined	O	O
using	O	O
a	O	O
synthetic	O	O
peptide	O	O
substrate	O	O
both	O	O
in	O	O
the	O	O
absence	O	O
and	O	O
presence	O	O
of	O	O
an	O	O
inhibitor	O	O
specific	O	O
for	O	O
the	O	O
CaM	protein	protein
kinase	protein	protein
family	protein	protein
,	O	O
KN-62	O	protein
.	O	O
Stimulation	O	O
of	O	O
cells	O	O
with	O	O
anti-IgM	protein	protein
led	O	O
to	O	O
increased	O	O
activity	O	O
of	O	O
a	O	O
nuclear	protein	protein
kinase	protein	protein
that	O	O
could	O	O
phosphorylate	O	O
the	O	O
peptide,	O	O
and	O	O
this	O	O
activity	O	O
was	O	O
reduced	O	O
by	O	O
10	O	O
microM	O	O
KN-62	O	protein
.	O	O
Kinase	O	protein
activity	O	O
was	O	O
reduced	O	O
in	O	O
lysates	O	O
preadsorbed	O	O
using	O	O
an	O	O
antibody	protein	O
specific	O	O
for	O	O
CaM	protein	protein
kinase	protein	protein
II	protein	protein
.	O	O
Two-dimensional	O	O
phosphopeptide	O	O
maps	O	O
of	O	O
the	O	O
Ets-1	protein	protein
protein	O	protein
from	O	O
cells	O	O
incubated	O	O
with	O	O
ionomycin	O	O
or	O	O
anti-IgM	protein	protein
contained	O	O
two	O	O
unique	O	O
phosphopeptides	O	O
that	O	O
were	O	O
absent	O	O
in	O	O
untreated	O	O
cells.	O	O
Incubation	O	O
of	O	O
isolated	protein	O
Ets-1	protein	protein
protein	protein	protein
with	O	O
purified	O	protein
CaM	protein	protein
kinase	protein	protein
II	protein	protein
produced	O	O
phosphorylation	O	O
of	O	O
peptides	O	O
that	O	O
migrated	O	O
identically	O	O
to	O	O
those	O	O
found	O	O
in	O	O
cells	O	O
incubated	O	O
with	O	O
either	O	O
anti-IgM	protein	protein
or	O	O
ionomycin	O	O
.	O	O
These	O	O
data	O	O
suggest	O	O
a	O	O
model	O	O
of	O	O
signal	O	O
transduction	O	O
by	O	O
the	O	O
antigen	protein	O
receptor	protein	O
on	O	O
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
in	O	O
which	O	O
increased	O	O
intracellular	O	O
free	O	O
calcium	O	O
can	O	O
rapidly	O	O
activate	O	O
nuclear	protein	O
CaM	protein	protein
kinase	protein	protein
II	protein	protein
,	O	O
potentially	O	O
resulting	O	O
in	O	O
phosphorylation	O	O
and	O	O
regulation	O	O
of	O	O
DNA-binding	protein	protein
proteins	protein	protein
.	O	O

Transcriptional	O	O
activation	O	O
and	O	O
repression	O	O
,	O	O
two	O	O
properties	O	O
of	O	O
the	O	O
lymphoid-specific	protein	protein
transcription	protein	protein
factor	protein	protein
Oct-2a	protein	protein
.	O	O
The	O	O
lymphoid-specific	protein	protein
transcription	protein	protein
factor	protein	protein
Oct-2a	protein	protein
contains	O	O
two	O	O
transcriptional	protein	protein
activation	protein	protein
domains	protein	protein
which	O	O
are	O	O
located	O	O
within	O	O
the	O	O
N-terminal	protein	O
and	O	O
C-terminal	protein	protein
regions	protein	protein
.	O	O
To	O	O
study	O	O
their	O	O
differential	protein	O
activation	protein	O
properties	protein	O
,	O	O
we	O	O
linked	O	O
the	O	O
isolated	O	O
effector	protein	protein
domains	protein	protein
to	O	O
the	O	O
GAL4	protein	protein
DNA-binding	protein	protein
domain	protein	protein
.	O	O
We	O	O
have	O	O
shown	O	O
that	O	O
both	O	O
activating	O	O
regions	O	O
of	O	O
Oct-2a	protein	protein
,	O	O
isolated	O	O
from	O	O
their	O	O
natural	O	O
context,	O	O
can	O	O
activate	O	O
transcription	O	O
as	O	O
promoter	protein	DNA
factors	protein	O
.	O	O
In	O	O
contrast	O	O
to	O	O
the	O	O
C-terminus	protein	protein
,	O	O
activation	O	O
by	O	O
the	O	O
N-terminal	protein	protein
domain	protein	protein
is	O	O
dependent	O	O
on	O	O
a	O	O
yet	O	O
unidentified	O	O
factor(s)	O	O
binding	O	O
to	O	O
the	O	O
simian	DNA	O
virus	DNA	O
40	DNA	DNA
enhancer	DNA	DNA
.	O	O
The	O	O
results	O	O
obtained	O	O
by	O	O
duplication	O	O
of	O	O
activation	protein	O
domains	protein	O
or	O	O
their	O	O
mixed	O	O
combination	O	O
suggest	O	O
that	O	O
the	O	O
domains	O	O
are	O	O
functionally	O	O
independent.	O	O
However,	O	O
activation	O	O
from	O	O
a	O	O
remote	O	O
position	O	O
could	O	O
only	O	O
be	O	O
achieved	O	O
with	O	O
the	O	O
C-terminus	protein	protein
of	O	O
Oct-2a	protein	protein
in	O	O
B	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
lymphoid	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
higher	O	O
activation	O	O
levels	O	O
were	O	O
observed,	O	O
suggesting	O	O
that	O	O
distinct	O	O
B-cell-specific	protein	O
cofactors	protein	O
in	O	O
concert	O	O
with	O	O
the	O	O
effector	protein	protein
domains	protein	protein
of	O	O
Oct-2a	protein	protein
might	O	O
be	O	O
involved	O	O
in	O	O
mediating	O	O
transcription	O	O
from	O	O
proximal	O	O
and	O	O
remote	O	O
positions	O	O
.	O	O
Furthermore,	O	O
we	O	O
identified	O	O
a	O	O
repression	O	protein
domain	O	protein
at	O	O
the	O	O
N-terminus	O	O
of	O	O
Oct-2a	protein	protein
.	O	O
When	O	O
transferred	O	O
to	O	O
a	O	O
potent	O	O
activator	O	O
,	O	O
transcriptional	O	O
stimulation	O	O
was	O	O
inhibited	O	O
efficiently.	O	O
These	O	O
results	O	O
underscore	O	O
the	O	O
modular	O	O
structure	O	O
of	O	O
Oct-2a	protein	protein
with	O	O
separable	O	O
domains	O	O
for	O	O
activation	O	O
and	O	O
repression	O	O
and	O	O
suggest	O	O
that	O	O
Oct-2a	protein	protein
might	O	protein
have	O	O
complex	O	O
regulatory	O	O
functions	O	O
in	O	O
vivo.	O	O

Nonopsonic	O	O
phagocytosis	O	O
of	O	O
Pseudomonas	O	O
aeruginosa	O	O
by	O	O
macrophages	cell_type	cell_type
and	O	O
polymorphonuclear	cell_type	cell_type
leukocytes	cell_type	cell_type
requires	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
bacterial	O	O
flagellum	O	O
.	O	O
Whereas	O	O
the	O	O
mechanism	O	O
of	O	O
nonopsonic	O	O
phagocytosis	O	O
of	O	O
Pseudomonas	O	O
aeruginosa	O	O
has	O	O
been	O	O
described,	O	O
the	O	O
bacterial	O	O
ligands	O	O
required	O	O
are	O	O
poorly	O	O
understood.	O	O
To	O	O
identify	O	O
the	O	O
requisite	O	O
bacterial	O	O
ligands	O	O
,	O	O
studies	O	O
with	O	O
isogenic	O	O
mutants	O	O
of	O	O
P.	O	O
aeruginosa	O	O
PAK	O	O
lacking	O	O
pili	O	O
,	O	O
flagella	O	O
,	O	O
and	O	O
the	O	O
RpoN	protein	protein
sigma	protein	protein
factor	protein	protein
were	O	O
undertaken.	O	O
The	O	O
RpoN	O	protein
mutant	O	protein
,	O	O
lacking	O	O
pili	O	O
,	O	O
flagella	O	O
,	O	O
and	O	O
nonpilus	protein	O
adhesins	protein	O
,	O	O
bound	O	O
poorly	O	O
and	O	O
was	O	O
resistant	O	O
to	O	O
ingestion	O	O
by	O	O
both	O	O
macrophages	cell_type	cell_type
and	O	O
neutrophils	cell_type	cell_type
.	O	O
Pili	O	O
were	O	O
not	O	O
absolutely	O	O
required	O	O
for	O	O
binding	O	O
or	O	O
phagocytosis	O	O
of	O	O
P.	O	O
aeruginosa	O	O
.	O	O
The	O	O
presence	O	O
of	O	O
a	O	O
flagellum	O	O
was	O	O
not	O	O
required	O	O
for	O	O
binding	O	O
of	O	O
P.	O	O
aeruginosa	O	O
to	O	O
macrophages	cell_type	cell_type
but	O	O
was	O	O
critical	O	O
for	O	O
the	O	O
subsequent	O	O
internalization	O	O
of	O	O
the	O	O
bacterium	O	O
,	O	O
suggesting	O	O
that	O	O
this	O	O
factor	O	O
or	O	O
a	O	O
surface	O	O
ligand	O	O
associated	O	O
with	O	O
its	O	O
assembly	O	O
was	O	O
responsible	O	O
for	O	O
stimulation	O	O
of	O	O
nonopsonic	O	O
phagocytosis	O	O
.	O	O

Identification	O	O
of	O	O
essential	O	O
GATA	DNA	O
and	O	O
Ets	DNA	O
binding	DNA	O
motifs	DNA	O
within	O	O
the	O	O
promoter	O	O
of	O	O
the	O	O
platelet	DNA	protein
glycoprotein	DNA	protein
Ib	DNA	protein
alpha	DNA	protein
gene	DNA	O
.	O	O
Platelet	protein	protein
glycoprotein	protein	protein
(	O	O
GP	protein	O
)	O	O
Ib-IX-V	protein	protein
is	O	O
a	O	O
multisubunit	protein	protein
adhesion	protein	protein
receptor	protein	protein
that	O	O
supports	O	O
platelet	O	O
attachment	O	O
to	O	O
thrombogenic	O	O
surfaces	O	O
at	O	O
sites	O	O
of	O	O
vascular	O	protein
injury	O	O
.	O	O
The	O	O
congenital	O	O
absence	O	O
of	O	O
the	O	O
receptor	O	O
results	O	O
in	O	O
a	O	O
bleeding	O	O
disorder	O	O
associated	O	O
with	O	O
"giant"	cell_type	O
platelets	cell_type	cell_type
,	O	O
a	O	O
condition	O	O
linking	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
complex	O	O
to	O	O
platelet	O	O
morphogenesis	O	O
.	O	O
To	O	O
understand	O	O
better	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
GP	protein	protein
Ib-IX-V	protein	protein
complex	protein	protein
,	O	O
studies	O	O
were	O	O
undertaken	O	O
to	O	O
define	O	O
the	O	O
essential	O	O
genetic	DNA	O
elements	DNA	O
supporting	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
alpha-subunit	protein	O
of	O	O
the	O	O
complex	O	O
(	O	O
GP	protein	protein
Ib	protein	protein
alpha	protein	protein
).	O	O
GP	DNA	O
Ib	DNA	O
alpha	DNA	O
promoter	DNA	O
activity	O	O
was	O	O
evaluated	O	O
by	O	O
transfection	O	O
of	O	O
human	cell_type	cell_type
erythroleukemia	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
reporter	O	O
plasmids	O	DNA
coding	O	O
for	O	O
the	O	O
enzyme	protein	protein
,	O	O
luciferase	protein	protein
.	O	O
Studies	O	O
were	O	O
initiated	O	O
with	O	O
a	O	O
fragment	O	DNA
extending	O	DNA
2,738	O	DNA
nucleotides	O	DNA
5'	O	DNA
to	O	O
the	O	O
transcription	DNA	DNA
start	DNA	DNA
site	DNA	DNA
and	O	O
lead	O	O
to	O	O
the	O	O
identification	O	O
of	O	O
253	O	O
nucleotides	O	DNA
retaining	O	DNA
full	O	DNA
promoter	O	DNA
activity	O	O
in	O	O
human	cell_type	cell_type
erythroleukemia	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
cells	O	O
of	O	O
nonhematopoietic	cell_type	cell_type
lineage	cell_type	cell_type
,	O	O
human	cell_type	O
endothelial	cell_type	O
and	O	O
HeLa	cell_type	cell_line
cells	cell_type	cell_line
,	O	O
the	O	O
GP	DNA	protein
Ib	DNA	protein
alpha	DNA	protein
promoter	DNA	O
activity	O	O
was	O	O
no	O	O
greater	O	O
than	O	O
background	O	O
levels	O	O
obtained	O	O
with	O	O
promoterless	DNA	O
constructs	DNA	O
.	O	O
Gel	O	O
shift	O	O
assays	O	O
and	O	O
site-directed	O	O
mutagenesis	O	O
studies	O	O
defined	O	O
essential	O	O
GATA	DNA	O
and	O	O
Ets	DNA	O
binding	DNA	O
motifs	DNA	O
93	DNA	O
and	DNA	O
150	DNA	O
nucleotides	DNA	O
upstream	DNA	O
of	O	O
the	O	O
transcription	DNA	DNA
start	DNA	DNA
site	DNA	DNA
,	O	O
a	O	O
finding	O	O
which	O	O
further	O	O
substantiates	O	O
these	O	O
elements	O	O
as	O	O
important	O	O
determinants	O	O
of	O	O
megakaryocytic	O	DNA
gene	O	DNA
expression	O	O
.	O	O
The	O	O
results	O	O
define	O	O
essential	O	O
cis-acting	DNA	DNA
elements	DNA	DNA
responsible	O	O
for	O	O
the	O	O
expression	O	O
of	O	O
GP	protein	protein
Ib	protein	protein
alpha	protein	protein
and	O	O
provide	O	O
insights	O	O
into	O	O
molecular	O	O
events	O	O
coinciding	O	O
with	O	O
the	O	O
release	O	O
of	O	O
normal	cell_type	cell_type
platelets	cell_type	cell_type
into	O	O
the	O	O
bloodstream	O	O
.	O	O

CD30	protein	protein
ligation	O	O
induces	O	O
nuclear	protein	protein
factor-kappa	protein	protein
B	protein	protein
activation	O	O
in	O	O
human	cell_line	cell_line
T	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
CD30	protein	protein
is	O	O
a	O	O
recently	O	O
described	O	O
member	O	O
of	O	O
the	O	O
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
/nerve	protein	protein
growth	protein	protein
factor	protein	protein
receptor	protein	protein
superfamily	protein	protein
.	O	O
In	O	O
this	O	O
report,	O	O
we	O	O
show	O	O
that	O	O
following	O	O
incubation	O	O
of	O	O
L540	cell_line	cell_line
cells	cell_line	cell_line
(	O	O
Hodgkin's	cell_line	O
disease	cell_line	O
-derived,	cell_line	O
T	cell_line	O
cell-like,	cell_line	O
CD30	cell_line	protein
+	cell_line	O
cells	cell_line	O
)	O	O
with	O	O
the	O	O
agonistic	protein	O
anti-	protein	O
CD30	protein	protein
monoclonal	protein	protein
antibodies	protein	protein
(	O	O
mAb	protein	protein
)	O	O
M44	protein	O
and	O	O
M67	protein	protein
,	O	O
two	O	O
nuclear	protein	protein
factor	protein	protein
(NF)-kappa	protein	protein
B	protein	protein
DNA	O	O
binding	O	O
activities	O	O
were	O	O
induced	O	O
in	O	O
nuclear	O	O
extracts	O	O
,	O	O
as	O	O
determined	O	O
in	O	O
gel	O	O
retardation	O	O
assays	O	O
.	O	O
The	O	O
effect	O	O
of	O	O
the	O	O
mAb	protein	protein
towards	O	O
NF-kappa	protein	protein
B	protein	protein
activation	O	O
was	O	O
rapid,	O	O
as	O	O
it	O	O
occurred	O	O
within	O	O
20	O	O
min,	O	O
and	O	O
was	O	O
sustained	O	O
for	O	O
up	O	O
to	O	O
6	O	O
h.	O	O
By	O	O
comparison,	O	O
an	O	O
isotype-matched	protein	O
antibody	protein	O
had	O	O
no	O	O
effect	O	O
on	O	O
NF-kappa	protein	protein
B	protein	protein
activation	O	O
.	O	O
Moreover,	O	O
in	O	O
human	cell_line	O
T	cell_line	O
helper	cell_line	O
(Th)	cell_line	O
clones	cell_line	O
functionally	O	O
characterized	O	O
as	O	O
being	O	O
of	O	O
the	O	O
type	O	O
0,	O	O
type	O	O
1	O	O
and	O	O
type	O	O
2	O	O
(28%,	O	O
&lt;	O	O
1%	O	O
und	O	O
93%	O	O
CD30+,	O	O
respectively),	O	O
the	O	O
extent	O	O
of	O	O
CD30	protein	protein
-mediated	O	O
NF-kappa	protein	protein
B	protein	protein
activation	O	O
correlated	O	O
with	O	O
the	O	O
proportion	O	O
of	O	O
CD30+	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
In	O	O
all	O	O
cell	O	O
lines	O	O
investigated,	O	O
the	O	O
NF-kappa	protein	protein
B	protein	protein
complexes	protein	protein
induced	O	O
following	O	O
CD30	protein	protein
engagement	O	O
were	O	O
shown	O	O
to	O	O
contain	O	O
p50	protein	protein
NF-kappa	protein	protein
B1	protein	protein
,	O	O
p65	protein	protein
RelA	protein	protein
,	O	O
and	O	O
possibly	O	O
other	O	O
transcription	protein	protein
factors	protein	protein
.	O	O
Collectively,	O	O
our	O	O
results	O	O
demonstrate	O	O
that	O	O
nuclear	O	O
translocation	O	O
and	O	O
activation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
rank	O	O
among	O	O
the	O	O
short-term	O	O
cellular	O	O
responses	O	O
elicited	O	O
following	O	O
CD30	protein	protein
ligation	O	O
.	O	O

Pathogenesis	O	O
of	O	O
atherosclerosis	O	O
.	O	O
The	O	O
earliest	O	O
lesion	O	O
in	O	O
the	O	O
development	O	O
of	O	O
an	O	O
atherosclerotic	O	O
plaque	O	O
is	O	O
the	O	O
fatty	O	O
streak	O	O
.	O	O
This	O	O
chronic	O	O
inflammatory	O	O
reaction	O	O
results	O	O
from	O	O
a	O	O
sequence	O	O
of	O	O
events	O	O
that	O	O
begins	O	O
with	O	O
the	O	O
trapping	O	O
of	O	O
low	O	O
density	O	O
lipoprotein	O	O
(	O	O
LDL	O	O
)	O	O
in	O	O
the	O	O
subendothelial	O	O
space	O	O
of	O	O
the	O	O
artery	O	O
wall	O	O
.	O	O
The	O	O
trapped	O	O
LDL	O	O
is	O	O
seeded	O	O
with	O	O
oxidative	O	O
species	O	O
released	O	O
by	O	O
the	O	O
overlying	O	O
endothelium	O	O
,	O	O
and	O	O
lipid	O	O
oxidation	O	O
is	O	O
initiated	O	O
within	O	O
the	O	O
LDL	O	O
particle.	O	O
Some	O	O
of	O	O
the	O	O
lipids	O	O
that	O	O
result	O	O
lead	O	O
to	O	O
the	O	O
activation	O	O
of	O	O
NFkB-like	protein	protein
transcription	protein	protein
factors	protein	protein
that	O	O
cause	O	O
the	O	O
expression	O	O
of	O	O
genes	O	O
whose	O	O
protein	protein	O
products	protein	O
mediate	O	O
monocyte	O	O
binding	O	O
,	O	O
monocyte	cell_type	O
chemotaxis	O	O
into	O	O
the	O	O
subendothelial	O	O
space	O	O
,	O	O
and	O	O
conversion	O	O
into	O	O
macrophages	cell_type	cell_type
.	O	O
At	O	O
least	O	O
1	O	O
major	DNA	DNA
gene	DNA	DNA
modulates	O	O
the	O	O
oxidation	O	O
of	O	O
LDL	O	O
lipids	O	O
and/or	O	O
the	O	O
biologic	O	O
response	O	O
to	O	O
these	O	O
lipids.	O	O
The	O	O
inverse	O	O
relation	O	O
between	O	O
high	O	O
density	O	O
lipoprotein	O	O
(	O	O
HDL	O	O
)	O	O
and	O	O
atherosclerotic	O	O
events	O	O
may	O	O
in	O	O
part	O	O
be	O	O
due	O	O
to	O	O
enzymes	protein	O
associated	O	O
with	O	O
HDL	O	O
that	O	O
destroy	O	O
the	O	O
biologically	O	O
active	O	O
lipids	O	O
generated	O	O
in	O	O
LDL	O	O
.	O	O

Estrogen	protein	O
and	O	O
progesterone	protein	protein
receptors	protein	protein
in	O	O
vernal	O	O
keratoconjunctivitis	O	O
.	O	O
PURPOSE:	O	O
Sex-related	O	O
influences	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
vernal	O	O
keratoconjunctivitis	O	O
(	O	O
VKC	O	protein
),	O	O
an	O	O
allergic	O	O
eosinophilic	O	O
disease.	O	O
METHODS:	O	O
The	O	O
authors	O	O
evaluated	O	O
tarsal	O	O
and	O	O
bulbar	O	O
conjunctival	O	O
biopsies	O	O
from	O	O
seven	O	O
patients	O	O
with	O	O
severe	O	O
and	O	O
symptomatic	O	O
VKC	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
estrogen	protein	O
and	O	O
progesterone	protein	protein
receptors	protein	protein
by	O	O
using	O	O
monoclonal	protein	protein
antibodies	protein	protein
with	O	O
a	O	O
peroxidase-antiperoxidase	O	protein
technique	O	protein
.	O	O
RESULTS:	O	O
Both	O	O
the	O	O
epithelium	O	O
and	O	O
subepithelium	O	O
of	O	O
the	O	O
tarsal	O	O
and	O	O
bulbar	O	O
conjunctiva	O	O
of	O	O
patients	O	O
with	O	O
VKC	O	O
,	O	O
but	O	O
not	O	O
those	O	O
of	O	O
four	O	O
nonatopic	O	O
control	O	O
subjects	O	O
,	O	O
showed	O	O
intense	O	O
positive	O	O
staining	O	O
for	O	O
estrogen	O	O
and	O	O
progesterone	protein	protein
receptors	protein	protein
.	O	O
Immunofluorescence	O	O
colocalization	O	O
of	O	O
both	O	O
estrogen	protein	O
and	O	O
progesterone	protein	protein
receptors	protein	protein
with	O	O
eosinophil	protein	protein
cationic	protein	protein
protein	protein	protein
showed	O	O
that	O	O
approximately	O	O
70%	O	O
of	O	O
positive	cell_type	cell_type
cells	cell_type	cell_type
were	O	O
eosinophils	cell_type	cell_type
.	O	O
CONCLUSIONS:	O	O
Sexual	O	O
hormones	O	O
,	O	O
through	O	O
their	O	O
receptors	protein	O
,	O	O
may	O	O
influence	O	O
the	O	O
activity	O	O
of	O	O
eosinophils	cell_type	cell_type
in	O	O
patients	O	O
with	O	O
VKC	O	O
.	O	O

CIITA	protein	protein
activates	O	O
the	O	O
expression	O	O
of	O	O
MHC	DNA	protein
class	DNA	protein
II	DNA	protein
genes	DNA	O
in	O	O
mouse	O	O
T	O	O
cells.	O	O
It	O	O
has	O	O
long	O	O
been	O	O
a	O	O
puzzle	O	O
that	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
molecules	protein	protein
are	O	O
expressed	O	O
in	O	O
human	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
after	O	O
activation	O	O
but	O	O
not	O	O
in	O	O
mouse	cell_type	cell_line
T	cell_type	cell_line
cells	cell_type	cell_line
;	O	O
this	O	O
expression	O	O
is	O	O
believed	O	O
to	O	O
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
cell	O	O
mediated	O	O
immune	O	O
response	O	O
.	O	O
Recently	O	O
the	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
transactivator	protein	protein
(	O	O
CIITA	protein	protein
)	O	O
has	O	O
been	O	O
reported	O	O
to	O	O
be	O	O
a	O	O
major	protein	protein
regulatory	protein	protein
factor	protein	protein
for	O	O
both	O	O
the	O	O
constitutive	O	O
and	O	O
IFN	O	protein
inducible	O	O
expression	O	O
of	O	O
MHC	DNA	protein
class	DNA	protein
II	DNA	protein
genes	DNA	O
.	O	O
Here	O	O
we	O	O
show	O	O
that	O	O
human	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
expressing	O	O
MHC	O	protein
class	O	protein
II	O	protein
have	O	O
CIITA	protein	protein
transcripts	O	O
while	O	O
MHC	O	protein
class	O	protein
II-negative	O	protein
human	cell_type	protein
T	cell_type	O
cells	cell_type	O
and	O	O
mouse	cell_type	cell_line
T	cell_type	cell_line
cells	cell_type	cell_line
do	O	O
not.	O	O
The	O	O
expression	O	O
of	O	O
MHC	DNA	protein
class	DNA	protein
II	DNA	protein
genes	DNA	O
in	O	O
mouse	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
can	O	O
be	O	O
reconstituted	O	O
upon	O	O
transfection	O	O
with	O	O
the	O	O
human	DNA	DNA
CIITA	DNA	DNA
cDNA	DNA	DNA
.	O	O
These	O	O
data	O	O
indicate	O	O
that	O	O
the	O	O
expression	O	O
of	O	O
CIITA	protein	protein
explains	O	O
the	O	O
expression	O	O
or	O	O
lack	O	O
of	O	O
expression	O	O
of	O	O
MHC	protein	protein
class	protein	protein
II	protein	protein
in	O	O
human	cell_type	O
and	O	O
mouse	cell_type	O
T	cell_type	O
cells	cell_type	O
respectively.	O	O

Anti-Ro(SSA)	protein	O
autoantibodies	protein	O
are	O	O
associated	O	O
with	O	O
T	DNA	protein
cell	DNA	protein
receptor	DNA	protein
beta	DNA	protein
genes	DNA	O
in	O	O
systemic	O	O
lupus	O	O
erythematosus	O	O
patients	O	O
.	O	O
Several	O	O
of	O	O
the	O	O
heterogeneous	O	O
clinical	O	O
manifestations	O	O
of	O	O
systemic	O	O
lupus	O	O
erythematosus	O	O
have	O	O
been	O	O
associated	O	O
with	O	O
specific	O	O
autoantibodies	protein	O
.	O	O
Associations	O	O
between	O	O
HLA	protein	protein
class	protein	protein
II	protein	protein
antigens	protein	protein
and	O	O
autoantibodies	protein	O
to	O	O
the	O	O
ribonucleoproteins	protein	protein
Ro(SSA)	protein	protein
and	O	O
La(SSB)	protein	O
have	O	O
been	O	O
reported	O	O
in	O	O
these	O	O
patients.	O	O
Because	O	O
HLA	protein	protein
class	protein	protein
II	protein	protein
molecules	protein	protein
present	O	O
antigen	O	O
to	O	O
T	protein	protein
cell	protein	protein
receptors	protein	protein
(	O	O
TCRs	protein	protein
),	O	O
we	O	O
have	O	O
searched	O	O
for	O	O
a	O	O
TCR	DNA	DNA
gene	DNA	DNA
associated	O	O
with	O	O
the	O	O
production	O	O
of	O	O
anti-	protein	protein
Ro(SSA)	protein	protein
antibodies	protein	protein
.	O	O
A	O	O
pair	O	O
of	O	O
restriction	DNA	O
fragment	DNA	O
length	DNA	O
polymorphisms	DNA	O
(	O	O
RFLPs	DNA	protein
),	O	O
one	O	O
of	O	O
which	O	O
hybridizes	O	O
to	O	O
the	O	O
TCR	DNA	protein
constant	DNA	protein
region	DNA	protein
C	DNA	protein
beta	DNA	protein
1	DNA	protein
and	O	O
the	O	O
other	O	O
to	O	O
the	O	O
C	DNA	protein
beta	DNA	protein
2	DNA	protein
gene	DNA	O
,	O	O
has	O	O
been	O	O
identified,	O	O
suggesting	O	O
these	O	O
may	O	O
be	O	O
genotypic	O	O
markers	O	O
for	O	O
an	O	O
extended	O	O
region	O	O
of	O	O
the	O	O
TCR	DNA	protein
beta	DNA	protein
locus	DNA	O
.	O	O
This	O	O
RFLP	DNA	DNA
pair	DNA	DNA
occurs	O	O
in	O	O
76%	O	O
of	O	O
patients	O	O
with	O	O
Ro(SSA)	protein	O
precipitins,	O	O
84%	O	O
of	O	O
anti-	O	O
Ro(SSA)	protein	O
-positive	O	O
patients	O	O
lacking	O	O
La(SSB)	protein	O
precipitins	protein	O
,	O	O
but	O	O
only	O	O
41%	O	O
of	O	O
the	O	O
patients	O	O
lacking	O	O
both	O	O
precipitins	protein	O
(P	O	O
=	O	O
0.0004).	O	O
This	O	O
disproportionate	O	O
occurrence	O	O
in	O	O
a	O	O
subset	O	O
of	O	O
lupus	O	O
patients	O	O
indicates	O	O
that	O	O
these	O	O
RFLPs	DNA	protein
are	O	O
not	O	O
disease	O	O
susceptibility	O	O
markers,	O	O
but	O	O
rather	O	O
are	O	O
important	O	O
markers	O	O
for	O	O
TCR	DNA	DNA
genes	DNA	DNA
whose	O	O
products	O	O
are	O	O
involved	O	O
in	O	O
the	O	O
production	O	O
of	O	O
anti-	protein	protein
Ro(SSA)	protein	protein
antibodies	protein	protein
.	O	O
The	O	O
majority	O	O
of	O	O
patients	O	O
who	O	O
have	O	O
these	O	O
RFLPs	DNA	protein
and	O	O
HLA	protein	protein
class	protein	protein
II	protein	protein
antigens	protein	protein
previously	O	O
associated	O	O
with	O	O
the	O	O
anti-	O	O
Ro(SSA)	protein	O
response	O	O
make	O	O
this	O	O
antibody,	O	O
suggesting	O	O
that	O	O
interactions	O	O
between	O	O
products	O	O
of	O	O
these	O	O
loci	DNA	O
occur	DNA	O
in	O	O
response	O	O
to	O	O
Ro(SSA)	protein	O
.	O	O

Inhibition	O	O
of	O	O
NF-AT	protein	protein
-dependent	O	O
transcription	O	O
by	O	O
NF-kappa	protein	protein
B	protein	protein
:	O	O
implications	O	O
for	O	O
differential	O	O
gene	O	O
expression	O	O
in	O	O
T	cell_type	O
helper	cell_type	O
cell	cell_type	O
subsets	cell_type	O
.	O	O
Activation	O	O
of	O	O
individual	O	O
CD4+	cell_line	cell_type
T	cell_line	cell_type
cells	cell_line	cell_type
results	O	O
in	O	O
differential	O	O
lymphokine	protein	O
expression	O	O
:	O	O
interleukin	protein	protein
2	protein	protein
(	O	O
IL-2	protein	protein
)	O	O
is	O	O
preferentially	O	O
produced	O	O
by	O	O
T	cell_line	O
helper	cell_line	O
type	cell_line	O
1	cell_line	O
(TH1)	cell_line	O
cells	cell_line	O
,	O	O
which	O	O
are	O	O
involved	O	O
in	O	O
cell-mediated	O	O
immune	O	O
responses,	O	O
whereas	O	O
IL-4	protein	protein
is	O	O
synthesized	O	O
by	O	O
TH2	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
which	O	O
are	O	O
essential	O	O
for	O	O
humoral	O	O
immunity	O	O
.	O	O
The	O	O
Ca(2+)	protein	protein
-dependent	protein	protein
factor	protein	protein
NF-ATp	protein	protein
plays	O	O
a	O	O
key	O	O
role	O	O
in	O	O
the	O	O
inducible	O	O
transcription	O	O
of	O	O
both	O	O
these	O	O
lymphokine	DNA	DNA
genes	DNA	DNA
.	O	O
However,	O	O
while	O	O
IL2	protein	protein
expression	O	O
requires	O	O
the	O	O
contribution	O	O
of	O	O
Ca(2+)-	O	protein
and	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
-dependent	O	O
signals	O	O
,	O	O
we	O	O
report	O	O
that	O	O
activation	O	O
of	O	O
human	protein	protein
IL4	protein	protein
transcription	O	O
through	O	O
the	O	O
Ca(2+)-dependent	O	O
pathway	O	O
is	O	O
diminished	O	O
by	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
stimulation	O	O
in	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
This	O	O
phenomenon	O	O
is	O	O
due	O	O
to	O	O
mutually	O	O
exclusive	O	O
binding	O	O
of	O	O
NF-ATp	protein	protein
and	O	O
NF-kappa	protein	protein
B	protein	protein
to	O	O
the	O	O
P	DNA	DNA
sequence	DNA	DNA
,	O	O
an	O	O
element	O	O
located	O	O
69	DNA	DNA
bp	DNA	DNA
upstream	DNA	DNA
of	O	O
the	O	O
IL4	DNA	protein
transcription	DNA	O
initiation	DNA	O
site	DNA	O
.	O	O
Human	DNA	DNA
IL4	DNA	DNA
promoter	DNA	DNA
-mediated	O	O
transcription	O	O
is	O	O
downregulated	O	O
in	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
stimulated	O	O
with	O	O
the	O	O
NF-kappa	protein	protein
B	protein	protein
-activating	protein	O
cytokine	protein	protein
tumor	protein	protein
necrosis	protein	protein
factor	protein	protein
alpha	protein	protein
and	O	O
suppressed	O	O
in	O	O
RelA	cell_line	cell_line
-overexpressing	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
In	O	O
contrast,	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
stimulation	O	O
or	O	O
RelA	protein	protein
overexpression	O	O
does	O	O
not	O	O
affect	O	O
the	O	O
activity	O	O
of	O	O
a	O	O
human	DNA	DNA
IL4	DNA	DNA
promoter	DNA	DNA
containing	O	O
a	O	O
mouse	DNA	DNA
P	DNA	DNA
sequence	DNA	DNA
,	O	O
which	O	O
is	O	O
a	O	O
higher-affinity	DNA	DNA
site	DNA	DNA
for	O	O
NF-ATp	protein	protein
and	O	O
a	O	O
lower-affinity	DNA	DNA
site	DNA	DNA
for	O	O
RelA	protein	protein
.	O	O
Thus,	O	O
competition	O	O
between	O	O
two	O	O
general	O	O
transcriptional	protein	O
activators	protein	O
,	O	O
RelA	protein	protein
and	O	O
NF-ATp	protein	protein
,	O	O
mediates	O	O
the	O	O
inhibitory	O	O
effect	O	O
of	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
stimulation	O	O
on	O	O
IL4	protein	O
expression	O	O
and	O	O
may	O	O
contribute	O	O
to	O	O
differential	O	O
gene	O	O
expression	O	O
in	O	O
TH	cell_line	cell_type
cells	cell_line	cell_type
.	O	O

Regulation	O	O
of	O	O
the	O	O
balance	O	O
of	O	O
cytokine	protein	protein
production	O	O
and	O	O
the	O	O
signal	O	protein
transducer	O	protein
and	O	protein
activator	O	protein
of	O	protein
transcription	O	protein
(	O	O
STAT	protein	protein
)	O	protein
transcription	O	protein
factor	O	protein
activity	O	O
by	O	O
cytokines	protein	protein
and	O	O
inflammatory	O	O
synovial	O	O
fluids.	O	O
The	O	O
balance	O	O
between	O	O
type	O	O
1	O	O
and	O	O
2	O	O
T	O	O
helper	O	O
cell	O	O
cytokine	O	protein
production	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
several	O	O
animal	O	O
models	O	O
of	O	O
autoimmunity,	O	O
and	O	O
skewed	O	O
patterns	O	O
of	O	O
cytokine	protein	protein
expression	O	O
have	O	O
been	O	O
described	O	O
in	O	O
human	O	O
inflammatory	O	O
diseases	O	O
.	O	O
Many	O	O
cytokines	protein	protein
activate	O	O
signal	protein	protein
transducer	protein	protein
and	protein	protein
activation	protein	O
of	protein	O
transcription	protein	O
(	protein	O
STAT	protein	protein
)	protein	protein
transcription	protein	protein
factors	protein	protein
,	O	O
which,	O	O
in	O	O
turn,	O	O
activate	O	O
transcription	O	O
of	O	O
inflammatory	O	O
effector	O	O
genes.	O	O
We	O	O
used	O	O
mononuclear	cell_line	O
cell	cell_line	O
priming	cell_line	O
cultures	cell_line	O
and	O	O
inflammatory	cell_type	O
synovial	cell_type	O
fluids	cell_type	O
(	O	O
SFs	cell_type	O
)	O	O
derived	O	O
from	O	O
arthritis	O	O
patients	O	O
to	O	O
examine	O	O
the	O	O
regulation	O	O
of	O	O
cytokine	protein	protein
production	O	O
and	O	O
STAT	protein	protein
activity	O	O
by	O	O
an	O	O
inflammatory	O	O
synovial	O	O
microenvironment	O	O
.	O	O
Exposure	O	O
to	O	O
SFs	cell_type	O
during	O	O
priming	O	O
resulted	O	O
in	O	O
an	O	O
81%	O	O
inhibition	O	O
of	O	O
interferon	protein	protein
(IFN)-gamma	protein	protein
,	O	O
but	O	O
not	O	O
interleukin	protein	protein
(IL)	protein	protein
4	protein	protein
,	O	O
production	O	O
by	O	O
effector	cell_type	cell_type
cells	cell_type	cell_type
generated	O	O
in	O	O
priming	O	O
cultures.	O	O
SF	O	O
suppression	O	O
was	O	O
mediated	O	O
by	O	O
IL-4	protein	protein
and	O	O
IL-10	protein	protein
and	O	O
inhibition	O	O
of	O	O
IL-12	protein	protein
expression	O	O
,	O	O
and	O	O
it	O	O
was	O	O
reversed	O	O
in	O	O
a	O	O
dominant	O	O
fashion	O	O
by	O	O
exogenous	O	O
IL-12.	O	protein
SFs	cell_type	protein
blocked	O	O
the	O	O
sustained	O	O
activity	O	O
of	O	O
transcription	protein	protein
factor	protein	protein
Stat1	protein	protein
,	O	O
but	O	O
not	O	O
Stat3	protein	protein
,	O	O
during	O	O
the	O	O
priming	O	O
period,	O	O
and	O	O
Stat1	protein	protein
activity	O	O
was	O	O
differentially	O	O
regulated	O	O
by	O	O
cytokines	protein	protein
in	O	O
parallel	O	O
with	O	O
their	O	O
positive	O	O
or	O	O
negative	O	O
regulation	O	O
of	O	O
IFN-gamma	protein	protein
production	O	O
.	O	O
Active	O	O
Stat3	protein	protein
,	O	O
but	O	O
not	O	O
Stat1	protein	protein
,	O	O
was	O	O
detected	O	O
in	O	O
cells	O	O
from	O	O
inflamed	O	O
joints	O	O
.	O	O
These	O	O
results	O	O
suggest	O	O
a	O	O
role	O	O
for	O	O
altered	O	O
balance	O	O
of	O	O
Stat1	O	protein
and	O	O
Stat3	O	protein
transcriptional	O	O
activity	O	O
in	O	O
the	O	O
regulation	O	O
of	O	O
T	cell_type	O
cell	cell_type	O
differentiation	O	O
and	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
inflammatory	O	O
synovitis	O	O
.	O	O

Triggering	O	O
of	O	O
complement	protein	protein
receptors	protein	protein
CR1	protein	protein
(	O	O
CD35	protein	protein
)	O	O
and	O	O
CR3	protein	protein
(	O	O
CD11b/CD18	protein	protein
)	O	O
induces	O	O
nuclear	O	O
translocation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
(	O	O
p50/p65	protein	protein
)	O	O
in	O	O
human	cell_type	cell_type
monocytes	cell_type	cell_type
and	O	O
enhances	O	O
viral	O	O
replication	O	O
in	O	O
HIV-infected	cell_type	cell_line
monocytic	cell_type	cell_line
cells	cell_type	cell_line
.	O	O
Monocyte/macrophages	cell_type	O
may	O	O
harbor	O	O
HIV	O	O
in	O	O
a	O	O
nonproductive	O	O
fashion	O	O
for	O	O
prolonged	O	O
periods	O	O
of	O	O
time.	O	O
Viral	O	O
gene	O	O
expression	O	O
may	O	O
be	O	O
reactivated	O	O
by	O	O
stimulation	O	O
of	O	O
the	O	O
cells	O	O
with	O	O
LPS	O	O
or	O	O
cytokines	protein	protein
such	O	O
as	O	O
TNF-alpha	protein	protein
in	O	O
vitro.	O	O
The	O	O
effect	O	O
of	O	O
LPS	O	O
and	O	O
TNF-alpha	protein	protein
is	O	O
mediated	O	O
by	O	O
their	O	O
ability	O	O
to	O	O
induce	O	O
nuclear	O	O
translocation	O	O
of	O	O
the	O	O
DNA-binding	protein	O
heterodimer	protein	O
NF-kappa	protein	protein
B	protein	protein
(	O	O
p50/p65	protein	protein
),	O	O
which	O	O
binds	O	O
to	O	O
a	O	O
specific	O	O
sequence	O	O
in	O	O
the	O	O
HIV-long	DNA	DNA
terminal	DNA	DNA
repeat	DNA	DNA
.	O	O
The	O	O
present	O	O
study	O	O
demonstrates	O	O
that	O	O
triggering	O	O
of	O	O
complement	protein	protein
receptors	protein	protein
CR1	protein	protein
(	O	O
CD35	protein	protein
)	O	O
and	O	O
CR3	protein	protein
(	O	O
CD11b/CD18	protein	protein
)	O	O
enhances	O	O
viral	O	O
replication	O	O
in	O	O
HIV-infected	cell_line	cell_line
human	cell_line	cell_line
monocytic	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Monocytic	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
and	O	O
normal	O	cell_type
peripheral	O	cell_type
blood	O	cell_type
monocytes	O	cell_type
were	O	O
infected	O	O
with	O	O
HIV-1	O	O
in	O	O
vitro	O	O
and	O	O
cultured	O	O
in	O	O
the	O	O
presence	O	O
or	O	O
absence	O	O
of	O	O
F(ab')2	protein	O
fragments	protein	O
of	O	O
monoclonal	protein	protein
anti-	protein	protein
CR1	protein	protein
or	O	O
anti-	protein	O
CR3	protein	protein
Abs	protein	protein
or	O	O
with	O	O
C3	protein	protein
fragments	protein	protein
.	O	O
Stimulation	O	O
of	O	O
CR1	protein	protein
or	O	O
CR3	protein	protein
induces	O	O
a	O	O
two-	O	O
to	O	O
fourfold	O	O
increase	O	O
in	O	O
the	O	O
amount	O	O
of	O	O
cell-associated	O	O
and	O	O
released	O	O
p24	protein	protein
Ag	protein	protein
in	O	O
cell	cell_line	O
cultures	cell_line	O
that	O	O
was	O	O
equivalent	O	O
to	O	O
that	O	O
observed	O	O
in	O	O
control	cell_line	O
cultures	cell_line	O
triggered	O	O
with	O	O
LPS	O	O
.	O	O
We	O	O
further	O	O
observed	O	O
that	O	O
stimulation	O	O
of	O	O
CR1	protein	protein
or	O	O
CR3	protein	protein
induces	O	O
the	O	O
nuclear	O	O
translocation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
p50/p65	protein	protein
in	O	O
infected	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Translocation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
p50/p65	protein	protein
was	O	O
also	O	O
observed	O	O
following	O	O
stimulation	O	O
of	O	O
CR1	protein	protein
or	O	O
CR3	protein	O
of	O	O
uninfected	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
monocytes	cell_type	cell_type
from	O	O
HIV-seronegative	O	O
donors	O	O
.	O	O
The	O	O
amount	O	O
of	O	O
protein	O	O
translocated	O	O
was	O	O
similar	O	O
to	O	O
that	O	O
observed	O	O
when	O	O
cells	O	O
were	O	O
stimulated	O	O
with	O	O
rhTNF-alpha	protein	protein
.	O	O
TNF-alpha	protein	protein
did	O	O
not	O	O
mediate	O	O
the	O	O
translocation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
p50/p65	protein	protein
induced	O	O
by	O	O
triggering	O	O
of	O	O
complement	protein	protein
receptors	protein	protein
.	O	O
Taken	O	O
together,	O	O
these	O	O
observations	O	O
suggest	O	O
that	O	O
HIV	O	O
gene	O	O
expression	O	O
may	O	O
be	O	O
activated	O	O
in	O	O
infected	cell_type	O
monocytes	cell_type	cell_type
through	O	O
interaction	O	O
of	O	O
the	O	O
cells	O	O
with	O	O
complement-opsonized	protein	O
particles	protein	O
and	O	O
that	O	O
enhanced	O	O
viral	O	O
replication	O	O
is	O	O
associated	O	O
with	O	O
C3	protein	protein
receptor	protein	protein
-mediated	O	O
nuclear	O	O
translocation	O	O
of	O	O
the	O	O
NF-kappa	protein	protein
B	protein	protein
complex	protein	protein
.	O	O

Attenuation	O	O
of	O	O
gamma	protein	protein
interferon	protein	protein
-induced	O	O
tyrosine	O	O
phosphorylation	O	O
in	O	O
mononuclear	cell_type	cell_type
phagocytes	cell_type	cell_type
infected	O	O
with	O	O
Leishmania	O	O
donovani	O	O
:	O	O
selective	O	O
inhibition	O	O
of	O	O
signaling	O	O
through	O	O
Janus	protein	protein
kinases	protein	protein
and	O	O
Stat1	protein	protein
.	O	O
The	O	O
induction	O	O
of	O	O
gene	O	O
transcription	O	O
in	O	O
response	O	O
to	O	O
gamma	protein	protein
interferon	protein	protein
is	O	O
impaired	O	O
in	O	O
mononuclear	cell_type	cell_type
phagocytes	cell_type	cell_type
infected	O	O
with	O	O
Leishmania	O	O
donovani	O	O
,	O	O
and	O	O
the	O	O
mechanisms	O	O
involved	O	O
are	O	O
not	O	O
fully	O	O
understood.	O	O
The	O	O
changes	O	O
in	O	O
gene	O	O
expression	O	O
brought	O	O
about	O	O
by	O	O
gamma	protein	protein
interferon	protein	protein
are	O	O
thought	O	O
to	O	O
involve	O	O
transient	O	O
increases	O	O
in	O	O
the	O	O
activities	O	O
of	O	O
cellular	protein	protein
protein	protein	protein
tyrosine	protein	protein
kinases	protein	protein
,	O	O
including	O	O
the	O	O
Janus	protein	protein
kinases	protein	protein
Jak1	protein	protein
and	O	O
Jak2	protein	protein
,	O	O
leading	O	O
to	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
Stat1	protein	protein
.	O	O
To	O	O
investigate	O	O
the	O	O
mechanisms	O	O
accounting	O	O
for	O	O
the	O	O
impaired	O	O
responses	O	O
to	O	O
gamma	protein	protein
interferon	protein	protein
,	O	O
a	O	O
model	O	O
system	O	O
for	O	O
examining	O	O
overall	O	O
changes	O	O
in	O	O
protein	O	O
tyrosine	O	O
phosphorylation	O	O
,	O	O
activation	O	O
of	O	O
Jak1	protein	protein
and	O	O
Jak2	protein	O
and	O	O
phosphorylation	O	O
of	O	O
Stat1	protein	protein
was	O	O
developed	O	O
in	O	O
phorbol	cell_line	O
12-myristate	cell_line	O
13-acetate	cell_line	O
-differentiated	cell_line	O
U-937	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Analysis	O	O
of	O	O
whole-cell	O	O
lysates	O	O
by	O	O
antiphosphotyrosine	O	O
immunoblotting	O	O
showed	O	O
that	O	O
incubation	O	O
with	O	O
gamma	protein	protein
interferon	protein	protein
brought	O	O
about	O	O
specific	O	O
increases	O	O
in	O	O
phosphotyrosine	O	O
labeling	O	O
of	O	O
several	O	O
proteins.	O	O
Increased	O	O
labeling	O	O
of	O	O
these	O	O
proteins	O	O
occurred	O	O
to	O	O
similar	O	O
extents	O	O
in	O	O
control	cell_type	O
cells	cell_type	O
and	O	O
in	O	O
cells	O	O
that	O	O
had	O	O
been	O	O
infected	O	O
with	O	O
L.	O	O
donovani	O	O
for	O	O
16	O	O
h.	O	O
Jak1	protein	protein
,	O	O
Jak2	protein	protein
,	O	O
and	O	O
Stat1	protein	protein
were	O	O
immunoprecipitated	O	O
from	O	O
control	O	O
and	O	O
interferon-treated	cell_line	O
cells	cell_line	O
,	O	O
and	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
these	O	O
proteins,	O	O
detected	O	O
by	O	O
antiphosphotyrosine	O	O
immunoblotting	O	O
was	O	O
used	O	O
to	O	O
measured	O	O
their	O	O
activation.	O	O
Tyrosine	O	O
phosphorylation	O	O
of	O	O
Jak1	protein	protein
,	O	O
Jak2	protein	protein
,	O	O
and	O	O
Stat1	protein	protein
increased	O	O
markedly,	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner,	O	O
in	O	O
U-937	cell_line	cell_line
cells	cell_line	cell_line
incubated	O	O
with	O	O
gamma	protein	protein
interferon	protein	protein
.	O	O
In	O	O
contrast,	O	O
in	O	O
cells	O	O
infected	O	O
with	O	O
L.	O	O
donovani	O	O
,	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
Jak1	protein	protein
,	O	O
Jak2	protein	protein
,	O	O
and	O	O
Stat1	protein	protein
was	O	O
markedly	O	O
impaired.	O	O
This	O	O
effect	O	O
was	O	O
dependent	O	O
upon	O	O
the	O	O
duration	O	O
of	O	O
exposure	O	O
to	O	O
L.	O	O
donovani	O	O
and	O	O
was	O	O
maximal	O	O
and	O	O
complete	O	O
at	O	O
16	O	O
h.	O	O
Results	O	O
similar	O	O
to	O	O
those	O	O
observed	O	O
with	O	O
U-937	cell_line	cell_line
cells	cell_line	cell_line
were	O	O
also	O	O
obtained	O	O
with	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
monocytes	cell_type	cell_type
.	O	O
These	O	O
findings	O	O
indicate	O	O
that	O	O
infection	O	O
of	O	O
human	cell_type	cell_type
mononuclear	cell_type	cell_type
phagocytes	cell_type	cell_type
with	O	O
L.	O	O
donovani	O	O
leads	O	O
to	O	O
impaired	O	O
gamma	protein	O
interferon	protein	protein
-mediated	O	O
tyrosine	O	O
phosphorylation	O	O
and	O	O
selective	O	O
effects	O	O
on	O	O
the	O	O
Jak-	O	protein
Stat1	protein	protein
pathway	O	O
.	O	O
Unresponsiveness	O	O
to	O	O
gamma	protein	protein
interferon	protein	protein
for	O	O
activation	O	O
of	O	O
this	O	O
pathway	O	O
may	O	O
explain	O	O
impaired	O	O
transcriptional	O	O
responses	O	O
in	O	O
leishmania-infected	cell_type	cell_type
cells	cell_type	cell_type
.	O	O

Mutually	O	O
exclusive	O	O
interaction	O	O
of	O	O
a	O	O
novel	O	O
matrix	protein	protein
attachment	protein	O
region	protein	O
binding	protein	O
protein	protein	O
and	O	O
the	O	O
NF-muNR	protein	DNA
enhancer	protein	DNA
repressor	protein	DNA
.	O	O
Implications	O	O
for	O	O
regulation	O	O
of	O	O
immunoglobulin	protein	protein
heavy	protein	protein
chain	protein	protein
expression	O	O
.	O	O
The	O	O
immunoglobulin	protein	protein
heavy	protein	protein
chain	protein	protein
(	O	O
IgH	protein	DNA
)	O	DNA
intronic	O	DNA
enhancer	O	DNA
stimulates	O	O
transcription	O	O
from	O	O
functional	O	O
promoters	O	DNA
in	O	O
B	O	cell_type
lymphocytes	O	cell_type
but	O	O
not	O	O
other	O	O
cell	O	O
types.	O	O
The	O	O
observation	O	O
that	O	O
binding	O	O
sites	O	O
for	O	O
the	O	O
nuclear	protein	O
factor-mu	protein	O
negative	protein	O
regulator	protein	O
(	protein	O
NF-muNR	protein	DNA
)	protein	DNA
enhancer	protein	DNA
repressor	protein	DNA
overlap	protein	DNA
nuclear	protein	DNA
matrix	protein	DNA
attachment	protein	DNA
regions	protein	DNA
(	O	O
MARs	protein	protein
)	O	O
in	O	O
this	O	O
enhancer	DNA	O
has	O	O
lead	O	O
to	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
cell	O	O
type	O	O
specificity	O	O
of	O	O
the	O	O
enhancer	DNA	O
might	O	O
be	O	O
controlled	O	O
by	O	O
regulating	O	O
nuclear	O	O
matrix	O	O
attachment	O	O
(Scheuermann,	O	O
R.	O	O
H.,	O	O
and	O	O
Chen,	O	O
U.	O	O
(1989)	O	O
Genes	O	O
&amp;	O	O
Dev.	O	O
3,	O	O
1255-1266).	O	O
To	O	O
understand	O	O
the	O	O
role	O	O
of	O	O
MARs	protein	protein
in	O	O
IgH	DNA	DNA
enhancer	DNA	DNA
regulation	O	O
,	O	O
we	O	O
have	O	O
identified	O	O
a	O	O
novel	O	O
MAR-binding	protein	protein
protein	protein	protein
,	O	O
MAR-BP1	protein	protein
,	O	O
from	O	O
soluble	O	O
nuclear	O	O
matrix	O	O
preparations	O	O
based	O	O
on	O	O
its	O	O
ability	O	O
to	O	O
bind	O	O
to	O	O
the	O	O
MARs	protein	protein
associated	O	O
with	O	O
the	O	O
IgH	DNA	DNA
enhancer	DNA	DNA
.	O	O
Purified	O	O
MAR-BP1	protein	protein
migrates	O	O
as	O	O
a	O	O
33-kDa	protein	protein
protein	protein	protein
,	O	O
and	O	O
it	O	O
can	O	O
be	O	O
found	O	O
in	O	O
nuclear	O	O
matrix	O	O
preparations	O	O
from	O	O
a	O	O
number	O	O
of	O	O
different	O	O
types	O	O
of	O	O
lymphoid	cell_line	O
cell	cell_line	O
lines	cell_line	O
.	O	O
Although	O	O
specific	O	O
binding	O	O
sites	O	O
have	O	O
been	O	O
difficult	O	O
to	O	O
localize	O	O
by	O	O
chemical	O	O
or	O	O
enzymatic	O	O
footprinting	O	O
procedures	O	O
,	O	O
NF-muNR	protein	DNA
binding	O	DNA
sites	O	DNA
are	O	O
critical	O	O
for	O	O
efficient	O	O
MAR-BP1	protein	protein
binding	O	protein
.	O	O
Indeed,	O	O
binding	O	O
of	O	O
the	O	O
IgH	DNA	DNA
enhancer	DNA	DNA
to	O	O
either	O	O
intact	O	O
nuclear	O	O
matrix	O	O
preparations	O	O
or	O	O
to	O	O
MAR-BP1	protein	protein
is	O	O
mutually	O	O
exclusive	O	O
to	O	O
NF-muNR	protein	protein
binding	O	protein
.	O	O
These	O	O
results	O	O
are	O	O
consistent	O	O
with	O	O
a	O	O
model	O	O
for	O	O
cell-type	O	O
specific	O	O
regulation	O	O
in	O	O
which	O	O
binding	O	O
of	O	O
the	O	O
NF-muNR	protein	protein
repressor	protein	protein
to	O	O
the	O	O
IgH	DNA	DNA
enhancer	DNA	DNA
prevents	O	O
nuclear	O	O
matrix	O	O
attachment	O	O
in	O	O
inappropriate	O	O
cells	O	O
by	O	O
interfering	O	O
with	O	O
MAR-BP1	protein	protein
/enhancer	DNA	O
interaction	O	O
.	O	O

PU.1	protein	protein
(	O	O
Spi-1	protein	protein
)	O	O
and	O	O
C/EBP	protein	protein
alpha	protein	protein
regulate	O	O
expression	O	O
of	O	O
the	O	O
granulocyte-macrophage	DNA	DNA
colony-stimulating	DNA	DNA
factor	DNA	DNA
receptor	DNA	DNA
alpha	DNA	DNA
gene	DNA	DNA
.	O	O
Growth	protein	protein
factor	protein	protein
receptors	protein	protein
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
hematopoiesis	O	O
.	O	O
In	O	O
order	O	O
to	O	O
further	O	O
understand	O	O
the	O	O
mechanisms	O	O
directing	O	O
the	O	O
expression	O	O
of	O	O
these	O	O
key	O	O
regulators	O	O
of	O	O
hematopoiesis	O	O
,	O	O
we	O	O
initiated	O	O
a	O	O
study	O	O
investigating	O	O
the	O	O
transcription	protein	protein
factors	protein	protein
activating	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
granulocyte-macrophage	DNA	protein
colony-stimulating	DNA	protein
factor	DNA	protein
(	DNA	O
GM-CSF	DNA	protein
)	DNA	O
receptor	DNA	O
alpha	DNA	DNA
gene	DNA	DNA
.	O	O
Here,	O	O
we	O	O
demonstrate	O	O
that	O	O
the	O	O
human	DNA	protein
GM-CSF	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
promoter	DNA	O
directs	O	O
reporter	DNA	O
gene	DNA	O
activity	O	O
in	O	O
a	O	O
tissue-specific	O	O
fashion	O	O
in	O	O
myelomonocytic	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
which	O	O
correlates	O	O
with	O	O
its	O	O
expression	O	O
pattern	O	O
as	O	O
analyzed	O	O
by	O	O
reverse	O	O
transcription	O	O
PCR	O	O
.	O	O
The	O	O
GM-CSF	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
promoter	DNA	O
contains	O	O
an	O	O
important	O	O
functional	O	O
site	O	O
between	O	O
positions	O	DNA
-53	O	DNA
and	O	O
-41	O	O
as	O	O
identified	O	O
by	O	O
deletion	O	O
analysis	O	O
of	O	O
reporter	DNA	O
constructs	DNA	O
.	O	O
We	O	O
show	O	O
that	O	O
the	O	O
myeloid	O	O
and	O	O
B	protein	O
cell	protein	O
transcription	protein	protein
factor	protein	protein
PU.1	protein	protein
binds	O	O
specifically	O	O
to	O	O
this	O	O
site.	O	O
Furthermore,	O	O
we	O	O
demonstrate	O	O
that	O	O
a	O	O
CCAAT	DNA	DNA
site	DNA	DNA
located	O	O
upstream	O	O
of	O	O
the	O	O
PU.1	DNA	DNA
site	DNA	DNA
between	O	O
positions	O	DNA
-70	O	DNA
and	O	O
-54	O	O
is	O	O
involved	O	O
in	O	O
positive-negative	O	O
regulation	O	O
of	O	O
the	O	O
GM-CSF	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
promoter	DNA	O
activity	O	O
.	O	O
C/EBP	protein	protein
alpha	protein	protein
is	O	O
the	O	O
major	O	O
CCAAT/enhancer	protein	protein
-binding	protein	protein
protein	protein	protein
(	O	O
C/EBP	protein	protein
)	O	O
form	O	O
binding	O	O
to	O	O
this	O	O
site	O	O
in	O	O
nuclear	O	O
extracts	O	O
of	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Point	O	O
mutations	O	O
of	O	O
either	O	O
the	O	O
PU.1	DNA	DNA
site	DNA	DNA
or	O	O
the	O	O
C/EBP	DNA	DNA
site	DNA	DNA
that	O	O
abolish	O	O
the	O	O
binding	O	O
of	O	O
the	O	O
respective	O	O
factors	O	O
result	O	O
in	O	O
a	O	O
significant	O	O
decrease	O	O
of	O	O
GM-CSF	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
promoter	DNA	O
activity	O	O
in	O	O
myelomonocytic	cell_type	cell_line
cells	cell_type	cell_line
only.	O	O
Furthermore,	O	O
we	O	O
demonstrate	O	O
that	O	O
in	O	O
myeloid	O	O
and	O	O
B	O	O
cell	O	O
extracts	O	O
,	O	O
PU.1	protein	protein
forms	O	O
a	O	O
novel,	O	O
specific,	O	O
more	O	O
slowly	O	O
migrating	O	O
complex	O	O
(	O	O
PU-SF	protein	protein
)	O	O
when	O	O
binding	O	O
the	O	O
GM-CSF	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
promoter	DNA	DNA
PU.1	DNA	DNA
site	DNA	DNA
.	O	O
This	O	O
is	O	O
the	O	O
first	O	O
demonstration	O	O
of	O	O
a	O	O
specific	O	O
interaction	O	O
with	O	O
PU.1	protein	protein
on	O	O
a	O	O
myeloid	DNA	O
PU.1	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
.	O	O
The	O	O
novel	O	O
complex	O	O
is	O	O
distinct	O	O
from	O	O
that	O	O
described	O	O
previously	O	O
as	O	O
binding	O	O
to	O	O
B	DNA	O
cell	DNA	DNA
enhancer	DNA	DNA
sites	DNA	DNA
and	O	O
can	O	O
be	O	O
formed	O	O
by	O	O
addition	O	O
of	O	O
PU.1	protein	protein
to	O	O
extracts	O	O
from	O	O
certain	O	O
nonmyeloid	cell_type	O
cell	cell_type	O
types	cell_type	O
which	O	O
do	O	O
not	O	O
express	O	O
PU.1	protein	protein
,	O	O
including	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
epithelial	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
but	O	O
not	O	O
from	O	O
erythroid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Furthermore,	O	O
we	O	O
demonstrate	O	O
that	O	O
the	O	O
PU-SF	protein	protein
complex	protein	protein
binds	O	O
to	O	O
PU.1	protein	DNA
sites	O	DNA
found	O	O
on	O	O
a	O	O
number	O	O
of	O	O
myeloid	DNA	O
promoters	DNA	O
,	O	O
and	O	O
its	O	O
formation	O	O
requires	O	O
an	O	O
intact	O	O
PU.1	DNA	DNA
site	DNA	DNA
adjacent	O	O
to	O	O
a	O	O
single-stranded	O	O
region.	O	O
Expression	O	O
of	O	O
PU.1	protein	protein
in	O	O
nonmyeloid	cell_type	cell_type
cells	cell_type	cell_type
can	O	O
activate	O	O
the	O	O
GM-CSF	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
promoter	DNA	O
.	O	O
Deletion	O	O
of	O	O
the	O	O
amino-terminal	protein	protein
region	protein	protein
of	O	O
PU.1	protein	protein
results	O	O
in	O	O
a	O	O
failure	O	O
to	O	O
form	O	O
the	O	O
PU-SF	protein	protein
complex	O	protein
and	O	O
in	O	O
a	O	O
concomitant	O	O
loss	O	O
of	O	O
transactivation,	O	O
suggesting	O	O
that	O	O
formation	O	O
of	O	O
the	O	O
PU-SF	protein	protein
complex	protein	protein
is	O	O
of	O	O
functional	O	O
importance	O	O
for	O	O
the	O	O
activity	O	O
of	O	O
the	O	O
GM-CSF	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
promoter	DNA	O
.	O	O
Finally,	O	O
we	O	O
demonstrate	O	O
that	O	O
C/EBP	protein	protein
alpha	protein	protein
can	O	O
also	O	O
active	O	O
the	O	O
GM-CSF	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
promoter	DNA	O
in	O	O
nonmyeloid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
(ABSTRACT	O	O
TRUNCATED	O	O
AT	O	O
400	O	O
WORDS)	O	O

HMG-I	protein	protein
binds	O	O
to	O	O
GATA	DNA	O
motifs	DNA	O
:	O	O
implications	O	O
for	O	O
an	O	O
HPFH	O	O
syndrome	O	O
.	O	O
We	O	O
have	O	O
examined	O	O
binding	O	O
of	O	O
the	O	O
nuclear	protein	protein
protein	protein	protein
HMG-I	protein	protein
to	O	O
the	O	O
human	DNA	DNA
gamma-globin	DNA	DNA
promoter	DNA	DNA
.	O	O
We	O	O
find	O	O
that	O	O
HMG-I	protein	protein
binds	O	O
preferentially	O	O
to	O	O
the	O	O
more	O	O
3'	O	O
of	O	O
a	O	O
pair	O	O
of	O	O
GATA	DNA	O
motifs	DNA	O
in	O	O
the	O	O
gamma-globin	DNA	DNA
promoter	DNA	DNA
;	O	O
this	O	O
paired	O	O
motif	O	O
is	O	O
bound	O	O
by	O	O
the	O	O
erythroid	protein	protein
factor	protein	protein
GATA-1	protein	protein
.	O	O
A	O	O
naturally	O	O
occurring	O	O
mutation	O	O
(-175	O	O
T-C)	O	O
in	O	O
the	O	O
area	O	O
bound	O	O
by	O	O
HMG-I	protein	protein
results	O	O
in	O	O
overexpression	O	O
of	O	O
gamma-globin	protein	protein
in	O	O
adult	cell_type	cell_type
red	cell_type	cell_type
blood	cell_type	cell_type
cells	cell_type	cell_type
(	O	O
HPFH	cell_type	O
)	O	O
and	O	O
up-regulation	O	O
of	O	O
the	O	O
gamma-globin	DNA	DNA
promoter	DNA	DNA
in	O	O
in	O	O
vitro	O	O
expression	O	O
assays	O	O
;	O	O
HMG-I	protein	protein
does	O	O
not	O	O
bind	O	O
to	O	O
this	O	O
mutant	DNA	DNA
sequence	DNA	DNA
.	O	O
A	O	O
survey	O	O
of	O	O
GATA	DNA	O
motifs	DNA	O
from	O	O
other	O	O
globin	DNA	O
cis-elements	DNA	DNA
demonstrates	O	O
HMG-I	protein	protein
binding	O	O
to	O	O
most	O	O
of	O	O
them.	O	O
These	O	O
findings	O	O
implicate	O	O
HMG-I	protein	protein
in	O	O
the	O	O
HPFH	cell_type	O
phenotype	O	O
;	O	O
we	O	O
speculate	O	O
that	O	O
it	O	O
may	O	O
participate	O	O
in	O	O
the	O	O
formation	O	O
of	O	O
multiprotein	protein	protein
complexes	protein	protein
that	O	O
regulate	O	O
globin	O	DNA
gene	O	DNA
expression	O	O
.	O	O

Constitutive	O	O
activation	O	O
of	O	O
different	O	O
Jak	protein	protein
tyrosine	protein	protein
kinases	protein	protein
in	O	O
human	protein	cell_line
T	protein	cell_line
cell	protein	cell_line
leukemia	protein	cell_line
virus	protein	cell_line
type	protein	cell_line
1	protein	cell_line
(	protein	cell_line
HTLV-1	protein	cell_line
)	protein	O
tax	protein	protein
protein	protein	protein
or	O	O
virus-transformed	cell_line	O
cells	cell_line	O
.	O	O
HTLV-1	O	O
infection	O	O
causes	O	O
an	O	O
adult	O	O
T	O	O
cell	O	O
leukemia	O	O
in	O	O
humans	O	O
.	O	O
The	O	O
viral	protein	O
encoded	protein	O
protein	protein	O
tax	protein	O
,	O	O
is	O	O
thought	O	O
to	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
oncogenesis	O	O
.	O	O
Our	O	O
previous	O	O
data	O	O
obtained	O	O
from	O	O
a	O	O
tax	protein	O
transgenic	O	O
mouse	O	O
model	O	O
revealed	O	O
that	O	O
tax	protein	O
transforms	O	O
mouse	cell_type	O
fibroblasts	cell_type	cell_type
but	O	O
not	O	O
thymocytes	cell_type	cell_type
,	O	O
despite	O	O
comparable	O	O
levels	O	O
of	O	O
tax	protein	O
expression	O	O
in	O	O
both	O	O
tissues.	O	O
Constitutive	O	O
tyrosine	O	O
phosphorylation	O	O
of	O	O
a	O	O
130-kD	protein	protein
protein	protein	protein
(s)	O	O
was	O	O
observed	O	O
in	O	O
the	O	O
tax	protein	O
transformed	cell_line	cell_line
fibroblast	cell_line	cell_line
B	cell_line	cell_line
line	cell_line	cell_line
and	O	O
in	O	O
HTLV-1	cell_line	O
transformed	cell_line	cell_line
human	cell_line	cell_line
lymphoid	cell_line	cell_line
lines	cell_line	cell_line
,	O	O
but	O	O
not	O	O
in	O	O
thymocytes	cell_type	cell_type
from	O	O
Thy-tax	O	O
transgenic	O	O
mice	O	O
.	O	O
Phosphotyrosine	O	O
immunoprecipitation	O	O
followed	O	O
by	O	O
Western	O	O
blot	O	O
analysis	O	O
with	O	O
a	O	O
set	O	O
of	O	O
Jak	protein	protein
kinase	protein	protein
specific	protein	protein
antibodies	protein	protein
,	O	O
identified	O	O
p130	O	protein
as	O	O
Jak2	protein	protein
in	O	O
the	O	O
tax	protein	O
transformed	O	O
mouse	cell_line	O
fibroblastic	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
and	O	O
Jak3	protein	O
in	O	O
HTLV-1	cell_line	O
transformed	cell_line	cell_line
human	cell_line	cell_line
T	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
Phosphorylation	O	O
of	O	O
Jak2	protein	protein
in	O	O
tax	cell_line	cell_line
transformed	cell_line	cell_line
cells	cell_line	cell_line
resulted	O	O
from	O	O
high	O	O
expression	O	O
of	O	O
IL-6	protein	protein
.	O	O
Tyrosine	O	O
phosphorylation	O	O
of	O	O
this	O	O
protein	O	O
could	O	O
also	O	O
be	O	O
induced	O	O
in	O	O
Balb/c3T3	cell_line	cell_line
cells	cell_line	cell_line
using	O	O
a	O	O
supernatant	O	O
from	O	O
the	O	O
B	cell_line	DNA
line	cell_line	DNA
,	O	O
which	O	O
was	O	O
associated	O	O
with	O	O
induction	O	O
of	O	O
cell	O	O
proliferation	O	O
.	O	O
Both	O	O
phosphorylation	O	O
and	O	O
proliferation	O	O
were	O	O
inhibited	O	O
by	O	O
IL-6	protein	protein
neutralizing	protein	protein
antibodies	protein	protein
.	O	O
Constitutive	O	O
phosphorylation	O	O
of	O	O
Jak	protein	protein
kinases	protein	protein
may	O	O
facilitate	O	O
tumor	O	O
growth	O	O
in	O	O
both	O	O
HTLV-1	cell_type	O
infected	cell_type	O
human	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
the	O	O
transgenic	O	O
mouse	O	O
model	O	O
.	O	O

Regulation	O	O
of	O	O
c-jun	RNA	RNA
mRNA	RNA	RNA
expression	O	O
by	O	O
hydroxyurea	O	O
in	O	O
human	cell_line	cell_type
K562	cell_line	cell_type
cells	cell_line	cell_type
during	O	O
erythroid	O	O
differentiation	O	O
[published	O	O
erratum	O	O
appears	O	O
in	O	O
Biochim	O	O
Biophys	O	O
Acta	O	O
1995	O	O
Dec	O	O
27;1264(3):409]	O	O
Hydroxyurea	O	O
(	O	O
HU	O	protein
)	O	O
is	O	O
an	O	O
antitumor	O	O
agent	O	O
which	O	O
also	O	O
induces	O	O
hemoglobinization	O	O
during	O	O
erythroid	O	O
differentiation	O	O
.	O	O
In	O	O
addition,	O	O
HU	O	protein
stimulates	O	O
the	O	O
synthesis	O	O
of	O	O
fetal	protein	O
hemoglobin	protein	protein
in	O	O
sickle	O	O
cell	O	O
anemia	O	O
patients	O	O
.	O	O
To	O	O
further	O	O
understand	O	O
its	O	O
mechanism	O	O
of	O	O
action,	O	O
we	O	O
investigated	O	O
the	O	O
effects	O	O
of	O	O
HU	O	O
on	O	O
regulation	O	O
of	O	O
c-jun	DNA	DNA
expression	O	O
prior	O	O
to	O	O
the	O	O
onset	O	O
of	O	O
erythroid	O	O
differentiation	O	O
of	O	O
K562	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
HU	O	O
induced	O	O
a	O	O
dose-dependent	O	O
stimulation	O	O
of	O	O
c-jun	DNA	DNA
synthesis.	O	O
The	O	O
levels	O	O
of	O	O
c-jun	RNA	RNA
mRNA	RNA	RNA
was	O	O
elevated	O	O
4	O	O
to	O	O
7.5-fold	O	O
by	O	O
HU	O	protein
within	O	O
2	O	O
h.	O	O
This	O	O
was	O	O
followed	O	O
by	O	O
a	O	O
gradual	O	O
decline	O	O
to	O	O
the	O	O
basal	O	O
level	O	O
by	O	O
24	O	O
h.	O	O
Both	O	O
nuclear	O	O
run-on	O	O
and	O	O
actinomycin	O	O
D	O	O
pulse	O	O
experiments	O	O
strongly	O	O
indicate	O	O
that	O	O
HU	O	O
regulates	O	O
c-jun	RNA	O
mRNA	RNA	O
expression	O	O
by	O	O
increasing	O	O
the	O	O
rate	O	O
of	O	O
synthesis	O	O
as	O	O
well	O	O
as	O	O
stabilizing	O	O
the	O	O
c-jun	RNA	RNA
mRNA	RNA	RNA
.	O	O
In	O	O
addition,	O	O
the	O	O
level	O	O
of	O	O
jun	protein	O
protein	protein	O
was	O	O
elevated	O	O
by	O	O
2	O	O
to	O	O
5-fold	O	O
within	O	O
4	O	O
h	O	O
in	O	O
HU	cell_line	cell_line
treated	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Furthermore,	O	O
concentrations	O	O
of	O	O
HU	O	O
below	O	O
250	O	O
microM	O	O
slightly	O	O
increased	O	O
the	O	O
5X	O	O
AP-1	protein	protein
/CAT	protein	protein
activity	O	O
.	O	O
These	O	O
results	O	O
strongly	O	O
suggest	O	O
that	O	O
HU	O	O
induces	O	O
both	O	O
transcriptional	O	O
and	O	O
post-transcription	O	O
regulation	O	O
of	O	O
c-jun	DNA	DNA
during	O	O
erythroid	O	O
differentiation	O	O
.	O	O

In	O	O
vivo	O	O
and	O	O
in	O	O
vitro	O	O
effects	O	O
of	O	O
glucocorticoids	O	O
on	O	O
lymphocyte	O	O
proliferation	O	O
in	O	O
man	O	O
:	O	O
relationship	O	O
to	O	O
glucocorticoid	protein	protein
receptors	protein	protein
.	O	O
Interrelations	O	O
between	O	O
the	O	O
hypothalamic-pituitary-adrenal	O	O
system	O	O
(	O	O
HPA	O	O
)	O	O
and	O	O
the	O	O
immune	O	O
system	O	O
represent	O	O
a	O	O
well-documented	O	O
biological	O	O
phenomenon	O	O
.	O	O
While	O	O
in	O	O
vitro	O	O
administration	O	O
of	O	O
glucocorticoids	O	O
may	O	O
inhibit	O	O
concanavalin	O	O
A	O	O
(Con	O	O
A)-	O	O
and	O	O
phytohemagglutinin	O	protein
(PHA)-	O	protein
induced	O	O
T-cell	O	O
proliferation	O	O
,	O	O
pokeweed	protein	O
mitogen	protein	protein
(	O	O
PWM	protein	protein
)-driven	O	O
B-cell	O	O
mitogenesis	O	O
is	O	O
relatively	O	O
resistant	O	O
to	O	O
glucocorticoids	O	O
.	O	O
To	O	O
further	O	O
explore	O	O
the	O	O
link	O	O
between	O	O
the	O	O
HPA	O	O
and	O	O
the	O	O
immune	O	O
system	O	O
in	O	O
relation	O	O
to	O	O
glucocorticoid	protein	protein
receptor	protein	protein
function	O	O
,	O	O
dose-response	O	O
curves	O	O
were	O	O
obtained	O	O
for	O	O
Con	O	O
A	O	O
-and	O	O
PHA	protein	protein
-induced	O	O
T-cell	O	O
mitogenesis	O	O
,	O	O
PWM	protein	protein
-generated	O	O
B-cell	O	O
mitogenesis	O	O
and	O	O
spontaneous	O	O
lymphocyte	O	O
proliferation	O	O
in	O	O
13	O	O
healthy	O	O
controls	O	O
.	O	O
Glucocorticoid	O	O
effects	O	O
were	O	O
assessed	O	O
in	O	O
vivo	O	O
by	O	O
depletion	O	O
of	O	O
endogenous	O	O
glucocorticoids	O	O
after	O	O
oral	O	O
administration	O	O
of	O	O
1.5	O	O
g	O	O
metyrapone	O	O
(	O	O
MET	O	O
)	O	O
and	O	O
subsequent	O	O
glucocorticoid	O	O
replacement	O	O
,	O	O
and	O	O
in	O	O
vitro	O	O
by	O	O
incubation	O	O
of	O	O
the	O	O
cells	O	O
with	O	O
different	O	O
doses	O	O
of	O	O
dexamethasone	O	O
(	O	O
DEX	O	O
).	O	O
There	O	O
was	O	O
a	O	O
significant	O	O
decrease	O	O
in	O	O
PWM	protein	protein
-induced	O	O
B-cell	O	O
mitogenesis	O	O
and	O	O
a	O	O
more	O	O
pronounced	O	O
effect	O	O
of	O	O
DEX	O	O
administered	O	O
in	O	O
vitro	O	O
on	O	O
spontaneous	O	O
lymphocyte	O	O
proliferation	O	O
after	O	O
MET	O	O
treatment	O	O
when	O	O
compared	O	O
with	O	O
the	O	O
DEX	O	O
plus	O	O
MET	O	O
pretreated	O	O
condition	O	O
in	O	O
vivo.	O	O
These	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
inhibition	O	O
of	O	O
spontaneous	O	O
lymphocyte	O	O
proliferation	O	O
by	O	O
glucocorticoids	O	O
in	O	O
vitro	O	O
is	O	O
related	O	O
to	O	O
glucocorticoid	protein	protein
receptor	protein	protein
function	O	O
.	O	O
The	O	O
decrease	O	O
in	O	O
PWM	protein	protein
-generated	O	O
B-cell	O	O
proliferation	O	O
following	O	O
cortisol	O	O
depletion	O	O
by	O	O
MET	O	protein
may	O	O
be	O	O
seen	O	O
in	O	O
connection	O	O
with	O	O
impaired	O	O
glucocorticoid	O	O
-mediated	O	O
induction	O	O
of	O	O
interleukin-1	protein	protein
receptor	protein	protein
synthesis	O	O
.	O	O

Transcription	O	O
specific	O	O
differences	O	O
visualized	O	O
by	O	O
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
pattern	O	O
on	O	O
interphase	O	O
nuclei	O	O
of	O	O
different	O	O
cell	O	O
types.	O	O
Application	O	O
of	O	O
a	O	O
"formamide	O	O
free"	O	O
and	O	O
thus	O	O
"material	O	O
preserving"	O	O
in	O	O
situ	O	O
hybridization	O	O
technique	O	O
using	O	O
the	O	O
cDNA	DNA	O
of	O	O
the	O	O
myf3	DNA	DNA
gene	DNA	DNA
revealed	O	O
the	O	O
following	O	O
results:	O	O
Human	cell_type	cell_type
rhabdomyosarcoma	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
characterized	O	O
by	O	O
a	O	O
high	O	O
expression	O	O
of	O	O
myf3	DNA	O
show	O	O
intensive	O	O
hybridization	O	O
signals	O	O
in	O	O
their	O	O
interphase	O	O
.	O	O
RNase	protein	protein
treatment	O	O
prior	O	O
to	O	O
hybridization	O	O
considerably	O	O
reduces	O	O
the	O	O
size	O	O
of	O	O
this	O	O
signals.	O	O
In	O	O
comparison,	O	O
isolated	O	O
nuclei	O	O
of	O	O
human	cell_type	cell_type
lymphocytes	cell_type	cell_type
in	O	O
which	O	O
no	O	O
need	O	O
for	O	O
the	O	O
expression	O	O
of	O	O
this	O	O
gene	O	O
exists,	O	O
show	O	O
barely	O	O
hybridization	O	O
signals	O	O
.	O	O
Correspondingly,	O	O
RNase	protein	protein
treatment	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
hybridization	O	O
pattern	O	O
at	O	O
all.	O	O
In	O	O
conclusion	O	O
an	O	O
increased	O	O
transcription	O	O
efficiency	O	O
of	O	O
a	O	O
cell	O	O
type	O	O
specific	O	O
gene	O	O
is	O	O
accompanied	O	O
by	O	O
a	O	O
higher	O	O
hybridization	O	O
accessibility	O	O
in	O	O
the	O	O
corresponding	O	O
cell	O	O
nuclei	O	O
.	O	O

Oncogenicity	O	O
of	O	O
human	O	O
papillomavirus-	O	O
or	O	O
adenovirus-	O	O
transformed	O	O
cells	O	O
correlates	O	O
with	O	O
resistance	O	O
to	O	O
lysis	O	O
by	O	O
natural	cell_type	cell_type
killer	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
The	O	O
reasons	O	O
for	O	O
the	O	O
dissimilar	O	O
oncogenicities	O	O
of	O	O
human	O	O
adenoviruses	O	O
and	O	O
human	O	O
papillomaviruses	O	O
(	O	O
HPV	O	O
)	O	O
in	O	O
humans	O	O
are	O	O
unknown	O	O
but	O	O
may	O	O
relate	O	O
to	O	O
differences	O	O
in	O	O
the	O	O
capacities	O	O
of	O	O
the	O	O
E1A	protein	protein
and	O	O
E7	protein	protein
proteins	protein	protein
to	O	O
target	cell_type	O
cells	cell_type	O
for	O	O
rejection	O	O
by	O	O
the	O	O
host	cell_type	O
natural	cell_type	O
killer	cell_type	O
(NK)	cell_type	O
cell	cell_type	O
response	O	O
.	O	O
As	O	O
one	O	O
test	O	O
of	O	O
this	O	O
hypothesis,	O	O
we	O	O
compared	O	O
the	O	O
abilities	O	O
of	O	O
E1A	protein	protein
-and	O	O
E7	protein	O
-expressing	O	O
human	O	O
fibroblastic	O	O
or	O	O
keratinocyte-derived	O	cell_line
human	O	cell_line
cells	O	cell_line
to	O	O
be	O	O
selectively	O	O
killed	O	O
by	O	O
either	O	O
unstimulated	cell_type	O
or	O	O
interferon	cell_line	O
(IFN)-activated	cell_line	O
NK	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
Cells	O	O
expressing	O	O
the	O	O
E1A	protein	protein
oncoprotein	protein	protein
were	O	O
selectively	O	O
killed	O	O
by	O	O
unstimulated	cell_line	cell_type
NK	cell_line	cell_type
cells	cell_line	cell_type
,	O	O
while	O	O
the	O	O
same	O	O
parental	cell_type	O
cells	cell_type	O
but	O	O
expressing	O	O
the	O	O
HPV	O	protein
type	O	protein
16	O	protein
(	O	O
HPV-16	O	protein
)	O	O
or	O	O
HPV-18	O	protein
E7	protein	protein
oncoprotein	protein	protein
were	O	O
resistant	O	O
to	O	O
NK	O	O
cell	O	O
lysis	O	O
.	O	O
The	O	O
ability	O	O
of	O	O
IFN-activated	cell_line	cell_line
NK	cell_line	cell_line
cells	cell_line	cell_line
to	O	O
selectively	O	O
kill	O	O
virally	O	O
transformed	O	cell_line
cells	O	cell_line
depends	O	O
on	O	O
IFN	protein	protein
's	O	O
ability	O	O
to	O	O
induce	O	O
resistance	O	O
to	O	O
NK	O	O
cell	O	O
lysis	O	O
in	O	O
normal	O	O
(i.e.,	O	O
non-viral	cell_line	O
oncogene-expressing	cell_line	O
)	O	O
but	O	O
not	O	O
virally	cell_line	O
transformed	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
E1A	protein	protein
blocked	O	O
IFN	protein	protein
's	O	O
induction	O	O
of	O	O
cytolytic	O	O
resistance	O	O
,	O	O
resulting	O	O
in	O	O
the	O	O
selective	O	O
lysis	O	O
of	O	O
adenovirus-transformed	cell_line	cell_type
cells	cell_line	cell_type
by	O	O
IFN	cell_line	protein
-activated	cell_line	O
NK	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
The	O	O
extent	O	O
of	O	O
IFN	protein	protein
-induced	O	O
NK	O	O
cell	O	O
killing	O	O
of	O	O
E1A	cell_line	cell_type
-expressing	cell_line	cell_type
cells	cell_line	cell_type
was	O	O
proportional	O	O
to	O	O
the	O	O
level	O	O
of	O	O
E1A	protein	protein
expression	O	O
and	O	O
correlated	O	O
with	O	O
the	O	O
ability	O	O
of	O	O
E1A	protein	protein
to	O	O
block	O	O
IFN	protein	DNA
-stimulated	O	DNA
gene	O	DNA
expression	O	O
in	O	O
target	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
contrast,	O	O
E7	protein	O
blocked	O	O
neither	O	O
IFN	protein	DNA
-stimulated	O	DNA
gene	O	DNA
expression	O	O
nor	O	O
IFN	protein	protein
's	O	O
induction	O	O
of	O	O
cytolytic	O	O
resistance	O	O
,	O	O
thereby	O	O
precluding	O	O
the	O	O
selective	O	O
lysis	O	O
of	O	O
HPV	cell_line	cell_line
-transformed	cell_line	cell_line
cells	cell_line	cell_line
by	O	O
IFN	cell_line	protein
-activated	cell_line	O
NK	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
In	O	O
conclusion,	O	O
E1A	protein	protein
expression	O	O
marks	O	O
cells	O	O
for	O	O
destruction	O	O
by	O	O
the	O	O
host	O	O
NK	cell_type	O
cell	cell_type	O
response	O	O
,	O	O
whereas	O	O
the	O	O
E7	protein	protein
oncoprotein	protein	protein
lacks	O	O
this	O	O
activity.	O	O

Regulation	O	O
of	O	O
IkB	protein	O
alpha	protein	O
phosphorylation	O	O
by	O	O
PKC-	O	protein
and	O	O
Ca(2+)-	O	O
dependent	O	O
signal	O	O
transduction	O	O
pathways	O	O
.	O	O
The	O	O
Ca(2+)	protein	O
-dependent	protein	O
phosphatase	protein	O
calcineurin	protein	protein
,	O	O
a	O	O
target	O	O
of	O	O
FK506	O	O
and	O	O
CsA	O	O
,	O	O
synergizes	O	O
with	O	O
PKC	protein	protein
-induced	O	O
activation	O	O
of	O	O
nuclear	protein	protein
factor	protein	protein
(NF)-kappa	protein	protein
B	protein	protein
in	O	O
T	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
We	O	O
have	O	O
investigated	O	O
whether	O	O
this	O	O
synergy	O	O
is	O	O
present	O	O
in	O	O
other	O	O
cell	O	O
types	O	O
and	O	O
the	O	O
mechanism(s)	O	O
by	O	O
which	O	O
these	O	O
two	O	O
pathways	O	O
lead	O	O
to	O	O
NF-kappa	protein	protein
B	protein	protein
activation	O	O
.	O	O
While	O	O
this	O	O
synergy	O	O
is	O	O
present	O	O
in	O	O
other	O	O
cell	O	O
types,	O	O
in	O	O
the	O	O
monocytic	cell_line	cell_line
cell	cell_line	cell_line
line	cell_line	cell_line
U937	cell_line	cell_line
calcineurin	protein	cell_line
is	O	O
also	O	O
sufficient	O	O
to	O	O
activate	O	O
NF-kappa	protein	protein
B	protein	protein
.	O	O
Having	O	O
previously	O	O
shown	O	O
that	O	O
Ca(2+)-	O	O
and	O	O
PKC-	O	O
dependent	O	O
pathways	O	O
synergize	O	O
by	O	O
accelerating	O	O
the	O	O
degradation	O	O
of	O	O
IkB	protein	protein
alpha	protein	protein
,	O	O
we	O	O
focused	O	O
on	O	O
the	O	O
regulation	O	O
of	O	O
IkB	protein	O
alpha	protein	O
phosphorylation	O	O
.	O	O
While	O	O
PKC	protein	protein
-dependent	O	O
pathways	O	O
sequentially	O	O
result	O	O
in	O	O
the	O	O
phosphorylation	O	O
and	O	O
in	O	O
an	O	O
incomplete	O	O
degradation	O	O
of	O	O
IkB	protein	protein
alpha	protein	protein
in	O	O
T	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
,	O	O
co-activation	O	O
of	O	O
Ca(2+)	O	O
-dependent	O	O
pathways	O	O
accelerates	O	O
the	O	O
rate	O	O
of	O	O
IkB	protein	O
alpha	protein	O
phosphorylation	O	O
and	O	O
results	O	O
in	O	O
its	O	O
complete	O	O
degradation.	O	O
Activation	O	O
of	O	O
Ca(2+)	O	O
-dependent	O	O
pathways	O	O
alone	O	O
do	O	O
not	O	O
result	O	O
in	O	O
the	O	O
phosphorylation	O	O
and/or	O	O
degradation	O	O
of	O	O
IkB	protein	protein
alpha	protein	protein
in	O	O
Jurkat	cell_line	O
T	cell_line	O
or	O	O
in	O	O
U937	cell_line	cell_line
cells	cell_line	cell_line
.	O	O
Treatment	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
the	O	O
selective	O	O
PKC	protein	protein
inhibitor	O	O
GF109203X	O	O
abrogates	O	O
the	O	O
PMA	O	O
-induced	O	O
IkB	protein	O
alpha	protein	O
phosphorylation	O	O
/degradation	O	O
irrespective	O	O
of	O	O
activation	O	O
of	O	O
Ca(2+)	O	O
-dependent	O	O
pathways	O	O
,	O	O
but	O	O
not	O	O
the	O	O
phosphorylation	O	O
and	O	O
degradation	O	O
of	O	O
IkB	protein	protein
alpha	protein	protein
induced	O	O
by	O	O
TNF-alpha	protein	protein
,	O	O
a	O	O
PKC	protein	protein
-independent	O	O
stimulus	O	O
.	O	O
Contrary	O	O
to	O	O
the	O	O
interaction	O	O
with	O	O
PKC	protein	protein
,	O	O
Ca(2+)	O	O
-dependent	O	O
pathways	O	O
synergize	O	O
with	O	O
TNF-alpha	protein	protein
not	O	O
at	O	O
the	O	O
level	O	O
of	O	O
IkB	protein	O
alpha	protein	O
phosphorylation	O	O
,	O	O
but	O	O
at	O	O
the	O	O
level	O	O
of	O	O
its	O	O
degradation.	O	O
These	O	O
results	O	O
indicate	O	O
that	O	O
Ca(2+)	O	O
-dependent	O	O
pathways	O	O
,	O	O
including	O	O
the	O	O
phosphatase	protein	protein
calcineurin	protein	protein
,	O	O
participate	O	O
in	O	O
the	O	O
regulation	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
in	O	O
a	O	O
cell	O	O
specific	O	O
fashion	O	O
and	O	O
synergize	O	O
with	O	O
PKC	protein	protein
-dependent	O	O
and	O	O
-independent	O	O
pathways	O	O
at	O	O
the	O	O
level	O	O
of	O	O
IkB	protein	O
alpha	protein	O
phosphorylation	O	O
and	O	O
degradation	O	O
.	O	O

Vitamin	O	O
E	O	O
therapy	O	O
of	O	O
acute	O	O
CCl4	O	protein
-induced	O	O
hepatic	O	O
injury	O	O
in	O	O
mice	O	O
is	O	O
associated	O	O
with	O	O
inhibition	O	O
of	O	O
nuclear	protein	protein
factor	protein	protein
kappa	protein	protein
B	protein	protein
binding	O	O
.	O	O
Oxidative	O	O
stress	O	O
,	O	O
with	O	O
reactive	O	O
oxygen	O	O
intermediate	O	O
formation	O	O
,	O	O
may	O	O
represent	O	O
a	O	O
common	O	O
mechanism	O	O
by	O	O
which	O	O
liver	O	O
injury	O	O
is	O	O
induced	O	O
by	O	O
diverse	O	O
etiologies.	O	O
Oxidative	O	O
stress	O	O
enhances	O	O
nuclear	protein	protein
factor	protein	protein
kappa	protein	protein
B	protein	protein
(	O	O
NF-kappa	protein	protein
B	protein	protein
)	O	O
activity	O	O
,	O	O
and	O	O
NF-kappa	protein	protein
B	protein	protein
activity	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
enhance	O	O
the	O	O
expression	O	O
of	O	O
cytotoxic	protein	protein
cytokines	protein	protein
.	O	O
Acute	O	O
hepatic	O	O
injury	O	O
caused	O	O
by	O	O
reactive	O	O
oxygen	O	O
intermediate	O	O
production	O	O
was	O	O
induced	O	O
by	O	O
an	O	O
intraperitoneal	O	O
injection	O	O
of	O	O
CCl4	O	protein
in	O	O
mice	O	O
.	O	O
This	O	O
injury	O	O
was	O	O
significantly	O	O
inhibited	O	O
by	O	O
intravenous	O	O
pretreatment	O	O
of	O	O
the	O	O
mice	O	O
with	O	O
a	O	O
water-soluble	O	O
emulsion	O	O
of	O	O
alpha-tocopherol	O	O
.	O	O
Alpha-tocopherol	O	O
treatment	O	O
of	O	O
the	O	O
mice	O	O
given	O	O
the	O	O
CCl4	O	protein
also	O	O
reduced	O	O
the	O	O
NF-kappa	protein	protein
B	protein	protein
binding	O	O
to	O	O
levels	O	O
approaching	O	O
those	O	O
found	O	O
in	O	O
normal	O	O
mice	O	O
.	O	O
In	O	O
vitro	O	O
treatment	O	O
of	O	O
a	O	O
monocyte/macrophage	O	cell_line
cell	O	cell_line
line	O	cell_line
with	O	O
CCl4	O	O
led	O	O
to	O	O
enhanced	O	O
NF-kappa	protein	protein
B	protein	protein
binding	O	O
and	O	O
an	O	O
increase	O	O
in	O	O
tumor	RNA	protein
necrosis	RNA	protein
factor-alpha	RNA	protein
(	RNA	O
TNF-alpha	RNA	protein
)	RNA	O
messenger	RNA	O
RNA	RNA	O
levels	O	O
.	O	O
Liver	O	O
specimens	O	O
taken	O	O
from	O	O
patients	O	O
with	O	O
acute	O	O
fulminant	O	O
hepatitis	O	O
had	O	O
markedly	O	O
increased	O	O
NF-kappa	protein	protein
B	protein	protein
binding	O	O
activity	O	O
in	O	O
comparison	O	O
with	O	O
the	O	O
binding	O	O
of	O	O
normal	O	O
livers	O	O
.	O	O
These	O	O
data	O	O
demonstrate	O	O
that	O	O
abolishing	O	O
acute	O	O
hepatic	O	O
injury	O	O
with	O	O
alpha-tocopherol	O	O
,	O	O
a	O	O
free	O	O
radical	O	O
scavenger	O	O
,	O	O
also	O	O
eliminated	O	O
increased	O	O
NF-kappa	protein	protein
B	protein	protein
binding	O	O
.	O	O
It	O	O
is	O	O
tempting	O	O
to	O	O
speculate	O	O
that	O	O
enhanced	O	O
NF-kappa	protein	protein
B	protein	protein
expression	O	O
caused	O	O
by	O	O
free	O	O
radical	O	O
production/oxidative	O	O
stress	O	O
may	O	O
modulate	O	O
liver	O	O
injury	O	O
,	O	O
perhaps	O	O
through	O	O
an	O	O
effect	O	O
on	O	O
cytotoxic	protein	cell_type
cytokine	protein	cell_type
synthesis	O	O
.	O	O

Immunosuppression	O	O
by	O	O
glucocorticoids	O	O
:	O	O
inhibition	O	O
of	O	O
NF-kappa	protein	protein
B	protein	protein
activity	O	O
through	O	O
induction	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
synthesis	O	O
[see	O	O
comments]	O	O
Glucocorticoids	O	O
are	O	O
among	O	O
the	O	O
most	O	O
potent	O	O
anti-inflammatory	O	O
and	O	O
immunosuppressive	O	O
agents	O	O
.	O	O
They	O	O
inhibit	O	O
synthesis	O	O
of	O	O
almost	O	O
all	O	O
known	O	O
cytokines	protein	protein
and	O	O
of	O	O
several	O	O
cell	protein	protein
surface	protein	protein
molecules	protein	protein
required	O	O
for	O	O
immune	O	O
function	O	O
,	O	O
but	O	O
the	O	O
mechanism	O	O
underlying	O	O
this	O	O
activity	O	O
has	O	O
been	O	O
unclear.	O	O
Here	O	O
it	O	O
is	O	O
shown	O	O
that	O	O
glucocorticoids	O	O
are	O	O
potent	O	O
inhibitors	O	O
of	O	O
nuclear	protein	protein
factor	protein	protein
kappa	protein	protein
B	protein	protein
(	O	O
NF-kappa	protein	protein
B	protein	protein
)	O	O
activation	O	O
in	O	O
mice	O	O
and	O	O
cultured	cell_line	O
cells	cell_line	O
.	O	O
This	O	O
inhibition	O	O
is	O	O
mediated	O	O
by	O	O
induction	O	O
of	O	O
the	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	O	protein
inhibitory	O	protein
protein,	O	O
which	O	O
traps	O	O
activated	O	O
NF-kappa	protein	protein
B	protein	protein
in	O	O
inactive	protein	O
cytoplasmic	protein	protein
complexes	protein	protein
.	O	O
Because	O	O
NF-kappa	protein	protein
B	protein	protein
activates	O	O
many	O	O
immunoregulatory	DNA	DNA
genes	DNA	DNA
in	O	O
response	O	O
to	O	O
pro-inflammatory	O	O
stimuli,	O	O
the	O	O
inhibition	O	O
of	O	O
its	O	O
activity	O	O
can	O	O
be	O	O
a	O	O
major	O	O
component	O	O
of	O	O
the	O	O
anti-inflammatory	O	O
activity	O	O
of	O	O
glucocorticoids	O	O
.	O	O

Transcriptional	O	O
repression	O	O
of	O	O
the	O	O
interleukin-2	DNA	DNA
gene	DNA	DNA
by	O	O
vitamin	O	O
D3	O	O
:	O	O
direct	O	O
inhibition	O	O
of	O	O
NFATp/AP-1	protein	protein
complex	protein	protein
formation	O	O
by	O	O
a	O	O
nuclear	protein	protein
hormone	protein	protein
receptor	protein	protein
.	O	O
T-	O	O
lymphocyte	O	O
proliferation	O	O
is	O	O
suppressed	O	O
by	O	O
1,25-dihydroxyvitamin	O	O
D3	O	O
[	O	O
1,25(OH)2D3	O	O
],	O	O
the	O	O
active	O	O
metabolite	O	O
of	O	O
vitamin	O	O
D3	O	O
,	O	O
and	O	O
is	O	O
associated	O	O
with	O	O
a	O	O
decrease	O	O
in	O	O
interleukin	O	protein
2	O	protein
(IL-2)	O	protein
,	O	O
gamma	O	protein
interferon	O	protein
,	O	O
and	O	O
granulocyte-macrophage	O	protein
colony-stimulating	O	protein
factor	O	protein
mRNA	O	O
levels	O	O
.	O	O
We	O	O
report	O	O
here	O	O
that	O	O
1,25(OH)2D3	O	O
-mediated	O	O
repression	O	O
in	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
is	O	O
cycloheximide	O	O
resistant	O	O
,	O	O
suggesting	O	O
that	O	O
it	O	O
is	O	O
a	O	O
direct	O	O
transcriptional	O	O
repressive	O	O
effect	O	O
on	O	O
IL-2	protein	protein
expression	O	O
by	O	O
the	O	O
vitamin	protein	O
D3	protein	O
receptor	protein	O
(	O	O
VDR	protein	protein
).	O	O
We	O	O
therefore	O	O
examined	O	O
vitamin	O	O
D3	O	O
-mediated	O	O
repression	O	O
of	O	O
activated	O	O
IL-2	protein	protein
expression	O	O
by	O	O
cotransfecting	O	O
Jurkat	cell_line	cell_line
cells	cell_line	cell_line
with	O	O
IL-2	DNA	protein
promoter/reporter	DNA	O
constructs	DNA	O
and	O	O
a	O	O
VDR	DNA	protein
overexpression	DNA	O
vector	DNA	O
and	O	O
by	O	O
DNA	O	O
binding	O	O
.	O	O
We	O	O
delineated	O	O
an	O	O
element	O	O
conferring	O	O
both	O	O
DNA	O	O
binding	O	O
by	O	O
the	O	O
receptor	O	O
in	O	O
vitro	O	O
and	O	O
1,25(OH)2D3	O	O
-mediated	O	O
repression	O	O
in	O	O
vivo	O	O
to	O	O
a	O	O
short	O	DNA
40-bp	DNA	DNA
region	DNA	DNA
encompassing	O	O
an	O	O
important	O	O
positive	DNA	DNA
regulatory	DNA	DNA
element	DNA	DNA
,	O	O
NF-AT-1	DNA	protein
,	O	O
which	O	O
is	O	O
bound	O	O
by	O	O
a	O	O
T-cell-specific	protein	protein
transcription	protein	protein
factor	protein	protein
,	O	O
NFATp	protein	protein
,	O	O
as	O	O
well	O	O
as	O	O
by	O	O
AP-1	protein	protein
.	O	O
VDR	protein	protein
DNA-binding	protein	O
mutants	protein	O
were	O	O
unable	O	O
to	O	O
either	O	O
bind	O	O
to	O	O
this	O	O
element	O	O
in	O	O
vitro	O	O
or	O	O
repress	O	O
in	O	O
vivo;	O	O
the	O	O
VDR	protein	protein
DNA-binding	protein	protein
domain	protein	protein
alone,	O	O
however,	O	O
bound	O	O
the	O	O
element	O	O
but	O	O
also	O	O
could	O	O
not	O	O
repress	O	O
IL-2	protein	protein
expression	O	O
.	O	O
These	O	O
results	O	O
indicate	O	O
that	O	O
DNA	O	O
binding	O	O
by	O	O
VDR	protein	protein
is	O	O
necessary	O	O
but	O	O
not	O	O
sufficient	O	O
to	O	O
mediate	O	O
IL-2	protein	protein
repression	O	O
.	O	O
By	O	O
combining	O	O
partially	protein	O
purified	protein	O
proteins	protein	O
in	O	O
vitro,	O	O
we	O	O
observed	O	O
the	O	O
loss	O	O
of	O	O
the	O	O
bound	O	O
NFATp	protein	protein
/AP-1-DNA	protein	protein
complex	protein	protein
upon	O	O
inclusion	O	O
of	O	O
VDR	protein	protein
or	O	O
VDR	protein	protein
-retinoid	protein	protein
X	protein	protein
receptor	protein	protein
.	O	O
Order	O	O
of	O	O
addition	O	O
and	O	O
off-rate	O	O
experiments	O	O
indicate	O	O
that	O	O
the	O	O
VDR	protein	protein
-retinoid	protein	protein
X	protein	protein
receptor	protein	protein
heterodimer	protein	protein
blocks	O	O
NFATp	protein	protein
/	protein	protein
AP-1	protein	protein
complex	protein	protein
formation	O	O
and	O	O
then	O	O
stably	O	O
associates	O	O
with	O	O
the	O	O
NF-AT-1	DNA	DNA
element	DNA	DNA
.	O	O
This	O	O
direct	O	O
inhibition	O	O
by	O	O
a	O	O
nuclear	O	protein
hormone	O	protein
receptor	O	protein
of	O	O
transcriptional	protein	protein
activators	protein	protein
of	O	O
the	O	O
IL-2	DNA	DNA
gene	DNA	DNA
may	O	O
provide	O	O
a	O	O
mechanistic	O	O
explanation	O	O
of	O	O
how	O	O
vitamin	O	O
derivatives	O	O
can	O	O
act	O	O
as	O	O
potent	O	O
immunosuppressive	O	O
agents	O	O
.	O	O

Tissue-specific	O	O
regulation	O	O
of	O	O
the	O	O
rabbit	DNA	O
15-lipoxygenase	DNA	DNA
gene	DNA	DNA
in	O	O
erythroid	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
a	O	O
transcriptional	DNA	O
silencer	DNA	O
.	O	O
The	O	O
15-lipoxygenase	DNA	DNA
(lox)	DNA	DNA
gene	DNA	DNA
is	O	O
expressed	O	O
in	O	O
a	O	O
tissue-specific	O	O
manner	O	O
,	O	O
predominantly	O	O
in	O	O
erythroid	cell_type	cell_type
cells	cell_type	cell_type
but	O	O
also	O	O
in	O	O
airway	cell_type	cell_type
epithelial	cell_type	cell_type
cells	cell_type	cell_type
and	O	O
eosinophils	cell_type	cell_type
.	O	O
We	O	O
demonstrate	O	O
in	O	O
this	O	O
report	O	O
that	O	O
the	O	O
5'	DNA	DNA
flanking	DNA	DNA
DNA	DNA	DNA
of	O	O
the	O	O
15-lox	DNA	DNA
gene	DNA	DNA
contains	O	O
sequences	O	O
which	O	O
down-regulate	O	O
its	O	O
activity	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
non-erythroid	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
but	O	O
not	O	O
in	O	O
two	O	O
erythroid	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
The	O	O
element	O	O
has	O	O
characteristics	O	O
of	O	O
a	O	O
transcriptional	DNA	O
'silencer'	DNA	O
since	O	O
it	O	O
functions	O	O
in	O	O
both	O	O
orientations.	O	O
The	O	O
main	O	O
activity	O	O
of	O	O
the	O	O
silencer	DNA	DNA
has	O	O
been	O	O
mapped	O	O
to	O	O
the	O	O
first	O	O
900	O	O
bp	O	O
of	O	O
5'	DNA	DNA
flanking	DNA	DNA
DNA	DNA	DNA
,	O	O
which	O	O
contains	O	O
nine	O	O
binding	O	O
sites	O	O
for	O	O
a	O	O
nuclear	protein	protein
factor	protein	protein
present	O	O
in	O	O
non-	O	cell_line
erythroid	cell_type	cell_line
cells	cell_type	cell_line
but	O	O
not	O	O
in	O	O
erythroid	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
These	O	O
binding	O	O
sites	O	O
have	O	O
similar	O	O
sequences	O	O
and	O	O
multiple	O	O
copies	O	O
of	O	O
the	O	O
binding	DNA	DNA
sites	DNA	DNA
confer	O	O
tissue-specific	O	O
down-regulation	O	O
when	O	O
attached	O	O
to	O	O
a	O	O
minimal	DNA	DNA
lox	DNA	DNA
promoter	DNA	DNA
fragment	DNA	DNA
.	O	O
The	O	O
5'	DNA	DNA
flanking	DNA	DNA
DNA	DNA	DNA
also	O	O
contains	O	O
a	O	O
cluster	O	O
of	O	O
three	O	O
binding	DNA	DNA
sites	DNA	DNA
for	O	O
the	O	O
GATA	protein	protein
family	protein	protein
of	O	O
transcription	protein	protein
factors	protein	protein
.	O	O

Phosphorylation	O	O
of	O	O
the	O	O
transcription	protein	protein
factor	protein	protein
NFATp	protein	protein
inhibits	O	O
its	O	O
DNA	O	O
binding	O	O
activity	O	O
in	O	O
cyclosporin	cell_line	O
A-treated	cell_line	cell_line
human	cell_line	cell_line
B	cell_line	cell_line
and	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Cyclosporin	O	O
A	O	O
(	O	O
CsA	O	O
)	O	O
exerts	O	O
its	O	O
immunosuppressive	O	O
effect	O	O
by	O	O
inhibiting	O	O
the	O	O
activity	O	O
of	O	O
nuclear	protein	protein
factor	protein	protein
of	O	protein
activated	O	protein
T	cell_type	protein
cells	cell_type	protein
(	O	O
NFAT	protein	protein
),	O	O
thus	O	O
preventing	O	O
transcriptional	O	O
induction	O	O
of	O	O
several	O	O
cytokine	O	protein
genes.	O	O
This	O	O
effect	O	O
is	O	O
thought	O	O
to	O	O
be	O	O
largely	O	O
mediated	O	O
through	O	O
inactivation	O	O
of	O	O
the	O	O
phosphatase	O	protein
calcineurin	protein	protein
,	O	O
which	O	O
in	O	O
turn	O	O
inhibits	O	O
translocation	O	O
of	O	O
an	O	O
NFAT	protein	protein
component	O	O
to	O	O
the	O	O
nucleus.	O	O
Here	O	O
we	O	O
report	O	O
that	O	O
CsA	O	O
treatment	O	O
of	O	O
Raji	cell_line	cell_line
B	cell_line	cell_line
and	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
yields	O	O
a	O	O
phosphorylated	O	O
form	O	O
of	O	O
NFATp	protein	protein
that	O	O
is	O	O
inhibited	O	O
in	O	O
DNA-binding	O	O
and	O	O
in	O	O
its	O	O
ability	O	O
to	O	O
form	O	O
an	O	O
NFAT	protein	protein
complex	protein	protein
with	O	O
Fos	protein	protein
and	O	O
Jun	protein	protein
.	O	O
Immunoblot	O	O
analyses	O	O
and	O	O
metabolic	O	O
labeling	O	O
with	O	O
[32P]orthophosphate	O	O
show	O	O
that	O	O
CsA	O	O
alters	O	O
NFATp	protein	protein
migration	O	O
on	O	O
SDS-polyacrylamide	O	O
gel	O	O
electrophoresis	O	O
by	O	O
increasing	O	O
its	O	O
phosphorylation	O	O
level	O	O
without	O	O
affecting	O	O
subcellular	O	O
distribution.	O	O
Dephosphorylation	O	O
by	O	O
in	O	O
vitro	O	O
treatment	O	O
with	O	O
calcineurin	protein	protein
or	O	O
alkaline	protein	O
phosphatase	protein	O
restores	O	O
NFATp	protein	protein
DNA	O	O
binding	O	O
activity	O	O
and	O	O
its	O	O
ability	O	O
to	O	O
reconstitute	O	O
an	O	O
NFAT	protein	protein
complex	protein	protein
with	O	O
Fos	protein	protein
and	O	O
Jun	protein	protein
proteins.	O	O
These	O	O
data	O	O
point	O	O
to	O	O
a	O	O
new	O	O
mechanism	O	O
for	O	O
CsA	O	O
-sensitive	O	O
regulation	O	O
of	O	O
NFATp	protein	protein
in	O	O
which	O	O
dephosphorylation	O	O
is	O	O
critical	O	O
for	O	O
DNA	O	O
binding.	O	O

Transcription	protein	protein
factors	protein	protein
as	O	O
targets	O	O
for	O	O
oxidative	O	O
signalling	O	O
during	O	O
lymphocyte	O	O
activation	O	O
.	O	O
We	O	O
previously	O	O
have	O	O
demonstrated	O	O
a	O	O
requirement	O	O
for	O	O
oxidative	O	O
events	O	O
during	O	O
cell	O	O
cycle	O	O
entry	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
and	O	O
have	O	O
hypothesised	O	O
that	O	O
reactive	O	O
oxygen	O	O
species	O	O
may	O	O
act	O	O
as	O	O
intracellular	O	O
signalling	O	O
agents	O	O
during	O	O
lymphocyte	O	O
activation	O	O
.	O	O
In	O	O
the	O	O
current	O	O
study,	O	O
cysteamine	O	O
,	O	O
an	O	O
aminothiol	O	O
compound	O	O
with	O	O
antioxidant	O	O
activity	O	O
,	O	O
has	O	O
been	O	O
used	O	O
to	O	O
further	O	O
investigate	O	O
the	O	O
role	O	O
of	O	O
oxidative	O	O
signalling	O	O
during	O	O
lymphocyte	O	O
activation	O	O
.	O	O
Treatment	O	O
of	O	O
normal	O	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
lymphocytes	cell_type	cell_type
with	O	O
cysteamine	O	O
in	O	O
vitro	O	O
was	O	O
found	O	O
to	O	O
inhibit	O	O
proliferation	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
,	O	O
with	O	O
essentially	O	O
complete	O	O
inhibition	O	O
occurring	O	O
at	O	O
a	O	O
dose	O	O
of	O	O
400	O	O
microM.	O	O
This	O	O
inhibitory	O	O
effect	O	O
was	O	O
limited	O	O
to	O	O
the	O	O
first	O	O
2	O	O
h	O	O
after	O	O
mitogenic	O	O
activation	O	O
,	O	O
localizing	O	O
the	O	O
time-frame	O	O
of	O	O
action	O	O
of	O	O
cysteamine	O	O
to	O	O
within	O	O
the	O	O
commitment	O	O
period	O	O
.	O	O
It	O	O
therefore	O	O
was	O	O
of	O	O
interest	O	O
to	O	O
establish	O	O
which,	O	O
if	O	O
any,	O	O
commitment	O	O
events	O	O
were	O	O
affected	O	O
by	O	O
oxidative	O	O
signalling	O	O
during	O	O
cell	O	O
cycle	O	O
entry	O	O
.	O	O
Taking	O	O
the	O	O
IL-2	DNA	DNA
gene	DNA	DNA
as	O	O
a	O	O
candidate,	O	O
we	O	O
examined	O	O
the	O	O
effect	O	O
of	O	O
cysteamine	O	O
treatment	O	O
on	O	O
early	DNA	O
gene	DNA	O
expression	O	O
during	O	O
lymphocyte	O	O
activation	O	O
,	O	O
and	O	O
on	O	O
the	O	O
activity	O	O
of	O	O
transcription	protein	protein
factors	protein	protein
AP-1	protein	protein
,	O	O
NF-kappa	protein	protein
B	protein	protein
,	O	O
NF-AT	protein	protein
and	O	O
Oct1	protein	protein
,	O	O
whose	O	O
functions	O	O
are	O	O
required	O	O
for	O	O
expression	O	O
of	O	O
the	O	O
IL-2	protein	protein
mRNA.	O	O
Cysteamine	O	O
treatment	O	O
inhibited	O	O
both	O	O
expression	O	O
of	O	O
the	O	O
IL-2	RNA	RNA
mRNA	RNA	RNA
and	O	O
secretion	O	O
of	O	O
IL-2	protein	protein
into	O	O
the	O	O
culture	O	O
medium	O	O
.	O	O
The	O	O
inhibitory	O	O
effect	O	O
of	O	O
cysteamine	O	O
may	O	O
be	O	O
mediated	O	O
at	O	O
least	O	O
in	O	O
part	O	O
by	O	O
an	O	O
effect	O	O
on	O	O
transcription	protein	O
factor	protein	O
function	O	O
,	O	O
as	O	O
the	O	O
DNA	O	O
binding	O	O
activities	O	O
of	O	O
AP-1	protein	protein
and	O	O
NF-kappa	protein	protein
B	protein	protein
extracted	O	O
from	O	O
mitogen-stimulated	cell_type	cell_line
cells	cell_type	cell_line
were	O	O
significantly	O	O
inhibited	O	O
by	O	O
cysteamine	O	O
treatment	O	O
.	O	O
Interestingly,	O	O
Oct1	O	protein
and	O	O
NF-AT	O	protein
DNA	O	O
binding	O	O
activity	O	O
were	O	O
not	O	O
affected	O	O
by	O	O
cysteamine	O	O
treatment,	O	O
suggesting	O	O
that	O	O
oxidative	O	O
signalling	O	O
processes	O	O
operate	O	O
in	O	O
a	O	O
selective	O	O
manner.	O	O
The	O	O
identification	O	O
of	O	O
regulatory	protein	protein
proteins	protein	protein
,	O	O
such	O	O
as	O	O
transcription	protein	protein
factors	protein	protein
,	O	O
as	O	O
molecular	O	O
targets	O	O
for	O	O
oxidative	O	O
signalling	O	O
provides	O	O
further	O	O
evidence	O	O
to	O	O
implicate	O	O
oxidative	O	O
signalling	O	O
as	O	O
being	O	O
intimately	O	O
involved	O	O
in	O	O
the	O	O
G0	O	O
to	O	O
G1	O	O
phase	O	O
transition	O	O
in	O	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O

Sex	O	O
and	O	O
age	O	O
distribution	O	O
of	O	O
1,25(OH)2D3	protein	O
receptors	protein	O
in	O	O
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
from	O	O
normal	O	O
human	O	O
subjects	O	O
.	O	O
Specific	O	protein
receptors	O	protein
for	O	O
1,25	O	O
Dihydroxyvitamin	O	O
D3	O	O
have	O	O
been	O	O
described	O	O
in	O	O
human	O	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
mononuclear	cell_type	cell_type
cells	cell_type	cell_type
(	O	O
PBMC	cell_type	cell_type
).	O	O
We	O	O
have	O	O
tried	O	O
to	O	O
find	O	O
out	O	O
whether	O	O
these	O	O
receptors	O	O
could	O	O
show	O	O
any	O	O
difference	O	O
in	O	O
sex	O	O
or	O	O
age	O	O
distribution.	O	O
Twenty	O	O
two	O	O
healthy	O	O
men	O	O
aged	O	O
21-66	O	O
yr	O	O
(mean	O	O
+/-	O	O
SD	O	O
41.0	O	O
+/-	O	O
13.6)	O	O
and	O	O
nineteen	O	O
healthy	O	O
women	O	O
aged	O	O
22-60	O	O
yr	O	O
(38.9	O	O
+/-	O	O
13.9)	O	O
have	O	O
been	O	O
studied.	O	O
The	O	O
mean	O	O
dissociation	O	O
constant	O	O
(	O	O
Kd	O	O
)	O	O
was	O	O
similar	O	O
in	O	O
both	O	O
sexes	O	O
(1.35	O	O
+/-	O	O
0.70	O	O
x	O	O
10(-10)	O	O
M	O	O
in	O	O
males,	O	O
1.13	O	O
+/-	O	O
0.66	O	O
x	O	O
10(-10)	O	O
M	O	O
in	O	O
females),	O	O
but	O	O
the	O	O
concentration	O	O
of	O	O
binding	O	O
sites	O	O
(Nmax)	O	O
was	O	O
significantly	O	O
lower	O	O
in	O	O
females	O	O
(2.32	O	O
+/-	O	O
0.92	O	O
fmol/10(7)	O	O
PBMC	cell_type	cell_type
vs	O	O
4.43	O	O
+/-	O	O
1.38	O	O
fmol/10(7)	O	O
PBMC	cell_type	cell_type
in	O	O
males	O	O
;	O	O
p	O	O
=	O	O
0.0001).	O	O
Neither	O	O
Kd	O	O
nor	O	O
Nmax	O	O
were	O	O
significantly	O	O
correlated	O	O
with	O	O
age.	O	O
No	O	O
difference	O	O
was	O	O
found	O	O
between	O	O
pre	O	O
and	O	O
post	O	O
menopausal	O	O
women	O	O
.	O	O
Further	O	O
studies	O	O
are	O	O
needed	O	O
to	O	O
elucidate	O	O
if	O	O
this	O	O
sex	O	O
difference	O	O
in	O	O
PBMC	protein	cell_type
receptors	protein	O
for	O	O
1.25	O	O
Dihydroxyvitamin	O	O
D3	O	O
is	O	O
of	O	O
any	O	O
pathophysiological	O	O
relevance	O	O
.	O	O

Expression	O	O
of	O	O
Id2	O	protein
and	O	O
Id3	O	RNA
mRNA	O	RNA
in	O	O
human	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
Helix-loop-helix	protein	protein
(	protein	O
HLH	protein	protein
)	protein	protein
transcription	protein	protein
factors	protein	protein
are	O	O
involved	O	O
in	O	O
cellular	O	O
growth	O	O
and	O	O
differentiation	O	O
.	O	O
The	O	O
Id	protein	O
(	O	O
inhibitor	O	O
of	O	O
DNA	O	O
binding	O	O
and	O	O
differentiation	O	O
)	O	O
HLH	protein	protein
proteins	protein	protein
,	O	O
in	O	O
a	O	O
dominantly	O	O
negative	O	O
fashion,	O	O
regulate	O	O
transcriptional	O	O
activities	O	O
of	O	O
basic	protein	protein
HLH	protein	protein
proteins	protein	protein
.	O	O
We	O	O
examined	O	O
by	O	O
northern	O	O
hybridization	O	O
the	O	O
expression	O	O
of	O	O
Id2	O	protein
and	O	O
Id3	O	RNA
mRNA	O	RNA
in	O	O
human	cell_line	cell_line
leukemia/lymphoma	cell_line	cell_line
lines	cell_line	cell_line
and	O	O
patient	O	O
samples	O	O
,	O	O
as	O	O
well	O	O
as	O	O
resting	O	O
and	O	O
activated	cell_line	O
normal	cell_line	cell_type
human	cell_line	cell_type
lymphocytes	cell_line	cell_type
from	O	O
peripheral	O	cell_type
blood	O	cell_type
(	O	O
PBL	cell_type	cell_type
).	O	O
The	O	O
Id2	RNA	RNA
mRNA	RNA	RNA
was	O	O
abundantly	O	O
expressed	O	O
in	O	O
5/12	cell_line	O
T-cell	cell_line	O
and	O	O
3/4	cell_line	O
B-cell	cell_line	cell_line
lines	cell_line	cell_line
,	O	O
and	O	O
Id3	RNA	RNA
mRNA	RNA	RNA
was	O	O
detected	O	O
in	O	O
4/12	cell_line	O
T-cell	cell_line	O
and	O	O
3/4	cell_line	O
B-cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
Interestingly,	O	O
Id2	RNA	protein
,	O	O
but	O	O
not	O	O
Id3	RNA	protein
,	O	O
mRNA	O	RNA
was	O	O
strongly	O	O
expressed	O	O
in	O	O
4/5	cell_line	cell_line
T-cell	cell_line	cell_line
lines	cell_line	cell_line
infected	O	O
with	O	O
human	O	O
T-cell	O	O
leukemia	O	O
virus	O	O
type	O	O
I	O	O
(	O	O
HTLV-I	O	O
)	O	O
(	O	O
ATL-1k	cell_line	DNA
,	O	O
MT-2	cell_line	cell_line
,	O	O
S-LB1	cell_line	protein
)	O	O
and	O	O
type	O	protein
II	O	protein
(	O	O
Mo	cell_line	O
)	O	O
.	O	O
Another	O	O
unexpected	O	O
finding	O	O
was	O	O
that	O	O
T-cell	O	O
leukemias	O	O
and	O	O
T-cell	cell_line	cell_line
lines	cell_line	cell_line
often	O	O
expressed	O	O
either	O	O
Id2	RNA	protein
or	O	O
Id3	RNA	RNA
mRNA	RNA	RNA
.	O	O
In	O	O
addition,	O	O
resting	cell_type	O
PBL	cell_type	cell_type
constitutively	O	cell_type
expressed	O	O
prominent	O	O
levels	O	O
of	O	O
Id2	RNA	RNA
mRNA	RNA	RNA
,	O	O
but	O	O
not	O	O
Id3	RNA	RNA
mRNA	RNA	RNA
.	O	O
Upon	O	O
PHA	protein	protein
-stimulation	O	O
,	O	O
Id2	protein	protein
expression	O	O
decreased	O	O
and	O	O
Id3	protein	protein
levels	O	O
increased	O	O
with	O	O
biphasic	O	O
kinetics.	O	O
Taken	O	O
together,	O	O
our	O	O
studies	O	O
revealed	O	O
three	O	O
unexpected	O	O
findings	O	O
which	O	O
require	O	O
further	O	O
analysis:	O	O
(1)	O	O
expression	O	O
of	O	O
Id2	RNA	RNA
mRNA	RNA	RNA
is	O	O
often	O	O
associated	O	O
with	O	O
lymphocytic	O	O
transformation	O	O
by	O	O
HTLV-I	O	O
or	O	O
-II;	O	O
(2)	O	O
T-cells	O	cell_type
usually	O	cell_type
express	O	O
either	O	O
Id2	protein	protein
or	O	O
Id3	RNA	RNA
mRNA	RNA	RNA
,	O	O
but	O	O
B-cells	O	cell_type
often	O	O
express	O	O
both	O	O
simultaneously;	O	O
(3)	O	O
non-dividing,	O	O
normal	O	O
PBL	cell_type	cell_type
express	O	O
high	O	O
levels	O	O
of	O	O
Id2	protein	protein
and	O	O
no	O	O
Id3	RNA	RNA
mRNA	RNA	RNA
;	O	O
and	O	O
with	O	O
the	O	O
onset	O	O
of	O	O
cellular	O	O
proliferation,	O	O
levels	O	O
of	O	O
Id2	RNA	RNA
mRNA	RNA	RNA
decrease	O	O
while	O	O
levels	O	O
of	O	O
Id3	RNA	RNA
mRNA	RNA	RNA
increase,	O	O
suggesting	O	O
that	O	O
regulation	O	O
of	O	O
expression	O	O
of	O	O
these	O	O
closely	O	O
related	O	O
genes	DNA	O
is	O	O
disparate.	O	O

Salicylates	O	O
inhibit	O	O
lipopolysaccharide	O	O
-induced	O	O
transcriptional	O	O
activation	O	O
of	O	O
the	O	O
tissue	O	DNA
factor	O	DNA
gene	O	DNA
in	O	O
human	cell_type	cell_type
monocytic	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
Binding	O	O
of	O	O
plasma	protein	O
Factor	protein	O
VII/VIIa	protein	O
to	O	O
the	O	O
tissue	protein	protein
factor	protein	protein
(TF)	protein	protein
receptor	protein	protein
initiates	O	O
the	O	O
coagulation	protein	O
protease	protein	O
cascades	O	O
.	O	O
TF	O	protein
expression	O	O
by	O	O
circulating	cell_type	cell_type
monocytes	cell_type	cell_type
is	O	O
associated	O	O
with	O	O
thrombotic	O	O
and	O	O
inflammatory	O	O
complications	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
diseases.	O	O
Transcriptional	O	O
activation	O	O
of	O	O
the	O	O
human	DNA	DNA
TF	DNA	DNA
gene	DNA	DNA
in	O	O
monocytic	cell_type	cell_type
cells	cell_type	cell_type
exposed	O	O
to	O	O
bacterial	O	O
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
is	O	O
mediated	O	O
by	O	O
binding	O	O
of	O	O
c-Rel/p65	protein	protein
heterodimers	protein	protein
to	O	O
a	O	O
kappa	DNA	DNA
B	DNA	DNA
site	DNA	DNA
in	O	O
the	O	O
TF	DNA	DNA
promoter	DNA	DNA
.	O	O
Here,	O	O
we	O	O
report	O	O
that	O	O
a	O	O
family	O	O
of	O	O
anti-inflammatory	O	O
agents	O	O
,	O	O
known	O	O
as	O	O
the	O	O
salicylates,	O	O
inhibited	O	O
LPS	O	O
induction	O	O
of	O	O
TF	O	protein
activity	O	O
and	O	O
TF	DNA	DNA
gene	DNA	DNA
transcription	O	O
in	O	O
human	cell_type	cell_type
monocytes	cell_type	cell_type
and	O	O
monocytic	cell_line	cell_line
THP-1	cell_line	cell_line
cells	cell_line	cell_line
at	O	O
clinically	O	O
relevant	O	O
doses.	O	O
Furthermore,	O	O
sodium	O	O
salicylate	O	O
blocked	O	O
the	O	O
LPS	O	O
-induced	O	O
proteolytic	O	O
degradation	O	O
of	O	O
I	protein	protein
kappa	protein	protein
B	protein	protein
alpha	protein	protein
,	O	O
which	O	O
prevented	O	O
the	O	O
nuclear	O	O
translocation	O	O
of	O	O
c-Rel/p65	protein	protein
heterodimers	protein	protein
.	O	O
In	O	O
contrast,	O	O
two	O	O
other	O	O
nonsteroidal	O	O
anti-inflammatory	O	O
drugs	O	O
,	O	O
ibuprofen	O	O
and	O	O
indomethacin	O	O
,	O	O
did	O	O
not	O	O
inhibit	O	O
LPS	O	O
induction	O	O
of	O	O
the	O	O
TF	DNA	DNA
gene	DNA	DNA
.	O	O
These	O	O
results	O	O
indicated	O	O
that	O	O
salicylates	O	O
inhibited	O	O
LPS	O	O
induction	O	O
of	O	O
TF	DNA	DNA
gene	DNA	DNA
transcription	O	O
in	O	O
monocytic	cell_type	cell_type
cells	cell_type	cell_type
by	O	O
preventing	O	O
nuclear	O	O
translocation	O	O
of	O	O
c-Rel/p65	protein	protein
heterodimers	protein	protein
.	O	O
The	O	O
clinical	O	O
benefits	O	O
of	O	O
salicylates	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
several	O	O
diseases,	O	O
including	O	O
atherosclerosis	O	O
and	O	O
rheumatoid	O	O
arthritis	O	O
,	O	O
may	O	O
be	O	O
related	O	O
to	O	O
their	O	O
ability	O	O
to	O	O
reduce	O	O
monocyte	O	O
gene	O	O
expression	O	O
.	O	O

Activation	O	O
of	O	O
the	O	O
signal	O	protein
transducer	O	protein
and	O	protein
transcription	O	protein
(	O	O
STAT	protein	protein
)	O	O
signaling	O	O
pathway	O	O
in	O	O
a	O	O
primary	O	cell_line
T	O	cell_line
cell	O	cell_line
response	O	cell_line
.	O	O
Critical	O	O
role	O	O
for	O	O
IL-6	protein	protein
.	O	O
The	O	O
T	O	O
cell	O	O
activation	O	O
is	O	O
initiated	O	O
by	O	O
interaction	O	O
of	O	O
specific	O	O
Ags	protein	O
with	O	O
TCR	protein	protein
,	O	O
followed	O	O
by	O	O
activation	O	O
of	O	O
intracellular	O	O
biochemical	O	O
events	O	O
leading	O	O
to	O	O
activation	O	O
of	O	O
several	O	O
genes.	O	O
The	O	O
activation	O	O
of	O	O
signal	O	protein
transducer	O	protein
and	O	protein
activator	O	protein
of	O	protein
transcription	protein	protein
(STAT)	protein	protein
proteins	protein	protein
in	O	O
a	O	O
primary	O	O
TCR	protein	protein
-mediated	O	O
activation	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
have	O	O
been	O	O
explored.	O	O
In	O	O
purified	cell_type	O
human	cell_type	cell_type
peripheral	cell_type	cell_type
blood	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
,	O	O
nuclear	protein	protein
STAT	protein	protein
proteins	protein	protein
were	O	O
activated	O	O
approximately	O	O
3	O	O
h	O	O
after	O	O
activation	O	O
by	O	O
cross-linked	O	O
anti-CD3	protein	protein
Abs	protein	protein
.	O	O
These	O	O
STAT	protein	protein
proteins	protein	protein
were	O	O
detected	O	O
by	O	O
using	O	O
the	O	O
IFN-gamma-activated	DNA	protein
sequence	DNA	protein
(	O	O
GAS	DNA	DNA
)	O	O
and	O	O
related	O	O
oligonucleotides	O	O
as	O	O
probes	O	O
in	O	O
electrophoretic	O	O
mobility	O	O
shift	O	O
assay	O	O
.	O	O
Analysis	O	O
of	O	O
the	O	O
nuclear	O	O
extracts	O	O
with	O	O
anti-STAT	protein	protein
Abs	protein	protein
indicated	O	O
that	O	O
they	O	O
contained	O	O
STAT-3	protein	protein
and	O	O
additional	O	O
proteins	O	O
crossreactive	O	O
with	O	O
the	O	O
STAT	protein	protein
family	protein	protein
.	O	O
The	O	O
induction	O	O
of	O	O
STAT	protein	protein
activity	O	O
was	O	O
inhibited	O	O
completely	O	O
by	O	O
pretreatment	O	O
with	O	O
either	O	O
cycloheximide	O	O
or	O	O
cyclosporin	O	O
A	O	O
,	O	O
thus	O	O
indicating	O	O
that	O	O
the	O	O
induction	O	O
was	O	O
due	O	O
to	O	O
a	O	O
secondary	protein	O
factor	protein	O
produced	O	O
by	O	O
the	O	O
activated	O	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
As	O	O
neutralizing	protein	O
anti-	protein	O
IL-6	protein	protein
Abs	protein	protein
effectively	O	O
down-regulated	O	O
the	O	O
early	O	O
induction	O	O
of	O	O
STAT	protein	protein
proteins	protein	protein
and	O	O
as	O	O
exogenously	O	O
added	O	O
IL-6	protein	protein
rapidly	O	O
activated	O	O
DNA	O	O
binding	O	O
similar	O	O
to	O	O
TCR	protein	protein
-mediated	O	O
bindings	O	O
,	O	O
it	O	O
can	O	O
be	O	O
concluded	O	O
that	O	O
IL-6	protein	protein
is	O	O
the	O	O
factor	O	O
responsible	O	O
for	O	O
the	O	O
activation	O	O
of	O	O
STAT	protein	protein
proteins	protein	protein
in	O	O
a	O	O
primary	O	cell_line
T	O	cell_line
cell	O	cell_line
response	O	cell_line
.	O	O

The	O	O
normal	O	O
cell	O	O
cycle	O	O
activation	O	O
program	O	O
is	O	O
exploited	O	O
during	O	O
the	O	O
infection	O	O
of	O	O
quiescent	cell_type	cell_type
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
by	O	O
Epstein-Barr	O	O
virus	O	O
.	O	O
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
in	O	O
the	O	O
peripheral	O	O
circulation	O	O
are	O	O
maintained	O	O
in	O	O
a	O	O
non-proliferative	O	O
state	O	O
.	O	O
Antigen	O	O
recognition	O	O
stimulates	O	O
limited	O	O
proliferation,	O	O
whereas	O	O
infection	O	O
with	O	O
Epstein-Barr	O	O
virus	O	O
(	O	O
EBV	O	O
)	O	O
results	O	O
in	O	O
continual	O	O
proliferation	O	O
and	O	O
the	O	O
outgrowth	O	O
of	O	O
immortal	cell_line	cell_line
cell	cell_line	cell_line
lines	cell_line	cell_line
.	O	O
Because	O	O
it	O	O
is	O	O
not	O	O
clear	O	O
at	O	O
which	O	O
point	O	O
in	O	O
cell	O	O
cycle	O	O
the	O	O
peripheral	cell_type	cell_type
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
are	O	O
arrested,	O	O
we	O	O
characterized	O	O
the	O	O
expression	O	O
of	O	O
several	O	O
cell	DNA	O
cycle-associated	DNA	O
genes	DNA	O
in	O	O
quiescent	O	O
and	O	O
stimulated	O	O
cells	O	O
.	O	O
We	O	O
show	O	O
that	O	O
the	O	O
expression	O	O
of	O	O
four	O	O
cell	DNA	O
genes	DNA	O
,	O	O
cdc-2	DNA	DNA
,	O	O
cyclin	DNA	protein
E	DNA	protein
,	O	O
CD23	DNA	protein
,	O	O
and	O	O
cyclin	DNA	protein
D2	DNA	protein
,	O	O
are	O	O
up-regulated	O	O
approximately	O	O
100-fold	O	O
as	O	O
a	O	O
result	O	O
of	O	O
EBV	O	O
-mediated	O	O
immortalization	O	O
.	O	O
Because	O	O
these	O	O
genes	O	O
play	O	O
a	O	O
positive	O	O
role	O	O
in	O	O
cell	O	O
proliferation,	O	O
we	O	O
suggest	O	O
that	O	O
this	O	O
regulatory	O	O
switch	O	O
contributes	O	O
to	O	O
controlling	O	O
entry	O	O
into	O	O
the	O	O
cell	O	O
cycle	O	O
.	O	O
Transient	O	O
stimulation	O	O
of	O	O
quiescent	cell_type	cell_type
B	cell_type	cell_type
lymphocytes	cell_type	cell_type
with	O	O
either	O	O
a	O	O
cocktail	O	O
of	O	O
anti-CD40	protein	protein
,	O	O
anti-IgM	protein	protein
,	O	O
and	O	O
IL4	protein	protein
,	O	O
or	O	O
EBV	O	O
results	O	O
in	O	O
the	O	O
rapid	O	O
expression	O	O
of	O	O
the	O	O
same	O	O
four	O	O
genes,	O	O
suggesting	O	O
that,	O	O
after	O	O
infection,	O	O
EBV	O	O
exploits	O	O
the	O	O
normal	O	O
program	O	O
of	O	O
B-lymphocyte	cell_type	cell_type
cell	O	cell_type
cycle	O	O
activation	O	O
.	O	O

Expression	O	O
of	O	O
the	O	O
chemokine	protein	protein
receptor	protein	protein
BLR2/EBI1	protein	protein
is	O	O
specifically	O	O
transactivated	O	O
by	O	O
Epstein-Barr	protein	protein
virus	protein	protein
nuclear	protein	protein
antigen	protein	protein
2	protein	protein
.	O	O
In	O	O
our	O	O
attempt	O	O
to	O	O
identify	O	O
chemokine	protein	protein
receptors	protein	protein
that	O	O
are	O	O
related	O	O
to	O	O
Burkitt's	protein	O
lymphoma	protein	O
receptor	protein	O
1	protein	O
(	O	O
BLR1	protein	protein
)	O	O
and	O	O
are	O	O
expressed	O	O
in	O	O
activated	cell_type	cell_type
lymphocytes	cell_type	cell_type
we	O	O
used	O	O
RT-PCR	O	O
resulting	O	O
in	O	O
the	O	O
isolation	O	O
of	O	O
a	O	O
cDNA	O	DNA
encoding	O	O
a	O	O
seven	protein	O
transmembrane	protein	O
receptor	protein	O
termed	O	O
BLR2	protein	protein
.	O	O
The	O	O
protein	O	O
shows	O	O
significant	O	O
sequence	O	O
similarities	O	O
to	O	O
the	O	O
family	O	O
of	O	O
G-protein	protein	protein
coupled	protein	protein
chemokine	protein	protein
receptors	protein	protein
and	O	O
turned	O	O
out	O	O
to	O	O
be	O	O
identical	O	O
to	O	O
the	O	O
recently	O	O
described	O	O
receptor	protein	O
EBI1	protein	protein
.	O	O
Northern	O	O
blot	O	O
analysis	O	O
revealed	O	O
that	O	O
BLR2	RNA	RNA
mRNA	RNA	RNA
could	O	O
be	O	O
highly	O	O
stimulated	O	O
in	O	O
mitogen-	O	O
and	O	O
anti-CD3-	O	O
treated	O	O
peripheral	O	cell_type
blood	O	cell_type
lymphocytes	O	cell_type
.	O	O
BLR2	RNA	RNA
-specific	RNA	RNA
mRNA	RNA	RNA
could	O	O
be	O	O
detected	O	O
in	O	O
all	O	O
Epstein-Barr	cell_line	O
virus	cell_line	O
positive	cell_line	O
B	cell_line	O
cell	cell_line	O
lines	cell_line	O
.	O	O
We	O	O
show	O	O
that	O	O
transcription	O	O
of	O	O
the	O	O
BLR2	DNA	DNA
gene	DNA	DNA
could	O	O
be	O	O
specifically	O	O
induced	O	O
in	O	O
Epstein-Barr	cell_line	O
virus	cell_line	O
negative	cell_line	O
BL	cell_line	O
41	cell_line	O
cells	cell_line	O
via	O	O
estrogen-mediated	O	O
activation	O	O
of	O	O
Epstein-Barr	protein	protein
virus	protein	protein
nuclear	protein	protein
antigen	protein	protein
2	protein	protein
,	O	O
a	O	O
key	O	O
regulator	O	O
of	O	O
viral	DNA	O
and	DNA	O
cellular	DNA	O
genes	DNA	O
in	O	O
immortalized	cell_line	cell_type
B	cell_line	cell_type
cells	cell_line	cell_type
.	O	O
Our	O	O
data	O	O
suggest	O	O
an	O	O
involvement	O	O
of	O	O
BLR2	protein	protein
in	O	O
the	O	O
regulation	O	O
of	O	O
migration	O	O
in	O	O
activated	cell_type	cell_type
lymphocytes	cell_type	cell_type
and	O	O
in	O	O
viral	O	O
pathogenesis	O	O
.	O	O

A	O	O
central	O	O
role	O	O
for	O	O
a	O	O
single	DNA	O
c-Myb	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
in	O	O
a	O	O
thymic	DNA	O
locus	DNA	DNA
control	DNA	DNA
region	DNA	DNA
.	O	O
Locus	DNA	DNA
control	DNA	DNA
regions	DNA	DNA
(	O	O
LCRs	DNA	DNA
)	O	O
are	O	O
powerful	O	O
assemblies	O	O
of	O	O
cis	DNA	DNA
elements	DNA	DNA
that	O	O
organize	O	O
the	O	O
actions	O	O
of	O	O
cell-type-specific	protein	O
trans-acting	protein	protein
factors	protein	protein
.	O	O
A	O	O
2.3-kb	protein	DNA
LCR	protein	DNA
in	O	O
the	O	O
human	DNA	DNA
adenosine	DNA	DNA
deaminase	DNA	DNA
(ADA)	DNA	DNA
gene	DNA	DNA
first	DNA	DNA
intron	DNA	DNA
,	O	O
which	O	O
controls	O	O
expression	O	O
in	O	O
thymocytes	cell_type	cell_type
,	O	O
is	O	O
composed	O	O
of	O	O
a	O	O
200-bp	DNA	DNA
enhancer	DNA	DNA
domain	DNA	DNA
and	O	O
extended	O	O
flanking	O	O
sequences	O	O
that	O	O
facilitate	O	O
activation	O	O
from	O	O
within	O	O
chromatin	DNA	DNA
.	O	O
Prior	O	O
analyses	O	O
have	O	O
demonstrated	O	O
that	O	O
the	O	O
enhancer	DNA	O
contains	O	O
a	O	O
28-bp	DNA	DNA
core	DNA	DNA
region	DNA	DNA
and	O	O
local	O	O
adjacent	O	O
augmentative	O	O
cis	DNA	DNA
elements	DNA	DNA
.	O	O
We	O	O
now	O	O
show	O	O
that	O	O
the	O	O
core	O	O
contains	O	O
a	O	O
single	O	O
critical	O	O
c-Myb	DNA	DNA
binding	DNA	DNA
site	DNA	DNA
.	O	O
In	O	O
both	O	O
transiently	cell_line	O
cotransfected	cell_line	O
human	cell_line	cell_type
cells	cell_line	cell_type
and	O	O
stable	O	O
chromatin-integrated	cell_line	O
yeast	cell_line	O
cells	cell_line	O
,	O	O
c-Myb	protein	protein
strongly	O	O
transactivated	DNA	O
reporter	DNA	O
constructs	DNA	O
that	O	O
contained	O	O
polymerized	DNA	O
core	DNA	O
sequences	DNA	O
.	O	O
c-Myb	protein	protein
protein	protein	protein
was	O	O
strongly	O	O
evident	O	O
in	O	O
T	cell_type	O
lymphoblasts	cell_type	O
in	O	O
which	O	O
the	O	O
enhancer	DNA	O
was	O	O
active	O	O
and	O	O
was	O	O
localized	O	O
within	O	O
discrete	O	O
nuclear	O	O
structures	O	O
.	O	O
Fetal	O	O
murine	O	O
thymus	O	O
exhibited	O	O
a	O	O
striking	O	O
concordance	O	O
of	O	O
endogenous	O	protein
c-myb	DNA	protein
expression	O	O
with	O	O
that	O	O
of	O	O
mouse	DNA	O
ADA	DNA	O
and	O	O
human	DNA	O
ADA	DNA	O
LCR	DNA	DNA
-directed	O	O
transgene	O	O
expression	O	O
.	O	O
Point	O	O
mutation	O	O
of	O	O
the	O	O
c-Myb	DNA	DNA
site	DNA	DNA
within	O	O
the	O	O
intact	O	O
2.3-kb	protein	DNA
LCR	protein	DNA
severely	O	O
attenuated	O	O
enhancer	O	O
activity	O	O
in	O	O
transfections	O	O
and	O	O
LCR	DNA	O
activity	O	O
in	O	O
transgenic	cell_line	cell_type
thymocytes	cell_line	cell_type
.	O	O
Within	O	O
the	O	O
context	O	O
of	O	O
a	O	O
complex	DNA	O
enhancer	DNA	O
and	O	O
LCR	DNA	DNA
,	O	O
c-Myb	protein	protein
can	O	O
act	O	O
as	O	O
an	O	O
organizer	O	O
of	O	O
thymocyte-specific	DNA	DNA
gene	DNA	DNA
expression	O	O
via	O	O
a	O	O
single	O	O
binding	O	O
site.	O	O

A	O	O
regulatory	DNA	DNA
element	DNA	DNA
in	O	O
the	O	O
human	DNA	DNA
interleukin	DNA	DNA
2	DNA	DNA
gene	DNA	DNA
promoter	DNA	DNA
is	O	O
a	O	O
binding	DNA	O
site	DNA	O
for	O	O
the	O	O
zinc	protein	protein
finger	protein	protein
proteins	protein	protein
Sp1	protein	protein
and	O	O
EGR-1	protein	DNA
.	O	O
Activation	O	O
of	O	O
the	O	O
interleukin	DNA	protein
2	DNA	protein
(	DNA	O
IL-2	DNA	protein
)	DNA	O
gene	DNA	O
after	O	O
antigen	O	O
recognition	O	O
is	O	O
a	O	O
critical	O	O
event	O	O
for	O	O
T	O	O
cell	O	O
proliferation	O	O
and	O	O
effector	O	O
function.	O	O
Prior	O	O
studies	O	O
have	O	O
identified	O	O
several	O	O
transcription	protein	protein
factors	protein	protein
that	O	O
contribute	O	O
to	O	O
the	O	O
activity	O	O
of	O	O
the	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
in	O	O
stimulated	cell_type	O
T	cell_type	cell_type
lymphocytes	cell_type	cell_type
.	O	O
Here	O	O
we	O	O
describe	O	O
a	O	O
novel	O	DNA
regulatory	DNA	DNA
element	DNA	DNA
within	O	O
the	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
located	O	O
immediately	O	O
upstream	O	O
of	O	O
the	O	O
nuclear	DNA	protein
factor	DNA	protein
of	DNA	protein
activated	DNA	protein
T	DNA	protein
cell	DNA	protein
(	DNA	O
NFAT	DNA	protein
)	DNA	protein
domain	DNA	protein
.	O	O
This	O	O
region	O	O
(termed	O	O
the	O	O
zinc	DNA	protein
finger	DNA	protein
protein	DNA	protein
binding	DNA	protein
region	DNA	protein
(	O	O
ZIP	DNA	protein
))	O	O
serves	O	O
as	O	O
binding	O	O
site	O	O
for	O	O
two	O	O
differently	O	O
regulated	O	O
zinc	protein	protein
finger	protein	protein
proteins	protein	protein
:	O	O
the	O	O
constitutively	protein	O
expressed	protein	O
transcription	protein	protein
factor	protein	protein
Sp1	protein	protein
and	O	O
the	O	O
inducible	protein	O
early	protein	O
growth	protein	O
response	protein	O
protein	protein	O
EGR-1	protein	DNA
.	O	O
In	O	O
unstimulated	cell_type	cell_line
cells	cell_type	cell_line
which	O	O
do	O	O
not	O	O
secrete	O	O
IL-2	protein	protein
,	O	O
only	O	O
Sp1	protein	protein
binds	O	O
to	O	O
this	O	O
region,	O	O
while	O	O
in	O	O
stimulated	cell_line	O
IL-2	cell_line	cell_line
secreting	cell_line	cell_line
cells	cell_line	cell_line
the	O	O
inducible	protein	O
EGR-1	protein	DNA
protein	protein	DNA
recognizes	O	O
this	O	O
element.	O	O
In	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
the	O	O
ZIP	DNA	DNA
site	DNA	DNA
serves	O	O
as	O	O
an	O	O
activator	O	O
for	O	O
IL-2	protein	DNA
gene	O	DNA
expression	O	O
,	O	O
and	O	O
a	O	O
combination	O	O
of	O	O
ZIP	DNA	protein
and	O	O
NFAT	DNA	protein
binding	DNA	O
sites	DNA	O
is	O	O
required	O	O
for	O	O
maximal	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
activity	O	O
.	O	O
These	O	O
results	O	O
suggest	O	O
a	O	O
critical	O	O
role	O	O
of	O	O
the	O	O
ZIP	DNA	DNA
site	DNA	DNA
for	O	O
IL-2	DNA	DNA
promoter	DNA	DNA
activity	O	O
.	O	O

Activation	O	O
of	O	O
the	O	O
HIV-1	DNA	DNA
enhancer	DNA	DNA
by	O	O
the	O	O
LEF-1	protein	protein
HMG	protein	protein
protein	protein	protein
on	O	O
nucleosome-assembled	DNA	O
DNA	DNA	O
in	O	O
vitro.	O	O
Lymphoid	protein	O
enhancer-binding	protein	O
factor	protein	O
1	protein	O
(	O	O
LEF-1	protein	protein
)	O	O
is	O	O
a	O	O
regulatory	protein	O
high	protein	O
mobility	protein	O
group	protein	O
(HMG)	protein	O
protein	protein	O
that	O	O
activates	O	O
the	O	O
T	DNA	protein
cell	DNA	protein
receptor	DNA	protein
alpha	DNA	protein
(	DNA	O
TCR	DNA	protein
alpha	DNA	protein
)	DNA	O
enhancer	DNA	O
in	O	O
a	O	O
context-restricted	O	O
manner	O	O
in	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
.	O	O
In	O	O
this	O	O
paper	O	O
we	O	O
demonstrate	O	O
that	O	O
the	O	O
distal	O	DNA
region	O	DNA
of	O	O
the	O	O
human	DNA	O
immunodeficiency	DNA	O
virus-1	DNA	O
(	DNA	O
HIV-1	DNA	DNA
)	DNA	DNA
enhancer	DNA	DNA
,	O	O
which	O	O
contains	O	O
DNA-binding	DNA	DNA
sites	DNA	DNA
for	O	O
LEF-1	protein	protein
and	O	O
Ets-1,	O	O
also	O	O
provides	O	O
a	O	O
functional	O	O
context	O	O
for	O	O
activation	O	O
by	O	O
LEF-1	protein	protein
.	O	O
First,	O	O
we	O	O
show	O	O
that	O	O
mutations	O	O
in	O	O
the	O	O
LEF-1	DNA	DNA
-binding	DNA	DNA
site	DNA	DNA
inhibit	O	O
the	O	O
activity	O	O
of	O	O
multimerized	DNA	O
copies	DNA	O
of	O	O
the	O	O
HIV-1	DNA	DNA
enhancer	DNA	DNA
in	O	O
Jurkat	cell_line	cell_line
T	cell_line	cell_line
cells	cell_line	cell_line
,	O	O
and	O	O
that	O	O
LEF-1	protein	protein
/GAL4	protein	protein
can	O	O
activate	O	O
a	O	O
GAL4-substituted	DNA	DNA
HIV-1	DNA	DNA
enhancer	DNA	DNA
80-	O	O
to	O	O
100-fold	O	O
in	O	O
vivo.	O	O
Second,	O	O
recombinant	protein	O
LEF-1	protein	protein
is	O	O
shown	O	O
to	O	O
activate	O	O
HIV-1	O	O
transcription	O	O
on	O	O
chromatin-assembled	DNA	O
DNA	DNA	O
in	O	O
vitro.	O	O
By	O	O
using	O	O
a	O	O
nucleosome	protein	protein
-assembly	O	O
system	O	O
derived	O	O
from	O	O
Drosophila	O	O
embryos	O	O
,	O	O
we	O	O
find	O	O
that	O	O
the	O	O
packaging	O	O
of	O	O
DNA	O	O
into	O	O
chromatin	DNA	DNA
in	O	O
vitro	O	O
strongly	O	O
represses	O	O
HIV-1	O	O
transcription	O	O
and	O	O
that	O	O
repression	O	O
can	O	O
be	O	O
counteracted	O	O
efficiently	O	O
by	O	O
preincubation	O	O
of	O	O
the	O	O
DNA	O	O
with	O	O
LEF-1	protein	protein
(or	O	O
LEF-1	protein	protein
and	O	O
Ets-1	protein	protein
)	O	O
supplemented	O	O
with	O	O
fractions	O	O
containing	O	O
the	O	O
promoter-binding	protein	O
protein	protein	O
,	O	O
Sp1	protein	protein
.	O	O
Addition	O	O
of	O	O
TFE-3	protein	protein
,	O	O
which	O	O
binds	O	O
to	O	O
an	O	O
E-box	DNA	DNA
motif	DNA	DNA
upstream	O	O
of	O	O
the	O	O
LEF-1	O	protein
and	O	O
Ets-1	O	DNA
sites	O	DNA
,	O	O
further	O	O
augments	O	O
transcription	O	O
in	O	O
this	O	O
system.	O	O
Individually	O	O
or	O	O
collectively,	O	O
none	O	O
of	O	O
the	O	O
three	O	O
enhancer-binding	protein	protein
proteins	protein	protein
(	O	O
LEF-1	protein	protein
,	O	O
Ets-1	protein	protein
,	O	O
and	O	O
TFE-3	protein	protein
)	O	O
could	O	O
activate	O	O
transcription	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
Sp1	protein	protein
.	O	O
A	O	O
truncation	protein	O
mutant	protein	O
of	O	O
LEF-1	protein	protein
(	O	O
HMG-88	protein	protein
),	O	O
which	O	O
contains	O	O
the	O	O
HMG	protein	protein
box	protein	protein
but	O	O
lacks	O	O
the	O	O
trans-activation	protein	protein
domain	protein	protein
,	O	O
did	O	O
not	O	O
activate	O	O
transcription	O	O
from	O	O
nucleosomal	DNA	O
DNA	DNA	O
,	O	O
indicating	O	O
that	O	O
bending	O	O
of	O	O
DNA	O	O
by	O	O
the	O	O
HMG	protein	protein
domain	protein	protein
is	O	O
not	O	O
sufficient	O	O
to	O	O
activate	O	O
transcription	O	O
in	O	O
vitro.	O	O
We	O	O
conclude	O	O
that	O	O
transcription	O	O
activation	O	O
by	O	O
LEF-1	protein	protein
in	O	O
vitro	O	O
is	O	O
a	O	O
chromatin	DNA	DNA
-dependent	O	DNA
process	O	O
that	O	O
requires	O	O
a	O	O
functional	O	O
trans-activation	protein	protein
domain	protein	protein
in	O	O
addition	O	O
to	O	O
the	O	O
HMG	protein	protein
domain	protein	protein
.	O	O

HIV-1	protein	O
envelope	protein	O
glycoproteins	protein	protein
induce	O	O
activation	O	O
of	O	O
activated	O	protein
protein-1	protein	protein
in	O	O
CD4+	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
[published	O	O
erratum	O	O
appears	O	O
in	O	O
J	O	O
Biol	O	O
Chem	O	O
1995	O	O
Dec	O	O
1;270(48):29038]	O	O
Activation	O	O
of	O	O
CD4	cell_type	cell_type
positive	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
is	O	O
a	O	O
primary	O	O
requirement	O	O
for	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
(	O	O
HIV	O	O
)	O	O
entry	O	O
,	O	O
efficient	O	O
HIV	O	O
replication	O	O
,	O	O
and	O	O
progression	O	O
to	O	O
AIDS	O	O
,	O	O
Utilizing	O	O
CD4	cell_line	cell_type
positive	cell_line	cell_type
T	cell_line	cell_type
cell	cell_line	cell_type
lines	cell_line	O
and	O	O
purified	cell_type	O
T	cell_type	cell_type
cells	cell_type	cell_type
from	O	O
normal	O	O
individuals	O	O
,	O	O
we	O	O
have	O	O
demonstrated	O	O
that	O	O
native	protein	O
envelope	protein	O
glycoproteins	protein	protein
of	O	O
HIV	O	O
,	O	O
gp	protein	O
160	protein	O
,	O	O
can	O	O
induce	O	O
activation	O	O
of	O	O
transcription	protein	O
factor,	protein	protein
activated	protein	protein
protein-1	protein	protein
(	O	O
AP-1	protein	protein
).	O	O
The	O	O
stimulatory	O	O
effects	O	O
of	O	O
gp160	protein	O
are	O	O
mediated	O	O
through	O	O
the	O	O
CD4	protein	protein
molecule	protein	protein
,	O	O
since	O	O
treatment	O	O
of	O	O
gp160	protein	O
with	O	O
soluble	O	O
CD4-IgG	protein	protein
abrogates	O	O
its	O	O
activity,	O	O
and	O	O
CD4	cell_line	protein
negative	cell_line	protein
T	cell_line	protein
cell	cell_line	protein
lines	cell_line	protein
fail	O	O
to	O	O
be	O	O
stimulated	O	O
with	O	O
gp160	protein	protein
.	O	O
Immunoprecipitation	O	O
of	O	O
the	O	O
gp	protein	O
160	protein	protein
-induced	O	O
nuclear	O	O
extracts	O	O
with	O	O
polyclonal	protein	O
antibodies	protein	O
to	O	O
Fos	protein	O
and	O	O
Jun	protein	protein
proteins	protein	protein
indicates	O	O
that	O	O
AP-1	protein	protein
complex	protein	protein
is	O	O
comprised	O	O
of	O	O
members	O	O
of	O	O
these	O	O
family	O	O
of	O	O
proteins.	O	O
The	O	O
gp160	protein	O
-induced	protein	O
AP-1	protein	protein
complex	protein	protein
is	O	O
dependent	O	O
upon	O	O
protein	O	O
tyrosine	O	O
phosphorylation	O	O
and	O	O
is	O	O
protein	O	O
synthesis-independent	O	O
.	O	O
This	O	O
stimulation	O	O
can	O	O
also	O	O
be	O	O
abolished	O	O
by	O	O
inhibitors	O	O
of	O	O
protein	protein	protein
kinase	protein	protein
C	protein	protein
,	O	O
but	O	O
it	O	O
is	O	O
unaffected	O	O
by	O	O
calcium	O	O
channel	O	O
blocker	O	O
or	O	O
cyclosporine	O	O
A	O	O
.	O	O
This	O	O
gp160	protein	O
treatment	O	O
adversely	O	O
affects	O	O
the	O	O
functional	O	O
capabilities	O	O
of	O	O
T	cell_type	cell_type
cells	cell_type	cell_type
:	O	O
pre-treatment	O	O
of	O	O
CD4+	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
with	O	O
gp160	protein	O
for	O	O
4	O	O
h	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
inhibited	O	O
anti-CD3	protein	protein
-induced	O	O
interleukin-2	protein	protein
secretion	O	O
.	O	O
Effects	O	O
similar	O	O
to	O	O
gp160	protein	O
were	O	O
seen	O	O
with	O	O
anti-CD4	protein	protein
mAb	protein	protein
.	O	O
The	O	O
aberrant	O	O
activation	O	O
of	O	O
AP-1	protein	protein
by	O	O
gp160	protein	O
in	O	O
CD4	cell_type	cell_type
positive	cell_type	cell_type
T	cell_type	cell_type
cells	cell_type	cell_type
could	O	O
result	O	O
in	O	O
up-regulation	O	O
of	O	O
cytokines	protein	protein
containing	O	O
AP-1	DNA	DNA
sites	DNA	DNA
,	O	O
e.g.	O	O
interleukin-3	protein	protein
and	O	O
granulocyte	protein	protein
macrophage	protein	protein
colony-stimulating	protein	protein
factor	protein	protein
,	O	O
and	O	O
concurrently	O	O
lead	O	O
to	O	O
T	cell_type	O
cell	cell_type	O
unresponsiveness	O	O
by	O	O
inhibiting	O	O
interleukin-2	protein	protein
secretion	O	O
.	O	O
